<SEC-DOCUMENT>0001809519-26-000152.txt : 20260805
<SEC-HEADER>0001809519-26-000152.hdr.sgml : 20260805
<ACCEPTANCE-DATETIME>20260805160902
ACCESSION NUMBER:		0001809519-26-000152
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		56
CONFORMED PERIOD OF REPORT:	20260630
FILED AS OF DATE:		20260805
DATE AS OF CHANGE:		20260805

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GoodRx Holdings, Inc.
		CENTRAL INDEX KEY:			0001809519
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
		ORGANIZATION NAME:           	06 Technology
		EIN:				475104396
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39549
		FILM NUMBER:		261243518

	BUSINESS ADDRESS:	
		STREET 1:		2701 OLYMPIC BOULEVARD
		CITY:			SANTA MONICA
		STATE:			CA
		ZIP:			90404
		BUSINESS PHONE:		(855) 268-2822

	MAIL ADDRESS:	
		STREET 1:		2701 OLYMPIC BOULEVARD
		CITY:			SANTA MONICA
		STATE:			CA
		ZIP:			90404
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>gdrx-20260630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e2c6b-4e55-7a2c-b1a0-3572b2490625,g:6d96a486-c103-4d24-b5e6-d8e2b8fbb013,d:91b19d4037914b6f9fbe39bcf6851dbe-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:us-gaap="http://fasb.org/us-gaap/2026" xmlns:srt="http://fasb.org/srt/2026" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ecd="http://xbrl.sec.gov/ecd/2026" xmlns:gdrx="http://goodrx.com/20260630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/><title>gdrx-20260630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-26">0001809519</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-27">12-31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-28">2026</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-29">Q2</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-30">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="gdrx-20260630.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>gdrx:segment</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="counterparty"><xbrli:measure>gdrx:counterparty</xbrli:measure></xbrli:unit><xbrli:unit id="plaintiff"><xbrli:measure>gdrx:plaintiff</xbrli:measure></xbrli:unit><xbrli:unit id="case"><xbrli:measure>gdrx:case</xbrli:measure></xbrli:unit><xbrli:unit id="defendant"><xbrli:measure>gdrx:Defendant</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-07-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-07-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:ResearchAndDevelopmentExpense</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:ResearchAndDevelopmentExpense</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:ResearchAndDevelopmentExpense</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:ResearchAndDevelopmentExpense</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:SellingAndMarketingExpense</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:SellingAndMarketingExpense</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:SellingAndMarketingExpense</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:SellingAndMarketingExpense</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:GeneralAndAdministrativeExpense</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:GeneralAndAdministrativeExpense</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:GeneralAndAdministrativeExpense</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:GeneralAndAdministrativeExpense</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gdrx:CustomerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gdrx:CustomerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gdrx:CustomerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gdrx:MinorityEquityInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">gdrx:OperatingLeaseRightOfUseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">gdrx:OperatingLeaseRightOfUseAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gdrx:VividRxClearRxIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-13</xbrli:startDate><xbrli:endDate>2025-01-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gdrx:VitacarePrescriptionServicesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gdrx:VitacarePrescriptionServicesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gdrx:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gdrx:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gdrx:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gdrx:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gdrx:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gdrx:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gdrx:A2024TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gdrx:A2024TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gdrx:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gdrx:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-02</xbrli:startDate><xbrli:endDate>2023-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">gdrx:PrivacyProtectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-02</xbrli:startDate><xbrli:endDate>2023-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">gdrx:ElectronicCommunicationPrivacyActPrivacyProtectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-02</xbrli:startDate><xbrli:endDate>2023-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gdrx:SDFLClassActionMatterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-27</xbrli:startDate><xbrli:endDate>2023-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gdrx:NDCAClassActionMatterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-25</xbrli:startDate><xbrli:endDate>2024-11-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gdrx:SDFLClassActionMatterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gdrx:SDFLClassActionMatterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:PrepaidExpenseAndOtherAssetsCurrent</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:PrepaidExpenseAndOtherAssetsCurrent</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:PrescriptionTransactionsRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:PrescriptionTransactionsRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:PrescriptionTransactionsRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:PrescriptionTransactionsRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:SubscriptionRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:SubscriptionRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:SubscriptionRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:SubscriptionRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:PharmaManufacturerSolutionsRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:PharmaManufacturerSolutionsRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:PharmaManufacturerSolutionsRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:PharmaManufacturerSolutionsRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:OtherRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:OtherRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:OtherRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:OtherRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">gdrx:NewRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">gdrx:NewRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">gdrx:FranciscoPartnersStockPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">gdrx:CommonClassAAndClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">gdrx:IdeaMenLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">gdrx:CommonClassAAndClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">gdrx:SpectrumStockPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">gdrx:CommonClassAAndClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">gdrx:CommonClassAAndClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">gdrx:CommonClassAAndClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">gdrx:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">gdrx:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">gdrx:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001809519</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">gdrx:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-261 f-262 f-263 f-264 f-282" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"/><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-315 f-316 f-317 f-318 f-319 f-320 f-321 f-322 f-323 f-324" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"/><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-341 f-342" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"/></ix:resources></ix:header></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="position:absolute;top:45pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_1"></div><div style="position:var(--position);top:45pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:495pt"/></tr><tr style="height:3pt"><td style="border-bottom:3pt double #000;font-size:0;text-align:left;vertical-align:top"/></tr></tbody></table></div></div></div><div style="line-height:15pt;position:var(--position);top:56pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:15pt;font-style:normal;font-weight:bold;left:246.44pt;position:var(--position);white-space:pre">UNITED STATES</span></div><div style="line-height:15pt;position:var(--position);top:74pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:15pt;font-style:normal;font-weight:bold;left:146.9pt;position:var(--position);white-space:pre">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="line-height:10pt;position:var(--position);top:92pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:bold;left:243.26pt;position:var(--position);white-space:pre">WASHINGTON, D.C. 20549</span></div><div style="line-height:10pt;position:var(--position);top:104pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:217.04pt;position:var(--position);white-space:pre">________________________________</span></div><div style="font-size:15pt;line-height:15pt;position:var(--position);top:122pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:15pt;font-style:normal;font-weight:bold;left:265.18pt;position:var(--position);white-space:pre">FORM </span><span style="font-family:'Arial', sans-serif;font-size:15pt;font-style:normal;font-weight:bold;left:313.48pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric></span></div><div style="line-height:10pt;position:var(--position);top:140pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:217.04pt;position:var(--position);white-space:pre">________________________________</span></div><div style="line-height:8pt;position:var(--position);top:155pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre">(Mark One)</span></div><div style="position:var(--position);top:167.6pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:494.25pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:23.25pt"/><td style="padding:0;width:471pt"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:23.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:23.25pt"><span style="color:#000000;font-family:'Wingdings', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">x</ix:nonNumeric></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:23.25pt;position:var(--position);width:471pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:471pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size:12pt;line-height:8pt;position:var(--position);top:189.85pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:221pt;position:var(--position);white-space:pre">For the quarterly period ended </span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:339.06pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">June 30, 2026</ix:nonNumeric></span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:391pt;position:var(--position);white-space:pre"> </span></div><div style="line-height:8pt;position:var(--position);top:202.45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:300pt;position:var(--position);white-space:pre">OR</span></div><div style="position:var(--position);top:215.05pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:494.25pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:23.25pt"/><td style="padding:0;width:471pt"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:23.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:23.25pt"><span style="color:#000000;font-family:'Wingdings', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">o</ix:nonNumeric></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:23.25pt;position:var(--position);width:471pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:471pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height:8pt;position:var(--position);top:238.3pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:215pt;position:var(--position);white-space:pre">For the transition period from ______ to ______.</span></div><div style="font-size:12pt;line-height:8pt;position:var(--position);top:251.9pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:236.3pt;position:var(--position);white-space:pre">Commission File Number: </span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:337.52pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-39549</ix:nonNumeric></span></div><div style="line-height:10pt;position:var(--position);top:261.5pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:217.04pt;position:var(--position);white-space:pre">________________________________</span></div><div style="font-size:20pt;line-height:20pt;position:var(--position);top:276.5pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:20pt;font-style:normal;font-weight:bold;left:198.84pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">GoodRx Holdings, Inc.</ix:nonNumeric></span></div><div style="line-height:8pt;position:var(--position);top:300.5pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:204.79pt;position:var(--position);white-space:pre">(Exact Name of Registrant as Specified in its Charter)</span></div><div style="line-height:10pt;position:var(--position);top:310.1pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:217.04pt;position:var(--position);white-space:pre">________________________________</span></div><div style="position:var(--position);top:325.1pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:489pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:244.5pt"/><td style="padding:0;width:244.5pt"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:244.5pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:244.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:104.71pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:244.5pt;position:var(--position);width:244.5pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:244.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:100.94pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">47-5104396</ix:nonNumeric></span></div></div></div></td></tr><tr style="height:20.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:14.25pt;width:244.5pt"><div><div style="line-height:7pt;position:var(--position);top:3.75pt;width:244.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:74.28pt;position:var(--position);text-decoration:none;white-space:pre">(State or other jurisdiction of</span></div><div style="line-height:7pt;position:var(--position);top:12.15pt;width:244.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:72.34pt;position:var(--position);text-decoration:none;white-space:pre">incorporation or organization)</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:244.5pt;position:var(--position);top:14.25pt;width:244.5pt"><div><div style="line-height:7pt;position:var(--position);top:3.75pt;width:244.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:95.45pt;position:var(--position);text-decoration:none;white-space:pre">(I.R.S. Employer</span></div><div style="line-height:7pt;position:var(--position);top:12.15pt;width:244.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:92.73pt;position:var(--position);text-decoration:none;white-space:pre">Identification No.)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:34.5pt;width:244.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:244.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:122.25pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:244.5pt;position:var(--position);top:34.5pt;width:244.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:244.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:122.25pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:48.75pt;width:244.5pt"><div><div style="font-size:12pt;line-height:8pt;position:var(--position);top:4.65pt;width:244.5pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:75.85pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">2701 Olympic Boulevard</ix:nonNumeric></span></div><div style="font-size:12pt;line-height:8pt;position:var(--position);top:14.25pt;width:244.5pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:88.51pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Santa Monica</ix:nonNumeric></span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:140pt;position:var(--position);white-space:pre">, </span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:144.44pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-11">CA</ix:nonNumeric></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:244.5pt;position:var(--position);top:48.75pt;width:244.5pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:244.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:111.15pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">90404</ix:nonNumeric></span></div></div></div></td></tr><tr style="height:12pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:72pt;width:244.5pt"><div><div style="line-height:7pt;position:var(--position);top:3.75pt;width:244.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:56.97pt;position:var(--position);text-decoration:none;white-space:pre">(Address of principal executive offices)</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:244.5pt;position:var(--position);top:72pt;width:244.5pt"><div><div style="line-height:7pt;position:var(--position);top:3.75pt;width:244.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:104.97pt;position:var(--position);text-decoration:none;white-space:pre">(Zip Code)</span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size:12pt;line-height:8pt;position:var(--position);top:417.1pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:278.7pt;position:var(--position);white-space:pre">(</span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:281.36pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">855</ix:nonNumeric></span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:294.68pt;position:var(--position);white-space:pre">) </span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:299.56pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">268-2822</ix:nonNumeric></span></div><div style="line-height:8pt;position:var(--position);top:426.7pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:204.8pt;position:var(--position);white-space:pre">(Registrant&#8217;s telephone number, including area code)</span></div><div style="line-height:8pt;position:var(--position);top:439.3pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:299.12pt;position:var(--position);white-space:pre">N/A</span></div><div style="line-height:8pt;position:var(--position);top:448.9pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:149.96pt;position:var(--position);white-space:pre">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="line-height:10pt;position:var(--position);top:458.5pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:217.04pt;position:var(--position);white-space:pre">________________________________</span></div><div style="line-height:8pt;position:var(--position);top:473.5pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);white-space:pre">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="position:var(--position);top:486.1pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:196.5pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:96pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:196.5pt"/></tr><tr style="height:23.25pt"><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:196.5pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:196.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:63.85pt;position:var(--position);text-decoration:none;white-space:pre">Title of each class</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:196.5pt;position:var(--position);width:3pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:3pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:0.39pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:199.5pt;position:var(--position);width:96pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:96pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:33.35pt;position:var(--position);text-decoration:none;white-space:pre">Trading</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:96pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:28.69pt;position:var(--position);text-decoration:none;white-space:pre">Symbol(s)</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:295.5pt;position:var(--position);width:3pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:3pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:0.39pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:298.5pt;position:var(--position);width:196.5pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:196.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:13.91pt;position:var(--position);text-decoration:none;white-space:pre">Name of each exchange on which registered</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:23.25pt;width:196.5pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:196.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:5.89pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-15">Class A common stock, $0.0001 par value per share</ix:nonNumeric></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:196.5pt;position:var(--position);top:23.25pt;width:3pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:3pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:0.39pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:199.5pt;position:var(--position);top:23.25pt;width:96pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:96pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:36.45pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-16">GDRX</ix:nonNumeric></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:295.5pt;position:var(--position);top:23.25pt;width:3pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:3pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:0.39pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:298.5pt;position:var(--position);top:23.25pt;width:196.5pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:196.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:43.63pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-17">The Nasdaq Stock Market LLC</ix:nonNumeric></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height:8pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:531.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);white-space:pre;width:458.85pt">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities</span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);white-space:pre;width:2.22pt"> </span></div><div style="line-height:8pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:541.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.86pt">Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and</span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);white-space:pre;width:2.22pt"> </span></div><div style="font-size:12pt;line-height:8pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:550.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:244.49pt">(2) has been subject to such filing requirements for the past 90 days. </span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:302.99pt;position:var(--position);text-decoration:none;white-space:pre;width:13.04pt"><ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric></span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:316.03pt;position:var(--position);white-space:pre;width:2.22pt"> </span><span style="font-family:'Wingdings', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:318.25pt;position:var(--position);white-space:pre;width:8.48pt">x</span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:326.73pt;position:var(--position);white-space:pre;width:14.65pt"> No </span><span style="font-family:'Wingdings', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:341.38pt;position:var(--position);white-space:pre;width:7.12pt">o</span></div><div style="line-height:8pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:563.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);white-space:pre;width:458.95pt">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted</span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);white-space:pre;width:2.22pt"> </span></div><div style="line-height:8pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:573pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.84pt">pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the</span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);white-space:pre;width:2.22pt"> </span></div><div style="font-size:12pt;line-height:8pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:582.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:158.34pt">registrant was required to submit such files). </span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:216.84pt;position:var(--position);text-decoration:none;white-space:pre;width:13.04pt"><ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric></span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:229.88pt;position:var(--position);white-space:pre;width:2.22pt"> </span><span style="font-family:'Wingdings', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:232.1pt;position:var(--position);white-space:pre;width:8.48pt">x</span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:240.58pt;position:var(--position);white-space:pre;width:14.65pt"> No </span><span style="font-family:'Wingdings', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:255.23pt;position:var(--position);white-space:pre;width:7.12pt">o</span></div><div style="line-height:8pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:595.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);white-space:pre;width:458.94pt">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller</span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.22pt"> </span></div><div style="line-height:8pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:604.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.99pt">reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting</span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);white-space:pre;width:2.22pt"> </span></div><div style="line-height:8pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:614.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:279.12pt">company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="position:var(--position);top:627pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:134.25pt"/><td style="padding:0;width:109.5pt"/><td style="padding:0;width:8.25pt"/><td style="padding:0;width:228.75pt"/><td style="padding:0;width:14.25pt"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:134.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:134.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Large accelerated filer</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:134.25pt;position:var(--position);width:109.5pt"><div><div style="line-height:8pt;position:var(--position);top:6.59pt;width:109.5pt"><span style="color:#000000;font-family:'Wingdings', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">o</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:252pt;position:var(--position);width:228.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:228.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Accelerated filer</ix:nonNumeric></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:480.75pt;position:var(--position);width:14.25pt"><div><div style="line-height:8pt;position:var(--position);top:6.59pt;width:14.25pt"><span style="color:#000000;font-family:'Wingdings', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">x</span></div></div></div></td></tr><tr style="height:3pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:17.25pt;width:134.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:134.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Non-accelerated filer</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:134.25pt;position:var(--position);top:17.25pt;width:109.5pt"><div><div style="line-height:8pt;position:var(--position);top:6.59pt;width:109.5pt"><span style="color:#000000;font-family:'Wingdings', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">o</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:252pt;position:var(--position);top:17.25pt;width:228.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:228.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Smaller reporting company</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:480.75pt;position:var(--position);top:17.25pt;width:14.25pt"><div><div style="line-height:8pt;position:var(--position);top:6.59pt;width:14.25pt"><span style="color:#000000;font-family:'Wingdings', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-21">o</ix:nonNumeric></span></div></div></div></td></tr><tr style="height:3pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:34.5pt;width:134.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:134.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Emerging growth company</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:134.25pt;position:var(--position);top:34.5pt;width:109.5pt"><div><div style="line-height:8pt;position:var(--position);top:6.59pt;width:109.5pt"><span style="color:#000000;font-family:'Wingdings', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-22">o</ix:nonNumeric></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr></tbody></table></div></div></div><div style="line-height:8pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:683.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);white-space:pre;width:458.93pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for</span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);white-space:pre;width:2.22pt"> </span></div><div style="line-height:8pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:693.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:433.77pt">complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-family:'Wingdings', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:492.27pt;position:var(--position);white-space:pre;width:7.12pt">o</span></div><div style="font-size:12pt;line-height:8pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:705.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);white-space:pre;width:416.04pt">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="font-family:'Wingdings', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:510.54pt;position:var(--position);text-decoration:none;white-space:pre;width:7.12pt"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-23">o</ix:nonNumeric></span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:517.6600000000001pt;position:var(--position);white-space:pre;width:14.65pt"> No </span><span style="font-family:'Wingdings', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:532.31pt;position:var(--position);white-space:pre;width:8.48pt">x</span></div><div style="font-size:12pt;line-height:8pt;position:var(--position);top:718.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);white-space:pre">As of</span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:112.71000000000001pt;position:var(--position);text-decoration:none;white-space:pre"> </span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:114.93pt;position:var(--position);text-decoration:none;white-space:pre">July&#160;28, 2026</span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:162.44pt;position:var(--position);white-space:pre">, the registrant had </span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:231.25pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonFraction unitRef="shares" contextRef="c-2" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-24">107,181,201</ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:275.65pt;position:var(--position);white-space:pre"> shares of Class A common stock, $0.0001 par value per share, and </span></div><div style="font-size:12pt;line-height:8pt;position:var(--position);top:728.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-25">233,964,187</ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:102.9pt;position:var(--position);white-space:pre"> shares of Class B common stock, $0.0001 par value per share, outstanding.</span></div><div style="position:var(--position);top:737.75pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:494.25pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:494.25pt"/></tr><tr style="height:3pt"><td style="border-bottom:3pt double #000;font-size:0;text-align:left;vertical-align:top"/></tr></tbody></table></div></div></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="position:absolute;top:45pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_7"></div><div style="line-height:9pt;position:var(--position);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:228.33pt;position:var(--position);white-space:pre">FORWARD-LOOKING STATEMENTS</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:67.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.9pt">This Quarterly Report on Form 10-Q contains forward-looking statements. We intend such forward-looking statements</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:78.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.83pt">to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:89.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.97pt">1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). All</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:100.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.93pt">statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q may be forward-looking</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:111pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.85pt">statements. In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expects,&#8221;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:121.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.91pt">&#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;could,&#8221; &#8220;intends,&#8221; &#8220;targets,&#8221; &#8220;projects,&#8221; &#8220;contemplates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;forecasts,&#8221; &#8220;predicts,&#8221;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:132.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.97pt">&#8220;potential&#8221; or &#8220;continue&#8221; or the negative of these terms or other similar expressions. Forward-looking statements contained in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:143.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:109.43pt">this Quarterly Report on Fo</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:167.93pt;position:var(--position);text-decoration:none;white-space:pre;width:69.7pt">rm 10-Q include, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:237.63pt;position:var(--position);text-decoration:none;white-space:pre;width:84.95pt">but are not limited to,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:322.58pt;position:var(--position);text-decoration:none;white-space:pre;width:230.9pt"> statements regarding our future results of operations and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:154.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">financial position, industry and business trends, the anticipated impact of ongoing changes in the U.S. retail pharmacy</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:165pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">landscape and macroeconomic environment, the impact of store closures and the announced bankruptcy of one of our retail</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:175.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">partners on our business, the potential impact of the new government-sponsored direct-to-consumer platform called</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:186.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">&#8220;TrumpRx.gov&#8221; and other evolving federal initiatives on our business, our value proposition, our collaborations and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:197.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:353.87pt">partnerships with third parties, including our integrated savings program, the impact of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:412.37pt;position:var(--position);text-decoration:none;white-space:pre;width:12.5pt">the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:424.87pt;position:var(--position);text-decoration:none;white-space:pre;width:128.48pt"> volume reduction in one of our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:208.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt">integrated savings programs, the anticipated expansion of our condition-specific subscription program, our direct contracting</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:219pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt">approach with select pharmacies, the impact of the sunset of certain of our offerings, anticipated impacts of our restructuring</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:229.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt">and cost saving initiatives, stock compensation, our stock repurchase program, realizability of deferred tax assets, impacts</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:240.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">from recent tax legislation, potential outcomes and estimated impacts of certain legal proceedings, our business strategy,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:251.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:317.35pt">our plans, market opportunity and growth and our objectives for future operation</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:375.85pt;position:var(--position);white-space:pre;width:7pt">s.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:268.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.87pt">The forward-looking statements in this Quarterly Report on Form 10-Q are only predictions. We have based these</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:279pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.98pt">forward-looking statements largely on our current expectations and projections about future events and financial trends that</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:289.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.93pt">we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:300.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.95pt">and unknown risks, uncertainties and other important factors that may cause our actual results, performance or</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:311.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.88pt">achievements to be materially different from any future results, performance or achievements expressed or implied by the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:322.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.87pt">forward-looking statements, including, but not limited to, risks related to our limited operating history and early stage of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:333pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.92pt">growth; our recent growth rates may not be sustainable or indicative of future growth; our ability to achieve broad market</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:343.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.96pt">education and change consumer purchasing habits; our general ability to continue to attract, acquire and retain consumers</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:354.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.89pt">in a cost-effective manner; our significant reliance on our prescription transactions offering and ability to expand our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:365.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.89pt">offerings; changes in medication pricing and the significant impact of pricing structures negotiated by industry participants;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:376.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.91pt">our general inability to control the categories and types of prescriptions for which we can offer savings or discounted prices;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:387pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.87pt">our reliance on a limited number of industry participants, including pharmacy benefit managers, pharmacies, and pharma</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:397.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.97pt">manufacturers; the competitive nature of our industry; risks related to pandemics, epidemics or outbreak of infectious</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:408.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.88pt">disease; the accuracy of our estimate of our addressable market and other operational metrics; our ability to respond to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:419.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.98pt">changes in the market for prescription pricing and to maintain and expand the use of GoodRx codes; our ability to maintain</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:430.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.95pt">positive perception of our platform or maintain and enhance our brand; risks related to any failure to maintain effective</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:441pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.95pt">internal control over &#64257;nancial reporting; risks related to use of social media, emails, text messages and other messaging</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:451.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.89pt">channels as part of our marketing strategy; our dependence on our information technology systems and those of our third-</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:462.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.98pt">party vendors, and risks related to any failure or significant disruptions thereof; risks related to the use of AI and machine</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:473.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.87pt">learning in our business; risks related to government regulation of the internet, e-commerce, consumer data and privacy,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:484.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.89pt">information technology and cybersecurity; risks related to a decrease in consumer willingness to receive correspondence or</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:495pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.83pt">any technical, legal or any other restrictions to send such correspondence; risks related to any failure to comply with</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:505.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.93pt">applicable data protection, privacy and security, advertising and consumer protection laws, regulations, standards, and other</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:516.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.95pt">requirements; our ability to utilize our net operating loss carryforwards and certain other tax attributes; the risk that we may</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:527.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.92pt">be unable to realize expected benefits from our restructuring and cost reduction efforts; our ability to attract, develop,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:538.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.86pt">motivate and retain well-qualified employees; risks related to our acquisition strategy; risks related to our debt arrangements;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:549pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.83pt">interruptions or delays in service on our apps or websites or any undetected errors or design faults; our reliance on third-</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:559.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.99pt">party platforms to distribute our platform and offerings, including software as-a-service technologies; systems failures or</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:570.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.86pt">other disruptions in the operations of these parties on which we depend; risks related to climate change; the increasing</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:581.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.91pt">focus on environmental sustainability and social initiatives; risks related to our intellectual property; risks related to operating</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:592.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.96pt">in the healthcare industry; risks related to our organizational structure; litigation related risks; our ability to accurately</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:603pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.99pt">forecast revenue and appropriately plan our expenses in the future; risks related to general economic factors, natural</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:613.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.97pt">disasters or other unexpected events; risks related to the healthcare reform legislation and other proposed or future changes</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:624.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.97pt">impacting the healthcare industry and healthcare spending which may adversely affect our business, financial condition and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:635.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.82pt">results of operations; as well as the other important factors discussed in the sections entitled &#8220;Risk Factors&#8221; of our Annual</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3199999999999pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:646.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:188.91pt">Report on Form 10-K for the fiscal year ended </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:247.41pt;position:var(--position);text-decoration:none;white-space:pre;width:79.75pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:327.16pt;position:var(--position);white-space:pre;width:8.87pt"> (&#8220;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:336.03pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:356.03pt;position:var(--position);white-space:pre;width:27.86pt"> 10-K&#8221;)</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:383.89pt;position:var(--position);white-space:pre;width:2.89pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:386.78pt;position:var(--position);white-space:pre;width:166.62pt">and in our other filings with the Securities</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:657pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.9pt">and Exchange Commission (&#8220;SEC&#8221;). The forward-looking statements in this Quarterly Report on Form 10-Q are based upon</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:667.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.93pt">information available to us as of the date of this Quarterly Report on Form 10-Q, and while we believe such information</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:678.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.89pt">forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:689.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.83pt">not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:700.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.95pt">information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:711pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:46.49pt">statements.</span></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.83pt">You should read this Quarterly Report on Form 10-Q and the documents that we reference in this Quarterly Report on</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:55.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.95pt">Form 10-Q and have filed as exhibits to this Quarterly Report on Form 10-Q with the understanding that our actual future</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:66.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.92pt">results, levels of activity, performance and achievements may be materially different from what we expect. We qualify all of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:77.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.94pt">our forward-looking statements by these cautionary statements. These forward-looking statements speak only as of the date</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:88.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.83pt">of this Quarterly Report on Form 10-Q. Except as required by applicable law, we do not plan to publicly update or revise any</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:99pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.86pt">forward-looking statements contained in this Quarterly Report on Form 10-Q, whether as a result of any new information,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:109.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:105.95pt">future events or otherwise.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:164.45pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:126.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.9pt">We periodically post information that may be important to investors on our investor relations website at https://</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:137.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.93pt">investors.goodrx.com. We intend to use our website as a means of disclosing material non-public information and for</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:148.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.89pt">complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:159pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.9pt">encouraged to consult our website regularly for important information, in addition to following GoodRx&#8217;s press releases,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:169.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.98pt">filings with the SEC and public conference calls and webcasts. The information contained on, or that may be accessed</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:180.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:455.77pt">through, our website is not incorporated by reference into, and is not a part of, this Quarterly Report on Form 10-Q.</span></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="position:absolute;top:45pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_10"></div><div style="line-height:9pt;position:var(--position);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:268.05pt;position:var(--position);white-space:pre">Table of Contents</span></div><div style="position:var(--position);top:67.8pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:494.25pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:52.5pt"/><td style="padding:0;width:408pt"/><td style="padding:0;width:33.75pt"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:460.5pt;position:var(--position);width:33.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:33.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:6.13pt;position:var(--position);text-decoration:none;white-space:pre">Page</span></div></div></div></td></tr><tr style="height:15.75pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:30pt;width:52.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:52.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_13">PART I.</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:52.5pt;position:var(--position);top:30pt;width:408pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:408pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_13">FINANCIAL INFORMATION</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:44.25pt;width:52.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:52.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_16">Item 1.</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:52.5pt;position:var(--position);top:44.25pt;width:408pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:408pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_16">Financial Statements</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:460.5pt;position:var(--position);top:44.25pt;width:33.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:33.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:14.37pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_16">1</a></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:52.5pt;position:var(--position);top:58.5pt;width:408pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:408pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_19">Condensed Consolidated Balance Sheets</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:460.5pt;position:var(--position);top:58.5pt;width:33.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:33.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:14.37pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_19">1</a></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:52.5pt;position:var(--position);top:72.75pt;width:408pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:408pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_22">Condensed Consolidated Statements of Operations</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:460.5pt;position:var(--position);top:72.75pt;width:33.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:33.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:14.37pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_22">2</a></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:52.5pt;position:var(--position);top:87pt;width:408pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:408pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_25">Condensed Consolidated Statements of Stockholders&#8217; Equity</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:460.5pt;position:var(--position);top:87pt;width:33.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:33.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:14.37pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_25">3</a></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:52.5pt;position:var(--position);top:101.25pt;width:408pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:408pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_31">Condensed Consolidated Statements of Cash Flows</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:460.5pt;position:var(--position);top:101.25pt;width:33.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:33.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:14.37pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_31">5</a></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:52.5pt;position:var(--position);top:115.5pt;width:408pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:408pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_34">Notes to Condensed Consolidated Financial Statements</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:460.5pt;position:var(--position);top:115.5pt;width:33.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:33.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:14.37pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_34">7</a></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:129.75pt;width:52.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:52.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_73">Item 2.</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:52.5pt;position:var(--position);top:129.75pt;width:408pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:408pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_73">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:460.5pt;position:var(--position);top:129.75pt;width:33.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:33.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.87pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_73">15</a></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:144pt;width:52.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:52.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_109">Item 3.</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:52.5pt;position:var(--position);top:144pt;width:408pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:408pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_109">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:460.5pt;position:var(--position);top:144pt;width:33.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:33.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.87pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_109">24</a></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:158.25pt;width:52.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:52.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_112">Item 4.</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:52.5pt;position:var(--position);top:158.25pt;width:408pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:408pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_112">Controls and Procedures</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:460.5pt;position:var(--position);top:158.25pt;width:33.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:33.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.87pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_112">24</a></span></div></div></div></td></tr><tr style="height:15.75pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:188.25pt;width:52.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:52.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_115">PART II.</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:52.5pt;position:var(--position);top:188.25pt;width:408pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:408pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_115">OTHER INFORMATION</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:202.5pt;width:52.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:52.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_118">Item 1.</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:52.5pt;position:var(--position);top:202.5pt;width:408pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:408pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_118">Legal Proceedings</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:460.5pt;position:var(--position);top:202.5pt;width:33.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:33.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.87pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_118">25</a></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:216.75pt;width:52.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:52.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_121">Item 1A.</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:52.5pt;position:var(--position);top:216.75pt;width:408pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:408pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_121">Risk Factors</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:460.5pt;position:var(--position);top:216.75pt;width:33.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:33.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.87pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_121">25</a></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:231pt;width:52.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:52.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_124">Item 2.</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:52.5pt;position:var(--position);top:231pt;width:408pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:408pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_124">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:460.5pt;position:var(--position);top:231pt;width:33.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:33.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.87pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_124">25</a></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:245.25pt;width:52.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:52.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_127">Item 3.</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:52.5pt;position:var(--position);top:245.25pt;width:408pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:408pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_127">Defaults Upon Senior Securities</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:460.5pt;position:var(--position);top:245.25pt;width:33.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:33.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.87pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_127">25</a></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:259.5pt;width:52.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:52.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_130">Item 4.</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:52.5pt;position:var(--position);top:259.5pt;width:408pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:408pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_130">Mine Safety Disclosures</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:460.5pt;position:var(--position);top:259.5pt;width:33.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:33.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.87pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_130">25</a></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:273.75pt;width:52.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:52.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_133">Item 5.</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:52.5pt;position:var(--position);top:273.75pt;width:408pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:408pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_133">Other Information</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:460.5pt;position:var(--position);top:273.75pt;width:33.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:33.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.87pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_133">25</a></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:288pt;width:52.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:52.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_139">Item 6.</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:52.5pt;position:var(--position);top:288pt;width:408pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:408pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_139">Exhibits</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:460.5pt;position:var(--position);top:288pt;width:33.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:33.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.87pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_139">26</a></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:52.5pt;position:var(--position);top:302.25pt;width:408pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:408pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_142">Signatures</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:460.5pt;position:var(--position);top:302.25pt;width:33.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:33.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.87pt;position:var(--position);text-decoration:none;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_142">27</a></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:303.22pt;position:var(--position);white-space:pre">1</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="position:absolute;top:45pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_13"></div><div style="line-height:9pt;position:var(--position);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre">PART I. FINANCIAL INFORMATION</span></div><div style="position:absolute;top:55.8pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_16"></div><div style="line-height:9pt;position:var(--position);top:55.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre">Item 1. Financial Statements</span></div><div style="position:absolute;top:78.6pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_19"></div><div style="line-height:9pt;position:var(--position);top:78.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:257.8pt;position:var(--position);white-space:pre">GoodRx Holdings, Inc.</span></div><div style="line-height:9pt;position:var(--position);top:89.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:217.33pt;position:var(--position);white-space:pre">Condensed Consolidated Balance Sheets</span></div><div style="line-height:9pt;position:var(--position);top:100.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:282.52pt;position:var(--position);white-space:pre">(Unaudited)</span></div><div style="position:var(--position);top:123pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:331.5pt"/><td style="padding:0;width:80.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:80.25pt"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:331.5pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands, except par values)</span></div></div></div></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);width:80.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:14.15pt;position:var(--position);text-decoration:none;white-space:pre">June 30, 2026</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);width:80.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:4.16pt;position:var(--position);text-decoration:none;white-space:pre">December 31, 2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:14.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Assets</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:28.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Current assets</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:42.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Cash and cash equivalents</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:42.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-31">296,113</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:42.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-32">261,820</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:57pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Accounts receivable, net</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:57pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-33">182,140</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:57pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-34">235,746</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:71.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Prescription reimbursement assets</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:71.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:33.88pt"></span></span><span style="left:36.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="gdrx:PrescriptionReimbursementAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-35">1,076,012</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:71.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="gdrx:PrescriptionReimbursementAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-36">98,331</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:85.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Prepaid expenses and other current assets</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:85.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-37">45,062</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:85.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-38">47,205</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:99.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">Total current assets</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:99.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:33.88pt"></span></span><span style="left:36.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-39">1,599,327</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:99.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-40">643,102</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:114pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Property and equipment, net</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:114pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-41">11,514</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:114pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-42">12,268</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:128.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Goodwill</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:128.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-43">430,331</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:128.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-44">430,331</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:142.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Intangible assets, net</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:142.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-45">58,254</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:142.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-46">64,082</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:156.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Capitalized software, net</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:156.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="3" id="f-47">140,300</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:156.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="3" id="f-48">139,261</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:171pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Operating lease right-of-use assets, net</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:171pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-49">27,630</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:171pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-50">28,808</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:185.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Deferred tax assets, net</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:185.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-51">47,335</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:185.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-52">57,111</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:199.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Other assets</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:199.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-53">28,237</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:199.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-54">29,095</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:213.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">Total assets</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:213.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:28.88pt"></span></span><span style="left:36.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-55">2,342,928</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:213.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:28.88pt"></span></span><span style="left:36.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-56">1,404,058</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:228pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Liabilities and stockholders' equity</span></div></div></div></td><td style="background-color:#ffffff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:242.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Current liabilities</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:256.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Accounts payable</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:256.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-57">8,906</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:256.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-58">19,405</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:270.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Prescription reimbursement liabilities</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:270.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:33.88pt"></span></span><span style="left:36.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="gdrx:PrescriptionReimbursementLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-59">1,039,995</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:270.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="gdrx:PrescriptionReimbursementLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-60">130,139</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:285pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Accrued expenses and other current liabilities</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:285pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="gdrx:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-61">98,610</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:285pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="gdrx:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-62">86,705</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:299.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Current portion of debt</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:299.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="f-63">5,000</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:299.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="f-64">5,000</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:313.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Operating lease liabilities, current</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:313.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-65">5,358</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:313.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-66">4,753</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:327.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">Total current liabilities</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:327.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:33.88pt"></span></span><span style="left:36.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-67">1,157,869</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:327.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-68">246,002</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:342pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Debt, net</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:342pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-69">481,588</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:342pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-70">483,264</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:356.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Operating lease liabilities, net of current portion</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:356.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-71">47,004</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:356.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-72">49,789</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:370.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Other liabilities</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:370.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-73">8,866</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:370.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-74">8,741</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:384.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">Total liabilities</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:384.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:33.88pt"></span></span><span style="left:36.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-75">1,695,327</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:384.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-76">787,796</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:399pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Commitments and contingencies (Note 7)</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-77"></ix:nonFraction></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><ix:nonFraction unitRef="usd" contextRef="c-5" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-78"></ix:nonFraction></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:413.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Stockholders' equity</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:24.75pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:427.5pt;width:331.5pt"><div><div style="font-size:12pt;line-height:9pt;position:var(--position);top:4.01pt;width:331.5pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);white-space:pre">Preferred stock, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:77.6pt;position:var(--position);text-decoration:none;white-space:pre">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-79"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-80">0.0001</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:110.1pt;position:var(--position);white-space:pre"> par value; </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:154.57999999999998pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-81"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-82">50,000</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:182.07999999999998pt;position:var(--position);white-space:pre"> shares authorized and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:276.05pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-83"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="f-84"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="f-85"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-86">nil</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:285.03pt;position:var(--position);white-space:pre"> shares </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);top:14.81pt;width:331.5pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);white-space:pre">issued and outstanding at </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:125.61pt;position:var(--position);text-decoration:none;white-space:pre">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:182.60999999999999pt;position:var(--position);white-space:pre"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:202.60999999999999pt;position:var(--position);text-decoration:none;white-space:pre">December&#160;31, 2025</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:427.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:64.88pt"></span></span><span style="left:67.50999999999999pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-87">&#8212;</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:427.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:64.88pt"></span></span><span style="left:67.50999999999999pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-88">&#8212;</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:57pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:452.25pt;width:331.5pt"><div><div style="font-size:12pt;line-height:9pt;position:var(--position);top:3.86pt;width:331.5pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);white-space:pre">Common stock, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.6pt;position:var(--position);text-decoration:none;white-space:pre">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-89"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-90"><ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-91"><ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-92">0.0001</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:109.1pt;position:var(--position);white-space:pre"> par value; Class A: </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:189.07pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-93"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-94">2,000,000</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:229.07pt;position:var(--position);white-space:pre"> shares authorized, </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);top:14.66pt;width:331.5pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-95"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-96">106,164</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:53.129999999999995pt;position:var(--position);white-space:pre"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:73.13pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-97"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-98">107,088</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:105.63pt;position:var(--position);white-space:pre"> shares issued and outstanding at </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:242.6pt;position:var(--position);text-decoration:none;white-space:pre">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:299.6pt;position:var(--position);white-space:pre"> and </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);top:25.46pt;width:331.5pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:99.6pt;position:var(--position);white-space:pre">, respectively; and Class B: </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:210.54999999999998pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-99"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-100">1,000,000</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:250.54999999999998pt;position:var(--position);white-space:pre"> shares authorized, </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);top:36.26pt;width:331.5pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-101"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-102">233,964</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:53.129999999999995pt;position:var(--position);white-space:pre"> shares issued and outstanding at </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:190.1pt;position:var(--position);text-decoration:none;white-space:pre">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:247.1pt;position:var(--position);white-space:pre"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:267.1pt;position:var(--position);text-decoration:none;white-space:pre">December&#160;31, </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);top:47.06pt;width:331.5pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:452.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:47.06pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:63.88pt"></span></span><span style="left:66.51pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-103">34</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:452.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:47.06pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:63.88pt"></span></span><span style="left:66.51pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-104">34</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:509.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Additional paid-in capital</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:509.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:33.88pt"></span></span><span style="left:36.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-105">2,048,436</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:509.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:33.88pt"></span></span><span style="left:36.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-106">2,026,802</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:523.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Accumulated deficit</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:523.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:30.89pt"></span></span><span style="left:33.52pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-107">1,400,869</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:523.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:30.89pt"></span></span><span style="left:33.52pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-108">1,410,574</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:537.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">Total stockholders' equity</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:537.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-109">647,601</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:537.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-110">616,262</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:552pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">Total liabilities and stockholders' equity</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:552pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:28.88pt"></span></span><span style="left:36.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-111">2,342,928</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:552pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:28.88pt"></span></span><span style="left:36.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-112">1,404,058</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height:9pt;position:var(--position);top:706.05pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:158.54pt;position:var(--position);white-space:pre">See accompanying notes to condensed consolidated financial statements.</span></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:303.22pt;position:var(--position);white-space:pre">2</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="position:absolute;top:45pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_22"></div><div style="line-height:9pt;position:var(--position);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:257.8pt;position:var(--position);white-space:pre">GoodRx Holdings, Inc.</span></div><div style="line-height:9pt;position:var(--position);top:55.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:195.86pt;position:var(--position);white-space:pre">Condensed Consolidated Statements of Operations</span></div><div style="line-height:9pt;position:var(--position);top:66.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:282.52pt;position:var(--position);white-space:pre">(Unaudited)</span></div><div style="position:var(--position);top:89.4pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:225pt"/><td style="padding:0;width:65.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:65.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:65.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:65.25pt"/></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:225pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);width:133.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:133.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:27.25pt;position:var(--position);text-decoration:none;white-space:pre">Three Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:133.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:50.77pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);width:133.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:133.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:32.13pt;position:var(--position);text-decoration:none;white-space:pre">Six Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:133.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:50.77pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:23.25pt;width:225pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands, except for per share amounts)</span></div></div></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:23.25pt;width:65.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:23.74pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:23.25pt;width:65.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:23.74pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:23.25pt;width:65.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:23.74pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:23.25pt;width:65.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:23.74pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:37.5pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Revenue</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:37.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:21.38pt"></span></span><span style="left:29.009999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-113">200,411</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:37.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:21.38pt"></span></span><span style="left:29.009999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-114">203,070</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:37.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:21.38pt"></span></span><span style="left:29.009999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-115">394,417</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:37.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:21.38pt"></span></span><span style="left:29.009999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-116">406,040</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:51.75pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Costs and operating expenses:</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:24.75pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:66pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.01pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Cost of revenue, exclusive of depreciation and </span></div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:25.13pt;position:var(--position);text-decoration:none;white-space:pre">amortization presented separately below</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:66pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-117">20,999</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:66pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-118">13,350</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:66pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-119">41,155</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:66pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-120">26,714</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:90.75pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Product development and technology</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:90.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-121">26,711</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:90.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-122">29,933</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:90.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-123">56,888</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:90.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-124">61,075</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:105pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Sales and marketing</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:105pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-125">81,986</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:105pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-126">84,870</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:105pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.38pt"></span></span><span style="left:29.009999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-127">163,039</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:105pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.38pt"></span></span><span style="left:29.009999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-128">169,412</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:119.25pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">General and administrative</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:119.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-129">24,814</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:119.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-130">28,379</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:119.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-131">51,633</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:119.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-132">58,009</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:133.5pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Depreciation and amortization</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:133.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-133">22,269</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:133.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-134">19,729</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:133.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-135">44,061</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:133.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-136">40,641</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:147.75pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Total costs and operating expenses</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:147.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.38pt"></span></span><span style="left:29.009999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-137">176,779</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:147.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.38pt"></span></span><span style="left:29.009999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-138">176,261</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:147.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.38pt"></span></span><span style="left:29.009999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-139">356,776</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:147.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.38pt"></span></span><span style="left:29.009999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-140">355,851</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:162pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Operating income</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:162pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-141">23,632</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:162pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-142">26,809</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:162pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-143">37,641</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:162pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-144">50,189</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:176.25pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Other expense, net:</span></div></div></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:190.5pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Other income</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:190.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:43.88pt"></span></span><span style="left:46.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-145">625</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:190.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:43.88pt"></span></span><span style="left:46.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-146">694</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:190.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:43.88pt"></span></span><span style="left:46.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-147">625</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:190.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:43.88pt"></span></span><span style="left:46.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-148">694</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:204.75pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Interest income</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:204.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:39.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:InterestIncomeOther" format="ixt:num-dot-decimal" scale="3" id="f-149">1,019</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:204.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:39.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:InterestIncomeOther" format="ixt:num-dot-decimal" scale="3" id="f-150">2,803</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:204.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:39.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestIncomeOther" format="ixt:num-dot-decimal" scale="3" id="f-151">2,416</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:204.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:39.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:InterestIncomeOther" format="ixt:num-dot-decimal" scale="3" id="f-152">6,735</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:219pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Interest expense</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:219pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:33.39pt"></span></span><span style="left:36.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-153">9,810</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:219pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.39pt"></span></span><span style="left:31.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-154">10,729</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:219pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.39pt"></span></span><span style="left:31.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-155">19,577</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:219pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.39pt"></span></span><span style="left:31.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-156">21,373</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:233.25pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Total other expense, net</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:233.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:33.39pt"></span></span><span style="left:36.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-157">8,166</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:233.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:33.39pt"></span></span><span style="left:36.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-158">7,232</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:233.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.39pt"></span></span><span style="left:31.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-159">16,536</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:233.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.39pt"></span></span><span style="left:31.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-160">13,944</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:247.5pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Income before income taxes</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:247.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-161">15,466</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:247.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-162">19,577</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:247.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-163">21,105</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:247.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-164">36,245</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:261.75pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Income tax expense</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:261.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:33.39pt"></span></span><span style="left:36.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-165">6,930</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:261.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:33.39pt"></span></span><span style="left:36.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-166">6,734</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:261.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.39pt"></span></span><span style="left:31.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-167">11,400</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:261.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.39pt"></span></span><span style="left:31.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-168">12,350</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:276pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Net income</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:276pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:39.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-169">8,536</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:276pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:26.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-170">12,843</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:276pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:39.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-171">9,705</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:276pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:26.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-172">23,895</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:290.25pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Earnings per share:</span></div></div></div></td><td style="background-color:#ffffff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:304.5pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Basic</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:304.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-173">0.03</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:304.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usdPerShare" contextRef="c-11" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-174">0.04</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:304.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-175">0.03</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:304.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-176">0.06</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:318.75pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Diluted</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:318.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-177">0.02</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:318.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usdPerShare" contextRef="c-11" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-178">0.04</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:318.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-179">0.03</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:318.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-180">0.06</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:24.75pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:333pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.01pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Weighted average shares used in computing </span></div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">earnings per share:</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:357.75pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Basic</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:357.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.38pt"></span></span><span style="left:29.009999999999998pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-181">339,277</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:357.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.38pt"></span></span><span style="left:29.009999999999998pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-182">356,623</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:357.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.38pt"></span></span><span style="left:29.009999999999998pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-183">339,839</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:357.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.38pt"></span></span><span style="left:29.009999999999998pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-184">367,847</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:372pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Diluted</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:372pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.38pt"></span></span><span style="left:29.009999999999998pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-185">348,058</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:372pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.38pt"></span></span><span style="left:29.009999999999998pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-186">357,159</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:372pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.38pt"></span></span><span style="left:29.009999999999998pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-187">344,676</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:372pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.38pt"></span></span><span style="left:29.009999999999998pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-188">368,345</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:24.75pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:400.5pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.01pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Stock-based compensation included in costs and </span></div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">operating expenses:</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:15.75pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:425.25pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Cost of revenue</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:425.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:43.88pt"></span></span><span style="left:51.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-189">58</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:425.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:38.88pt"></span></span><span style="left:46.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-190">122</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:425.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:38.88pt"></span></span><span style="left:46.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-191">110</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:425.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:38.88pt"></span></span><span style="left:46.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-192">222</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:441pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Product development and technology</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:441pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:39.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-193">4,554</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:441pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:39.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-194">6,323</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:441pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:39.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-195">8,762</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:441pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-196">11,993</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:455.25pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Sales and marketing</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:455.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:39.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-197">4,203</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:455.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:39.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-198">5,929</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:455.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:39.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-199">8,452</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:455.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-200">11,811</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:469.5pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">General and administrative</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:469.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:39.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-201">7,778</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:469.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:39.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-202">9,041</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:469.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-203">15,778</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:469.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.38pt"></span></span><span style="left:34.01pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-204">16,563</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height:10pt;position:var(--position);top:586.908pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:158.4pt;position:var(--position);top:-2.482pt;white-space:pre">See accompanying notes to condensed consolidated financial statements</span><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:italic;font-weight:normal;left:450.82000000000005pt;position:var(--position);top:-2.758pt;white-space:pre">.</span></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:303.22pt;position:var(--position);white-space:pre">3</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="position:absolute;top:45pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_25"></div><div style="line-height:9pt;position:var(--position);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:257.8pt;position:var(--position);white-space:pre">GoodRx Holdings, Inc.</span></div><div style="line-height:9pt;position:var(--position);top:55.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:174.88pt;position:var(--position);white-space:pre">Condensed Consolidated Statements of Stockholders&#8217; Equity</span></div><div style="line-height:9pt;position:var(--position);top:66.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:282.52pt;position:var(--position);white-space:pre">(Unaudited)</span></div><div style="position:var(--position);top:89.4pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:183pt"/><td style="padding:0;width:60pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:60pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:60pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:60pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:60pt"/></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:183pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);width:123pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:123pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:22.88pt;position:var(--position);text-decoration:none;white-space:pre">Class A and Class B</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:123pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:32.2pt;position:var(--position);text-decoration:none;white-space:pre">Common Stock</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td rowspan="2" style="font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);width:60pt"><div><div style="line-height:8pt;position:var(--position);top:9.3pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:10.47pt;position:var(--position);text-decoration:none;white-space:pre">Additional</span></div><div style="line-height:8pt;position:var(--position);top:18.9pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:16.68pt;position:var(--position);text-decoration:none;white-space:pre">Paid-in </span></div><div style="line-height:8pt;position:var(--position);top:28.5pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:16.68pt;position:var(--position);text-decoration:none;white-space:pre">Capital </span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td rowspan="2" style="font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);width:60pt"><div><div style="line-height:8pt;position:var(--position);top:18.9pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:4.92pt;position:var(--position);text-decoration:none;white-space:pre">Accumulated </span></div><div style="line-height:8pt;position:var(--position);top:28.5pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:17.79pt;position:var(--position);text-decoration:none;white-space:pre">Deficit </span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td rowspan="2" style="font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);width:60pt"><div><div style="line-height:8pt;position:var(--position);top:9.3pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:20.46pt;position:var(--position);text-decoration:none;white-space:pre">Total</span></div><div style="line-height:8pt;position:var(--position);top:18.9pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:3.75pt;position:var(--position);text-decoration:none;white-space:pre">Stockholders' </span></div><div style="line-height:8pt;position:var(--position);top:28.5pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:17.79pt;position:var(--position);text-decoration:none;white-space:pre">Equity </span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:23.25pt;width:183pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:23.25pt;width:60pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:16.68pt;position:var(--position);text-decoration:none;white-space:pre">Shares </span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:23.25pt;width:60pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:14.91pt;position:var(--position);text-decoration:none;white-space:pre">Amount</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:37.5pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Balance at December 31, 2025</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:37.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:21.13pt"></span></span><span style="left:23.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-205">341,052</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:37.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:38.63pt"></span></span><span style="left:46.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-206">34</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:37.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:8.63pt"></span></span><span style="left:16.26pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-207">2,026,802</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:37.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:5.64pt"></span></span><span style="left:13.27pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-208">1,410,574</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:37.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:16.13pt"></span></span><span style="left:23.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-209">616,262</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:51.75pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Stock options exercised</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:51.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:38.63pt"></span></span><span style="left:41.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-32" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="f-210">192</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:51.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:51.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:43.63pt"></span></span><span style="left:46.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-211">95</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:51.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:51.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:43.63pt"></span></span><span style="left:46.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-212">95</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:66pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Stock-based compensation</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:66pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:66pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:66pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.13pt"></span></span><span style="left:28.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-213">19,683</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:66pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:66pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.13pt"></span></span><span style="left:28.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-214">19,683</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:24.75pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:80.25pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.01pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Vesting and settlement of restricted stock </span></div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">units</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:80.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.13pt"></span></span><span style="left:33.76pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-32" decimals="-3" name="gdrx:StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits" format="ixt:num-dot-decimal" scale="3" id="f-215">2,965</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:80.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:80.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:80.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:80.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:24.75pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:105pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.01pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Common stock withheld related to net </span></div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">share settlement</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:105pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.14pt"></span></span><span style="left:30.77pt;position:var(--position)">(<ix:nonFraction unitRef="shares" contextRef="c-32" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-216">1,096</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:105pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:105pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.14pt"></span></span><span style="left:30.77pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-217">2,582</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:105pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:105pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.14pt"></span></span><span style="left:30.77pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-218">2,582</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:129.75pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Repurchases of Class A common stock</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:129.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.14pt"></span></span><span style="left:30.77pt;position:var(--position)">(<ix:nonFraction unitRef="shares" contextRef="c-32" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="3" id="f-219">5,536</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:129.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:129.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:23.14pt"></span></span><span style="left:25.77pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-220">12,641</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:129.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:129.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:23.14pt"></span></span><span style="left:25.77pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-221">12,641</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:144pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Net income</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:144pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:144pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:144pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:144pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.13pt"></span></span><span style="left:33.76pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-222">1,169</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:144pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.13pt"></span></span><span style="left:33.76pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-223">1,169</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:158.25pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Balance at March 31, 2026</span></div></div></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:158.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:21.13pt"></span></span><span style="left:23.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-224">337,577</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:158.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:38.63pt"></span></span><span style="left:46.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-225">34</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:158.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:8.63pt"></span></span><span style="left:16.26pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-226">2,031,357</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:158.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:5.64pt"></span></span><span style="left:13.27pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-227">1,409,405</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:158.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:16.13pt"></span></span><span style="left:23.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-228">621,986</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:172.5pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Stock-based compensation</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:172.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:172.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:172.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.13pt"></span></span><span style="left:28.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-229">19,835</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:172.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:172.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.13pt"></span></span><span style="left:28.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-230">19,835</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:24.75pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:186.75pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.01pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Vesting and settlement of restricted stock </span></div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">units</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:186.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.13pt"></span></span><span style="left:33.76pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-41" decimals="-3" name="gdrx:StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits" format="ixt:num-dot-decimal" scale="3" id="f-231">3,729</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:186.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:186.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:186.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:186.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:24.75pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:211.5pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.01pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Common stock withheld related to net </span></div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">share settlement</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:211.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.14pt"></span></span><span style="left:30.77pt;position:var(--position)">(<ix:nonFraction unitRef="shares" contextRef="c-41" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-232">1,335</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:211.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:211.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.14pt"></span></span><span style="left:30.77pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-233">3,186</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:211.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:211.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.14pt"></span></span><span style="left:30.77pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-234">3,186</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:236.25pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Repurchases of Class A common stock</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:236.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:236.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:236.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:43.63pt"></span></span><span style="left:46.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" sign="-" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-235">61</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:236.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:236.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:43.63pt"></span></span><span style="left:46.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-236">61</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:24.75pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:250.5pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.01pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Issuance of common stock through </span></div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">employee stock purchase plan</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:250.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:38.63pt"></span></span><span style="left:41.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="f-237">157</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:250.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:250.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:38.63pt"></span></span><span style="left:41.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-238">369</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:250.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:250.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:38.63pt"></span></span><span style="left:41.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-239">369</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:275.25pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Net income</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:275.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:275.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:275.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:275.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.13pt"></span></span><span style="left:33.76pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-240">8,536</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:275.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.13pt"></span></span><span style="left:33.76pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-241">8,536</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:289.5pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Balance at June 30, 2026</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:289.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:24.87pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonFraction unitRef="shares" contextRef="c-43" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-242">340,128</ix:nonFraction></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:289.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:38.63pt"></span></span><span style="left:46.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-243">34</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:289.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:8.63pt"></span></span><span style="left:16.26pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-244">2,048,436</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:289.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:5.64pt"></span></span><span style="left:13.27pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-245">1,400,869</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:289.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:16.13pt"></span></span><span style="left:23.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-246">647,601</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height:9pt;position:var(--position);top:404.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:158.54pt;position:var(--position);white-space:pre">See accompanying notes to condensed consolidated financial statements.</span></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:303.22pt;position:var(--position);white-space:pre">4</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="position:absolute;top:45pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_28"></div><div style="line-height:9pt;position:var(--position);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:257.8pt;position:var(--position);white-space:pre">GoodRx Holdings, Inc.</span></div><div style="line-height:9pt;position:var(--position);top:55.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:174.88pt;position:var(--position);white-space:pre">Condensed Consolidated Statements of Stockholders&#8217; Equity</span></div><div style="line-height:9pt;position:var(--position);top:66.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:282.52pt;position:var(--position);white-space:pre">(Unaudited)</span></div><div style="position:var(--position);top:89.4pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:183pt"/><td style="padding:0;width:60pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:60pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:60pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:60pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:60pt"/></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:183pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);width:123pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:123pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:22.88pt;position:var(--position);text-decoration:none;white-space:pre">Class A and Class B</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:123pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:32.2pt;position:var(--position);text-decoration:none;white-space:pre">Common Stock</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td rowspan="2" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);width:60pt"><div><div style="line-height:8pt;position:var(--position);top:9.3pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:10.47pt;position:var(--position);text-decoration:none;white-space:pre">Additional</span></div><div style="line-height:8pt;position:var(--position);top:18.9pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:16.68pt;position:var(--position);text-decoration:none;white-space:pre">Paid-in </span></div><div style="line-height:8pt;position:var(--position);top:28.5pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:16.68pt;position:var(--position);text-decoration:none;white-space:pre">Capital</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td rowspan="2" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);width:60pt"><div><div style="line-height:8pt;position:var(--position);top:18.9pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:4.92pt;position:var(--position);text-decoration:none;white-space:pre">Accumulated </span></div><div style="line-height:8pt;position:var(--position);top:28.5pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:17.79pt;position:var(--position);text-decoration:none;white-space:pre">Deficit</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td rowspan="2" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);width:60pt"><div><div style="line-height:8pt;position:var(--position);top:9.3pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:20.46pt;position:var(--position);text-decoration:none;white-space:pre">Total</span></div><div style="line-height:8pt;position:var(--position);top:18.9pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:3.75pt;position:var(--position);text-decoration:none;white-space:pre">Stockholders' </span></div><div style="line-height:8pt;position:var(--position);top:28.5pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:17.79pt;position:var(--position);text-decoration:none;white-space:pre">Equity</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:23.25pt;width:183pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:23.25pt;width:60pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:16.68pt;position:var(--position);text-decoration:none;white-space:pre">Shares </span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:23.25pt;width:60pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:14.91pt;position:var(--position);text-decoration:none;white-space:pre">Amount</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:37.5pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Balance at December 31, 2024</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:37.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:21.13pt"></span></span><span style="left:23.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-46" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-247">382,815</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:37.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:38.63pt"></span></span><span style="left:46.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-248">38</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:37.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:8.63pt"></span></span><span style="left:16.26pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-249">2,165,633</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:37.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:5.64pt"></span></span><span style="left:13.27pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-250">1,441,013</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:37.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:16.13pt"></span></span><span style="left:23.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-251">724,658</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:51.75pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Stock options exercised</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:51.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.63pt"></span></span><span style="left:51.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-50" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="f-252">4</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:51.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:51.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.63pt"></span></span><span style="left:51.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-253">2</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:51.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:51.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.63pt"></span></span><span style="left:51.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-254">2</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:66pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Stock-based compensation</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:66pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:66pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:66pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.13pt"></span></span><span style="left:28.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-255">23,312</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:66pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:66pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.13pt"></span></span><span style="left:28.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-256">23,312</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:24.75pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:80.25pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.01pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Vesting and settlement of restricted stock </span></div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">units</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:80.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.13pt"></span></span><span style="left:33.76pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-50" decimals="-3" name="gdrx:StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits" format="ixt:num-dot-decimal" scale="3" id="f-257">2,136</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:80.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:80.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:80.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:80.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:24.75pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:105pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.01pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Common stock withheld related to net </span></div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">share settlement</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:105pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.64pt"></span></span><span style="left:38.27pt;position:var(--position)">(<ix:nonFraction unitRef="shares" contextRef="c-50" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="f-258">802</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:105pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:105pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.14pt"></span></span><span style="left:30.77pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-259">3,757</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:105pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:105pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.14pt"></span></span><span style="left:30.77pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-260">3,757</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:129.75pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);white-space:pre">Repurchases of Class A common stock </span><span style="font-family:'Arial', sans-serif;font-size:5.8500000000000005pt;font-style:normal;font-weight:normal;left:170.09pt;position:var(--position);top:-2.293pt;vertical-align:super;white-space:pre">(1)</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:129.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:23.14pt"></span></span><span style="left:25.77pt;position:var(--position)">(<ix:nonFraction unitRef="shares" contextRef="c-50" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="3" id="f-261">23,340</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:129.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:45.64pt"></span></span><span style="left:48.27pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-262">2</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:129.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:18.14pt"></span></span><span style="left:20.77pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-263">100,918</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:129.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:129.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:18.14pt"></span></span><span style="left:20.77pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-264">100,920</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:144pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Net income</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:144pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:144pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:144pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:144pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.13pt"></span></span><span style="left:28.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-265">11,052</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:144pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.13pt"></span></span><span style="left:28.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-266">11,052</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:158.25pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Balance at March 31, 2025</span></div></div></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:158.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:21.13pt"></span></span><span style="left:23.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-54" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-267">360,813</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:158.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:38.63pt"></span></span><span style="left:46.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-268">36</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:158.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:8.63pt"></span></span><span style="left:16.26pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-269">2,084,272</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:158.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:5.64pt"></span></span><span style="left:13.27pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-270">1,429,961</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:158.25pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:16.13pt"></span></span><span style="left:23.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-271">654,347</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:172.5pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Stock options exercised</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:172.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.63pt"></span></span><span style="left:51.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-58" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="f-272">2</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:172.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:172.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.63pt"></span></span><span style="left:51.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-273">1</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:172.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:172.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.63pt"></span></span><span style="left:51.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-274">1</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:186.75pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Stock-based compensation</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:186.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:186.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:186.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.13pt"></span></span><span style="left:28.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-275">25,880</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:186.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:186.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.13pt"></span></span><span style="left:28.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-276">25,880</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:24.75pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:201pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.01pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Vesting and settlement of restricted stock </span></div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">units</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:201pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:31.13pt"></span></span><span style="left:33.76pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-58" decimals="-3" name="gdrx:StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits" format="ixt:num-dot-decimal" scale="3" id="f-277">3,014</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:201pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:201pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:201pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:201pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:24.75pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:225.75pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.01pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Common stock withheld related to net </span></div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">share settlement</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:225.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.14pt"></span></span><span style="left:30.77pt;position:var(--position)">(<ix:nonFraction unitRef="shares" contextRef="c-58" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-278">1,056</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:225.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:225.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.14pt"></span></span><span style="left:30.77pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-279">4,548</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:225.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:225.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.14pt"></span></span><span style="left:30.77pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-280">4,548</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:250.5pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Repurchases of Class A common stock</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:250.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:23.14pt"></span></span><span style="left:25.77pt;position:var(--position)">(<ix:nonFraction unitRef="shares" contextRef="c-58" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="3" id="f-281">10,224</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:250.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:45.64pt"></span></span><span style="left:48.27pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-282">1</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:250.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:23.14pt"></span></span><span style="left:25.77pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-283">46,351</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:250.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:250.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:23.14pt"></span></span><span style="left:25.77pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-284">46,352</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:24.75pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:264.75pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.01pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Issuance of common stock through </span></div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">employee stock purchase plan</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:264.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:38.63pt"></span></span><span style="left:41.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-58" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="f-285">222</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:264.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:264.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:38.63pt"></span></span><span style="left:41.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-286">860</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:264.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:264.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:38.63pt"></span></span><span style="left:41.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-287">860</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:289.5pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Net income</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:289.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:289.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:289.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:44.63pt"></span></span><span style="left:47.260000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:289.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.13pt"></span></span><span style="left:28.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-288">12,843</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:289.5pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:26.13pt"></span></span><span style="left:28.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-289">12,843</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:303.75pt;width:183pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:183pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Balance at June 30, 2025</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:183pt;position:var(--position);top:303.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:21.13pt"></span></span><span style="left:23.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-61" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-290">352,771</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:246pt;position:var(--position);top:303.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:38.63pt"></span></span><span style="left:46.260000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-291">35</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:309pt;position:var(--position);top:303.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:8.63pt"></span></span><span style="left:16.26pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-292">2,060,114</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:372pt;position:var(--position);top:303.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:5.64pt"></span></span><span style="left:13.27pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-293">1,417,118</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:435pt;position:var(--position);top:303.75pt;width:60pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:16.13pt"></span></span><span style="left:23.759999999999998pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-294">643,031</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height:9pt;position:var(--position);top:418.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:158.54pt;position:var(--position);white-space:pre">See accompanying notes to condensed consolidated financial statements.</span></div><div style="line-height:9pt;position:var(--position);top:435.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre">_____________________________________________________</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:446pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:10.98pt">(1)</span><ix:footnote id="fn-1" continuedAt="fn-1-1" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:381.69pt">Repurchases of Class A common stock for the three months ended March 31, 2025 include </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:476.19pt;position:var(--position);text-decoration:none;white-space:pre;width:46.57pt"><ix:nonFraction unitRef="shares" contextRef="c-65" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-295">20.0</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:522.76pt;position:var(--position);text-decoration:none;white-space:pre;width:30.61pt"> shares</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></ix:footnote></div><ix:continuation id="fn-1-1"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:456.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:458.86pt">repurchased from related parties (after giving effect to the automatic conversion of Class B common stock to Class</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:467.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:338pt">A common stock upon such repurchase) for an aggregate consideration of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:432.5pt;position:var(--position);text-decoration:none;white-space:pre;width:54.14pt">$<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-296">84.9</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:486.64pt;position:var(--position);text-decoration:none;white-space:pre;width:59.25pt">. See "Note </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:545.89pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">9</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:550.89pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:478.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:81.18pt">Stockholders' Equity</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:175.68pt;position:var(--position);text-decoration:none;white-space:pre;width:106.61pt">" for additional information.</span></div></ix:continuation></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:303.22pt;position:var(--position);white-space:pre">5</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="position:absolute;top:45pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_31"></div><div style="line-height:9pt;position:var(--position);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:257.8pt;position:var(--position);white-space:pre">GoodRx Holdings, Inc.</span></div><div style="line-height:9pt;position:var(--position);top:55.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:194.61pt;position:var(--position);white-space:pre">Condensed Consolidated Statements of Cash Flows</span></div><div style="line-height:9pt;position:var(--position);top:66.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:282.52pt;position:var(--position);white-space:pre">(Unaudited)</span></div><div style="position:var(--position);top:89.4pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:331.5pt"/><td style="padding:0;width:80.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:80.25pt"/></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);width:163.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:163.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:47.13pt;position:var(--position);text-decoration:none;white-space:pre">Six Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:163.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:65.77pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:23.25pt;width:331.5pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:23.25pt;width:80.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.24pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:23.25pt;width:80.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.24pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:37.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Cash flows from operating activities</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:51.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Net income</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:51.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-297">9,705</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:51.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-298">23,895</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:24.75pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:66pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.01pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Adjustments to reconcile net income to net cash provided by operating </span></div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">activities:</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:90.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Depreciation and amortization</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:90.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-299">44,061</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:90.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-300">40,641</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:105pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Amortization of debt issuance costs and discounts</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:105pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:58.88pt"></span></span><span style="left:61.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="f-301">932</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:105pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:58.88pt"></span></span><span style="left:61.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="f-302">869</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:119.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Non-cash operating lease expense</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:119.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-303">1,910</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:119.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-304">2,065</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:133.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Stock-based compensation expense</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:133.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-305">33,102</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:133.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-306">40,589</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:147.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Deferred income taxes</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:147.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-307">9,776</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:147.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:64.88pt"></span></span><span style="left:67.50999999999999pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-308">&#8212;</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:162pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Loss on operating lease asset</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:162pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:64.88pt"></span></span><span style="left:67.50999999999999pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="gdrx:LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets" format="ixt:fixed-zero" scale="3" id="f-309">&#8212;</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:162pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="gdrx:LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets" format="ixt:num-dot-decimal" scale="3" id="f-310">4,409</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:176.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Other</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:176.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" format="ixt:num-dot-decimal" scale="3" id="f-311">1,069</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:176.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:58.88pt"></span></span><span style="left:61.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="f-312">456</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:190.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Changes in operating assets and liabilities:</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:204.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">Accounts receivable</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:204.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-313">53,606</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:204.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:43.39pt"></span></span><span style="left:46.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-314">43,093</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:219pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);white-space:pre">Prescription reimbursement assets </span><span style="font-family:'Arial', sans-serif;font-size:5.8500000000000005pt;font-style:normal;font-weight:normal;left:161.54pt;position:var(--position);top:-2.293pt;vertical-align:super;white-space:pre">(1)</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:219pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:38.39pt"></span></span><span style="left:41.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="gdrx:IncreaseDecreaseInPrescriptionReimbursementAssets" format="ixt:num-dot-decimal" scale="3" id="f-315">977,681</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:219pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:43.39pt"></span></span><span style="left:46.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="gdrx:IncreaseDecreaseInPrescriptionReimbursementAssets" format="ixt:num-dot-decimal" scale="3" id="f-316">16,027</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:233.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);white-space:pre">Prepaid expenses and other assets </span><span style="font-family:'Arial', sans-serif;font-size:5.8500000000000005pt;font-style:normal;font-weight:normal;left:164.1pt;position:var(--position);top:-2.293pt;vertical-align:super;white-space:pre">(1)</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:233.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-317">2,929</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:233.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:58.88pt"></span></span><span style="left:61.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-318">231</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:247.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);white-space:pre">Accounts payable </span><span style="font-family:'Arial', sans-serif;font-size:5.8500000000000005pt;font-style:normal;font-weight:normal;left:94.11999999999999pt;position:var(--position);top:-2.293pt;vertical-align:super;white-space:pre">(1)</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:247.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.39pt"></span></span><span style="left:51.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-319">9,871</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:247.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-320">3,579</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:261.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);white-space:pre">Prescription reimbursement liabilities </span><span style="font-family:'Arial', sans-serif;font-size:5.8500000000000005pt;font-style:normal;font-weight:normal;left:169.48pt;position:var(--position);top:-2.293pt;vertical-align:super;white-space:pre">(1)</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:261.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="gdrx:IncreaseDecreaseInPrescriptionReimbursableLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-321">909,856</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:261.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.39pt"></span></span><span style="left:51.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="gdrx:IncreaseDecreaseInPrescriptionReimbursableLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-322">1,313</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:276pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);white-space:pre">Accrued expenses and other current liabilities </span><span style="font-family:'Arial', sans-serif;font-size:5.8500000000000005pt;font-style:normal;font-weight:normal;left:204.53pt;position:var(--position);top:-2.293pt;vertical-align:super;white-space:pre">(1)</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:276pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-323">16,063</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:276pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-324">5,585</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:290.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">Operating lease liabilities</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:290.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.39pt"></span></span><span style="left:51.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="gdrx:IncreaseDecreaseOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-325">2,912</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:290.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.39pt"></span></span><span style="left:51.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="gdrx:IncreaseDecreaseOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-326">3,187</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:304.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">Other liabilities</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:304.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:58.88pt"></span></span><span style="left:61.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="f-327">125</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:304.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:58.88pt"></span></span><span style="left:61.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="f-328">294</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:318.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:29.63pt;position:var(--position);text-decoration:none;white-space:pre">Net cash provided by operating activities</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:318.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-329">92,670</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:318.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-330">58,993</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:333pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Cash flows from investing activities</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:347.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Purchase of property and equipment</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:347.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.39pt"></span></span><span style="left:51.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-331">1,498</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:347.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:55.89pt"></span></span><span style="left:58.52pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-332">532</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:361.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Acquisition</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:361.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:64.88pt"></span></span><span style="left:67.50999999999999pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="3" id="f-333">&#8212;</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:361.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:43.39pt"></span></span><span style="left:46.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="f-334">30,000</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:375.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Capitalized software</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:375.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:43.39pt"></span></span><span style="left:46.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForSoftware" format="ixt:num-dot-decimal" scale="3" id="f-335">34,555</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:375.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:43.39pt"></span></span><span style="left:46.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:PaymentsForSoftware" format="ixt:num-dot-decimal" scale="3" id="f-336">39,659</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:390pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:29.63pt;position:var(--position);text-decoration:none;white-space:pre">Net cash used in investing activities</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:390pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:43.39pt"></span></span><span style="left:46.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-337">36,053</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:390pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:43.39pt"></span></span><span style="left:46.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-338">70,191</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:404.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Cash flows from financing activities</span></div></div></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:418.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Payments on long-term debt</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:418.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.39pt"></span></span><span style="left:51.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-339">2,500</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:418.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.39pt"></span></span><span style="left:51.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-340">2,500</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:432.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);white-space:pre">Repurchases of Class A common stock </span><span style="font-family:'Arial', sans-serif;font-size:5.8500000000000005pt;font-style:normal;font-weight:normal;left:161.09pt;position:var(--position);top:-2.293pt;vertical-align:super;white-space:pre">(2)</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:432.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:43.39pt"></span></span><span style="left:46.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-341">14,520</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:432.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:38.39pt"></span></span><span style="left:41.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-342">145,888</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:447pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Proceeds from exercise of stock options</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:447pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:63.88pt"></span></span><span style="left:66.51pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-343">95</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:447pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:68.88pt"></span></span><span style="left:71.50999999999999pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-344">3</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:461.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Employee taxes paid related to net share settlement of equity awards</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:461.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.39pt"></span></span><span style="left:51.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="gdrx:EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards" format="ixt:num-dot-decimal" scale="3" id="f-345">5,768</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:461.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.39pt"></span></span><span style="left:51.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="gdrx:EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards" format="ixt:num-dot-decimal" scale="3" id="f-346">8,305</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:475.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Proceeds from employee stock purchase plan</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:475.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:58.88pt"></span></span><span style="left:61.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockPlans" scale="3" id="f-347">369</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:475.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:58.88pt"></span></span><span style="left:61.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:ProceedsFromStockPlans" scale="3" id="f-348">860</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:489.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:29.63pt;position:var(--position);text-decoration:none;white-space:pre">Net cash used in financing activities</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:489.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:43.39pt"></span></span><span style="left:46.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-349">22,324</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:489.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:38.39pt"></span></span><span style="left:41.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-350">155,830</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:504pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:29.63pt;position:var(--position);text-decoration:none;white-space:pre">Net change in cash and cash equivalents</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:504pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-351">34,293</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:504pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:38.39pt"></span></span><span style="left:41.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-352">167,028</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:518.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Cash and cash equivalents</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:532.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Beginning of period</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:532.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-353">261,820</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:532.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-354">448,346</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:546.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">End of period</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:546.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-355">296,113</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:546.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-356">281,318</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:561pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Supplemental disclosure of cash flow information</span></div></div></div></td><td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:575.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Non cash investing and financing activities:</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:589.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Right-of-use assets obtained in exchange for operating lease liabilities</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:589.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:53.88pt"></span></span><span style="left:61.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="f-357">732</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:589.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-358">9,098</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:603.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Stock-based compensation included in capitalized software</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:603.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="gdrx:NoncashStockBasedCompensationIncludedInCapitalizedSoftware" format="ixt:num-dot-decimal" scale="3" id="f-359">6,416</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:603.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="gdrx:NoncashStockBasedCompensationIncludedInCapitalizedSoftware" format="ixt:num-dot-decimal" scale="3" id="f-360">8,603</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:24.75pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:618pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.01pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Capitalized software included in accounts payable and accrued expenses and </span></div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">other current liabilities</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:618pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="gdrx:CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-361">5,485</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:618pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="gdrx:CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-362">6,645</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:303.22pt;position:var(--position);white-space:pre">6</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="line-height:9pt;position:var(--position);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:158.54pt;position:var(--position);white-space:pre">See accompanying notes to condensed consolidated financial statements.</span></div><div style="line-height:9pt;position:var(--position);top:61.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre">_____________________________________________________</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:72.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:10.98pt">(1)</span><ix:footnote id="fn-2" continuedAt="fn-2-1" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:458.91pt">Prior to December 31, 2025, prescription reimbursement assets were presented as a component of prepaid</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></ix:footnote></div><ix:continuation id="fn-2-1"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:83.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:144.47pt">expenses and other current assets, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:238.97pt;position:var(--position);text-decoration:none;white-space:pre;width:314.53pt">and prescription reimbursement liabilities as a component of accounts payable</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:94.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:201.92pt">and accrued expenses and other current liabilities</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:296.41999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:257.08pt">. Prior period amounts have been reclassified to conform to the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:105pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:458.87pt">current period presentation. These reclassifications had no impact on previously reported cash flows provided by</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:115.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:76.95pt">operating activities.</span></div></ix:continuation><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:126.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:10.98pt">(2)</span><ix:footnote id="fn-3" continuedAt="fn-3-1" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:202.45pt">Repurchases of Class A common stock for the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:296.95pt;position:var(--position);text-decoration:none;white-space:pre;width:139.98pt">six months ended June 30, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:436.93pt;position:var(--position);text-decoration:none;white-space:pre;width:37.48pt"> include </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:474.41pt;position:var(--position);text-decoration:none;white-space:pre;width:47.45pt"><ix:nonFraction unitRef="shares" contextRef="c-65" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-363">20.0</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:521.86pt;position:var(--position);text-decoration:none;white-space:pre;width:31.49pt"> shares</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></ix:footnote></div><ix:continuation id="fn-3-1"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:137.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:458.86pt">repurchased from related parties (after giving effect to the automatic conversion of Class B common stock to Class</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:148.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:338pt">A common stock upon such repurchase) for an aggregate consideration of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:432.5pt;position:var(--position);text-decoration:none;white-space:pre;width:54.14pt">$<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-364">84.9</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:486.64pt;position:var(--position);text-decoration:none;white-space:pre;width:59.25pt">. See "Note </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:545.89pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">9</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:550.89pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:159pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:187.79pt">Stockholders' Equity" for additional information.</span></div></ix:continuation></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:303.22pt;position:var(--position);white-space:pre">7</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="position:absolute;top:45pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_34"></div><div style="line-height:9pt;position:var(--position);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:257.8pt;position:var(--position);white-space:pre">GoodRx Holdings, Inc.</span></div><div style="line-height:9pt;position:var(--position);top:55.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:186.37pt;position:var(--position);white-space:pre">Notes to Condensed Consolidated Financial Statements</span></div><div style="line-height:9pt;position:var(--position);top:66.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:282.52pt;position:var(--position);white-space:pre">(Unaudited)</span></div><div style="position:absolute;top:95.4pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_37"></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:95.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">1</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:63.5pt;position:var(--position);white-space:pre;width:5pt">. </span><ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="f-365" continuedAt="f-365-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:102.9pt">Description of Business</span></ix:nonNumeric></div><ix:continuation id="f-365-1"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:112.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:174.11pt">GoodRx Holdings, Inc. was incorporated in </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:250.61pt;position:var(--position);text-decoration:none;white-space:pre;width:66.68pt">September 2015</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:317.28999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:236.21pt"> and has no material assets or standalone operations other</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:123pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">than its ownership in its consolidated subsidiaries. GoodRx, Inc. ("GoodRx"), a Delaware corporation initially formed in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:133.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt">September 2011, is a wholly-owned subsidiary of GoodRx Intermediate Holdings, LLC, which itself is a wholly-owned</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:144.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:142.93pt">subsidiary of GoodRx Holdings, Inc.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:201.43pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:161.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.87pt">GoodRx Holdings, Inc. and its subsidiaries (collectively, "we," "us" or "our") offer information and tools to help</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:172.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">consumers compare prices and save on their prescription drug purchases. We operate a price comparison platform that</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:183pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:193.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">through our codes that can be used to save money on prescriptions across the United States (the "prescription transactions</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:204.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">offering"). We also offer other healthcare products and services, including subscription programs, solutions for</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:215.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt">pharmaceutical manufacturers and other customers, referred to as GoodRx Pharma Direct ("Pharma Direct"), and telehealth</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:226.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:35.48pt">services.</span></div></ix:continuation><div style="position:absolute;top:255pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_40"></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:255pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">2</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:63.5pt;position:var(--position);white-space:pre;width:5pt">. </span><ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-366" continuedAt="f-366-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:188.84pt">Summary of Significant Accounting Policies</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:257.34000000000003pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></ix:nonNumeric></div><ix:continuation id="f-366-1" continuedAt="f-366-2"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:271.8pt;width:612pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-367" continuedAt="f-367-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:91.92pt">Basis of Presentation</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:150.42000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></ix:nonNumeric></div><ix:continuation id="f-367-1"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:288.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:477pt">The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:299.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) and applicable rules and regulations of the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:310.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">Securities and Exchange Commission (&#8220;SEC&#8221;) regarding interim financial information. Certain information and disclosures</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:321pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">normally included in our annual consolidated financial statements prepared in accordance with GAAP have been condensed</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:331.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">or omitted. Accordingly, these condensed consolidated financial statements should be read in conjunction with our audited</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:342.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:215.88pt">consolidated financial statements for the year ended </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:274.38pt;position:var(--position);text-decoration:none;white-space:pre;width:80.53pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:354.91pt;position:var(--position);text-decoration:none;white-space:pre;width:198.43pt"> and the related notes, which are included in our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:353.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:210.48pt">Annual Report on Form 10-K filed with the SEC on </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:268.98pt;position:var(--position);text-decoration:none;white-space:pre;width:74.89pt">February&#160;26, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:343.87pt;position:var(--position);text-decoration:none;white-space:pre;width:9.39pt"> ("</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:353.26pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:373.26pt;position:var(--position);text-decoration:none;white-space:pre;width:52.63pt"> 10-K"). The </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:425.89pt;position:var(--position);text-decoration:none;white-space:pre;width:80.39pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:506.28pt;position:var(--position);text-decoration:none;white-space:pre;width:47.21pt"> condensed</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:364.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt">consolidated balance sheet was derived from our audited consolidated financial statements as of that date. The condensed</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:375pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">consolidated financial statements include, in the opinion of management, all adjustments, consisting of normal and recurring</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:385.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">items, necessary for the fair statement of our condensed consolidated financial statements. The operating results for the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:396.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:178.17pt">three and six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:236.67pt;position:var(--position);text-decoration:none;white-space:pre;width:316.66pt"> are not necessarily indicative of the results expected for the full year ending</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:407.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt">December&#160;31, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:137.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:424.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:328.28pt">There have been no material changes in significant accounting policies during the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:404.78pt;position:var(--position);text-decoration:none;white-space:pre;width:148.69pt">three and six months ended June 30,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:435pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:78.5pt;position:var(--position);text-decoration:none;white-space:pre;width:123.17pt"> from those disclosed in &#8220;Note </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:201.67pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">2</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:206.67pt;position:var(--position);text-decoration:none;white-space:pre;width:5.29pt">. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:211.96pt;position:var(--position);text-decoration:none;white-space:pre;width:173.57pt">Summary of Significant Accounting Policies</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:385.53pt;position:var(--position);text-decoration:none;white-space:pre;width:167.95pt">&#8221; in the notes to our consolidated financial</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:445.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:107.45pt">statements included in our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:165.95pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:185.95pt;position:var(--position);text-decoration:none;white-space:pre;width:23.99pt"> 10-K.</span></div></ix:continuation><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:474.6pt;width:612pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-368" continuedAt="f-368-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:116.38pt">Principles of Consolidation</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:174.88pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></ix:nonNumeric></div><ix:continuation id="f-368-1"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:491.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:477pt">The condensed consolidated financial statements include the accounts of GoodRx Holdings, Inc., its wholly owned</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:502.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt">subsidiaries and variable interest entities for which we are the primary beneficiary. Intercompany balances and transactions</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:513pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">have been eliminated in consolidation. Results of businesses acquired are included in our condensed consolidated financial</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:523.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:209.9pt">statements from their respective dates of acquisition.</span></div></ix:continuation><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:552.6pt;width:612pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="f-369" continuedAt="f-369-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:82.91pt">Segment Reporting</span></ix:nonNumeric></div><ix:continuation id="f-369-1"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:569.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.96pt">Operating segments are defined as components of an enterprise for which separate financial information is available</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:580.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">that is regularly provided to the chief operating decision maker ("CODM") in deciding how to allocate resources and in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:591pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:299.38pt">assessing performance. Our CODM manages our business on the basis of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:357.88pt;position:var(--position);text-decoration:none;white-space:pre;width:15pt"><ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-370">one</ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:372.88pt;position:var(--position);text-decoration:none;white-space:pre;width:79.47pt"> operating segment.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:607.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:320.63pt">Our operating segment derives revenue in a manner as described in "Note </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:397.13pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">2</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:402.13pt;position:var(--position);text-decoration:none;white-space:pre;width:6.84pt">. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:408.97pt;position:var(--position);text-decoration:none;white-space:pre;width:144.46pt">Summary of Significant Accounting</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:618.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:30.97pt">Policies</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:89.47pt;position:var(--position);text-decoration:none;white-space:pre;width:300.07pt">" in the notes to our consolidated financial statements included in our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:389.54pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:409.54pt;position:var(--position);text-decoration:none;white-space:pre;width:143.89pt"> 10-K. Our CODM is our principal</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:629.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">executive officer, who is our Chief Executive Officer and President. Consolidated net income or loss is the measure of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:640.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">segment profit or loss reviewed by our CODM in assessing segment performance and deciding how to allocate resources.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:651pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt">Our CODM uses consolidated net income or loss to monitor budget versus actual results, review historical company</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:661.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">performance trends, conduct benchmark analysis of our peers and competitors, and evaluate management&#8217;s compensation.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:672.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">Significant expenses included in the reported measure of segment profit or loss regularly provided to our CODM are on a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:683.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:416.38pt">consolidated basis as presented in the accompanying condensed consolidated statements of operations.</span></div></ix:continuation></ix:continuation></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:303.22pt;position:var(--position);white-space:pre">8</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><ix:continuation id="f-366-2" continuedAt="f-366-3"><div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-371" continuedAt="f-371-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:72.45pt">Use of Estimates</span></ix:nonNumeric></div><ix:continuation id="f-371-1"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:61.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.97pt">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:72.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:83.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">including the accompanying notes. We base our estimates on historical factors; current circumstances; macroeconomic</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:94.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">events and conditions; and the experience and judgment of our management. We evaluate our estimates and assumptions</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:105pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.98pt">on an ongoing basis. Actual results can differ materially from these estimates, and such differences can affect the results of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:115.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:147.42pt">operations reported in future periods.</span></div></ix:continuation><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:144.6pt;width:612pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-372" continuedAt="f-372-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:144.36pt">Certain Risks and Concentrations</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:202.86pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></ix:nonNumeric></div><ix:continuation id="f-372-1" continuedAt="f-372-2"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:161.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.99pt">Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:172.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:168.95pt">cash equivalents and accounts receivable.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:189pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.98pt">We maintain cash deposits with multiple financial institutions in the United States which, at times, may exceed federally</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:199.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">insured limits. Cash may be withdrawn or redeemed on demand. We believe that the financial institutions that hold our cash</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:210.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">are financially sound and, accordingly, minimal credit risk exists with respect to these balances. However, market conditions</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:221.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">can impact the viability of these institutions. In the event of failure of any of the financial institutions where we maintain our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:232.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.81pt">cash and cash equivalents, there can be no assurance that we will be able to access uninsured funds in a timely manner or</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.31pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:243pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:242.77pt">at all. We have not experienced any losses in such accounts.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:259.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.9pt">We consider all short-term, highly liquid investments purchased with an original maturity of three months or less at the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:270.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">date of purchase to be cash equivalents. Cash equivalents, consisting of U.S. treasury securities money market funds, of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:281.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:55.39pt">$<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-373">114.0</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:113.89pt;position:var(--position);text-decoration:none;white-space:pre;width:21.2pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:135.09pt;position:var(--position);text-decoration:none;white-space:pre;width:56.05pt">$<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="f-374">164.0</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:191.14pt;position:var(--position);text-decoration:none;white-space:pre;width:13.7pt"> at </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:204.84pt;position:var(--position);text-decoration:none;white-space:pre;width:58.2pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:263.03999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:21.2pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:284.24pt;position:var(--position);text-decoration:none;white-space:pre;width:80.17pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:364.41pt;position:var(--position);text-decoration:none;white-space:pre;width:189.05pt">, respectively, were classified as Level 1 of the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:292.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:305.34pt">fair value hierarchy and valued using quoted market prices in active markets.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:309pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.99pt">We extend credit to our customers based on an evaluation of their ability to pay amounts due under contractual</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div></ix:continuation><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:319.8pt;width:612pt"><ix:continuation id="f-372-2"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:251.63pt">arrangements and generally do not obtain or require collateral.</span></ix:continuation><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:310.13pt;position:var(--position);text-decoration:none;white-space:pre;width:67.53pt"> For each of the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:377.66pt;position:var(--position);text-decoration:none;white-space:pre;width:173.34pt">three and six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:551pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:330.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:10pt">no</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:143.57pt"> customer accounted for more than </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:212.07pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt">10%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:230.07pt;position:var(--position);text-decoration:none;white-space:pre;width:130.62pt"> of our revenue. For each of the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:360.69pt;position:var(--position);text-decoration:none;white-space:pre;width:172.36pt">three and six months ended June 30, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:533.05pt;position:var(--position);text-decoration:none;white-space:pre;width:5.27pt">, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:538.3199999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:15pt">one</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3199999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:341.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:97.04pt">customer accounted for </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:155.54000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt"><ix:nonFraction unitRef="number" contextRef="c-69" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-375"><ix:nonFraction unitRef="number" contextRef="c-70" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-376">12</ix:nonFraction></ix:nonFraction>%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:173.54000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:63.55pt"> of our revenue.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:237.09pt;position:var(--position);text-decoration:none;white-space:pre;width:13.39pt"> At </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:250.48pt;position:var(--position);text-decoration:none;white-space:pre;width:57.38pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:307.86pt;position:var(--position);text-decoration:none;white-space:pre;width:5.19pt">, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:313.05pt;position:var(--position);text-decoration:none;white-space:pre;width:15pt">one</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:328.05pt;position:var(--position);text-decoration:none;white-space:pre;width:97.04pt"> customer accounted for</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:425.09pt;position:var(--position);text-decoration:none;white-space:pre;width:2.69pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:427.78pt;position:var(--position);text-decoration:none;white-space:pre;width:17.34pt"><ix:nonFraction unitRef="number" contextRef="c-71" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-377">11</ix:nonFraction>%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:445.12pt;position:var(--position);text-decoration:none;white-space:pre;width:2.69pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:447.81pt;position:var(--position);text-decoration:none;white-space:pre;width:105.53pt">of our accounts receivable</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:352.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:47pt">balance. At </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:105.5pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:184.47pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:189.47pt;position:var(--position);text-decoration:none;white-space:pre;width:10pt">no</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:199.47pt;position:var(--position);text-decoration:none;white-space:pre;width:141.95pt"> customer accounted for more than </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:341.42pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt">10%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:359.42pt;position:var(--position);text-decoration:none;white-space:pre;width:143.95pt"> of our accounts receivable balance.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:381pt;width:612pt"><ix:nonNumeric contextRef="c-1" name="gdrx:PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock" id="f-378" continuedAt="f-378-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:342.75pt">Prescription Reimbursement Assets and Prescription Reimbursement Liabilities</span></ix:nonNumeric></div><ix:continuation id="f-378-1"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:397.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.87pt">Consumer direct pricing is an affordability solution under our pharma direct offering that allows pharma manufacturers to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:408.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">use our platform to set and fund a portion of the consumer cash price for their prescription drugs at the point of sale. We</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:419.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">generally require deposits from pharma manufacturers which are included as a component of prescription reimbursement</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:430.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">liabilities on our condensed consolidated balance sheets and shall not be offset against other amounts owed to us. We</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:441pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">generally invoice pharma manufacturers for the funded amounts a month in arrears and payment is generally due within</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:451.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">thirty days of invoicing. Funded amounts owed to us are presented as a component of prescription reimbursement assets on</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:462.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:177.96pt">our condensed consolidated balance sheets.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:479.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.91pt">We remit reimbursements of the funded amounts to pharmacies, or intermediaries. Funded amounts owed to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:490.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:447.2pt">pharmacies, or intermediaries, are presented as a component of prescription reimbursement liabilities on our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:505.7pt;position:var(--position);text-decoration:none;white-space:pre;width:47.73pt"> condensed</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:501pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:55.54pt">consolidated </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:114.03999999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:439.4pt">balance sheets. Pharmacies, or intermediaries, may also require deposits from us. These deposits are</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:511.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">included as a component of prescription reimbursement assets on our condensed consolidated balance sheets and shall not</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:522.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:159.14pt">be offset against other amounts owed </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:217.64pt;position:var(--position);text-decoration:none;white-space:pre;width:48.92pt">to them. At </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:266.56pt;position:var(--position);text-decoration:none;white-space:pre;width:59.28pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:325.84pt;position:var(--position);text-decoration:none;white-space:pre;width:22.28pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:348.12pt;position:var(--position);text-decoration:none;white-space:pre;width:81.25pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:429.37pt;position:var(--position);text-decoration:none;white-space:pre;width:124.11pt">, a majority of our prescription</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:533.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:112.93pt">reimbursement assets were </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:171.43pt;position:var(--position);text-decoration:none;white-space:pre;width:18.48pt">with </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:189.91pt;position:var(--position);text-decoration:none;white-space:pre;width:13.99pt"><ix:nonFraction unitRef="counterparty" contextRef="c-4" decimals="INF" name="gdrx:PrescriptionReimbursementAssetsNumberOfCounterparties" format="ixt-sec:numwordsen" scale="0" id="f-379"><ix:nonFraction unitRef="counterparty" contextRef="c-5" decimals="INF" name="gdrx:PrescriptionReimbursementAssetsNumberOfCounterparties" format="ixt-sec:numwordsen" scale="0" id="f-380">two</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:203.9pt;position:var(--position);text-decoration:none;white-space:pre;width:59.47pt"> counterparties</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:263.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span></div></ix:continuation><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:562.2pt;width:612pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:EquityMethodInvestmentsPolicy" id="f-381" continuedAt="f-381-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:82.43pt">Equity Investments</span></ix:nonNumeric></div><ix:continuation id="f-381-1"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:579pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.96pt">We retain minority equity interests in privately-held companies without readily determinable fair values. Our ownership</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:589.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:97.34pt">interests are less than </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:155.84pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt"><ix:nonFraction unitRef="number" contextRef="c-72" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-382">20</ix:nonFraction>%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:173.84pt;position:var(--position);text-decoration:none;white-space:pre;width:379.63pt"> of the voting stock of the investees and we do not have the ability to exercise significant</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:600.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">influence over the operating and financial policies of the investees. The equity investments are accounted for under the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:611.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:404.8pt">measurement alternative in accordance with Accounting Standards Codification ("ASC") 321, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:463.3pt;position:var(--position);text-decoration:none;white-space:pre;width:90.2pt">Investments &#8211; Equity</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:622.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:39.47pt">Securities</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:97.97pt;position:var(--position);text-decoration:none;white-space:pre;width:455.36pt">, which is cost minus impairment, if any, plus or minus changes resulting from observable price changes. We did</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:633pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt">not recognize any changes resulting from observable price changes or impairment losses on our minority equity interest</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:643.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:93.2pt">investments during the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:151.7pt;position:var(--position);text-decoration:none;white-space:pre;width:171.03pt">three and six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:322.73pt;position:var(--position);text-decoration:none;white-space:pre;width:20.16pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:342.89pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:362.89pt;position:var(--position);text-decoration:none;white-space:pre;width:190.49pt">. Equity investments included in other assets on</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:654.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:199.94pt">our condensed consolidated balance sheets were </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:258.44pt;position:var(--position);text-decoration:none;white-space:pre;width:50.45pt">$<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="f-383"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="f-384">15.0</ix:nonFraction></ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:308.89pt;position:var(--position);text-decoration:none;white-space:pre;width:24.5pt"> as of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:333.39pt;position:var(--position);text-decoration:none;white-space:pre;width:57pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:390.39pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:410.39pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:489.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span></div></ix:continuation><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:683.4pt;width:612pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="f-385" continuedAt="f-385-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:142.36pt">Impairment of Long-Lived Assets</span></ix:nonNumeric></div><ix:continuation id="f-385-1" continuedAt="f-385-2"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:700.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:335.34pt">We account for the impairment of long-lived assets in accordance with ASC 360, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:411.84pt;position:var(--position);text-decoration:none;white-space:pre;width:128.1pt">Property, Plant, and Equipment</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:539.94pt;position:var(--position);text-decoration:none;white-space:pre;width:13.55pt">. In</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:711pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">accordance with ASC 360, long-lived assets to be held and used are reviewed for impairment when events or changes in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:721.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.84pt">circumstances indicate that their carrying values may not be recoverable. We perform impairment testing at the asset group</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:732.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">level that represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div></ix:continuation></div></ix:continuation></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:303.22pt;position:var(--position);white-space:pre">9</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><ix:continuation id="f-366-3"><ix:continuation id="f-385-2"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">assets and liabilities. An impairment loss is recognized when estimated undiscounted future cash flows expected to result</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:55.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">from the use of the asset and its eventual disposition are less than its carrying value. If an asset is determined to be</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:66.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:438.79pt">impaired, the impairment is measured by the amount that the carrying value of the asset exceeds its fair value.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:83.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:352.98pt">During the three months ended March 31, 2025, we recognized an impairment loss of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:429.48pt;position:var(--position);text-decoration:none;white-space:pre;width:46.21pt">$<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-5" name="us-gaap:TangibleAssetImpairmentCharges" scale="6" id="f-386">4.4</ix:nonFraction>&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:475.69pt;position:var(--position);text-decoration:none;white-space:pre;width:77.73pt"> within general and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:94.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:425.74pt">administrative expenses to reduce the carrying value of an asset group to its estimated fair value of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:484.24pt;position:var(--position);text-decoration:none;white-space:pre;width:47.18pt">$<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-387">3.4</ix:nonFraction>&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:531.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:22.06pt">. The</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:105pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">impairment charge was due to a significant deterioration in the sublease market and rental rates whereby the carrying value</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:115.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">of the asset group was not recoverable. We otherwise have not recognized any impairment losses of our long-lived assets</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:126.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:42.48pt">during the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:100.97999999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:170.47pt">three and six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:271.45pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:291.45pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:311.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span></div></ix:continuation><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:155.4pt;width:612pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-388" continuedAt="f-388-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:157.83pt">Recent Accounting Pronouncements</span></ix:nonNumeric></div><ix:continuation id="f-388-1"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:172.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:183.95pt">Recently Adopted Accounting Pronouncement</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:189pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.95pt">In July 2025, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU")</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:199.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:39.62pt">2025-05, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:98.12pt;position:var(--position);text-decoration:none;white-space:pre;width:455.32pt">Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:210.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:300.32pt">Contract Assets for Private Companies and Certain Not-For-Profit Entities. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:358.82pt;position:var(--position);text-decoration:none;white-space:pre;width:194.66pt">This ASU amends ASC 326-20 in part to provide</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:221.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt">a practical expedient election to assume that current conditions as of the balance sheet date do not change for the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:232.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">remaining life of current accounts receivable and/or current contract assets arising from transactions accounted for under</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.34pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:243pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:47.55pt">Topic 606, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:106.05pt;position:var(--position);text-decoration:none;white-space:pre;width:170.02pt">Revenue from Contracts with Customers</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:276.07pt;position:var(--position);text-decoration:none;white-space:pre;width:277.35pt">. This ASU is effective for all entities for annual reporting periods</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:253.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt">beginning after December 15, 2025, and for interim reporting periods within those annual reporting periods. We adopted this</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:264.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">standard effective January 1, 2026, and the adoption did not have a material impact on our condensed consolidated</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:275.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:81.96pt">financial statements.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:298.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:255.43pt">Recently Issued Accounting Pronouncements - Not Yet Adopted</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:315pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:218.4pt">In September 2025, the FASB issued ASU 2025-06, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:294.9pt;position:var(--position);text-decoration:none;white-space:pre;width:258.55pt">Intangibles-Goodwill and Other-Internal-Use Software (Subtopic</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:325.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:37.58pt">350-40), </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:96.08pt;position:var(--position);text-decoration:none;white-space:pre;width:457.29pt">which amends certain aspects of the accounting for and disclosure of software costs under ASC 350-40. The</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:336.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">amendments in this ASU, amongst other things, eliminate accounting considerations of software development stages and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:347.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">instead require entities to capitalize internal-use software costs when management commits to funding the software project</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:358.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.98pt">and it is probable the project will be completed and will be used to perform the function intended. This ASU will be effective</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:369pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">for all entities for annual reporting periods beginning after December 15, 2027, and for interim reporting periods within those</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:379.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt">annual reporting periods. Early adoption of this ASU is permitted and can be applied retrospectively, prospectively or on a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:390.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.83pt">modified prospective basis. We are currently evaluating the impact of the adoption of this ASU on our consolidated financial</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:401.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:141.44pt">statements and related disclosures.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:418.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:211.81pt">In November 2024, the FASB issued ASU 2024-03, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:288.31pt;position:var(--position);text-decoration:none;white-space:pre;width:265.07pt">Income Statement - Reporting Comprehensive Income - Expense</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:429pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:376.4pt">Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:434.9pt;position:var(--position);text-decoration:none;white-space:pre;width:118.48pt">, which is intended to improve</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:439.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">the disclosures of expenses by providing more detailed information about the types of expenses in commonly presented</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:450.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt">expense captions. This ASU requires entities to disclose the amounts of purchases of inventory, employee compensation,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:461.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">depreciation and intangible asset amortization included in each relevant expense caption; as well as a qualitative description</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:472.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. This ASU also</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:483pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">requires disclosure of the total amount of selling expense and, in annual reporting periods, an entity&#8217;s definition of selling</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:493.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.84pt">expenses. In January 2025, the FASB issued ASU 2025-01 which clarified the effective date of this ASU. This ASU applies</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:504.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">to all public entities and will be effective for fiscal years beginning after December 15, 2026, and for interim periods within</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:515.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">fiscal years beginning after December 15, 2027. Early adoption of this ASU is permitted. This ASU should be applied either</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:526.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:495pt">prospectively to financial statements issued for reporting periods after the effective date of this ASU or retrospectively to any</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:537pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">or all prior periods presented in the financial statements. We are currently evaluating the impact of the adoption of this ASU</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:547.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:210.4pt">on our consolidated financial statements disclosures.</span></div></ix:continuation></ix:continuation><div style="position:absolute;top:576.6pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_43"></div><div style="font-size:12pt;line-height:9pt;position:var(--position);top:576.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre">3</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:63.5pt;position:var(--position);text-decoration:none;white-space:pre">. </span><ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="f-389" continuedAt="f-389-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre">Business Combination</span></ix:nonNumeric></div><ix:continuation id="f-389-1"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:593.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.91pt">On January 13, 2025, we acquired substantially all of the assets and assembled workforce of VCRx, a prescription</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:604.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:177.33pt">savings business of Vivid Clear Rx, Inc., for </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:235.83pt;position:var(--position);text-decoration:none;white-space:pre;width:50.71pt">$<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="f-390">30.0</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:286.53999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:266.96pt"> in cash. VCRx operates a price comparison platform that provides</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:615pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:495pt">consumer prescription savings through its partnership with PBMs. The acquisition expands our consumer reach particularly</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:625.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:208.22pt">with respect to our prescription transactions offering.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:642.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:194.22pt">Goodwill associated with this acquisition totaled </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:270.72pt;position:var(--position);text-decoration:none;white-space:pre;width:50.18pt">$<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-391">11.0</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:320.9pt;position:var(--position);text-decoration:none;white-space:pre;width:232.48pt"> and primarily related to the expected long-term synergies</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:653.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">and other benefits, including the acquired assembled workforce. The goodwill is deductible for tax purposes. Identifiable</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:664.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:123.6pt">intangible assets related to this</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:182.1pt;position:var(--position);text-decoration:none;white-space:pre;width:47.55pt"> acquisition </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:229.65pt;position:var(--position);text-decoration:none;white-space:pre;width:29.53pt">totaled </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:259.18pt;position:var(--position);text-decoration:none;white-space:pre;width:50.49pt">$<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="f-392">19.0</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:309.66999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:40.6pt">, of which </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:350.27pt;position:var(--position);text-decoration:none;white-space:pre;width:50.49pt">$<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="f-393">18.1</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:400.76pt;position:var(--position);text-decoration:none;white-space:pre;width:152.66pt"> was attributable to a customer related</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:675pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:190.4pt">intangible asset, with an estimated useful life of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:248.9pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt"><ix:nonNumeric contextRef="c-77" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-394">6</ix:nonNumeric></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:253.9pt;position:var(--position);text-decoration:none;white-space:pre;width:24.49pt"> years</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:278.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span></div></ix:continuation></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:300.44pt;position:var(--position);white-space:pre">10</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="position:absolute;top:45pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_49"></div><div style="font-size:12pt;line-height:9pt;position:var(--position);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre">4</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:63.5pt;position:var(--position);white-space:pre">. </span><ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" id="f-395" continuedAt="f-395-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre">Accrued Expenses and Other Current Liabilities</span></ix:nonNumeric></div><ix:continuation id="f-395-1"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:61.8pt;width:612pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="f-396" continuedAt="f-396-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:276.85pt">Accrued expenses and other current liabilities consist of the following:</span></ix:nonNumeric></div><ix:continuation id="f-396-1"><div style="position:var(--position);top:84.6pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:331.5pt"/><td style="padding:0;width:80.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:80.25pt"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:331.5pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);width:80.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:14.15pt;position:var(--position);text-decoration:none;white-space:pre">June 30, 2026</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);width:80.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:4.16pt;position:var(--position);text-decoration:none;white-space:pre">December 31, 2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:14.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Accrued bonus and other payroll related</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:14.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="gdrx:AccruedBonusAndOtherPayrollRelatedCurrent" format="ixt:num-dot-decimal" scale="3" id="f-397">23,691</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:14.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="gdrx:AccruedBonusAndOtherPayrollRelatedCurrent" format="ixt:num-dot-decimal" scale="3" id="f-398">25,434</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:28.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Accrued legal settlement</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:28.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-399">30,500</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:28.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-400">30,500</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:42.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Accrued marketing</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:42.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedMarketingCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-401">20,255</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:42.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedMarketingCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-402">11,063</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:57pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Deferred revenue</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:57pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-403">8,767</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:57pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-404">6,705</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:15.75pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:71.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Other accrued expenses</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:71.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-405">15,397</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:71.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-406">13,003</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:15.75pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:87pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Total accrued expenses and other current liabilities</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:87pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="gdrx:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-407">98,610</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:87pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="gdrx:AccruedExpensesAndOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-408">86,705</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:198.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.9pt">Deferred revenue represents payments received in advance for subscriptions and providing services for certain</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:209.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:153.08pt">advertising contracts with customers</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:211.58pt;position:var(--position);text-decoration:none;white-space:pre;width:246.45pt">. We expect substantially all of the deferred revenue at </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:458.03pt;position:var(--position);text-decoration:none;white-space:pre;width:62.44pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:520.47pt;position:var(--position);text-decoration:none;white-space:pre;width:32.9pt"> will be</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:219.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:273.61pt">recognized as revenue within the subsequent twelve months. Of the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:332.11pt;position:var(--position);text-decoration:none;white-space:pre;width:45.57pt">$<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-409">6.7</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:377.68pt;position:var(--position);text-decoration:none;white-space:pre;width:94.07pt"> of deferred revenue at </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:471.75pt;position:var(--position);text-decoration:none;white-space:pre;width:79.21pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:550.96pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:230.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:45.57pt">$<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-410">0.9</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:104.07pt;position:var(--position);text-decoration:none;white-space:pre;width:20.24pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:124.31pt;position:var(--position);text-decoration:none;white-space:pre;width:45.57pt">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-411">5.4</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:169.88pt;position:var(--position);text-decoration:none;white-space:pre;width:157.78pt"> was recognized as revenue during the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:327.66pt;position:var(--position);text-decoration:none;white-space:pre;width:171.31pt">three and six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:498.97pt;position:var(--position);text-decoration:none;white-space:pre;width:54.43pt">, respectively.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:241.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:127.61pt">Revenue recognized during the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:186.11pt;position:var(--position);text-decoration:none;white-space:pre;width:170.75pt">three and six months ended June 30, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:356.86pt;position:var(--position);text-decoration:none;white-space:pre;width:12.58pt"> of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:369.44pt;position:var(--position);text-decoration:none;white-space:pre;width:45.49pt">$<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-412"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-413">0.9</ix:nonFraction></ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:414.93pt;position:var(--position);text-decoration:none;white-space:pre;width:20.08pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:435.01pt;position:var(--position);text-decoration:none;white-space:pre;width:45.49pt">$<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-414">5.2</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:480.5pt;position:var(--position);text-decoration:none;white-space:pre;width:72.88pt">, respectively, was</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:252.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:128.95pt">included as deferred revenue at </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:187.45pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt">December&#160;31, 2024</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:266.41999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span></div></ix:continuation><div style="position:absolute;top:281.15pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_52"></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:281.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">5</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:63.5pt;position:var(--position);white-space:pre;width:5pt">. </span><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-415" continuedAt="f-415-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:59.47pt">Income Taxes</span></ix:nonNumeric></div><ix:continuation id="f-415-1"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:297.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.98pt">We generally calculate income taxes in interim periods by applying an estimated annual effective income tax rate to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:308.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.82pt">income or loss before income taxes and by calculating the tax effect of discrete items recognized during such periods. Our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3199999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:319.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt">estimated annual effective income tax rate is based on our estimated full year income or loss and the related income taxes</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:330.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">for each jurisdiction in which we operate. This rate can be affected by estimates of full year pre-tax income or loss and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:341.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:91.8pt">permanent differences.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:357.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:147.74pt">The effective income tax rate for the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:224.24pt;position:var(--position);text-decoration:none;white-space:pre;width:140.88pt">three months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:365.12pt;position:var(--position);text-decoration:none;white-space:pre;width:20.56pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:385.68pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:405.68pt;position:var(--position);text-decoration:none;white-space:pre;width:21.55pt"> was </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:427.23pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt"><ix:nonFraction unitRef="number" contextRef="c-10" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-416">44.8</ix:nonFraction>%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:452.73pt;position:var(--position);text-decoration:none;white-space:pre;width:20.56pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:473.29pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt"><ix:nonFraction unitRef="number" contextRef="c-11" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-417">34.4</ix:nonFraction>%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:498.79pt;position:var(--position);text-decoration:none;white-space:pre;width:54.59pt">, respectively.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.34pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:368.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:151.03pt">The effective income tax rate for the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:209.53pt;position:var(--position);text-decoration:none;white-space:pre;width:133.73pt">six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:343.26pt;position:var(--position);text-decoration:none;white-space:pre;width:21.5pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:364.76pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:384.76pt;position:var(--position);text-decoration:none;white-space:pre;width:22.49pt"> was </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:407.25pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-418">54.0</ix:nonFraction>%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:432.75pt;position:var(--position);text-decoration:none;white-space:pre;width:21.5pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:454.25pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-419">34.1</ix:nonFraction>%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:479.75pt;position:var(--position);text-decoration:none;white-space:pre;width:73.64pt">, respectively. The</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:379.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:408.77pt">primary differences between our effective income tax rates and the federal statutory tax rate for the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:467.27pt;position:var(--position);text-decoration:none;white-space:pre;width:86.05pt">three and six months</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3199999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:390.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:84.89pt">ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:143.39pt;position:var(--position);text-decoration:none;white-space:pre;width:20.26pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:163.65pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:183.65pt;position:var(--position);text-decoration:none;white-space:pre;width:369.8pt"> were due to the effects of non-deductible officers&#8217; stock-based compensation expense, state</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:401.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:422.17pt">income taxes, benefits from research and development tax credits, and tax effects from our equity awards.</span></div></ix:continuation><div style="position:absolute;top:429.95pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_55"></div><div style="font-size:12pt;line-height:9pt;position:var(--position);top:429.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre">6</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:63.5pt;position:var(--position);white-space:pre">. </span><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-420" continuedAt="f-420-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre">Debt</span></ix:nonNumeric></div><ix:continuation id="f-420-1" continuedAt="f-420-2"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:446.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:421.5pt">Our First Lien Credit Agreement (as amended from time to time, the "Credit Agreement") provides for (i) a </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:498pt;position:var(--position);text-decoration:none;white-space:pre;width:55.5pt">$<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-421">500.0</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:457.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:90.78pt">term loan maturing on </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:149.28pt;position:var(--position);text-decoration:none;white-space:pre;width:53.91pt">July 10, 2029</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:203.19pt;position:var(--position);text-decoration:none;white-space:pre;width:281.45pt"> ("2024 Term Loan Facility"); and (ii) a revolving credit facility for up to </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:484.64pt;position:var(--position);text-decoration:none;white-space:pre;width:50.66pt">$<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-5" name="gdrx:LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension" scale="6" id="f-422">88.0</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:535.3pt;position:var(--position);text-decoration:none;white-space:pre;width:18.2pt"> (the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:468.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:158.35pt">"Revolving Credit Facility") maturing on </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:216.85pt;position:var(--position);text-decoration:none;white-space:pre;width:55.71pt">April 10, 2029</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:272.56pt;position:var(--position);text-decoration:none;white-space:pre;width:27.87pt">. As of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:300.43pt;position:var(--position);text-decoration:none;white-space:pre;width:57.24pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:357.67pt;position:var(--position);text-decoration:none;white-space:pre;width:195.64pt">, there were no changes to the terms of our 2024</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.31pt;position:var(--position);text-decoration:none;white-space:pre;width:2.34pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:479.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:277.33pt">Term Loan Facility and Revolving Credit Facility as disclosed in Note </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:335.83pt;position:var(--position);text-decoration:none;white-space:pre;width:10pt">12</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:345.83pt;position:var(--position);text-decoration:none;white-space:pre;width:207.51pt"> to our consolidated financial statements included in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:489.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:15.49pt">our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:73.99pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:93.99000000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:23.99pt"> 10-K.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:506.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:218.84pt">The effective interest rate on our term loans for the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:295.34000000000003pt;position:var(--position);text-decoration:none;white-space:pre;width:146.78pt">three months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:442.12pt;position:var(--position);text-decoration:none;white-space:pre;width:22.92pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:465.04pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:485.04pt;position:var(--position);text-decoration:none;white-space:pre;width:23.91pt"> was </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:508.95pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt"><ix:nonFraction unitRef="number" contextRef="c-81" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="f-423">7.85</ix:nonFraction>%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:534.45pt;position:var(--position);text-decoration:none;white-space:pre;width:18.96pt"> and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:517.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt"><ix:nonFraction unitRef="number" contextRef="c-82" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="f-424">8.60</ix:nonFraction>%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:84pt;position:var(--position);text-decoration:none;white-space:pre;width:272.89pt">, respectively. The effective interest rate on our term loans for the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:356.89pt;position:var(--position);text-decoration:none;white-space:pre;width:134.98pt">six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:491.87pt;position:var(--position);text-decoration:none;white-space:pre;width:22pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:513.87pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:533.87pt;position:var(--position);text-decoration:none;white-space:pre;width:19.49pt"> was</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:528.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt"><ix:nonFraction unitRef="number" contextRef="c-83" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="f-425">7.86</ix:nonFraction>%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:84pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:104pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt"><ix:nonFraction unitRef="number" contextRef="c-84" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="f-426">8.56</ix:nonFraction>%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:129.5pt;position:var(--position);text-decoration:none;white-space:pre;width:54.31pt">, respectively.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:545.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:33.33pt">We had </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:109.83pt;position:var(--position);text-decoration:none;white-space:pre;width:10pt"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="f-427"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="f-428">no</ix:nonFraction></ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:119.83pt;position:var(--position);text-decoration:none;white-space:pre;width:216.35pt"> borrowings against the Revolving Credit Facility as of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:336.18pt;position:var(--position);text-decoration:none;white-space:pre;width:57pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:393.18pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:413.18pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:492.15pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:561.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:322.86pt">We had outstanding letters of credit issued against the Revolving Credit Facility</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:399.36pt;position:var(--position);text-decoration:none;white-space:pre;width:16.89pt"> for </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:416.25pt;position:var(--position);text-decoration:none;white-space:pre;width:46.15pt">$<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-429">7.6</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:462.4pt;position:var(--position);text-decoration:none;white-space:pre;width:21.4pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:483.8pt;position:var(--position);text-decoration:none;white-space:pre;width:46.15pt">$<ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-430">7.8</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:529.95pt;position:var(--position);text-decoration:none;white-space:pre;width:23.4pt"> as of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:572.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:59.54pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:118.03999999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:22.54pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:140.57999999999998pt;position:var(--position);text-decoration:none;white-space:pre;width:81.51pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:222.09pt;position:var(--position);text-decoration:none;white-space:pre;width:331.33pt">, respectively, which reduce our available borrowings under the Revolving Credit</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:583.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:29.8pt">Facility.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:600.35pt;width:612pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtTableTextBlock" id="f-431" continuedAt="f-431-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:122.44pt">Our debt balance is as follows:</span></ix:nonNumeric></div><ix:continuation id="f-431-1"><div style="position:var(--position);top:623.15pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:331.5pt"/><td style="padding:0;width:80.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:80.25pt"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:331.5pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);width:80.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:14.15pt;position:var(--position);text-decoration:none;white-space:pre">June 30, 2026</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);width:80.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:4.16pt;position:var(--position);text-decoration:none;white-space:pre">December 31, 2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:14.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Principal balance under 2024 Term Loan Facility</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:14.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-432">492,500</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:14.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-433">495,000</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:28.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Less: Unamortized debt issuance costs and discounts</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:28.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.39pt"></span></span><span style="left:51.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-434">5,912</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:28.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.39pt"></span></span><span style="left:51.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-435">6,736</ix:nonFraction>)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:42.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:42.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-436">486,588</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:42.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-437">488,264</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:691.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:166.66pt">The estimated fair value of our debt was </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:243.16pt;position:var(--position);text-decoration:none;white-space:pre;width:55.98pt">$<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:LongTermDebtFairValue" scale="6" id="f-438">469.1</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:299.14pt;position:var(--position);text-decoration:none;white-space:pre;width:26.09pt"> as of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:325.23pt;position:var(--position);text-decoration:none;white-space:pre;width:58.06pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:383.29pt;position:var(--position);text-decoration:none;white-space:pre;width:170.13pt"> and approximated its carrying value as of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:701.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:137.47pt;position:var(--position);text-decoration:none;white-space:pre;width:265.73pt">, based on inputs categorized as Level 2 in the fair value hierarchy.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:718.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.98pt">Under the Credit Agreement, we are subject to a financial covenant requiring maintenance of a First Lien Net Leverage</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:729.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:228.5pt">Ratio (as defined in the Credit Agreement) not to exceed </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:287pt;position:var(--position);text-decoration:none;white-space:pre;width:12.5pt"><ix:nonFraction unitRef="number" contextRef="c-83" decimals="3" name="gdrx:LineOfCreditMaximumFinancialCovenantNetLeverageRatio" scale="-2" id="f-439">8.2</ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:299.5pt;position:var(--position);text-decoration:none;white-space:pre;width:12.82pt"> to </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:312.32pt;position:var(--position);text-decoration:none;white-space:pre;width:12.5pt">1.0</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:324.82pt;position:var(--position);text-decoration:none;white-space:pre;width:228.55pt"> only in the event that the amounts outstanding under the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div></ix:continuation></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:300.81pt;position:var(--position);white-space:pre">11</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><ix:continuation id="f-420-2"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt">Revolving Credit Facility exceed a specified percentage of commitments under the Revolving Credit Facility, and other</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:55.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:210.31pt">nonfinancial covenants under the Credit Agreement. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:268.81pt;position:var(--position);text-decoration:none;white-space:pre;width:11.23pt">At </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:280.03999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:57.46pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:337.5pt;position:var(--position);text-decoration:none;white-space:pre;width:215.96pt">, we were in compliance with our covenants under the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:66.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:72.46pt">Credit Agreement.</span></div></ix:continuation><div style="position:absolute;top:95.4pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_58"></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:95.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">7</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:63.5pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">. </span><ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-440" continuedAt="f-440-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:142.86pt">Commitments and Contingencies</span></ix:nonNumeric></div><ix:continuation id="f-440-1" continuedAt="f-440-2"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:112.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:113.64pt">Aside from the below, as of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:190.14pt;position:var(--position);text-decoration:none;white-space:pre;width:58.06pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:248.2pt;position:var(--position);text-decoration:none;white-space:pre;width:305.19pt">, there were no material changes to our commitments and contingencies as</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:123pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:310.36pt">disclosed in the notes to our consolidated financial statements included in our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:368.86pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:388.86pt;position:var(--position);text-decoration:none;white-space:pre;width:23.99pt"> 10-K.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:145.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:87.91pt">Legal Contingencies</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:162.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:126.58pt">Consumer privacy class action</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:203.07999999999998pt;position:var(--position);text-decoration:none;white-space:pre;width:219.43pt"> - Between February 2, 2023, and March 30, 2023, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:422.51pt;position:var(--position);text-decoration:none;white-space:pre;width:13.99pt"><ix:nonFraction unitRef="plaintiff" contextRef="c-93" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" format="ixt-sec:numwordsen" scale="0" id="f-441">five</ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:436.5pt;position:var(--position);text-decoration:none;white-space:pre;width:102.95pt"> individual plaintiffs filed </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:539.45pt;position:var(--position);text-decoration:none;white-space:pre;width:13.99pt"><ix:nonFraction unitRef="case" contextRef="c-94" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="f-442">five</ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:173.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">separate putative class action lawsuits against Google, Meta, Criteo and us, alleging generally that we have not adequately</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:184.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:457.3pt">protected consumer privacy and that we communicated consumer information to third parties, including the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:515.8pt;position:var(--position);text-decoration:none;white-space:pre;width:20.49pt"><ix:nonFraction unitRef="defendant" contextRef="c-93" decimals="INF" name="us-gaap:LossContingencyNumberOfDefendants" format="ixt-sec:numwordsen" scale="0" id="f-443">three</ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:536.29pt;position:var(--position);text-decoration:none;white-space:pre;width:17.17pt"> co-</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:195pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:50.96pt">defendants. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:109.46000000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:18.48pt"><ix:nonFraction unitRef="plaintiff" contextRef="c-95" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" format="ixt-sec:numwordsen" scale="0" id="f-444">Four</ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:127.94pt;position:var(--position);text-decoration:none;white-space:pre;width:425.46pt"> of the plaintiffs allege common law intrusion upon seclusion and unjust enrichment claims, as well as</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:205.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">claims under California&#8217;s Confidentiality of Medical Information Act, Invasion of Privacy Act, Consumer Legal Remedies Act,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:216.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:119.79pt">and Unfair Competition Law. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:178.29000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:17pt"><ix:nonFraction unitRef="plaintiff" contextRef="c-96" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" format="ixt-sec:numwordsen" scale="0" id="f-445">One</ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:195.29pt;position:var(--position);text-decoration:none;white-space:pre;width:40.27pt"> of these </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:235.56pt;position:var(--position);text-decoration:none;white-space:pre;width:15.49pt"><ix:nonFraction unitRef="plaintiff" contextRef="c-95" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" format="ixt-sec:numwordsen" scale="0" id="f-446">four</ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:251.05pt;position:var(--position);text-decoration:none;white-space:pre;width:302.44pt"> plaintiffs additionally brings a claim under the Electronic Communications</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:227.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">Privacy Act. The fifth plaintiff brings claims for common-law unjust enrichment and violations of New York&#8217;s General</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:238.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:495pt">Business Law. Four of these cases were originally filed in the United States District Court for the Northern District of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:249pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt">California ("NDCA") (Cases No. 3:23-cv-00501; 3:23-cv-00744; 3:23-cv-00940; and 4:23-cv-01293). One case was originally</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:259.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">filed in the United States District Court for the Southern District of New York (Case No. 1:23-cv-00943); however, that case</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:270.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:348pt">was voluntarily dismissed and re-filed in the NDCA (Case No. 3:23-cv-01508). These </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:406.5pt;position:var(--position);text-decoration:none;white-space:pre;width:13.99pt"><ix:nonFraction unitRef="plaintiff" contextRef="c-93" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" format="ixt-sec:numwordsen" scale="0" id="f-447">five</ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:420.49pt;position:var(--position);text-decoration:none;white-space:pre;width:132.92pt"> matters have been consolidated</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:281.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">and assigned to U.S. District Judge Araceli Mart&#237;nez-Olgu&#237;n in the NDCA. The court also set a briefing schedule for filing a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:292.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">single consolidated complaint, which the plaintiffs filed on May 21, 2023 (Case No. 3:23-cv-00501-AMO; the "NDCA Class</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:303pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.83pt">Action Matter"), as well as motions to dismiss and motions to compel arbitration. In addition to the aforementioned claims,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:313.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">the plaintiffs in the now consolidated matter bring claims under the Illinois Consumer Fraud and Deceptive Business</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:324.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.83pt">Practices Act, common law negligence and negligence per se, in each case, pleaded in the alternative. The plaintiffs are</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:335.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">seeking various forms of monetary damages (such as statutory damages, compensatory damages, attorneys&#8217; fees and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:346.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt">disgorgement of profits) as well as injunctive relief. Briefing on the motions to dismiss and motions to compel arbitration was</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:357pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:123.99pt">completed on August 24, 2023.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:373.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:91.15pt">On October 27, 2023, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:167.65pt;position:var(--position);text-decoration:none;white-space:pre;width:10.99pt"><ix:nonFraction unitRef="plaintiff" contextRef="c-97" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" format="ixt-sec:numwordsen" scale="0" id="f-448">six</ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:178.64pt;position:var(--position);text-decoration:none;white-space:pre;width:374.82pt"> plaintiffs filed a class action complaint (Case No. 1:23-cv-24127-BB; the &#8220;SDFL Class Action</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:384.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.82pt">Matter&#8221;) against us in the United States District Court for the Southern District of Florida ("SDFL"). The plaintiffs alleged, on</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3199999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:395.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">behalf of the same nationwide class as the NDCA Class Action Matter, substantially the same statutory and common law</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:406.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">violation claims as alleged in that matter as well as claims based on the federal Electronic Communications Privacy Act,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:417pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">invasion of privacy under California common law and the California constitution, invasion of privacy under New Jersey's</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:427.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt">Constitution, and violations of Pennsylvania&#8217;s Wiretapping and Electronic Surveillance Control Act, Florida&#8217;s Security of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:438.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">Communications Act, New York&#8217;s Civil Rights Law and Stop Hack and Improve Electronic Data Security Act. The plaintiffs in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:449.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">the SDFL Class Action Matter seek various forms of monetary damages as well as injunctive and other unspecified equitable</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:460.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:21.97pt">relief.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:477pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.9pt">On October 27, 2023, we entered into a proposed settlement agreement with the plaintiffs in the SDFL Class Action</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:487.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">Matter, on behalf of a nationwide settlement class that includes the NDCA Class Action Matter, which provides for a payment</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:498.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:10.36pt">of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:68.86pt;position:var(--position);text-decoration:none;white-space:pre;width:50.81pt">$<ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="6" id="f-449">13.0</ix:nonFraction>&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:119.67pt;position:var(--position);text-decoration:none;white-space:pre;width:433.66pt"> by us. On October 30, 2023, the plaintiffs in the SDFL Class Action Matter filed a motion and memorandum</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:509.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">in support of preliminary approval of the proposed class action settlement and, on October 31, 2023, the SDFL granted</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:520.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">preliminary approval of the proposed settlement. Members of the class have the opportunity to opt-out of the class and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:531pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:116.44pt">commence their own actions.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:547.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.83pt">In response to the proposed settlement in the SDFL Class Action Matter, plaintiffs in the NDCA Class Action Matter filed</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:558.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.84pt">(i) on November 1, 2023, a motion in the NDCA for an order to require us to cease litigation of, or alternatively file a motion</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:569.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.84pt">to stay in, the SDFL Class Action Matter and enjoin us from seeking settlement with counsel other than plaintiffs&#8217; counsel in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:580.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.85pt">the NDCA Class Action Matter; and (ii) on November 2, 2023, a motion in the SDFL for that court to allow them to intervene</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:591pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">and appear in the SDFL action, transfer the SDFL Class Action Matter to the NDCA and reconsider and deny its preliminary</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:601.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:495pt">approval of the proposed settlement. The SDFL has issued an order requiring the SDFL plaintiffs to, among other things, file</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:612.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">a response to the NDCA plaintiffs' motion to intervene. Additionally, U.S. District Judge Araceli Mart&#237;nez-Olgu&#237;n in the NDCA</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:623.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">issued an order for us to show cause as to why we should not be sanctioned for an alleged failure to provide notification to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:634.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.8pt">the NDCA of the pendency of the SDFL Class Action Matter. We filed our written response to this order on November 8,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:645pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">2023. The NDCA held a hearing on November 14, 2023, and ordered parties to the litigation to participate in mediation. The</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:655.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">parties participated in mediation on January 10, 2024, and agreed to participate in an additional day of mediation, which</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:666.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:109.96pt">occurred on March 7, 2024.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:683.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.83pt">On December 3, 2024, the SDFL plaintiffs filed a voluntary motion to dismiss, with prejudice, which was approved by</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:694.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">the court on December 4, 2024. On November 25, 2024, we entered into a settlement agreement with the NDCA plaintiffs</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:705pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:13.21pt">for </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:71.71000000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:50.67pt">$<ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:PaymentsForLegalSettlements" scale="6" id="f-450">25.0</ix:nonFraction>&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:122.38pt;position:var(--position);text-decoration:none;white-space:pre;width:431.01pt">, subject to approval by the court. On June 12, 2025, the court denied the motion for preliminary approval of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:715.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">the settlement with prejudice, with leave for the plaintiffs to refile with additional information requested by the court. Based</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:726.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:244.27pt">on the settlement agreement, an estimated probable loss of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:302.77pt;position:var(--position);text-decoration:none;white-space:pre;width:50.99pt">$<ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="f-451">25.0</ix:nonFraction>&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:353.76pt;position:var(--position);text-decoration:none;white-space:pre;width:199.7pt"> was included within accrued expenses and other</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:737.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">current liabilities on our condensed consolidated balance sheets as of June 30, 2026 and December 31, 2025. Additionally,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div></ix:continuation></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:300.44pt;position:var(--position);white-space:pre">12</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><ix:continuation id="f-440-2"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:137.82pt">we estimated a probable loss of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:196.32pt;position:var(--position);text-decoration:none;white-space:pre;width:46.93pt">$<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="f-452">5.5</ix:nonFraction>&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:243.25pt;position:var(--position);text-decoration:none;white-space:pre;width:310.1pt"> relating to the indemnification of certain parties named in the class action</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:55.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">lawsuits, which was included within accrued expenses and other current liabilities on our condensed consolidated balance</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:66.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.83pt">sheets as of June 30, 2026 and December 31, 2025. While these amounts represent our best judgment of the probable</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:77.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">losses based on the information currently available to us, they are subject to significant judgments and estimates and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:88.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:366.79pt">numerous factors beyond our control, including, without limitation, final approval of the court.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:425.29pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:105pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.87pt">On November 19, 2025, together with another party named in the class action lawsuit, we filed an amended settlement</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:115.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt">agreement. On November 26, 2025, plaintiffs filed a motion for preliminary approval of the class settlement. On January 16,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:126.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">2026, the court denied the motion for preliminary approval of the settlement, requesting additional information from the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:137.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">plaintiffs. On March 24, 2026, the plaintiffs filed an administrative motion for leave to submit supplemental brief to address</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:148.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">the court's concerns and request for status conference. On March 26, 2026, the court denied the motion but granted</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:159pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:251.65pt">plaintiffs leave to submit a new motion for preliminary approval.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:310.15pt;position:var(--position);text-decoration:none;white-space:pre;width:243.27pt"> Plaintiffs filed a new motion for preliminary approval on June</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:169.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:233.26pt">1, 2026, which is set for a hearing on September 3, 2026.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:291.76pt;position:var(--position);text-decoration:none;white-space:pre;width:261.67pt"> The terms of the amended settlement agreement were reflective</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:180.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:495pt">of the aggregate probable loss recorded in connection with this matter and, as such, we did not accrue for any additional</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:191.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">amounts. The results of legal proceedings are inherently uncertain, and upon final resolution of these matters, it is</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:202.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:278.2pt">reasonably possible that the actual loss may differ from our estimates.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:219pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:106.98pt">Consumer state litigations </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:183.48000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:369.95pt">- On May 28, 2024, The Bert and Annette Mullens Foundation ("Mullens Foundation") filed a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:229.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">lawsuit against us in Pope County, Arkansas, alleging that we violated an Arkansas statute related to the distribution of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:240.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.98pt">health-related discount cards. Specifically, the statute provides that each discount card must &#8220;expressly provide in bold and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:251.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt">prominent type that the discounts are not insurance.&#8221; Ark. Code Ann. &#167; 4-106-201(1). Furthermore, the statute provides that</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:262.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">each card must &#8220;expressly provide in bold and prominent type on the card or in a statement attached to the card that the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:273pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt">consumer has the right to cancel his or her registration within thirty (30) days from the effective date of the card.&#8221; Ark. Code</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:283.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.98pt">Ann. &#167; 4-106-201(2). The plaintiff alleges that our cards did not comply with these requirements, and sought an injunction</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:294.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.83pt">and statutory damages. We filed a motion to dismiss the complaint, which was denied on December 2, 2024. On May 9,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:305.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.85pt">2025, the Arkansas Attorney General moved to intervene in the case. On May 13, 2025, the plaintiff moved for partial</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:316.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">summary judgment, which we and the Arkansas Attorney General opposed. Separately, on September 24, 2025, the State of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:327pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">Arkansas, ex rel. Tim Griffin, Attorney General, filed suit in Faulkner County, Arkansas alleging the same violations of Ark.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:337.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">Code Ann. &#167; 4-106-201 et seq. as the Mullens Foundation in addition to violations of the Arkansas Deceptive Trade</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:348.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">Practices Act ("ADTPA"). On September 25, 2025, the Circuit Court of Faulkner County entered a Consent Judgment</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:359.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt">through which the plaintiff, acting parens patriae for the people of Arkansas, released us from any and all claims and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:370.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">remedies available or potentially available under the ADTPA and the discount card statute, Ark. Code Ann. &#167;&#167; 4-106-201 et</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:381pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">seq. for GoodRx discount cards sold, marketed, promoted, advertised, or otherwise distributed in Arkansas from January 1,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:391.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:277.95pt">2022 until the effective date of the agreement. As part of the Consent </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:336.45pt;position:var(--position);text-decoration:none;white-space:pre;width:41.99pt">Judgment,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:378.44pt;position:var(--position);text-decoration:none;white-space:pre;width:175.02pt"> we also agreed to pay immaterial monetary</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:402.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt">relief. On July 20, 2026, the Arkansas Attorney General moved to intervene to move for summary judgment dismissing the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:413.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:102.45pt">Mullens Foundation case.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:430.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:132.69pt">Furthermore, on June 11, 2024, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:209.19pt;position:var(--position);text-decoration:none;white-space:pre;width:171.17pt">the Minnesota Teamsters Service Bureau </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:380.36pt;position:var(--position);text-decoration:none;white-space:pre;width:173.06pt">also filed a lawsuit against us in Hennepin</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:441pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">County, Minnesota, alleging that we violated a Minnesota statute related to the distribution of health-related discount cards.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:451.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">Specifically, the statute provides that each discount card must &#8220;expressly provide in bold and prominent type that the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:462.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">discounts are not insurance.&#8221; Minn. Stat. Ann. &#167; 325F.784, subd. 1(1). The plaintiff alleges that our cards do not comply with</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:473.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.85pt">these requirements and also seeks an injunction and statutory damages. We filed a motion to dismiss the complaint, which</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:484.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt">was denied on December 17, 2024. On June 10, 2025, the plaintiff moved to dismiss some of our counterclaims; the court</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:495pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">granted the motion to dismiss. Discovery has been completed in Minnesota. On October 10, 2025, we moved for summary</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:505.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">judgment and plaintiff moved for partial summary judgment. On February 5, 2026, the court entered an order on our motion</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:516.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:495pt">for summary judgment, directing that judgment be entered dismissing plaintiff&#8217;s claims as time-barred. On April 10, 2026,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:527.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:335.69pt">plaintiff filed a notice of appeal regarding the court&#8217;s summary judgment decision. O</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:394.19pt;position:var(--position);text-decoration:none;white-space:pre;width:70.9pt">n June 18, 2026, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:465.09pt;position:var(--position);text-decoration:none;white-space:pre;width:88.3pt">plaintiff filed their brief</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:538.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:219.92pt">on appeal and we filed our opposition on July 20, 2026.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:555pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:368.94pt">We intend to vigorously defend against the claims asserted in the Mullens Foundation </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:445.44pt;position:var(--position);text-decoration:none;white-space:pre;width:25.48pt">matter</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:470.92pt;position:var(--position);text-decoration:none;white-space:pre;width:82.54pt"> and the Minnesota</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.34pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:565.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">Teamsters Service Bureau matters as we believe we have meritorious defenses to such claims. While it is reasonably</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:576.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.79pt">possible a loss may have been incurred, we have not accrued a loss as a loss is not probable and we are unable to estimate</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.29pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:587.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:90.46pt">a loss or range of loss.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:604.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.9pt">These pending proceedings involve complex questions of fact and law and may require the expenditure of significant</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:615pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">funds and the diversion of other resources to defend. In addition, during the normal course of business, we (including our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:625.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">directors and officers whom we indemnify) may become subject to, and are presently involved in, legal proceedings, claims</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:636.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">and litigation. Such matters are subject to many uncertainties and outcomes are not predictable with assurance. Aside from</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:647.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.83pt">the consumer privacy class action matter, we have not accrued for a material loss for any other matters as a loss is not</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:658.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">probable and a loss, or a range of loss, is not reasonably estimable. Accruals for loss contingencies are recognized when a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:669pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:363.28pt">loss is probable, and the amount of such loss can be reasonably estimated. See "Note </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:421.78pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">4</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:426.78pt;position:var(--position);text-decoration:none;white-space:pre;width:126.71pt">. Accrued Expenses and Other</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:679.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.98pt">Current Liabilities" for additional information. Loss recoveries are recognized when a loss has been incurred and the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:690.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:227.44pt">recovery is probable. Insurance recovery receivables of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:285.94pt;position:var(--position);text-decoration:none;white-space:pre;width:50.44pt">$<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="us-gaap:InsuranceSettlementsReceivable" scale="6" id="f-453"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:InsuranceSettlementsReceivable" scale="6" id="f-454">11.9</ix:nonFraction></ix:nonFraction>&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:336.38pt;position:var(--position);text-decoration:none;white-space:pre;width:217.1pt"> were included in prepaid expenses and other current</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:701.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:399.43pt">assets on our condensed consolidated balance sheets as of June 30, 2026 and December 31, 2025.</span></div></ix:continuation></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:300.44pt;position:var(--position);white-space:pre">13</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="position:absolute;top:45pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_61"></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">8</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:63.5pt;position:var(--position);white-space:pre;width:5pt">. </span><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-455" continuedAt="f-455-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:37.47pt">Revenue</span></ix:nonNumeric></div><ix:continuation id="f-455-1"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:61.8pt;width:612pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-456" continuedAt="f-456-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:30.98pt">For the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:107.48pt;position:var(--position);text-decoration:none;white-space:pre;width:170.47pt">three and six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:277.95pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:297.95pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:317.95pt;position:var(--position);text-decoration:none;white-space:pre;width:136.42pt">, revenue comprised the following:</span></ix:nonNumeric></div><ix:continuation id="f-456-1"><div style="position:var(--position);top:84.6pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:207pt"/><td style="padding:0;width:69.75pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:69.75pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:69.75pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:69.75pt"/></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:207pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.75pt;position:var(--position);text-decoration:none;white-space:pre">Three Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.63pt;position:var(--position);text-decoration:none;white-space:pre">Six Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:23.25pt;width:207pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:37.5pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Prescription transactions revenue</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-457">106,390</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-458">143,064</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-459">220,082</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-460">291,987</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:51.75pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Subscription revenue</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-461">28,514</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-462">20,463</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-463">52,907</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-464">41,480</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:66pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Pharma Direct revenue</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:66pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-465">61,628</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:66pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-466">34,981</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:66pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:33.51pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-467">113,858</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:66pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-468">63,629</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:80.25pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Other revenue</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-469">3,879</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-470">4,562</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-471">7,570</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-472">8,944</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:94.5pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Total revenue</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:94.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-473">200,411</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:94.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-474">203,070</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:94.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-475">394,417</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:94.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-476">406,040</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation><div style="position:absolute;top:216.35pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_64"></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:216.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">9</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:63.5pt;position:var(--position);white-space:pre;width:5pt">. </span><ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-477" continuedAt="f-477-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:89.06pt">Stockholders' Equity</span></ix:nonNumeric></div><ix:continuation id="f-477-1"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:233.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:449.38pt">On February 27, 2024, our board of directors ("Board") authorized the repurchase of up to an aggregate of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:525.88pt;position:var(--position);text-decoration:none;white-space:pre;width:27.5pt">$<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="srt:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="f-478">450.0</ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:243.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:25.45pt">million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:83.95pt;position:var(--position);text-decoration:none;white-space:pre;width:469.54pt"> of our Class A common stock with no expiration date. Repurchases under this repurchase program may be made in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:254.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">the open market, in privately negotiated transactions or otherwise, with the amount and timing of repurchases to be</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:265.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">determined at our discretion, depending on market conditions and corporate needs, or under a trading plan intended to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:276.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">satisfy the affirmative defense conditions of Rule 10b5-1(c)(1) under the Exchange Act. This repurchase program does not</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:287.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.81pt">obligate us to acquire any particular amount of Class A common stock and may be modified, suspended or terminated at any</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.31pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:297.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">time at the discretion of our Board. Repurchased shares are subsequently retired and returned to the status of authorized</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:308.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:78.5pt">but unissued. As of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:137pt;position:var(--position);text-decoration:none;white-space:pre;width:57pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:194pt;position:var(--position);text-decoration:none;white-space:pre;width:36.49pt">, we had </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:230.49pt;position:var(--position);text-decoration:none;white-space:pre;width:50.45pt">$<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="f-479">60.3</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:280.94pt;position:var(--position);text-decoration:none;white-space:pre;width:272.39pt"> available for future repurchases of our Class A common stock under</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:319.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:99.94pt">this repurchase program.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:336.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:134.9pt">In March 2025, we repurchased </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:211.4pt;position:var(--position);text-decoration:none;white-space:pre;width:46.64pt"><ix:nonFraction unitRef="shares" contextRef="c-121" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-480">10.0</ix:nonFraction>&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:258.03999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:6.19pt">, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:264.23pt;position:var(--position);text-decoration:none;white-space:pre;width:41.64pt"><ix:nonFraction unitRef="shares" contextRef="c-122" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-481">7.0</ix:nonFraction>&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:305.87pt;position:var(--position);text-decoration:none;white-space:pre;width:24.88pt">, and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:330.75pt;position:var(--position);text-decoration:none;white-space:pre;width:41.64pt"><ix:nonFraction unitRef="shares" contextRef="c-123" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-482">3.0</ix:nonFraction>&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:372.39pt;position:var(--position);text-decoration:none;white-space:pre;width:180.96pt"> shares of our Class A common stock (after</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:347.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.85pt">giving effect to the automatic conversion of our Class B common stock to Class A common stock upon such repurchase)</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:357.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">from related parties, Francisco Partners IV, L.P. and Francisco Partners IV-A, Idea Men, LLC, and Spectrum Equity VII, L.P.,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:368.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">Spectrum VII Investment Managers' Fund, L.P., and Spectrum VII Co-Investment Fund, L.P., respectively, for an aggregate</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:379.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:58.72pt">repurchase of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:117.22pt;position:var(--position);text-decoration:none;white-space:pre;width:46.07pt"><ix:nonFraction unitRef="shares" contextRef="c-124" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-483">20.0</ix:nonFraction>&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:163.29000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:207.38pt"> shares of our Class A common stock at a price of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:370.67pt;position:var(--position);text-decoration:none;white-space:pre;width:22.5pt">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-125" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="f-484">4.20</ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:393.17pt;position:var(--position);text-decoration:none;white-space:pre;width:160.28pt"> per share, in each case representing a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:390.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:159.48pt">discount from our closing share price of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:217.98pt;position:var(--position);text-decoration:none;white-space:pre;width:22.5pt">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-126" decimals="2" name="us-gaap:SharePrice" scale="0" id="f-485">4.42</ix:nonFraction></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:240.48pt;position:var(--position);text-decoration:none;white-space:pre;width:312.89pt"> as of the last trading day prior to the execution date of these transactions. The</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:401.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:218.56pt">aggregate consideration for these repurchases was </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:277.06pt;position:var(--position);text-decoration:none;white-space:pre;width:52.39pt">$<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-486">84.9</ix:nonFraction> million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:329.45pt;position:var(--position);text-decoration:none;white-space:pre;width:223.94pt">, inclusive of direct costs and estimated excise taxes</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:411.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:139.45pt">associated with these transactions.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:428.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.89pt">These related party repurchases were approved by our Board and its Audit and Risk Committee as part of the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:439.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:152.92pt">aforementioned repurchase programs.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:456.35pt;width:612pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRepurchaseAgreements" id="f-487" continuedAt="f-487-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:372.33pt">The following table presents information about our repurchases of our Class A common stock:</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:448.83pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></ix:nonNumeric></div><ix:continuation id="f-487-1"><div style="position:var(--position);text-align:justify;text-align-last:var(--justify);top:479.15pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:207pt"/><td style="padding:0;width:69.75pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:69.75pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:69.75pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:69.75pt"/></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.75pt;position:var(--position);text-decoration:none;white-space:pre">Three Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.63pt;position:var(--position);text-decoration:none;white-space:pre">Six Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:23.25pt;width:207pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:37.5pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Number of shares repurchased</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:54.38pt"></span></span><span style="left:57.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-127" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:fixed-zero" scale="3" id="f-488">&#8212;</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-128" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="3" id="f-489">10,224</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-129" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="3" id="f-490">5,536</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-130" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:num-dot-decimal" scale="3" id="f-491">33,564</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:51.75pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);white-space:pre">Cost of shares repurchased </span><span style="font-family:'Arial', sans-serif;font-size:5.8500000000000005pt;font-style:normal;font-weight:normal;left:115.58999999999999pt;position:var(--position);top:-2.293pt;vertical-align:super;white-space:pre">(1)</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:45.39pt"></span></span><span style="left:53.02pt;position:var(--position)">(<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" sign="-" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-492">61</ix:nonFraction>)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-493">46,352</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-494">12,580</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-495">147,272</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:550.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:265pt">_____________________________________________________</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:560.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:10.98pt">(1)</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:458.93pt">Cost of shares repurchased for the three months ended June 30, 2026 represents a change to the estimated</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:571.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:305.91pt">excise taxes associated with past repurchases of our Class A common stock.</span></div></ix:continuation></ix:continuation><div style="position:absolute;top:600.55pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_67"></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:600.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:10pt">10</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);white-space:pre;width:5pt">. </span><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-496" continuedAt="f-496-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:73.5pt;position:var(--position);text-decoration:none;white-space:pre;width:160.89pt">Basic and Diluted Earnings Per Share</span></ix:nonNumeric></div><ix:continuation id="f-496-1" continuedAt="f-496-2"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:617.35pt;width:612pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-497" continuedAt="f-497-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:79.47pt">The computation of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:155.97pt;position:var(--position);text-decoration:none;white-space:pre;width:74.96pt">earnings per share</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:230.93pt;position:var(--position);text-decoration:none;white-space:pre;width:30.49pt"> for the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:261.41999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:170.47pt">three and six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:431.89pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:451.89pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:471.89pt;position:var(--position);text-decoration:none;white-space:pre;width:53.46pt"> is as follows:</span></ix:nonNumeric></div><ix:continuation id="f-497-1" continuedAt="f-497-2"><div style="position:var(--position);text-align:justify;text-align-last:var(--justify);top:634.15pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:207pt"/><td style="padding:0;width:69.75pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:69.75pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:69.75pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:69.75pt"/></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:207pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.75pt;position:var(--position);text-decoration:none;white-space:pre">Three Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.63pt;position:var(--position);text-decoration:none;white-space:pre">Six Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:23.25pt;width:207pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands, except per share amounts)</span></div></div></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:37.5pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Numerator:</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:51.75pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Net income</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-498">8,536</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-499">12,843</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-500">9,705</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-501">23,895</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:66pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Denominator:</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:80.25pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Weighted average shares - basic</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:33.51pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-502">339,277</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:33.51pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-503">356,623</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:33.51pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-504">339,839</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:33.51pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-505">367,847</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:300.44pt;position:var(--position);white-space:pre">14</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><ix:continuation id="f-496-2"><ix:continuation id="f-497-2"><div style="position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:207pt"/><td style="padding:0;width:69.75pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:69.75pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:69.75pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:69.75pt"/></tr><tr style="height:27.75pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:207pt"><div><div style="line-height:9pt;position:var(--position);top:7.01pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Dilutive impact of stock options and restricted </span></div><div style="line-height:9pt;position:var(--position);top:17.81pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">stock units</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:17.81pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="f-506">8,781</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:17.81pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.38pt"></span></span><span style="left:51.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="f-507">536</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:17.81pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="f-508">4,837</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:17.81pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.38pt"></span></span><span style="left:51.010000000000005pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="f-509">498</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:27.75pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Weighted average shares - diluted</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:27.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:34.62pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-510">348,058</ix:nonFraction></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:27.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:34.62pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-511">357,159</ix:nonFraction></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:27.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:34.62pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-512">344,676</ix:nonFraction></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:27.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:34.62pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-513">368,345</ix:nonFraction></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:42pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Earnings per share:</span></div></div></div></td><td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:56.25pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Basic</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:56.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-514">0.03</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:56.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usdPerShare" contextRef="c-11" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-515">0.04</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:56.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-516">0.03</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:56.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-517">0.06</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:70.5pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Diluted</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:70.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-518">0.02</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:70.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usdPerShare" contextRef="c-11" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-519">0.04</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:70.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-520">0.03</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:70.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-521">0.06</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:140.75pt;width:612pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-522" continuedAt="f-522-1" escape="true"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:425.91pt">The following weighted average potentially dilutive shares are excluded from the computation of diluted </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:502.41pt;position:var(--position);text-decoration:none;white-space:pre;width:50.98pt">earnings per</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></ix:nonNumeric></div><ix:continuation id="f-522-1"><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:151.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:22.49pt">share</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:80.99pt;position:var(--position);text-decoration:none;white-space:pre;width:317.36pt"> for the periods presented because including them would have been antidilutive:</span></div><div style="position:var(--position);top:174.35pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:207pt"/><td style="padding:0;width:69.75pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:69.75pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:69.75pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:69.75pt"/></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:207pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.75pt;position:var(--position);text-decoration:none;white-space:pre">Three Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.63pt;position:var(--position);text-decoration:none;white-space:pre">Six Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:23.25pt;width:207pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:37.5pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Stock options and restricted stock units</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:39.62pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonFraction unitRef="shares" contextRef="c-131" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-523">39,720</ix:nonFraction></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:39.62pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonFraction unitRef="shares" contextRef="c-132" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-524">57,042</ix:nonFraction></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:39.62pt;position:var(--position);text-decoration:none;white-space:pre"><ix:nonFraction unitRef="shares" contextRef="c-133" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-525">42,808</ix:nonFraction></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)"><ix:nonFraction unitRef="shares" contextRef="c-134" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-526">49,102</ix:nonFraction><span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div></ix:continuation></ix:continuation></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:300.44pt;position:var(--position);white-space:pre">15</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="position:absolute;top:45pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_73"></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre;width:413.13pt">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:61.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.92pt">You should read the following discussion and analysis of our financial condition and results of operations together with</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.4200000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:71.88pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.96pt">our unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.46pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:81.96pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.84pt">on Form 10-Q, as well as Part II, Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.3399999999999pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:92.04pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.91pt">Operations&#8221; and Part II, Item 8, &#8220;Financial Statements and Supplementary Data&#8221; included in our Annual Report on Form 10-</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:102.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:107.98pt">K for the fiscal year ended </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:166.48000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:79.31pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:245.79pt;position:var(--position);white-space:pre;width:256.43pt"> filed with the Securities and Exchange Commission ("SEC") on </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:502.22pt;position:var(--position);text-decoration:none;white-space:pre;width:51.14pt">February&#160;26,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:112.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:78.5pt;position:var(--position);white-space:pre;width:8.53pt"> (&#8220;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:87.03pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:107.03pt;position:var(--position);white-space:pre;width:446.44pt"> 10-K&#8221;). This discussion contains forward-looking statements based upon current plans, expectations and beliefs</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.47pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:122.28pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.89pt">involving risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:132.36pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:417.41pt">statements as a result of various factors, including those set forth in the "Risk Factors" sections of our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:475.91pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:495.91pt;position:var(--position);white-space:pre;width:57.43pt"> 10-K and this</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.3399999999999pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:142.44pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.84pt">Quarterly Report on Form 10-Q and other factors set forth in other parts of this Quarterly Report on Form 10-Q and our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.3399999999999pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:152.52pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:79.94pt">filings with the SEC.</span></div><div style="position:absolute;top:180.6pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_76"></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:180.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre;width:145.4pt">Glossary of Selected Terminology</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:197.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:399.3pt">As used in this Quarterly Report on Form 10-Q, unless the context otherwise requires, references to:</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:475.8pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:214.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:3.15pt">&#8226;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:2.99pt">&#8220;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:115.49pt;position:var(--position);white-space:pre;width:12pt">we</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:127.49pt;position:var(--position);white-space:pre;width:13.21pt">,&#8221; &#8220;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:140.7pt;position:var(--position);white-space:pre;width:10.49pt">us</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:151.19pt;position:var(--position);white-space:pre;width:13.21pt">,&#8221; &#8220;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:164.4pt;position:var(--position);white-space:pre;width:14.48pt">our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:178.88pt;position:var(--position);white-space:pre;width:13.21pt">,&#8221; &#8220;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:192.09pt;position:var(--position);white-space:pre;width:34.96pt">GoodRx</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:227.05pt;position:var(--position);white-space:pre;width:326.36pt">,&#8221; and similar references refer to GoodRx Holdings, Inc. and its consolidated</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:225pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:49.96pt">subsidiaries.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:241.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:3.15pt">&#8226;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:2.99pt">&#8220;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:115.49pt;position:var(--position);white-space:pre;width:47.97pt">consumers</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:163.46pt;position:var(--position);white-space:pre;width:2.99pt">&#8221;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:166.45pt;position:var(--position);white-space:pre;width:386.99pt"> refer to the general population in the United States that uses or otherwise purchases healthcare</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:252.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:161.54pt">products and services. References to &#8220;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:274.03999999999996pt;position:var(--position);white-space:pre;width:66.47pt">our consumers</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:340.51pt;position:var(--position);white-space:pre;width:22.01pt">&#8221; or &#8220;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:362.52pt;position:var(--position);white-space:pre;width:86.95pt">GoodRx consumers</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:449.47pt;position:var(--position);white-space:pre;width:104.03pt">&#8221; refer to consumers that</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:263.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:157.28pt">have used one or more of our offerings.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:280.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:3.15pt">&#8226;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:2.99pt">&#8220;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:115.49pt;position:var(--position);white-space:pre;width:72.82pt">discounted price</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:188.31pt;position:var(--position);white-space:pre;width:365.16pt">&#8221; refers to a price for a prescription provided on our platform that represents a negotiated</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:291pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.9pt">rate provided by one of our PBM partners at a retail pharmacy or under a direct contract with one of our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:301.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.85pt">partner pharmacies. Through our platform, our discounted prices are free to access for consumers by saving a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:312.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:441pt">GoodRx code to their mobile device for their selected prescription and presenting it at the chosen pharmacy.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);white-space:pre;width:2.34pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:323.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.87pt">The term &#8220;discounted price&#8221; excludes prices we may otherwise source, such as prices from patient assistance</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:334.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.94pt">programs for low-income individuals and Medicare prices, and any negotiated rates offered through our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:345pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:87.29pt">subscription offerings.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:361.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:3.15pt">&#8226;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:2.99pt">&#8220;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:115.49pt;position:var(--position);white-space:pre;width:58.81pt">GoodRx code</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:174.3pt;position:var(--position);white-space:pre;width:2.99pt">&#8221;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:177.29000000000002pt;position:var(--position);white-space:pre;width:376.18pt"> refers to codes that can be accessed by our consumers through our apps or websites or that</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:372.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.9pt">can be provided to our consumers directly by healthcare professionals, including physicians and pharmacists,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:383.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.89pt">that allow our consumers free access to our discounted prices or a lower list price for their prescriptions when</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:394.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:197.78pt">such code is presented at their chosen pharmacy.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:411pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:3.15pt">&#8226;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:2.99pt">&#8220;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:115.49pt;position:var(--position);white-space:pre;width:117.35pt">Monthly Active Consumers</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:232.84pt;position:var(--position);white-space:pre;width:2.99pt">&#8221;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:235.82999999999998pt;position:var(--position);white-space:pre;width:317.63pt"> refers to the number of unique consumers who have used a GoodRx code to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:421.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:441pt">purchase a prescription medication in a given calendar month and have saved money compared to the list</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:432.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.89pt">price of the medication. A unique consumer who uses a GoodRx code more than once in a calendar month to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:443.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.94pt">purchase prescription medications is only counted as one Monthly Active Consumer in that month. A unique</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:454.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.84pt">consumer who uses a GoodRx code in two or three calendar months within a quarter will be counted as a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:465pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.87pt">Monthly Active Consumer in each such month. Monthly Active Consumers do not include subscribers to our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:475.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.91pt">subscription offerings, consumers of our GoodRx Pharma Direct ("Pharma Direct") offering, or consumers who</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:486.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.89pt">used our telehealth offering. When presented for a period longer than a month, Monthly Active Consumers is</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:497.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.92pt">averaged over the number of calendar months in such period. For example, a unique consumer who uses a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:508.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.91pt">GoodRx code twice in January, but who did not use our prescription transactions offering again in February or</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:519pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.83pt">March, is counted as 1 in January and as 0 in both February and March, thus contributing 0.33 to our Monthly</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);white-space:pre;width:2.01pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:529.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.9pt">Active Consumers for such quarter (average of 1, 0 and 0). A unique consumer who uses a GoodRx code in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:540.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.84pt">January and in March, but did not use our prescription transactions offering in February, would be counted as 1</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:551.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.99pt">in January, 0 in February and 1 in March, thus contributing 0.66 to our Monthly Active Consumers for such</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:562.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);text-decoration:none;white-space:pre;width:438.78pt">quarter. Monthly Active Consumers from acquired companies are included beginning from the acquisition date.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:579pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:3.15pt">&#8226;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:3.19pt">"</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:115.69pt;position:var(--position);white-space:pre;width:83.45pt">partner pharmacies</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:199.14pt;position:var(--position);white-space:pre;width:353.5pt">" refers to select licensed pharmacies with whom we have direct contractual agreements.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:595.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:3.15pt">&#8226;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:2.99pt">&#8220;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:115.49pt;position:var(--position);white-space:pre;width:19.98pt">PBM</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:135.47pt;position:var(--position);white-space:pre;width:2.99pt">&#8221;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:138.46pt;position:var(--position);white-space:pre;width:415.03pt"> refers to a pharmacy benefit manager. PBMs aggregate demand to negotiate prescription medication</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:606.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.93pt">prices with pharmacies and pharma manufacturers. PBMs find most of their demand through relationships with</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:617.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:441pt">insurance companies and employers. However, nearly all PBMs also have consumer direct or cash network</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:628.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.91pt">pricing that they negotiate with pharmacies for consumers who choose to purchase prescriptions outside of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:639pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:41.48pt">insurance.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:655.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:3.15pt">&#8226;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:2.99pt">&#8220;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:115.49pt;position:var(--position);white-space:pre;width:32.48pt">pharma</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:147.97pt;position:var(--position);white-space:pre;width:154.9pt">&#8221; is an abbreviation for pharmaceutical.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:672.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:3.15pt">&#8226;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:2.99pt">&#8220;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:115.49pt;position:var(--position);white-space:pre;width:35.98pt">savings,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:151.47pt;position:var(--position);white-space:pre;width:2.99pt">&#8221;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:154.46pt;position:var(--position);white-space:pre;width:8.11pt"> &#8220;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:162.57pt;position:var(--position);white-space:pre;width:25.49pt">saved</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:188.06pt;position:var(--position);white-space:pre;width:2.99pt">&#8221;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:191.05pt;position:var(--position);white-space:pre;width:362.31pt"> and similar references refer to the difference between the list price for a particular</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:683.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.87pt">prescription at a particular pharmacy and the price paid by the GoodRx consumer for that prescription utilizing</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:694.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.88pt">a GoodRx code available through our platform at that same pharmacy. In certain circumstances, we may show</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:705pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.85pt">a list price on our platform when such list price is lower than the negotiated price available using a GoodRx</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:715.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.9pt">code and, in certain circumstances, a consumer may use a GoodRx code and pay the list price at a pharmacy</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:726.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.86pt">if such list price is lower than the negotiated price available using a GoodRx code. We do not earn revenue</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:737.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:441pt">from such transactions, but our savings calculation includes an estimate of the savings achieved by the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:300.44pt;position:var(--position);white-space:pre">16</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.94pt">consumer because our platform has directed the consumer to the pharmacy with the low list price. This</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:55.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.89pt">estimate of savings when the consumer pays the list price is based on internal data and is calculated as the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:66.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:441pt">difference between the average list price across all pharmacies where GoodRx consumers paid the list price</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:77.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.87pt">and the average list price paid by consumers in the pharmacies to which we directed them. We do not</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:88.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.95pt">calculate savings based on insurance prices as we do not have information about a consumer&#8217;s specific</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:99pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.98pt">coverage or price. We do not believe savings are representative or indicative of our revenue or results of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:109.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:44.48pt">operations.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:126.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:3.15pt">&#8226;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:2.99pt">&#8220;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:115.49pt;position:var(--position);white-space:pre;width:50.97pt">subscribers</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:166.46pt;position:var(--position);white-space:pre;width:387pt">&#8221; and similar references refer to our consumers that are subscribed to our subscription offerings,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:137.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:71.82pt">GoodRx Gold (&#8220;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:184.32pt;position:var(--position);white-space:pre;width:20.48pt">Gold</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:204.8pt;position:var(--position);white-space:pre;width:348.68pt">&#8221;), condition-specific subscription programs which first launched in June 2025,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:148.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:171.66pt">RxSmartSaver+ powered by GoodRx ("</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:284.15999999999997pt;position:var(--position);white-space:pre;width:66.73pt">RxSmartSaver+</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:350.89pt;position:var(--position);white-space:pre;width:202.52pt">") which launched in July 2025, and GoodRx</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:159pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:440.95pt">Companion which launched its monthly and annual plans in May and July 2026, respectively. References to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:169.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:441pt">subscription plans as of a particular date represent an active subscription to any one of our aforementioned</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:180.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:196.53pt">subscription offerings as of the specified date. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:309.03pt;position:var(--position);text-decoration:none;white-space:pre;width:244.39pt">For Gold and RxSmartSaver+, each subscription plan may</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:191.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);text-decoration:none;white-space:pre;width:392.75pt">represent more than one subscriber since family subscription plans may include multiple members.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:208.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.85pt">Certain monetary amounts, percentages, and other figures included in this Quarterly Report on Form 10-Q have been</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:219pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.93pt">subject to rounding adjustments. Percentage amounts included in this Quarterly Report on Form 10-Q have not in all cases</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:229.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.8pt">been calculated on the basis of such rounded figures, but on the basis of such amounts prior to rounding. For this reason,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:240.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.92pt">percentage amounts in this Quarterly Report on Form 10-Q may vary from those obtained by performing the same</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:251.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.9pt">calculations using the figures in our condensed consolidated financial statements included elsewhere in this Quarterly</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:262.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.85pt">Report on Form 10-Q. Certain other amounts that appear in this Quarterly Report on Form 10-Q may not sum due to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:273pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:37.48pt">rounding.</span></div><div style="position:absolute;top:301.8pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_79"></div><div style="line-height:9pt;position:var(--position);top:301.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre">Overview</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:318.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.89pt">Our mission is to help Americans save time and money when filling their medications. To achieve this, we are building</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:329.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.97pt">the leading consumer-focused digital healthcare platform in the United States. For instance, in the first quarter of 2026, we</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:340.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.85pt">announced the launch of Employer Direct, a new platform designed to help employers address gaps in traditional insurance</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:351pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.94pt">coverage by pairing their existing benefits with integrated cash pricing in order to expand affordability and access for their</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:361.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.97pt">employees. We also continued to grow our consumer direct pricing and announced a collaboration with a pharmaceutical</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:372.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:388.26pt">manufacturer to offer eligible patients nationwide access to certain medications, including Lipitor</span><span style="font-family:'Arial', sans-serif;font-size:5.8500000000000005pt;font-style:normal;font-weight:normal;left:446.76pt;position:var(--position);top:-2.293pt;vertical-align:super;white-space:pre;width:4.31pt">&#174;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:451.07pt;position:var(--position);white-space:pre;width:41.62pt">, Celebrex</span><span style="font-family:'Arial', sans-serif;font-size:5.8500000000000005pt;font-style:normal;font-weight:normal;left:492.69pt;position:var(--position);top:-2.293pt;vertical-align:super;white-space:pre;width:4.31pt">&#174;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:497pt;position:var(--position);white-space:pre;width:31.47pt">, Viagra</span><span style="font-family:'Arial', sans-serif;font-size:5.8500000000000005pt;font-style:normal;font-weight:normal;left:528.47pt;position:var(--position);top:-2.293pt;vertical-align:super;white-space:pre;width:4.31pt">&#174;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:532.78pt;position:var(--position);white-space:pre;width:20.65pt">, and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:383.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:32.98pt">Norvasc</span><span style="font-family:'Arial', sans-serif;font-size:5.8500000000000005pt;font-style:normal;font-weight:normal;left:91.47999999999999pt;position:var(--position);top:-2.293pt;vertical-align:super;white-space:pre;width:4.31pt">&#174;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:95.78999999999999pt;position:var(--position);white-space:pre;width:457.6pt">, at a significantly lower cash price through our platform. Additionally, we launched GoodRx Companion in the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:394.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.88pt">second quarter of 2026, a new subscription offering that provides consumers access to free and low-cost generic</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:405pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:339.67pt">medications, affordable online care visits, and savings on routine healthcare services.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:421.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.85pt">With respect to the healthcare landscape, change has become a constant with positive and negative impacts on our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:432.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.9pt">business. Widening coverage gaps, elevated out-of-pocket costs, and a growing uninsured population are increasing</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:443.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.84pt">demand for pricing transparency and affordability solutions. As a result, cost is becoming a more significant factor earlier in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:454.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.89pt">the patient journey, with consumers and providers actively evaluating cost before prescribing and filling, pharma</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:465pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.97pt">manufacturers expanding direct-to-consumer strategies, employers seeking solutions for high-cost therapies, and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:475.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.86pt">pharmacies adapting to more transparent, digitally enabled fulfillment models. As these dynamics evolve, how affordability is</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:486.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.93pt">presented and experienced by consumers is becoming increasingly important, shaping not just awareness, but whether</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:497.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.96pt">patients ultimately move forward with treatments. Separately, as previously described in Part II, Item 7, &#8220;Management&#8217;s</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:508.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:371.82pt">Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:430.32pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:450.32pt;position:var(--position);white-space:pre;width:28.57pt"> 10-K, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:478.89pt;position:var(--position);text-decoration:none;white-space:pre;width:26.98pt">certain</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:505.87pt;position:var(--position);white-space:pre;width:47.54pt"> major drug</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:519pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.99pt">producers and manufacturers have negotiated or are in negotiations with the current Presidential administration to receive</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:529.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:495pt">relief from the potential imposition of a 100% tariff on any branded or patented pharmaceutical product produced outside of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:540.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:78.02pt">the United States. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:136.51999999999998pt;position:var(--position);text-decoration:none;white-space:pre;width:416.97pt">As a result of these negotiations, certain manufacturers have announced their participation in a new</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:551.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">government-sponsored direct-to-consumer platform called &#8220;TrumpRx.gov&#8221; ("TrumpRx"), which was launched in February</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:562.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">2026 and is designed to offer consumers discounts on their products and some specialty brands. GoodRx is a key</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:573pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:402.33pt">integration partner for pharma manufacturers offering discounted cash prices on TrumpRx at launch. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:460.83pt;position:var(--position);text-decoration:none;white-space:pre;width:13.33pt">We</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:474.16pt;position:var(--position);text-decoration:none;white-space:pre;width:79.34pt"> are observing early</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:583.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">utilization of the platform, with initial demand concentrated in GLP-1 therapies. Based on preliminary data, this utilization</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:594.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.98pt">appears to be incremental, expanding access to new patients rather than displacing existing demand, and has not had a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:605.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:165.07pt">material impact on our business to date. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:223.57pt;position:var(--position);text-decoration:none;white-space:pre;width:329.75pt">In May 2026, an expansion of TrumpRx was announced to include more than 600</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3199999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:616.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt">generic medications and additional price-comparison and pharmacy fulfillment tools, with integrated discount offerings from</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:627pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:240.99pt">GoodRx and other direct-to-consumer pharmacy platforms. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:299.49pt;position:var(--position);white-space:pre;width:253.88pt">The potential impact of TrumpRx on our business, offerings, or</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:637.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.99pt">results of operations remains uncertain and could be material. With the introduction of these federal initiatives, including the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:648.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.88pt">renewed focus on Most-Favored-Nation pricing, the market is shifting decisively toward greater transparency and direct-to-</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:659.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:394.81pt">consumer access. For us, this evolution is both an opportunity and a clear validation of our mission.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:676.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.98pt">Conversely, we have seen rapid changes in the U.S. retail pharmacy landscape with announcements of store closures</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:687pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.98pt">and reduction of footprint from various retail pharmacies, including Rite Aid and Walgreens. In early May 2025, Rite Aid</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:697.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.91pt">announced its plan to pursue a sale of substantially all of its assets through a voluntary bankruptcy process. Consequently,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:708.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.91pt">we saw several PBMs remove Rite Aid from their networks, causing immediate cessation in the associated claims volume,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:719.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.87pt">as well as rapid store closures, which altogether adversely impacted our ability to recapture these claims in the near term.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);white-space:pre;width:2.01pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:730.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.86pt">As an extension of the changing retail pharmacy landscape, we have seen and continue to expect heightened renegotiations</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:300.44pt;position:var(--position);white-space:pre">17</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.86pt">between pharmacies and PBMs, including changes in retailer reimbursement models, as a result of the pharmacies'</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:55.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.9pt">increased focus on rationalizing their spending. Furthermore, in the second quarter of 2025, we saw a material volume</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:66.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.9pt">reduction in one of our integrated savings programs, which integrate our competitive discounts and pricing in a seamless</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:77.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.87pt">experience at the pharmacy counter for eligible plan members served by certain PBM partners. Integrated savings programs</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:88.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.89pt">are operated through PBMs who decide how to implement and manage these programs. These external factors have</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:99pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.88pt">adversely impacted our prescription transactions revenue, financial results, and Monthly Active Consumers, all of which we</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:109.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:382.26pt">expect will continue in the near term and are reflected in our year-over-year comparative results </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:440.76pt;position:var(--position);text-decoration:none;white-space:pre;width:22.99pt">below</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:463.75pt;position:var(--position);white-space:pre;width:2.5pt">.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:126.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.93pt">While our prescription transactions offering remains foundational to our business, we are increasingly directing</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:137.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.98pt">investment toward Pharma Direct and subscription offerings, which are becoming larger contributors to our growth. Within</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:148.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.89pt">Pharma Direct, we are expanding manufacturer-sponsored affordability programs and creating additional ways for</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:159pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.93pt">manufacturers to reach and engage consumers through the GoodRx platform. Within subscriptions, we are broadening our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:169.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.85pt">offerings and making them a more integrated part of the consumer experience to deliver value beyond an individual</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:180.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.93pt">prescription and deepen our relationships with consumers. As these offerings continue to scale, we expect near-term</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:191.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:38.42pt">pressure </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:96.92pt;position:var(--position);white-space:pre;width:456.52pt">on our Monthly Active Consumers, prescription transactions revenue and unit economics during 2026. However,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:202.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.98pt">we believe this evolution will deliver greater value to consumers, deepen engagement, improve retention and position us for</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:213pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:175.88pt">more durable, sustainable long-term growth.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:229.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:30.98pt">For the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:107.48pt;position:var(--position);text-decoration:none;white-space:pre;width:139.48pt">three months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:246.96pt;position:var(--position);white-space:pre;width:143.95pt"> as compared to the same period of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:390.91pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:410.91pt;position:var(--position);white-space:pre;width:2.5pt">:</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:246.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:3.15pt">&#8226;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:38.49pt">Revenue </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:150.99pt;position:var(--position);text-decoration:none;white-space:pre;width:41.99pt">decreased</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:192.98000000000002pt;position:var(--position);white-space:pre;width:12.5pt"> to </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:205.48000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:55.45pt">$200.4 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:260.93pt;position:var(--position);white-space:pre;width:22.98pt"> from </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:283.90999999999997pt;position:var(--position);text-decoration:none;white-space:pre;width:55.45pt">$203.1 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:339.36pt;position:var(--position);white-space:pre;width:2.5pt">;</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:263.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:3.15pt">&#8226;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);text-decoration:none;white-space:pre;width:46.33pt">Net income</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:158.82999999999998pt;position:var(--position);white-space:pre;width:21.72pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:180.55pt;position:var(--position);text-decoration:none;white-space:pre;width:75.67pt">net income margin</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:256.22pt;position:var(--position);white-space:pre;width:26.2pt"> were </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:282.41999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:46.31pt">$8.5 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:328.73pt;position:var(--position);white-space:pre;width:21.72pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:350.45pt;position:var(--position);text-decoration:none;white-space:pre;width:20.5pt">4.3%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:370.95pt;position:var(--position);white-space:pre;width:112.73pt">, respectively, compared to </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:483.68pt;position:var(--position);text-decoration:none;white-space:pre;width:51.31pt">$12.8 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:534.99pt;position:var(--position);white-space:pre;width:18.36pt"> and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:274.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);text-decoration:none;white-space:pre;width:20.5pt">6.3%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:133pt;position:var(--position);white-space:pre;width:72.47pt">, respectively; and</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:291pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:3.15pt">&#8226;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:213.06pt">Adjusted EBITDA and Adjusted EBITDA Margin were </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:325.56pt;position:var(--position);text-decoration:none;white-space:pre;width:50.47pt">$63.7 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:376.03pt;position:var(--position);white-space:pre;width:20.04pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:396.07pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt">31.8%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:421.57pt;position:var(--position);white-space:pre;width:109.37pt">, respectively, compared to </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:530.94pt;position:var(--position);text-decoration:none;white-space:pre;width:22.5pt">$69.4</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:301.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);text-decoration:none;white-space:pre;width:25.45pt">million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:137.95pt;position:var(--position);white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:157.95pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt">34.2%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:183.45pt;position:var(--position);white-space:pre;width:54.31pt">, respectively.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:318.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:30.98pt">For the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:107.48pt;position:var(--position);text-decoration:none;white-space:pre;width:129.98pt">six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:237.46pt;position:var(--position);white-space:pre;width:143.95pt"> as compared to the same period of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:381.41pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:401.41pt;position:var(--position);white-space:pre;width:2.5pt">:</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:335.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:3.15pt">&#8226;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:38.49pt">Revenue </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:150.99pt;position:var(--position);text-decoration:none;white-space:pre;width:41.99pt">decreased</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:192.98000000000002pt;position:var(--position);white-space:pre;width:12.5pt"> to </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:205.48000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:55.45pt">$394.4 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:260.93pt;position:var(--position);white-space:pre;width:22.98pt"> from </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:283.90999999999997pt;position:var(--position);text-decoration:none;white-space:pre;width:55.45pt">$406.0 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:339.36pt;position:var(--position);white-space:pre;width:2.5pt">;</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:352.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:3.15pt">&#8226;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);text-decoration:none;white-space:pre;width:46.33pt">Net income</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:158.82999999999998pt;position:var(--position);white-space:pre;width:21.72pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:180.55pt;position:var(--position);text-decoration:none;white-space:pre;width:75.67pt">net income margin</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:256.22pt;position:var(--position);white-space:pre;width:26.2pt"> were </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:282.41999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:46.31pt">$9.7 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:328.73pt;position:var(--position);white-space:pre;width:21.72pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:350.45pt;position:var(--position);text-decoration:none;white-space:pre;width:20.5pt">2.5%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:370.95pt;position:var(--position);white-space:pre;width:112.73pt">, respectively, compared to </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:483.68pt;position:var(--position);text-decoration:none;white-space:pre;width:51.31pt">$23.9 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:534.99pt;position:var(--position);white-space:pre;width:18.36pt"> and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:363pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);text-decoration:none;white-space:pre;width:20.5pt">5.9%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:133pt;position:var(--position);white-space:pre;width:72.47pt">, respectively; and</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:379.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:3.15pt">&#8226;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);white-space:pre;width:223.84pt">Adjusted EBITDA and Adjusted EBITDA Margin were </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:336.34000000000003pt;position:var(--position);text-decoration:none;white-space:pre;width:57.01pt">$122.0 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:393.35pt;position:var(--position);white-space:pre;width:23.12pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:416.47pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt">30.9%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:441.97pt;position:var(--position);white-space:pre;width:111.47pt">, respectively, compared to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:390.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:112.5pt;position:var(--position);text-decoration:none;white-space:pre;width:55.45pt">$139.2 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:167.95pt;position:var(--position);white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:187.95pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt">34.3%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:213.45pt;position:var(--position);white-space:pre;width:54.31pt">, respectively.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:407.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:41.54pt">Revenue, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:118.03999999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:44.53pt">net income</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:162.57pt;position:var(--position);white-space:pre;width:21.1pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:183.67000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:44.53pt">net income</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:228.2pt;position:var(--position);white-space:pre;width:325.28pt"> margin are financial measures prepared in conformity with accounting principles</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:418.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.99pt">generally accepted in the United States ("GAAP"). Adjusted EBITDA and Adjusted EBITDA Margin are non-GAAP financial</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:429pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.86pt">measures. For a reconciliation and presentation of Adjusted EBITDA and Adjusted EBITDA Margin to the most directly</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:439.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.87pt">comparable GAAP financial measures, information about why we consider Adjusted EBITDA and Adjusted EBITDA Margin</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:450.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.86pt">useful and a discussion of the material risks and limitations of these measures, please see &#8220;Key Financial and Operating</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:461.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:193.91pt">Metrics&#8212;Non-GAAP Financial Measures" below.</span></div><div style="position:absolute;top:490.2pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_88"></div><div style="line-height:9pt;position:var(--position);top:490.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre">Key Financial and Operating Metrics</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:507pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.88pt">We use Monthly Active Consumers, subscription plans, Adjusted EBITDA and Adjusted EBITDA Margin to assess our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:517.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.94pt">performance, make strategic and offering decisions and build our financial projections. The number of Monthly Active</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:528.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.9pt">Consumers and subscription plans are key indicators of the scale of our consumer base and a gauge for our marketing and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:539.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.93pt">engagement efforts. We believe these operating metrics reflect our scale, growth and engagement with consumers. As our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:550.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.94pt">business continues to evolve, we are reassessing the Monthly Active Consumers metric as a primary indicator of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:561pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:306.64pt">performance to ensure it aligns with how we measure growth and profitability.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:589.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre;width:115.89pt">Monthly Active Consumers</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:606.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.91pt">The factors described in the "Overview" section have adversely impacted our Monthly Active Consumers beginning in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:617.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:109.98pt">the second quarter of 2025.</span></div><div style="position:var(--position);top:640.2pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:106.5pt"/><td style="padding:0;width:62.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:62.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:62.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:62.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:62.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:62.25pt"/></tr><tr style="height:12pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td colspan="11" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:106.5pt;position:var(--position);width:388.5pt"><div><div style="line-height:7pt;position:var(--position);top:3.94pt;width:388.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:159.68pt;position:var(--position);text-decoration:none;white-space:pre">Three Months Ended</span></div></div></div></td></tr><tr style="height:20.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:12pt;width:106.5pt"><div><div style="line-height:7pt;position:var(--position);top:12.21pt;width:106.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in millions)</span></div></div></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:106.5pt;position:var(--position);top:12pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.79pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:17.13pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div><div style="line-height:7pt;position:var(--position);top:12.19pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:23.34pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:171.75pt;position:var(--position);top:12pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.79pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:14.99pt;position:var(--position);text-decoration:none;white-space:pre">March 31,</span></div><div style="line-height:7pt;position:var(--position);top:12.19pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:23.34pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:237pt;position:var(--position);top:12pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.79pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:8.38pt;position:var(--position);text-decoration:none;white-space:pre">December 31,</span></div><div style="line-height:7pt;position:var(--position);top:12.19pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:23.34pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:302.25pt;position:var(--position);top:12pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.79pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:7.22pt;position:var(--position);text-decoration:none;white-space:pre">September 30,</span></div><div style="line-height:7pt;position:var(--position);top:12.19pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:23.34pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:367.5pt;position:var(--position);top:12pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.79pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:17.13pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div><div style="line-height:7pt;position:var(--position);top:12.19pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:23.34pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:432.75pt;position:var(--position);top:12pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.79pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:14.99pt;position:var(--position);text-decoration:none;white-space:pre">March 31,</span></div><div style="line-height:7pt;position:var(--position);top:12.19pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:23.34pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td></tr><tr style="height:12pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:32.25pt;width:106.5pt"><div><div style="line-height:7pt;position:var(--position);top:3.94pt;width:106.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Monthly Active Consumers</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:106.5pt;position:var(--position);top:32.25pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.94pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:normal;left:49.9pt;position:var(--position);text-decoration:none;white-space:pre">5.0</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:171.75pt;position:var(--position);top:32.25pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.94pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:normal;left:49.9pt;position:var(--position);text-decoration:none;white-space:pre">5.3</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:237pt;position:var(--position);top:32.25pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.94pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:normal;left:49.9pt;position:var(--position);text-decoration:none;white-space:pre">5.3</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:302.25pt;position:var(--position);top:32.25pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.94pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:normal;left:49.9pt;position:var(--position);text-decoration:none;white-space:pre">5.4</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:367.5pt;position:var(--position);top:32.25pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.94pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:normal;left:49.9pt;position:var(--position);text-decoration:none;white-space:pre">5.7</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:432.75pt;position:var(--position);top:32.25pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.94pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:normal;left:49.9pt;position:var(--position);text-decoration:none;white-space:pre">6.4</span></div></div></div></td></tr></tbody></table></div></div></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:300.44pt;position:var(--position);white-space:pre">18</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre;width:81.43pt">Subscription Plans</span></div><div style="position:var(--position);top:67.8pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:106.5pt"/><td style="padding:0;width:62.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:62.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:62.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:62.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:62.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:62.25pt"/></tr><tr style="height:12pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td colspan="11" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:106.5pt;position:var(--position);width:388.5pt"><div><div style="line-height:7pt;position:var(--position);top:3.94pt;width:388.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:185.51pt;position:var(--position);text-decoration:none;white-space:pre">As of</span></div></div></div></td></tr><tr style="height:20.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:12pt;width:106.5pt"><div><div style="line-height:7pt;position:var(--position);top:12.21pt;width:106.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:106.5pt;position:var(--position);top:12pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.79pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:17.13pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div><div style="line-height:7pt;position:var(--position);top:12.19pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:23.34pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:171.75pt;position:var(--position);top:12pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.79pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:14.99pt;position:var(--position);text-decoration:none;white-space:pre">March 31,</span></div><div style="line-height:7pt;position:var(--position);top:12.19pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:23.34pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:237pt;position:var(--position);top:12pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.79pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:8.38pt;position:var(--position);text-decoration:none;white-space:pre">December 31,</span></div><div style="line-height:7pt;position:var(--position);top:12.19pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:23.34pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:302.25pt;position:var(--position);top:12pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.79pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:7.22pt;position:var(--position);text-decoration:none;white-space:pre">September 30,</span></div><div style="line-height:7pt;position:var(--position);top:12.19pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:23.34pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:367.5pt;position:var(--position);top:12pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.79pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:17.13pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div><div style="line-height:7pt;position:var(--position);top:12.19pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:23.34pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:432.75pt;position:var(--position);top:12pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.79pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:14.99pt;position:var(--position);text-decoration:none;white-space:pre">March 31,</span></div><div style="line-height:7pt;position:var(--position);top:12.19pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:bold;left:23.34pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td></tr><tr style="height:12pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:32.25pt;width:106.5pt"><div><div style="line-height:7pt;position:var(--position);top:3.94pt;width:106.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Subscription plans</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:106.5pt;position:var(--position);top:32.25pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.94pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:normal;left:47.95pt;position:var(--position);text-decoration:none;white-space:pre">764</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:171.75pt;position:var(--position);top:32.25pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.94pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:normal;left:47.95pt;position:var(--position);text-decoration:none;white-space:pre">717</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:237pt;position:var(--position);top:32.25pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.94pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:normal;left:47.95pt;position:var(--position);text-decoration:none;white-space:pre">674</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:302.25pt;position:var(--position);top:32.25pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.94pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:normal;left:47.95pt;position:var(--position);text-decoration:none;white-space:pre">671</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:367.5pt;position:var(--position);top:32.25pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.94pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:normal;left:47.95pt;position:var(--position);text-decoration:none;white-space:pre">668</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:432.75pt;position:var(--position);top:32.25pt;width:62.25pt"><div><div style="line-height:7pt;position:var(--position);top:3.94pt;width:62.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:7pt;font-style:normal;font-weight:normal;left:47.95pt;position:var(--position);text-decoration:none;white-space:pre">680</span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:135.05pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre;width:131.89pt">Non-GAAP Financial Measures</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:151.85pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.94pt">Adjusted EBITDA and Adjusted EBITDA Margin are key measures we use to assess our financial performance and are</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:162.65pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.97pt">also used for internal planning and forecasting purposes. We believe Adjusted EBITDA and Adjusted EBITDA Margin are</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:173.45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.95pt">helpful to investors, analysts and other interested parties because they can assist in providing a more consistent and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:184.25pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.98pt">comparable overview of our operations across our historical financial periods. In addition, these measures are frequently</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:195.05pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:369.88pt">used by analysts, investors and other interested parties to evaluate and assess performance.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:211.85pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.94pt">We define Adjusted EBITDA for a particular period as net income or loss before interest, taxes, depreciation and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:222.65pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.91pt">amortization, and as further adjusted, as applicable, for acquisition related expenses, stock-based compensation expense,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:233.45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.88pt">payroll tax expense related to stock-based compensation, loss on extinguishment of debt, financing related expenses, loss</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:244.25pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.85pt">on operating lease assets, restructuring related expenses, legal settlement expenses, gain on sale of business and other</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:255.05pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.89pt">income or expense, net. These excluded items are either non-cash charges or such that we believe they do not represent</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:265.85pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.97pt">our underlying core operating performance and that their exclusion provides investors with a better understanding of the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:276.65pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.91pt">factors and trends affecting our business. Adjusted EBITDA Margin represents Adjusted EBITDA as a percentage of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);white-space:pre;width:2.01pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:287.45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.89pt">Adjusted Revenue. Adjusted Revenue is a non-GAAP financial measure defined as revenue excluding client contract</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:298.25pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:495pt">termination costs associated with restructuring related activities. We exclude these costs from revenue because we believe</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:309.05pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:358.6pt">they are not indicative of past or future underlying performance of the business. For the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:417.1pt;position:var(--position);text-decoration:none;white-space:pre;width:136.22pt">three and six months ended June</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3199999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:319.85pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:35pt">30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:93.5pt;position:var(--position);white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:113.5pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:133.5pt;position:var(--position);white-space:pre;width:149.97pt">, revenue equaled Adjusted Revenue.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:336.65pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.89pt">Adjusted EBITDA and Adjusted EBITDA Margin are non-GAAP financial measures and are presented for supplemental</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:347.45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.94pt">informational purposes only and should not be considered as alternatives or substitutes to financial information presented in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:358.25pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.84pt">accordance with GAAP. These measures have certain limitations in that they do not include the impact of certain costs that</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:369.05pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.98pt">are reflected in our condensed consolidated statements of operations that are necessary to run our business. Other</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:379.85pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.93pt">companies, including other companies in our industry, may not use these measures or may calculate these measures</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:390.65pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:473.06pt">differently than as presented in this Quarterly Report on Form 10-Q, limiting their usefulness as comparative measures.</span></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:300.44pt;position:var(--position);white-space:pre">19</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:187.16pt">The following table presents a reconciliation of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:263.65999999999997pt;position:var(--position);text-decoration:none;white-space:pre;width:44.02pt">net income</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:307.68pt;position:var(--position);white-space:pre;width:245.67pt">, the most directly comparable financial measure calculated in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:55.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:251.44pt">accordance with GAAP, to Adjusted EBITDA, and presents </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:309.94pt;position:var(--position);text-decoration:none;white-space:pre;width:46pt">net income</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:355.94pt;position:var(--position);white-space:pre;width:197.49pt"> margin, the most directly comparable financial</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:66.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:306.2pt">measure calculated in accordance with GAAP, with Adjusted EBITDA Margin:</span></div><div style="position:var(--position);top:89.4pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:225pt"/><td style="padding:0;width:65.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:65.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:65.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:65.25pt"/></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);width:133.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:133.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:27.25pt;position:var(--position);text-decoration:none;white-space:pre">Three Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:133.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:50.77pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);width:133.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:133.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:32.13pt;position:var(--position);text-decoration:none;white-space:pre">Six Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:133.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:50.77pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:23.25pt;width:225pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(dollars in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:23.25pt;width:65.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:23.74pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:23.25pt;width:65.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:23.74pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:23.25pt;width:65.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:23.74pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:23.25pt;width:65.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:23.74pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:37.5pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Net income</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:37.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:23.38pt"></span></span><span style="left:31.009999999999998pt;position:var(--position)">8,536<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:37.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:18.38pt"></span></span><span style="left:26.009999999999998pt;position:var(--position)">12,843<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:37.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:23.38pt"></span></span><span style="left:31.009999999999998pt;position:var(--position)">9,705<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:37.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:18.38pt"></span></span><span style="left:26.009999999999998pt;position:var(--position)">23,895<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:51.75pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Adjusted to exclude the following:</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:66pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Interest income</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:66pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:25.39pt"></span></span><span style="left:28.02pt;position:var(--position)">(1,019)<span style="display:inline-block;height:6.55pt;width:8pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:66pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:25.39pt"></span></span><span style="left:28.02pt;position:var(--position)">(2,803)<span style="display:inline-block;height:6.55pt;width:8pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:66pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:25.39pt"></span></span><span style="left:28.02pt;position:var(--position)">(2,416)<span style="display:inline-block;height:6.55pt;width:8pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:66pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:25.39pt"></span></span><span style="left:28.02pt;position:var(--position)">(6,735)<span style="display:inline-block;height:6.55pt;width:8pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:80.25pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Interest expense</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:80.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.38pt"></span></span><span style="left:31.009999999999998pt;position:var(--position)">9,810<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:80.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:23.38pt"></span></span><span style="left:26.009999999999998pt;position:var(--position)">10,729<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:80.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:23.38pt"></span></span><span style="left:26.009999999999998pt;position:var(--position)">19,577<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:80.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:23.38pt"></span></span><span style="left:26.009999999999998pt;position:var(--position)">21,373<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:94.5pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Income tax expense</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:94.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.38pt"></span></span><span style="left:31.009999999999998pt;position:var(--position)">6,930<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:94.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.38pt"></span></span><span style="left:31.009999999999998pt;position:var(--position)">6,734<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:94.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:23.38pt"></span></span><span style="left:26.009999999999998pt;position:var(--position)">11,400<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:94.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:23.38pt"></span></span><span style="left:26.009999999999998pt;position:var(--position)">12,350<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:108.75pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Depreciation and amortization</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:108.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:23.38pt"></span></span><span style="left:26.009999999999998pt;position:var(--position)">22,269<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:108.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:23.38pt"></span></span><span style="left:26.009999999999998pt;position:var(--position)">19,729<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:108.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:23.38pt"></span></span><span style="left:26.009999999999998pt;position:var(--position)">44,061<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:108.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:23.38pt"></span></span><span style="left:26.009999999999998pt;position:var(--position)">40,641<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:123pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Other income</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:123pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:32.89pt"></span></span><span style="left:35.52pt;position:var(--position)">(625)<span style="display:inline-block;height:6.55pt;width:8pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:123pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:32.89pt"></span></span><span style="left:35.52pt;position:var(--position)">(694)<span style="display:inline-block;height:6.55pt;width:8pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:123pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:32.89pt"></span></span><span style="left:35.52pt;position:var(--position)">(625)<span style="display:inline-block;height:6.55pt;width:8pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:123pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:32.89pt"></span></span><span style="left:35.52pt;position:var(--position)">(694)<span style="display:inline-block;height:6.55pt;width:8pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:137.25pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);white-space:pre">Acquisition related expenses </span><span style="font-family:'Arial', sans-serif;font-size:5.8500000000000005pt;font-style:normal;font-weight:normal;left:133.08pt;position:var(--position);top:-2.293pt;vertical-align:super;white-space:pre">(1)</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:137.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">275<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:137.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.88pt"></span></span><span style="left:44.510000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:137.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">527<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:137.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)">26<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:151.5pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);white-space:pre">Restructuring related expenses </span><span style="font-family:'Arial', sans-serif;font-size:5.8500000000000005pt;font-style:normal;font-weight:normal;left:143.07pt;position:var(--position);top:-2.293pt;vertical-align:super;white-space:pre">(2)</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:151.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">572<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:151.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">546<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:151.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.38pt"></span></span><span style="left:31.009999999999998pt;position:var(--position)">5,858<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:151.5pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.38pt"></span></span><span style="left:31.009999999999998pt;position:var(--position)">1,765<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:165.75pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);white-space:pre">Legal settlement expenses </span><span style="font-family:'Arial', sans-serif;font-size:5.8500000000000005pt;font-style:normal;font-weight:normal;left:125.6pt;position:var(--position);top:-2.293pt;vertical-align:super;white-space:pre">(3)</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:165.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.88pt"></span></span><span style="left:44.510000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:165.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">355<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:165.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.88pt"></span></span><span style="left:44.510000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:165.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">355<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:180pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Stock-based compensation expense</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:180pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:23.38pt"></span></span><span style="left:26.009999999999998pt;position:var(--position)">16,593<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:180pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:23.38pt"></span></span><span style="left:26.009999999999998pt;position:var(--position)">21,415<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:180pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:23.38pt"></span></span><span style="left:26.009999999999998pt;position:var(--position)">33,102<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:180pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:23.38pt"></span></span><span style="left:26.009999999999998pt;position:var(--position)">40,589<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td></tr><tr style="height:24.75pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:194.25pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.01pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Payroll tax expense related to stock-based </span></div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:25.13pt;position:var(--position);text-decoration:none;white-space:pre">compensation</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:194.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">399<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:194.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">549<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:194.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">821<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:194.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:14.81pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.38pt"></span></span><span style="left:31.009999999999998pt;position:var(--position)">1,234<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:219pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);white-space:pre">Loss on operating lease asset </span><span style="font-family:'Arial', sans-serif;font-size:5.8500000000000005pt;font-style:normal;font-weight:normal;left:138.1pt;position:var(--position);top:-2.293pt;vertical-align:super;white-space:pre">(4)</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:219pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.88pt"></span></span><span style="left:44.510000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:219pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.88pt"></span></span><span style="left:44.510000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:219pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:41.88pt"></span></span><span style="left:44.510000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:219pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.38pt"></span></span><span style="left:31.009999999999998pt;position:var(--position)">4,409<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:233.25pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Adjusted EBITDA</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:233.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:18.38pt"></span></span><span style="left:26.009999999999998pt;position:var(--position)">63,740<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:233.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:18.38pt"></span></span><span style="left:26.009999999999998pt;position:var(--position)">69,403<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:233.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:13.38pt"></span></span><span style="left:21.009999999999998pt;position:var(--position)">122,010<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:233.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:13.38pt"></span></span><span style="left:21.009999999999998pt;position:var(--position)">139,208<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:261.75pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Revenue</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:261.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:13.38pt"></span></span><span style="left:21.009999999999998pt;position:var(--position)">200,411<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:261.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:13.38pt"></span></span><span style="left:21.009999999999998pt;position:var(--position)">203,070<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:261.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:13.38pt"></span></span><span style="left:21.009999999999998pt;position:var(--position)">394,417<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:261.75pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:13.38pt"></span></span><span style="left:21.009999999999998pt;position:var(--position)">406,040<span style="display:inline-block;height:6.55pt;width:10.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:276pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:3.75pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Net income margin</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:276pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:41.01pt;position:var(--position)"></span><span style="left:41.01pt;position:var(--position)">4.3%<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:276pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:41.01pt;position:var(--position)"></span><span style="left:41.01pt;position:var(--position)">6.3%<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:276pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:41.01pt;position:var(--position)"></span><span style="left:41.01pt;position:var(--position)">2.5%<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:276pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:41.01pt;position:var(--position)"></span><span style="left:41.01pt;position:var(--position)">5.9%<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:290.25pt;width:225pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:225pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Adjusted EBITDA Margin</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:225pt;position:var(--position);top:290.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:36.01pt;position:var(--position)"></span><span style="left:36.01pt;position:var(--position)">31.8%<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:293.25pt;position:var(--position);top:290.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:36.01pt;position:var(--position)"></span><span style="left:36.01pt;position:var(--position)">34.2%<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:361.5pt;position:var(--position);top:290.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:36.01pt;position:var(--position)"></span><span style="left:36.01pt;position:var(--position)">30.9%<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:429.75pt;position:var(--position);top:290.25pt;width:65.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:65.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:36.01pt;position:var(--position)"></span><span style="left:36.01pt;position:var(--position)">34.3%<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height:9pt;position:var(--position);top:398.9pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre">_____________________________________________________</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:409.7pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:10.98pt">(1)</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);white-space:pre;width:458.95pt">Acquisition related expenses principally include costs for actual or planned acquisitions including related third-party</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:420.5pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);white-space:pre;width:458.89pt">fees, legal, consulting and other expenditures, and as applicable, severance costs and retention or performance</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:431.3pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);white-space:pre;width:458.92pt">bonuses to employees related to acquisitions. From time to time, acquisition related expenses may also include</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:442.1pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);white-space:pre;width:228.86pt">similar transaction related costs for business dispositions.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:452.9pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:10.98pt">(2)</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);white-space:pre;width:458.9pt">Restructuring related expenses include costs for various workforce optimization and organizational changes to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:463.7pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);white-space:pre;width:458.98pt">better align with our strategic goals and future scale including employee severance and other personnel related</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:474.5pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);white-space:pre;width:458.94pt">costs, and as applicable, contract termination costs, and losses from the disposal of certain technology and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:485.3pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);white-space:pre;width:81.45pt">capitalized software.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:496.1pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:10.98pt">(3)</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:24.49pt">Legal </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:118.99pt;position:var(--position);white-space:pre;width:394.8pt">settlement expenses consist of periodic settlement costs for significant or unusual litigation matters.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:506.9pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:10.98pt">(4)</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);white-space:pre;width:458.94pt">Loss on operating lease asset represents losses incurred from time to time relating to the impairment or</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:517.7pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);white-space:pre;width:146.81pt">abandonment of leased office space.</span></div><div style="position:absolute;top:546.5pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_91"></div><div style="line-height:9pt;position:var(--position);top:546.5pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre">Components of our Results of Operations</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:563.3pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:321.76pt">For a description of the components of our results of operations, refer to Note </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:398.26pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">2</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:403.26pt;position:var(--position);white-space:pre;width:150.18pt"> to our audited consolidated financial</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:574.1pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:107.69pt">statements included in our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:166.19pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:186.19pt;position:var(--position);white-space:pre;width:367.29pt"> 10-K. In addition, for a description of primary drivers that may cause our revenue, costs and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:584.9pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.94pt">operating expenses to fluctuate from period to period, including seasonality, refer to Part II, Item 7, &#8220;Management&#8217;s</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:595.7pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:358.3pt">Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:416.8pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:436.8pt;position:var(--position);white-space:pre;width:23.99pt"> 10-K.</span></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:300.44pt;position:var(--position);white-space:pre">20</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="position:absolute;top:45pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_94"></div><div style="line-height:9pt;position:var(--position);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre">Results of Operations</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);top:61.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre">Three Months Ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:208.38pt;position:var(--position);white-space:pre"> Compared to </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:268.82pt;position:var(--position);text-decoration:none;white-space:pre">Three Months Ended June 30, 2025</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:78.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:243.87pt">The following table sets forth our results of operations for the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:320.37pt;position:var(--position);text-decoration:none;white-space:pre;width:139.48pt">three months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:459.85pt;position:var(--position);white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:479.85pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:499.85pt;position:var(--position);white-space:pre;width:2.5pt">:</span></div><div style="position:var(--position);top:95.4pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:177.75pt"/><td style="padding:0;width:50.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:50.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:50.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:50.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:50.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:51pt"/></tr><tr style="height:51.75pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:177.75pt"><div><div style="line-height:8pt;position:var(--position);top:42.77pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(dollars in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:177.75pt;position:var(--position);width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:4.35pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:14.25pt;position:var(--position);text-decoration:none;white-space:pre">Three </span></div><div style="line-height:8pt;position:var(--position);top:13.95pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:10.92pt;position:var(--position);text-decoration:none;white-space:pre">Months </span></div><div style="line-height:8pt;position:var(--position);top:23.55pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:12.92pt;position:var(--position);text-decoration:none;white-space:pre">Ended</span></div><div style="line-height:8pt;position:var(--position);top:33.15pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:9.14pt;position:var(--position);text-decoration:none;white-space:pre">June 30, </span></div><div style="line-height:8pt;position:var(--position);top:42.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:16.24pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:231pt;position:var(--position);width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:33.15pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:6.04pt;position:var(--position);text-decoration:none;white-space:pre">% of Total </span></div><div style="line-height:8pt;position:var(--position);top:42.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:8.48pt;position:var(--position);text-decoration:none;white-space:pre">Revenue</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:284.25pt;position:var(--position);width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:4.35pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:14.25pt;position:var(--position);text-decoration:none;white-space:pre">Three </span></div><div style="line-height:8pt;position:var(--position);top:13.95pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:10.92pt;position:var(--position);text-decoration:none;white-space:pre">Months </span></div><div style="line-height:8pt;position:var(--position);top:23.55pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:12.92pt;position:var(--position);text-decoration:none;white-space:pre">Ended</span></div><div style="line-height:8pt;position:var(--position);top:33.15pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:9.14pt;position:var(--position);text-decoration:none;white-space:pre">June 30, </span></div><div style="line-height:8pt;position:var(--position);top:42.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:16.24pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:337.5pt;position:var(--position);width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:33.15pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:6.04pt;position:var(--position);text-decoration:none;white-space:pre">% of Total </span></div><div style="line-height:8pt;position:var(--position);top:42.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:8.48pt;position:var(--position);text-decoration:none;white-space:pre">Revenue</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:390.75pt;position:var(--position);width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:42.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:4.49pt;position:var(--position);text-decoration:none;white-space:pre">Change ($)</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:444pt;position:var(--position);width:51pt"><div><div style="line-height:8pt;position:var(--position);top:42.75pt;width:51pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:3.53pt;position:var(--position);text-decoration:none;white-space:pre">Change (%)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:51.75pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Revenue:</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:66pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Prescription transactions revenue</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:177.75pt;position:var(--position);top:66pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:6.38pt"></span></span><span style="left:14.010000000000002pt;position:var(--position)">106,390<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:231pt;position:var(--position);top:66pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">53%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:284.25pt;position:var(--position);top:66pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:6.38pt"></span></span><span style="left:14.010000000000002pt;position:var(--position)">143,064<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:337.5pt;position:var(--position);top:66pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">70%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:390.75pt;position:var(--position);top:66pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:8.39pt"></span></span><span style="left:16.02pt;position:var(--position)">(36,674)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:444pt;position:var(--position);top:66pt;width:51pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:51pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:14.45pt;position:var(--position);text-decoration:none;white-space:pre">(26%)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:80.25pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Subscription revenue</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:177.75pt;position:var(--position);top:80.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">28,514<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:231pt;position:var(--position);top:80.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">14%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:284.25pt;position:var(--position);top:80.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">20,463<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:337.5pt;position:var(--position);top:80.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">10%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:390.75pt;position:var(--position);top:80.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:21.38pt"></span></span><span style="left:24.009999999999998pt;position:var(--position)">8,051<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:444pt;position:var(--position);top:80.25pt;width:51pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:51pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.44pt;position:var(--position);text-decoration:none;white-space:pre">39%</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:94.5pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Pharma Direct revenue</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:177.75pt;position:var(--position);top:94.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">61,628<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:231pt;position:var(--position);top:94.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">31%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:284.25pt;position:var(--position);top:94.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">34,981<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:337.5pt;position:var(--position);top:94.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">17%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:390.75pt;position:var(--position);top:94.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">26,647<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:444pt;position:var(--position);top:94.5pt;width:51pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:51pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.44pt;position:var(--position);text-decoration:none;white-space:pre">76%</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:108.75pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Other revenue</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:177.75pt;position:var(--position);top:108.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:21.38pt"></span></span><span style="left:24.009999999999998pt;position:var(--position)">3,879<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:231pt;position:var(--position);top:108.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">2%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:284.25pt;position:var(--position);top:108.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:21.38pt"></span></span><span style="left:24.009999999999998pt;position:var(--position)">4,562<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:337.5pt;position:var(--position);top:108.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">2%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:390.75pt;position:var(--position);top:108.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:25.89pt"></span></span><span style="left:28.52pt;position:var(--position)">(683)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:444pt;position:var(--position);top:108.75pt;width:51pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:51pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:14.45pt;position:var(--position);text-decoration:none;white-space:pre">(15%)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:123pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Total revenue</span></div></div></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:177.75pt;position:var(--position);top:123pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:11.38pt"></span></span><span style="left:14.010000000000002pt;position:var(--position)">200,411<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:284.25pt;position:var(--position);top:123pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:11.38pt"></span></span><span style="left:14.010000000000002pt;position:var(--position)">203,070<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:137.25pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Costs and operating expenses:</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:36pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:151.5pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.46pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Cost of revenue, exclusive of </span></div><div style="line-height:9pt;position:var(--position);top:15.26pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:25.13pt;position:var(--position);text-decoration:none;white-space:pre">depreciation and amortization </span></div><div style="line-height:9pt;position:var(--position);top:26.06pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:25.13pt;position:var(--position);text-decoration:none;white-space:pre">presented separately below</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:177.75pt;position:var(--position);top:151.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:26.06pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">20,999<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:231pt;position:var(--position);top:151.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:26.06pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">10%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:284.25pt;position:var(--position);top:151.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:26.06pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">13,350<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:337.5pt;position:var(--position);top:151.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:26.06pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">7%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:390.75pt;position:var(--position);top:151.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:26.06pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:21.38pt"></span></span><span style="left:24.009999999999998pt;position:var(--position)">7,649<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:444pt;position:var(--position);top:151.5pt;width:51pt"><div><div style="line-height:9pt;position:var(--position);top:26.06pt;width:51pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.44pt;position:var(--position);text-decoration:none;white-space:pre">57%</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:187.5pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Product development and technology</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:177.75pt;position:var(--position);top:187.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">26,711<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:231pt;position:var(--position);top:187.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">13%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:284.25pt;position:var(--position);top:187.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">29,933<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:337.5pt;position:var(--position);top:187.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">15%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:390.75pt;position:var(--position);top:187.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:18.39pt"></span></span><span style="left:21.02pt;position:var(--position)">(3,222)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:444pt;position:var(--position);top:187.5pt;width:51pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:51pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:14.45pt;position:var(--position);text-decoration:none;white-space:pre">(11%)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:201.75pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Sales and marketing</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:177.75pt;position:var(--position);top:201.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">81,986<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:231pt;position:var(--position);top:201.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">41%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:284.25pt;position:var(--position);top:201.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">84,870<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:337.5pt;position:var(--position);top:201.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">42%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:390.75pt;position:var(--position);top:201.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:18.39pt"></span></span><span style="left:21.02pt;position:var(--position)">(2,884)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:444pt;position:var(--position);top:201.75pt;width:51pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:51pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.95pt;position:var(--position);text-decoration:none;white-space:pre">(3%)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:216pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">General and administrative</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:177.75pt;position:var(--position);top:216pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">24,814<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:231pt;position:var(--position);top:216pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">12%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:284.25pt;position:var(--position);top:216pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">28,379<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:337.5pt;position:var(--position);top:216pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">14%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:390.75pt;position:var(--position);top:216pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:18.39pt"></span></span><span style="left:21.02pt;position:var(--position)">(3,565)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:444pt;position:var(--position);top:216pt;width:51pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:51pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:14.45pt;position:var(--position);text-decoration:none;white-space:pre">(13%)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:230.25pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Depreciation and amortization</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:177.75pt;position:var(--position);top:230.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">22,269<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:231pt;position:var(--position);top:230.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">11%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:284.25pt;position:var(--position);top:230.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">19,729<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:337.5pt;position:var(--position);top:230.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">10%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:390.75pt;position:var(--position);top:230.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:21.38pt"></span></span><span style="left:24.009999999999998pt;position:var(--position)">2,540<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:444pt;position:var(--position);top:230.25pt;width:51pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:51pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.44pt;position:var(--position);text-decoration:none;white-space:pre">13%</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:244.5pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Total costs and operating expenses</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:177.75pt;position:var(--position);top:244.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:11.38pt"></span></span><span style="left:14.010000000000002pt;position:var(--position)">176,779<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:284.25pt;position:var(--position);top:244.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:11.38pt"></span></span><span style="left:14.010000000000002pt;position:var(--position)">176,261<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:258.75pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Operating income</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:177.75pt;position:var(--position);top:258.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">23,632<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:284.25pt;position:var(--position);top:258.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">26,809<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:273pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Other expense, net:</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:287.25pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Other income</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:177.75pt;position:var(--position);top:287.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.88pt"></span></span><span style="left:31.509999999999998pt;position:var(--position)">625<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:231pt;position:var(--position);top:287.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">0%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:284.25pt;position:var(--position);top:287.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.88pt"></span></span><span style="left:31.509999999999998pt;position:var(--position)">694<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:337.5pt;position:var(--position);top:287.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">0%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:390.75pt;position:var(--position);top:287.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:30.89pt"></span></span><span style="left:33.52pt;position:var(--position)">(69)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:444pt;position:var(--position);top:287.25pt;width:51pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:51pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:14.45pt;position:var(--position);text-decoration:none;white-space:pre">(10%)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:301.5pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Interest income</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:177.75pt;position:var(--position);top:301.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:21.38pt"></span></span><span style="left:24.009999999999998pt;position:var(--position)">1,019<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:231pt;position:var(--position);top:301.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">1%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:284.25pt;position:var(--position);top:301.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:21.38pt"></span></span><span style="left:24.009999999999998pt;position:var(--position)">2,803<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:337.5pt;position:var(--position);top:301.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">1%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:390.75pt;position:var(--position);top:301.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:18.39pt"></span></span><span style="left:21.02pt;position:var(--position)">(1,784)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:444pt;position:var(--position);top:301.5pt;width:51pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:51pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:14.45pt;position:var(--position);text-decoration:none;white-space:pre">(64%)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:315.75pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Interest expense</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:177.75pt;position:var(--position);top:315.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:18.39pt"></span></span><span style="left:21.02pt;position:var(--position)">(9,810)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:231pt;position:var(--position);top:315.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">5%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:284.25pt;position:var(--position);top:315.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:13.39pt"></span></span><span style="left:16.02pt;position:var(--position)">(10,729)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:337.5pt;position:var(--position);top:315.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">5%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:390.75pt;position:var(--position);top:315.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.88pt"></span></span><span style="left:31.509999999999998pt;position:var(--position)">919<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:444pt;position:var(--position);top:315.75pt;width:51pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:51pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.95pt;position:var(--position);text-decoration:none;white-space:pre">(9%)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:330pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Total other expense, net</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:177.75pt;position:var(--position);top:330pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:18.39pt"></span></span><span style="left:21.02pt;position:var(--position)">(8,166)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:284.25pt;position:var(--position);top:330pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:18.39pt"></span></span><span style="left:21.02pt;position:var(--position)">(7,232)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:344.25pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Income before income taxes</span></div></div></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:177.75pt;position:var(--position);top:344.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">15,466<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:284.25pt;position:var(--position);top:344.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">19,577<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:358.5pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Income tax expense</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:177.75pt;position:var(--position);top:358.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:18.39pt"></span></span><span style="left:21.02pt;position:var(--position)">(6,930)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:231pt;position:var(--position);top:358.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">3%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:284.25pt;position:var(--position);top:358.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:18.39pt"></span></span><span style="left:21.02pt;position:var(--position)">(6,734)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:337.5pt;position:var(--position);top:358.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">3%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:390.75pt;position:var(--position);top:358.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:25.89pt"></span></span><span style="left:28.52pt;position:var(--position)">(196)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:444pt;position:var(--position);top:358.5pt;width:51pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:51pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.94pt;position:var(--position);text-decoration:none;white-space:pre">3%</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:372.75pt;width:177.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:177.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Net income</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:177.75pt;position:var(--position);top:372.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:24.009999999999998pt;position:var(--position)">8,536<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:284.25pt;position:var(--position);top:372.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:11.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">12,843<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/></tr></tbody></table></div></div></div><div style="line-height:9pt;position:var(--position);top:505.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre">Revenue</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);top:522.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre">All</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:86.48pt;position:var(--position);white-space:pre"> of our revenue has been generated in the United States.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:539pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:135.96pt">Prescription transactions revenue </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:212.46pt;position:var(--position);text-decoration:none;white-space:pre;width:41.99pt">decreased</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:254.45pt;position:var(--position);white-space:pre;width:2.51pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:256.96000000000004pt;position:var(--position);text-decoration:none;white-space:pre;width:50.46pt">$36.7 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:307.41999999999996pt;position:var(--position);white-space:pre;width:15.51pt">, or </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:322.93pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt">26%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:340.93pt;position:var(--position);white-space:pre;width:150.94pt">, year-over-year, primarily driven by a </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:491.87pt;position:var(--position);text-decoration:none;white-space:pre;width:36.99pt">decrease</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:528.86pt;position:var(--position);white-space:pre;width:24.51pt"> in the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:549.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:176.3pt">number of our Monthly Active Consumers </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:234.8pt;position:var(--position);text-decoration:none;white-space:pre;width:318.65pt">due to the broader changes in the retail pharmacy landscape including store</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:560.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">closures and volume reduction in one of our integrated savings programs as discussed above, as well as the deliberate shift</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:571.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:309.33pt">of product and marketing investment toward our new subscription offerings. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:367.83pt;position:var(--position);white-space:pre;width:185.59pt">The year-over-year decrease was also due to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:582.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.85pt">lower unit economics which we expect to continue in the near-term as we made deliberate decisions to favor long-term</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:593pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.89pt">durability and certainty. The impact from these factors was partially offset by revenue contribution from a prescription</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:603.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:312.36pt">delivery technology business we acquired in October 2025, which provided </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:370.86pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:375.86pt;position:var(--position);text-decoration:none;white-space:pre;width:16.75pt"> 3%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:392.61pt;position:var(--position);white-space:pre;width:160.88pt"> year-over-year increase in prescription</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:614.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:85.97pt">transactions revenue.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:631.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:6pt">S</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:82.5pt;position:var(--position);text-decoration:none;white-space:pre;width:82.72pt">ubscription revenue </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:165.22pt;position:var(--position);text-decoration:none;white-space:pre;width:38.98pt">increased</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:204.2pt;position:var(--position);text-decoration:none;white-space:pre;width:3.38pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:207.58pt;position:var(--position);text-decoration:none;white-space:pre;width:46.33pt">$8.1 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:253.91pt;position:var(--position);text-decoration:none;white-space:pre;width:17.25pt">, or </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:271.15999999999997pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt">39%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:289.15999999999997pt;position:var(--position);text-decoration:none;white-space:pre;width:69.72pt">, year-over-year, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:358.88pt;position:var(--position);text-decoration:none;white-space:pre;width:78.06pt">primarily driven by </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:436.94pt;position:var(--position);text-decoration:none;white-space:pre;width:108.99pt">the expansion and growth </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:545.9300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:7.5pt">of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:642.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:269.64pt">our condition-specific subscription programs, in particular weight </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:328.14pt;position:var(--position);text-decoration:none;white-space:pre;width:15.99pt">loss</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:344.13pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:346.63pt;position:var(--position);text-decoration:none;white-space:pre;width:4.19pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:350.82pt;position:var(--position);text-decoration:none;white-space:pre;width:94.39pt">as well as a resulting </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:445.21pt;position:var(--position);text-decoration:none;white-space:pre;width:33.98pt">increase</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:479.19pt;position:var(--position);text-decoration:none;white-space:pre;width:74.23pt"> in the number of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:653pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:96.57pt">subscription plans with </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:155.07pt;position:var(--position);text-decoration:none;white-space:pre;width:55.71pt">764&#160;thousand</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:210.78pt;position:var(--position);text-decoration:none;white-space:pre;width:105.01pt"> subscription plans as of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:315.79pt;position:var(--position);text-decoration:none;white-space:pre;width:59.42pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:375.21pt;position:var(--position);text-decoration:none;white-space:pre;width:58.61pt"> compared to </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:433.82pt;position:var(--position);text-decoration:none;white-space:pre;width:55.71pt">668 thousand</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:489.53pt;position:var(--position);text-decoration:none;white-space:pre;width:28.13pt"> as of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:517.6600000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:35.71pt">June&#160;30,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:663.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:78.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:680.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:97.4pt">Pharma Direct revenue </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:173.9pt;position:var(--position);text-decoration:none;white-space:pre;width:38.98pt">increased</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:212.88pt;position:var(--position);white-space:pre;width:3.32pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:216.2pt;position:var(--position);text-decoration:none;white-space:pre;width:51.27pt">$26.6 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:267.47pt;position:var(--position);white-space:pre;width:17.13pt">, or </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:284.6pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt">76%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:302.6pt;position:var(--position);white-space:pre;width:250.76pt">, year-over-year, driven by organic growth as we continued to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:691.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:328.45pt">expand our market penetration with pharma manufacturers and other customers, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:386.95pt;position:var(--position);text-decoration:none;white-space:pre;width:125.98pt">in particular our GLP-1 access </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:512.9300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:37.97pt">programs</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:550.9pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:702.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:177.38pt">which are part of our consumer direct pricing</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:235.88pt;position:var(--position);white-space:pre;width:2.5pt">.</span></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:300.44pt;position:var(--position);white-space:pre">21</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="line-height:9pt;position:var(--position);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre">Costs and Operating Expenses</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:61.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:235.89pt">Cost of revenue, exclusive of depreciation and amortization</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:78.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:70.33pt">Cost of revenue </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:146.82999999999998pt;position:var(--position);text-decoration:none;white-space:pre;width:38.98pt">increased</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:185.81pt;position:var(--position);white-space:pre;width:3.95pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:189.76pt;position:var(--position);text-decoration:none;white-space:pre;width:46.9pt">$7.6 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:236.66pt;position:var(--position);white-space:pre;width:18.39pt">, or </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:255.05pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt">57%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:273.05pt;position:var(--position);white-space:pre;width:155.63pt">, year-over-year, primarily driven by a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:428.68pt;position:var(--position);text-decoration:none;white-space:pre;width:124.67pt"> $3.8 million increase in costs</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:89.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:217.66pt">related to our condition-specific subscription programs</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:276.15999999999997pt;position:var(--position);white-space:pre;width:277.31pt">, a $3.8 million increase in prescription delivery costs as a result of a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:100.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:320.3pt">prescription delivery technology business we acquired in October 2025 and a </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:378.8pt;position:var(--position);text-decoration:none;white-space:pre;width:52.02pt">$3.0 million i</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:430.82pt;position:var(--position);white-space:pre;width:122.58pt">ncrease in fulfillment costs for</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:111pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.88pt">certain solutions provided to customers under our Pharma Direct offering. The impact of these drivers was partially offset by</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:121.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:7.96pt">a </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:66.46pt;position:var(--position);text-decoration:none;white-space:pre;width:164.71pt">$1.8 million decrease in processing fees.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:231.17pt;position:var(--position);white-space:pre;width:322.16pt"> We expect cost of revenue to continue to increase on a year-over-year basis in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:132.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:482.43pt">the near term as we continue to scale and expand our offerings, particularly our Pharma Direct and subscription offerings.</span></div><div style="line-height:9pt;position:var(--position);top:161.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre">Product development and technology</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:178.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:154.92pt">Product development and technology </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:231.42pt;position:var(--position);text-decoration:none;white-space:pre;width:38.5pt">expenses</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:269.91999999999996pt;position:var(--position);white-space:pre;width:3.49pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:273.40999999999997pt;position:var(--position);text-decoration:none;white-space:pre;width:41.99pt">decreased</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:315.4pt;position:var(--position);white-space:pre;width:3.49pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:318.89pt;position:var(--position);text-decoration:none;white-space:pre;width:46.44pt">$3.2 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:365.33pt;position:var(--position);white-space:pre;width:17.47pt">, or </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:382.8pt;position:var(--position);text-decoration:none;white-space:pre;width:17.34pt">11%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:400.14pt;position:var(--position);white-space:pre;width:66.45pt">, year-over-year,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:466.59pt;position:var(--position);text-decoration:none;white-space:pre;width:86.88pt"> primarily driven by a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:189pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:275.4pt">decrease in personnel related costs due to lower average headcount.</span></div><div style="line-height:9pt;position:var(--position);top:217.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre">Sales and marketing</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:234.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:134.98pt">Sales and marketing expenses </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:211.48pt;position:var(--position);text-decoration:none;white-space:pre;width:41.99pt">decreased</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:253.47pt;position:var(--position);white-space:pre;width:4.88pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:258.35pt;position:var(--position);text-decoration:none;white-space:pre;width:47.83pt">$2.9 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:306.18pt;position:var(--position);white-space:pre;width:20.25pt">, or </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:326.43pt;position:var(--position);text-decoration:none;white-space:pre;width:13pt">3%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:339.43pt;position:var(--position);white-space:pre;width:214.02pt">, year-over-year, primarily driven by a decrease in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:245.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:86.97pt">advertising expenses.</span></div><div style="line-height:9pt;position:var(--position);top:274.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre">General and administrative</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:291pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:153.57pt">General and administrative expenses </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:230.07pt;position:var(--position);text-decoration:none;white-space:pre;width:41.99pt">decreased</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:272.06pt;position:var(--position);white-space:pre;width:3.16pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:275.22pt;position:var(--position);text-decoration:none;white-space:pre;width:46.11pt">$3.6 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:321.33000000000004pt;position:var(--position);white-space:pre;width:16.81pt">, or </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:338.14pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt">13%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:356.14pt;position:var(--position);white-space:pre;width:134.02pt">, year-over-year, primarily driven </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:490.16pt;position:var(--position);text-decoration:none;white-space:pre;width:9.5pt">by</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:499.66pt;position:var(--position);white-space:pre;width:53.79pt"> credit losses</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:301.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:326.93pt">recognized in 2025 on accounts receivables associated with Rite Aid's bankruptcy.</span></div><div style="line-height:9pt;position:var(--position);top:330.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre">Depreciation and amortization</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:347.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:127.74pt">Depreciation and amortization </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:204.24pt;position:var(--position);text-decoration:none;white-space:pre;width:38.5pt">expenses</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:242.74pt;position:var(--position);white-space:pre;width:4.44pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:247.18pt;position:var(--position);text-decoration:none;white-space:pre;width:38.98pt">increased</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:286.15999999999997pt;position:var(--position);white-space:pre;width:4.44pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:290.6pt;position:var(--position);text-decoration:none;white-space:pre;width:47.39pt">$2.5 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:337.99pt;position:var(--position);white-space:pre;width:19.37pt">, or </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:357.36pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt">13%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:375.36pt;position:var(--position);white-space:pre;width:71.84pt">, year-over-year, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:447.2pt;position:var(--position);text-decoration:none;white-space:pre;width:106.22pt">primarily driven by higher</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:358.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">amortization related to capitalized software due to higher capitalization costs for platform improvements and the introduction</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:369pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:118.47pt">of new products and features.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:397.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre;width:66.45pt">Interest Income</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:414.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:68.73pt">Interest income </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:145.23000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:41.99pt">decreased</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:187.22pt;position:var(--position);white-space:pre;width:4.88pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:192.1pt;position:var(--position);text-decoration:none;white-space:pre;width:47.83pt">$1.8 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:239.93pt;position:var(--position);white-space:pre;width:20.25pt">, or </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:260.18pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt">64%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:278.18pt;position:var(--position);white-space:pre;width:275.27pt">, year-over-year, primarily due to lower average balance of cash</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:425.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:273.87pt">equivalents held in U.S. treasury securities money market funds and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:332.37pt;position:var(--position);text-decoration:none;white-space:pre;width:75.94pt">lower interest rates</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:408.31pt;position:var(--position);white-space:pre;width:2.5pt">.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:454.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre;width:71.95pt">Interest Expense</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:471pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:2.5pt">I</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:79pt;position:var(--position);text-decoration:none;white-space:pre;width:64.19pt">nterest expense</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:143.19pt;position:var(--position);white-space:pre;width:2.7pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:145.89pt;position:var(--position);text-decoration:none;white-space:pre;width:41.99pt">decreased</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:187.88pt;position:var(--position);white-space:pre;width:2.7pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:190.57999999999998pt;position:var(--position);text-decoration:none;white-space:pre;width:45.65pt">$0.9 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:236.23pt;position:var(--position);white-space:pre;width:15.89pt">, or </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:252.12pt;position:var(--position);text-decoration:none;white-space:pre;width:13pt">9%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:265.12pt;position:var(--position);white-space:pre;width:288.31pt">, year-over-year primarily due to lower average debt balances and lower</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:481.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:54.47pt">interest rates.</span></div><div style="line-height:9pt;position:var(--position);top:510.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre">Income Taxes</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:527.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:33.38pt">For the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:109.88pt;position:var(--position);text-decoration:none;white-space:pre;width:145.48pt">three months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:255.36pt;position:var(--position);text-decoration:none;white-space:pre;width:22.4pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:277.76pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:297.76pt;position:var(--position);text-decoration:none;white-space:pre;width:137.37pt">, we had income tax expense of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:435.13pt;position:var(--position);text-decoration:none;white-space:pre;width:46.65pt">$6.9 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:481.78pt;position:var(--position);text-decoration:none;white-space:pre;width:22.4pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:504.18pt;position:var(--position);text-decoration:none;white-space:pre;width:46.65pt">$6.7 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:550.8299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:538.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:206.89pt">respectively, and an effective income tax rate of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:265.39pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt">44.8%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:290.89pt;position:var(--position);text-decoration:none;white-space:pre;width:23.82pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:314.71pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt">34.4%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:340.21pt;position:var(--position);text-decoration:none;white-space:pre;width:213.19pt">, respectively. While income tax expense remained</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:549pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">relatively flat year-over-year, the increase in effective income tax rate was primarily driven by an increase in the estimated</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:559.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">annual effective income tax rate and tax effects from our equity awards, partially offset by a decrease in income before</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:570.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:55.48pt">income taxes.</span></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:300.44pt;position:var(--position);white-space:pre">22</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="position:absolute;top:45pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_97"></div><div style="font-size:12pt;line-height:9pt;position:var(--position);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre">Six Months Ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:197.4pt;position:var(--position);white-space:pre"> Compared to </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:257.84000000000003pt;position:var(--position);text-decoration:none;white-space:pre">Six Months Ended June 30, 2025</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:61.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:243.87pt">The following table sets forth our results of operations for the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:320.37pt;position:var(--position);text-decoration:none;white-space:pre;width:129.98pt">six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:450.35pt;position:var(--position);white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:470.35pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:490.35pt;position:var(--position);white-space:pre;width:2.5pt">:</span></div><div style="position:var(--position);top:84.6pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:178.5pt"/><td style="padding:0;width:50.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:50.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:50.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:50.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:50.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:50.25pt"/></tr><tr style="height:51.75pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:178.5pt"><div><div style="line-height:8pt;position:var(--position);top:42.77pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(dollars in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:178.5pt;position:var(--position);width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:13.95pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:3.82pt;position:var(--position);text-decoration:none;white-space:pre">Six Months </span></div><div style="line-height:8pt;position:var(--position);top:23.55pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:12.92pt;position:var(--position);text-decoration:none;white-space:pre">Ended</span></div><div style="line-height:8pt;position:var(--position);top:33.15pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:9.14pt;position:var(--position);text-decoration:none;white-space:pre">June 30, </span></div><div style="line-height:8pt;position:var(--position);top:42.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:16.24pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:231.75pt;position:var(--position);width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:33.15pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:6.04pt;position:var(--position);text-decoration:none;white-space:pre">% of Total </span></div><div style="line-height:8pt;position:var(--position);top:42.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:8.48pt;position:var(--position);text-decoration:none;white-space:pre">Revenue</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:285pt;position:var(--position);width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:13.95pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:3.82pt;position:var(--position);text-decoration:none;white-space:pre">Six Months </span></div><div style="line-height:8pt;position:var(--position);top:23.55pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:12.92pt;position:var(--position);text-decoration:none;white-space:pre">Ended</span></div><div style="line-height:8pt;position:var(--position);top:33.15pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:9.14pt;position:var(--position);text-decoration:none;white-space:pre">June 30, </span></div><div style="line-height:8pt;position:var(--position);top:42.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:16.24pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:338.25pt;position:var(--position);width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:33.15pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:6.04pt;position:var(--position);text-decoration:none;white-space:pre">% of Total </span></div><div style="line-height:8pt;position:var(--position);top:42.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:8.48pt;position:var(--position);text-decoration:none;white-space:pre">Revenue</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:391.5pt;position:var(--position);width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:42.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:4.49pt;position:var(--position);text-decoration:none;white-space:pre">Change ($)</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:444.75pt;position:var(--position);width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:42.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:3.15pt;position:var(--position);text-decoration:none;white-space:pre">Change (%)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:51.75pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Revenue:</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:66pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Prescription transactions revenue</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:178.5pt;position:var(--position);top:66pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:6.38pt"></span></span><span style="left:14.010000000000002pt;position:var(--position)">220,082<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:231.75pt;position:var(--position);top:66pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">56%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:285pt;position:var(--position);top:66pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:6.38pt"></span></span><span style="left:14.010000000000002pt;position:var(--position)">291,987<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:338.25pt;position:var(--position);top:66pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">72%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:391.5pt;position:var(--position);top:66pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:8.39pt"></span></span><span style="left:16.02pt;position:var(--position)">(71,905)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:444.75pt;position:var(--position);top:66pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:14.07pt;position:var(--position);text-decoration:none;white-space:pre">(25%)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:80.25pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Subscription revenue</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:178.5pt;position:var(--position);top:80.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">52,907<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:231.75pt;position:var(--position);top:80.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">13%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:285pt;position:var(--position);top:80.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">41,480<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:338.25pt;position:var(--position);top:80.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">10%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:391.5pt;position:var(--position);top:80.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">11,427<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:444.75pt;position:var(--position);top:80.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">28%</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:94.5pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);white-space:pre">Pharma Direct revenue</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:178.5pt;position:var(--position);top:94.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:11.38pt"></span></span><span style="left:14.010000000000002pt;position:var(--position)">113,858<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:231.75pt;position:var(--position);top:94.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">29%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:285pt;position:var(--position);top:94.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">63,629<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:338.25pt;position:var(--position);top:94.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">16%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:391.5pt;position:var(--position);top:94.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">50,229<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:444.75pt;position:var(--position);top:94.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">79%</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:108.75pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Other revenue</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:178.5pt;position:var(--position);top:108.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:21.38pt"></span></span><span style="left:24.009999999999998pt;position:var(--position)">7,570<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:231.75pt;position:var(--position);top:108.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">2%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:285pt;position:var(--position);top:108.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:21.38pt"></span></span><span style="left:24.009999999999998pt;position:var(--position)">8,944<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:338.25pt;position:var(--position);top:108.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">2%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:391.5pt;position:var(--position);top:108.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:18.39pt"></span></span><span style="left:21.02pt;position:var(--position)">(1,374)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:444.75pt;position:var(--position);top:108.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:14.07pt;position:var(--position);text-decoration:none;white-space:pre">(15%)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:123pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Total revenue</span></div></div></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:178.5pt;position:var(--position);top:123pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:11.38pt"></span></span><span style="left:14.010000000000002pt;position:var(--position)">394,417<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:285pt;position:var(--position);top:123pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:11.38pt"></span></span><span style="left:14.010000000000002pt;position:var(--position)">406,040<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:137.25pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Costs and operating expenses:</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:36pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:151.5pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.46pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Cost of revenue, exclusive of </span></div><div style="line-height:9pt;position:var(--position);top:15.26pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:25.13pt;position:var(--position);text-decoration:none;white-space:pre">depreciation and amortization </span></div><div style="line-height:9pt;position:var(--position);top:26.06pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:25.13pt;position:var(--position);text-decoration:none;white-space:pre">presented separately below</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:178.5pt;position:var(--position);top:151.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:26.06pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">41,155<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:231.75pt;position:var(--position);top:151.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:26.06pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">10%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:285pt;position:var(--position);top:151.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:26.06pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">26,714<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:338.25pt;position:var(--position);top:151.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:26.06pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">7%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:391.5pt;position:var(--position);top:151.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:26.06pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">14,441<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:444.75pt;position:var(--position);top:151.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:26.06pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">54%</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:187.5pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Product development and technology</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:178.5pt;position:var(--position);top:187.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">56,888<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:231.75pt;position:var(--position);top:187.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">14%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:285pt;position:var(--position);top:187.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">61,075<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:338.25pt;position:var(--position);top:187.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">15%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:391.5pt;position:var(--position);top:187.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:18.39pt"></span></span><span style="left:21.02pt;position:var(--position)">(4,187)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:444.75pt;position:var(--position);top:187.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.57pt;position:var(--position);text-decoration:none;white-space:pre">(7%)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:201.75pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Sales and marketing</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:178.5pt;position:var(--position);top:201.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:11.38pt"></span></span><span style="left:14.010000000000002pt;position:var(--position)">163,039<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:231.75pt;position:var(--position);top:201.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">41%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:285pt;position:var(--position);top:201.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:11.38pt"></span></span><span style="left:14.010000000000002pt;position:var(--position)">169,412<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:338.25pt;position:var(--position);top:201.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">42%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:391.5pt;position:var(--position);top:201.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:18.39pt"></span></span><span style="left:21.02pt;position:var(--position)">(6,373)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:444.75pt;position:var(--position);top:201.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.57pt;position:var(--position);text-decoration:none;white-space:pre">(4%)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:216pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">General and administrative</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:178.5pt;position:var(--position);top:216pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">51,633<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:231.75pt;position:var(--position);top:216pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">13%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:285pt;position:var(--position);top:216pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">58,009<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:338.25pt;position:var(--position);top:216pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">14%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:391.5pt;position:var(--position);top:216pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:18.39pt"></span></span><span style="left:21.02pt;position:var(--position)">(6,376)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:444.75pt;position:var(--position);top:216pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:14.07pt;position:var(--position);text-decoration:none;white-space:pre">(11%)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:230.25pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Depreciation and amortization</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:178.5pt;position:var(--position);top:230.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">44,061<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:231.75pt;position:var(--position);top:230.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">11%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:285pt;position:var(--position);top:230.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">40,641<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:338.25pt;position:var(--position);top:230.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:17.06pt;position:var(--position);text-decoration:none;white-space:pre">10%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:391.5pt;position:var(--position);top:230.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:21.38pt"></span></span><span style="left:24.009999999999998pt;position:var(--position)">3,420<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:444.75pt;position:var(--position);top:230.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">8%</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:244.5pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Total costs and operating expenses</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:178.5pt;position:var(--position);top:244.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:11.38pt"></span></span><span style="left:14.010000000000002pt;position:var(--position)">356,776<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:285pt;position:var(--position);top:244.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:11.38pt"></span></span><span style="left:14.010000000000002pt;position:var(--position)">355,851<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:258.75pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Operating income</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:178.5pt;position:var(--position);top:258.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">37,641<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:285pt;position:var(--position);top:258.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">50,189<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:273pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Other expense, net:</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:287.25pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Other income</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:178.5pt;position:var(--position);top:287.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.88pt"></span></span><span style="left:31.509999999999998pt;position:var(--position)">625<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:231.75pt;position:var(--position);top:287.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">0%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:285pt;position:var(--position);top:287.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.88pt"></span></span><span style="left:31.509999999999998pt;position:var(--position)">694<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:338.25pt;position:var(--position);top:287.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">0%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:391.5pt;position:var(--position);top:287.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:30.89pt"></span></span><span style="left:33.52pt;position:var(--position)">(69)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:444.75pt;position:var(--position);top:287.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:14.07pt;position:var(--position);text-decoration:none;white-space:pre">(10%)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:301.5pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Interest income</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:178.5pt;position:var(--position);top:301.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:21.38pt"></span></span><span style="left:24.009999999999998pt;position:var(--position)">2,416<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:231.75pt;position:var(--position);top:301.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">1%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:285pt;position:var(--position);top:301.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:21.38pt"></span></span><span style="left:24.009999999999998pt;position:var(--position)">6,735<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:338.25pt;position:var(--position);top:301.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">2%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:391.5pt;position:var(--position);top:301.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:18.39pt"></span></span><span style="left:21.02pt;position:var(--position)">(4,319)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:444.75pt;position:var(--position);top:301.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:14.07pt;position:var(--position);text-decoration:none;white-space:pre">(64%)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:315.75pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Interest expense</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:178.5pt;position:var(--position);top:315.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:13.39pt"></span></span><span style="left:16.02pt;position:var(--position)">(19,577)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:231.75pt;position:var(--position);top:315.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">5%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:285pt;position:var(--position);top:315.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:13.39pt"></span></span><span style="left:16.02pt;position:var(--position)">(21,373)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:338.25pt;position:var(--position);top:315.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">5%</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:391.5pt;position:var(--position);top:315.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:21.38pt"></span></span><span style="left:24.009999999999998pt;position:var(--position)">1,796<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:444.75pt;position:var(--position);top:315.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.57pt;position:var(--position);text-decoration:none;white-space:pre">(8%)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:330pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Total other expense, net</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:178.5pt;position:var(--position);top:330pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:13.39pt"></span></span><span style="left:16.02pt;position:var(--position)">(16,536)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:285pt;position:var(--position);top:330pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:13.39pt"></span></span><span style="left:16.02pt;position:var(--position)">(13,944)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:344.25pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Income before income taxes</span></div></div></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:178.5pt;position:var(--position);top:344.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">21,105<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:285pt;position:var(--position);top:344.25pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">36,245<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:358.5pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Income tax expense</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:178.5pt;position:var(--position);top:358.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:13.39pt"></span></span><span style="left:16.02pt;position:var(--position)">(11,400)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:231.75pt;position:var(--position);top:358.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">3%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:285pt;position:var(--position);top:358.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:13.39pt"></span></span><span style="left:16.02pt;position:var(--position)">(12,350)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:338.25pt;position:var(--position);top:358.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:19.56pt;position:var(--position);text-decoration:none;white-space:pre">3%</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:391.5pt;position:var(--position);top:358.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:28.88pt"></span></span><span style="left:31.509999999999998pt;position:var(--position)">950<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:444.75pt;position:var(--position);top:358.5pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.57pt;position:var(--position);text-decoration:none;white-space:pre">(8%)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:372.75pt;width:178.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:178.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Net income</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:178.5pt;position:var(--position);top:372.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:16.38pt"></span></span><span style="left:24.009999999999998pt;position:var(--position)">9,705<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:285pt;position:var(--position);top:372.75pt;width:50.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:11.38pt"></span></span><span style="left:19.009999999999998pt;position:var(--position)">23,895<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/></tr></tbody></table></div></div></div><div style="font-size:12pt;line-height:9pt;position:var(--position);top:482.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre">Reven</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:85.48pt;position:var(--position);text-decoration:none;white-space:pre">ue</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:499.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.94pt">The year-over-year changes in prescription transactions revenue, subscription revenue, and Pharma Direct revenue</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:510.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:231.21pt">were driven by the same factors described above for the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:289.71000000000004pt;position:var(--position);text-decoration:none;white-space:pre;width:141.88pt">three months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:431.59pt;position:var(--position);text-decoration:none;white-space:pre;width:121.85pt"> compared to the same period</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:521pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:10pt">of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:88.5pt;position:var(--position);white-space:pre;width:2.5pt">.</span></div><div style="line-height:9pt;position:var(--position);top:549.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre">Costs and Operating Expenses</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:566.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:235.89pt">Cost of revenue, exclusive of depreciation and amortization</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:583.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:74.08pt">Cost of revenue </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:150.57999999999998pt;position:var(--position);text-decoration:none;white-space:pre;width:38.98pt">increased</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:189.56pt;position:var(--position);white-space:pre;width:5.2pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:194.76pt;position:var(--position);text-decoration:none;white-space:pre;width:53.15pt">$14.4 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:247.91pt;position:var(--position);white-space:pre;width:20.89pt">, or </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:268.8pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt">54%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:286.8pt;position:var(--position);white-space:pre;width:266.6pt">, year-over-year, primarily driven by a $7.3 million increase in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:594.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.97pt">prescription delivery costs as a result of a prescription delivery technology business we acquired in October 2025, a $6.3</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:605pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.97pt">million increase in costs related to our condition-specific subscription programs, and a $6.0 million increase in fulfillment</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:615.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:333.14pt">costs for certain solutions provided to customers under our Pharma Direct offering. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:391.64pt;position:var(--position);text-decoration:none;white-space:pre;width:161.71pt">The impact of these drivers was partially</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:626.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">offset by a $3.2 million decrease in processing fees. We expect cost of revenue to continue to increase on a year-over-year</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:637.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">basis in the near term as we continue to scale and expand our offerings, particularly our Pharma Direct and subscription</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:648.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:36.82pt">offerings.</span></div><div style="line-height:9pt;position:var(--position);top:677pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre">Remaining Costs and Operating Expenses, Interest Income, Interest Expense and Income Taxes</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:693.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.9pt">The year-over-year changes in product development and technology, sales and marketing, depreciation and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:704.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt">amortization expenses, interest income, interest expense and income taxes were primarily driven by the same factors</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:715.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:100.47pt">described above for the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:158.97pt;position:var(--position);text-decoration:none;white-space:pre;width:144.48pt">three months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:303.45pt;position:var(--position);text-decoration:none;white-space:pre;width:138.95pt"> compared to the same period of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:442.4pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:462.4pt;position:var(--position);text-decoration:none;white-space:pre;width:90.96pt">. In addition, the year-</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:726.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">over-year decrease in general and administrative expenses was further driven by a $4.4 million impairment loss related to a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:737pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:157.79pt">leased office space recognized in 2025.</span></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:300.44pt;position:var(--position);white-space:pre">23</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="position:absolute;top:45pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_100"></div><div style="line-height:9pt;position:var(--position);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre">Liquidity and Capital Resources</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:61.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.9pt">Since our inception, we have financed our operations primarily through net cash provided by operating activities, equity</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:72.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:301.67pt">issuances, and borrowings under our long-term debt arrangements. As of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:360.17pt;position:var(--position);text-decoration:none;white-space:pre;width:58.66pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:418.83pt;position:var(--position);white-space:pre;width:134.55pt">, our principal sources of liquidity</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:83.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:295.13pt">are our cash and cash equivalents and borrowings available under our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:353.63pt;position:var(--position);text-decoration:none;white-space:pre;width:51.61pt">$88.0 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:405.24pt;position:var(--position);white-space:pre;width:148.21pt"> secured revolving credit facility that</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:94.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:49.57pt">matures on </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:108.07pt;position:var(--position);text-decoration:none;white-space:pre;width:58.05pt">April 10, 2029</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:166.12pt;position:var(--position);white-space:pre;width:31.38pt">. As of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:197.5pt;position:var(--position);text-decoration:none;white-space:pre;width:59.58pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:257.08000000000004pt;position:var(--position);white-space:pre;width:165.29pt">, we had cash and cash equivalents of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:422.37pt;position:var(--position);text-decoration:none;white-space:pre;width:56.74pt">$296.1 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:479.11pt;position:var(--position);white-space:pre;width:22.58pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:501.69pt;position:var(--position);text-decoration:none;white-space:pre;width:51.74pt">$80.4 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:105pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:168.71pt">available under our revolving credit facility.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:227.21pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:121.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:23.68pt">As of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:100.18pt;position:var(--position);text-decoration:none;white-space:pre;width:57.68pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:157.86pt;position:var(--position);white-space:pre;width:395.47pt">, there were no material changes to our primary short-term and long-term requirements for liquidity</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:132.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.95pt">and capital or to our contractual commitments as disclosed in Part II, Item 7, "Management's Discussion and Analysis of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:143.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:214.07pt">Financial Condition and Results of Operations" of our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:272.57pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:292.57pt;position:var(--position);white-space:pre;width:23.99pt"> 10-K.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:160.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.9pt">Based on our current conditions, we believe that our net cash provided by operating activities and cash on hand will be</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:171pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.95pt">adequate to meet our operating, investing and financing needs for at least the next twelve months from the date of the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:181.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.91pt">issuance of the accompanying unaudited condensed consolidated financial statements. Our future capital requirements will</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:192.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.98pt">depend on many factors, including the growth of our business, the timing and extent of investments, sales and marketing</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:203.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:343.72pt">activities, and many other factors as described in Part I, Item 1A, "Risk Factors" of our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:402.22pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:422.22pt;position:var(--position);white-space:pre;width:23.99pt"> 10-K.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:220.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.95pt">If necessary, we may borrow funds under our revolving credit facility to finance our liquidity requirements, subject to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:231pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.87pt">customary borrowing conditions. To the extent additional funds are necessary to meet our long-term liquidity needs as we</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:241.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.85pt">continue to execute our business strategy, we anticipate that they will be obtained through the incurrence of additional</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:252.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.88pt">indebtedness, additional equity financings or a combination of these potential sources of funds; however, such financing</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:263.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.95pt">may not be available on favorable terms, or at all. In particular, the current economic uncertainty, including rising inflation,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:274.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.84pt">new or increased tariffs and socio-political events, has resulted in, and may continue to result in, significant disruption of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:285pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.92pt">global financial markets, including rising interest rates, which could reduce our ability to access capital. If we are unable to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:295.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.85pt">raise additional funds when needed or on the terms desired, our business, financial condition and results of operations could</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:306.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:87.82pt">be adversely affected.</span></div><div style="line-height:9pt;position:var(--position);top:335.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre">Holding Company Status</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:352.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.9pt">GoodRx Holdings, Inc. is a holding company that does not conduct any business operations of its own. As a result,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:363pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.89pt">GoodRx Holdings, Inc. is largely dependent upon cash distributions and other transfers from its subsidiaries to meet its</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:373.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.99pt">obligations and to make future dividend payments, if any. Our existing debt arrangements contain covenants restricting</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:384.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.94pt">payments of dividends by our subsidiaries, including GoodRx, Inc., unless certain conditions are met. These covenants</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:395.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.87pt">provide for certain exceptions for specific types of payments. Based on these restrictions, all of the net assets of GoodRx,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:406.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:298.27pt">Inc. were restricted pursuant to the terms of our debt arrangements as of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:356.77pt;position:var(--position);text-decoration:none;white-space:pre;width:58.06pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:414.83pt;position:var(--position);white-space:pre;width:138.64pt">. Since the restricted net assets of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:417pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.94pt">GoodRx, Inc. and its subsidiaries exceed 25% of our consolidated net assets, in accordance with Regulation S-X, see Note</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:427.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:10pt">18</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:68.5pt;position:var(--position);white-space:pre;width:247.83pt"> to our consolidated financial statements included in our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:316.33pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:336.33pt;position:var(--position);white-space:pre;width:217.05pt"> 10-K for the condensed parent company financial</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:438.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:146.92pt">information of GoodRx Holdings, Inc.</span></div><div style="line-height:9pt;position:var(--position);top:467.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre">Cash Flows</span></div><div style="position:var(--position);top:490.2pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:331.5pt"/><td style="padding:0;width:80.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:80.25pt"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);width:163.5pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:163.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:30.04pt;position:var(--position);text-decoration:none;white-space:pre">Six Months Ended June 30,</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:14.25pt;width:331.5pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:14.25pt;width:80.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.24pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:14.25pt;width:80.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.24pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:28.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Net cash provided by operating activities</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:28.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">92,670<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:28.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">58,993<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:42.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Net cash used in investing activities</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:42.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:43.39pt"></span></span><span style="left:46.02pt;position:var(--position)">(36,053)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:42.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:43.39pt"></span></span><span style="left:46.02pt;position:var(--position)">(70,191)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:57pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Net cash used in financing activities</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:57pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:43.39pt"></span></span><span style="left:46.02pt;position:var(--position)">(22,324)</span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:57pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:38.39pt"></span></span><span style="left:41.02pt;position:var(--position)">(155,830)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:71.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Net change in cash and cash equivalents</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:71.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">34,293<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:71.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:33.39pt"></span></span><span style="left:41.02pt;position:var(--position)">(167,028)</span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height:9pt;position:var(--position);top:598.7pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre">Net cash provided by operating activities</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:615.5pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:18.25pt">The </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.75pt;position:var(--position);text-decoration:none;white-space:pre;width:50.71pt">$33.7 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:145.45999999999998pt;position:var(--position);white-space:pre;width:63.97pt"> year-over-year </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:209.43pt;position:var(--position);text-decoration:none;white-space:pre;width:33.98pt">increase</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:243.41pt;position:var(--position);white-space:pre;width:49.53pt"> in net cash </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:292.94pt;position:var(--position);text-decoration:none;white-space:pre;width:46.74pt">provided by</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:339.68pt;position:var(--position);white-space:pre;width:66.25pt"> operations was </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:405.93pt;position:var(--position);text-decoration:none;white-space:pre;width:47.26pt">driven by a </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:453.19pt;position:var(--position);text-decoration:none;white-space:pre;width:50.71pt">$46.0 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:503.9pt;position:var(--position);text-decoration:none;white-space:pre;width:2.76pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:506.66pt;position:var(--position);text-decoration:none;white-space:pre;width:36.99pt">decrease</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:543.65pt;position:var(--position);text-decoration:none;white-space:pre;width:9.75pt"> in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:626.3pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:241.99pt">cash outflow from changes in operating assets and liabilities</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:300.49pt;position:var(--position);white-space:pre;width:84.25pt">, partially offset by a </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:384.74pt;position:var(--position);text-decoration:none;white-space:pre;width:50.84pt">$12.4 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:435.58pt;position:var(--position);white-space:pre;width:2.89pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:438.47pt;position:var(--position);text-decoration:none;white-space:pre;width:36.99pt">decrease</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:475.46pt;position:var(--position);white-space:pre;width:78.02pt"> in net income after</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:637.1pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.9pt">adjusting for non-cash adjustments. Changes in operating assets and liabilities were principally driven by the timing of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:647.9pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.9pt">collections of prescription reimbursement assets and accounts receivable, as well as payments of prescription</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:658.7pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:269.37pt">reimbursement liabilities, accrued expenses, and accounts payable.</span></div><div style="line-height:9pt;position:var(--position);top:687.5pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre">Net cash used in investing activities</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:704.3pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:18.42pt">The </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.92pt;position:var(--position);text-decoration:none;white-space:pre;width:50.88pt">$34.1 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:145.8pt;position:var(--position);white-space:pre;width:64.31pt"> year-over-year </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:210.11pt;position:var(--position);text-decoration:none;white-space:pre;width:36.99pt">decrease</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:247.1pt;position:var(--position);white-space:pre;width:50.21pt"> in net cash </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:297.31pt;position:var(--position);text-decoration:none;white-space:pre;width:29.42pt">used in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:326.73pt;position:var(--position);white-space:pre;width:226.71pt"> investing activities was primarily driven by cash paid for</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:715.1pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:191.42pt">VCRx, a business we acquired in January 2025.</span></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:300.44pt;position:var(--position);white-space:pre">24</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="line-height:9pt;position:var(--position);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre">Net cash used in financing activities</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:61.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:19.44pt">The </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:95.94pt;position:var(--position);text-decoration:none;white-space:pre;width:56.9pt">$133.5 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:152.84pt;position:var(--position);white-space:pre;width:66.35pt"> year-over-year </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:219.19pt;position:var(--position);text-decoration:none;white-space:pre;width:36.99pt">decrease</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:256.18pt;position:var(--position);white-space:pre;width:54.29pt"> in net cash </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:310.47pt;position:var(--position);text-decoration:none;white-space:pre;width:30.44pt">used in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:340.91pt;position:var(--position);white-space:pre;width:212.47pt"> financing activities was almost entirely driven by a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:72.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:36.99pt">decrease</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:95.49000000000001pt;position:var(--position);white-space:pre;width:236.92pt"> in payments for repurchases of our Class A common stock.</span></div><div style="position:absolute;top:101.4pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_103"></div><div style="line-height:9pt;position:var(--position);top:101.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre">Recent Accounting Pronouncements</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:118.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:58.91pt">Refer to Note </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:135.41pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">2</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:140.41pt;position:var(--position);white-space:pre;width:413.05pt"> to our condensed consolidated financial statements appearing elsewhere in this Quarterly Report on</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:129pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:45.96pt">Form 10-Q.</span></div><div style="position:absolute;top:157.8pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_106"></div><div style="line-height:9pt;position:var(--position);top:157.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre">Critical Accounting Policies and Estimates</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:174.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:43.99pt">During the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:120.49000000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:139.53pt">three months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:260.02pt;position:var(--position);white-space:pre;width:293.48pt">, there have been no significant changes to our critical accounting policies</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:185.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.89pt">and estimates compared with those disclosed in Part II, Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:196.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:175.41pt">Condition and Results of Operations&#8221; of our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:233.91pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:253.91pt;position:var(--position);white-space:pre;width:23.99pt"> 10-K.</span></div><div style="position:absolute;top:225pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_109"></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:225pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre;width:284.78pt">Item 3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:241.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.84pt">There have been no material changes in our market risk from the disclosure included in Part II, Item 7A, &#8220;Quantitative</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:252.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:215.38pt">and Qualitative Disclosures About Market Risk&#8221; of our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:273.88pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:293.88pt;position:var(--position);white-space:pre;width:23.99pt"> 10-K.</span></div><div style="position:absolute;top:281.4pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_112"></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:281.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre;width:138.39pt">Item 4. Controls and Procedures</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:298.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre;width:242.77pt">Limitations on Effectiveness of Controls and Procedures</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:315pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.9pt">In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:325.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.94pt">procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:336.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.91pt">control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:347.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.95pt">constraints and that management is required to apply judgment in evaluating the benefits of possible controls and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:358.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:132.43pt">procedures relative to their costs.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:387pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre;width:214.81pt">Evaluation of Disclosure Controls and Procedures</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:403.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.94pt">Our management, with the participation of our principal executive officer and principal financial officer, evaluated, as of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:414.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.97pt">the end of the period covered by this Quarterly Report on Form 10-Q, the effectiveness of our disclosure controls and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:425.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.96pt">procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on that evaluation, our principal</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:436.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:274.15pt">executive officer and principal financial officer concluded that, as of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:332.65pt;position:var(--position);text-decoration:none;white-space:pre;width:58.12pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:390.77pt;position:var(--position);white-space:pre;width:162.72pt">, our disclosure controls and procedures</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:447pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.97pt">were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:457.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.87pt">under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:468.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.97pt">and forms, and that such information is accumulated and communicated to our management, including our principal</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:479.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:465.37pt">executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:508.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre;width:227.28pt">Changes in Internal Control Over Financial Reporting</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:525pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.93pt">There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f)</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:535.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:150.85pt">under the Exchange Act) during the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:209.35pt;position:var(--position);text-decoration:none;white-space:pre;width:145.63pt">three months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:354.98pt;position:var(--position);white-space:pre;width:198.36pt"> that have materially affected, or are reasonably</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:546.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:270.63pt">likely to materially affect, our internal control over financial reporting.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:329.13pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:300.44pt;position:var(--position);white-space:pre">25</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="position:absolute;top:45pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_115"></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre;width:134.37pt">PART II. OTHER INFORMATION</span></div><div style="position:absolute;top:61.8pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_118"></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:61.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre;width:110.93pt">Item 1. Legal Proceedings</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:78.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:301.56pt">The information required under this Part II, Item 1 is set forth in Note </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:378.06pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">7</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:383.06pt;position:var(--position);white-space:pre;width:170.34pt"> to our condensed consolidated financial</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:89.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:411.27pt">statements included in this Quarterly Report on Form 10-Q and is incorporated herein by this reference.</span></div><div style="position:absolute;top:118.2pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_121"></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:118.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">I</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:61pt;position:var(--position);text-decoration:none;white-space:pre;width:88.94pt">tem 1A. Risk Factors</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:135pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:349.08pt">There have been no material changes to the risk factors previously disclosed in our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:425.58pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:445.58pt;position:var(--position);white-space:pre;width:107.75pt"> 10-K. For a discussion of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:145.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:459.15pt">potential risks and uncertainties related to us, see the information included in Part I, Item 1A, "Risk Factors" of our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:517.65pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:537.65pt;position:var(--position);white-space:pre;width:15.74pt"> 10-</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:156.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:8.5pt">K.</span></div><div style="position:absolute;top:185.4pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_124"></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:185.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre;width:290.3pt">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:348.8pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:202.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre;width:167.88pt">Unregistered Sales of Equity Securities</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:226.38pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:219pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:23.99pt">None.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:247.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre;width:171.88pt">Issuer Repurchases of Equity Securities</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:264.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:5.49pt">T</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:81.99pt;position:var(--position);text-decoration:none;white-space:pre;width:318.01pt">here have been no share repurchases under our stock repurchase program </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:400pt;position:var(--position);white-space:pre;width:30.83pt">for the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:430.83pt;position:var(--position);text-decoration:none;white-space:pre;width:122.66pt">three months ended June 30,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:275.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:78.5pt;position:var(--position);white-space:pre;width:46.34pt">. See Note </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:124.84pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">9</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:129.84pt;position:var(--position);white-space:pre;width:423.58pt"> to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:286.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.92pt">10-Q for additional information related to our stock repurchase program, which was publicly announced on February 29,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:297pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:22.5pt">2024.</span></div><div style="position:absolute;top:325.8pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_127"></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:325.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre;width:167.87pt">Item 3. Defaults Upon Senior Securities</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:342.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:23.99pt">None.</span></div><div style="position:absolute;top:371.4pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_130"></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:371.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre;width:134.42pt">Item 4. Mine Safety Disclosures</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:388.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:59.46pt">Not applicable.</span></div><div style="position:absolute;top:417pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_133"></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:417pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);white-space:pre;width:106.91pt">Item 5. Other Information</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:445.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:128.39pt">Insider Trading Arrangements</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:462.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:135.9pt">During the three months ended </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:212.4pt;position:var(--position);text-decoration:none;white-space:pre;width:60.78pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:273.18pt;position:var(--position);white-space:pre;width:280.3pt">, none of our directors or officers (as defined in Section 16 of the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:473.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:65.9pt">Exchange Act), </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:124.4pt;position:var(--position);text-decoration:none;white-space:pre;width:32.5pt"><ix:nonNumeric contextRef="c-10" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-527"><ix:nonNumeric contextRef="c-10" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-528">adopted</ix:nonNumeric></ix:nonNumeric></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:156.9pt;position:var(--position);text-decoration:none;white-space:pre;width:40.42pt">, modified</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:197.32pt;position:var(--position);white-space:pre;width:15.89pt"> or </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:213.21pt;position:var(--position);text-decoration:none;white-space:pre;width:42.47pt"><ix:nonNumeric contextRef="c-10" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-529"><ix:nonNumeric contextRef="c-10" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-530">terminated</ix:nonNumeric></ix:nonNumeric></span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:255.68pt;position:var(--position);white-space:pre;width:297.71pt"> any contract, instruction or written plan for the purchase or sale of our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:484.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:494.84pt">securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any "non-</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:495pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:401.01pt">Rule 10b5-1 trading arrangement" (as defined in Item 408(c) of Regulation S-K of the Exchange Act).</span></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="-sec-extract:summary;position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:300.44pt;position:var(--position);white-space:pre">26</span></div></div></div><div style="-sec-extract:summary;position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="-sec-extract:exhibit;color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="position:absolute;top:45pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_139"></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:65.96pt">Item 6. Exhibits</span></div><div style="position:var(--position);top:67.8pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:50.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:216.75pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:30pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:60pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:35.25pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:39.75pt"/><td style="padding:0;width:3pt"/><td style="padding:0;width:45pt"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td colspan="7" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:273pt;position:var(--position);width:174pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:174pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.4pt;position:var(--position);text-decoration:none;white-space:pre">Incorporated by Reference</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td rowspan="2" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:450pt;position:var(--position);width:45pt"><div><div style="line-height:8pt;position:var(--position);top:9.3pt;width:45pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:12.07pt;position:var(--position);text-decoration:none;white-space:pre">Filed/</span></div><div style="line-height:8pt;position:var(--position);top:18.9pt;width:45pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:3.19pt;position:var(--position);text-decoration:none;white-space:pre">Furnished</span></div><div style="line-height:8pt;position:var(--position);top:28.5pt;width:45pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:5.63pt;position:var(--position);text-decoration:none;white-space:pre">Herewith</span></div></div></div></td></tr><tr style="height:23.25pt"><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:14.25pt;width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:11.81pt;position:var(--position);text-decoration:none;white-space:pre">Exhibit</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:10.03pt;position:var(--position);text-decoration:none;white-space:pre">Number</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:53.25pt;position:var(--position);top:14.25pt;width:216.75pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:216.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:71.98pt;position:var(--position);text-decoration:none;white-space:pre">Exhibit Description</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:273pt;position:var(--position);top:14.25pt;width:30pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:30pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:5.01pt;position:var(--position);text-decoration:none;white-space:pre">Form</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:306pt;position:var(--position);top:14.25pt;width:60pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:15.57pt;position:var(--position);text-decoration:none;white-space:pre">File No.</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:369pt;position:var(--position);top:14.25pt;width:35.25pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:35.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:4.31pt;position:var(--position);text-decoration:none;white-space:pre">Exhibit</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:407.25pt;position:var(--position);top:14.25pt;width:39.75pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:39.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:9.22pt;position:var(--position);text-decoration:none;white-space:pre">Filing</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:39.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:11.22pt;position:var(--position);text-decoration:none;white-space:pre">Date</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:3pt"><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:40.5pt;width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:19.57pt;position:var(--position);text-decoration:none;white-space:pre">3.1</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:53.25pt;position:var(--position);top:40.5pt;width:216.75pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:216.75pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="-sec-extract:exhibit;color:inherit;text-decoration:inherit;z-index:1" href="https://www.sec.gov/Archives/edgar/data/1809519/000119312520256438/d35545dex31.htm">Amended and Restated Certificate of Incorporation</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:273pt;position:var(--position);top:40.5pt;width:30pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:30pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:8.78pt;position:var(--position);text-decoration:none;white-space:pre">8-K</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:306pt;position:var(--position);top:40.5pt;width:60pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:10.91pt;position:var(--position);text-decoration:none;white-space:pre">001-39549</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:369pt;position:var(--position);top:40.5pt;width:35.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:35.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:12.07pt;position:var(--position);text-decoration:none;white-space:pre">3.1</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:407.25pt;position:var(--position);top:40.5pt;width:39.75pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:39.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:6.55pt;position:var(--position);text-decoration:none;white-space:pre">9/28/20</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:3pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:57.75pt;width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:19.57pt;position:var(--position);text-decoration:none;white-space:pre">3.2</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:53.25pt;position:var(--position);top:57.75pt;width:216.75pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:216.75pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="-sec-extract:exhibit;color:inherit;text-decoration:inherit;z-index:1" href="https://www.sec.gov/Archives/edgar/data/0001809519/000119312520256438/d35545dex32.htm">Amended and Restated Bylaws</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:273pt;position:var(--position);top:57.75pt;width:30pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:30pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:8.78pt;position:var(--position);text-decoration:none;white-space:pre">8-K</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:306pt;position:var(--position);top:57.75pt;width:60pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:10.91pt;position:var(--position);text-decoration:none;white-space:pre">001-39549</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:369pt;position:var(--position);top:57.75pt;width:35.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:35.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:12.07pt;position:var(--position);text-decoration:none;white-space:pre">3.2</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:407.25pt;position:var(--position);top:57.75pt;width:39.75pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:39.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:6.55pt;position:var(--position);text-decoration:none;white-space:pre">9/28/20</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:3pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:75pt;width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:19.57pt;position:var(--position);text-decoration:none;white-space:pre">4.1</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:53.25pt;position:var(--position);top:75pt;width:216.75pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:216.75pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="-sec-extract:exhibit;color:inherit;text-decoration:inherit;z-index:1" href="https://www.sec.gov/Archives/edgar/data/1809519/000119312520234662/d949310dex41.htm">Form of Certificate of Class A Common Stock</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:273pt;position:var(--position);top:75pt;width:30pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:30pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:8.78pt;position:var(--position);text-decoration:none;white-space:pre">S-1</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:306pt;position:var(--position);top:75pt;width:60pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:8.69pt;position:var(--position);text-decoration:none;white-space:pre">333-248465</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:369pt;position:var(--position);top:75pt;width:35.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:35.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:12.07pt;position:var(--position);text-decoration:none;white-space:pre">4.1</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:407.25pt;position:var(--position);top:75pt;width:39.75pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:39.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:6.55pt;position:var(--position);text-decoration:none;white-space:pre">8/28/20</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:3pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:92.25pt;width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:19.57pt;position:var(--position);text-decoration:none;white-space:pre">4.2</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:53.25pt;position:var(--position);top:92.25pt;width:216.75pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:216.75pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="-sec-extract:exhibit;color:inherit;text-decoration:inherit;z-index:1" href="https://www.sec.gov/Archives/edgar/data/1809519/000119312520254694/d62083dex44.htm">Form of Certificate of Class B Common Stock</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:273pt;position:var(--position);top:92.25pt;width:30pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:30pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:8.78pt;position:var(--position);text-decoration:none;white-space:pre">S-8</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:306pt;position:var(--position);top:92.25pt;width:60pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:60pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:8.69pt;position:var(--position);text-decoration:none;white-space:pre">333-249069</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:369pt;position:var(--position);top:92.25pt;width:35.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:35.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:12.07pt;position:var(--position);text-decoration:none;white-space:pre">4.4</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:407.25pt;position:var(--position);top:92.25pt;width:39.75pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:39.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:6.55pt;position:var(--position);text-decoration:none;white-space:pre">9/25/20</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:3pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:109.5pt;width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:15.13pt;position:var(--position);text-decoration:none;white-space:pre">10.1&#8224;</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:53.25pt;position:var(--position);top:109.5pt;width:216.75pt"><div><div style="font-size:12pt;line-height:8pt;position:var(--position);top:3.75pt;width:216.75pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="-sec-extract:exhibit;color:inherit;text-decoration:inherit;z-index:1" href="ex101-thirdamendedrestated.htm">Third Amended &amp; Restated Non-Employee Director </a></span></div><div style="font-size:12pt;line-height:8pt;position:var(--position);top:13.35pt;width:216.75pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="-sec-extract:exhibit;color:inherit;text-decoration:inherit;z-index:1" href="ex101-thirdamendedrestated.htm">Compensation Program, dated May 27, 2026</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:450pt;position:var(--position);top:109.5pt;width:45pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:45pt"><span style="font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:20.94pt;position:var(--position);white-space:pre">*</span></div></div></div></td></tr><tr style="height:3pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:135.75pt;width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:17.35pt;position:var(--position);text-decoration:none;white-space:pre">31.1</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:53.25pt;position:var(--position);top:135.75pt;width:216.75pt"><div><div style="font-size:12pt;line-height:8pt;position:var(--position);top:3.75pt;width:216.75pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="-sec-extract:exhibit;color:inherit;text-decoration:inherit;z-index:1" href="gdrxq226-ex311.htm">Certification of Chief Executive Officer pursuant to Rule </a></span></div><div style="font-size:12pt;line-height:8pt;position:var(--position);top:13.35pt;width:216.75pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="-sec-extract:exhibit;color:inherit;text-decoration:inherit;z-index:1" href="gdrxq226-ex311.htm">13a-14(a)/15d-14(a)</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:450pt;position:var(--position);top:135.75pt;width:45pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:45pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:20.94pt;position:var(--position);text-decoration:none;white-space:pre">*</span></div></div></div></td></tr><tr style="height:3pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:162pt;width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:17.35pt;position:var(--position);text-decoration:none;white-space:pre">31.2</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:53.25pt;position:var(--position);top:162pt;width:216.75pt"><div><div style="font-size:12pt;line-height:8pt;position:var(--position);top:3.75pt;width:216.75pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="-sec-extract:exhibit;color:inherit;text-decoration:inherit;z-index:1" href="gdrxq226-ex312.htm">Certification of Chief Financial Officer pursuant to Rule </a></span></div><div style="font-size:12pt;line-height:8pt;position:var(--position);top:13.35pt;width:216.75pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="-sec-extract:exhibit;color:inherit;text-decoration:inherit;z-index:1" href="gdrxq226-ex312.htm">13a-14(a)/15d-14(a)</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:450pt;position:var(--position);top:162pt;width:45pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:45pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:20.94pt;position:var(--position);text-decoration:none;white-space:pre">*</span></div></div></div></td></tr><tr style="height:3pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:188.25pt;width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:17.35pt;position:var(--position);text-decoration:none;white-space:pre">32.1</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:53.25pt;position:var(--position);top:188.25pt;width:216.75pt"><div><div style="font-size:12pt;line-height:8pt;position:var(--position);top:3.75pt;width:216.75pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="-sec-extract:exhibit;color:inherit;text-decoration:inherit;z-index:1" href="gdrxq226-ex321.htm">Certification of Chief Executive Officer pursuant to 18 </a></span></div><div style="font-size:12pt;line-height:8pt;position:var(--position);top:13.35pt;width:216.75pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="-sec-extract:exhibit;color:inherit;text-decoration:inherit;z-index:1" href="gdrxq226-ex321.htm">U.S.C. Section 1350</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:450pt;position:var(--position);top:188.25pt;width:45pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:45pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:19.39pt;position:var(--position);text-decoration:none;white-space:pre">**</span></div></div></div></td></tr><tr style="height:3pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:214.5pt;width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:17.35pt;position:var(--position);text-decoration:none;white-space:pre">32.2</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:53.25pt;position:var(--position);top:214.5pt;width:216.75pt"><div><div style="font-size:12pt;line-height:8pt;position:var(--position);top:3.75pt;width:216.75pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="-sec-extract:exhibit;color:inherit;text-decoration:inherit;z-index:1" href="gdrxq226-ex322.htm">Certification of Chief Financial Officer pursuant to 18 U.S.C. </a></span></div><div style="font-size:12pt;line-height:8pt;position:var(--position);top:13.35pt;width:216.75pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="-sec-extract:exhibit;color:inherit;text-decoration:inherit;z-index:1" href="gdrxq226-ex322.htm">Section 1350</a></span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:450pt;position:var(--position);top:214.5pt;width:45pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:45pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:19.39pt;position:var(--position);text-decoration:none;white-space:pre">**</span></div></div></div></td></tr><tr style="height:3pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:32.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:240.75pt;width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:10.69pt;position:var(--position);text-decoration:none;white-space:pre">101.INS</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:53.25pt;position:var(--position);top:240.75pt;width:216.75pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:216.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Inline XBRL Instance Document &#8211; the instance document </span></div><div style="line-height:8pt;position:var(--position);top:13.35pt;width:216.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">does not appear in the Interactive Data File because its </span></div><div style="line-height:8pt;position:var(--position);top:22.95pt;width:216.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">XBRL tags are embedded within the Inline XBRL document</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:450pt;position:var(--position);top:240.75pt;width:45pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:45pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:20.94pt;position:var(--position);text-decoration:none;white-space:pre">*</span></div></div></div></td></tr><tr style="height:3pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:276pt;width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:8.92pt;position:var(--position);text-decoration:none;white-space:pre">101.SCH</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:53.25pt;position:var(--position);top:276pt;width:216.75pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:216.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Inline XBRL Taxonomy Extension Schema Document</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:450pt;position:var(--position);top:276pt;width:45pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:45pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:20.94pt;position:var(--position);text-decoration:none;white-space:pre">*</span></div></div></div></td></tr><tr style="height:3pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:293.25pt;width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:9.58pt;position:var(--position);text-decoration:none;white-space:pre">101.CAL</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:53.25pt;position:var(--position);top:293.25pt;width:216.75pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:216.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Inline XBRL Taxonomy Extension Calculation Linkbase </span></div><div style="line-height:8pt;position:var(--position);top:13.35pt;width:216.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Document</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:450pt;position:var(--position);top:293.25pt;width:45pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:45pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:20.94pt;position:var(--position);text-decoration:none;white-space:pre">*</span></div></div></div></td></tr><tr style="height:3pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:319.5pt;width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:9.36pt;position:var(--position);text-decoration:none;white-space:pre">101.DEF</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:53.25pt;position:var(--position);top:319.5pt;width:216.75pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:216.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Inline XBRL Taxonomy Extension Definition Linkbase </span></div><div style="line-height:8pt;position:var(--position);top:13.35pt;width:216.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Document</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:450pt;position:var(--position);top:319.5pt;width:45pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:45pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:20.94pt;position:var(--position);text-decoration:none;white-space:pre">*</span></div></div></div></td></tr><tr style="height:3pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:345.75pt;width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:9.8pt;position:var(--position);text-decoration:none;white-space:pre">101.LAB</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:53.25pt;position:var(--position);top:345.75pt;width:216.75pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:216.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Inline XBRL Taxonomy Extension Label Linkbase </span></div><div style="line-height:8pt;position:var(--position);top:13.35pt;width:216.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Document</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:450pt;position:var(--position);top:345.75pt;width:45pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:45pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:20.94pt;position:var(--position);text-decoration:none;white-space:pre">*</span></div></div></div></td></tr><tr style="height:3pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:372pt;width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:9.14pt;position:var(--position);text-decoration:none;white-space:pre">101.PRE</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:53.25pt;position:var(--position);top:372pt;width:216.75pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:216.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Inline XBRL Taxonomy Extension Presentation Linkbase </span></div><div style="line-height:8pt;position:var(--position);top:13.35pt;width:216.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Document</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:450pt;position:var(--position);top:372pt;width:45pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:45pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:20.94pt;position:var(--position);text-decoration:none;white-space:pre">*</span></div></div></div></td></tr><tr style="height:3pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:398.25pt;width:50.25pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:50.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:18.46pt;position:var(--position);text-decoration:none;white-space:pre">104</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:53.25pt;position:var(--position);top:398.25pt;width:216.75pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:216.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Cover Page Interactive Data File (formatted as Inline XBRL </span></div><div style="line-height:8pt;position:var(--position);top:13.35pt;width:216.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">and contained in Exhibit 101)</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:450pt;position:var(--position);top:398.25pt;width:45pt"><div><div style="line-height:8pt;position:var(--position);top:3.75pt;width:45pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:20.94pt;position:var(--position);text-decoration:none;white-space:pre">*</span></div></div></div></td></tr></tbody></table></div></div></div><div style="line-height:9pt;position:var(--position);top:494.3pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre">_____________________________________________________</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:505.1pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:3.5pt">*</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:58.44pt">Filed herewith.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:515.9pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:7pt">**</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:78.94pt">Furnished herewith.</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:526.7pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:5pt">&#8224;</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:216.92pt">Indicates management contract or compensatory plan.</span></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-family:Arial, sans-serif;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt;word-wrap:break-word"><div style="position:var(--position);top:747pt"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:22.12pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:300.44pt;position:var(--position);white-space:pre">27</span></div></div></div><div style="position:var(--position)"><div style="width:495pt"><div style="line-height:10pt;position:var(--position);top:13.5pt;width:612pt"><span style="color:#0000ff;font-family:'Arial', sans-serif;font-size:10pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:underline;white-space:pre"><a style="color:inherit;text-decoration:inherit;z-index:1" href="#i91b19d4037914b6f9fbe39bcf6851dbe_10">Table of Contents</a></span></div></div></div><div><div style="position:absolute;top:45pt" id="i91b19d4037914b6f9fbe39bcf6851dbe_142"></div><div style="line-height:9pt;position:var(--position);top:73.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:276.52pt;position:var(--position);white-space:pre">SIGNATURES</span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:96.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);white-space:pre;width:476.92pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);white-space:pre;width:2.5pt"> </span></div><div style="line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:107.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);white-space:pre;width:262.91pt">signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="position:var(--position);top:130.2pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:494.25pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:234.75pt"/><td style="padding:0;width:24.75pt"/><td style="padding:0;width:234.75pt"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td colspan="2" style="font-size:0;text-align:left;vertical-align:top"><div style="left:234.75pt;position:var(--position);width:259.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:259.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">GOODRX HOLDINGS, INC.</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:28.5pt;width:234.75pt"><div><div style="font-size:12pt;line-height:9pt;position:var(--position);top:4.31pt;width:234.75pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);white-space:pre">Date: </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:26.13pt;position:var(--position);text-decoration:none;white-space:pre">August&#160;5, 2026</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:234.75pt;position:var(--position);top:28.5pt;width:24.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:24.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">By:</span></div></div></div></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:259.5pt;position:var(--position);top:28.5pt;width:234.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:234.75pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);white-space:pre">/s/ Wendy Barnes</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:259.5pt;position:var(--position);top:42.75pt;width:234.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:234.75pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);white-space:pre">Wendy Barnes</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:259.5pt;position:var(--position);top:57pt;width:234.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:234.75pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);white-space:pre">Chief Executive Officer &amp; President</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:259.5pt;position:var(--position);top:71.25pt;width:234.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.34pt;width:234.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(Principal Executive Officer) </span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:99.75pt;width:234.75pt"><div><div style="font-size:12pt;line-height:9pt;position:var(--position);top:4.31pt;width:234.75pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);white-space:pre">Date: </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:26.13pt;position:var(--position);text-decoration:none;white-space:pre">August&#160;5, 2026</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:234.75pt;position:var(--position);top:99.75pt;width:24.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:24.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">By:</span></div></div></div></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:259.5pt;position:var(--position);top:99.75pt;width:234.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:234.75pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);white-space:pre">/s/ Christopher McGinnis</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:259.5pt;position:var(--position);top:114pt;width:234.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:234.75pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);white-space:pre">Christopher McGinnis</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:259.5pt;position:var(--position);top:128.25pt;width:234.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:234.75pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);white-space:pre">Chief Financial Officer &amp; Treasurer</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:259.5pt;position:var(--position);top:142.5pt;width:234.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.34pt;width:234.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(Principal Financial Officer)</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:171pt;width:234.75pt"><div><div style="font-size:12pt;line-height:9pt;position:var(--position);top:4.31pt;width:234.75pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);white-space:pre">Date: </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:26.13pt;position:var(--position);text-decoration:none;white-space:pre">August&#160;5, 2026</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:234.75pt;position:var(--position);top:171pt;width:24.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:24.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">By:</span></div></div></div></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:259.5pt;position:var(--position);top:171pt;width:234.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:234.75pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);white-space:pre">/s/ Thomas Chan</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:259.5pt;position:var(--position);top:185.25pt;width:234.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:234.75pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);white-space:pre">Thomas Chan</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:259.5pt;position:var(--position);top:199.5pt;width:234.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:234.75pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);white-space:pre">Chief Accounting Officer</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"/><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:259.5pt;position:var(--position);top:213.75pt;width:234.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.34pt;width:234.75pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);white-space:pre">(Principal Accounting Officer)</span></div></div></div></td></tr></tbody></table></div></div></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex101-thirdamendedrestated.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head><title>EX 10.1 - Third Amended &amp; Restated Non-Employee Director Compensation Program effective May 27, 2026</title></head><body><div style="background-color:#E4E4E4;font-family:Arial, sans-serif;word-wrap:break-word"><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt"><div style="position:absolute;top:778.32pt"><div style="width:468pt"></div></div><div style="position:absolute"><div style="width:468pt"><div style="line-height:7.44pt;position:absolute;top:36pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:483.19pt;position:absolute;white-space:pre">Exhibit 10.1</font></div></div></div><div><div id="i7a94055aec1042169d4d760e108f68a6_1" style="position:absolute;top:72pt"></div><div style="line-height:7.44pt;position:absolute;top:72pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:237.23pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre">GOODRX</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:286.15999999999997pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:288.71999999999997pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre">HOLDINGS,</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:349.90999999999997pt;letter-spacing:-0.004em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:352.62pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre">INC.</font></div><div style="line-height:7.44pt;position:absolute;top:97.75pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:154.36pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre">NON-EMPLOYEE</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:244.27pt;letter-spacing:-0.031em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:246.68pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre">DIRECTOR</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:305.21000000000004pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:307.77pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre">COMPENSATION</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:397.69000000000005pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:400.25pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre">PROGRAM</font></div><div style="line-height:7.44pt;position:absolute;top:123.5pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:173.51pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre">Third Amended</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:247.76pt;letter-spacing:-0.04em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:250.07pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre">and</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:267.52pt;letter-spacing:-0.031em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:269.93pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre">Restated</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:310.12pt;letter-spacing:-0.022em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:312.63pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre">effective</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:350.87pt;letter-spacing:-0.027em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:353.33pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre">as</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:362.92999999999995pt;letter-spacing:-0.027em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:365.39pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:374.37pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:bold;left:376.92999999999995pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre">May 27, 2026</font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:149.9pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:113pt;position:absolute;text-decoration:none;white-space:pre;width:328.05pt">Eligible Directors (as defined below) on the board of directors (the &#8220;</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:441.05pt;position:absolute;text-decoration:none;white-space:pre;width:28.11pt">Board</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:469.16pt;position:absolute;text-decoration:none;white-space:pre;width:65.33pt">&#8221;) of GoodRx</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.49pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:163.1pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:77pt;position:absolute;text-decoration:none;white-space:pre;width:43.07pt">Holdings,</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:120.07pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.83pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:122.9pt;position:absolute;text-decoration:none;white-space:pre;width:16.79pt">Inc.</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:139.69pt;letter-spacing:-0.022em;position:absolute;text-decoration:none;white-space:pre;width:2.68pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:142.37pt;position:absolute;text-decoration:none;white-space:pre;width:17.09pt">(the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:159.45999999999998pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:162.19pt;position:absolute;text-decoration:none;white-space:pre;width:4.88pt">&#8220;</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:167.07pt;position:absolute;text-decoration:none;white-space:pre;width:43.37pt">Company</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:210.44pt;position:absolute;text-decoration:none;white-space:pre;width:8.54pt">&#8221;)</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:218.98pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:221.71pt;position:absolute;text-decoration:none;white-space:pre;width:20.76pt">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:242.47pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:245.2pt;position:absolute;text-decoration:none;white-space:pre;width:10.38pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:255.58pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:258.31pt;position:absolute;text-decoration:none;white-space:pre;width:32.96pt">eligible</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:291.27pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:294pt;position:absolute;text-decoration:none;white-space:pre;width:8.55pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:302.55pt;letter-spacing:-0.022em;position:absolute;text-decoration:none;white-space:pre;width:2.68pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:305.23pt;position:absolute;text-decoration:none;white-space:pre;width:31.73pt">receive</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:336.96pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:339.69pt;position:absolute;text-decoration:none;white-space:pre;width:19.54pt">cash</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:359.23pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.83pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:362.06pt;position:absolute;text-decoration:none;white-space:pre;width:15.88pt">and</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:377.94pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.83pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:380.77pt;position:absolute;text-decoration:none;white-space:pre;width:27.48pt">equity</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:408.25pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.83pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:411.08pt;position:absolute;text-decoration:none;white-space:pre;width:61.07pt">compensation</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:472.15pt;letter-spacing:-0.022em;position:absolute;text-decoration:none;white-space:pre;width:2.68pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:474.83pt;position:absolute;text-decoration:none;white-space:pre;width:9.16pt">as</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:483.99pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:486.72pt;position:absolute;text-decoration:none;white-space:pre;width:12.21pt">set</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:498.93pt;letter-spacing:-0.004em;position:absolute;text-decoration:none;white-space:pre;width:2.88pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:501.81pt;position:absolute;text-decoration:none;white-space:pre;width:21.37pt">forth</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:523.1800000000001pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.83pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:526.01pt;position:absolute;text-decoration:none;white-space:pre;width:8.55pt">in</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.56pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:176.3pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:77pt;position:absolute;text-decoration:none;white-space:pre;width:296.71pt">this Non- Employee Director Compensation Program (this &#8220;</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:373.71pt;position:absolute;text-decoration:none;white-space:pre;width:40.32pt">Program</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:414.03pt;position:absolute;text-decoration:none;white-space:pre;width:120.56pt">&#8221;). The cash and equity</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.5899999999999pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:189.5pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:77pt;position:absolute;text-decoration:none;white-space:pre;width:61.07pt">compensation</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:138.07pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.2pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:140.27pt;position:absolute;text-decoration:none;white-space:pre;width:42.13pt">described</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:182.4pt;letter-spacing:-0.036000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.5pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:184.9pt;position:absolute;text-decoration:none;white-space:pre;width:8.55pt">in</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:193.45pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:195.7pt;position:absolute;text-decoration:none;white-space:pre;width:15.88pt">this</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:211.58pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:213.83pt;position:absolute;text-decoration:none;white-space:pre;width:37.86pt">Program</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:251.69pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.3pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:253.99pt;position:absolute;text-decoration:none;white-space:pre;width:20.76pt">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:274.75pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.3pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:277.05pt;position:absolute;text-decoration:none;white-space:pre;width:10.38pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:287.43pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:289.68pt;position:absolute;text-decoration:none;white-space:pre;width:18.93pt">paid</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:308.61pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.34pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:310.95pt;position:absolute;text-decoration:none;white-space:pre;width:9.16pt">or</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:320.11pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.2pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:322.31pt;position:absolute;text-decoration:none;white-space:pre;width:10.38pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:332.69pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:334.94pt;position:absolute;text-decoration:none;white-space:pre;width:26.56pt">made,</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:361.5pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:363.75pt;position:absolute;text-decoration:none;white-space:pre;width:9.16pt">as</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:372.91pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:375.16pt;position:absolute;text-decoration:none;white-space:pre;width:47.92pt">applicable,</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:423.08pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:425.33pt;position:absolute;text-decoration:none;white-space:pre;width:59.82pt">automatically</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:485.15pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:487.4pt;position:absolute;text-decoration:none;white-space:pre;width:9.16pt">as</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:496.56pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:498.81pt;position:absolute;text-decoration:none;white-space:pre;width:12.21pt">set</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:511.02pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.2pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:513.22pt;position:absolute;text-decoration:none;white-space:pre;width:21.37pt">forth</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.5899999999999pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:202.7pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:77pt;position:absolute;text-decoration:none;white-space:pre;width:27.47pt">herein</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:104.47pt;letter-spacing:-0.045em;position:absolute;text-decoration:none;white-space:pre;width:2.48pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:106.95pt;position:absolute;text-decoration:none;white-space:pre;width:15.88pt">and</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:122.83pt;letter-spacing:-0.04em;position:absolute;text-decoration:none;white-space:pre;width:2.53pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:125.36pt;position:absolute;text-decoration:none;white-space:pre;width:33.59pt">without</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:158.95pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.42pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:161.37pt;position:absolute;text-decoration:none;white-space:pre;width:155.49pt">further action of the Board, to each</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:316.86pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.88pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:319.74pt;position:absolute;text-decoration:none;white-space:pre;width:214.81pt">member of the Board who is not an employee of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.55pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:215.9pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:77pt;position:absolute;text-decoration:none;white-space:pre;width:457.45pt">the Company or any of its parents, affiliates or subsidiaries and who is determined by the Board to be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.45pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:229.1pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:77pt;position:absolute;text-decoration:none;white-space:pre;width:32.96pt">eligible</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:109.96000000000001pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.22pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:112.18pt;position:absolute;text-decoration:none;white-space:pre;width:8.55pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:120.72999999999999pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.22pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:122.95pt;position:absolute;text-decoration:none;white-space:pre;width:31.73pt">receive</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:154.68pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.22pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:156.9pt;position:absolute;text-decoration:none;white-space:pre;width:61.07pt">compensation</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:217.97pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.72pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:220.69pt;position:absolute;text-decoration:none;white-space:pre;width:25.04pt">under</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:245.73pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.72pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:248.45pt;position:absolute;text-decoration:none;white-space:pre;width:15.88pt">this</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:264.33000000000004pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.72pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:267.05pt;position:absolute;text-decoration:none;white-space:pre;width:37.86pt">Program</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:304.90999999999997pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.72pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:307.63pt;position:absolute;text-decoration:none;white-space:pre;width:26.55pt">(each,</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:334.18pt;letter-spacing:-0.022em;position:absolute;text-decoration:none;white-space:pre;width:2.67pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:336.85pt;position:absolute;text-decoration:none;white-space:pre;width:10.38pt">an</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:347.23pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.82pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:350.05pt;position:absolute;text-decoration:none;white-space:pre;width:4.88pt">&#8220;</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:354.93pt;position:absolute;text-decoration:none;white-space:pre;width:35.41pt">Eligible</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:390.34pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.82pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:393.16pt;position:absolute;text-decoration:none;white-space:pre;width:37.86pt">Director</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:431.02pt;position:absolute;text-decoration:none;white-space:pre;width:11.29pt">&#8221;),</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:442.31pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.82pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:445.13pt;position:absolute;text-decoration:none;white-space:pre;width:18.94pt">who</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:464.07pt;letter-spacing:-0.022em;position:absolute;text-decoration:none;white-space:pre;width:2.67pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:466.74pt;position:absolute;text-decoration:none;white-space:pre;width:18.93pt">may</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:485.67pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.82pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:488.49pt;position:absolute;text-decoration:none;white-space:pre;width:10.38pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:498.87pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.72pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:501.59pt;position:absolute;text-decoration:none;white-space:pre;width:32.96pt">eligible</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.55pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:242.3pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:77pt;position:absolute;text-decoration:none;white-space:pre;width:457.52pt">to receive such cash or equity compensation, unless such Eligible Director declines the receipt of such</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.52pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:255.5pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:77pt;position:absolute;text-decoration:none;white-space:pre;width:278.48pt">cash or equity compensation by written notice to the Company.</font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:280.6pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:113.1pt;position:absolute;text-decoration:none;white-space:pre;width:421.38pt">This Program, as amended, shall become effective as of the date first set forth above (the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.48pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:293.8pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:77.1pt;position:absolute;text-decoration:none;white-space:pre;width:4.88pt">&#8220;</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:81.97999999999999pt;position:absolute;text-decoration:none;white-space:pre;width:40.27pt">Effective</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:122.25pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:124.8pt;position:absolute;text-decoration:none;white-space:pre;width:21.37pt">Date</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:146.17pt;position:absolute;text-decoration:none;white-space:pre;width:8.54pt">&#8221;)</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:154.70999999999998pt;letter-spacing:-0.027em;position:absolute;text-decoration:none;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:157.31pt;position:absolute;text-decoration:none;white-space:pre;width:15.88pt">and</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:173.19pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:175.74pt;position:absolute;text-decoration:none;white-space:pre;width:20.76pt">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:196.5pt;letter-spacing:-0.04em;position:absolute;text-decoration:none;white-space:pre;width:2.45pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:198.95pt;position:absolute;text-decoration:none;white-space:pre;width:30.52pt">remain</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:229.47pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:232.01999999999998pt;position:absolute;text-decoration:none;white-space:pre;width:8.55pt">in</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:240.57pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:243.12pt;position:absolute;text-decoration:none;white-space:pre;width:25.01pt">effect</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:268.13pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.7pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:270.83pt;position:absolute;text-decoration:none;white-space:pre;width:20.15pt">until</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:290.98pt;letter-spacing:-0.04em;position:absolute;text-decoration:none;white-space:pre;width:2.45pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:293.43pt;position:absolute;text-decoration:none;white-space:pre;width:6.1pt">it</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:299.53pt;letter-spacing:-0.027em;position:absolute;text-decoration:none;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:302.13pt;position:absolute;text-decoration:none;white-space:pre;width:7.33pt">is</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:309.46000000000004pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:312.01pt;position:absolute;text-decoration:none;white-space:pre;width:31.75pt">revised</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:343.76pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:346.30999999999995pt;position:absolute;text-decoration:none;white-space:pre;width:9.16pt">or</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:355.47pt;letter-spacing:-0.027em;position:absolute;text-decoration:none;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:358.07000000000005pt;position:absolute;text-decoration:none;white-space:pre;width:42.13pt">rescinded</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:400.20000000000005pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:402.75pt;position:absolute;text-decoration:none;white-space:pre;width:11pt">by</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:413.75pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:416pt;position:absolute;text-decoration:none;white-space:pre;width:29.91pt">further</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:445.90999999999997pt;letter-spacing:-0.045em;position:absolute;text-decoration:none;white-space:pre;width:2.4pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:448.30999999999995pt;position:absolute;text-decoration:none;white-space:pre;width:26.86pt">action</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:475.16999999999996pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:477.41999999999996pt;position:absolute;text-decoration:none;white-space:pre;width:9.16pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:486.58000000000004pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.3pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:488.88pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:502.30999999999995pt;letter-spacing:-0.045em;position:absolute;text-decoration:none;white-space:pre;width:2.4pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:504.71000000000004pt;position:absolute;text-decoration:none;white-space:pre;width:29.62pt">Board.</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.33pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:307pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:77.1pt;position:absolute;text-decoration:none;white-space:pre;width:19.54pt">This</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:96.63999999999999pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.17pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:98.81pt;position:absolute;text-decoration:none;white-space:pre;width:37.86pt">Program</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:136.67pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.17pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:138.84pt;position:absolute;text-decoration:none;white-space:pre;width:18.93pt">may</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:157.76999999999998pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.17pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:159.94pt;position:absolute;text-decoration:none;white-space:pre;width:10.38pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:170.32pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.22pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:172.54pt;position:absolute;text-decoration:none;white-space:pre;width:42.44pt">amended,</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:214.98pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.17pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:217.15pt;position:absolute;text-decoration:none;white-space:pre;width:39.69pt">modified</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:256.84000000000003pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.17pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:259.01pt;position:absolute;text-decoration:none;white-space:pre;width:9.16pt">or</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:268.16999999999996pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.17pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:270.34000000000003pt;position:absolute;text-decoration:none;white-space:pre;width:47pt">terminated</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:317.34000000000003pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.22pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:319.56pt;position:absolute;text-decoration:none;white-space:pre;width:11pt">by</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:330.56pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.17pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:332.73pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:346.15999999999997pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.17pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:348.33000000000004pt;position:absolute;text-decoration:none;white-space:pre;width:26.87pt">Board</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:375.20000000000005pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.17pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:377.37pt;position:absolute;text-decoration:none;white-space:pre;width:7.93pt">at</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:385.29999999999995pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.22pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:387.52pt;position:absolute;text-decoration:none;white-space:pre;width:15.88pt">any</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:403.4pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.17pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:405.57000000000005pt;position:absolute;text-decoration:none;white-space:pre;width:19.53pt">time</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:425.1pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.17pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:427.27pt;position:absolute;text-decoration:none;white-space:pre;width:8.55pt">in</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:435.82000000000005pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.17pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:437.99pt;position:absolute;text-decoration:none;white-space:pre;width:10.38pt">its</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:448.37pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.22pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:450.59000000000003pt;position:absolute;text-decoration:none;white-space:pre;width:17.71pt">sole</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:468.29999999999995pt;letter-spacing:-0.04em;position:absolute;text-decoration:none;white-space:pre;width:2.42pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:470.72pt;position:absolute;text-decoration:none;white-space:pre;width:46.1pt">discretion.</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:516.82pt;letter-spacing:0.113em;position:absolute;text-decoration:none;white-space:pre;width:4.1pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:520.92pt;position:absolute;text-decoration:none;white-space:pre;width:13.44pt">No</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.36pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:320.2pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:77.1pt;position:absolute;text-decoration:none;white-space:pre;width:34.79pt">Eligible</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:111.88999999999999pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.82pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:114.71pt;position:absolute;text-decoration:none;white-space:pre;width:36.62pt">Director</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:151.32999999999998pt;letter-spacing:-0.004em;position:absolute;text-decoration:none;white-space:pre;width:2.87pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:154.2pt;position:absolute;text-decoration:none;white-space:pre;width:20.76pt">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:174.95999999999998pt;letter-spacing:-0.004em;position:absolute;text-decoration:none;white-space:pre;width:2.87pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:177.82999999999998pt;position:absolute;text-decoration:none;white-space:pre;width:20.76pt">have</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:198.58999999999997pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.72pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:201.31pt;position:absolute;text-decoration:none;white-space:pre;width:15.88pt">any</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:217.19pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.82pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:220.01pt;position:absolute;text-decoration:none;white-space:pre;width:25.04pt">rights</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:245.04999999999998pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.82pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:247.87pt;position:absolute;text-decoration:none;white-space:pre;width:46.71pt">hereunder,</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:294.58pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.82pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:297.4pt;position:absolute;text-decoration:none;white-space:pre;width:28.69pt">except</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:326.09000000000003pt;letter-spacing:-0.004em;position:absolute;text-decoration:none;white-space:pre;width:2.87pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:328.96000000000004pt;position:absolute;text-decoration:none;white-space:pre;width:19.54pt">with</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:348.5pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.82pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:351.32000000000005pt;position:absolute;text-decoration:none;white-space:pre;width:31.13pt">respect</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:382.45000000000005pt;letter-spacing:-0.004em;position:absolute;text-decoration:none;white-space:pre;width:2.87pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:385.32000000000005pt;position:absolute;text-decoration:none;white-space:pre;width:8.55pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:393.87pt;letter-spacing:-0.022em;position:absolute;text-decoration:none;white-space:pre;width:2.67pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:396.53999999999996pt;position:absolute;text-decoration:none;white-space:pre;width:27.48pt">equity</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:424.02pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.82pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:426.84000000000003pt;position:absolute;text-decoration:none;white-space:pre;width:31.14pt">awards</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:457.98pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.82pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:460.79999999999995pt;position:absolute;text-decoration:none;white-space:pre;width:32.97pt">granted</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:493.77pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.82pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:496.59000000000003pt;position:absolute;text-decoration:none;white-space:pre;width:37.87pt">pursuant</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.46pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:333.4pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:77.1pt;position:absolute;text-decoration:none;white-space:pre;width:126.42pt">to Section 2 of this Program.</font></div><div style="line-height:7.62pt;position:absolute;top:358.75pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.004em;white-space:pre"><font style="left:113pt;position:absolute">1.<font style="display:inline-block;height:7.62pt;width:27.83pt"></font></font></font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;text-decoration:underline;white-space:pre">Cash</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:170.99pt;letter-spacing:-0.04em;position:absolute;text-decoration:underline;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:173.3pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:underline;white-space:pre">Compensation</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:235.74pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre">.</font></div><div style="line-height:7.62pt;position:absolute;top:383.9pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.004em;white-space:pre"><font style="left:149pt;position:absolute">a.<font style="display:inline-block;height:7.62pt;width:28.45pt"></font></font></font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:185pt;position:absolute;text-decoration:underline;white-space:pre">Annual</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:217.37pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:underline;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:220.03pt;position:absolute;text-decoration:underline;white-space:pre">Retainers</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:261.54pt;position:absolute;white-space:pre">.</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:264.29pt;letter-spacing:0.336em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:270.73pt;position:absolute;white-space:pre">Each</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:292.7pt;letter-spacing:-0.013000000000000001em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:295.31pt;position:absolute;white-space:pre">Eligible</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:330.1pt;letter-spacing:-0.013000000000000001em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:332.71000000000004pt;position:absolute;white-space:pre">Director</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:369.33000000000004pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:371.99pt;position:absolute;white-space:pre">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:392.75pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:395.40999999999997pt;position:absolute;white-space:pre">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:405.79pt;letter-spacing:-0.013000000000000001em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:408.4pt;position:absolute;white-space:pre">eligible</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:441.36pt;letter-spacing:-0.013000000000000001em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:443.97pt;position:absolute;white-space:pre">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:452.52pt;letter-spacing:-0.013000000000000001em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:455.13pt;position:absolute;white-space:pre">receive</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:486.86pt;letter-spacing:-0.013000000000000001em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:489.47pt;position:absolute;white-space:pre">an</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:499.85pt;letter-spacing:-0.013000000000000001em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:502.46pt;position:absolute;white-space:pre">annual </font></div><div style="line-height:7.62pt;position:absolute;top:397.1pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre">cash retainer of $50,000 for service on the Board.</font></div><div style="line-height:7.62pt;position:absolute;top:422.35pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.004em;white-space:pre"><font style="left:149pt;position:absolute">b.<font style="display:inline-block;height:7.62pt;width:27.83pt"></font></font></font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:185pt;position:absolute;text-decoration:underline;white-space:pre">Additional Annual Retainers</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:311.4pt;position:absolute;white-space:pre">.</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:314.15pt;letter-spacing:0.181em;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:318.89pt;position:absolute;white-space:pre">An Eligible Director shall be eligible to receive </font></div><div style="line-height:7.62pt;position:absolute;top:435.55pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre">the following additional annual retainers, as applicable&#58;</font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:448.75pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.004em;white-space:pre"><font style="left:185pt;position:absolute;width:10.25pt">(i)<font style="display:inline-block;height:7.62pt;width:25.55pt"></font></font></font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:220.8pt;position:absolute;white-space:pre;width:313.45pt">Chairman of the Board or Co-Chairman of the Board. An Eligible</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.25pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:461.95pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:94.95pt;position:absolute;white-space:pre;width:439.34pt">Director serving as the Chairman of the Board or Co-Chairman of the Board shall be eligible to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.29pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:475.15pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:94.95pt;position:absolute;white-space:pre;width:285.46pt">receive an additional annual retainer of $75,000 for such service.</font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:488.35pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.004em;white-space:pre"><font style="left:185pt;position:absolute;width:13.26pt">(ii)<font style="display:inline-block;height:7.62pt;width:22.54pt"></font></font></font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:220.8pt;position:absolute;text-decoration:underline;white-space:pre;width:25.04pt">Audit</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:245.84pt;letter-spacing:-0.063em;position:absolute;text-decoration:underline;white-space:pre;width:2.29pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:248.13pt;position:absolute;text-decoration:underline;white-space:pre;width:15.88pt">and</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:264.01pt;letter-spacing:-0.063em;position:absolute;text-decoration:underline;white-space:pre;width:2.29pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:266.3pt;position:absolute;text-decoration:underline;white-space:pre;width:20.16pt">Risk</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:286.46pt;letter-spacing:-0.063em;position:absolute;text-decoration:underline;white-space:pre;width:2.29pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:288.75pt;position:absolute;text-decoration:underline;white-space:pre;width:48.84pt">Committee</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:337.59000000000003pt;position:absolute;white-space:pre;width:2.75pt">.</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:340.34000000000003pt;letter-spacing:-0.059000000000000004em;position:absolute;white-space:pre;width:2.34pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:342.68pt;position:absolute;white-space:pre;width:13.44pt">An</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:356.12pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.29pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:358.40999999999997pt;position:absolute;white-space:pre;width:34.79pt">Eligible</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:393.2pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.29pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:395.49pt;position:absolute;white-space:pre;width:36.62pt">Director</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:432.11pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.29pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:434.4pt;position:absolute;white-space:pre;width:32.37pt">serving</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:466.77pt;letter-spacing:-0.059000000000000004em;position:absolute;white-space:pre;width:2.34pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:469.11pt;position:absolute;white-space:pre;width:9.16pt">as</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:478.27pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.29pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:480.56pt;position:absolute;white-space:pre;width:53.74pt">Chairperson</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.3pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:501.55pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:94.95pt;position:absolute;white-space:pre;width:9.16pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:104.11pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.67pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:106.78pt;position:absolute;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:120.21000000000001pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.67pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:122.88pt;position:absolute;white-space:pre;width:25.04pt">Audit</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:147.92000000000002pt;letter-spacing:-0.045em;position:absolute;white-space:pre;width:2.42pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:150.34pt;position:absolute;white-space:pre;width:15.88pt">and</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:166.22pt;letter-spacing:-0.05em;position:absolute;white-space:pre;width:2.36pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:168.57999999999998pt;position:absolute;white-space:pre;width:20.16pt">Risk</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:188.74pt;letter-spacing:-0.05em;position:absolute;white-space:pre;width:2.36pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:191.10000000000002pt;position:absolute;white-space:pre;width:48.84pt">Committee</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:239.94pt;letter-spacing:-0.045em;position:absolute;white-space:pre;width:2.42pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:242.36pt;position:absolute;white-space:pre;width:20.76pt">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:263.12pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.57pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:265.69pt;position:absolute;white-space:pre;width:10.38pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:276.07pt;letter-spacing:-0.036000000000000004em;position:absolute;white-space:pre;width:2.52pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:278.59pt;position:absolute;white-space:pre;width:32.96pt">eligible</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:311.55pt;letter-spacing:-0.036000000000000004em;position:absolute;white-space:pre;width:2.52pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:314.07pt;position:absolute;white-space:pre;width:8.55pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:322.62pt;letter-spacing:-0.036000000000000004em;position:absolute;white-space:pre;width:2.52pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:325.14pt;position:absolute;white-space:pre;width:31.73pt">receive</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:356.87pt;letter-spacing:-0.036000000000000004em;position:absolute;white-space:pre;width:2.52pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:359.39pt;position:absolute;white-space:pre;width:10.38pt">an</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:369.77pt;letter-spacing:-0.036000000000000004em;position:absolute;white-space:pre;width:2.52pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:372.28999999999996pt;position:absolute;white-space:pre;width:43.96pt">additional</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:416.25pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.57pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:418.82pt;position:absolute;white-space:pre;width:29.31pt">annual</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:448.13pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.57pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:450.7pt;position:absolute;white-space:pre;width:33.56pt">retainer</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:484.26pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.57pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:486.83pt;position:absolute;white-space:pre;width:9.16pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:495.99pt;letter-spacing:-0.045em;position:absolute;white-space:pre;width:2.42pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:498.40999999999997pt;position:absolute;white-space:pre;width:35.75pt">$20,000</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.16pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:514.75pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:94.95pt;position:absolute;white-space:pre;width:12.82pt">for</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:107.77000000000001pt;letter-spacing:-0.004em;position:absolute;white-space:pre;width:2.88pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:110.65pt;position:absolute;white-space:pre;width:20.16pt">such</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:130.81pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.83pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:133.64pt;position:absolute;white-space:pre;width:182.66pt">service. An Eligible Director serving as a</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:316.3pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.83pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:319.13pt;position:absolute;white-space:pre;width:48.1pt">member of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:367.22999999999996pt;letter-spacing:-0.004em;position:absolute;white-space:pre;width:2.88pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:370.11pt;position:absolute;white-space:pre;width:41.39pt">the Audit</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:411.5pt;letter-spacing:-0.004em;position:absolute;white-space:pre;width:2.88pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:414.38pt;position:absolute;white-space:pre;width:38.96pt">and Risk</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:453.34pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.83pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:456.17pt;position:absolute;white-space:pre;width:78.01pt">Committee (other</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.1800000000001pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:527.95pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:94.95pt;position:absolute;white-space:pre;width:439.34pt">than the Chairperson) shall be eligible to receive an additional annual retainer of $10,000 for such</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.29pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:541.15pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:94.95pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:33.16pt">service.</font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:554.35pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.004em;white-space:pre"><font style="left:185pt;position:absolute;width:16.27pt">(iii)<font style="display:inline-block;height:7.62pt;width:19.53pt"></font></font></font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:220.8pt;position:absolute;text-decoration:underline;white-space:pre;width:63.52pt">Compensation</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:284.32pt;letter-spacing:-0.063em;position:absolute;text-decoration:underline;white-space:pre;width:2.39pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:286.71pt;position:absolute;text-decoration:underline;white-space:pre;width:48.84pt">Committee</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:335.55pt;position:absolute;white-space:pre;width:2.75pt">.</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:338.3pt;letter-spacing:0.068em;position:absolute;white-space:pre;width:3.82pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:342.12pt;position:absolute;white-space:pre;width:13.44pt">An</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:355.56pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.39pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:357.95pt;position:absolute;white-space:pre;width:34.79pt">Eligible</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:392.74pt;letter-spacing:-0.059000000000000004em;position:absolute;white-space:pre;width:2.44pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:395.18pt;position:absolute;white-space:pre;width:36.62pt">Director</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:431.8pt;letter-spacing:-0.059000000000000004em;position:absolute;white-space:pre;width:2.44pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:434.24pt;position:absolute;white-space:pre;width:32.37pt">serving</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:466.61pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.39pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:469pt;position:absolute;white-space:pre;width:9.16pt">as</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:478.16pt;letter-spacing:-0.059000000000000004em;position:absolute;white-space:pre;width:2.44pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:480.6pt;position:absolute;white-space:pre;width:53.74pt">Chairperson</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.3399999999999pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:567.55pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:9.16pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:104.16pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:106.89pt;position:absolute;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:120.32pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:123.05pt;position:absolute;white-space:pre;width:63.52pt">Compensation</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:186.57pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.68pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:189.25pt;position:absolute;white-space:pre;width:48.84pt">Committee</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:238.09pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:240.82pt;position:absolute;white-space:pre;width:20.76pt">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:261.58000000000004pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:264.31pt;position:absolute;white-space:pre;width:10.38pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:274.69pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:277.41999999999996pt;position:absolute;white-space:pre;width:32.96pt">eligible</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:310.38pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.58pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:312.96000000000004pt;position:absolute;white-space:pre;width:8.55pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:321.51pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.68pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:324.19pt;position:absolute;white-space:pre;width:31.73pt">receive</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:355.92pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:358.65pt;position:absolute;white-space:pre;width:10.38pt">an</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:369.03pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.68pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:371.71pt;position:absolute;white-space:pre;width:43.96pt">additional</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:415.67pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:418.4pt;position:absolute;white-space:pre;width:29.31pt">annual</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:447.71pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:450.44pt;position:absolute;white-space:pre;width:33.56pt">retainer</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:484pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:486.73pt;position:absolute;white-space:pre;width:9.16pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:495.89pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:498.62pt;position:absolute;white-space:pre;width:35.75pt">$15,000</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.37pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:580.75pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:72.86pt">for such service.</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:167.86pt;letter-spacing:0.181em;position:absolute;white-space:pre;width:4.99pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:172.85pt;position:absolute;white-space:pre;width:361.48pt">An Eligible Director serving as a member of the Compensation Committee (other</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.3299999999999pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:593.95pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:439.34pt">than the Chairperson) shall be eligible to receive an additional annual retainer of $10,000 for such</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.3399999999999pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:607.15pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:33.16pt">service.</font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:620.35pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.004em;white-space:pre"><font style="left:185pt;position:absolute;width:15.71pt">(iv)<font style="display:inline-block;height:7.62pt;width:20.04pt"></font></font></font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:220.75pt;position:absolute;text-decoration:underline;white-space:pre;width:245.16pt">Nominating and Corporate Governance Committee</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:465.91pt;position:absolute;white-space:pre;width:2.75pt">.</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:468.66pt;letter-spacing:0.181em;position:absolute;white-space:pre;width:9.7pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:478.36pt;position:absolute;white-space:pre;width:55.94pt">An Eligible</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.3pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:633.55pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:439.3pt">Director serving as Chairperson of the Nominating and Corporate Governance Committee shall be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.3pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:646.75pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:341.71pt">eligible to receive an additional annual retainer of $10,000 for such service.</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:436.71pt;letter-spacing:0.181em;position:absolute;white-space:pre;width:5.58pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:442.29pt;position:absolute;white-space:pre;width:92.03pt">An Eligible Director</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.3199999999999pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:659.95pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:439.31pt">serving as a member of the Nominating and Corporate Governance Committee (other than the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.31pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:673.15pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:429.26pt">Chairperson) shall be eligible to receive an additional annual retainer of $10,000 for such service.</font></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt"><div style="position:absolute;top:778.32pt"><div style="width:468pt"></div></div><div style="position:absolute"><div style="width:468pt"></div></div><div><div id="i7a94055aec1042169d4d760e108f68a6_4" style="position:absolute;top:67.68pt"></div><div style="line-height:7.62pt;position:absolute;top:67.68pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;text-decoration:none;white-space:pre">Chairperson)</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:152.4pt;letter-spacing:-0.022em;position:absolute;text-decoration:none;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:154.91pt;position:absolute;text-decoration:none;white-space:pre">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:175.67000000000002pt;letter-spacing:-0.022em;position:absolute;text-decoration:none;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:178.18pt;position:absolute;text-decoration:none;white-space:pre">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:188.56pt;letter-spacing:-0.013000000000000001em;position:absolute;text-decoration:none;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:191.17000000000002pt;position:absolute;text-decoration:none;white-space:pre">eligible</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:224.13pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:226.79pt;position:absolute;text-decoration:none;white-space:pre">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:235.34pt;letter-spacing:-0.013000000000000001em;position:absolute;text-decoration:none;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:237.95pt;position:absolute;text-decoration:none;white-space:pre">receive</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:269.68pt;letter-spacing:-0.013000000000000001em;position:absolute;text-decoration:none;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:272.28999999999996pt;position:absolute;text-decoration:none;white-space:pre">an</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:282.66999999999996pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:285.33000000000004pt;position:absolute;text-decoration:none;white-space:pre">additional</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:329.28999999999996pt;letter-spacing:-0.022em;position:absolute;text-decoration:none;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:331.8pt;position:absolute;text-decoration:none;white-space:pre">annual</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:361.11pt;letter-spacing:-0.022em;position:absolute;text-decoration:none;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:363.62pt;position:absolute;text-decoration:none;white-space:pre">retainer</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:397.18pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:399.84pt;position:absolute;text-decoration:none;white-space:pre">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:409pt;letter-spacing:-0.004em;position:absolute;text-decoration:none;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:411.71pt;position:absolute;text-decoration:none;white-space:pre">$10,000</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:447.46pt;letter-spacing:-0.027em;position:absolute;text-decoration:none;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:449.92pt;position:absolute;text-decoration:none;white-space:pre">for</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:462.74pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:465.4pt;position:absolute;text-decoration:none;white-space:pre">such</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:485.56pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre"> service.</font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:98.08pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.004em;white-space:pre"><font style="left:149pt;position:absolute;width:7.55pt">c.<font style="display:inline-block;height:7.62pt;width:28.3pt"></font></font></font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:184.85pt;position:absolute;text-decoration:underline;white-space:pre;width:38.47pt">Payment</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:223.32pt;letter-spacing:-0.022em;position:absolute;text-decoration:underline;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:226.05pt;position:absolute;text-decoration:underline;white-space:pre;width:9.16pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:235.20999999999998pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:underline;white-space:pre;width:2.88pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:238.09pt;position:absolute;text-decoration:underline;white-space:pre;width:41.51pt">Retainers</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:279.6pt;position:absolute;white-space:pre;width:2.75pt">.</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:282.35pt;letter-spacing:0.154em;position:absolute;white-space:pre;width:4.66pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:287.01pt;position:absolute;white-space:pre;width:17.09pt">The</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:304.1pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:306.83000000000004pt;position:absolute;white-space:pre;width:29.31pt">annual</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:336.14pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.88pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:339.02pt;position:absolute;white-space:pre;width:19.54pt">cash</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:358.56pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.68pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:361.24pt;position:absolute;white-space:pre;width:37.84pt">retainers</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:399.08000000000004pt;letter-spacing:-0.013000000000000001em;position:absolute;white-space:pre;width:2.83pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:401.90999999999997pt;position:absolute;white-space:pre;width:42.13pt">described</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:444.04pt;letter-spacing:-0.013000000000000001em;position:absolute;white-space:pre;width:2.83pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:446.87pt;position:absolute;white-space:pre;width:8.55pt">in</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:455.42pt;letter-spacing:-0.013000000000000001em;position:absolute;white-space:pre;width:2.83pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:458.25pt;position:absolute;white-space:pre;width:37.25pt">Sections</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:495.5pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:498.23pt;position:absolute;white-space:pre;width:17.7pt">1(a)</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:515.9300000000001pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:518.6600000000001pt;position:absolute;white-space:pre;width:15.88pt">and</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.54pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:111.28pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:18.32pt">1(b)</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:113.32pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.14pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:115.46000000000001pt;position:absolute;white-space:pre;width:20.76pt">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:136.22pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.14pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:138.36pt;position:absolute;white-space:pre;width:10.38pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:148.74pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.14pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:150.88pt;position:absolute;white-space:pre;width:29.3pt">earned</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:180.18pt;letter-spacing:-0.059000000000000004em;position:absolute;white-space:pre;width:2.19pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:182.37pt;position:absolute;white-space:pre;width:11pt">on</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:193.37pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.14pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:195.51pt;position:absolute;white-space:pre;width:4.88pt">a</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:200.39pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.14pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:202.53pt;position:absolute;white-space:pre;width:39.68pt">quarterly</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:242.21pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.14pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:244.35pt;position:absolute;white-space:pre;width:21.99pt">basis</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:266.34000000000003pt;letter-spacing:-0.059000000000000004em;position:absolute;white-space:pre;width:2.19pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:268.53pt;position:absolute;white-space:pre;width:25.04pt">based</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:293.57pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.14pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:295.71000000000004pt;position:absolute;white-space:pre;width:11pt">on</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:306.71000000000004pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.14pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:308.85pt;position:absolute;white-space:pre;width:4.88pt">a</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:313.73pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.14pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:315.87pt;position:absolute;white-space:pre;width:37.23pt">calendar</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:353.1pt;letter-spacing:-0.059000000000000004em;position:absolute;white-space:pre;width:2.19pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:355.29pt;position:absolute;white-space:pre;width:31.13pt">quarter</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:386.42pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.14pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:388.56pt;position:absolute;white-space:pre;width:15.88pt">and</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:404.44pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.14pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:406.58pt;position:absolute;white-space:pre;width:20.76pt">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:427.34pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.14pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:429.48pt;position:absolute;white-space:pre;width:10.38pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:439.86pt;letter-spacing:-0.059000000000000004em;position:absolute;white-space:pre;width:2.19pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:442.05pt;position:absolute;white-space:pre;width:18.93pt">paid</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:460.98pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.14pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:463.12pt;position:absolute;white-space:pre;width:11pt">by</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:474.12pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.14pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:476.26pt;position:absolute;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:489.69pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.14pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:491.83pt;position:absolute;white-space:pre;width:42.76pt">Company</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.5899999999999pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:124.48pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:58.32pt">in arrears not</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:153.32pt;letter-spacing:-0.004em;position:absolute;white-space:pre;width:2.87pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:156.19pt;position:absolute;white-space:pre;width:19.52pt">later</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:175.70999999999998pt;letter-spacing:-0.004em;position:absolute;white-space:pre;width:2.87pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:178.57999999999998pt;position:absolute;white-space:pre;width:18.93pt">than</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:197.51pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.82pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:200.32999999999998pt;position:absolute;white-space:pre;width:11pt">30</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:211.32999999999998pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.67pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:214pt;position:absolute;white-space:pre;width:20.16pt">days</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:234.16pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.82pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:236.98pt;position:absolute;white-space:pre;width:42.75pt">following</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:279.73pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.82pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:282.55pt;position:absolute;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:295.98pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.82pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:298.8pt;position:absolute;white-space:pre;width:51pt">end of each</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:349.8pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.82pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:352.62pt;position:absolute;white-space:pre;width:74.02pt">calendar quarter.</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:426.64pt;letter-spacing:0.181em;position:absolute;white-space:pre;width:4.9pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:431.54pt;position:absolute;white-space:pre;width:9.16pt">In</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:440.7pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.82pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:443.52pt;position:absolute;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:456.95pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.82pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:459.77pt;position:absolute;white-space:pre;width:23.81pt">event</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:483.58pt;letter-spacing:-0.004em;position:absolute;white-space:pre;width:2.87pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:486.45pt;position:absolute;white-space:pre;width:48.08pt">an Eligible</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.53pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:137.68pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:115.11pt">Director does not serve as</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:210.11pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.89pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:213pt;position:absolute;white-space:pre;width:321.51pt">a director, or in the applicable positions described in Section 1(b), for an</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.51pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:150.88pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:25.02pt">entire</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:120.02pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.59pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:122.61pt;position:absolute;white-space:pre;width:37.23pt">calendar</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:159.84pt;letter-spacing:-0.013000000000000001em;position:absolute;white-space:pre;width:2.74pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:162.57999999999998pt;position:absolute;white-space:pre;width:33.88pt">quarter,</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:196.45999999999998pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.59pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:199.05pt;position:absolute;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:212.48000000000002pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.59pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:215.07pt;position:absolute;white-space:pre;width:33.56pt">retainer</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:248.63pt;letter-spacing:-0.013000000000000001em;position:absolute;white-space:pre;width:2.74pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:251.37pt;position:absolute;white-space:pre;width:18.93pt">paid</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:270.3pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.59pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:272.89pt;position:absolute;white-space:pre;width:8.55pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:281.44pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.59pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:284.03pt;position:absolute;white-space:pre;width:20.16pt">such</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:304.19pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.69pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:306.88pt;position:absolute;white-space:pre;width:34.79pt">Eligible</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:341.66999999999996pt;letter-spacing:-0.013000000000000001em;position:absolute;white-space:pre;width:2.74pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:344.40999999999997pt;position:absolute;white-space:pre;width:36.62pt">Director</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:381.03pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.64pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:383.67pt;position:absolute;white-space:pre;width:20.76pt">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:404.43pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.64pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:407.07pt;position:absolute;white-space:pre;width:10.38pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:417.45pt;letter-spacing:-0.013000000000000001em;position:absolute;white-space:pre;width:2.74pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:420.19pt;position:absolute;white-space:pre;width:36.63pt">prorated</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:456.82pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.59pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:459.41pt;position:absolute;white-space:pre;width:12.82pt">for</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:472.23pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.64pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:474.87pt;position:absolute;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:488.3pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.59pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:490.89pt;position:absolute;white-space:pre;width:31.76pt">portion</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:522.65pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.69pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:525.3399999999999pt;position:absolute;white-space:pre;width:9.16pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.5pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:164.08pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:371.86pt">such calendar quarter actually served as a director, or in such position, as applicable.</font></div><div style="line-height:7.62pt;position:absolute;top:189.33pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.004em;white-space:pre"><font style="left:113pt;position:absolute">2.<font style="display:inline-block;height:7.62pt;width:27.83pt"></font></font></font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;text-decoration:underline;white-space:pre">Equity</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:178.31pt;letter-spacing:-0.045em;position:absolute;text-decoration:underline;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:180.57pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:underline;white-space:pre">Compensation</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:243.01pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre">.</font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:214.48pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.004em;white-space:pre"><font style="left:149pt;position:absolute;width:7.55pt">a.<font style="display:inline-block;height:7.62pt;width:28.3pt"></font></font></font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:184.85pt;position:absolute;text-decoration:underline;white-space:pre;width:34.79pt">General</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:219.64pt;position:absolute;white-space:pre;width:2.75pt">.</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:222.39pt;letter-spacing:0.181em;position:absolute;white-space:pre;width:6.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:228.64pt;position:absolute;white-space:pre;width:305.75pt">Eligible Directors automatically shall be granted the equity awards</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.39pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:227.68pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:42.13pt">described</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:137.13pt;letter-spacing:-0.059000000000000004em;position:absolute;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:139.39pt;position:absolute;white-space:pre;width:29.62pt">below.</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:169.01pt;letter-spacing:-0.054em;position:absolute;white-space:pre;width:2.31pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:171.32pt;position:absolute;white-space:pre;width:17.09pt">The</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:188.41pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.21pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:190.62pt;position:absolute;white-space:pre;width:31.14pt">awards</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:221.76pt;letter-spacing:-0.05em;position:absolute;white-space:pre;width:2.35pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:224.11pt;position:absolute;white-space:pre;width:42.13pt">described</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:266.24pt;letter-spacing:-0.054em;position:absolute;white-space:pre;width:2.31pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:268.55pt;position:absolute;white-space:pre;width:26.87pt">below</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:295.41999999999996pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.21pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:297.63pt;position:absolute;white-space:pre;width:20.76pt">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:318.39pt;letter-spacing:-0.05em;position:absolute;white-space:pre;width:2.35pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:320.74pt;position:absolute;white-space:pre;width:10.38pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:331.12pt;letter-spacing:-0.05em;position:absolute;white-space:pre;width:2.35pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:333.47pt;position:absolute;white-space:pre;width:32.97pt">granted</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:366.44pt;letter-spacing:-0.054em;position:absolute;white-space:pre;width:2.31pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:368.75pt;position:absolute;white-space:pre;width:25.04pt">under</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:393.79pt;letter-spacing:-0.059000000000000004em;position:absolute;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:396.05pt;position:absolute;white-space:pre;width:15.88pt">and</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:411.93pt;letter-spacing:-0.054em;position:absolute;white-space:pre;width:2.31pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:414.24pt;position:absolute;white-space:pre;width:20.76pt">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:435pt;letter-spacing:-0.05em;position:absolute;white-space:pre;width:2.35pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:437.35pt;position:absolute;white-space:pre;width:10.38pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:447.73pt;letter-spacing:-0.05em;position:absolute;white-space:pre;width:2.35pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:450.08pt;position:absolute;white-space:pre;width:31.14pt">subject</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:481.22pt;letter-spacing:-0.059000000000000004em;position:absolute;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:483.48pt;position:absolute;white-space:pre;width:8.55pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:492.03pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.21pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:494.24pt;position:absolute;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:507.67pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.21pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:509.88pt;position:absolute;white-space:pre;width:24.42pt">terms</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.3pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:240.88pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:439.33pt">and provisions of the Company&#8217;s 2020 Incentive Award Plan or any other applicable Company</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.3299999999999pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:254.08pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:167.01pt">equity incentive plan then-maintained</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:262.01pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.67pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:264.68pt;position:absolute;white-space:pre;width:11pt">by</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:275.68pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.72pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:278.4pt;position:absolute;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:291.83000000000004pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.67pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:294.5pt;position:absolute;white-space:pre;width:42.76pt">Company</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:337.26pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.72pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:339.98pt;position:absolute;white-space:pre;width:23.82pt">(such</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:363.8pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.67pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:366.47pt;position:absolute;white-space:pre;width:21.68pt">plan,</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:388.15pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.67pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:390.82pt;position:absolute;white-space:pre;width:9.16pt">as</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:399.98pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.67pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:402.65pt;position:absolute;white-space:pre;width:18.93pt">may</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:421.58pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.72pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:424.3pt;position:absolute;white-space:pre;width:10.38pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:434.68pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.67pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:437.35pt;position:absolute;white-space:pre;width:39.69pt">amended</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:477.04pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.67pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:479.71pt;position:absolute;white-space:pre;width:21.37pt">from</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:501.08pt;letter-spacing:-0.045em;position:absolute;white-space:pre;width:2.47pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:503.55pt;position:absolute;white-space:pre;width:19.53pt">time</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:523.0799999999999pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.67pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:525.75pt;position:absolute;white-space:pre;width:8.55pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.3pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:267.28pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:50.85pt">time, the &#8220;</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:145.85pt;position:absolute;white-space:pre;width:56.42pt">Equity Plan</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:202.26999999999998pt;position:absolute;white-space:pre;width:332.04pt">&#8221;) and may be granted subject to the execution and delivery of award</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.31pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:280.48pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:52.81pt">agreements,</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:147.81pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:150.41pt;position:absolute;white-space:pre;width:41.53pt">including</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:191.94pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:194.54000000000002pt;position:absolute;white-space:pre;width:36.62pt">attached</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:231.16pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:233.76pt;position:absolute;white-space:pre;width:37.56pt">exhibits,</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:271.32pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:273.91999999999996pt;position:absolute;white-space:pre;width:8.55pt">in</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:282.47pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:285.07pt;position:absolute;white-space:pre;width:55.57pt">substantially</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:340.64pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:343.24pt;position:absolute;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:356.67pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:359.27pt;position:absolute;white-space:pre;width:25.65pt">forms</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:384.92pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:387.52pt;position:absolute;white-space:pre;width:40.92pt">approved</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:428.44pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:431.04pt;position:absolute;white-space:pre;width:11pt">by</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:442.04pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:444.64pt;position:absolute;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:458.07pt;letter-spacing:-0.04em;position:absolute;white-space:pre;width:2.5pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:460.57pt;position:absolute;white-space:pre;width:26.87pt">Board</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:487.44pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:490.04pt;position:absolute;white-space:pre;width:21.37pt">prior</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:511.41pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.65pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:514.06pt;position:absolute;white-space:pre;width:8.55pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:522.61pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:525.21pt;position:absolute;white-space:pre;width:9.16pt">or</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.37pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:293.68pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:439.36pt">in connection with such grants. All applicable terms of the Equity Plan apply to this Program as if</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.36pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:306.88pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:20.76pt">fully</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:115.76pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:118.31pt;position:absolute;white-space:pre;width:12.21pt">set</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:130.52pt;letter-spacing:-0.04em;position:absolute;white-space:pre;width:2.45pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:132.97pt;position:absolute;white-space:pre;width:21.37pt">forth</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:154.34pt;letter-spacing:-0.045em;position:absolute;white-space:pre;width:2.4pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:156.74pt;position:absolute;white-space:pre;width:30.22pt">herein,</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:186.95999999999998pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:189.51pt;position:absolute;white-space:pre;width:15.88pt">and</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:205.39pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:207.94pt;position:absolute;white-space:pre;width:10.98pt">all</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:218.92000000000002pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:221.51999999999998pt;position:absolute;white-space:pre;width:26.87pt">grants</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:248.39pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:250.94pt;position:absolute;white-space:pre;width:9.16pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:260.1pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:262.7pt;position:absolute;white-space:pre;width:27.48pt">equity</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:290.18pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:292.73pt;position:absolute;white-space:pre;width:31.14pt">awards</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:323.87pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:326.41999999999996pt;position:absolute;white-space:pre;width:29.92pt">hereby</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:356.34pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:358.89pt;position:absolute;white-space:pre;width:13.42pt">are</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:372.31pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:374.86pt;position:absolute;white-space:pre;width:31.14pt">subject</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:406pt;letter-spacing:-0.036000000000000004em;position:absolute;white-space:pre;width:2.5pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:408.5pt;position:absolute;white-space:pre;width:8.55pt">in</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:417.05pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:419.6pt;position:absolute;white-space:pre;width:10.98pt">all</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:430.58pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:433.18pt;position:absolute;white-space:pre;width:35.41pt">respects</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:468.59pt;letter-spacing:-0.04em;position:absolute;white-space:pre;width:2.45pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:471.04pt;position:absolute;white-space:pre;width:8.55pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:479.59pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:482.14pt;position:absolute;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:495.57pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:498.12pt;position:absolute;white-space:pre;width:24.42pt">terms</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:522.54pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:525.0899999999999pt;position:absolute;white-space:pre;width:9.16pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.25pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:320.08pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:108.43pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.81pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:111.24pt;position:absolute;white-space:pre;width:29.31pt">Equity</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:140.55pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.81pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:143.36pt;position:absolute;white-space:pre;width:22.29pt">Plan.</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:165.65pt;letter-spacing:0.154em;position:absolute;white-space:pre;width:4.59pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:170.24pt;position:absolute;white-space:pre;width:50.05pt">Capitalized</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:220.29000000000002pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.81pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:223.1pt;position:absolute;white-space:pre;width:24.42pt">terms</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:247.52pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.81pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:250.33pt;position:absolute;white-space:pre;width:14.05pt">not</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:264.38pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.71pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:267.09000000000003pt;position:absolute;white-space:pre;width:42.74pt">otherwise</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:309.83000000000004pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.71pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:312.53999999999996pt;position:absolute;white-space:pre;width:32.97pt">defined</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:345.51pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.81pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:348.32pt;position:absolute;white-space:pre;width:27.47pt">herein</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:375.79pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.66pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:378.45pt;position:absolute;white-space:pre;width:20.76pt">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:399.21pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.71pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:401.92pt;position:absolute;white-space:pre;width:20.76pt">have</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:422.68pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.71pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:425.39pt;position:absolute;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:438.82pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.71pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:441.53pt;position:absolute;white-space:pre;width:42.14pt">meanings</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:483.67pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.81pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:486.48pt;position:absolute;white-space:pre;width:36.63pt">ascribed</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:523.11pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.66pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:525.77pt;position:absolute;white-space:pre;width:8.55pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.3199999999999pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:333.28pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:106.56pt">them in the Equity Plan.</font></div><div style="line-height:7.62pt;position:absolute;top:346.48pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.004em;white-space:pre"><font style="left:149pt;position:absolute">b.<font style="display:inline-block;height:7.62pt;width:27.83pt"></font></font></font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:185pt;position:absolute;text-decoration:underline;white-space:pre">Initial</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:211.24pt;letter-spacing:-0.04em;position:absolute;text-decoration:underline;white-space:pre"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:213.55pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:underline;white-space:pre">Awards</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:247.20999999999998pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre">.</font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:371.63pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:179.1pt;letter-spacing:-0.027em;position:absolute;text-decoration:none;white-space:pre;width:5.22pt">i.</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><font style="left:184.32pt;position:absolute;width:0pt"><font style="display:inline-block;height:7.62pt;width:36.68pt"></font></font><font style="left:221pt;position:absolute;width:203.25pt">Each Eligible Director who is initially elected</font></font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:424.25pt;letter-spacing:-0.004em;position:absolute;text-decoration:none;white-space:pre;width:3.01pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:427.26pt;position:absolute;text-decoration:none;white-space:pre;width:55.57pt">or appointed</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:482.83000000000004pt;letter-spacing:-0.004em;position:absolute;text-decoration:none;white-space:pre;width:3.01pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:485.84000000000003pt;position:absolute;text-decoration:none;white-space:pre;width:8.55pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:494.39pt;letter-spacing:-0.004em;position:absolute;text-decoration:none;white-space:pre;width:3.01pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:497.4pt;position:absolute;text-decoration:none;white-space:pre;width:37.25pt">serve on</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.65pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:384.83pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:162.43pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.59pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:165.02pt;position:absolute;text-decoration:none;white-space:pre;width:26.87pt">Board</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:191.89pt;letter-spacing:-0.04em;position:absolute;text-decoration:none;white-space:pre;width:2.49pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:194.38pt;position:absolute;text-decoration:none;white-space:pre;width:20.13pt">after</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:214.51pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.38pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:216.89pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:230.32pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.59pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:232.91pt;position:absolute;text-decoration:none;white-space:pre;width:40.27pt">Effective</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:273.18pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.59pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:275.77pt;position:absolute;text-decoration:none;white-space:pre;width:20.75pt">Date</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:296.52pt;letter-spacing:-0.04em;position:absolute;text-decoration:none;white-space:pre;width:2.49pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:299.01pt;position:absolute;text-decoration:none;white-space:pre;width:59.82pt">automatically</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:358.83000000000004pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.59pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:361.41999999999996pt;position:absolute;text-decoration:none;white-space:pre;width:20.76pt">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:382.18pt;letter-spacing:-0.04em;position:absolute;text-decoration:none;white-space:pre;width:2.49pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:384.66999999999996pt;position:absolute;text-decoration:none;white-space:pre;width:10.38pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:395.05pt;letter-spacing:-0.04em;position:absolute;text-decoration:none;white-space:pre;width:2.49pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:397.53999999999996pt;position:absolute;text-decoration:none;white-space:pre;width:32.97pt">granted</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:430.51pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.59pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:433.1pt;position:absolute;text-decoration:none;white-space:pre;width:4.88pt">a</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:437.98pt;letter-spacing:-0.04em;position:absolute;text-decoration:none;white-space:pre;width:2.49pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:440.47pt;position:absolute;text-decoration:none;white-space:pre;width:44.56pt">Restricted</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:485.03pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.59pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:487.62pt;position:absolute;text-decoration:none;white-space:pre;width:25.04pt">Stock</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:512.6600000000001pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.34pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:515pt;position:absolute;text-decoration:none;white-space:pre;width:19.54pt">Unit</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.54pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:398.03pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;text-decoration:none;white-space:pre;width:26.86pt">award</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:175.86pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.39pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:178.25pt;position:absolute;text-decoration:none;white-space:pre;width:19.54pt">with</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:197.79pt;letter-spacing:-0.036000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:200.34pt;position:absolute;text-decoration:none;white-space:pre;width:4.88pt">a</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:205.22pt;letter-spacing:-0.045em;position:absolute;text-decoration:none;white-space:pre;width:2.45pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:207.67000000000002pt;position:absolute;text-decoration:none;white-space:pre;width:23.81pt">value</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:231.48000000000002pt;letter-spacing:-0.036000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:234.03pt;position:absolute;text-decoration:none;white-space:pre;width:9.16pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:243.19pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:245.79000000000002pt;position:absolute;text-decoration:none;white-space:pre;width:41.25pt">$200,000</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:287.03999999999996pt;letter-spacing:-0.036000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:289.59000000000003pt;position:absolute;text-decoration:none;white-space:pre;width:17.09pt">(the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:306.68pt;letter-spacing:-0.045em;position:absolute;text-decoration:none;white-space:pre;width:2.45pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:309.13pt;position:absolute;text-decoration:none;white-space:pre;width:4.88pt">&#8220;</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:314.01pt;position:absolute;text-decoration:none;white-space:pre;width:28.09pt">Initial</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:342.1pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:344.7pt;position:absolute;text-decoration:none;white-space:pre;width:29.92pt">Equity</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:374.62pt;letter-spacing:-0.036000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:377.16999999999996pt;position:absolute;text-decoration:none;white-space:pre;width:29.94pt">Award</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:407.11pt;position:absolute;text-decoration:none;white-space:pre;width:11.29pt">&#8221;).</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:418.4pt;letter-spacing:0.11800000000000001em;position:absolute;text-decoration:none;white-space:pre;width:4.23pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:422.63pt;position:absolute;text-decoration:none;white-space:pre;width:17.09pt">The</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:439.72pt;letter-spacing:-0.036000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:442.27pt;position:absolute;text-decoration:none;white-space:pre;width:33.59pt">number</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:475.86pt;letter-spacing:-0.045em;position:absolute;text-decoration:none;white-space:pre;width:2.45pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:478.31pt;position:absolute;text-decoration:none;white-space:pre;width:9.16pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:487.47pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.6pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:490.07pt;position:absolute;text-decoration:none;white-space:pre;width:44.56pt">Restricted</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.63pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:411.23pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;text-decoration:none;white-space:pre;width:25.04pt">Stock</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:174.04pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.83pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:176.87pt;position:absolute;text-decoration:none;white-space:pre;width:23.82pt">Units</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:200.69pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:203.42000000000002pt;position:absolute;text-decoration:none;white-space:pre;width:31.14pt">subject</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:234.56pt;letter-spacing:-0.004em;position:absolute;text-decoration:none;white-space:pre;width:2.88pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:237.44pt;position:absolute;text-decoration:none;white-space:pre;width:8.55pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:245.99pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.83pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:248.82pt;position:absolute;text-decoration:none;white-space:pre;width:10.38pt">an</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:259.2pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.83pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:262.03pt;position:absolute;text-decoration:none;white-space:pre;width:26.24pt">Initial</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:288.27pt;letter-spacing:-0.004em;position:absolute;text-decoration:none;white-space:pre;width:2.88pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:291.15pt;position:absolute;text-decoration:none;white-space:pre;width:29.31pt">Equity</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:320.46000000000004pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.83pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:323.28999999999996pt;position:absolute;text-decoration:none;white-space:pre;width:29.92pt">Award</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:353.21000000000004pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.83pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:356.03999999999996pt;position:absolute;text-decoration:none;white-space:pre;width:17.09pt">will</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:373.13pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:375.86pt;position:absolute;text-decoration:none;white-space:pre;width:10.38pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:386.24pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:388.97pt;position:absolute;text-decoration:none;white-space:pre;width:49.45pt">determined</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:438.42pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.83pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:441.25pt;position:absolute;text-decoration:none;white-space:pre;width:11pt">by</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:452.25pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.83pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:455.08pt;position:absolute;text-decoration:none;white-space:pre;width:36.65pt">dividing</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:491.73pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.83pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:494.56pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:507.99pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.73pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:510.72pt;position:absolute;text-decoration:none;white-space:pre;width:23.81pt">value</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.53pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:424.43pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;text-decoration:none;white-space:pre;width:11pt">by</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:160pt;letter-spacing:-0.027em;position:absolute;text-decoration:none;white-space:pre;width:2.67pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:162.67pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:176.1pt;letter-spacing:-0.022em;position:absolute;text-decoration:none;white-space:pre;width:2.72pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:178.82pt;position:absolute;text-decoration:none;white-space:pre;width:71.43pt">30-calendar-day</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:250.25pt;letter-spacing:-0.027em;position:absolute;text-decoration:none;white-space:pre;width:2.67pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:252.92000000000002pt;position:absolute;text-decoration:none;white-space:pre;width:34.18pt">average</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:287.1pt;letter-spacing:-0.022em;position:absolute;text-decoration:none;white-space:pre;width:2.72pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:289.82pt;position:absolute;text-decoration:none;white-space:pre;width:31.76pt">closing</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:321.58000000000004pt;letter-spacing:-0.036000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.57pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:324.15pt;position:absolute;text-decoration:none;white-space:pre;width:21.97pt">price</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:346.12pt;letter-spacing:-0.022em;position:absolute;text-decoration:none;white-space:pre;width:2.72pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:348.84000000000003pt;position:absolute;text-decoration:none;white-space:pre;width:12.82pt">for</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:361.65999999999997pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.62pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:364.28pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:377.71000000000004pt;letter-spacing:-0.036000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.57pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:380.28pt;position:absolute;text-decoration:none;white-space:pre;width:50.7pt">Company&#8217;s</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:430.98pt;letter-spacing:-0.036000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.57pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:433.55pt;position:absolute;text-decoration:none;white-space:pre;width:38.48pt">common</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:472.03pt;letter-spacing:-0.036000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.57pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:474.6pt;position:absolute;text-decoration:none;white-space:pre;width:23.21pt">stock</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:497.81pt;letter-spacing:-0.036000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.57pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:500.38pt;position:absolute;text-decoration:none;white-space:pre;width:34.21pt">through</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.5899999999999pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:437.63pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;text-decoration:none;white-space:pre;width:385.53pt">and including the date prior to the applicable grant date (with any fractional Restricted</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.53pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:450.83pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;text-decoration:none;white-space:pre;width:270.35pt">Stock Units being rounded down to the next whole number).</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:419.35pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:3.11pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:422.46pt;position:absolute;text-decoration:none;white-space:pre;width:112.16pt">The Initial Equity Award</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.62pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:464.03pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;text-decoration:none;white-space:pre;width:385.61pt">shall be granted on the date on which such Eligible Director is appointed or elected to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.61pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:477.23pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;text-decoration:none;white-space:pre;width:385.64pt">serve on the Board, and shall vest as to one-third of the shares underlying the Initial</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.64pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:490.43pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;text-decoration:none;white-space:pre;width:235.51pt">Equity Award on each of the first three anniversaries</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:384.51pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:3.02pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:387.53pt;position:absolute;text-decoration:none;white-space:pre;width:147.12pt">of the applicable grant date, such</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.65pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:503.63pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;text-decoration:none;white-space:pre;width:385.58pt">that the Initial Equity Award is fully vested on the third anniversary of the grant date,</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.5799999999999pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:516.83pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;text-decoration:none;white-space:pre;width:31.14pt">subject</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:180.14pt;letter-spacing:-0.068em;position:absolute;text-decoration:none;white-space:pre;width:2.01pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:182.15pt;position:absolute;text-decoration:none;white-space:pre;width:8.55pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:190.7pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.06pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:192.76pt;position:absolute;text-decoration:none;white-space:pre;width:20.16pt">such</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:212.92000000000002pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.16pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:215.07999999999998pt;position:absolute;text-decoration:none;white-space:pre;width:34.79pt">Eligible</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:249.87pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.11pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:251.98000000000002pt;position:absolute;text-decoration:none;white-space:pre;width:44.56pt">Director&#8217;s</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:296.53999999999996pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.2pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:298.74pt;position:absolute;text-decoration:none;white-space:pre;width:43.36pt">continued</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:342.1pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.16pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:344.26pt;position:absolute;text-decoration:none;white-space:pre;width:31.13pt">service</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:375.39pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.06pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:377.45pt;position:absolute;text-decoration:none;white-space:pre;width:34.21pt">through</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:411.66pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.11pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:413.77pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:427.2pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.2pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:429.4pt;position:absolute;text-decoration:none;white-space:pre;width:45.17pt">applicable</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:474.57pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.06pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:476.63pt;position:absolute;text-decoration:none;white-space:pre;width:31.76pt">vesting</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:508.39pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.2pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:510.59pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:20.61pt">date.</font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:530.03pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.004em;white-space:pre"><font style="left:149pt;position:absolute;width:7.55pt">c.<font style="display:inline-block;height:7.62pt;width:28.4pt"></font></font></font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:184.95pt;position:absolute;text-decoration:underline;white-space:pre;width:32.37pt">Annual</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:217.32pt;letter-spacing:-0.04em;position:absolute;text-decoration:underline;white-space:pre;width:2.31pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:219.63pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:underline;white-space:pre;width:33.66pt">Awards</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:253.29000000000002pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.66pt">.</font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:542.63pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.031em;white-space:pre"><font style="left:179.1pt;position:absolute;width:5.12pt">i.<font style="display:inline-block;height:7.62pt;width:36.78pt"></font></font></font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:221pt;position:absolute;white-space:pre;width:313.22pt">An Eligible Director who is serving on the Board as of the date of the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.22pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:555.83pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;white-space:pre;width:238.24pt">annual meeting of the Company&#8217;s stockholders (the &#8220;</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:387.24pt;position:absolute;white-space:pre;width:74.7pt">Annual Meeting</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:461.94pt;position:absolute;white-space:pre;width:72.39pt">&#8221;) each calendar</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.3299999999999pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:569.03pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;white-space:pre;width:18.92pt">year</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:167.92000000000002pt;letter-spacing:0.181em;position:absolute;white-space:pre;width:4.74pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:172.66pt;position:absolute;white-space:pre;width:59.82pt">automatically</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:232.48000000000002pt;letter-spacing:0.181em;position:absolute;white-space:pre;width:4.74pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:237.22pt;position:absolute;white-space:pre;width:20.76pt">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:257.98pt;letter-spacing:0.177em;position:absolute;white-space:pre;width:4.69pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:262.67pt;position:absolute;white-space:pre;width:10.38pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:273.05pt;letter-spacing:0.17200000000000001em;position:absolute;white-space:pre;width:4.64pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:277.69pt;position:absolute;white-space:pre;width:32.97pt">granted</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:310.65999999999997pt;letter-spacing:0.177em;position:absolute;white-space:pre;width:4.69pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:315.35pt;position:absolute;white-space:pre;width:4.88pt">a</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:320.23pt;letter-spacing:0.181em;position:absolute;white-space:pre;width:4.74pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:324.97pt;position:absolute;white-space:pre;width:44.56pt">Restricted</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:369.53pt;letter-spacing:0.17200000000000001em;position:absolute;white-space:pre;width:4.64pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:374.16999999999996pt;position:absolute;white-space:pre;width:25.04pt">Stock</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:399.21000000000004pt;letter-spacing:0.17200000000000001em;position:absolute;white-space:pre;width:4.64pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:403.85pt;position:absolute;white-space:pre;width:19.54pt">Unit</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:423.39pt;letter-spacing:0.181em;position:absolute;white-space:pre;width:4.74pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:428.13pt;position:absolute;white-space:pre;width:26.86pt">award</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:454.99pt;letter-spacing:0.15em;position:absolute;white-space:pre;width:4.4pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:459.39pt;position:absolute;white-space:pre;width:19.54pt">with</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:478.93pt;letter-spacing:0.17200000000000001em;position:absolute;white-space:pre;width:4.64pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:483.57pt;position:absolute;white-space:pre;width:4.88pt">a</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:488.45pt;letter-spacing:0.17200000000000001em;position:absolute;white-space:pre;width:4.64pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:493.09pt;position:absolute;white-space:pre;width:23.81pt">value</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:516.9pt;letter-spacing:0.17200000000000001em;position:absolute;white-space:pre;width:4.64pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:521.54pt;position:absolute;white-space:pre;width:9.16pt">of</font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:582.23pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;text-decoration:none;white-space:pre;width:41.25pt">$200,000</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:136.25pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.18pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:138.43pt;position:absolute;text-decoration:none;white-space:pre;width:14.04pt">(an</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:152.47pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.18pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:154.65pt;position:absolute;text-decoration:none;white-space:pre;width:4.88pt">&#8220;</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:159.53pt;position:absolute;text-decoration:none;white-space:pre;width:39.71pt">Ongoing</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:199.24pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.18pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:201.42000000000002pt;position:absolute;text-decoration:none;white-space:pre;width:34.21pt">Annual</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:235.63pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.23pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:237.86pt;position:absolute;text-decoration:none;white-space:pre;width:29.94pt">Award</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:267.8pt;position:absolute;text-decoration:none;white-space:pre;width:11.29pt">&#8221;).</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:279.09000000000003pt;letter-spacing:0.04em;position:absolute;text-decoration:none;white-space:pre;width:3.31pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:282.4pt;position:absolute;text-decoration:none;white-space:pre;width:17.09pt">The</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:299.49pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.23pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:301.72pt;position:absolute;text-decoration:none;white-space:pre;width:33.59pt">number</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:335.31pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.18pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:337.49pt;position:absolute;text-decoration:none;white-space:pre;width:9.16pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:346.65pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.18pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:348.83000000000004pt;position:absolute;text-decoration:none;white-space:pre;width:44.56pt">Restricted</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:393.39pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.18pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:395.57pt;position:absolute;text-decoration:none;white-space:pre;width:25.04pt">Stock</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:420.61pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.23pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:422.84pt;position:absolute;text-decoration:none;white-space:pre;width:23.82pt">Units</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:446.66pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.18pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:448.84pt;position:absolute;text-decoration:none;white-space:pre;width:91.05pt">subject to an Annual</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:539.89pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:595.43pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;text-decoration:none;white-space:pre;width:444.95pt">Award will be determined by dividing the value by the 30-calendar-day average closing price for the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:539.95pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:608.63pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;text-decoration:none;white-space:pre;width:50.7pt">Company&#8217;s</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:145.7pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.52pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:148.22pt;position:absolute;text-decoration:none;white-space:pre;width:38.48pt">common</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:186.7pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.52pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:189.22pt;position:absolute;text-decoration:none;white-space:pre;width:23.21pt">stock</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:212.43pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.52pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:214.95pt;position:absolute;text-decoration:none;white-space:pre;width:34.21pt">through</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:249.16pt;letter-spacing:-0.022em;position:absolute;text-decoration:none;white-space:pre;width:2.62pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:251.78pt;position:absolute;text-decoration:none;white-space:pre;width:15.88pt">and</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:267.65999999999997pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.52pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:270.18pt;position:absolute;text-decoration:none;white-space:pre;width:41.53pt">including</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:311.71000000000004pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.52pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:314.23pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:327.65999999999997pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.52pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:330.18pt;position:absolute;text-decoration:none;white-space:pre;width:209.69pt">date prior to the applicable grant date (with any</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:539.87pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:621.83pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;text-decoration:none;white-space:pre;width:174.96pt">fractional Restricted Stock Units being </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:269.96000000000004pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:35.41pt">rounded</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:305.37pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.41pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:307.78pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:24.08pt">down</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:331.86pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.41pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:334.27pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:8.37pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:342.64pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.41pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:345.05pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:13.16pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:358.21pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.45pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:360.66pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:18.57pt">next</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:379.23pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.41pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:381.64pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:26.42pt">whole</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:408.06pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.41pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:410.47pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:39.28pt">number).</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:449.75pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.41pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:452.16pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:21.61pt">Each</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:473.77pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.45pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:476.22pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:31.83pt">Annual</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:508.05pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.41pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:510.46pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:29.47pt">Award</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:539.9300000000001pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.16pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:635.03pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:20.31pt">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:115.31pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:117.56pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:10.2pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:127.75999999999999pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.29pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:130.05pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:32.34pt">granted</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:162.39pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:164.64pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:10.82pt">on</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:175.45999999999998pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:177.70999999999998pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:13.16pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:190.87pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:193.12pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:29.68pt">date of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:222.8pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:225.05pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:13.16pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:238.21pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:240.46pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:44.27pt">applicable</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:284.73pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:286.98pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:31.83pt">Annual</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:318.81pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.29pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:321.1pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:36.01pt">Meeting</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:357.11pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:359.36pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:15.61pt">and</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:374.97pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:377.22pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:20.31pt">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:397.53pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:399.78pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:17.35pt">vest</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:417.13pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.29pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:419.42pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:8.37pt">in</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:427.79pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:430.04pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:14.9pt">full</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:444.94pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:447.19pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:10.82pt">on</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:458.01pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:460.26pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:13.16pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:473.42pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.29pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:475.71pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:27.43pt">earlier</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:503.14pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:505.39pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:8.37pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:513.76pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:516.01pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:23.97pt">occur</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:539.98pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.16pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:648.23pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:8.98pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:103.98pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:106.24pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:10.1pt">(i)</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:116.34pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.22pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:118.56pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:13.16pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:131.72pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.22pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:133.94pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:21.9pt">one- </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:155.84pt;position:absolute;text-decoration:none;white-space:pre;width:18.92pt">year</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:174.76pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:177.01999999999998pt;position:absolute;text-decoration:none;white-space:pre;width:63.26pt">anniversary of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:240.28pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:242.54pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:255.97pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.12pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:258.09000000000003pt;position:absolute;text-decoration:none;white-space:pre;width:45.17pt">applicable</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:303.26pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.22pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:305.48pt;position:absolute;text-decoration:none;white-space:pre;width:22.59pt">grant</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:328.07pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:330.33000000000004pt;position:absolute;text-decoration:none;white-space:pre;width:18.31pt">date</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:348.64pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.12pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:350.76pt;position:absolute;text-decoration:none;white-space:pre;width:15.88pt">and</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:366.64pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.12pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:368.76pt;position:absolute;text-decoration:none;white-space:pre;width:13.42pt">(ii)</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:382.18pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.22pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:384.4pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:397.83pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.12pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:399.95pt;position:absolute;text-decoration:none;white-space:pre;width:18.31pt">date</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:418.26pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:420.52pt;position:absolute;text-decoration:none;white-space:pre;width:9.16pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:429.68pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:431.94pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:445.37pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:447.63pt;position:absolute;text-decoration:none;white-space:pre;width:18.93pt">next</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:466.56pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:468.82pt;position:absolute;text-decoration:none;white-space:pre;width:32.37pt">Annual</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:501.19pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.17pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:503.36pt;position:absolute;text-decoration:none;white-space:pre;width:36.64pt">Meeting</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:540pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:661.43pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:41.94pt">following</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:136.94pt;letter-spacing:-0.068em;position:absolute;text-decoration:none;white-space:pre;width:2.01pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:138.95pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:13.16pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:152.11pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.06pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:154.17000000000002pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:22.14pt">grant</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:176.31pt;letter-spacing:-0.004em;position:absolute;text-decoration:none;white-space:pre;width:2.71pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:179.01999999999998pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:20.61pt">date,</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:199.63pt;letter-spacing:-0.013000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.61pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:202.24pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:30.51pt">subject</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:232.75pt;letter-spacing:-0.004em;position:absolute;text-decoration:none;white-space:pre;width:2.71pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:235.46pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:53.58pt">to continued</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:289.03999999999996pt;letter-spacing:-0.027em;position:absolute;text-decoration:none;white-space:pre;width:2.46pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:291.5pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:129.49pt">service through the applicable</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:420.99pt;letter-spacing:-0.013000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.61pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:423.6pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:31.13pt">vesting</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:454.73pt;letter-spacing:-0.022em;position:absolute;text-decoration:none;white-space:pre;width:2.51pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:457.24pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:20.61pt">date.</font></div></div></div><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt"><div style="position:absolute;top:778.32pt"><div style="width:468pt"></div></div><div style="position:absolute"><div style="width:468pt"></div></div><div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:84.78pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.031em;white-space:pre"><font style="left:179.95pt;position:absolute;width:7.83pt">ii.<font style="display:inline-block;height:7.62pt;width:28.02pt"></font></font></font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:215.79999999999998pt;position:absolute;white-space:pre;width:318.64pt">If an Eligible Director is elected or appointed to serve on the Board at</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.44pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:97.98pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;white-space:pre;width:15.88pt">any</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:164.88pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.84pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:167.72pt;position:absolute;white-space:pre;width:19.53pt">time</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:187.25pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.84pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:190.09pt;position:absolute;white-space:pre;width:22.59pt">other</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:212.68pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.74pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:215.42000000000002pt;position:absolute;white-space:pre;width:18.93pt">than</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:234.35pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.69pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:237.04000000000002pt;position:absolute;white-space:pre;width:7.93pt">at</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:244.97pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.74pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:247.70999999999998pt;position:absolute;white-space:pre;width:10.38pt">an</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:258.09000000000003pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.84pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:260.93pt;position:absolute;white-space:pre;width:32.37pt">Annual</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:293.3pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.74pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:296.03999999999996pt;position:absolute;white-space:pre;width:39.39pt">Meeting,</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:335.43pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.69pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:338.12pt;position:absolute;white-space:pre;width:20.16pt">such</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:358.28pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.69pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:360.97pt;position:absolute;white-space:pre;width:34.79pt">Eligible</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:395.76pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.84pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:398.6pt;position:absolute;white-space:pre;width:36.62pt">Director</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:435.22pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.74pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:437.96pt;position:absolute;white-space:pre;width:59.82pt">automatically</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:497.78pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.84pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:500.62pt;position:absolute;white-space:pre;width:20.76pt">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:521.38pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.74pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:524.12pt;position:absolute;white-space:pre;width:10.38pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.5pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:111.18pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;white-space:pre;width:32.97pt">granted</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:181.97pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.61pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:184.57999999999998pt;position:absolute;white-space:pre;width:4.88pt">a</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:189.46pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.61pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:192.07pt;position:absolute;white-space:pre;width:44.56pt">Restricted</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:236.63pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.61pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:239.24pt;position:absolute;white-space:pre;width:25.04pt">Stock</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:264.28pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.61pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:266.89pt;position:absolute;white-space:pre;width:19.54pt">Unit</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:286.43pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.66pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:289.09000000000003pt;position:absolute;white-space:pre;width:26.86pt">award</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:315.95pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.61pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:318.56pt;position:absolute;white-space:pre;width:8.54pt">(a</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:327.1pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.61pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:329.71000000000004pt;position:absolute;white-space:pre;width:4.88pt">&#8220;</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:334.59000000000003pt;position:absolute;white-space:pre;width:46.41pt">Pro-Rated</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:381pt;letter-spacing:-0.045em;position:absolute;white-space:pre;width:2.46pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:383.46000000000004pt;position:absolute;white-space:pre;width:34.21pt">Annual</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:417.67pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.66pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:420.33pt;position:absolute;white-space:pre;width:29.94pt">Award</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:450.27pt;position:absolute;white-space:pre;width:4.88pt">&#8221;</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:455.15pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.61pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:457.76pt;position:absolute;white-space:pre;width:15.88pt">and</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:473.64pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.61pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:476.25pt;position:absolute;white-space:pre;width:36.02pt">together</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:512.27pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.66pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:514.9300000000001pt;position:absolute;white-space:pre;width:19.54pt">with</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.47pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:124.38pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;white-space:pre;width:155.45pt">the Ongoing Annual Awards, the &#8220;</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:304.45pt;position:absolute;white-space:pre;width:71.61pt">Annual Awards</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:376.06pt;position:absolute;white-space:pre;width:158.48pt">&#8221;&#59; and the Annual Awards, together</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.54pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:137.58pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;white-space:pre;width:19.54pt">with</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:168.54pt;letter-spacing:-0.054em;position:absolute;white-space:pre;width:2.35pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:170.89pt;position:absolute;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:184.32pt;letter-spacing:-0.054em;position:absolute;white-space:pre;width:2.35pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:186.67000000000002pt;position:absolute;white-space:pre;width:26.24pt">Initial</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:212.91pt;letter-spacing:-0.05em;position:absolute;white-space:pre;width:2.39pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:215.3pt;position:absolute;white-space:pre;width:29.31pt">Equity</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:244.61pt;letter-spacing:-0.054em;position:absolute;white-space:pre;width:2.35pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:246.95999999999998pt;position:absolute;white-space:pre;width:32.67pt">Award,</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:279.63pt;letter-spacing:-0.054em;position:absolute;white-space:pre;width:2.35pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:281.98pt;position:absolute;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:295.40999999999997pt;letter-spacing:-0.05em;position:absolute;white-space:pre;width:2.39pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:297.8pt;position:absolute;white-space:pre;width:4.88pt">&#8220;</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:302.68pt;position:absolute;white-space:pre;width:37.86pt">Director</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:340.53999999999996pt;letter-spacing:-0.05em;position:absolute;white-space:pre;width:2.39pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:342.93pt;position:absolute;white-space:pre;width:29.92pt">Equity</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:372.85pt;letter-spacing:-0.063em;position:absolute;white-space:pre;width:2.25pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:375.1pt;position:absolute;white-space:pre;width:34.22pt">Awards</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:409.32pt;position:absolute;white-space:pre;width:11.29pt">&#8221;).</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:420.61pt;letter-spacing:-0.054em;position:absolute;white-space:pre;width:2.35pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:422.96pt;position:absolute;white-space:pre;width:17.09pt">The</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:440.05pt;letter-spacing:-0.054em;position:absolute;white-space:pre;width:2.35pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:442.4pt;position:absolute;white-space:pre;width:33.59pt">number</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:475.99pt;letter-spacing:-0.05em;position:absolute;white-space:pre;width:2.39pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:478.38pt;position:absolute;white-space:pre;width:9.16pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:487.54pt;letter-spacing:-0.05em;position:absolute;white-space:pre;width:2.39pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:489.93pt;position:absolute;white-space:pre;width:44.56pt">Restricted</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.49pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:150.78pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;white-space:pre;width:25.04pt">Stock</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:174.04pt;letter-spacing:-0.04em;position:absolute;white-space:pre;width:2.31pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:176.35pt;position:absolute;white-space:pre;width:23.82pt">Units</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:200.17000000000002pt;letter-spacing:-0.036000000000000004em;position:absolute;white-space:pre;width:2.36pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:202.53pt;position:absolute;white-space:pre;width:31.14pt">subject</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:233.67000000000002pt;letter-spacing:-0.04em;position:absolute;white-space:pre;width:2.31pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:235.98000000000002pt;position:absolute;white-space:pre;width:8.55pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:244.53pt;letter-spacing:-0.04em;position:absolute;white-space:pre;width:2.31pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:246.84pt;position:absolute;white-space:pre;width:4.88pt">a</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:251.72pt;letter-spacing:-0.036000000000000004em;position:absolute;white-space:pre;width:2.36pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:254.07999999999998pt;position:absolute;white-space:pre;width:44.57pt">Pro-Rated</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:298.65pt;letter-spacing:-0.036000000000000004em;position:absolute;white-space:pre;width:2.36pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:301.01pt;position:absolute;white-space:pre;width:32.37pt">Annual</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:333.38pt;letter-spacing:-0.036000000000000004em;position:absolute;white-space:pre;width:2.36pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:335.74pt;position:absolute;white-space:pre;width:29.92pt">Award</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:365.65999999999997pt;letter-spacing:-0.036000000000000004em;position:absolute;white-space:pre;width:2.36pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:368.02pt;position:absolute;white-space:pre;width:17.09pt">will</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:385.11pt;letter-spacing:-0.04em;position:absolute;white-space:pre;width:2.31pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:387.41999999999996pt;position:absolute;white-space:pre;width:10.38pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:397.8pt;letter-spacing:-0.04em;position:absolute;white-space:pre;width:2.31pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:400.11pt;position:absolute;white-space:pre;width:49.45pt">determined</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:449.56pt;letter-spacing:-0.036000000000000004em;position:absolute;white-space:pre;width:2.36pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:451.92pt;position:absolute;white-space:pre;width:11pt">by</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:462.92pt;letter-spacing:-0.036000000000000004em;position:absolute;white-space:pre;width:2.36pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:465.28pt;position:absolute;white-space:pre;width:51.3pt">multiplying</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:516.5799999999999pt;letter-spacing:-0.036000000000000004em;position:absolute;white-space:pre;width:2.36pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:518.94pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:12.1pt">(x)</font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:163.98pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:149pt;position:absolute;text-decoration:none;white-space:pre;width:385.51pt">$200,000, by (y) a fraction, the numerator of which is the remainder of 365 minus the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.51pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:177.18pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:148.95pt;position:absolute;text-decoration:none;white-space:pre;width:33.59pt">number</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:182.54pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.71pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:185.25pt;position:absolute;text-decoration:none;white-space:pre;width:9.16pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:194.41pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.71pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:197.12pt;position:absolute;text-decoration:none;white-space:pre;width:20.16pt">days</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:217.27999999999997pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.71pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:219.99pt;position:absolute;text-decoration:none;white-space:pre;width:36.63pt">between</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:256.62pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.56pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:259.18pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:272.61pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.71pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:275.32pt;position:absolute;text-decoration:none;white-space:pre;width:55.57pt">adjournment</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:330.89pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.71pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:333.6pt;position:absolute;text-decoration:none;white-space:pre;width:9.16pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:342.76pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.71pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:345.47pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:358.9pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.56pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:361.46pt;position:absolute;text-decoration:none;white-space:pre;width:15.26pt">last</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:376.72pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.71pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:379.42999999999995pt;position:absolute;text-decoration:none;white-space:pre;width:32.37pt">Annual</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:411.8pt;letter-spacing:-0.027em;position:absolute;text-decoration:none;white-space:pre;width:2.61pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:414.40999999999997pt;position:absolute;text-decoration:none;white-space:pre;width:36.64pt">Meeting</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:451.05pt;letter-spacing:-0.022em;position:absolute;text-decoration:none;white-space:pre;width:2.66pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:453.71pt;position:absolute;text-decoration:none;white-space:pre;width:15.88pt">and</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:469.59pt;letter-spacing:-0.022em;position:absolute;text-decoration:none;white-space:pre;width:2.66pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:472.25pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:485.68pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.71pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:488.39pt;position:absolute;text-decoration:none;white-space:pre;width:18.31pt">date</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:506.7pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.56pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:509.26pt;position:absolute;text-decoration:none;white-space:pre;width:9.16pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:518.4200000000001pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.71pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:521.13pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.56pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:190.38pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:148.95pt;position:absolute;text-decoration:none;white-space:pre;width:385.65pt">election or appointment, and the denominator of which is 365, and then dividing the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.5999999999999pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:203.58pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:148.95pt;position:absolute;text-decoration:none;white-space:pre;width:317.02pt">value by the 30-calendar-day average closing price for the Company&#8217;s</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:465.96999999999997pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:3.52pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:469.49pt;position:absolute;text-decoration:none;white-space:pre;width:38.48pt">common</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:507.96999999999997pt;letter-spacing:-0.022em;position:absolute;text-decoration:none;white-space:pre;width:3.37pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:511.34pt;position:absolute;text-decoration:none;white-space:pre;width:23.21pt">stock</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.55pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:216.78pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:148.95pt;position:absolute;text-decoration:none;white-space:pre;width:385.58pt">through and including the date prior to the applicable grant date (with any fractional</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.53pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:229.98pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:148.95pt;position:absolute;text-decoration:none;white-space:pre;width:44.56pt">Restricted</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:193.51pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:195.76999999999998pt;position:absolute;text-decoration:none;white-space:pre;width:25.04pt">Stock</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:220.81pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.36pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:223.17pt;position:absolute;text-decoration:none;white-space:pre;width:23.82pt">Units</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:246.99pt;letter-spacing:-0.045em;position:absolute;text-decoration:none;white-space:pre;width:2.46pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:249.45pt;position:absolute;text-decoration:none;white-space:pre;width:24.43pt">being</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:273.88pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.4pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:276.28pt;position:absolute;text-decoration:none;white-space:pre;width:36.04pt">rounded</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:312.32pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.4pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:314.72pt;position:absolute;text-decoration:none;white-space:pre;width:24.44pt">down</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:339.15999999999997pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.31pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:341.47pt;position:absolute;text-decoration:none;white-space:pre;width:8.55pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:350.02pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.31pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:352.33pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:365.76pt;letter-spacing:-0.045em;position:absolute;text-decoration:none;white-space:pre;width:2.46pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:368.22pt;position:absolute;text-decoration:none;white-space:pre;width:18.93pt">next</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:387.15pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.36pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:389.51pt;position:absolute;text-decoration:none;white-space:pre;width:26.87pt">whole</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:416.38pt;letter-spacing:-0.045em;position:absolute;text-decoration:none;white-space:pre;width:2.46pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:418.84pt;position:absolute;text-decoration:none;white-space:pre;width:40pt">number).</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:458.84pt;letter-spacing:0.363em;position:absolute;text-decoration:none;white-space:pre;width:6.94pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:465.78pt;position:absolute;text-decoration:none;white-space:pre;width:21.97pt">Each</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:487.75pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:490.01pt;position:absolute;text-decoration:none;white-space:pre;width:44.57pt">Pro-Rated</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.5799999999999pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:243.18pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:148.95pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:31.83pt">Annual</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:180.77999999999997pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:183.04pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:29.47pt">Award</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:212.51pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:214.76999999999998pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:20.31pt">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:235.07999999999998pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:237.33999999999997pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:10.2pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:247.54pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.3pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:249.83999999999997pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:32.34pt">granted</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:282.17999999999995pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:284.44pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:10.82pt">on</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:295.26pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:297.52pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:13.16pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:310.67999999999995pt;letter-spacing:-0.054em;position:absolute;text-decoration:none;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:312.94pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:17.95pt">date</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:330.89pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.3pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:333.19pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:8.98pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:342.16999999999996pt;letter-spacing:-0.05em;position:absolute;text-decoration:none;white-space:pre;width:2.3pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:344.47pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:19.8pt">such</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:364.27pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.66pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:366.92999999999995pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:44.27pt">applicable</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:411.2pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.66pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:413.86pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:34.07pt">election</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:447.93pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.66pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:450.59pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:8.98pt">or</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:459.57pt;letter-spacing:-0.013000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.71pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:462.28pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:53.97pt">appointment</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:516.25pt;letter-spacing:-0.013000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.71pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:518.96pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:15.61pt">and</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.5699999999999pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.66pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:256.38pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:148.95pt;position:absolute;text-decoration:none;white-space:pre;width:20.76pt">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:169.70999999999998pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.77pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:172.48pt;position:absolute;text-decoration:none;white-space:pre;width:17.71pt">vest</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:190.19pt;letter-spacing:0.181em;position:absolute;text-decoration:none;white-space:pre;width:4.95pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:195.14pt;position:absolute;text-decoration:none;white-space:pre;width:8.55pt">in</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:203.69pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.62pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:206.31pt;position:absolute;text-decoration:none;white-space:pre;width:15.26pt">full</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:221.57pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.77pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:224.33999999999997pt;position:absolute;text-decoration:none;white-space:pre;width:11pt">on</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:235.33999999999997pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.87pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:238.20999999999998pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:251.64pt;letter-spacing:-0.031em;position:absolute;text-decoration:none;white-space:pre;width:2.62pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:254.26pt;position:absolute;text-decoration:none;white-space:pre;width:28.06pt">earlier</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:282.32pt;letter-spacing:-0.027em;position:absolute;text-decoration:none;white-space:pre;width:2.67pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:284.99pt;position:absolute;text-decoration:none;white-space:pre;width:8.55pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:293.53999999999996pt;letter-spacing:-0.022em;position:absolute;text-decoration:none;white-space:pre;width:2.72pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:296.26pt;position:absolute;text-decoration:none;white-space:pre;width:24.42pt">occur</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:320.67999999999995pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.77pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:323.45pt;position:absolute;text-decoration:none;white-space:pre;width:9.16pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:332.61pt;letter-spacing:-0.027em;position:absolute;text-decoration:none;white-space:pre;width:2.67pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:335.28pt;position:absolute;text-decoration:none;white-space:pre;width:10.37pt">(i)</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:345.65pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.77pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:348.41999999999996pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:361.85pt;letter-spacing:-0.018000000000000002em;position:absolute;text-decoration:none;white-space:pre;width:2.77pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:364.62pt;position:absolute;text-decoration:none;white-space:pre;width:38.46pt">one-year</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:403.08pt;letter-spacing:-0.027em;position:absolute;text-decoration:none;white-space:pre;width:2.67pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:405.75pt;position:absolute;text-decoration:none;white-space:pre;width:63.41pt">anniversary of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:469.15999999999997pt;letter-spacing:-0.027em;position:absolute;text-decoration:none;white-space:pre;width:2.67pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:471.83pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:485.26pt;letter-spacing:-0.04em;position:absolute;text-decoration:none;white-space:pre;width:2.52pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:487.78pt;position:absolute;text-decoration:none;white-space:pre;width:46.82pt">date of the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.5999999999999pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:269.58pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:148.95pt;position:absolute;text-decoration:none;white-space:pre;width:15.26pt">last</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:164.20999999999998pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.13pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:166.33999999999997pt;position:absolute;text-decoration:none;white-space:pre;width:32.37pt">Annual</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:198.70999999999998pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.13pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:200.83999999999997pt;position:absolute;text-decoration:none;white-space:pre;width:36.64pt">Meeting</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:237.48pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.13pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:239.60999999999999pt;position:absolute;text-decoration:none;white-space:pre;width:43.35pt">preceding</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:282.96pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.18pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:285.14pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:298.57pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.13pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:300.7pt;position:absolute;text-decoration:none;white-space:pre;width:22.59pt">grant</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:323.28999999999996pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.13pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:325.41999999999996pt;position:absolute;text-decoration:none;white-space:pre;width:18.31pt">date</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:343.73pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.13pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:345.86pt;position:absolute;text-decoration:none;white-space:pre;width:15.88pt">and</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:361.74pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.18pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:363.91999999999996pt;position:absolute;text-decoration:none;white-space:pre;width:13.42pt">(ii)</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:377.34pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.13pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:379.47pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:392.9pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.13pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:395.03pt;position:absolute;text-decoration:none;white-space:pre;width:18.31pt">date</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:413.34pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.13pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:415.46999999999997pt;position:absolute;text-decoration:none;white-space:pre;width:9.16pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:424.63pt;letter-spacing:-0.059000000000000004em;position:absolute;text-decoration:none;white-space:pre;width:2.18pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:426.81pt;position:absolute;text-decoration:none;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:440.24pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.13pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:442.37pt;position:absolute;text-decoration:none;white-space:pre;width:18.93pt">next</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:461.3pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.13pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:463.43pt;position:absolute;text-decoration:none;white-space:pre;width:32.37pt">Annual</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:495.8pt;letter-spacing:-0.063em;position:absolute;text-decoration:none;white-space:pre;width:2.13pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:497.93pt;position:absolute;text-decoration:none;white-space:pre;width:36.64pt">Meeting</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.5699999999999pt;position:absolute;text-decoration:none;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:282.78pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:148.95pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:41.94pt">following</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:190.89pt;letter-spacing:-0.068em;position:absolute;text-decoration:none;white-space:pre;width:2.01pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:192.89999999999998pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:13.16pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:206.06pt;letter-spacing:-0.068em;position:absolute;text-decoration:none;white-space:pre;width:2.01pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:208.07pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:22.14pt">grant</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:230.20999999999998pt;letter-spacing:-0.004em;position:absolute;text-decoration:none;white-space:pre;width:2.71pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:232.92pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:110.02pt">date, subject to continued</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:342.94pt;letter-spacing:-0.013000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.61pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:345.54999999999995pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:82.56pt">service through the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:428.11pt;letter-spacing:-0.013000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:2.61pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:430.71999999999997pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:78.06pt">applicable vesting</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:508.78pt;letter-spacing:-0.027em;position:absolute;text-decoration:none;white-space:pre;width:2.46pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:511.24pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:none;white-space:pre;width:20.61pt">date.</font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:309.18pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.004em;white-space:pre"><font style="left:149pt;position:absolute;width:8.17pt">d.<font style="display:inline-block;height:7.62pt;width:27.68pt"></font></font></font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:184.85pt;position:absolute;text-decoration:underline;white-space:pre;width:131.06pt">Accelerated Vesting Events</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:315.90999999999997pt;position:absolute;white-space:pre;width:2.75pt">.</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:318.65999999999997pt;letter-spacing:0.181em;position:absolute;white-space:pre;width:9.22pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:327.88pt;position:absolute;white-space:pre;width:206.31pt">Notwithstanding the foregoing, an Eligible</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.19pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:322.38pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:43.66pt">Director&#8217;s</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:138.66pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.66pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:141.32pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:35.9pt">Director</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:177.22pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.56pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:179.78pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:28.77pt">Equity</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:208.55pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.51pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:211.06pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:40.8pt">Award(s)</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:251.86pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.66pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:254.52pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:20.31pt">shall</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:274.83000000000004pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.56pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:277.39pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:17.35pt">vest</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:294.74pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.56pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:297.3pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:8.37pt">in</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:305.66999999999996pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.51pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:308.18pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:14.9pt">full</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:323.08000000000004pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.66pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:325.74pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:53.95pt">immediately</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:379.69pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.51pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:382.2pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:20.92pt">prior</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:403.12pt;letter-spacing:-0.027em;position:absolute;white-space:pre;width:2.56pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:405.68pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:8.37pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:414.05pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.61pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:416.66pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:13.16pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:429.82pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.51pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:432.33pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:47.32pt">occurrence</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:479.65pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.51pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:482.16pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:8.98pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:491.14pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.66pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:493.8pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:4.79pt">a</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:498.59pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.51pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:501.1pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:33.05pt">Change</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.15pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.66pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:335.58pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:8.55pt">in</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:103.55pt;letter-spacing:-0.045em;position:absolute;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:105.81pt;position:absolute;white-space:pre;width:36.34pt">Control,</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:142.15pt;letter-spacing:-0.045em;position:absolute;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:144.41pt;position:absolute;white-space:pre;width:22.59pt">other</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:167pt;letter-spacing:-0.05em;position:absolute;white-space:pre;width:2.2pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:169.2pt;position:absolute;white-space:pre;width:18.93pt">than</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:188.13pt;letter-spacing:-0.054em;position:absolute;white-space:pre;width:2.16pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:190.29000000000002pt;position:absolute;white-space:pre;width:4.88pt">a</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:195.17000000000002pt;letter-spacing:-0.04em;position:absolute;white-space:pre;width:2.31pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:197.48000000000002pt;position:absolute;white-space:pre;width:82.42pt">Non-Transactional</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:279.9pt;letter-spacing:-0.04em;position:absolute;white-space:pre;width:2.31pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:282.21000000000004pt;position:absolute;white-space:pre;width:33.59pt">Change</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:315.8pt;letter-spacing:-0.05em;position:absolute;white-space:pre;width:2.2pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:318pt;position:absolute;white-space:pre;width:8.55pt">in</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:326.55pt;letter-spacing:-0.045em;position:absolute;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:328.81pt;position:absolute;white-space:pre;width:36.34pt">Control,</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:365.15pt;letter-spacing:-0.054em;position:absolute;white-space:pre;width:2.16pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:367.31pt;position:absolute;white-space:pre;width:8.55pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:375.86pt;letter-spacing:-0.045em;position:absolute;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:378.12pt;position:absolute;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:391.55pt;letter-spacing:-0.04em;position:absolute;white-space:pre;width:2.31pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:393.86pt;position:absolute;white-space:pre;width:26.86pt">extent</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:420.72pt;letter-spacing:-0.04em;position:absolute;white-space:pre;width:2.31pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:423.03pt;position:absolute;white-space:pre;width:51.31pt">outstanding</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:474.34pt;letter-spacing:-0.045em;position:absolute;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:476.6pt;position:absolute;white-space:pre;width:7.93pt">at</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:484.53pt;letter-spacing:-0.04em;position:absolute;white-space:pre;width:2.31pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:486.84pt;position:absolute;white-space:pre;width:20.16pt">such</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:507pt;letter-spacing:-0.045em;position:absolute;white-space:pre;width:2.26pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:509.26pt;position:absolute;white-space:pre;width:22.28pt">time.</font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:362.03pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.004em;white-space:pre"><font style="left:149pt;position:absolute;width:7.55pt">e.<font style="display:inline-block;height:7.62pt;width:28.3pt"></font></font></font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:184.85pt;position:absolute;text-decoration:underline;white-space:pre;width:39.06pt">Deferred</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:223.91pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:underline;white-space:pre;width:3.04pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:226.95pt;position:absolute;text-decoration:underline;white-space:pre;width:63.52pt">Compensation</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:290.47pt;letter-spacing:-0.009000000000000001em;position:absolute;text-decoration:underline;white-space:pre;width:3.04pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:293.51pt;position:absolute;text-decoration:underline;white-space:pre;width:19.54pt">Plan</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:313.05pt;position:absolute;white-space:pre;width:2.75pt">.</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:315.8pt;letter-spacing:0.363em;position:absolute;white-space:pre;width:7.12pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:322.91999999999996pt;position:absolute;white-space:pre;width:76.38pt">Eligible directors</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:399.3pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:3.04pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:402.34000000000003pt;position:absolute;white-space:pre;width:18.93pt">may</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:421.27pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:3.04pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:424.31pt;position:absolute;white-space:pre;width:20.74pt">elect</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:445.05pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:3.04pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:448.09pt;position:absolute;white-space:pre;width:8.55pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:456.64pt;letter-spacing:-0.004em;position:absolute;white-space:pre;width:3.09pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:459.73pt;position:absolute;white-space:pre;width:46.38pt">participate</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:506.11pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:3.04pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:509.15pt;position:absolute;white-space:pre;width:8.55pt">in</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:517.7pt;letter-spacing:-0.004em;position:absolute;white-space:pre;width:3.09pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:520.79pt;position:absolute;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.22pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:375.23pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:283.51pt">Company&#8217;s Deferred Compensation Plan for Directors (the &#8220;</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:italic;font-weight:bold;left:378.51pt;position:absolute;white-space:pre;width:21.98pt">DCP</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:400.49pt;position:absolute;white-space:pre;width:133.69pt">&#8221;) pursuant to the terms and</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.1800000000001pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:388.43pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:95pt;position:absolute;white-space:pre;width:234.48pt">conditions of the DCP, as in effect from time to time.</font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:422.68pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.004em;white-space:pre"><font style="left:113pt;position:absolute;width:8.17pt">3.<font style="display:inline-block;height:7.62pt;width:27.67pt"></font></font></font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:148.84pt;position:absolute;text-decoration:underline;white-space:pre;width:96.43pt">Compensation Limits</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:245.27pt;position:absolute;white-space:pre;width:2.75pt">.</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:248.02pt;letter-spacing:0.181em;position:absolute;white-space:pre;width:6.21pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:254.23pt;position:absolute;white-space:pre;width:280.16pt">Notwithstanding anything to the contrary in this Program, all</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.39pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:435.88pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:77pt;position:absolute;white-space:pre;width:61.07pt">compensation</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:138.07pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.8pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:140.87pt;position:absolute;white-space:pre;width:34.19pt">payable</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:175.06pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.7pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:177.76pt;position:absolute;white-space:pre;width:25.04pt">under</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:202.8pt;letter-spacing:-0.004em;position:absolute;white-space:pre;width:2.85pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:205.65pt;position:absolute;white-space:pre;width:15.88pt">this</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:221.53pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.7pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:224.23pt;position:absolute;white-space:pre;width:37.86pt">Program</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:262.09000000000003pt;letter-spacing:-0.004em;position:absolute;white-space:pre;width:2.85pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:264.94pt;position:absolute;white-space:pre;width:17.09pt">will</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:282.03pt;letter-spacing:-0.004em;position:absolute;white-space:pre;width:2.85pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:284.88pt;position:absolute;white-space:pre;width:10.38pt">be</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:295.26pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre;width:2.8pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:298.06pt;position:absolute;white-space:pre;width:31.14pt">subject</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:329.2pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.7pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:331.9pt;position:absolute;white-space:pre;width:8.55pt">to</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:340.45pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.65pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:343.1pt;position:absolute;white-space:pre;width:15.88pt">any</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:358.98pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.65pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:361.63pt;position:absolute;white-space:pre;width:25.03pt">limits</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:386.66pt;letter-spacing:-0.018000000000000002em;position:absolute;white-space:pre;width:2.7pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:389.36pt;position:absolute;white-space:pre;width:11pt">on</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:400.36pt;letter-spacing:-0.022em;position:absolute;white-space:pre;width:2.65pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:403.01pt;position:absolute;white-space:pre;width:13.43pt">the</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:416.44pt;letter-spacing:-0.031em;position:absolute;white-space:pre;width:2.55pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:418.99pt;position:absolute;white-space:pre;width:44.58pt">maximum</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:463.57pt;letter-spacing:-0.004em;position:absolute;white-space:pre;width:2.85pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:466.42pt;position:absolute;white-space:pre;width:32.98pt">amount</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:499.4pt;letter-spacing:-0.004em;position:absolute;white-space:pre;width:2.85pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:502.25pt;position:absolute;white-space:pre;width:9.16pt">of</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:511.41pt;letter-spacing:-0.004em;position:absolute;white-space:pre;width:2.85pt"> </font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:514.26pt;position:absolute;white-space:pre;width:20.16pt">non-</font><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:534.4200000000001pt;position:absolute;white-space:pre;width:2.75pt"> </font></div><div style="line-height:7.62pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:449.08pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:77pt;position:absolute;white-space:pre;width:403.29pt">employee Director compensation set forth in the Equity Plan, as in effect from time to time.</font></div><div style="line-height:7.62pt;position:absolute;top:474.13pt;width:612pt"><font style="font-family:&#39;Times New Roman&#39;, serif;font-size:11pt;font-style:normal;font-weight:normal;left:292.47pt;letter-spacing:-0.009000000000000001em;position:absolute;white-space:pre">*****</font></div></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>gdrxq226-ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head><title>GDRX Q2&#39;26 - EX31.1</title></head><body><div style="background-color:#E4E4E4;font-family:Arial, sans-serif;word-wrap:break-word"><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt"><div style="position:absolute;top:747pt"><div style="width:495pt"></div></div><div style="position:absolute"><div style="width:495pt"></div></div><div><div id="iaf693a52cc3347b390b8ff6da266d3e5_1" style="position:absolute;top:45pt"></div><div style="line-height:6.55pt;position:absolute;top:45pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:503.53pt;position:absolute;white-space:pre">Exhibit 31.1</font></div><div style="line-height:6.55pt;position:absolute;top:67.8pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:271.29pt;position:absolute;white-space:pre">CERTIFICATION </font></div><div style="line-height:6.55pt;position:absolute;top:90.6pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;white-space:pre">I, Wendy Barnes, certify that&#58;</font></div><div style="line-height:6.55pt;position:absolute;top:113.4pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;white-space:pre">1.</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre">I have reviewed this Quarterly Report on Form 10-Q of GoodRx Holdings, Inc.&#59;</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:136.2pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;white-space:pre;width:7.5pt">2.</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:458.84pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:147pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:458.88pt">material fact necessary to make the statements made, in light of the circumstances under which such statements</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:157.8pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:301.84pt">were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:180.6pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;white-space:pre;width:7.5pt">3.</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:458.91pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:191.4pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:458.89pt">present in all material respects the financial condition, results of operations and cash flows of the registrant as of,</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:202.2pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:173.93pt">and for, the periods presented in this report&#59;</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:225pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;white-space:pre;width:7.5pt">4.</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:458.92pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:235.8pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:458.98pt">and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:246.6pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:383.32pt">reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:269.4pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:10.98pt">(a)</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.97pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:280.2pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.92pt">be designed under our supervision, to ensure that material information relating to the registrant, including</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:291pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.87pt">its consolidated subsidiaries, is made known to us by others within those entities, particularly during the</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:301.8pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:176.88pt">period in which this report is being prepared&#59;</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:324.6pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:10.98pt">(b)</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:423pt">Designed such internal control over financial reporting, or caused such internal control over financial</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:335.4pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.98pt">reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:346.2pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.89pt">of financial reporting and the preparation of financial statements for external purposes in accordance with</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:357pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:164.42pt">generally accepted accounting principles&#59;</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:379.8pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:10.48pt">(c)</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.93pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:390.6pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.97pt">report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:401.4pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:253.42pt">the period covered by this report based on such evaluation&#59; and</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:424.2pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:10.98pt">(d)</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.98pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:435pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.91pt">during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:445.8pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.93pt">annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:456.6pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:172.38pt">internal control over financial reporting&#59; and</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:479.4pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;white-space:pre;width:7.5pt">5.</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:459pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:490.2pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:458.99pt">over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:501pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:179.91pt">persons performing the equivalent functions)&#58;</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:523.8pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:10.98pt">(a)</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.96pt">All significant deficiencies and material weaknesses in the design or operation of internal control over</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:534.6pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:423pt">financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process,</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:545.4pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:189.87pt">summarize and report financial information&#59; and</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:568.2pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:10.98pt">(b)</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:423pt">Any fraud, whether or not material, that involves management or other employees who have a significant</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:579pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:243.15pt">role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="position:absolute;top:601.8pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:absolute;width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tr style="height:0"><td style="padding:0;width:235.5pt"></td><td style="padding:0;width:24.75pt"></td><td style="padding:0;width:234.75pt"></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:absolute;width:235.5pt"><div><div style="font-size:12pt;line-height:6.55pt;position:absolute;top:4.31pt;width:235.5pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:absolute;white-space:pre">Date&#58; </font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:26.13pt;position:absolute;text-decoration:none;white-space:pre">August&#160;5, 2026</font></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:235.5pt;position:absolute;width:24.75pt"><div><div style="line-height:6.55pt;position:absolute;top:4.31pt;width:24.75pt"><font style="color:#000000;font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:absolute;text-decoration:none;white-space:pre">By&#58;</font></div></div></div></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:260.25pt;position:absolute;width:234.75pt"><div><div style="line-height:6.55pt;position:absolute;top:4.31pt;width:234.75pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:81.96pt;position:absolute;white-space:pre">&#47;s&#47; Wendy Barnes</font></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:260.25pt;position:absolute;top:14.25pt;width:234.75pt"><div><div style="line-height:6.55pt;position:absolute;top:4.31pt;width:234.75pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:87.96pt;position:absolute;white-space:pre">Wendy Barnes</font></div></div></div></td></tr><tr style="height:24.75pt"><td style="font-size:0;text-align:left;vertical-align:top"></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:260.25pt;position:absolute;top:28.5pt;width:234.75pt"><div><div style="line-height:6.55pt;position:absolute;top:4.04pt;width:234.75pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:47.24pt;position:absolute;white-space:pre">Chief Executive Officer &#38; President</font></div><div style="line-height:6.55pt;position:absolute;top:14.84pt;width:234.75pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:61.92pt;position:absolute;white-space:pre">(Principal Executive Officer)</font></div></div></div></td></tr></table></div></div></div></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>gdrxq226-ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head><title>GDRX Q2&#39;26 - EX31.2</title></head><body><div style="background-color:#E4E4E4;font-family:Arial, sans-serif;word-wrap:break-word"><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt"><div style="position:absolute;top:747pt"><div style="width:495pt"></div></div><div style="position:absolute"><div style="width:495pt"></div></div><div><div id="i5eb5b0f648d544dd98b2c032259cb14b_1" style="position:absolute;top:45pt"></div><div style="line-height:6.55pt;position:absolute;top:45pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:501.03pt;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:503.53pt;position:absolute;white-space:pre">Exhibit 31.2</font></div><div style="line-height:6.55pt;position:absolute;top:67.8pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:271.29pt;position:absolute;white-space:pre">CERTIFICATION </font></div><div style="line-height:6.55pt;position:absolute;top:90.6pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;white-space:pre">I, Christopher McGinnis, certify that&#58;</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:113.4pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;white-space:pre;width:7.5pt">1.</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:311.83pt">I have reviewed this Quarterly Report on Form 10-Q of GoodRx Holdings, Inc.&#59;</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:136.2pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;white-space:pre;width:7.5pt">2.</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:458.84pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:147pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:458.88pt">material fact necessary to make the statements made, in light of the circumstances under which such statements</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:157.8pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:301.84pt">were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:180.6pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;white-space:pre;width:7.5pt">3.</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:458.91pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:191.4pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:458.89pt">present in all material respects the financial condition, results of operations and cash flows of the registrant as of,</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:202.2pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:173.93pt">and for, the periods presented in this report&#59;</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:225pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;white-space:pre;width:7.5pt">4.</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:458.92pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:235.8pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:458.98pt">and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:246.6pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:383.32pt">reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:269.4pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:10.98pt">(a)</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.97pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:280.2pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.92pt">be designed under our supervision, to ensure that material information relating to the registrant, including</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:291pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.87pt">its consolidated subsidiaries, is made known to us by others within those entities, particularly during the</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:301.8pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:176.88pt">period in which this report is being prepared&#59;</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:324.6pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:10.98pt">(b)</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:423pt">Designed such internal control over financial reporting, or caused such internal control over financial</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:335.4pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.98pt">reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:346.2pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.89pt">of financial reporting and the preparation of financial statements for external purposes in accordance with</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:357pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:164.42pt">generally accepted accounting principles&#59;</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:379.8pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:10.48pt">(c)</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.93pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:390.6pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.97pt">report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:401.4pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:253.42pt">the period covered by this report based on such evaluation&#59; and</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:424.2pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:10.98pt">(d)</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.98pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:435pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.91pt">during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:445.8pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.93pt">annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:456.6pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:172.38pt">internal control over financial reporting&#59; and</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:479.4pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;white-space:pre;width:7.5pt">5.</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:459pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:490.2pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:458.99pt">over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:501pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:179.91pt">persons performing the equivalent functions)&#58;</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:523.8pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:10.98pt">(a)</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:422.96pt">All significant deficiencies and material weaknesses in the design or operation of internal control over</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:534.6pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:423pt">financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process,</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:545.4pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:189.87pt">summarize and report financial information&#59; and</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:568.2pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:10.98pt">(b)</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:423pt">Any fraud, whether or not material, that involves management or other employees who have a significant</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:579pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:130.5pt;position:absolute;white-space:pre;width:243.15pt">role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="position:absolute;top:601.8pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:absolute;width:494.25pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tr style="height:0"><td style="padding:0;width:234.75pt"></td><td style="padding:0;width:24.75pt"></td><td style="padding:0;width:234.75pt"></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:absolute;width:234.75pt"><div><div style="font-size:12pt;line-height:6.55pt;position:absolute;top:4.31pt;width:234.75pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:absolute;white-space:pre">Date&#58; </font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:26.13pt;position:absolute;text-decoration:none;white-space:pre">August&#160;5, 2026</font></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:234.75pt;position:absolute;width:24.75pt"><div><div style="line-height:6.55pt;position:absolute;top:4.31pt;width:24.75pt"><font style="color:#000000;font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:absolute;text-decoration:none;white-space:pre">By&#58;</font></div></div></div></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:259.5pt;position:absolute;width:234.75pt"><div><div style="line-height:6.55pt;position:absolute;top:4.31pt;width:234.75pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:68.16pt;position:absolute;white-space:pre">&#47;s&#47; Christopher McGinnis</font></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:absolute;top:14.25pt;width:234.75pt"><div><div style="line-height:6.55pt;position:absolute;top:4.31pt;width:234.75pt"><font style="color:#000000;font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:absolute;text-decoration:none;white-space:pre"> </font></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:234.75pt;position:absolute;top:14.25pt;width:24.75pt"><div><div style="line-height:6.55pt;position:absolute;top:4.31pt;width:24.75pt"><font style="color:#000000;font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:absolute;text-decoration:none;white-space:pre"> </font></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:259.5pt;position:absolute;top:14.25pt;width:234.75pt"><div><div style="line-height:6.55pt;position:absolute;top:4.31pt;width:234.75pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:74.16pt;position:absolute;white-space:pre">Christopher McGinnis</font></div></div></div></td></tr><tr style="height:24.75pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:absolute;top:28.5pt;width:234.75pt"><div><div style="line-height:6.55pt;position:absolute;top:14.81pt;width:234.75pt"><font style="color:#000000;font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:absolute;text-decoration:none;white-space:pre"> </font></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:234.75pt;position:absolute;top:28.5pt;width:24.75pt"><div><div style="line-height:6.55pt;position:absolute;top:14.81pt;width:24.75pt"><font style="color:#000000;font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:absolute;text-decoration:none;white-space:pre"> </font></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:259.5pt;position:absolute;top:28.5pt;width:234.75pt"><div><div style="line-height:6.55pt;position:absolute;top:4.04pt;width:234.75pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:48.51pt;position:absolute;white-space:pre">Chief Financial Officer &#38; Treasurer</font></div><div style="line-height:6.55pt;position:absolute;top:14.84pt;width:234.75pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:63.43pt;position:absolute;white-space:pre">(Principal Financial Officer)</font></div></div></div></td></tr></table></div></div></div></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>gdrxq226-ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head><title>GDRX Q2&#39;26 - EX32.1</title></head><body><div style="background-color:#E4E4E4;font-family:Arial, sans-serif;word-wrap:break-word"><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt"><div style="position:absolute;top:747pt"><div style="width:495pt"></div></div><div style="position:absolute"><div style="width:495pt"></div></div><div><div id="i5bb0401a44c34723a68a4b7831c23164_1" style="position:absolute;top:45pt"></div><div style="line-height:6.55pt;position:absolute;top:45pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:503.53pt;position:absolute;white-space:pre">Exhibit 32.1</font></div><div style="line-height:6.55pt;position:absolute;top:67.8pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:237.57pt;position:absolute;white-space:pre">CERTIFICATION PURSUANT TO</font></div><div style="line-height:6.55pt;position:absolute;top:90.6pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:188.33pt;position:absolute;white-space:pre">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="line-height:6.55pt;position:absolute;top:113.4pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:187.08pt;position:absolute;white-space:pre">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:136.2pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;white-space:pre;width:494.93pt">In connection with the Quarterly Report on Form 10-Q of GoodRx Holdings, Inc. (the &#8220;Company&#8221;) for the period ended</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="font-size:12pt;line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:147pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;text-decoration:none;white-space:pre;width:57.42pt">June&#160;30, 2026</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:115.92pt;position:absolute;white-space:pre;width:437.4pt"> as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3199999999999pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:157.8pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;white-space:pre;width:469.92pt">18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge&#58;</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:180.6pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;white-space:pre;width:10.98pt">(1)</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:458.94pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59;</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:191.4pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:15pt">and</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:214.2pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;white-space:pre;width:10.98pt">(2)</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:458.89pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:225pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:109.8pt">operations of the Company.</font></div><div style="position:absolute;top:247.8pt;width:612pt"><div style="font-size:0pt;left:64.5pt;position:absolute;width:489pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tr style="height:0"><td style="padding:0;width:229.5pt"></td><td style="padding:0;width:24.75pt"></td><td style="padding:0;width:234.75pt"></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:absolute;width:229.5pt"><div><div style="font-size:12pt;line-height:6.55pt;position:absolute;top:4.31pt;width:229.5pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:absolute;white-space:pre">Date&#58; </font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:26.13pt;position:absolute;text-decoration:none;white-space:pre">August&#160;5, 2026</font></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:229.5pt;position:absolute;width:24.75pt"><div><div style="line-height:6.55pt;position:absolute;top:4.31pt;width:24.75pt"><font style="color:#000000;font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:absolute;text-decoration:none;white-space:pre">By&#58;</font></div></div></div></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:254.25pt;position:absolute;width:234.75pt"><div><div style="line-height:6.55pt;position:absolute;top:4.31pt;width:234.75pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:81.96pt;position:absolute;white-space:pre">&#47;s&#47; Wendy Barnes</font></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:254.25pt;position:absolute;top:14.25pt;width:234.75pt"><div><div style="line-height:6.55pt;position:absolute;top:4.31pt;width:234.75pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:87.96pt;position:absolute;white-space:pre">Wendy Barnes</font></div></div></div></td></tr><tr style="height:24.75pt"><td style="font-size:0;text-align:left;vertical-align:top"></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:254.25pt;position:absolute;top:28.5pt;width:234.75pt"><div><div style="line-height:6.55pt;position:absolute;top:4.04pt;width:234.75pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:47.24pt;position:absolute;white-space:pre">Chief Executive Officer &#38; President</font></div><div style="line-height:6.55pt;position:absolute;top:14.84pt;width:234.75pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:61.92pt;position:absolute;white-space:pre">(Principal Executive Officer)</font></div></div></div></td></tr></table></div></div></div></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>gdrxq226-ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head><title>GDRX Q2&#39;26 - EX32.2</title></head><body><div style="background-color:#E4E4E4;font-family:Arial, sans-serif;word-wrap:break-word"><div style="--justify:justify;--position:absolute;background-color:#FFFFFF;border:1px solid #CCCC;content-visibility:auto;float:none;font-size:0;height:792pt;margin:10px auto 10px auto;overflow:hidden;padding:0;position:relative;width:612pt"><div style="position:absolute;top:747pt"><div style="width:495pt"></div></div><div style="position:absolute"><div style="width:495pt"></div></div><div><div id="i704f3581df8b42c5940f5bd4a8c7a886_1" style="position:absolute;top:45pt"></div><div style="line-height:6.55pt;position:absolute;top:45pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:501.03pt;position:absolute;white-space:pre"> </font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:503.53pt;position:absolute;white-space:pre">Exhibit 32.2</font></div><div style="line-height:6.55pt;position:absolute;top:67.8pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:237.57pt;position:absolute;white-space:pre">CERTIFICATION PURSUANT TO</font></div><div style="line-height:6.55pt;position:absolute;top:90.6pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:188.33pt;position:absolute;white-space:pre">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="line-height:6.55pt;position:absolute;top:113.4pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:187.08pt;position:absolute;white-space:pre">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:136.2pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;white-space:pre;width:494.93pt">In connection with the Quarterly Report on Form 10-Q of GoodRx Holdings, Inc. (the &#8220;Company&#8221;) for the period ended</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="font-size:12pt;line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:147pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;text-decoration:none;white-space:pre;width:57.42pt">June&#160;30, 2026</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:115.92pt;position:absolute;white-space:pre;width:437.4pt"> as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3199999999999pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:157.8pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;white-space:pre;width:469.92pt">18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge&#58;</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:180.6pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;white-space:pre;width:10.98pt">(1)</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:458.94pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59;</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:191.4pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:15pt">and</font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:214.2pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:absolute;white-space:pre;width:10.98pt">(2)</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:458.89pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of</font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:absolute;white-space:pre;width:2.5pt"> </font></div><div style="line-height:6.55pt;position:absolute;text-align:justify;text-align-last:var(--justify);top:225pt;width:612pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:absolute;white-space:pre;width:109.8pt">operations of the Company.</font></div><div style="position:absolute;top:247.8pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:absolute;width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tr style="height:0"><td style="padding:0;width:235.5pt"></td><td style="padding:0;width:24.75pt"></td><td style="padding:0;width:234.75pt"></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:absolute;width:235.5pt"><div><div style="font-size:12pt;line-height:6.55pt;position:absolute;top:4.31pt;width:235.5pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:absolute;white-space:pre">Date&#58; </font><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:26.13pt;position:absolute;text-decoration:none;white-space:pre">August&#160;5, 2026</font></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:235.5pt;position:absolute;width:24.75pt"><div><div style="line-height:6.55pt;position:absolute;top:4.31pt;width:24.75pt"><font style="color:#000000;font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:absolute;text-decoration:none;white-space:pre">By&#58;</font></div></div></div></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:260.25pt;position:absolute;width:234.75pt"><div><div style="line-height:6.55pt;position:absolute;top:4.31pt;width:234.75pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:68.16pt;position:absolute;white-space:pre">&#47;s&#47; Christopher McGinnis</font></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:absolute;top:14.25pt;width:235.5pt"><div><div style="line-height:6.55pt;position:absolute;top:4.31pt;width:235.5pt"><font style="color:#000000;font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:absolute;text-decoration:none;white-space:pre"> </font></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:235.5pt;position:absolute;top:14.25pt;width:24.75pt"><div><div style="line-height:6.55pt;position:absolute;top:4.31pt;width:24.75pt"><font style="color:#000000;font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:absolute;text-decoration:none;white-space:pre"> </font></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:260.25pt;position:absolute;top:14.25pt;width:234.75pt"><div><div style="line-height:6.55pt;position:absolute;top:4.31pt;width:234.75pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:74.16pt;position:absolute;white-space:pre">Christopher McGinnis</font></div></div></div></td></tr><tr style="height:24.75pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:absolute;top:28.5pt;width:235.5pt"><div><div style="line-height:6.55pt;position:absolute;top:14.81pt;width:235.5pt"><font style="color:#000000;font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:absolute;text-decoration:none;white-space:pre"> </font></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:235.5pt;position:absolute;top:28.5pt;width:24.75pt"><div><div style="line-height:6.55pt;position:absolute;top:14.81pt;width:24.75pt"><font style="color:#000000;font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:absolute;text-decoration:none;white-space:pre"> </font></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"><div style="left:260.25pt;position:absolute;top:28.5pt;width:234.75pt"><div><div style="line-height:6.55pt;position:absolute;top:4.04pt;width:234.75pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:48.51pt;position:absolute;white-space:pre">Chief Financial Officer &#38; Treasurer</font></div><div style="line-height:6.55pt;position:absolute;top:14.84pt;width:234.75pt"><font style="font-family:&#39;Arial&#39;, sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:63.43pt;position:absolute;white-space:pre">(Principal Financial Officer)</font></div></div></div></td></tr></table></div></div></div></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>gdrx-20260630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e2c6b-4e55-7a2c-b1a0-3572b2490625,g:6d96a486-c103-4d24-b5e6-d8e2b8fbb013-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:gdrx="http://goodrx.com/20260630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://goodrx.com/20260630">
  <xs:import namespace="http://fasb.org/srt/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2026" schemaLocation="https://xbrl.sec.gov/dei/2026/dei-2026.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2026" schemaLocation="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gdrx-20260630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gdrx-20260630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gdrx-20260630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gdrx-20260630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://goodrx.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnaudited" roleURI="http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>9952151 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParentheticalUnaudited" roleURI="http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited">
        <link:definition>9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsUnaudited" roleURI="http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited">
        <link:definition>9952153 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityUnaudited" roleURI="http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited">
        <link:definition>9952154 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>9952155 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsUnauditedParenthetical" roleURI="http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnauditedParenthetical">
        <link:definition>9952156 - Statement - Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsUnauditedParenthetical_1" roleURI="http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnauditedParenthetical_1">
        <link:definition>9952156 - Statement - Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityUnauditedParenthetical" roleURI="http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnauditedParenthetical">
        <link:definition>9952157 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical" roleURI="http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical">
        <link:definition>9952158 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusiness" roleURI="http://goodrx.com/role/DescriptionofBusiness">
        <link:definition>9952159 - Disclosure - Description of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://goodrx.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>9952160 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombination" roleURI="http://goodrx.com/role/BusinessCombination">
        <link:definition>9952161 - Disclosure - Business Combination</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherCurrentLiabilities" roleURI="http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilities">
        <link:definition>9952162 - Disclosure - Accrued Expenses and Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://goodrx.com/role/IncomeTaxes">
        <link:definition>9952163 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://goodrx.com/role/Debt">
        <link:definition>9952164 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://goodrx.com/role/CommitmentsandContingencies">
        <link:definition>9952165 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://goodrx.com/role/Revenue">
        <link:definition>9952166 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://goodrx.com/role/StockholdersEquity">
        <link:definition>9952167 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasicandDilutedEarningsPerShare" roleURI="http://goodrx.com/role/BasicandDilutedEarningsPerShare">
        <link:definition>9952168 - Disclosure - Basic and Diluted Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://goodrx.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherCurrentLiabilitiesTables" roleURI="http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables">
        <link:definition>9955512 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://goodrx.com/role/DebtTables">
        <link:definition>9955513 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://goodrx.com/role/RevenueTables">
        <link:definition>9955514 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://goodrx.com/role/StockholdersEquityTables">
        <link:definition>9955515 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasicandDilutedEarningsPerShareTables" roleURI="http://goodrx.com/role/BasicandDilutedEarningsPerShareTables">
        <link:definition>9955516 - Disclosure - Basic and Diluted Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesDetails" roleURI="http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails">
        <link:definition>9955517 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationDetails" roleURI="http://goodrx.com/role/BusinessCombinationDetails">
        <link:definition>9955518 - Disclosure - Business Combination (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails" roleURI="http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails">
        <link:definition>9955519 - Disclosure - Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherCurrentLiabilitiesAdditionalInformationDetails" roleURI="http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesAdditionalInformationDetails">
        <link:definition>9955520 - Disclosure - Accrued Expenses and Other Current Liabilities - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesAdditionalInformationDetails" roleURI="http://goodrx.com/role/IncomeTaxesAdditionalInformationDetails">
        <link:definition>9955521 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtAdditionalInformationDetails" roleURI="http://goodrx.com/role/DebtAdditionalInformationDetails">
        <link:definition>9955522 - Disclosure - Debt - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofDebtDetails" roleURI="http://goodrx.com/role/DebtScheduleofDebtDetails">
        <link:definition>9955523 - Disclosure - Debt - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://goodrx.com/role/CommitmentsandContingenciesDetails">
        <link:definition>9955524 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails_1" roleURI="http://goodrx.com/role/CommitmentsandContingenciesDetails_1">
        <link:definition>9955524 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDetails" roleURI="http://goodrx.com/role/RevenueDetails">
        <link:definition>9955525 - Disclosure - Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityAdditionalInformationDetails" roleURI="http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails">
        <link:definition>9955526 - Disclosure - Stockholders' Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofRepurchaseAgreementsDetails" roleURI="http://goodrx.com/role/StockholdersEquityScheduleofRepurchaseAgreementsDetails">
        <link:definition>9955527 - Disclosure - Stockholders' Equity - Schedule of Repurchase Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails" roleURI="http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails">
        <link:definition>9955528 - Disclosure - Basic and Diluted Earnings Per Share - Schedule Computation of Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasicandDilutedEarningsPerShareScheduleofWeightedAveragePotentiallyDilutiveSharesareExcludedfromComputationofDilutedLossEarningsPerShareDetails" roleURI="http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleofWeightedAveragePotentiallyDilutiveSharesareExcludedfromComputationofDilutedLossEarningsPerShareDetails">
        <link:definition>9955529 - Disclosure - Basic and Diluted Earnings Per Share - Schedule of Weighted-Average Potentially Dilutive Shares are Excluded from Computation of Diluted (Loss) Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="gdrx_PrescriptionReimbursementAssetsCurrent" abstract="false" name="PrescriptionReimbursementAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gdrx_PrescriptionReimbursementLiabilitiesCurrent" abstract="false" name="PrescriptionReimbursementLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gdrx_AccruedExpensesAndOtherCurrentLiabilities" abstract="false" name="AccruedExpensesAndOtherCurrentLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits" abstract="false" name="StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets" abstract="false" name="LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets" abstract="false" name="IncreaseDecreaseInPrescriptionReimbursementAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities" abstract="false" name="IncreaseDecreaseInPrescriptionReimbursableLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gdrx_IncreaseDecreaseOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards" abstract="false" name="EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gdrx_NoncashStockBasedCompensationIncludedInCapitalizedSoftware" abstract="false" name="NoncashStockBasedCompensationIncludedInCapitalizedSoftware" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gdrx_CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities" abstract="false" name="CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gdrx_DescriptionOfBusinessAbstract" abstract="true" name="DescriptionOfBusinessAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gdrx_PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock" abstract="false" name="PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="gdrx_AccountingPoliciesTable" abstract="true" name="AccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="gdrx_CustomerOneMember" abstract="true" name="CustomerOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gdrx_MinorityEquityInterestsMember" abstract="true" name="MinorityEquityInterestsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gdrx_OperatingLeaseRightOfUseAssetsMember" abstract="true" name="OperatingLeaseRightOfUseAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gdrx_AccountingPoliciesLineItems" abstract="true" name="AccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties" abstract="false" name="PrescriptionReimbursementAssetsNumberOfCounterparties" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="gdrx_VividRxClearRxIncMember" abstract="true" name="VividRxClearRxIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gdrx_VitacarePrescriptionServicesIncMember" abstract="true" name="VitacarePrescriptionServicesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gdrx_AccruedBonusAndOtherPayrollRelatedCurrent" abstract="false" name="AccruedBonusAndOtherPayrollRelatedCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gdrx_FirstLienCreditAgreementMember" abstract="true" name="FirstLienCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension" abstract="false" name="LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio" abstract="false" name="LineOfCreditMaximumFinancialCovenantNetLeverageRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="gdrx_A2024TermLoanMember" abstract="true" name="A2024TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gdrx_PrivacyProtectionMember" abstract="true" name="PrivacyProtectionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember" abstract="true" name="ElectronicCommunicationPrivacyActPrivacyProtectionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gdrx_SDFLClassActionMatterMember" abstract="true" name="SDFLClassActionMatterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gdrx_NDCAClassActionMatterMember" abstract="true" name="NDCAClassActionMatterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gdrx_PrescriptionTransactionsRevenueMember" abstract="true" name="PrescriptionTransactionsRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gdrx_SubscriptionRevenueMember" abstract="true" name="SubscriptionRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gdrx_PharmaManufacturerSolutionsRevenuesMember" abstract="true" name="PharmaManufacturerSolutionsRevenuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gdrx_OtherRevenueMember" abstract="true" name="OtherRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gdrx_NewRepurchaseProgramMember" abstract="true" name="NewRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gdrx_CommonClassAAndClassBMember" abstract="true" name="CommonClassAAndClassBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gdrx_FranciscoPartnersStockPurchaseAgreementMember" abstract="true" name="FranciscoPartnersStockPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gdrx_IdeaMenLLCMember" abstract="true" name="IdeaMenLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gdrx_SpectrumStockPurchaseAgreementMember" abstract="true" name="SpectrumStockPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="gdrx_EarningPerShareBasicAndDilutedAbstract" abstract="true" name="EarningPerShareBasicAndDilutedAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="gdrx_StockOptionsAndRestrictedStockUnitsMember" abstract="true" name="StockOptionsAndRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>gdrx-20260630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e2c6b-4e55-7a2c-b1a0-3572b2490625,g:6d96a486-c103-4d24-b5e6-d8e2b8fbb013-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019e2c6b-4f3a-7de1-ae08-5fe4169bcb04" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019e2c6b-4f3a-7d1d-842f-39b3510ceb7b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e2c6b-4f3a-7de1-ae08-5fe4169bcb04" xlink:to="loc_us-gaap_LiabilitiesCurrent_019e2c6b-4f3a-7d1d-842f-39b3510ceb7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_019e2c6b-4f3a-7be7-915c-b7dd4e4ee306" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e2c6b-4f3a-7de1-ae08-5fe4169bcb04" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_019e2c6b-4f3a-7be7-915c-b7dd4e4ee306" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019e2c6b-4f3a-773f-9c53-3222c607f349" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e2c6b-4f3a-7de1-ae08-5fe4169bcb04" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019e2c6b-4f3a-773f-9c53-3222c607f349" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_019e2c6b-4f3a-7000-9d37-a0827e16c3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e2c6b-4f3a-7de1-ae08-5fe4169bcb04" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_019e2c6b-4f3a-7000-9d37-a0827e16c3b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019e2c6b-4f3a-7644-a391-5781e46e29dd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019e2c6b-4f3a-70d9-b365-ed2299149edd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e2c6b-4f3a-7644-a391-5781e46e29dd" xlink:to="loc_us-gaap_AssetsCurrent_019e2c6b-4f3a-70d9-b365-ed2299149edd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019e2c6b-4f3a-7bf9-a5eb-825a2b7b2f70" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e2c6b-4f3a-7644-a391-5781e46e29dd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019e2c6b-4f3a-7bf9-a5eb-825a2b7b2f70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_019e2c6b-4f3a-7cc7-9966-a13b5e430ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e2c6b-4f3a-7644-a391-5781e46e29dd" xlink:to="loc_us-gaap_Goodwill_019e2c6b-4f3a-7cc7-9966-a13b5e430ee6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e2c6b-4f3a-71db-866a-0187dc80e5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e2c6b-4f3a-7644-a391-5781e46e29dd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e2c6b-4f3a-71db-866a-0187dc80e5ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_019e2c6b-4f3a-737d-b038-0018588251c2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e2c6b-4f3a-7644-a391-5781e46e29dd" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_019e2c6b-4f3a-737d-b038-0018588251c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e2c6b-4f3a-7c59-8d7a-707179693c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e2c6b-4f3a-7644-a391-5781e46e29dd" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e2c6b-4f3a-7c59-8d7a-707179693c3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019e2c6b-4f3a-7008-8ec7-f7612720862e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e2c6b-4f3a-7644-a391-5781e46e29dd" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019e2c6b-4f3a-7008-8ec7-f7612720862e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_019e2c6b-4f3a-76e2-be98-838d1d9c1300" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e2c6b-4f3a-7644-a391-5781e46e29dd" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_019e2c6b-4f3a-76e2-be98-838d1d9c1300" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019e2c6b-4f3a-789e-8182-fff6448a7d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e2c6b-4f3a-7ff8-ad46-78576955a1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e2c6b-4f3a-789e-8182-fff6448a7d2b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e2c6b-4f3a-7ff8-ad46-78576955a1e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_019e2c6b-4f3a-7f0b-b956-20b7062a3364" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e2c6b-4f3a-789e-8182-fff6448a7d2b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_019e2c6b-4f3a-7f0b-b956-20b7062a3364" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e2c6b-4f3a-7964-be56-fbf10846c7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e2c6b-4f3a-789e-8182-fff6448a7d2b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e2c6b-4f3a-7964-be56-fbf10846c7cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PrescriptionReimbursementAssetsCurrent_019e2c6b-4f3a-7314-bcfc-25f15f36312d" xlink:href="gdrx-20260630.xsd#gdrx_PrescriptionReimbursementAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e2c6b-4f3a-789e-8182-fff6448a7d2b" xlink:to="loc_gdrx_PrescriptionReimbursementAssetsCurrent_019e2c6b-4f3a-7314-bcfc-25f15f36312d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e2c6b-4f3a-7f0f-8016-4e7e1f952778" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019e2c6b-4f3a-706a-8370-0d3ef89b009c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e2c6b-4f3a-7f0f-8016-4e7e1f952778" xlink:to="loc_us-gaap_CommonStockValue_019e2c6b-4f3a-706a-8370-0d3ef89b009c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e2c6b-4f3a-7537-9728-77cff3b5c5bc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e2c6b-4f3a-7f0f-8016-4e7e1f952778" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e2c6b-4f3a-7537-9728-77cff3b5c5bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_019e2c6b-4f3a-7ac1-9a95-b8224be13d29" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e2c6b-4f3a-7f0f-8016-4e7e1f952778" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_019e2c6b-4f3a-7ac1-9a95-b8224be13d29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_019e2c6b-4f3a-7dbb-b09f-6d8e9f5e7e89" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e2c6b-4f3a-7f0f-8016-4e7e1f952778" xlink:to="loc_us-gaap_PreferredStockValue_019e2c6b-4f3a-7dbb-b09f-6d8e9f5e7e89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019e2c6b-4f3a-70fb-8af5-ffa497b2d9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019e2c6b-4f3a-7e05-a393-22b646da8094" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e2c6b-4f3a-70fb-8af5-ffa497b2d9e3" xlink:to="loc_us-gaap_AccountsPayableCurrent_019e2c6b-4f3a-7e05-a393-22b646da8094" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PrescriptionReimbursementLiabilitiesCurrent_019e2c6b-4f3a-7273-b78c-749b11bd3b77" xlink:href="gdrx-20260630.xsd#gdrx_PrescriptionReimbursementLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e2c6b-4f3a-70fb-8af5-ffa497b2d9e3" xlink:to="loc_gdrx_PrescriptionReimbursementLiabilitiesCurrent_019e2c6b-4f3a-7273-b78c-749b11bd3b77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_AccruedExpensesAndOtherCurrentLiabilities_019e2c6b-4f3a-728c-8c8f-7ae7ceff0a40" xlink:href="gdrx-20260630.xsd#gdrx_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e2c6b-4f3a-70fb-8af5-ffa497b2d9e3" xlink:to="loc_gdrx_AccruedExpensesAndOtherCurrentLiabilities_019e2c6b-4f3a-728c-8c8f-7ae7ceff0a40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_019e2c6b-4f3a-76c6-a651-fabd168c1a35" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e2c6b-4f3a-70fb-8af5-ffa497b2d9e3" xlink:to="loc_us-gaap_LongTermDebtCurrent_019e2c6b-4f3a-76c6-a651-fabd168c1a35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019e2c6b-4f3a-7c36-8114-87f2e704bdbf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e2c6b-4f3a-70fb-8af5-ffa497b2d9e3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019e2c6b-4f3a-7c36-8114-87f2e704bdbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e2c6b-4f3a-70a9-aa67-df0b8b0df42b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019e2c6b-4f3a-766c-8b05-d1f004a3710e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e2c6b-4f3a-70a9-aa67-df0b8b0df42b" xlink:to="loc_us-gaap_Liabilities_019e2c6b-4f3a-766c-8b05-d1f004a3710e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019e2c6b-4f3a-7738-a282-fae17cf0e2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e2c6b-4f3a-70a9-aa67-df0b8b0df42b" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019e2c6b-4f3a-7738-a282-fae17cf0e2f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e2c6b-4f3a-7f52-86fc-758d7db3294b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e2c6b-4f3a-70a9-aa67-df0b8b0df42b" xlink:to="loc_us-gaap_StockholdersEquity_019e2c6b-4f3a-7f52-86fc-758d7db3294b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:calculationLink xlink:role="http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e2c6b-4f3a-7f47-8e9d-da28f7f86799" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019e2c6b-4f3a-7b03-af50-c3d556950004" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e2c6b-4f3a-7f47-8e9d-da28f7f86799" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019e2c6b-4f3a-7b03-af50-c3d556950004" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_019e2c6b-4f3a-7ce9-a1c2-e0b5925fd486" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e2c6b-4f3a-7f47-8e9d-da28f7f86799" xlink:to="loc_us-gaap_CostsAndExpenses_019e2c6b-4f3a-7ce9-a1c2-e0b5925fd486" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019e2c6b-4f3a-737d-99d0-7651da9c270c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019e2c6b-4f3a-7600-9088-a44a342d9be3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019e2c6b-4f3a-737d-99d0-7651da9c270c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019e2c6b-4f3a-7600-9088-a44a342d9be3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_019e6dd9-b725-7e1f-b0c3-b0b31df70be4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestIncomeOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019e2c6b-4f3a-737d-99d0-7651da9c270c" xlink:to="loc_us-gaap_InterestIncomeOther_019e6dd9-b725-7e1f-b0c3-b0b31df70be4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_019e6dd9-b725-7cea-aee6-24da8821abcf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019e2c6b-4f3a-737d-99d0-7651da9c270c" xlink:to="loc_us-gaap_InterestExpenseNonoperating_019e6dd9-b725-7cea-aee6-24da8821abcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_019e2c6b-4f3a-7e22-a8d1-7fa01d680d58" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_019e2c6b-4f3a-73e8-a735-0e04a6e2e62f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019e2c6b-4f3a-7e22-a8d1-7fa01d680d58" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_019e2c6b-4f3a-73e8-a735-0e04a6e2e62f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019e2c6b-4f3a-7485-9def-b9adc0afd99d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019e2c6b-4f3a-7e22-a8d1-7fa01d680d58" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019e2c6b-4f3a-7485-9def-b9adc0afd99d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_019e2c6b-4f3a-7404-a090-9ca2d5c88edb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019e2c6b-4f3a-7e22-a8d1-7fa01d680d58" xlink:to="loc_us-gaap_SellingAndMarketingExpense_019e2c6b-4f3a-7404-a090-9ca2d5c88edb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019e2c6b-4f3a-79ab-a8dc-facafcf6ad21" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019e2c6b-4f3a-7e22-a8d1-7fa01d680d58" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019e2c6b-4f3a-79ab-a8dc-facafcf6ad21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_019e2c6b-4f3a-7cab-85df-0a42cc7c653c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019e2c6b-4f3a-7e22-a8d1-7fa01d680d58" xlink:to="loc_us-gaap_DepreciationAndAmortization_019e2c6b-4f3a-7cab-85df-0a42cc7c653c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e2c6b-4f3a-7af0-a1f6-3ca9e67e5535" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e2c6b-4f3a-73d0-b976-e980ae0fc462" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e2c6b-4f3a-7af0-a1f6-3ca9e67e5535" xlink:to="loc_us-gaap_OperatingIncomeLoss_019e2c6b-4f3a-73d0-b976-e980ae0fc462" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019e2c6b-4f3a-7b5a-a7dc-8bff7f63630e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e2c6b-4f3a-7af0-a1f6-3ca9e67e5535" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019e2c6b-4f3a-7b5a-a7dc-8bff7f63630e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e2c6b-4f3a-78d9-b4f9-9c303198b92f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e2c6b-4f3a-7beb-829f-b95a3b1911a7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e2c6b-4f3a-78d9-b4f9-9c303198b92f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e2c6b-4f3a-7beb-829f-b95a3b1911a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019e2c6b-4f3a-718e-8e23-0c7ad8fd98a0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e2c6b-4f3a-78d9-b4f9-9c303198b92f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019e2c6b-4f3a-718e-8e23-0c7ad8fd98a0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-7525-b3f9-fe94fbf92c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e2c6b-4f3a-7833-a15c-d75f2e44cb28" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-7525-b3f9-fe94fbf92c8c" xlink:to="loc_us-gaap_NetIncomeLoss_019e2c6b-4f3a-7833-a15c-d75f2e44cb28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_019e2c6b-4f3a-7ff3-9d70-36d239fc5ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-7525-b3f9-fe94fbf92c8c" xlink:to="loc_us-gaap_DepreciationAndAmortization_019e2c6b-4f3a-7ff3-9d70-36d239fc5ba9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_019e2c6b-4f3a-7ee4-8883-5a18e7ac8c91" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-7525-b3f9-fe94fbf92c8c" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_019e2c6b-4f3a-7ee4-8883-5a18e7ac8c91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019e2c6b-4f3a-710e-8460-cbd5343783b2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-7525-b3f9-fe94fbf92c8c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019e2c6b-4f3a-710e-8460-cbd5343783b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019e2c6b-4f3a-7ae6-8245-bb78341df31f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-7525-b3f9-fe94fbf92c8c" xlink:to="loc_us-gaap_ShareBasedCompensation_019e2c6b-4f3a-7ae6-8245-bb78341df31f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets_019e2c6b-4f3a-7066-a403-e72bb4d71653" xlink:href="gdrx-20260630.xsd#gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-7525-b3f9-fe94fbf92c8c" xlink:to="loc_gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets_019e2c6b-4f3a-7066-a403-e72bb4d71653" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_019e2c6b-4f3a-7131-a686-71e5fa81add3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-7525-b3f9-fe94fbf92c8c" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_019e2c6b-4f3a-7131-a686-71e5fa81add3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019e2c6b-4f3a-733a-9b44-8f8300b3ea26" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-7525-b3f9-fe94fbf92c8c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019e2c6b-4f3a-733a-9b44-8f8300b3ea26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets_019e2c6b-4f3a-7f78-be78-8f0b23ef74f2" xlink:href="gdrx-20260630.xsd#gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-7525-b3f9-fe94fbf92c8c" xlink:to="loc_gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets_019e2c6b-4f3a-7f78-be78-8f0b23ef74f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e2c6b-4f3a-7e42-aee3-39452a3b652c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-7525-b3f9-fe94fbf92c8c" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e2c6b-4f3a-7e42-aee3-39452a3b652c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019e2c6b-4f3a-787c-8692-d71f0f1b7df8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-7525-b3f9-fe94fbf92c8c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019e2c6b-4f3a-787c-8692-d71f0f1b7df8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities_019e2c6b-4f3a-79f8-8ec7-8ebee7363eb5" xlink:href="gdrx-20260630.xsd#gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-7525-b3f9-fe94fbf92c8c" xlink:to="loc_gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities_019e2c6b-4f3a-79f8-8ec7-8ebee7363eb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019e2c6b-4f3a-7fef-8ec7-c4e3b4dff58e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-7525-b3f9-fe94fbf92c8c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019e2c6b-4f3a-7fef-8ec7-c4e3b4dff58e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_IncreaseDecreaseOperatingLeaseLiabilities_019e2c6b-4f3a-7172-95d8-40caacfcf4c4" xlink:href="gdrx-20260630.xsd#gdrx_IncreaseDecreaseOperatingLeaseLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-7525-b3f9-fe94fbf92c8c" xlink:to="loc_gdrx_IncreaseDecreaseOperatingLeaseLiabilities_019e2c6b-4f3a-7172-95d8-40caacfcf4c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_019e2c6b-4f3a-7a6b-8e02-30bdc5e638c0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-7525-b3f9-fe94fbf92c8c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_019e2c6b-4f3a-7a6b-8e02-30bdc5e638c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_019e2c6b-4f3a-7144-984b-5e6f1471e182" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-7525-b3f9-fe94fbf92c8c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_019e2c6b-4f3a-7144-984b-5e6f1471e182" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e2c6b-4f3a-7bfa-bd8f-14bb26f8dad8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-79f5-abef-3b74dde7b0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e2c6b-4f3a-7bfa-bd8f-14bb26f8dad8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-79f5-abef-3b74dde7b0c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e2c6b-4f3a-792f-ae8f-99b18b9b0312" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e2c6b-4f3a-7bfa-bd8f-14bb26f8dad8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e2c6b-4f3a-792f-ae8f-99b18b9b0312" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e2c6b-4f3a-75a9-b934-2d17de910d46" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e2c6b-4f3a-7bfa-bd8f-14bb26f8dad8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e2c6b-4f3a-75a9-b934-2d17de910d46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e2c6b-4f3a-7221-83c9-490417cd7df5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019e2c6b-4f3a-749c-9beb-d69901e5114e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e2c6b-4f3a-7221-83c9-490417cd7df5" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019e2c6b-4f3a-749c-9beb-d69901e5114e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_019e2c6b-4f3a-7aa6-b569-e6038433d3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e2c6b-4f3a-7221-83c9-490417cd7df5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_019e2c6b-4f3a-7aa6-b569-e6038433d3fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForSoftware_019e2c6b-4f3a-78a9-b672-26f6860a25b6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsForSoftware"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e2c6b-4f3a-7221-83c9-490417cd7df5" xlink:to="loc_us-gaap_PaymentsForSoftware_019e2c6b-4f3a-78a9-b672-26f6860a25b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e2c6b-4f3a-7509-8560-66424f62e109" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_019e2c6b-4f3a-7fac-987b-3ab2d28fc213" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e2c6b-4f3a-7509-8560-66424f62e109" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_019e2c6b-4f3a-7fac-987b-3ab2d28fc213" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_019e2c6b-4f3a-7603-8f6c-3dc624ccd15c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e2c6b-4f3a-7509-8560-66424f62e109" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_019e2c6b-4f3a-7603-8f6c-3dc624ccd15c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019e2c6b-4f3a-7750-82c2-2fdba584f5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e2c6b-4f3a-7509-8560-66424f62e109" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019e2c6b-4f3a-7750-82c2-2fdba584f5e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards_019e2c6b-4f3a-7dc0-a498-5947be0d1d1b" xlink:href="gdrx-20260630.xsd#gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e2c6b-4f3a-7509-8560-66424f62e109" xlink:to="loc_gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards_019e2c6b-4f3a-7dc0-a498-5947be0d1d1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_019e6df3-b66e-7a1f-80c1-98bb57190399" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e2c6b-4f3a-7509-8560-66424f62e109" xlink:to="loc_us-gaap_ProceedsFromStockPlans_019e6df3-b66e-7a1f-80c1-98bb57190399" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_AccruedExpensesAndOtherCurrentLiabilities_019e2c6b-4f3a-7252-8f70-bff4a05cf3ac" xlink:href="gdrx-20260630.xsd#gdrx_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_AccruedBonusAndOtherPayrollRelatedCurrent_019e2c6b-4f3a-7d04-a5c4-e412d87cc241" xlink:href="gdrx-20260630.xsd#gdrx_AccruedBonusAndOtherPayrollRelatedCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_gdrx_AccruedExpensesAndOtherCurrentLiabilities_019e2c6b-4f3a-7252-8f70-bff4a05cf3ac" xlink:to="loc_gdrx_AccruedBonusAndOtherPayrollRelatedCurrent_019e2c6b-4f3a-7d04-a5c4-e412d87cc241" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019e2c6b-4f3a-7040-9225-1b6cbb3d329f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_gdrx_AccruedExpensesAndOtherCurrentLiabilities_019e2c6b-4f3a-7252-8f70-bff4a05cf3ac" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019e2c6b-4f3a-7040-9225-1b6cbb3d329f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_019e2c6b-4f3a-75ab-9a20-499561052628" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_gdrx_AccruedExpensesAndOtherCurrentLiabilities_019e2c6b-4f3a-7252-8f70-bff4a05cf3ac" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_019e2c6b-4f3a-75ab-9a20-499561052628" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_019e2c6b-4f3a-76b0-b1d2-5539ca510eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_gdrx_AccruedExpensesAndOtherCurrentLiabilities_019e2c6b-4f3a-7252-8f70-bff4a05cf3ac" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_019e2c6b-4f3a-76b0-b1d2-5539ca510eb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019e2c6b-4f3a-7960-b3d7-bb02a3c1e157" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_gdrx_AccruedExpensesAndOtherCurrentLiabilities_019e2c6b-4f3a-7252-8f70-bff4a05cf3ac" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019e2c6b-4f3a-7960-b3d7-bb02a3c1e157" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019e2c6b-4f3a-7afa-9282-b6d2fc3b1e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019e2c6b-4f3a-7d73-910d-38a9e827c71b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019e2c6b-4f3a-7afa-9282-b6d2fc3b1e7e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019e2c6b-4f3a-7d73-910d-38a9e827c71b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_019e2c6b-4f3a-7fc9-a16d-68d733865662" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019e2c6b-4f3a-7afa-9282-b6d2fc3b1e7e" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_019e2c6b-4f3a-7fc9-a16d-68d733865662" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>gdrx-20260630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e2c6b-4e55-7a2c-b1a0-3572b2490625,g:6d96a486-c103-4d24-b5e6-d8e2b8fbb013-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://goodrx.com/role/Cover" xlink:type="simple" xlink:href="gdrx-20260630.xsd#Cover"/>
  <link:definitionLink xlink:role="http://goodrx.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_019e2c6b-4e56-7983-b0f8-88a287a4bf3a" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_DocumentInformationTable_019e2c6b-4e56-7983-b0f8-88a287a4bf3a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4e56-79ea-87b0-d06b371374f8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_019e2c6b-4e56-7983-b0f8-88a287a4bf3a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4e56-79ea-87b0-d06b371374f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019e2c6b-4e56-79ea-87b0-d06b371374f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4e56-79ea-87b0-d06b371374f8" xlink:to="loc_us-gaap_ClassOfStockDomain_019e2c6b-4e56-79ea-87b0-d06b371374f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019e2c6b-4e56-7b79-8dde-844b70d51d74" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4e56-79ea-87b0-d06b371374f8" xlink:to="loc_us-gaap_ClassOfStockDomain_019e2c6b-4e56-7b79-8dde-844b70d51d74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_019e2c6b-4e56-7dfd-949a-3909135c0da0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019e2c6b-4e56-7b79-8dde-844b70d51d74" xlink:to="loc_us-gaap_CommonClassAMember_019e2c6b-4e56-7dfd-949a-3909135c0da0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_019e2c6b-4e56-7626-b1ef-4e4391bfad30" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019e2c6b-4e56-7b79-8dde-844b70d51d74" xlink:to="loc_us-gaap_CommonClassBMember_019e2c6b-4e56-7626-b1ef-4e4391bfad30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019e2c6b-4e56-75fa-8493-8547da1e5440" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_DocumentType_019e2c6b-4e56-75fa-8493-8547da1e5440" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_019e2c6b-4e56-7691-a651-bd23052856fb" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_DocumentQuarterlyReport_019e2c6b-4e56-7691-a651-bd23052856fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019e2c6b-4e56-7142-b132-af750b5eccfa" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_DocumentPeriodEndDate_019e2c6b-4e56-7142-b132-af750b5eccfa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_019e2c6b-4e56-743d-a817-746c8e1e2e6b" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_DocumentTransitionReport_019e2c6b-4e56-743d-a817-746c8e1e2e6b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019e2c6b-4e56-70dc-85f2-9bbd671cae90" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityFileNumber_019e2c6b-4e56-70dc-85f2-9bbd671cae90" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019e2c6b-4e56-7c26-89c9-3c528412c556" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityRegistrantName_019e2c6b-4e56-7c26-89c9-3c528412c556" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019e2c6b-4e56-7169-b790-ac9943c9dd88" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019e2c6b-4e56-7169-b790-ac9943c9dd88" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019e2c6b-4e56-775a-a2d8-ff38b8efaf3f" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityTaxIdentificationNumber_019e2c6b-4e56-775a-a2d8-ff38b8efaf3f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019e2c6b-4e56-7339-8967-e6234efd1b47" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityAddressAddressLine1_019e2c6b-4e56-7339-8967-e6234efd1b47" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019e2c6b-4e56-76c1-b062-596ce10efdba" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityAddressCityOrTown_019e2c6b-4e56-76c1-b062-596ce10efdba" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019e2c6b-4e56-7086-81c7-7c4b02dd9d31" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityAddressStateOrProvince_019e2c6b-4e56-7086-81c7-7c4b02dd9d31" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019e2c6b-4e56-7213-8ca9-819cd07f212f" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityAddressPostalZipCode_019e2c6b-4e56-7213-8ca9-819cd07f212f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019e2c6b-4e56-7642-8122-59bf17424f5a" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_CityAreaCode_019e2c6b-4e56-7642-8122-59bf17424f5a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019e2c6b-4e56-7bb2-860b-a8e23a7d0ba6" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_LocalPhoneNumber_019e2c6b-4e56-7bb2-860b-a8e23a7d0ba6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019e2c6b-4e56-7fa2-8e32-825c105c0f91" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_Security12bTitle_019e2c6b-4e56-7fa2-8e32-825c105c0f91" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019e2c6b-4e56-714e-ba7b-bb0a5c6c7f6e" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_TradingSymbol_019e2c6b-4e56-714e-ba7b-bb0a5c6c7f6e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019e2c6b-4e56-7e5f-841c-e4c2826f6181" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_SecurityExchangeName_019e2c6b-4e56-7e5f-841c-e4c2826f6181" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_019e2c6b-4e56-7e1f-8808-1fa29435e08b" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityCurrentReportingStatus_019e2c6b-4e56-7e1f-8808-1fa29435e08b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_019e2c6b-4e56-77d2-a7c7-4ddf34d0c974" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityInteractiveDataCurrent_019e2c6b-4e56-77d2-a7c7-4ddf34d0c974" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_019e2c6b-4e56-7dda-ae0e-9141d03818ac" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityFilerCategory_019e2c6b-4e56-7dda-ae0e-9141d03818ac" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_019e2c6b-4f3a-7db6-9b78-2dff12702760" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntitySmallBusiness_019e2c6b-4f3a-7db6-9b78-2dff12702760" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019e2c6b-4f3a-7dad-8c04-e21b6771e77e" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityEmergingGrowthCompany_019e2c6b-4f3a-7dad-8c04-e21b6771e77e" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_019e2c6b-4f3a-76fb-891b-6886d24f9ad6" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityShellCompany_019e2c6b-4f3a-76fb-891b-6886d24f9ad6" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_019e2c6b-4f3a-7d81-bc1d-2e6e15c0fc84" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_019e2c6b-4f3a-7d81-bc1d-2e6e15c0fc84" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019e2c6b-4f3a-70ba-9c3c-b441c120a300" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityCentralIndexKey_019e2c6b-4f3a-70ba-9c3c-b441c120a300" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_019e2c6b-4f3a-70f4-9c80-ff4b96742a64" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_CurrentFiscalYearEndDate_019e2c6b-4f3a-70f4-9c80-ff4b96742a64" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_019e2c6b-4f3a-7201-bea0-d61b594caf62" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_DocumentFiscalYearFocus_019e2c6b-4f3a-7201-bea0-d61b594caf62" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_019e2c6b-4f3a-73ee-a2f4-c49e404e1ce1" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_DocumentFiscalPeriodFocus_019e2c6b-4f3a-73ee-a2f4-c49e404e1ce1" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019e2c6b-4f3a-7327-8c0b-f990a7dd7bf0" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_AmendmentFlag_019e2c6b-4f3a-7327-8c0b-f990a7dd7bf0" xlink:type="arc" order="28"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CondensedConsolidatedBalanceSheetsParentheticalUnaudited"/>
  <link:definitionLink xlink:role="http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-731b-9d12-f86d4123cb8c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019e2c6b-4f3a-7b14-942c-7c0d59a1daf7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-731b-9d12-f86d4123cb8c" xlink:to="loc_us-gaap_StatementTable_019e2c6b-4f3a-7b14-942c-7c0d59a1daf7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7067-8f94-ca7cd389afa1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019e2c6b-4f3a-7b14-942c-7c0d59a1daf7" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7067-8f94-ca7cd389afa1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-7067-8f94-ca7cd389afa1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7067-8f94-ca7cd389afa1" xlink:to="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-7067-8f94-ca7cd389afa1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-7307-8a9c-f5a5be98d33b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7067-8f94-ca7cd389afa1" xlink:to="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-7307-8a9c-f5a5be98d33b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_019e2c6b-4f3a-73bc-b502-7f21e432f23f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-7307-8a9c-f5a5be98d33b" xlink:to="loc_us-gaap_CommonClassAMember_019e2c6b-4f3a-73bc-b502-7f21e432f23f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_019e2c6b-4f3a-7891-9114-2fe6ba975974" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-7307-8a9c-f5a5be98d33b" xlink:to="loc_us-gaap_CommonClassBMember_019e2c6b-4f3a-7891-9114-2fe6ba975974" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019e2c6b-4f3a-779f-9b7b-2b70c2ebfa53" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-731b-9d12-f86d4123cb8c" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019e2c6b-4f3a-779f-9b7b-2b70c2ebfa53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_019e2c6b-4f3a-77c1-b080-8d8c74623ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-731b-9d12-f86d4123cb8c" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_019e2c6b-4f3a-77c1-b080-8d8c74623ec7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_019e2c6b-4f3a-7258-a6a8-58daf175584b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-731b-9d12-f86d4123cb8c" xlink:to="loc_us-gaap_PreferredStockSharesIssued_019e2c6b-4f3a-7258-a6a8-58daf175584b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_019e2c6b-4f3a-7445-9668-f9babe101788" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-731b-9d12-f86d4123cb8c" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_019e2c6b-4f3a-7445-9668-f9babe101788" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_019e2c6b-4f3a-7af6-b242-72bbf18fc2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-731b-9d12-f86d4123cb8c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_019e2c6b-4f3a-7af6-b242-72bbf18fc2c0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_019e2c6b-4f3a-7787-8e51-75741ed30d99" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-731b-9d12-f86d4123cb8c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_019e2c6b-4f3a-7787-8e51-75741ed30d99" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_019e2c6b-4f3a-7b75-8697-a1a63909494b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-731b-9d12-f86d4123cb8c" xlink:to="loc_us-gaap_CommonStockSharesIssued_019e2c6b-4f3a-7b75-8697-a1a63909494b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019e2c6b-4f3a-77f6-95ea-f401aefd60ab" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-731b-9d12-f86d4123cb8c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019e2c6b-4f3a-77f6-95ea-f401aefd60ab" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CondensedConsolidatedStatementsofStockholdersEquityUnaudited"/>
  <link:definitionLink xlink:role="http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-79fd-be9e-7876566ff437" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019e2c6b-4f3a-7820-a77d-df7283118d67" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-79fd-be9e-7876566ff437" xlink:to="loc_us-gaap_StatementTable_019e2c6b-4f3a-7820-a77d-df7283118d67" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-72ef-809b-da5c4fe18e21" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019e2c6b-4f3a-7820-a77d-df7283118d67" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-72ef-809b-da5c4fe18e21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-72ef-809b-da5c4fe18e21_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-72ef-809b-da5c4fe18e21" xlink:to="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-72ef-809b-da5c4fe18e21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-74eb-aef8-9d0e5c6f0b00" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-72ef-809b-da5c4fe18e21" xlink:to="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-74eb-aef8-9d0e5c6f0b00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019e2c6b-4f3a-7b8d-875a-7954af00dd57" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-74eb-aef8-9d0e5c6f0b00" xlink:to="loc_us-gaap_CommonStockMember_019e2c6b-4f3a-7b8d-875a-7954af00dd57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_019e2c6b-4f3a-7d1e-ae90-bec0e8a23840" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-74eb-aef8-9d0e5c6f0b00" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_019e2c6b-4f3a-7d1e-ae90-bec0e8a23840" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_019e2c6b-4f3a-72c8-b92b-77693d0c257a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-74eb-aef8-9d0e5c6f0b00" xlink:to="loc_us-gaap_RetainedEarningsMember_019e2c6b-4f3a-72c8-b92b-77693d0c257a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-79fd-be9e-7876566ff437" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_019e2c6b-4f3a-7933-9508-b642ac0db315" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_SharesOutstanding_019e2c6b-4f3a-7933-9508-b642ac0db315" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e2c6b-4f3a-7381-a71d-7e49725b3859" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_StockholdersEquity_019e2c6b-4f3a-7381-a71d-7e49725b3859" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019e2c6b-4f3a-7524-9ac5-88ad7875d015" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019e2c6b-4f3a-7524-9ac5-88ad7875d015" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019e2c6b-4f3a-7dae-9c49-ec80c42028b8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019e2c6b-4f3a-7dae-9c49-ec80c42028b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019e2c6b-4f3a-74a5-b078-41634da5d9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019e2c6b-4f3a-74a5-b078-41634da5d9fc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits_019e2c6b-4f3a-7e18-82d8-774afdc30b3e" xlink:href="gdrx-20260630.xsd#gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits_019e2c6b-4f3a-7e18-82d8-774afdc30b3e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_019e2c6b-4f3a-70a1-a705-ca0ecc62acb8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_019e2c6b-4f3a-70a1-a705-ca0ecc62acb8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_019e2c6b-4f3a-7faa-b930-9520bcdd8116" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_019e2c6b-4f3a-7faa-b930-9520bcdd8116" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_019e2c6b-4f3a-7952-80cb-f68fb4c3152d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_019e2c6b-4f3a-7952-80cb-f68fb4c3152d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_019e2c6b-4f3a-73f1-a099-750a327edb03" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_019e2c6b-4f3a-73f1-a099-750a327edb03" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e2c6b-4f3a-7af0-8d67-e5de3aaf0ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_NetIncomeLoss_019e2c6b-4f3a-7af0-8d67-e5de3aaf0ff9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_019e2c6b-4f3a-72d7-a0da-323e1820e2e7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_019e2c6b-4f3a-72d7-a0da-323e1820e2e7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_019e2c6b-4f3a-763f-919e-f1d7d47fca61" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_019e2c6b-4f3a-763f-919e-f1d7d47fca61" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_019e2c6b-4f3a-7ac9-8c95-fa6cdf397ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e2c6b-4f3a-72b0-a220-096928f8d66c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnauditedParenthetical" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CondensedConsolidatedStatementsofOperationsUnauditedParenthetical"/>
  <link:definitionLink xlink:role="http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019fb437-5495-7053-ae27-786139be7003" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019fb437-5495-7830-b154-ac39ed577986" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019fb437-5495-7053-ae27-786139be7003" xlink:to="loc_us-gaap_StatementTable_019fb437-5495-7830-b154-ac39ed577986" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeLocationBalanceAxis_019fb437-5495-7613-b173-ef98cf2421fb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfIncomeLocationBalanceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019fb437-5495-7830-b154-ac39ed577986" xlink:to="loc_us-gaap_StatementOfIncomeLocationBalanceAxis_019fb437-5495-7613-b173-ef98cf2421fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019fb437-5495-7d0b-9eee-cc4b18a7312e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019fb437-5495-7053-ae27-786139be7003" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019fb437-5495-7d0b-9eee-cc4b18a7312e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnauditedParenthetical_1" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CondensedConsolidatedStatementsofOperationsUnauditedParenthetical_1"/>
  <link:definitionLink xlink:role="http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnauditedParenthetical_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019fb437-5495-7053-ae27-786139be7003" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019fb437-5495-7830-b154-ac39ed577986" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019fb437-5495-7053-ae27-786139be7003" xlink:to="loc_us-gaap_StatementTable_019fb437-5495-7830-b154-ac39ed577986" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019fb437-5495-7d0b-9eee-cc4b18a7312e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019fb437-5495-7053-ae27-786139be7003" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019fb437-5495-7d0b-9eee-cc4b18a7312e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnauditedParenthetical" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CondensedConsolidatedStatementsofStockholdersEquityUnauditedParenthetical"/>
  <link:definitionLink xlink:role="http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-74e6-b366-9a33cea84adf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019e2c6b-4f3a-79d5-99b4-453db7f29685" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-74e6-b366-9a33cea84adf" xlink:to="loc_us-gaap_StatementTable_019e2c6b-4f3a-79d5-99b4-453db7f29685" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-744e-afb1-e3ff3bdab86a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019e2c6b-4f3a-79d5-99b4-453db7f29685" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-744e-afb1-e3ff3bdab86a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-744e-afb1-e3ff3bdab86a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-744e-afb1-e3ff3bdab86a" xlink:to="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-744e-afb1-e3ff3bdab86a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-7f87-b18b-421d9200fa20" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-744e-afb1-e3ff3bdab86a" xlink:to="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-7f87-b18b-421d9200fa20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019e2c6b-4f3a-7383-8b67-e4911a966427" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-7f87-b18b-421d9200fa20" xlink:to="loc_us-gaap_CommonStockMember_019e2c6b-4f3a-7383-8b67-e4911a966427" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-793a-bb89-68a5943dc7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019e2c6b-4f3a-79d5-99b4-453db7f29685" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-793a-bb89-68a5943dc7a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-793a-bb89-68a5943dc7a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-793a-bb89-68a5943dc7a1" xlink:to="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-793a-bb89-68a5943dc7a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-70fc-b378-df52802d1ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-793a-bb89-68a5943dc7a1" xlink:to="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-70fc-b378-df52802d1ac8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_019e2c6b-4f3a-71cf-b1ac-445aa3fc1ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-70fc-b378-df52802d1ac8" xlink:to="loc_us-gaap_RelatedPartyMember_019e2c6b-4f3a-71cf-b1ac-445aa3fc1ab0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_019e2c6b-4f3a-7cf2-a361-13b6686fb947" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-74e6-b366-9a33cea84adf" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_019e2c6b-4f3a-7cf2-a361-13b6686fb947" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_019e2c6b-4f3a-7c85-977a-f6a64be090a8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-74e6-b366-9a33cea84adf" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_019e2c6b-4f3a-7c85-977a-f6a64be090a8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical"/>
  <link:definitionLink xlink:role="http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-702c-8943-c6b8ccf61d38" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019e2c6b-4f3a-7d7a-b8a5-4ddc2fcdd563" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-702c-8943-c6b8ccf61d38" xlink:to="loc_us-gaap_StatementTable_019e2c6b-4f3a-7d7a-b8a5-4ddc2fcdd563" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-76cb-ab00-ba5b31a9316f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019e2c6b-4f3a-7d7a-b8a5-4ddc2fcdd563" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-76cb-ab00-ba5b31a9316f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-76cb-ab00-ba5b31a9316f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-76cb-ab00-ba5b31a9316f" xlink:to="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-76cb-ab00-ba5b31a9316f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-779f-8872-1b7dcf1c2134" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-76cb-ab00-ba5b31a9316f" xlink:to="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-779f-8872-1b7dcf1c2134" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_019e2c6b-4f3a-752b-ac6a-46ec2644989e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-779f-8872-1b7dcf1c2134" xlink:to="loc_us-gaap_RelatedPartyMember_019e2c6b-4f3a-752b-ac6a-46ec2644989e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-7822-ba0a-9870f254741e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019e2c6b-4f3a-7d7a-b8a5-4ddc2fcdd563" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-7822-ba0a-9870f254741e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-7822-ba0a-9870f254741e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-7822-ba0a-9870f254741e" xlink:to="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-7822-ba0a-9870f254741e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-7078-8aae-e4e6bafdefb7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-7822-ba0a-9870f254741e" xlink:to="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-7078-8aae-e4e6bafdefb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019e2c6b-4f3a-73d8-81e3-c6b30fa686fe" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-7078-8aae-e4e6bafdefb7" xlink:to="loc_us-gaap_CommonStockMember_019e2c6b-4f3a-73d8-81e3-c6b30fa686fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_019e2c6b-4f3a-796c-87ae-29ac6d488bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-702c-8943-c6b8ccf61d38" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_019e2c6b-4f3a-796c-87ae-29ac6d488bcf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_019e2c6b-4f3a-7b93-b6ca-9af78f922db6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-702c-8943-c6b8ccf61d38" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_019e2c6b-4f3a-7b93-b6ca-9af78f922db6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3a-7509-8374-07b2b334ddbd" xlink:href="gdrx-20260630.xsd#gdrx_AccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_AccountingPoliciesTable_019e2c6b-4f3a-75ea-8cdf-2bf65c15ed43" xlink:href="gdrx-20260630.xsd#gdrx_AccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3a-7509-8374-07b2b334ddbd" xlink:to="loc_gdrx_AccountingPoliciesTable_019e2c6b-4f3a-75ea-8cdf-2bf65c15ed43" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_019e2c6b-4f3a-720f-96c8-ba1421ed335c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gdrx_AccountingPoliciesTable_019e2c6b-4f3a-75ea-8cdf-2bf65c15ed43" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_019e2c6b-4f3a-720f-96c8-ba1421ed335c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019e2c6b-4f3a-720f-96c8-ba1421ed335c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_019e2c6b-4f3a-720f-96c8-ba1421ed335c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019e2c6b-4f3a-720f-96c8-ba1421ed335c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019e2c6b-4f3a-7e85-a03d-08e33a1809c7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_019e2c6b-4f3a-720f-96c8-ba1421ed335c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019e2c6b-4f3a-7e85-a03d-08e33a1809c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_019e2c6b-4f3a-76ad-a0f7-0f01a5a10abf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019e2c6b-4f3a-7e85-a03d-08e33a1809c7" xlink:to="loc_us-gaap_MoneyMarketFundsMember_019e2c6b-4f3a-76ad-a0f7-0f01a5a10abf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019e2c6b-4f3a-71e5-953f-26504406a5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gdrx_AccountingPoliciesTable_019e2c6b-4f3a-75ea-8cdf-2bf65c15ed43" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019e2c6b-4f3a-71e5-953f-26504406a5c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e2c6b-4f3a-71e5-953f-26504406a5c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019e2c6b-4f3a-71e5-953f-26504406a5c5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e2c6b-4f3a-71e5-953f-26504406a5c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e2c6b-4f3a-7e28-9f99-a657ba432ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019e2c6b-4f3a-71e5-953f-26504406a5c5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e2c6b-4f3a-7e28-9f99-a657ba432ebe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_019e2c6b-4f3a-735a-bbe5-92c1237e2c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e2c6b-4f3a-7e28-9f99-a657ba432ebe" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_019e2c6b-4f3a-735a-bbe5-92c1237e2c2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_019e2c6b-4f3a-7221-a4f5-fc2c39a7380b" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gdrx_AccountingPoliciesTable_019e2c6b-4f3a-75ea-8cdf-2bf65c15ed43" xlink:to="loc_srt_MajorCustomersAxis_019e2c6b-4f3a-7221-a4f5-fc2c39a7380b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_019e2c6b-4f3a-7221-a4f5-fc2c39a7380b_default" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_019e2c6b-4f3a-7221-a4f5-fc2c39a7380b" xlink:to="loc_srt_NameOfMajorCustomerDomain_019e2c6b-4f3a-7221-a4f5-fc2c39a7380b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_019e2c6b-4f3a-730a-ace7-1da819d41e17" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_019e2c6b-4f3a-7221-a4f5-fc2c39a7380b" xlink:to="loc_srt_NameOfMajorCustomerDomain_019e2c6b-4f3a-730a-ace7-1da819d41e17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_CustomerOneMember_019e2c6b-4f3a-71e0-a8c2-5ac43890710c" xlink:href="gdrx-20260630.xsd#gdrx_CustomerOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_019e2c6b-4f3a-730a-ace7-1da819d41e17" xlink:to="loc_gdrx_CustomerOneMember_019e2c6b-4f3a-71e0-a8c2-5ac43890710c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_019e2c6b-4f3a-7f9f-9a6d-6a62c3772e80" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gdrx_AccountingPoliciesTable_019e2c6b-4f3a-75ea-8cdf-2bf65c15ed43" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_019e2c6b-4f3a-7f9f-9a6d-6a62c3772e80" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_019e2c6b-4f3a-7f9f-9a6d-6a62c3772e80_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_019e2c6b-4f3a-7f9f-9a6d-6a62c3772e80" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_019e2c6b-4f3a-7f9f-9a6d-6a62c3772e80_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_019e2c6b-4f3a-7661-9424-0816c931e9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_019e2c6b-4f3a-7f9f-9a6d-6a62c3772e80" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_019e2c6b-4f3a-7661-9424-0816c931e9c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_019e2c6b-4f3a-798f-b7e1-4af1ed58c2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_019e2c6b-4f3a-7661-9424-0816c931e9c2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_019e2c6b-4f3a-798f-b7e1-4af1ed58c2d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_019f8793-69df-7346-8ffd-2bfb6aeaf787" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_019e2c6b-4f3a-7661-9424-0816c931e9c2" xlink:to="loc_us-gaap_AccountsReceivableMember_019f8793-69df-7346-8ffd-2bfb6aeaf787" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_019e2c6b-4f3a-71fe-a74d-4aed7a727ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gdrx_AccountingPoliciesTable_019e2c6b-4f3a-75ea-8cdf-2bf65c15ed43" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_019e2c6b-4f3a-71fe-a74d-4aed7a727ca7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_019e2c6b-4f3a-71fe-a74d-4aed7a727ca7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_019e2c6b-4f3a-71fe-a74d-4aed7a727ca7" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_019e2c6b-4f3a-71fe-a74d-4aed7a727ca7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_019e2c6b-4f3a-7936-a25f-8869215340c7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_019e2c6b-4f3a-71fe-a74d-4aed7a727ca7" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_019e2c6b-4f3a-7936-a25f-8869215340c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_019e2c6b-4f3a-7ba4-8bb0-60260b680b05" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_019e2c6b-4f3a-7936-a25f-8869215340c7" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_019e2c6b-4f3a-7ba4-8bb0-60260b680b05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019e2c6b-4f3a-754e-ab88-a366720c9a68" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gdrx_AccountingPoliciesTable_019e2c6b-4f3a-75ea-8cdf-2bf65c15ed43" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019e2c6b-4f3a-754e-ab88-a366720c9a68" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_019e2c6b-4f3a-754e-ab88-a366720c9a68_default" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019e2c6b-4f3a-754e-ab88-a366720c9a68" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_019e2c6b-4f3a-754e-ab88-a366720c9a68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_019e2c6b-4f3a-793c-ba5f-1aefd20fec80" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019e2c6b-4f3a-754e-ab88-a366720c9a68" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_019e2c6b-4f3a-793c-ba5f-1aefd20fec80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_MinorityEquityInterestsMember_019e2c6b-4f3a-73b6-b69e-e523929de7a4" xlink:href="gdrx-20260630.xsd#gdrx_MinorityEquityInterestsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_019e2c6b-4f3a-793c-ba5f-1aefd20fec80" xlink:to="loc_gdrx_MinorityEquityInterestsMember_019e2c6b-4f3a-73b6-b69e-e523929de7a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019e2c6b-4f3a-7df4-9a82-f4c3a45aa22b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_gdrx_AccountingPoliciesTable_019e2c6b-4f3a-75ea-8cdf-2bf65c15ed43" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019e2c6b-4f3a-7df4-9a82-f4c3a45aa22b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e2c6b-4f3a-7df4-9a82-f4c3a45aa22b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019e2c6b-4f3a-7df4-9a82-f4c3a45aa22b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e2c6b-4f3a-7df4-9a82-f4c3a45aa22b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e2c6b-4f3a-7a76-8e11-1db9e0f9e16c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019e2c6b-4f3a-7df4-9a82-f4c3a45aa22b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e2c6b-4f3a-7a76-8e11-1db9e0f9e16c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_OperatingLeaseRightOfUseAssetsMember_019e2c6b-4f3a-70e4-8d3b-83579ac146b4" xlink:href="gdrx-20260630.xsd#gdrx_OperatingLeaseRightOfUseAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e2c6b-4f3a-7a76-8e11-1db9e0f9e16c" xlink:to="loc_gdrx_OperatingLeaseRightOfUseAssetsMember_019e2c6b-4f3a-70e4-8d3b-83579ac146b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_019e2c6b-4f3a-7454-83cc-f869e7207a34" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3a-7509-8374-07b2b334ddbd" xlink:to="loc_us-gaap_NumberOfOperatingSegments_019e2c6b-4f3a-7454-83cc-f869e7207a34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019e2c6b-4f3a-7134-a69f-eed59bda22eb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3a-7509-8374-07b2b334ddbd" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019e2c6b-4f3a-7134-a69f-eed59bda22eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_019e2c6b-4f3a-79cb-b33e-064859e9b0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3a-7509-8374-07b2b334ddbd" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_019e2c6b-4f3a-79cb-b33e-064859e9b0b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties_019f878c-b651-74cd-875b-8b210356968a" xlink:href="gdrx-20260630.xsd#gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3a-7509-8374-07b2b334ddbd" xlink:to="loc_gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties_019f878c-b651-74cd-875b-8b210356968a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_019e2c6b-4f3a-76df-8929-490bfca737f3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3a-7509-8374-07b2b334ddbd" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_019e2c6b-4f3a-76df-8929-490bfca737f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_019e2c6b-4f3a-774a-b40c-3c0f4a371887" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3a-7509-8374-07b2b334ddbd" xlink:to="loc_us-gaap_EquityMethodInvestments_019e2c6b-4f3a-774a-b40c-3c0f4a371887" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_019e2c6b-4f3a-7322-9e70-bb3a88f4d397" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3a-7509-8374-07b2b334ddbd" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_019e2c6b-4f3a-7322-9e70-bb3a88f4d397" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e2c6b-4f3a-70f3-bfdd-dee6c1f83154" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3a-7509-8374-07b2b334ddbd" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e2c6b-4f3a-70f3-bfdd-dee6c1f83154" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://goodrx.com/role/BusinessCombinationDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#BusinessCombinationDetails"/>
  <link:definitionLink xlink:role="http://goodrx.com/role/BusinessCombinationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_019e2c6b-4f3a-758e-80f7-88f6d415044f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019e2c6b-4f3a-799e-bc48-7c3c4213fc06" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019e2c6b-4f3a-758e-80f7-88f6d415044f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019e2c6b-4f3a-799e-bc48-7c3c4213fc06" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_019e2c6b-4f3a-7b73-98cd-cdbe9e1c21f3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019e2c6b-4f3a-799e-bc48-7c3c4213fc06" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_019e2c6b-4f3a-7b73-98cd-cdbe9e1c21f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019e2c6b-4f3a-7b73-98cd-cdbe9e1c21f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_019e2c6b-4f3a-7b73-98cd-cdbe9e1c21f3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019e2c6b-4f3a-7b73-98cd-cdbe9e1c21f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019e2c6b-4f3a-72b2-bebb-eacf357e626b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_019e2c6b-4f3a-7b73-98cd-cdbe9e1c21f3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019e2c6b-4f3a-72b2-bebb-eacf357e626b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_VividRxClearRxIncMember_019e2c6b-4f3a-7c52-bca9-1947e88e387b" xlink:href="gdrx-20260630.xsd#gdrx_VividRxClearRxIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019e2c6b-4f3a-72b2-bebb-eacf357e626b" xlink:to="loc_gdrx_VividRxClearRxIncMember_019e2c6b-4f3a-7c52-bca9-1947e88e387b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_VitacarePrescriptionServicesIncMember_019e2c6b-4f3a-722b-b22a-4bcf1b8b2660" xlink:href="gdrx-20260630.xsd#gdrx_VitacarePrescriptionServicesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019e2c6b-4f3a-72b2-bebb-eacf357e626b" xlink:to="loc_gdrx_VitacarePrescriptionServicesIncMember_019e2c6b-4f3a-722b-b22a-4bcf1b8b2660" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019e2c6b-4f3a-7af0-a822-0ead2c490429" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019e2c6b-4f3a-799e-bc48-7c3c4213fc06" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019e2c6b-4f3a-7af0-a822-0ead2c490429" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019e2c6b-4f3a-7af0-a822-0ead2c490429_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019e2c6b-4f3a-7af0-a822-0ead2c490429" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019e2c6b-4f3a-7af0-a822-0ead2c490429_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019e2c6b-4f3a-76a6-b960-b263ede8f537" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019e2c6b-4f3a-7af0-a822-0ead2c490429" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019e2c6b-4f3a-76a6-b960-b263ede8f537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_019e2c6b-4f3a-7b5f-a660-465e9b77bb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019e2c6b-4f3a-76a6-b960-b263ede8f537" xlink:to="loc_us-gaap_CustomerRelationshipsMember_019e2c6b-4f3a-7b5f-a660-465e9b77bb4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_019e2c6b-4f3a-7b65-9937-ce91a180485d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019e2c6b-4f3a-758e-80f7-88f6d415044f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_019e2c6b-4f3a-7b65-9937-ce91a180485d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_019e2c6b-4f3a-7f69-bbbc-6393db46c6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019e2c6b-4f3a-758e-80f7-88f6d415044f" xlink:to="loc_us-gaap_Goodwill_019e2c6b-4f3a-7f69-bbbc-6393db46c6e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_019e2c6b-4f3a-7325-bce7-920cbde4988c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019e2c6b-4f3a-758e-80f7-88f6d415044f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_019e2c6b-4f3a-7325-bce7-920cbde4988c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_019e2c6b-4f3a-7723-b7c9-b49d58ce8a16" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019e2c6b-4f3a-758e-80f7-88f6d415044f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_019e2c6b-4f3a-7723-b7c9-b49d58ce8a16" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://goodrx.com/role/DebtAdditionalInformationDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#DebtAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://goodrx.com/role/DebtAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-7024-8c2d-9f26d6aeaeec" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_019e2c6b-4f3a-72c5-8c95-f8b66e595106" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-7024-8c2d-9f26d6aeaeec" xlink:to="loc_us-gaap_DebtInstrumentTable_019e2c6b-4f3a-72c5-8c95-f8b66e595106" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019e2c6b-4f3a-7cd9-88bd-67cbbca31ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_019e2c6b-4f3a-72c5-8c95-f8b66e595106" xlink:to="loc_us-gaap_DebtInstrumentAxis_019e2c6b-4f3a-7cd9-88bd-67cbbca31ef5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019e2c6b-4f3a-7cd9-88bd-67cbbca31ef5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_019e2c6b-4f3a-7cd9-88bd-67cbbca31ef5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019e2c6b-4f3a-7cd9-88bd-67cbbca31ef5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019e2c6b-4f3a-7e84-b8f8-f78bbf313544" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_019e2c6b-4f3a-7cd9-88bd-67cbbca31ef5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019e2c6b-4f3a-7e84-b8f8-f78bbf313544" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_FirstLienCreditAgreementMember_019e2c6b-4f3a-7949-ae59-3a63b49e1f8d" xlink:href="gdrx-20260630.xsd#gdrx_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019e2c6b-4f3a-7e84-b8f8-f78bbf313544" xlink:to="loc_gdrx_FirstLienCreditAgreementMember_019e2c6b-4f3a-7949-ae59-3a63b49e1f8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_019e2c6b-4f3a-7a8b-bcdb-9957e19e2549" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_019e2c6b-4f3a-72c5-8c95-f8b66e595106" xlink:to="loc_us-gaap_CreditFacilityAxis_019e2c6b-4f3a-7a8b-bcdb-9957e19e2549" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_019e2c6b-4f3a-7a8b-bcdb-9957e19e2549_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_019e2c6b-4f3a-7a8b-bcdb-9957e19e2549" xlink:to="loc_us-gaap_CreditFacilityDomain_019e2c6b-4f3a-7a8b-bcdb-9957e19e2549_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_019e2c6b-4f3a-79cd-a62d-555f0ba40a97" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_019e2c6b-4f3a-7a8b-bcdb-9957e19e2549" xlink:to="loc_us-gaap_CreditFacilityDomain_019e2c6b-4f3a-79cd-a62d-555f0ba40a97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_019e2c6b-4f3a-7321-ab4f-95bdefcb9ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_019e2c6b-4f3a-79cd-a62d-555f0ba40a97" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_019e2c6b-4f3a-7321-ab4f-95bdefcb9ed9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_019e2c6b-4f3a-79f2-a5ab-35ffcf3ec333" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_019e2c6b-4f3a-79cd-a62d-555f0ba40a97" xlink:to="loc_us-gaap_LetterOfCreditMember_019e2c6b-4f3a-79f2-a5ab-35ffcf3ec333" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_019e2c6b-4f3a-7af4-8b27-a5539d7f51cd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-7024-8c2d-9f26d6aeaeec" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_019e2c6b-4f3a-7af4-8b27-a5539d7f51cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension_019e2c6b-4f3a-7bc8-a066-b339905b25e6" xlink:href="gdrx-20260630.xsd#gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-7024-8c2d-9f26d6aeaeec" xlink:to="loc_gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension_019e2c6b-4f3a-7bc8-a066-b339905b25e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_019e2c6b-4f3a-728a-b7b0-a61b56b74483" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-7024-8c2d-9f26d6aeaeec" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_019e2c6b-4f3a-728a-b7b0-a61b56b74483" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_019e2c6b-4f3a-7fd3-a477-3be3ff2dbc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-7024-8c2d-9f26d6aeaeec" xlink:to="loc_us-gaap_LineOfCredit_019e2c6b-4f3a-7fd3-a477-3be3ff2dbc4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio_019e2c6b-4f3a-7002-ad53-57f3a7996ecb" xlink:href="gdrx-20260630.xsd#gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-7024-8c2d-9f26d6aeaeec" xlink:to="loc_gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio_019e2c6b-4f3a-7002-ad53-57f3a7996ecb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_019e2c6b-4f3a-71df-aab4-a7c92141ccd1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-7024-8c2d-9f26d6aeaeec" xlink:to="loc_us-gaap_LongTermDebtFairValue_019e2c6b-4f3a-71df-aab4-a7c92141ccd1" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://goodrx.com/role/DebtScheduleofDebtDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#DebtScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://goodrx.com/role/DebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-70f7-bee3-27fcea00437f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_019e2c6b-4f3a-7261-8e2c-c114c7261a91" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-70f7-bee3-27fcea00437f" xlink:to="loc_us-gaap_DebtInstrumentTable_019e2c6b-4f3a-7261-8e2c-c114c7261a91" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019e2c6b-4f3a-7d4f-90a1-eaf54caed77e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_019e2c6b-4f3a-7261-8e2c-c114c7261a91" xlink:to="loc_us-gaap_DebtInstrumentAxis_019e2c6b-4f3a-7d4f-90a1-eaf54caed77e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019e2c6b-4f3a-7d4f-90a1-eaf54caed77e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_019e2c6b-4f3a-7d4f-90a1-eaf54caed77e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019e2c6b-4f3a-7d4f-90a1-eaf54caed77e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019e2c6b-4f3a-7ac6-aec4-d2d5221a89de" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_019e2c6b-4f3a-7d4f-90a1-eaf54caed77e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019e2c6b-4f3a-7ac6-aec4-d2d5221a89de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_A2024TermLoanMember_019e2c6b-4f3a-78ef-bb51-8d579c81e2f7" xlink:href="gdrx-20260630.xsd#gdrx_A2024TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019e2c6b-4f3a-7ac6-aec4-d2d5221a89de" xlink:to="loc_gdrx_A2024TermLoanMember_019e2c6b-4f3a-78ef-bb51-8d579c81e2f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_FirstLienCreditAgreementMember_019e2c6b-4f3a-78ed-b86c-075043034ba1" xlink:href="gdrx-20260630.xsd#gdrx_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019e2c6b-4f3a-7ac6-aec4-d2d5221a89de" xlink:to="loc_gdrx_FirstLienCreditAgreementMember_019e2c6b-4f3a-78ed-b86c-075043034ba1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_019e2c6b-4f3a-7566-8070-8c641c3c8705" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-70f7-bee3-27fcea00437f" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_019e2c6b-4f3a-7566-8070-8c641c3c8705" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_019e2c6b-4f3a-73f2-8397-684d874bf42c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-70f7-bee3-27fcea00437f" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_019e2c6b-4f3a-73f2-8397-684d874bf42c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_019e2c6b-4f3a-75d3-a728-a1a78b0b2c48" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-70f7-bee3-27fcea00437f" xlink:to="loc_us-gaap_LongTermDebt_019e2c6b-4f3a-75d3-a728-a1a78b0b2c48" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://goodrx.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://goodrx.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_019e2c6b-4f3a-7504-b4d6-683a526d08df" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_LossContingenciesTable_019e2c6b-4f3a-7504-b4d6-683a526d08df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_019e2c6b-4f3a-7dd2-bd2e-02d537d4b187" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_019e2c6b-4f3a-7504-b4d6-683a526d08df" xlink:to="loc_us-gaap_LitigationStatusAxis_019e2c6b-4f3a-7dd2-bd2e-02d537d4b187" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_019e2c6b-4f3a-7dd2-bd2e-02d537d4b187_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_019e2c6b-4f3a-7dd2-bd2e-02d537d4b187" xlink:to="loc_us-gaap_LitigationStatusDomain_019e2c6b-4f3a-7dd2-bd2e-02d537d4b187_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_019e2c6b-4f3a-72af-bd07-bd05b2cf1a57" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_019e2c6b-4f3a-7dd2-bd2e-02d537d4b187" xlink:to="loc_us-gaap_LitigationStatusDomain_019e2c6b-4f3a-72af-bd07-bd05b2cf1a57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_019e2c6b-4f3a-7e17-bb10-1677cd96aa42" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_019e2c6b-4f3a-72af-bd07-bd05b2cf1a57" xlink:to="loc_us-gaap_PendingLitigationMember_019e2c6b-4f3a-7e17-bb10-1677cd96aa42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_019e2c6b-4f3a-7adf-bcb8-4503f713741e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_019e2c6b-4f3a-72af-bd07-bd05b2cf1a57" xlink:to="loc_us-gaap_SettledLitigationMember_019e2c6b-4f3a-7adf-bcb8-4503f713741e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_019e2c6b-4f3a-75ad-9ed9-975e27508238" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_019e2c6b-4f3a-7504-b4d6-683a526d08df" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_019e2c6b-4f3a-75ad-9ed9-975e27508238" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_019e2c6b-4f3a-75ad-9ed9-975e27508238_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_019e2c6b-4f3a-75ad-9ed9-975e27508238" xlink:to="loc_us-gaap_LossContingencyNatureDomain_019e2c6b-4f3a-75ad-9ed9-975e27508238_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_019e2c6b-4f3a-7176-982a-7b48938ac387" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_019e2c6b-4f3a-75ad-9ed9-975e27508238" xlink:to="loc_us-gaap_LossContingencyNatureDomain_019e2c6b-4f3a-7176-982a-7b48938ac387" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PrivacyProtectionMember_019e2c6b-4f3a-77e1-87ec-4de8ff332d18" xlink:href="gdrx-20260630.xsd#gdrx_PrivacyProtectionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_019e2c6b-4f3a-7176-982a-7b48938ac387" xlink:to="loc_gdrx_PrivacyProtectionMember_019e2c6b-4f3a-77e1-87ec-4de8ff332d18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember_019e2c6b-4f3a-729a-b1bc-54959e1aeba6" xlink:href="gdrx-20260630.xsd#gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_019e2c6b-4f3a-7176-982a-7b48938ac387" xlink:to="loc_gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember_019e2c6b-4f3a-729a-b1bc-54959e1aeba6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_019e2c6b-4f3a-7f18-968a-01e11fa26432" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_019e2c6b-4f3a-7504-b4d6-683a526d08df" xlink:to="loc_srt_LitigationCaseAxis_019e2c6b-4f3a-7f18-968a-01e11fa26432" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_019e2c6b-4f3a-7f18-968a-01e11fa26432_default" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_019e2c6b-4f3a-7f18-968a-01e11fa26432" xlink:to="loc_srt_LitigationCaseTypeDomain_019e2c6b-4f3a-7f18-968a-01e11fa26432_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_019e2c6b-4f3a-743c-bce3-df92af680ac3" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_019e2c6b-4f3a-7f18-968a-01e11fa26432" xlink:to="loc_srt_LitigationCaseTypeDomain_019e2c6b-4f3a-743c-bce3-df92af680ac3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_SDFLClassActionMatterMember_019e2c6b-4f3a-7ca1-b0b3-0a910e8889d5" xlink:href="gdrx-20260630.xsd#gdrx_SDFLClassActionMatterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_019e2c6b-4f3a-743c-bce3-df92af680ac3" xlink:to="loc_gdrx_SDFLClassActionMatterMember_019e2c6b-4f3a-7ca1-b0b3-0a910e8889d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_NDCAClassActionMatterMember_019e2c6b-4f3a-7ee0-bc97-c87d948203c7" xlink:href="gdrx-20260630.xsd#gdrx_NDCAClassActionMatterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_019e2c6b-4f3a-743c-bce3-df92af680ac3" xlink:to="loc_gdrx_NDCAClassActionMatterMember_019e2c6b-4f3a-7ee0-bc97-c87d948203c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationBalanceAxis_019e2c6b-4f3a-77c3-adc8-09c35b7bc2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfFinancialPositionLocationBalanceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_019e2c6b-4f3a-7504-b4d6-683a526d08df" xlink:to="loc_us-gaap_StatementOfFinancialPositionLocationBalanceAxis_019e2c6b-4f3a-77c3-adc8-09c35b7bc2c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_019e2c6b-4f3a-77da-8915-70e3d29346d9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_019e2c6b-4f3a-77da-8915-70e3d29346d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_019e2c6b-4f3a-7447-a249-795bc0363252" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_019e2c6b-4f3a-7447-a249-795bc0363252" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfDefendants_019e2c6b-4f3a-7fc0-85c5-267aa905fb34" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyNumberOfDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_LossContingencyNumberOfDefendants_019e2c6b-4f3a-7fc0-85c5-267aa905fb34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_019e2c6b-4f3a-7793-bda3-e31d0e57fa99" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_019e2c6b-4f3a-7793-bda3-e31d0e57fa99" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_019e2c6b-4f3a-71f9-bc97-6ba8651b8825" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_019e2c6b-4f3a-71f9-bc97-6ba8651b8825" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_019e2c6b-4f3a-7d6d-a0aa-7f77c7227787" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_019e2c6b-4f3a-7d6d-a0aa-7f77c7227787" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSettlementsReceivable_019e2c6b-4f3a-72d1-a033-9e2f7a7a1a80" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InsuranceSettlementsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_InsuranceSettlementsReceivable_019e2c6b-4f3a-72d1-a033-9e2f7a7a1a80" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://goodrx.com/role/CommitmentsandContingenciesDetails_1" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CommitmentsandContingenciesDetails_1"/>
  <link:definitionLink xlink:role="http://goodrx.com/role/CommitmentsandContingenciesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_019e2c6b-4f3a-7504-b4d6-683a526d08df" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_LossContingenciesTable_019e2c6b-4f3a-7504-b4d6-683a526d08df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_019e2c6b-4f3a-7dd2-bd2e-02d537d4b187" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_019e2c6b-4f3a-7504-b4d6-683a526d08df" xlink:to="loc_us-gaap_LitigationStatusAxis_019e2c6b-4f3a-7dd2-bd2e-02d537d4b187" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_019e2c6b-4f3a-7dd2-bd2e-02d537d4b187_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_019e2c6b-4f3a-7dd2-bd2e-02d537d4b187" xlink:to="loc_us-gaap_LitigationStatusDomain_019e2c6b-4f3a-7dd2-bd2e-02d537d4b187_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_019e2c6b-4f3a-72af-bd07-bd05b2cf1a57" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_019e2c6b-4f3a-7dd2-bd2e-02d537d4b187" xlink:to="loc_us-gaap_LitigationStatusDomain_019e2c6b-4f3a-72af-bd07-bd05b2cf1a57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_019e2c6b-4f3a-7e17-bb10-1677cd96aa42" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_019e2c6b-4f3a-72af-bd07-bd05b2cf1a57" xlink:to="loc_us-gaap_PendingLitigationMember_019e2c6b-4f3a-7e17-bb10-1677cd96aa42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_019e2c6b-4f3a-7adf-bcb8-4503f713741e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_019e2c6b-4f3a-72af-bd07-bd05b2cf1a57" xlink:to="loc_us-gaap_SettledLitigationMember_019e2c6b-4f3a-7adf-bcb8-4503f713741e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_019e2c6b-4f3a-75ad-9ed9-975e27508238" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_019e2c6b-4f3a-7504-b4d6-683a526d08df" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_019e2c6b-4f3a-75ad-9ed9-975e27508238" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_019e2c6b-4f3a-75ad-9ed9-975e27508238_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_019e2c6b-4f3a-75ad-9ed9-975e27508238" xlink:to="loc_us-gaap_LossContingencyNatureDomain_019e2c6b-4f3a-75ad-9ed9-975e27508238_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_019e2c6b-4f3a-7176-982a-7b48938ac387" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_019e2c6b-4f3a-75ad-9ed9-975e27508238" xlink:to="loc_us-gaap_LossContingencyNatureDomain_019e2c6b-4f3a-7176-982a-7b48938ac387" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PrivacyProtectionMember_019e2c6b-4f3a-77e1-87ec-4de8ff332d18" xlink:href="gdrx-20260630.xsd#gdrx_PrivacyProtectionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_019e2c6b-4f3a-7176-982a-7b48938ac387" xlink:to="loc_gdrx_PrivacyProtectionMember_019e2c6b-4f3a-77e1-87ec-4de8ff332d18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember_019e2c6b-4f3a-729a-b1bc-54959e1aeba6" xlink:href="gdrx-20260630.xsd#gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_019e2c6b-4f3a-7176-982a-7b48938ac387" xlink:to="loc_gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember_019e2c6b-4f3a-729a-b1bc-54959e1aeba6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_019e2c6b-4f3a-7f18-968a-01e11fa26432" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_019e2c6b-4f3a-7504-b4d6-683a526d08df" xlink:to="loc_srt_LitigationCaseAxis_019e2c6b-4f3a-7f18-968a-01e11fa26432" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_019e2c6b-4f3a-7f18-968a-01e11fa26432_default" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_019e2c6b-4f3a-7f18-968a-01e11fa26432" xlink:to="loc_srt_LitigationCaseTypeDomain_019e2c6b-4f3a-7f18-968a-01e11fa26432_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_019e2c6b-4f3a-743c-bce3-df92af680ac3" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_019e2c6b-4f3a-7f18-968a-01e11fa26432" xlink:to="loc_srt_LitigationCaseTypeDomain_019e2c6b-4f3a-743c-bce3-df92af680ac3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_SDFLClassActionMatterMember_019e2c6b-4f3a-7ca1-b0b3-0a910e8889d5" xlink:href="gdrx-20260630.xsd#gdrx_SDFLClassActionMatterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_019e2c6b-4f3a-743c-bce3-df92af680ac3" xlink:to="loc_gdrx_SDFLClassActionMatterMember_019e2c6b-4f3a-7ca1-b0b3-0a910e8889d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_NDCAClassActionMatterMember_019e2c6b-4f3a-7ee0-bc97-c87d948203c7" xlink:href="gdrx-20260630.xsd#gdrx_NDCAClassActionMatterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_019e2c6b-4f3a-743c-bce3-df92af680ac3" xlink:to="loc_gdrx_NDCAClassActionMatterMember_019e2c6b-4f3a-7ee0-bc97-c87d948203c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_019e2c6b-4f3a-77da-8915-70e3d29346d9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_019e2c6b-4f3a-77da-8915-70e3d29346d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_019e2c6b-4f3a-7447-a249-795bc0363252" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_019e2c6b-4f3a-7447-a249-795bc0363252" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfDefendants_019e2c6b-4f3a-7fc0-85c5-267aa905fb34" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyNumberOfDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_LossContingencyNumberOfDefendants_019e2c6b-4f3a-7fc0-85c5-267aa905fb34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_019e2c6b-4f3a-7793-bda3-e31d0e57fa99" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_019e2c6b-4f3a-7793-bda3-e31d0e57fa99" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_019e2c6b-4f3a-71f9-bc97-6ba8651b8825" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_019e2c6b-4f3a-71f9-bc97-6ba8651b8825" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_019e2c6b-4f3a-7d6d-a0aa-7f77c7227787" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_019e2c6b-4f3a-7d6d-a0aa-7f77c7227787" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSettlementsReceivable_019e2c6b-4f3a-72d1-a033-9e2f7a7a1a80" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InsuranceSettlementsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_InsuranceSettlementsReceivable_019e2c6b-4f3a-72d1-a033-9e2f7a7a1a80" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://goodrx.com/role/RevenueDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#RevenueDetails"/>
  <link:definitionLink xlink:role="http://goodrx.com/role/RevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_019e2c6b-4f3a-7402-8883-b45536ce7210" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_019e2c6b-4f3a-70c7-a457-6a450b284380" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019e2c6b-4f3a-7402-8883-b45536ce7210" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_019e2c6b-4f3a-70c7-a457-6a450b284380" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019e2c6b-4f3a-71e4-895d-403f13606c2f" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019e2c6b-4f3a-70c7-a457-6a450b284380" xlink:to="loc_srt_ProductOrServiceAxis_019e2c6b-4f3a-71e4-895d-403f13606c2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019e2c6b-4f3a-71e4-895d-403f13606c2f_default" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_019e2c6b-4f3a-71e4-895d-403f13606c2f" xlink:to="loc_srt_ProductsAndServicesDomain_019e2c6b-4f3a-71e4-895d-403f13606c2f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019e2c6b-4f3a-78f4-a8ed-084fba414a8e" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_019e2c6b-4f3a-71e4-895d-403f13606c2f" xlink:to="loc_srt_ProductsAndServicesDomain_019e2c6b-4f3a-78f4-a8ed-084fba414a8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PrescriptionTransactionsRevenueMember_019e2c6b-4f3a-741e-9cba-5adad414b965" xlink:href="gdrx-20260630.xsd#gdrx_PrescriptionTransactionsRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019e2c6b-4f3a-78f4-a8ed-084fba414a8e" xlink:to="loc_gdrx_PrescriptionTransactionsRevenueMember_019e2c6b-4f3a-741e-9cba-5adad414b965" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_SubscriptionRevenueMember_019e2c6b-4f3a-778f-b592-5ac846e44c15" xlink:href="gdrx-20260630.xsd#gdrx_SubscriptionRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019e2c6b-4f3a-78f4-a8ed-084fba414a8e" xlink:to="loc_gdrx_SubscriptionRevenueMember_019e2c6b-4f3a-778f-b592-5ac846e44c15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PharmaManufacturerSolutionsRevenuesMember_019e2c6b-4f3a-7c0c-909d-78facc6d8097" xlink:href="gdrx-20260630.xsd#gdrx_PharmaManufacturerSolutionsRevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019e2c6b-4f3a-78f4-a8ed-084fba414a8e" xlink:to="loc_gdrx_PharmaManufacturerSolutionsRevenuesMember_019e2c6b-4f3a-7c0c-909d-78facc6d8097" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_OtherRevenueMember_019e2c6b-4f3a-76c7-9e2a-b640078dcd8f" xlink:href="gdrx-20260630.xsd#gdrx_OtherRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019e2c6b-4f3a-78f4-a8ed-084fba414a8e" xlink:to="loc_gdrx_OtherRevenueMember_019e2c6b-4f3a-76c7-9e2a-b640078dcd8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019e2c6b-4f3a-70c3-896e-859683022b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019e2c6b-4f3a-7402-8883-b45536ce7210" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019e2c6b-4f3a-70c3-896e-859683022b6f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#StockholdersEquityAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019e2c6b-4f3a-7035-a5f4-026d2c1a7173" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-75d0-9083-770be1f9f301" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_019e2c6b-4f3a-7035-a5f4-026d2c1a7173" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-75d0-9083-770be1f9f301" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramAxis_019e2c6b-4f3a-717e-ab16-dacd2485e6e5" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-75d0-9083-770be1f9f301" xlink:to="loc_srt_ShareRepurchaseProgramAxis_019e2c6b-4f3a-717e-ab16-dacd2485e6e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain_019e2c6b-4f3a-717e-ab16-dacd2485e6e5_default" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ShareRepurchaseProgramAxis_019e2c6b-4f3a-717e-ab16-dacd2485e6e5" xlink:to="loc_srt_ShareRepurchaseProgramDomain_019e2c6b-4f3a-717e-ab16-dacd2485e6e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain_019e2c6b-4f3a-7d96-b0e0-4686d4eedb24" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ShareRepurchaseProgramAxis_019e2c6b-4f3a-717e-ab16-dacd2485e6e5" xlink:to="loc_srt_ShareRepurchaseProgramDomain_019e2c6b-4f3a-7d96-b0e0-4686d4eedb24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_NewRepurchaseProgramMember_019e2c6b-4f3a-7350-9ab9-402bd0cdc320" xlink:href="gdrx-20260630.xsd#gdrx_NewRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ShareRepurchaseProgramDomain_019e2c6b-4f3a-7d96-b0e0-4686d4eedb24" xlink:to="loc_gdrx_NewRepurchaseProgramMember_019e2c6b-4f3a-7350-9ab9-402bd0cdc320" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7ebf-8614-87df3da7c4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-75d0-9083-770be1f9f301" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7ebf-8614-87df3da7c4ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-7ebf-8614-87df3da7c4ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7ebf-8614-87df3da7c4ab" xlink:to="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-7ebf-8614-87df3da7c4ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-70ed-abc6-a2e479ef9563" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7ebf-8614-87df3da7c4ab" xlink:to="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-70ed-abc6-a2e479ef9563" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_019e2c6b-4f3a-7ebe-ae12-78cadc0feef3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-70ed-abc6-a2e479ef9563" xlink:to="loc_us-gaap_CommonClassAMember_019e2c6b-4f3a-7ebe-ae12-78cadc0feef3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_CommonClassAAndClassBMember_019e2c6b-4f3a-7289-bcc3-bfee3c0a8dcf" xlink:href="gdrx-20260630.xsd#gdrx_CommonClassAAndClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-70ed-abc6-a2e479ef9563" xlink:to="loc_gdrx_CommonClassAAndClassBMember_019e2c6b-4f3a-7289-bcc3-bfee3c0a8dcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_019e2c6b-4f3a-767a-9294-f2b64cab04d2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-75d0-9083-770be1f9f301" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_019e2c6b-4f3a-767a-9294-f2b64cab04d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_019e2c6b-4f3a-767a-9294-f2b64cab04d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_019e2c6b-4f3a-767a-9294-f2b64cab04d2" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_019e2c6b-4f3a-767a-9294-f2b64cab04d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_019e2c6b-4f3a-7d25-85c9-ce8379865369" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_019e2c6b-4f3a-767a-9294-f2b64cab04d2" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_019e2c6b-4f3a-7d25-85c9-ce8379865369" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_FranciscoPartnersStockPurchaseAgreementMember_019e2c6b-4f3a-7cc6-b823-dd2c97382717" xlink:href="gdrx-20260630.xsd#gdrx_FranciscoPartnersStockPurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_019e2c6b-4f3a-7d25-85c9-ce8379865369" xlink:to="loc_gdrx_FranciscoPartnersStockPurchaseAgreementMember_019e2c6b-4f3a-7cc6-b823-dd2c97382717" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_IdeaMenLLCMember_019e2c6b-4f3a-7947-95a8-9a15357c4844" xlink:href="gdrx-20260630.xsd#gdrx_IdeaMenLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_019e2c6b-4f3a-7d25-85c9-ce8379865369" xlink:to="loc_gdrx_IdeaMenLLCMember_019e2c6b-4f3a-7947-95a8-9a15357c4844" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_SpectrumStockPurchaseAgreementMember_019e2c6b-4f3a-72c9-baf1-a17172eb28c2" xlink:href="gdrx-20260630.xsd#gdrx_SpectrumStockPurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_019e2c6b-4f3a-7d25-85c9-ce8379865369" xlink:to="loc_gdrx_SpectrumStockPurchaseAgreementMember_019e2c6b-4f3a-72c9-baf1-a17172eb28c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-70ec-a6fb-bf069747737e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-75d0-9083-770be1f9f301" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-70ec-a6fb-bf069747737e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-70ec-a6fb-bf069747737e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-70ec-a6fb-bf069747737e" xlink:to="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-70ec-a6fb-bf069747737e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-7b8c-9456-24b5c72d94e3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-70ec-a6fb-bf069747737e" xlink:to="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-7b8c-9456-24b5c72d94e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_019e2c6b-4f3a-7132-b19f-59113d6bd6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-7b8c-9456-24b5c72d94e3" xlink:to="loc_us-gaap_RelatedPartyMember_019e2c6b-4f3a-7132-b19f-59113d6bd6cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-74bc-82de-9dc0661b2531" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-75d0-9083-770be1f9f301" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-74bc-82de-9dc0661b2531" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-74bc-82de-9dc0661b2531_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-74bc-82de-9dc0661b2531" xlink:to="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-74bc-82de-9dc0661b2531_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-7b1a-878f-464a408a94df" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-74bc-82de-9dc0661b2531" xlink:to="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-7b1a-878f-464a408a94df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019e2c6b-4f3a-7e74-96cb-a0af461fcf29" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-7b1a-878f-464a408a94df" xlink:to="loc_us-gaap_CommonStockMember_019e2c6b-4f3a-7e74-96cb-a0af461fcf29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_019e2c6b-4f3a-74f0-93d4-289350ee7e47" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019e2c6b-4f3a-7035-a5f4-026d2c1a7173" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_019e2c6b-4f3a-74f0-93d4-289350ee7e47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_019e2c6b-4f3a-769a-85c8-b2d0325d3a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019e2c6b-4f3a-7035-a5f4-026d2c1a7173" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_019e2c6b-4f3a-769a-85c8-b2d0325d3a3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_019e2c6b-4f3a-7639-8079-3fad871a5e14" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019e2c6b-4f3a-7035-a5f4-026d2c1a7173" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_019e2c6b-4f3a-7639-8079-3fad871a5e14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_019e2c6b-4f3a-71da-b1e7-a60059f4c861" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019e2c6b-4f3a-7035-a5f4-026d2c1a7173" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_019e2c6b-4f3a-71da-b1e7-a60059f4c861" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_019e2c6b-4f3a-7a75-a38a-8df073bcf275" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019e2c6b-4f3a-7035-a5f4-026d2c1a7173" xlink:to="loc_us-gaap_SharePrice_019e2c6b-4f3a-7a75-a38a-8df073bcf275" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_019e2c6b-4f3a-703c-834c-22c24a6ad3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019e2c6b-4f3a-7035-a5f4-026d2c1a7173" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_019e2c6b-4f3a-703c-834c-22c24a6ad3ea" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://goodrx.com/role/StockholdersEquityScheduleofRepurchaseAgreementsDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#StockholdersEquityScheduleofRepurchaseAgreementsDetails"/>
  <link:definitionLink xlink:role="http://goodrx.com/role/StockholdersEquityScheduleofRepurchaseAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e2c6b-4f3a-74b0-bf0a-e4e5c37f300b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-73c7-9048-a3256f4e2295" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e2c6b-4f3a-74b0-bf0a-e4e5c37f300b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-73c7-9048-a3256f4e2295" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7103-aec8-ebd5abc5b00e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-73c7-9048-a3256f4e2295" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7103-aec8-ebd5abc5b00e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-7103-aec8-ebd5abc5b00e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7103-aec8-ebd5abc5b00e" xlink:to="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-7103-aec8-ebd5abc5b00e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-77be-894a-defa6dea4018" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7103-aec8-ebd5abc5b00e" xlink:to="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-77be-894a-defa6dea4018" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_019e2c6b-4f3a-7d4d-b18f-4aee191978b8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-77be-894a-defa6dea4018" xlink:to="loc_us-gaap_CommonClassAMember_019e2c6b-4f3a-7d4d-b18f-4aee191978b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_019e2c6b-4f3a-7a84-89cf-033378f956fe" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e2c6b-4f3a-74b0-bf0a-e4e5c37f300b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_019e2c6b-4f3a-7a84-89cf-033378f956fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_019e2c6b-4f3a-7e75-98ac-956047ea8a86" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e2c6b-4f3a-74b0-bf0a-e4e5c37f300b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_019e2c6b-4f3a-7e75-98ac-956047ea8a86" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleofWeightedAveragePotentiallyDilutiveSharesareExcludedfromComputationofDilutedLossEarningsPerShareDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#BasicandDilutedEarningsPerShareScheduleofWeightedAveragePotentiallyDilutiveSharesareExcludedfromComputationofDilutedLossEarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleofWeightedAveragePotentiallyDilutiveSharesareExcludedfromComputationofDilutedLossEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019e2c6b-4f3a-7571-bdc0-429f1cc53e72" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019e2c6b-4f3a-7250-965e-aef6d691fd0d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019e2c6b-4f3a-7571-bdc0-429f1cc53e72" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019e2c6b-4f3a-7250-965e-aef6d691fd0d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019e2c6b-4f3a-7303-9cef-265ce245b436" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019e2c6b-4f3a-7250-965e-aef6d691fd0d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019e2c6b-4f3a-7303-9cef-265ce245b436" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019e2c6b-4f3a-7303-9cef-265ce245b436_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019e2c6b-4f3a-7303-9cef-265ce245b436" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019e2c6b-4f3a-7303-9cef-265ce245b436_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019e2c6b-4f3a-712c-b717-55ba10cd5664" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019e2c6b-4f3a-7303-9cef-265ce245b436" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019e2c6b-4f3a-712c-b717-55ba10cd5664" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_StockOptionsAndRestrictedStockUnitsMember_019e2c6b-4f3a-7d03-a1ca-90daae2b3859" xlink:href="gdrx-20260630.xsd#gdrx_StockOptionsAndRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019e2c6b-4f3a-712c-b717-55ba10cd5664" xlink:to="loc_gdrx_StockOptionsAndRestrictedStockUnitsMember_019e2c6b-4f3a-7d03-a1ca-90daae2b3859" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019e2c6b-4f3a-7389-a7fc-5e8c2f108bba" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019e2c6b-4f3a-7571-bdc0-429f1cc53e72" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019e2c6b-4f3a-7389-a7fc-5e8c2f108bba" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>gdrx-20260630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e2c6b-4e55-7a2c-b1a0-3572b2490625,g:6d96a486-c103-4d24-b5e6-d8e2b8fbb013-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019e2c6b-4ff6-72ba-8087-b7d962276921_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares used in computing earnings per share:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019e2c6b-4ff6-72a3-8c89-4c824bd01ef1_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_019e2c6b-4f3b-7fa4-a326-cc1d7a60aaed_verboseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_019e2c6b-4f3b-78f4-9a4d-64dfae0ce2a3_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_019e2c6b-4f3b-7b88-aeaa-a98a55eb5927_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareNet_019e2c6b-4f3b-764b-b1ec-ab2f17c952ab_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized software, net</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareNet_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Cost, Software to be Sold, Leased, or Marketed, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_019e2c6b-4ff6-7fd4-a373-46d997ea51aa_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.0001 par value; Class A: 2,000,000 shares authorized, 106,164 and 107,088 shares issued and outstanding at June&#160;30, 2026 and December&#160;31, 2025, respectively; and Class B: 1,000,000 shares authorized, 233,964 shares issued and outstanding at June&#160;30, 2026 and December&#160;31, 2025</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock_019e2c6b-4f3b-7bfc-821b-23438f698d29_terseLabel_en-US" xlink:label="lab_gdrx_PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prescription Reimbursement Assets and Prescription Reimbursement Liabilities</link:label>
    <link:label id="lab_gdrx_PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock_label_en-US" xlink:label="lab_gdrx_PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prescription Reimbursement Assets and Prescription Reimbursement Liabilities [Policy Text Block]</link:label>
    <link:label id="lab_gdrx_PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock_documentation_en-US" xlink:label="lab_gdrx_PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prescription Reimbursement Assets and Prescription Reimbursement Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock" xlink:href="gdrx-20260630.xsd#gdrx_PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock" xlink:to="lab_gdrx_PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_PrescriptionReimbursementLiabilitiesCurrent_019e2c6b-4ff5-7731-926a-00c943761dc9_terseLabel_en-US" xlink:label="lab_gdrx_PrescriptionReimbursementLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prescription reimbursement liabilities</link:label>
    <link:label id="lab_gdrx_PrescriptionReimbursementLiabilitiesCurrent_label_en-US" xlink:label="lab_gdrx_PrescriptionReimbursementLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prescription Reimbursement Liabilities, Current</link:label>
    <link:label id="lab_gdrx_PrescriptionReimbursementLiabilitiesCurrent_documentation_en-US" xlink:label="lab_gdrx_PrescriptionReimbursementLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prescription Reimbursement Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PrescriptionReimbursementLiabilitiesCurrent" xlink:href="gdrx-20260630.xsd#gdrx_PrescriptionReimbursementLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_PrescriptionReimbursementLiabilitiesCurrent" xlink:to="lab_gdrx_PrescriptionReimbursementLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_019e2c6b-4f3b-7331-8cc7-8d787d74b190_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued legal settlement</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards_019e2c6b-4ff6-757b-85ee-9d3a3872f856_negatedLabel_en-US" xlink:label="lab_gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Employee taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards_label_en-US" xlink:label="lab_gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Taxes Paid Related To Net Share Settlement Of Equity Awards</link:label>
    <link:label id="lab_gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards_documentation_en-US" xlink:label="lab_gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee taxes paid related to net share settlement of equity awards.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards" xlink:href="gdrx-20260630.xsd#gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards" xlink:to="lab_gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_019e2c6b-4ff6-715e-9146-b59aa548be22_verboseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_019e2c6b-4f3b-7031-848e-ee26b9911638_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_019e2c6b-4ff6-749b-8504-e407d7010300_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repurchased shares (in usd per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_019e2c6b-4ff6-73bc-a632-daac29a2cfc6_verboseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets_019e2c6b-4ff6-7255-9c86-2aeb3c9884fe_negatedTerseLabel_en-US" xlink:label="lab_gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prescription reimbursement assets</link:label>
    <link:label id="lab_gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets_label_en-US" xlink:label="lab_gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prescription Reimbursement Assets</link:label>
    <link:label id="lab_gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets_documentation_en-US" xlink:label="lab_gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prescription Reimbursement Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets" xlink:href="gdrx-20260630.xsd#gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets" xlink:to="lab_gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfDefendants_019e2c6b-4ff6-724a-a1b5-4e5c04859b39_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of defendants</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfDefendants_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfDefendants" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyNumberOfDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfDefendants" xlink:to="lab_us-gaap_LossContingencyNumberOfDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_019e2c6b-4f3b-7853-97d2-4a4d728eb314_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_AccruedExpensesAndOtherCurrentLiabilities_019e2c6b-4ff6-7ea9-aabb-f58081a7ba08_terseLabel_en-US" xlink:label="lab_gdrx_AccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_gdrx_AccruedExpensesAndOtherCurrentLiabilities_019e2c6b-4ff6-7370-9d28-c6d43b5f6929_totalLabel_en-US" xlink:label="lab_gdrx_AccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accrued expenses and other current liabilities</link:label>
    <link:label id="lab_gdrx_AccruedExpensesAndOtherCurrentLiabilities_label_en-US" xlink:label="lab_gdrx_AccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Expenses And Other Current Liabilities</link:label>
    <link:label id="lab_gdrx_AccruedExpensesAndOtherCurrentLiabilities_documentation_en-US" xlink:label="lab_gdrx_AccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued expenses and other current liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_AccruedExpensesAndOtherCurrentLiabilities" xlink:href="gdrx-20260630.xsd#gdrx_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_AccruedExpensesAndOtherCurrentLiabilities" xlink:to="lab_gdrx_AccruedExpensesAndOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_DescriptionOfBusinessAbstract_019e2c6b-4f3b-7df0-a0d3-35a2e4f2f788_terseLabel_en-US" xlink:label="lab_gdrx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Description Of Business [Abstract]</link:label>
    <link:label id="lab_gdrx_DescriptionOfBusinessAbstract_label_en-US" xlink:label="lab_gdrx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description Of Business [Abstract]</link:label>
    <link:label id="lab_gdrx_DescriptionOfBusinessAbstract_documentation_en-US" xlink:label="lab_gdrx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Description of business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_DescriptionOfBusinessAbstract" xlink:href="gdrx-20260630.xsd#gdrx_DescriptionOfBusinessAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_DescriptionOfBusinessAbstract" xlink:to="lab_gdrx_DescriptionOfBusinessAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_SubscriptionRevenueMember_019e2c6b-4ff5-7546-af4c-f82e36dba6a6_terseLabel_en-US" xlink:label="lab_gdrx_SubscriptionRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subscription revenue</link:label>
    <link:label id="lab_gdrx_SubscriptionRevenueMember_label_en-US" xlink:label="lab_gdrx_SubscriptionRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subscription Revenue [Member]</link:label>
    <link:label id="lab_gdrx_SubscriptionRevenueMember_documentation_en-US" xlink:label="lab_gdrx_SubscriptionRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Subscription Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_SubscriptionRevenueMember" xlink:href="gdrx-20260630.xsd#gdrx_SubscriptionRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_SubscriptionRevenueMember" xlink:to="lab_gdrx_SubscriptionRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_019e2c6b-4ff5-7d4d-a0e4-570cf5c3de4f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_019e2c6b-4ff6-797c-87b8-9bcb6dd24b7e_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_019e2c6b-4ff6-7b58-83de-2150c6b5d929_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities_019e2c6b-4ff6-7202-b0a7-6eea82eb5850_terseLabel_en-US" xlink:label="lab_gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prescription reimbursement liabilities</link:label>
    <link:label id="lab_gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities_label_en-US" xlink:label="lab_gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prescription Reimbursable Liabilities</link:label>
    <link:label id="lab_gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities_documentation_en-US" xlink:label="lab_gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prescription Reimbursable Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities" xlink:href="gdrx-20260630.xsd#gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities" xlink:to="lab_gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019e2c6b-4ff5-7160-86e8-ce802878d8fa_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ShareRepurchaseProgramDomain_019e2c6b-4ff5-76f2-99b7-10b68ceb8eb7_terseLabel_en-US" xlink:label="lab_srt_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_srt_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_srt_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ShareRepurchaseProgramDomain" xlink:to="lab_srt_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019e2c6b-4f3b-74f5-ba5a-588e64def056_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019e2c6b-4f3b-7e01-85f9-75b31dd7995d_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_019e2c6b-4f3b-7580-b945-b65fd5276aa1_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_019e2c6b-4ff6-7c5b-a37c-b3d186ace6c9_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_019e2c6b-4ff6-7951-8a62-c8db97892b7c_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_019e2c6b-4ff6-73cc-908b-a09dac72ae41_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_019e2c6b-4ff6-7a96-a45c-92883d8f3e40_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e2c6b-4ff6-7101-a4a3-7c6f319d0cd0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_019e2c6b-4ff6-71e5-a70d-0727a6f1358a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_019e2c6b-4ff6-7c88-9e0d-436b991aa31f_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019e2c6b-4ff6-7226-886c-52ff82bea346_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3b-7434-b8eb-d9d2dee1942c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_019e2c6b-4ff5-7a05-85c7-0a98804c9303_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Asset, Finite-Lived, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_019e2c6b-4ff6-7414-87e2-d59e3938c5aa_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer Benchmark</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_019e2c6b-4ff6-724e-b4c3-e9f1e1f929e6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_019e2c6b-4ff5-7582-9c49-d9f58d92a6d8_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other expense, net:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_019e2c6b-4f3b-73f4-b63b-a4831dac9ac9_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_AccruedBonusAndOtherPayrollRelatedCurrent_019e2c6b-4f3b-747d-987c-57926eda51d5_terseLabel_en-US" xlink:label="lab_gdrx_AccruedBonusAndOtherPayrollRelatedCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued bonus and other payroll related</link:label>
    <link:label id="lab_gdrx_AccruedBonusAndOtherPayrollRelatedCurrent_label_en-US" xlink:label="lab_gdrx_AccruedBonusAndOtherPayrollRelatedCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Bonus And Other Payroll Related Current</link:label>
    <link:label id="lab_gdrx_AccruedBonusAndOtherPayrollRelatedCurrent_documentation_en-US" xlink:label="lab_gdrx_AccruedBonusAndOtherPayrollRelatedCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued bonus and other payroll related current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_AccruedBonusAndOtherPayrollRelatedCurrent" xlink:href="gdrx-20260630.xsd#gdrx_AccruedBonusAndOtherPayrollRelatedCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_AccruedBonusAndOtherPayrollRelatedCurrent" xlink:to="lab_gdrx_AccruedBonusAndOtherPayrollRelatedCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_019e2c6b-4f3b-74f1-8b00-9bf5933dcaea_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current portion of debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_019e2c6b-4ff6-773b-91dc-be35452619f7_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_019e2c6b-4ff6-7999-81b0-4963c049670f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_019e2c6b-4ff5-723c-9607-d48c8ca2a838_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Asset, Excluding Intangible Asset and Goodwill, Impairment and Disposal [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019e2c6b-4ff6-7f1a-a8c9-fbfb6ff5c86f_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_019e2c6b-4ff6-7247-a6d9-c007f38cbf34_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_019e2c6b-4f3b-73c7-8116-fb3432729877_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_019e2c6b-4ff5-7aee-a8ce-3921f48b5da5_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of debt issuance costs and discounts</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4ff5-7137-9969-b78c4d77d8cc_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_019e2c6b-4ff5-76b2-ac33-322cef2a119d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Excluding Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_019e2c6b-4ff6-7a18-9c87-25bbd01ea286_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_019e2c6b-4ff6-7559-a223-2d2f2fb3dc58_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_019e2c6b-4ff6-7f4c-82bd-660206d686bb_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019e2c6b-4f3b-7505-b430-f0ea174eb231_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e2c6b-4ff6-7db1-830d-d6c3b99fe694_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_019e2c6b-4ff6-7a6e-a5b5-6b6dd1bd3709_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019e2c6b-4f3b-7431-b723-a4bc0f917585_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_019e2c6b-4f3b-71c2-b5c4-c08d431f423f_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Costs and operating expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_019e2c6b-4ff6-7a31-855f-e4684a4735f1_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_IdeaMenLLCMember_019e2c6b-4ff6-7074-b8f9-ce816b515cb6_terseLabel_en-US" xlink:label="lab_gdrx_IdeaMenLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Idea Men, LLC</link:label>
    <link:label id="lab_gdrx_IdeaMenLLCMember_label_en-US" xlink:label="lab_gdrx_IdeaMenLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Idea Men, LLC [Member]</link:label>
    <link:label id="lab_gdrx_IdeaMenLLCMember_documentation_en-US" xlink:label="lab_gdrx_IdeaMenLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Idea Men, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_IdeaMenLLCMember" xlink:href="gdrx-20260630.xsd#gdrx_IdeaMenLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_IdeaMenLLCMember" xlink:to="lab_gdrx_IdeaMenLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_019e2c6b-4ff6-7b6c-8ec6-bb35b7f1e38b_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassBMember_019e2c6b-4ff6-74a7-9ee4-ff6c185ad106_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Class B Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonClassBMember_019e2c6b-4ff6-7105-9e02-86b8d415c8f7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Class B</link:label>
    <link:label id="lab_us-gaap_CommonClassBMember_label_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Class B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonClassBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassBMember" xlink:to="lab_us-gaap_CommonClassBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_019e2c6b-4ff6-72d5-811e-f99dbf89aa0f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_VividRxClearRxIncMember_019e2c6b-4f3b-779a-b728-8674c8a600fc_terseLabel_en-US" xlink:label="lab_gdrx_VividRxClearRxIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">VividRx Clear Rx, Inc</link:label>
    <link:label id="lab_gdrx_VividRxClearRxIncMember_label_en-US" xlink:label="lab_gdrx_VividRxClearRxIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">VividRx Clear Rx, Inc [Member]</link:label>
    <link:label id="lab_gdrx_VividRxClearRxIncMember_documentation_en-US" xlink:label="lab_gdrx_VividRxClearRxIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">VividRx Clear Rx, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_VividRxClearRxIncMember" xlink:href="gdrx-20260630.xsd#gdrx_VividRxClearRxIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_VividRxClearRxIncMember" xlink:to="lab_gdrx_VividRxClearRxIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_019e2c6b-4f3b-761e-ac00-2628a99241be_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_019e2c6b-4ff6-7c11-8aee-9e2174611415_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_019e2c6b-4f3b-7f87-8542-4331e26916a7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_019e2c6b-4f3b-7901-8e66-fd64b8e0c536_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_019e2c6b-4ff6-781c-a36c-81e0d3156059_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_019e2c6b-4ff6-7392-8fbc-e6c1183ee376_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019e2c6b-4ff6-73c2-b89a-9a14df8c5e19_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_019e2c6b-4ff5-7a53-ba2e-d11db50d0f42_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_FirstLienCreditAgreementMember_019e2c6b-4f3b-700c-b6e0-29654958b303_terseLabel_en-US" xlink:label="lab_gdrx_FirstLienCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">First Lien Credit Agreement</link:label>
    <link:label id="lab_gdrx_FirstLienCreditAgreementMember_label_en-US" xlink:label="lab_gdrx_FirstLienCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">First Lien Credit Agreement [Member]</link:label>
    <link:label id="lab_gdrx_FirstLienCreditAgreementMember_documentation_en-US" xlink:label="lab_gdrx_FirstLienCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">First lien credit agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_FirstLienCreditAgreementMember" xlink:href="gdrx-20260630.xsd#gdrx_FirstLienCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_FirstLienCreditAgreementMember" xlink:to="lab_gdrx_FirstLienCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_019e2c6b-4f3b-76e0-8d65-9401b8cbaae1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principal balance under 2024 Term Loan Facility</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_019e2c6b-4f3b-73fb-8a89-e506d911064d_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_019e2c6b-4f3b-7030-88b0-afb4579dff3d_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019e2c6b-4f3b-75ae-acfd-10cc5cf5174d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019e2c6b-4ff6-7a9f-891e-b7a6f71d73a5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019e2c6b-4ff6-7e11-84a7-1b660ee52097_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_019e2c6b-4ff6-7231-a8e2-a2d5296ecd48_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation Of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_019e2c6b-4ff6-7eab-9e39-d691583e9496_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities_019e2c6b-4f3b-7850-9879-a1a73d0317fd_terseLabel_en-US" xlink:label="lab_gdrx_CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized software included in accounts payable and accrued expenses and other current liabilities</link:label>
    <link:label id="lab_gdrx_CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities_label_en-US" xlink:label="lab_gdrx_CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Software Included in Accounts Payable and Accrued Expenses and Other Current Liabilities</link:label>
    <link:label id="lab_gdrx_CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities_documentation_en-US" xlink:label="lab_gdrx_CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capitalized Software Included in Accounts Payable and Accrued Expenses and Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities" xlink:href="gdrx-20260630.xsd#gdrx_CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities" xlink:to="lab_gdrx_CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4ff6-7f2c-81f3-737605274d62_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_019e2c6b-4ff6-753e-9452-0a9390136587_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019e2c6b-4ff6-7878-a6e6-b9e8e21503c1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_019e2c6b-4f3b-7995-9516-71ed342b53e3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019e2c6b-4ff5-784c-88be-fc27d8bd9c41_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_NewRepurchaseProgramMember_019e2c6b-4ff6-72fa-b050-3e3973dace8b_terseLabel_en-US" xlink:label="lab_gdrx_NewRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Repurchase Program</link:label>
    <link:label id="lab_gdrx_NewRepurchaseProgramMember_label_en-US" xlink:label="lab_gdrx_NewRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Repurchase Program [Member]</link:label>
    <link:label id="lab_gdrx_NewRepurchaseProgramMember_documentation_en-US" xlink:label="lab_gdrx_NewRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">New Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_NewRepurchaseProgramMember" xlink:href="gdrx-20260630.xsd#gdrx_NewRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_NewRepurchaseProgramMember" xlink:to="lab_gdrx_NewRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_019e2c6b-4f3b-70e8-a000-2a0b3a35ceb7_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_019e2c6b-4ff6-78c8-a7ac-f7a872b66d34_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dilutive impact of stock options and restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_019e2c6b-4ff5-735b-ba54-68b4868bf22e_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repurchases of Class A common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_019e2c6b-4ff5-7f9e-ac80-374e9ad59d44_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of shares repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_019e2c6b-4f3b-7d58-83bf-e7b9d8a5a759_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_019e2c6b-4ff5-7140-8cd3-3757d4365aa7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019e2c6b-4ff6-7fdb-a3fc-e317f6156103_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_019e2c6b-4ff6-7020-91aa-993fc1207c37_terseLabel_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment loss</link:label>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tangible Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:to="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_019e2c6b-4ff6-7e8f-8a51-0961890787f9_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_019e2c6b-4ff5-7d17-80d0-f2273925f3c4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_019e2c6b-4f3b-7987-ba08-78ab3b3c6de9_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019e2c6b-4ff6-7185-8dd2-19ef530ac522_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Computation of (Loss) Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_019e2c6b-4ff5-7b1c-adf4-ead34916dd46_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_019e2c6b-4ff6-7bf7-8ec8-9e437437bc73_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_OperatingLeaseRightOfUseAssetsMember_019e2c6b-4ff6-7185-9057-c0c2782cf954_terseLabel_en-US" xlink:label="lab_gdrx_OperatingLeaseRightOfUseAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease Right Of Use Assets</link:label>
    <link:label id="lab_gdrx_OperatingLeaseRightOfUseAssetsMember_label_en-US" xlink:label="lab_gdrx_OperatingLeaseRightOfUseAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease Right Of Use Assets [Member]</link:label>
    <link:label id="lab_gdrx_OperatingLeaseRightOfUseAssetsMember_documentation_en-US" xlink:label="lab_gdrx_OperatingLeaseRightOfUseAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Lease Right Of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_OperatingLeaseRightOfUseAssetsMember" xlink:href="gdrx-20260630.xsd#gdrx_OperatingLeaseRightOfUseAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_OperatingLeaseRightOfUseAssetsMember" xlink:to="lab_gdrx_OperatingLeaseRightOfUseAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_019e2c6b-4ff6-7614-adba-d6f943de2b6c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of amount outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_019e2c6b-4f3b-7d42-bb21-4c5fce406d8a_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeLocationBalanceAxis_019e2c6b-4ff5-78ee-a592-a6bb6445fbb0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeLocationBalanceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeLocationBalanceAxis_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeLocationBalanceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Location, Statement of Income, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeLocationBalanceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfIncomeLocationBalanceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeLocationBalanceAxis" xlink:to="lab_us-gaap_StatementOfIncomeLocationBalanceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019e2c6b-4ff6-75a8-8c3a-d8354f9b26f0_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents, fair value disclosure</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_019e2c6b-4f3b-7e42-a784-124a3130948f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_019e2c6b-4ff5-76c9-bcf7-bfa53881ede5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019e2c6b-4ff6-7007-8f15-cf71e2ca06fc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_019e2c6b-4ff6-71f6-b777-5a201025ff33_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Useful Life (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Asset, Finite-Lived, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019e2c6b-4f3b-7165-9a2c-bc9d1dae432e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_019e2c6b-4f3b-75dc-a46f-ffe79f5caa7f_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_019e2c6b-4ff6-7035-bd08-5ae37c474dc6_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_019e2c6b-4ff6-7a5a-8f80-ff7983f37ed9_terseLabel_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase agreement, authorized amount</link:label>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Authorized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_019e2c6b-4f3b-7742-8304-e696d3df3f48_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_019e2c6b-4f3b-789e-90d4-cbf487e2ac59_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Settled Litigation</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_019e2c6b-4f3b-7aaf-88c0-e751ab1a422d_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_019e2c6b-4f3b-7c86-addd-ce21186c9e2f_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">End of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_019e2c6b-4ff6-73c1-a7d0-63169acbeb67_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_019e2c6b-4f3b-7f8e-b08c-57a5669a996e_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_019e2c6b-4f3b-7af1-a542-e7df2c656776_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: Unamortized debt issuance costs and discounts</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_019e2c6b-4ff6-7802-836e-345ea08c9538_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity investments included in other assets</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019e2c6b-4ff6-7e9a-a8a2-67af8f04a8ae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of Business Acquisitions By Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_019e2c6b-4f3b-7b2e-aedc-717c204b5236_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_019e2c6b-4ff6-7c05-9500-abcf29d8a552_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total costs and operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_019e2c6b-4f3b-7720-98dc-272c341c1afe_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_019e2c6b-4f3b-727c-8fda-d4cb3bf65260_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_019e2c6b-4f3b-70ca-b585-2b8ca6d042de_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_EarningPerShareBasicAndDilutedAbstract_019e2c6b-4ff6-770a-9c74-3938cd714bec_terseLabel_en-US" xlink:label="lab_gdrx_EarningPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings per share:</link:label>
    <link:label id="lab_gdrx_EarningPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_gdrx_EarningPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earning Per Share Basic And Diluted Abstract</link:label>
    <link:label id="lab_gdrx_EarningPerShareBasicAndDilutedAbstract_documentation_en-US" xlink:label="lab_gdrx_EarningPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Earning per share basic and diluted abstract.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_EarningPerShareBasicAndDilutedAbstract" xlink:href="gdrx-20260630.xsd#gdrx_EarningPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_EarningPerShareBasicAndDilutedAbstract" xlink:to="lab_gdrx_EarningPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_019e2c6b-4ff6-778d-8982-b95ee4563a4c_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_019e2c6b-4f3b-7fde-b981-1ebf532e08f4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_019e2c6b-4ff6-765e-bcf3-ed46a6077c14_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e2c6b-4ff6-7d81-a602-3952d0d9076a_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_019e2c6b-4ff6-78ec-92a9-e66eed6d8104_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_019e2c6b-4ff5-765c-99d9-9327b9944f6e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_019e2c6b-4f3b-7b9a-a0bd-0f09b8424924_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019e2c6b-4f3b-79c1-8985-6aba770e6bf9_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019e2c6b-4f3b-71cb-99b8-fa13bc316558_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember_019e2c6b-4ff6-7ab2-a53c-cbb48fb1d43a_terseLabel_en-US" xlink:label="lab_gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Electronic Communication Privacy Act, Privacy Protection</link:label>
    <link:label id="lab_gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember_label_en-US" xlink:label="lab_gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Electronic Communication Privacy Act, Privacy Protection [Member]</link:label>
    <link:label id="lab_gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember_documentation_en-US" xlink:label="lab_gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Electronic Communication Privacy Act, Privacy Protection</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember" xlink:href="gdrx-20260630.xsd#gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember" xlink:to="lab_gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_019e2c6b-4f3b-7bb9-b438-908c8ac5bdba_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_019e2c6b-4ff6-7584-a804-5a5eff9998e8_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued marketing</link:label>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Marketing Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:to="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_019e2c6b-4ff5-7695-a458-2fa0322b6eef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Weighted-Average Potentially Dilutive Shares are Excluded from Computation of Diluted (Loss) Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_019e2c6b-4f3b-7d4c-8760-30a250ef69b0_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_019e2c6b-4ff6-7856-970b-2b15e215ca26_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_019e2c6b-4ff5-77bb-80ff-ddaec70e3938_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Other Item</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_019e2c6b-4f3b-71a2-92f6-2a2cbaee7b34_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_019e2c6b-4f3b-7493-87a9-ba49f2af0dab_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4ff6-7932-a701-be3cd2924dba_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_019e2c6b-4ff5-750f-a1a3-20d4acf8580e_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payment for settlements</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_019f8793-69df-7b25-9fa7-19597a12725e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_019e2c6b-4ff6-7f4d-b50e-3e05b3770674_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_019e2c6b-4ff6-71e7-b62c-2119405cac42_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_019e2c6b-4f3b-7a12-8682-5443caf028b7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock through employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_019e2c6b-4f3b-73b3-9c9d-8bcaa51e2101_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_019e2c6b-4ff6-78c1-b0e5-508164ee2c5b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019e2c6b-4ff5-76ee-9d36-e7346924769d_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_019e2c6b-4f3b-7140-ac65-998957fa585a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_CommonClassAAndClassBMember_019e2c6b-4f3b-71bb-9b08-7b3a00f2bb35_terseLabel_en-US" xlink:label="lab_gdrx_CommonClassAAndClassBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class A and Class B Common Stock</link:label>
    <link:label id="lab_gdrx_CommonClassAAndClassBMember_label_en-US" xlink:label="lab_gdrx_CommonClassAAndClassBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Class A And Class B [Member]</link:label>
    <link:label id="lab_gdrx_CommonClassAAndClassBMember_documentation_en-US" xlink:label="lab_gdrx_CommonClassAAndClassBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common class A and class B.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_CommonClassAAndClassBMember" xlink:href="gdrx-20260630.xsd#gdrx_CommonClassAAndClassBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_CommonClassAAndClassBMember" xlink:to="lab_gdrx_CommonClassAAndClassBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_AccountingPoliciesTable_019e2c6b-4f3b-760d-8cca-a704c42c2d69_terseLabel_en-US" xlink:label="lab_gdrx_AccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Table]</link:label>
    <link:label id="lab_gdrx_AccountingPoliciesTable_label_en-US" xlink:label="lab_gdrx_AccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Table]</link:label>
    <link:label id="lab_gdrx_AccountingPoliciesTable_documentation_en-US" xlink:label="lab_gdrx_AccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounting policies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_AccountingPoliciesTable" xlink:href="gdrx-20260630.xsd#gdrx_AccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_AccountingPoliciesTable" xlink:to="lab_gdrx_AccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_019e2c6b-4ff6-787b-8476-1610e6331f19_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_019e2c6b-4ff6-79e6-9eda-15ee8a67a4cf_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019e2c6b-4f3b-7bcc-909f-545697a01b2d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets_019e2c6b-4ff6-7e73-b9f9-15df9b15e8cb_terseLabel_en-US" xlink:label="lab_gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss on operating lease asset</link:label>
    <link:label id="lab_gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets_label_en-US" xlink:label="lab_gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss On Abandonment And Impairment Of Operating Lease Assets</link:label>
    <link:label id="lab_gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets_documentation_en-US" xlink:label="lab_gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss On Abandonment And Impairment Of Operating Lease Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets" xlink:href="gdrx-20260630.xsd#gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets" xlink:to="lab_gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_019e2c6b-4ff6-7ad3-817f-8d55c0b51b07_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_019e2c6b-4f3b-77d2-ac54-af2d9f7bc9cc_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_019e2c6b-4ff6-7d49-b237-0385a2f180cb_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_019e2c6b-4f3b-765d-9357-0d51e63f4992_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseNonoperating" xlink:to="lab_us-gaap_InterestExpenseNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_019e2c6b-4f3b-795d-b5d1-2266b88e23e9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock through employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_019e2c6b-4ff6-79cf-84a5-45bed054c469_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_019e2c6b-4ff6-79a2-bb32-1a0cb533f2ce_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_StockOptionsAndRestrictedStockUnitsMember_019e2c6b-4ff6-7d9c-85fc-b9362a4d347d_terseLabel_en-US" xlink:label="lab_gdrx_StockOptionsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options and restricted stock units</link:label>
    <link:label id="lab_gdrx_StockOptionsAndRestrictedStockUnitsMember_label_en-US" xlink:label="lab_gdrx_StockOptionsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Options and Restricted Stock Units [Member]</link:label>
    <link:label id="lab_gdrx_StockOptionsAndRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_gdrx_StockOptionsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Options and Restricted Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_StockOptionsAndRestrictedStockUnitsMember" xlink:href="gdrx-20260630.xsd#gdrx_StockOptionsAndRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_StockOptionsAndRestrictedStockUnitsMember" xlink:to="lab_gdrx_StockOptionsAndRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019e2c6b-4f3b-7f78-bc7d-357cdebf7a07_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_019e2c6b-4f3b-745b-9ebf-d86dffa076e3_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_019e2c6b-4ff5-7580-b0cb-2432eecd3cdc_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repurchases of Class A common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_019e2c6b-4ff5-73f5-acbb-034fc2315b47_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_019e2c6b-4ff5-7f8b-b303-6452fc5843d3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_019e2c6b-4ff5-7ade-b857-ece8ecf005b5_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019e2c6b-4f3b-7fda-be9e-ab44306e6d3c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_019e2c6b-4ff6-7545-8422-3afa9eb60884_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_019e2c6b-4f3b-7119-9e40-00015801bc0e_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_IncreaseDecreaseOperatingLeaseLiabilities_019e2c6b-4ff5-7c44-a2d0-25f46600f6aa_terseLabel_en-US" xlink:label="lab_gdrx_IncreaseDecreaseOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_gdrx_IncreaseDecreaseOperatingLeaseLiabilities_label_en-US" xlink:label="lab_gdrx_IncreaseDecreaseOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Decrease Operating Lease Liabilities</link:label>
    <link:label id="lab_gdrx_IncreaseDecreaseOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_gdrx_IncreaseDecreaseOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (decrease) operating lease liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_IncreaseDecreaseOperatingLeaseLiabilities" xlink:href="gdrx-20260630.xsd#gdrx_IncreaseDecreaseOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_IncreaseDecreaseOperatingLeaseLiabilities" xlink:to="lab_gdrx_IncreaseDecreaseOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_019e2c6b-4ff6-7ba4-90f9-1011e31bdee4_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_019e2c6b-4ff5-7f0e-99db-5681b6094742_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_019e2c6b-4ff6-71f1-a912-0242d50ec2a9_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_019e2c6b-4ff6-7277-ad16-a70806526b04_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money Market Funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3b-7f4e-9fa5-aff5886f19bc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_019e2c6b-4ff6-766b-950f-08974da64904_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_SpectrumStockPurchaseAgreementMember_019e2c6b-4ff6-7f50-aba4-18b87fabfd8b_terseLabel_en-US" xlink:label="lab_gdrx_SpectrumStockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Spectrum Stock Purchase Agreement</link:label>
    <link:label id="lab_gdrx_SpectrumStockPurchaseAgreementMember_label_en-US" xlink:label="lab_gdrx_SpectrumStockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Spectrum Stock Purchase Agreement [Member]</link:label>
    <link:label id="lab_gdrx_SpectrumStockPurchaseAgreementMember_documentation_en-US" xlink:label="lab_gdrx_SpectrumStockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Spectrum Stock Purchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_SpectrumStockPurchaseAgreementMember" xlink:href="gdrx-20260630.xsd#gdrx_SpectrumStockPurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_SpectrumStockPurchaseAgreementMember" xlink:to="lab_gdrx_SpectrumStockPurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_019e2c6b-4ff6-7485-94c2-332e8ee48129_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_019e2c6b-4ff6-7fef-8ac8-e33c45b6752b_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e2c6b-4f3b-7e39-8fe1-e42abc391f52_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_019e2c6b-4ff6-79b2-87a6-9504f4bd9adf_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Common stock withheld related to net share settlement</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e2c6b-4f3b-7c02-beee-976e52b145c4_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_019e2c6b-4f3b-70db-bef2-c5f15a2a630f_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_SDFLClassActionMatterMember_019e2c6b-4f3b-797e-9269-cb1fae6b5156_terseLabel_en-US" xlink:label="lab_gdrx_SDFLClassActionMatterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SDFL Class Action Matter</link:label>
    <link:label id="lab_gdrx_SDFLClassActionMatterMember_label_en-US" xlink:label="lab_gdrx_SDFLClassActionMatterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SDFL Class Action Matter [Member]</link:label>
    <link:label id="lab_gdrx_SDFLClassActionMatterMember_documentation_en-US" xlink:label="lab_gdrx_SDFLClassActionMatterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">SDFL Class Action Matter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_SDFLClassActionMatterMember" xlink:href="gdrx-20260630.xsd#gdrx_SDFLClassActionMatterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_SDFLClassActionMatterMember" xlink:to="lab_gdrx_SDFLClassActionMatterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_019e2c6b-4ff6-75c1-9d5f-03897f3bc015_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product development and technology</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019e2c6b-4f3b-7ca7-8d51-d962b499deea_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_019e2c6b-4f3b-7127-b373-f4a016d78e13_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019e2c6b-4ff6-7c7e-a74e-7f42e28c8930_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019e2c6b-4f3b-77ef-a4e9-8b19a8ac9883_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_019e2c6b-4f3b-718e-9c90-0ec310928ea5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019e2c6b-4ff6-707e-a52f-41550647ce6f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Asset, Finite-Lived, Class</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Asset, Finite-Lived, Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019e2c6b-4f3b-7ebf-b6ac-06abb7735a26_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options exercised</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_019e2c6b-4ff6-70b4-b49d-60cb448cfb2e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties_019e2c6b-4ff5-77b2-8d97-b0222a2b439c_terseLabel_en-US" xlink:label="lab_gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of counterparty</link:label>
    <link:label id="lab_gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties_label_en-US" xlink:label="lab_gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prescription Reimbursement Assets, Number Of Counterparties</link:label>
    <link:label id="lab_gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties_documentation_en-US" xlink:label="lab_gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prescription Reimbursement Assets, Number Of Counterparties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties" xlink:href="gdrx-20260630.xsd#gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties" xlink:to="lab_gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_019e2c6b-4f3b-7270-898b-70503e004167_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued Expenses and Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019e2c6b-4f3b-7265-a01a-dbf60e6d3a35_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_019e2c6b-4f3b-70bd-9287-2c7225fc61c2_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_MinorityEquityInterestsMember_019e2c6b-4ff6-7494-b32f-7e8cf72a2e57_terseLabel_en-US" xlink:label="lab_gdrx_MinorityEquityInterestsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minority Equity Interests</link:label>
    <link:label id="lab_gdrx_MinorityEquityInterestsMember_label_en-US" xlink:label="lab_gdrx_MinorityEquityInterestsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minority Equity Interests [Member]</link:label>
    <link:label id="lab_gdrx_MinorityEquityInterestsMember_documentation_en-US" xlink:label="lab_gdrx_MinorityEquityInterestsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Minority Equity Interests.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_MinorityEquityInterestsMember" xlink:href="gdrx-20260630.xsd#gdrx_MinorityEquityInterestsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_MinorityEquityInterestsMember" xlink:to="lab_gdrx_MinorityEquityInterestsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_019e2c6b-4ff5-7539-b2f7-95aba0d77a7f_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_019e2c6b-4f3b-7bee-ac2b-c20178da1702_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_019e2c6b-4ff6-7dbd-ae0c-890ecb52ecde_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_019e2c6b-4ff6-70e6-8046-01bf23e9b844_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019e2c6b-4ff5-7a4d-b84f-018a4dbb7808_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_019e2c6b-4ff6-7c4f-bda4-97832f533433_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_019e2c6b-4ff6-700b-b443-ced53256371a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Description of Business</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_019e2c6b-4ff6-705a-aae6-da24a3a88437_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue, exclusive of depreciation and amortization presented separately below</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3b-784f-841d-79134f75b26c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_019e2c6b-4ff6-743f-9911-cd61af092070_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_019e2c6b-4ff6-70c6-b93a-d37091f2a2b1_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyMember_019e2c6b-4ff6-76da-a35f-2dc756708c86_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyMember_label_en-US" xlink:label="lab_us-gaap_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyMember" xlink:to="lab_us-gaap_RelatedPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_019e2c6b-4f3b-7c27-83fc-f885c472e7b7_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_019e2c6b-4ff6-7d5b-ab57-9f7ff2c5bb8a_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation Of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassAMember_019e2c6b-4ff6-7cd1-a551-edee1c5df941_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Class A Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_019e2c6b-4ff6-782f-af07-1c0087c22165_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Class A</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonClassAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_019e2c6b-4ff6-7fe1-86e4-95e237f8fb8f_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_NDCAClassActionMatterMember_019e2c6b-4ff5-7921-9242-e7c6ec6eb168_terseLabel_en-US" xlink:label="lab_gdrx_NDCAClassActionMatterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NDCA Class Action Matter</link:label>
    <link:label id="lab_gdrx_NDCAClassActionMatterMember_label_en-US" xlink:label="lab_gdrx_NDCAClassActionMatterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NDCA Class Action Matter [Member]</link:label>
    <link:label id="lab_gdrx_NDCAClassActionMatterMember_documentation_en-US" xlink:label="lab_gdrx_NDCAClassActionMatterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NDCA Class Action Matter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_NDCAClassActionMatterMember" xlink:href="gdrx-20260630.xsd#gdrx_NDCAClassActionMatterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_NDCAClassActionMatterMember" xlink:to="lab_gdrx_NDCAClassActionMatterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_019e2c6b-4ff6-7fa2-a47c-3e0cee3720ed_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_PrescriptionTransactionsRevenueMember_019e2c6b-4ff5-70dd-aa50-5838adfcd498_terseLabel_en-US" xlink:label="lab_gdrx_PrescriptionTransactionsRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prescription transactions revenue</link:label>
    <link:label id="lab_gdrx_PrescriptionTransactionsRevenueMember_label_en-US" xlink:label="lab_gdrx_PrescriptionTransactionsRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prescription Transactions Revenue [Member]</link:label>
    <link:label id="lab_gdrx_PrescriptionTransactionsRevenueMember_documentation_en-US" xlink:label="lab_gdrx_PrescriptionTransactionsRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prescription transactions revenue.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PrescriptionTransactionsRevenueMember" xlink:href="gdrx-20260630.xsd#gdrx_PrescriptionTransactionsRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_PrescriptionTransactionsRevenueMember" xlink:to="lab_gdrx_PrescriptionTransactionsRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_019e2c6b-4f3b-7efd-b072-f211f7a7c7fe_negatedLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Common stock withheld related to net share settlement (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_019e2c6b-4f3b-7748-a6aa-96a184a2c14b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_019e2c6b-4ff5-7d32-b393-4e2d6afa03f2_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_019e2c6b-4ff6-75dc-9038-dc541ba5794b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Acquisition</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_019e2c6b-4ff6-7170-8fef-2c6e0492256a_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash consideration</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_019e2c6b-4ff6-78de-aae6-9bf34ffad869_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract_019e2c6b-4ff6-70e8-8d14-206484bb9236_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_019e2c6b-4ff6-7dd1-a702-dbad6ac26fec_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase program, available for future repurchases</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Remaining Authorized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_019e2c6b-4f3b-7630-bc56-866428bf6d28_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_019e2c6b-4ff5-7b31-9628-0548363e62de_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_019e2c6b-4ff6-77c1-b4ed-3e5b417af02a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_019e2c6b-4ff6-78e0-bffb-49807c8c6631_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_CustomerOneMember_019e2c6b-4ff5-7461-9b9b-f0762c749c9a_terseLabel_en-US" xlink:label="lab_gdrx_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer One</link:label>
    <link:label id="lab_gdrx_CustomerOneMember_label_en-US" xlink:label="lab_gdrx_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer One [Member]</link:label>
    <link:label id="lab_gdrx_CustomerOneMember_documentation_en-US" xlink:label="lab_gdrx_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customer one.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_CustomerOneMember" xlink:href="gdrx-20260630.xsd#gdrx_CustomerOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_CustomerOneMember" xlink:to="lab_gdrx_CustomerOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e2c6b-4f3b-77e0-8871-ff3283d3ae57_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceSettlementsReceivable_019e2c6b-4f3b-796e-8060-87b3ad9b66c8_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceSettlementsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance recovery receivable</link:label>
    <link:label id="lab_us-gaap_InsuranceSettlementsReceivable_label_en-US" xlink:label="lab_us-gaap_InsuranceSettlementsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance Settlements Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSettlementsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InsuranceSettlementsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceSettlementsReceivable" xlink:to="lab_us-gaap_InsuranceSettlementsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_019e2c6b-4f3b-76fb-b68d-dcb3aba304c7_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies (Note 7)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_019e2c6b-4ff6-7485-b77d-420f8adea080_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_PrivacyProtectionMember_019e2c6b-4ff5-714f-a048-cab1a3d10be3_terseLabel_en-US" xlink:label="lab_gdrx_PrivacyProtectionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Privacy Protection</link:label>
    <link:label id="lab_gdrx_PrivacyProtectionMember_label_en-US" xlink:label="lab_gdrx_PrivacyProtectionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Privacy Protection [Member]</link:label>
    <link:label id="lab_gdrx_PrivacyProtectionMember_documentation_en-US" xlink:label="lab_gdrx_PrivacyProtectionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Privacy Protection</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PrivacyProtectionMember" xlink:href="gdrx-20260630.xsd#gdrx_PrivacyProtectionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_PrivacyProtectionMember" xlink:to="lab_gdrx_PrivacyProtectionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_PrescriptionReimbursementAssetsCurrent_019e2c6b-4f3b-785d-855b-c75306c332f2_terseLabel_en-US" xlink:label="lab_gdrx_PrescriptionReimbursementAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prescription reimbursement assets</link:label>
    <link:label id="lab_gdrx_PrescriptionReimbursementAssetsCurrent_label_en-US" xlink:label="lab_gdrx_PrescriptionReimbursementAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prescription Reimbursement Assets, Current</link:label>
    <link:label id="lab_gdrx_PrescriptionReimbursementAssetsCurrent_documentation_en-US" xlink:label="lab_gdrx_PrescriptionReimbursementAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prescription Reimbursement Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PrescriptionReimbursementAssetsCurrent" xlink:href="gdrx-20260630.xsd#gdrx_PrescriptionReimbursementAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_PrescriptionReimbursementAssetsCurrent" xlink:to="lab_gdrx_PrescriptionReimbursementAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019e2c6b-4f3b-7fc4-84e4-05164b59393b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019e2c6b-4f3b-7ded-857b-01b8c049fdf0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Asset, Finite-Lived, Class</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Asset, Finite-Lived, Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_FranciscoPartnersStockPurchaseAgreementMember_019e2c6b-4ff6-76b3-8c0e-13a7aae485c8_terseLabel_en-US" xlink:label="lab_gdrx_FranciscoPartnersStockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Francisco Partners Stock Purchase Agreement</link:label>
    <link:label id="lab_gdrx_FranciscoPartnersStockPurchaseAgreementMember_label_en-US" xlink:label="lab_gdrx_FranciscoPartnersStockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Francisco Partners Stock Purchase Agreement [Member]</link:label>
    <link:label id="lab_gdrx_FranciscoPartnersStockPurchaseAgreementMember_documentation_en-US" xlink:label="lab_gdrx_FranciscoPartnersStockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Francisco Partners Stock Purchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_FranciscoPartnersStockPurchaseAgreementMember" xlink:href="gdrx-20260630.xsd#gdrx_FranciscoPartnersStockPurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_FranciscoPartnersStockPurchaseAgreementMember" xlink:to="lab_gdrx_FranciscoPartnersStockPurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Award Types</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_019e2c6b-4f3b-73e0-9b9e-daa87804af46_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosure of cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_019e2c6b-4ff6-7c0f-9fcd-824512d1e9ed_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repurchased shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_019e2c6b-4ff6-7353-a057-e43032e51830_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_019e2c6b-4ff5-7931-8930-1d1d20479f40_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate on used amounts</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019e2c6b-4ff6-7ea3-a337-47f41eb40e55_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Asset, Class [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Asset, Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_019e2c6b-4ff6-7516-b651-9eeb4218746e_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Certain Risks and Concentrations</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_PharmaManufacturerSolutionsRevenuesMember_019e2c6b-4ff6-77cb-9b4a-c94c1cd41c91_terseLabel_en-US" xlink:label="lab_gdrx_PharmaManufacturerSolutionsRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pharma Direct revenue</link:label>
    <link:label id="lab_gdrx_PharmaManufacturerSolutionsRevenuesMember_label_en-US" xlink:label="lab_gdrx_PharmaManufacturerSolutionsRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pharma Manufacturer Solutions Revenues [member]</link:label>
    <link:label id="lab_gdrx_PharmaManufacturerSolutionsRevenuesMember_documentation_en-US" xlink:label="lab_gdrx_PharmaManufacturerSolutionsRevenuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pharma Manufacturer Solutions Revenues [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PharmaManufacturerSolutionsRevenuesMember" xlink:href="gdrx-20260630.xsd#gdrx_PharmaManufacturerSolutionsRevenuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_PharmaManufacturerSolutionsRevenuesMember" xlink:to="lab_gdrx_PharmaManufacturerSolutionsRevenuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_019e2c6b-4ff6-7a75-8398-97267189901b_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_019e2c6b-4ff5-7765-a19c-5e205ec602b0_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_019e2c6b-4ff5-753b-8707-220ef088b2ff_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_019e2c6b-4f3b-745f-bdd8-a367c301c807_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_019e2c6b-4ff5-7a02-a073-17c78b653150_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_019e2c6b-4ff6-76d8-afc5-a482c92a4d9c_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_019e2c6b-4ff6-704f-8676-2e0e7783ca5d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_019e2c6b-4ff6-71e3-ad75-32aafc119b02_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity method investment, ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_019e2c6b-4ff6-7c7b-b48e-8989e8cf3f69_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_019e2c6b-4f3b-7ba7-bf01-96668b4b17ef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_019e2c6b-4ff6-772c-b8e8-f7819e3f464d_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_019e2c6b-4f3b-7b60-a263-d07ed8503c9f_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_019e2c6b-4ff6-79a0-bb7f-4622e6182085_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_019e2c6b-4ff6-79dd-8416-93c45b7e9a95_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_019e2c6b-4f3b-7278-9a9d-b5474c87258a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repurchases of Class A common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_019e2c6b-4ff6-7c97-b1aa-8d6453d7c9e9_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_019e2c6b-4ff6-7389-9223-bb5e72845768_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_019e2c6b-4ff6-78d3-a43d-5cb62919d631_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_019e2c6b-4ff6-78f6-9c02-0dae0f9a734b_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_019e2c6b-4f3b-7cda-a951-499751aa6672_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_019e2c6b-4ff5-7f8d-a19e-71e4e321a4f9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_019e2c6b-4f3b-7e5c-b400-3b46c3b28849_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_019e2c6b-4ff6-7e3c-97f7-01327bfed81d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_019e2c6b-4ff6-7086-9ea9-36b08ac0212a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_019e2c6b-4ff6-7d3d-b7a0-dcaf21a9c9be_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOther_019e2c6b-4ff6-75cd-b0cf-2a6785438058_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOther_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestIncomeOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOther" xlink:to="lab_us-gaap_InterestIncomeOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_019e2c6b-4ff6-78d9-b8b0-c23e9c4cc41b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_019e2c6b-4ff6-728c-9504-34380be195e6_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related and Nonrelated Parties [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_019e2c6b-4f3b-7b84-8dd1-c3ff49e0812a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_019e2c6b-4f3b-7adc-8859-9cdf3fe6dd13_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Expenses and Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio_019e2c6b-4ff6-748a-b558-d813a35fc4c8_terseLabel_en-US" xlink:label="lab_gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum net leverage ratio</link:label>
    <link:label id="lab_gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio_label_en-US" xlink:label="lab_gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line Of Credit Maximum Financial Covenant Net Leverage Ratio</link:label>
    <link:label id="lab_gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio_documentation_en-US" xlink:label="lab_gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line of credit maximum financial covenant net leverage ratio.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio" xlink:href="gdrx-20260630.xsd#gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio" xlink:to="lab_gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_019e2c6b-4f3b-70b0-9f2c-6554f6818925_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e2c6b-4f3b-7eca-a4c6-722c426c4b96_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Asset, Class [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Asset, Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_019e2c6b-4f3b-7c7a-8704-94e92c9c0f91_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_019e2c6b-4f3b-7c99-b268-b10cd43599f9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, $0.0001 par value; 50,000 shares authorized and nil shares issued and outstanding at June&#160;30, 2026 and December&#160;31, 2025</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_A2024TermLoanMember_019e2c6b-4ff5-7133-bb43-81e80b8bb23a_terseLabel_en-US" xlink:label="lab_gdrx_A2024TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 Term Loan</link:label>
    <link:label id="lab_gdrx_A2024TermLoanMember_label_en-US" xlink:label="lab_gdrx_A2024TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2024 Term Loan [Member]</link:label>
    <link:label id="lab_gdrx_A2024TermLoanMember_documentation_en-US" xlink:label="lab_gdrx_A2024TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2024 Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_A2024TermLoanMember" xlink:href="gdrx-20260630.xsd#gdrx_A2024TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_A2024TermLoanMember" xlink:to="lab_gdrx_A2024TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_019e2c6b-4ff5-7807-918a-8725b74f1c8a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pending claims</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ShareRepurchaseProgramAxis_019e2c6b-4ff6-7ed5-8049-e85af2d6f90b_terseLabel_en-US" xlink:label="lab_srt_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_srt_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_srt_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ShareRepurchaseProgramAxis" xlink:to="lab_srt_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_OtherRevenueMember_019e2c6b-4f3b-79f5-8e48-a3a664364604_terseLabel_en-US" xlink:label="lab_gdrx_OtherRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other revenue</link:label>
    <link:label id="lab_gdrx_OtherRevenueMember_label_en-US" xlink:label="lab_gdrx_OtherRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Revenue [Member]</link:label>
    <link:label id="lab_gdrx_OtherRevenueMember_documentation_en-US" xlink:label="lab_gdrx_OtherRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other revenue.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_OtherRevenueMember" xlink:href="gdrx-20260630.xsd#gdrx_OtherRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_OtherRevenueMember" xlink:to="lab_gdrx_OtherRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_019e2c6b-4ff5-7f4e-a4cd-8f7bedda7262_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_019e2c6b-4ff6-7d28-bdfc-9436e582f2a8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension_019e2c6b-4f3b-77ff-af15-e6d1481288f3_terseLabel_en-US" xlink:label="lab_gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount subject to maturity extension</link:label>
    <link:label id="lab_gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension_label_en-US" xlink:label="lab_gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Borrowing Capacity, Subject to Maturity Extension</link:label>
    <link:label id="lab_gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension_documentation_en-US" xlink:label="lab_gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Borrowing Capacity, Subject to Maturity Extension</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension" xlink:href="gdrx-20260630.xsd#gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension" xlink:to="lab_gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_019e2c6b-4ff6-71dc-aeea-2257dc7086ba_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRepurchaseAgreements_019e2c6b-4ff6-77a1-b5ee-4a6b18d100b2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRepurchaseAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Repurchase Agreements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRepurchaseAgreements_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRepurchaseAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Repurchase Agreements [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRepurchaseAgreements" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfRepurchaseAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRepurchaseAgreements" xlink:to="lab_us-gaap_ScheduleOfRepurchaseAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_VitacarePrescriptionServicesIncMember_019e2c6b-4ff6-7460-99f2-317928c10a5b_terseLabel_en-US" xlink:label="lab_gdrx_VitacarePrescriptionServicesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">VitaCare Prescription Services, Inc</link:label>
    <link:label id="lab_gdrx_VitacarePrescriptionServicesIncMember_label_en-US" xlink:label="lab_gdrx_VitacarePrescriptionServicesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">VitaCare Prescription Services Inc [Member]</link:label>
    <link:label id="lab_gdrx_VitacarePrescriptionServicesIncMember_documentation_en-US" xlink:label="lab_gdrx_VitacarePrescriptionServicesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">vitaCare prescription services inc member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_VitacarePrescriptionServicesIncMember" xlink:href="gdrx-20260630.xsd#gdrx_VitacarePrescriptionServicesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_VitacarePrescriptionServicesIncMember" xlink:to="lab_gdrx_VitacarePrescriptionServicesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_019e2c6b-4ff6-7e41-b13d-7eac20b75cc3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_019e2c6b-4f3b-7bf6-ba9d-afdbbc9a6735_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e2c6b-4f3b-7f23-a441-a88ed9d15917_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_019e2c6b-4ff6-7bd2-b37b-58125291300e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_019e2c6b-4f3b-75e8-bdbf-f3d19246e47c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_019e2c6b-4f3b-7318-9e66-7484f8606ae4_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e2c6b-4ff6-7c87-89cb-99adae6dc82e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_019e2c6b-4f3b-7010-84c5-287618c83736_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForSoftware_019e2c6b-4f3b-7b9d-be65-f699debf3cf8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Capitalized software</link:label>
    <link:label id="lab_us-gaap_PaymentsForSoftware_label_en-US" xlink:label="lab_us-gaap_PaymentsForSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForSoftware" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsForSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForSoftware" xlink:to="lab_us-gaap_PaymentsForSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_019e2c6b-4ff6-79f9-8a54-84a02fbe0752_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_019e2c6b-4f3b-7edd-b361-01b3418119f6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_NoncashStockBasedCompensationIncludedInCapitalizedSoftware_019e2c6b-4ff6-74da-938a-1d75172cd9ba_terseLabel_en-US" xlink:label="lab_gdrx_NoncashStockBasedCompensationIncludedInCapitalizedSoftware" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation included in capitalized software</link:label>
    <link:label id="lab_gdrx_NoncashStockBasedCompensationIncludedInCapitalizedSoftware_label_en-US" xlink:label="lab_gdrx_NoncashStockBasedCompensationIncludedInCapitalizedSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash Stock Based Compensation Included In Capitalized Software</link:label>
    <link:label id="lab_gdrx_NoncashStockBasedCompensationIncludedInCapitalizedSoftware_documentation_en-US" xlink:label="lab_gdrx_NoncashStockBasedCompensationIncludedInCapitalizedSoftware" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Noncash stock-based compensation included in capitalized software development costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_NoncashStockBasedCompensationIncludedInCapitalizedSoftware" xlink:href="gdrx-20260630.xsd#gdrx_NoncashStockBasedCompensationIncludedInCapitalizedSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_NoncashStockBasedCompensationIncludedInCapitalizedSoftware" xlink:to="lab_gdrx_NoncashStockBasedCompensationIncludedInCapitalizedSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_019e2c6b-4ff6-7b37-9444-123beb771578_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets obtained in exchange for operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_019e2c6b-4ff5-7c3c-bc44-8868e0fe327c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_019e2c6b-4f3b-7200-87bd-6bbc9fab77bd_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_019e2c6b-4ff5-7281-ae63-60d65ddcc15f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_019e2c6b-4ff6-7481-9fba-bc823226d077_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e2c6b-4f3b-7425-8fe9-a782c43275a1_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_019e2c6b-4ff6-73ee-8684-38f3f617d80c_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAbstract" xlink:to="lab_us-gaap_NetIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits_019e2c6b-4f3b-740c-b112-c5cd3e45332f_terseLabel_en-US" xlink:label="lab_gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting and settlement of restricted stock units (in shares)</link:label>
    <link:label id="lab_gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits_label_en-US" xlink:label="lab_gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period Shares Vesting Of Restricted Stock Units</link:label>
    <link:label id="lab_gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits_documentation_en-US" xlink:label="lab_gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock issued during period shares, vesting of restricted stock units.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits" xlink:href="gdrx-20260630.xsd#gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits" xlink:to="lab_gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_019e2c6b-4f3b-7ee9-908f-5783128bdf59_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_019e2c6b-4f3b-76c0-9989-f18bbadd7935_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_019e2c6b-4f3b-753d-b99c-16594d9cb057_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_019e6ec6-7954-743e-be0d-b71387965cf2_netLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionLocationBalanceAxis_019e2c6b-4ff6-7d2f-8805-56e102791bfd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionLocationBalanceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Location, Statement of Financial Position, Balance [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionLocationBalanceAxis_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionLocationBalanceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Location, Statement of Financial Position, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationBalanceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfFinancialPositionLocationBalanceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionLocationBalanceAxis" xlink:to="lab_us-gaap_StatementOfFinancialPositionLocationBalanceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_019e2c6b-4ff6-7519-8222-fac8b9c89983_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_019e2c6b-4ff5-7441-bf28-510563cdda44_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_019e2c6b-4f3b-7815-823d-ef9fa334d2dc_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Settlement payment</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3b-7403-9499-d666a882307e_terseLabel_en-US" xlink:label="lab_gdrx_AccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Line Items]</link:label>
    <link:label id="lab_gdrx_AccountingPoliciesLineItems_label_en-US" xlink:label="lab_gdrx_AccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Line Items]</link:label>
    <link:label id="lab_gdrx_AccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_gdrx_AccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounting policies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_AccountingPoliciesLineItems" xlink:href="gdrx-20260630.xsd#gdrx_AccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_gdrx_AccountingPoliciesLineItems" xlink:to="lab_gdrx_AccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_019e2c6b-4ff6-7195-ac25-3e2a486a8bdb_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>gdrx-20260630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e2c6b-4e55-7a2c-b1a0-3572b2490625,g:6d96a486-c103-4d24-b5e6-d8e2b8fbb013-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://goodrx.com/role/Cover" xlink:type="simple" xlink:href="gdrx-20260630.xsd#Cover"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_019e2c6b-4e56-7a67-9038-68d0c8ad8333" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_019e2c6b-4e56-7983-b0f8-88a287a4bf3a" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e2c6b-4e56-7a67-9038-68d0c8ad8333" xlink:to="loc_dei_DocumentInformationTable_019e2c6b-4e56-7983-b0f8-88a287a4bf3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4e56-79ea-87b0-d06b371374f8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_019e2c6b-4e56-7983-b0f8-88a287a4bf3a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4e56-79ea-87b0-d06b371374f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019e2c6b-4e56-7b79-8dde-844b70d51d74" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4e56-79ea-87b0-d06b371374f8" xlink:to="loc_us-gaap_ClassOfStockDomain_019e2c6b-4e56-7b79-8dde-844b70d51d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_019e2c6b-4e56-7dfd-949a-3909135c0da0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019e2c6b-4e56-7b79-8dde-844b70d51d74" xlink:to="loc_us-gaap_CommonClassAMember_019e2c6b-4e56-7dfd-949a-3909135c0da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_019e2c6b-4e56-7626-b1ef-4e4391bfad30" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019e2c6b-4e56-7b79-8dde-844b70d51d74" xlink:to="loc_us-gaap_CommonClassBMember_019e2c6b-4e56-7626-b1ef-4e4391bfad30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_019e2c6b-4e56-7983-b0f8-88a287a4bf3a" xlink:to="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019e2c6b-4e56-75fa-8493-8547da1e5440" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_DocumentType_019e2c6b-4e56-75fa-8493-8547da1e5440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_019e2c6b-4e56-7691-a651-bd23052856fb" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_DocumentQuarterlyReport_019e2c6b-4e56-7691-a651-bd23052856fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019e2c6b-4e56-7142-b132-af750b5eccfa" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_DocumentPeriodEndDate_019e2c6b-4e56-7142-b132-af750b5eccfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_019e2c6b-4e56-743d-a817-746c8e1e2e6b" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_DocumentTransitionReport_019e2c6b-4e56-743d-a817-746c8e1e2e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019e2c6b-4e56-70dc-85f2-9bbd671cae90" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityFileNumber_019e2c6b-4e56-70dc-85f2-9bbd671cae90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019e2c6b-4e56-7c26-89c9-3c528412c556" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityRegistrantName_019e2c6b-4e56-7c26-89c9-3c528412c556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019e2c6b-4e56-7169-b790-ac9943c9dd88" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019e2c6b-4e56-7169-b790-ac9943c9dd88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019e2c6b-4e56-775a-a2d8-ff38b8efaf3f" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityTaxIdentificationNumber_019e2c6b-4e56-775a-a2d8-ff38b8efaf3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019e2c6b-4e56-7339-8967-e6234efd1b47" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityAddressAddressLine1_019e2c6b-4e56-7339-8967-e6234efd1b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019e2c6b-4e56-76c1-b062-596ce10efdba" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityAddressCityOrTown_019e2c6b-4e56-76c1-b062-596ce10efdba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019e2c6b-4e56-7086-81c7-7c4b02dd9d31" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityAddressStateOrProvince_019e2c6b-4e56-7086-81c7-7c4b02dd9d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019e2c6b-4e56-7213-8ca9-819cd07f212f" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityAddressPostalZipCode_019e2c6b-4e56-7213-8ca9-819cd07f212f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019e2c6b-4e56-7642-8122-59bf17424f5a" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_CityAreaCode_019e2c6b-4e56-7642-8122-59bf17424f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019e2c6b-4e56-7bb2-860b-a8e23a7d0ba6" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_LocalPhoneNumber_019e2c6b-4e56-7bb2-860b-a8e23a7d0ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019e2c6b-4e56-7fa2-8e32-825c105c0f91" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_Security12bTitle_019e2c6b-4e56-7fa2-8e32-825c105c0f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019e2c6b-4e56-714e-ba7b-bb0a5c6c7f6e" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_TradingSymbol_019e2c6b-4e56-714e-ba7b-bb0a5c6c7f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019e2c6b-4e56-7e5f-841c-e4c2826f6181" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_SecurityExchangeName_019e2c6b-4e56-7e5f-841c-e4c2826f6181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_019e2c6b-4e56-7e1f-8808-1fa29435e08b" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityCurrentReportingStatus_019e2c6b-4e56-7e1f-8808-1fa29435e08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_019e2c6b-4e56-77d2-a7c7-4ddf34d0c974" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityInteractiveDataCurrent_019e2c6b-4e56-77d2-a7c7-4ddf34d0c974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_019e2c6b-4e56-7dda-ae0e-9141d03818ac" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityFilerCategory_019e2c6b-4e56-7dda-ae0e-9141d03818ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_019e2c6b-4f3a-7db6-9b78-2dff12702760" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntitySmallBusiness_019e2c6b-4f3a-7db6-9b78-2dff12702760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019e2c6b-4f3a-7dad-8c04-e21b6771e77e" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityEmergingGrowthCompany_019e2c6b-4f3a-7dad-8c04-e21b6771e77e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_019e2c6b-4f3a-76fb-891b-6886d24f9ad6" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityShellCompany_019e2c6b-4f3a-76fb-891b-6886d24f9ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_019e2c6b-4f3a-7d81-bc1d-2e6e15c0fc84" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_019e2c6b-4f3a-7d81-bc1d-2e6e15c0fc84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019e2c6b-4f3a-70ba-9c3c-b441c120a300" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_EntityCentralIndexKey_019e2c6b-4f3a-70ba-9c3c-b441c120a300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_019e2c6b-4f3a-70f4-9c80-ff4b96742a64" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_CurrentFiscalYearEndDate_019e2c6b-4f3a-70f4-9c80-ff4b96742a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_019e2c6b-4f3a-7201-bea0-d61b594caf62" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_DocumentFiscalYearFocus_019e2c6b-4f3a-7201-bea0-d61b594caf62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_019e2c6b-4f3a-73ee-a2f4-c49e404e1ce1" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_DocumentFiscalPeriodFocus_019e2c6b-4f3a-73ee-a2f4-c49e404e1ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019e2c6b-4f3a-7327-8c0b-f990a7dd7bf0" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019e2c6b-4e56-71fb-b73d-12be86425399" xlink:to="loc_dei_AmendmentFlag_019e2c6b-4f3a-7327-8c0b-f990a7dd7bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_019e2c6b-4f3a-7362-afe6-2d7ff595d523" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_019e2c6b-4f3a-742c-a9d4-f228d8e06440" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019e2c6b-4f3a-7362-afe6-2d7ff595d523" xlink:to="loc_us-gaap_AssetsAbstract_019e2c6b-4f3a-742c-a9d4-f228d8e06440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_019e2c6b-4f3a-75a4-b7d0-18646b72a056" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019e2c6b-4f3a-742c-a9d4-f228d8e06440" xlink:to="loc_us-gaap_AssetsCurrentAbstract_019e2c6b-4f3a-75a4-b7d0-18646b72a056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e2c6b-4f3a-76a1-919a-05e95efee68c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019e2c6b-4f3a-75a4-b7d0-18646b72a056" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e2c6b-4f3a-76a1-919a-05e95efee68c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_019e2c6b-4f3a-762d-8a28-b3135f9d8b98" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019e2c6b-4f3a-75a4-b7d0-18646b72a056" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_019e2c6b-4f3a-762d-8a28-b3135f9d8b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PrescriptionReimbursementAssetsCurrent_019e2c6b-4f3a-73b3-b1df-306913819a21" xlink:href="gdrx-20260630.xsd#gdrx_PrescriptionReimbursementAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019e2c6b-4f3a-75a4-b7d0-18646b72a056" xlink:to="loc_gdrx_PrescriptionReimbursementAssetsCurrent_019e2c6b-4f3a-73b3-b1df-306913819a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e2c6b-4f3a-7581-bfdc-6631d2ed6f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019e2c6b-4f3a-75a4-b7d0-18646b72a056" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e2c6b-4f3a-7581-bfdc-6631d2ed6f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019e2c6b-4f3a-728a-bdd7-0bc990fee4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019e2c6b-4f3a-75a4-b7d0-18646b72a056" xlink:to="loc_us-gaap_AssetsCurrent_019e2c6b-4f3a-728a-bdd7-0bc990fee4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019e2c6b-4f3a-7dba-a3b8-0d560810e0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019e2c6b-4f3a-742c-a9d4-f228d8e06440" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019e2c6b-4f3a-7dba-a3b8-0d560810e0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_019e2c6b-4f3a-7131-acd2-dfe1fc91231e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019e2c6b-4f3a-742c-a9d4-f228d8e06440" xlink:to="loc_us-gaap_Goodwill_019e2c6b-4f3a-7131-acd2-dfe1fc91231e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e2c6b-4f3a-7600-b088-79113d59afda" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019e2c6b-4f3a-742c-a9d4-f228d8e06440" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e2c6b-4f3a-7600-b088-79113d59afda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_019e2c6b-4f3a-754a-8d87-d6177a873d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019e2c6b-4f3a-742c-a9d4-f228d8e06440" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_019e2c6b-4f3a-754a-8d87-d6177a873d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e2c6b-4f3a-7d99-a2c1-e18a4894a955" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019e2c6b-4f3a-742c-a9d4-f228d8e06440" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e2c6b-4f3a-7d99-a2c1-e18a4894a955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_019e2c6b-4f3a-77a1-ac7e-96ac146a5a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019e2c6b-4f3a-742c-a9d4-f228d8e06440" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_019e2c6b-4f3a-77a1-ac7e-96ac146a5a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019e2c6b-4f3a-747a-8138-af6e5d55913c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019e2c6b-4f3a-742c-a9d4-f228d8e06440" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019e2c6b-4f3a-747a-8138-af6e5d55913c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019e2c6b-4f3a-7b4f-8e43-1073a0226f21" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019e2c6b-4f3a-742c-a9d4-f228d8e06440" xlink:to="loc_us-gaap_Assets_019e2c6b-4f3a-7b4f-8e43-1073a0226f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019e2c6b-4f3a-7919-a2ce-2cf1738d5825" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019e2c6b-4f3a-7362-afe6-2d7ff595d523" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019e2c6b-4f3a-7919-a2ce-2cf1738d5825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_019e2c6b-4f3a-7f60-94dc-a1cab790d374" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019e2c6b-4f3a-7919-a2ce-2cf1738d5825" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_019e2c6b-4f3a-7f60-94dc-a1cab790d374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019e2c6b-4f3a-7fc5-a64e-3e7865297996" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019e2c6b-4f3a-7f60-94dc-a1cab790d374" xlink:to="loc_us-gaap_AccountsPayableCurrent_019e2c6b-4f3a-7fc5-a64e-3e7865297996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PrescriptionReimbursementLiabilitiesCurrent_019e2c6b-4f3a-7553-b91d-c68751b5b54f" xlink:href="gdrx-20260630.xsd#gdrx_PrescriptionReimbursementLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019e2c6b-4f3a-7f60-94dc-a1cab790d374" xlink:to="loc_gdrx_PrescriptionReimbursementLiabilitiesCurrent_019e2c6b-4f3a-7553-b91d-c68751b5b54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_AccruedExpensesAndOtherCurrentLiabilities_019e2c6b-4f3a-72f1-b41a-75226c3e550b" xlink:href="gdrx-20260630.xsd#gdrx_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019e2c6b-4f3a-7f60-94dc-a1cab790d374" xlink:to="loc_gdrx_AccruedExpensesAndOtherCurrentLiabilities_019e2c6b-4f3a-72f1-b41a-75226c3e550b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_019e2c6b-4f3a-74dd-be99-8d94e4602a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019e2c6b-4f3a-7f60-94dc-a1cab790d374" xlink:to="loc_us-gaap_LongTermDebtCurrent_019e2c6b-4f3a-74dd-be99-8d94e4602a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019e2c6b-4f3a-7f90-981d-1966e3b1775f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019e2c6b-4f3a-7f60-94dc-a1cab790d374" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019e2c6b-4f3a-7f90-981d-1966e3b1775f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019e2c6b-4f3a-7c73-9790-66949fa01cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019e2c6b-4f3a-7f60-94dc-a1cab790d374" xlink:to="loc_us-gaap_LiabilitiesCurrent_019e2c6b-4f3a-7c73-9790-66949fa01cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_019e2c6b-4f3a-7757-b4bf-64581b813baa" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019e2c6b-4f3a-7919-a2ce-2cf1738d5825" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_019e2c6b-4f3a-7757-b4bf-64581b813baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019e2c6b-4f3a-7bf7-9b86-df84abde6b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019e2c6b-4f3a-7919-a2ce-2cf1738d5825" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019e2c6b-4f3a-7bf7-9b86-df84abde6b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_019e2c6b-4f3a-7d2a-9c10-6ae12f5da9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019e2c6b-4f3a-7919-a2ce-2cf1738d5825" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_019e2c6b-4f3a-7d2a-9c10-6ae12f5da9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019e2c6b-4f3a-7991-b1fb-05fb64975635" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019e2c6b-4f3a-7919-a2ce-2cf1738d5825" xlink:to="loc_us-gaap_Liabilities_019e2c6b-4f3a-7991-b1fb-05fb64975635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019e2c6b-4f3a-79eb-970d-96de7c46e05c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019e2c6b-4f3a-7919-a2ce-2cf1738d5825" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019e2c6b-4f3a-79eb-970d-96de7c46e05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_019e2c6b-4f3a-7758-bcff-76c637b096b2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019e2c6b-4f3a-7919-a2ce-2cf1738d5825" xlink:to="loc_us-gaap_StockholdersEquityAbstract_019e2c6b-4f3a-7758-bcff-76c637b096b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_019e2c6b-4f3a-7b79-9262-5f8ab9f3ffd9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019e2c6b-4f3a-7758-bcff-76c637b096b2" xlink:to="loc_us-gaap_PreferredStockValue_019e2c6b-4f3a-7b79-9262-5f8ab9f3ffd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019e2c6b-4f3a-7879-b171-fde3557de3bd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019e2c6b-4f3a-7758-bcff-76c637b096b2" xlink:to="loc_us-gaap_CommonStockValue_019e2c6b-4f3a-7879-b171-fde3557de3bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_019e2c6b-4f3a-7c80-bf2a-a34eed6c654d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019e2c6b-4f3a-7758-bcff-76c637b096b2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_019e2c6b-4f3a-7c80-bf2a-a34eed6c654d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e2c6b-4f3a-78d1-8523-b6e8dc1424fc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019e2c6b-4f3a-7758-bcff-76c637b096b2" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e2c6b-4f3a-78d1-8523-b6e8dc1424fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e2c6b-4f3a-73ca-b14e-0ca2b5166ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019e2c6b-4f3a-7758-bcff-76c637b096b2" xlink:to="loc_us-gaap_StockholdersEquity_019e2c6b-4f3a-73ca-b14e-0ca2b5166ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e2c6b-4f3a-797d-bc63-fc9a58a3277f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019e2c6b-4f3a-7919-a2ce-2cf1738d5825" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e2c6b-4f3a-797d-bc63-fc9a58a3277f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CondensedConsolidatedBalanceSheetsParentheticalUnaudited"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_019e2c6b-4f3a-70be-9963-46d23737a452" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019e2c6b-4f3a-7b14-942c-7c0d59a1daf7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019e2c6b-4f3a-70be-9963-46d23737a452" xlink:to="loc_us-gaap_StatementTable_019e2c6b-4f3a-7b14-942c-7c0d59a1daf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7067-8f94-ca7cd389afa1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019e2c6b-4f3a-7b14-942c-7c0d59a1daf7" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7067-8f94-ca7cd389afa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-7307-8a9c-f5a5be98d33b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7067-8f94-ca7cd389afa1" xlink:to="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-7307-8a9c-f5a5be98d33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_019e2c6b-4f3a-73bc-b502-7f21e432f23f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-7307-8a9c-f5a5be98d33b" xlink:to="loc_us-gaap_CommonClassAMember_019e2c6b-4f3a-73bc-b502-7f21e432f23f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_019e2c6b-4f3a-7891-9114-2fe6ba975974" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-7307-8a9c-f5a5be98d33b" xlink:to="loc_us-gaap_CommonClassBMember_019e2c6b-4f3a-7891-9114-2fe6ba975974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-731b-9d12-f86d4123cb8c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019e2c6b-4f3a-7b14-942c-7c0d59a1daf7" xlink:to="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-731b-9d12-f86d4123cb8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019e2c6b-4f3a-779f-9b7b-2b70c2ebfa53" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-731b-9d12-f86d4123cb8c" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019e2c6b-4f3a-779f-9b7b-2b70c2ebfa53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_019e2c6b-4f3a-77c1-b080-8d8c74623ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-731b-9d12-f86d4123cb8c" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_019e2c6b-4f3a-77c1-b080-8d8c74623ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_019e2c6b-4f3a-7258-a6a8-58daf175584b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-731b-9d12-f86d4123cb8c" xlink:to="loc_us-gaap_PreferredStockSharesIssued_019e2c6b-4f3a-7258-a6a8-58daf175584b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_019e2c6b-4f3a-7445-9668-f9babe101788" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-731b-9d12-f86d4123cb8c" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_019e2c6b-4f3a-7445-9668-f9babe101788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_019e2c6b-4f3a-7af6-b242-72bbf18fc2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-731b-9d12-f86d4123cb8c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_019e2c6b-4f3a-7af6-b242-72bbf18fc2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_019e2c6b-4f3a-7787-8e51-75741ed30d99" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-731b-9d12-f86d4123cb8c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_019e2c6b-4f3a-7787-8e51-75741ed30d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_019e2c6b-4f3a-7b75-8697-a1a63909494b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-731b-9d12-f86d4123cb8c" xlink:to="loc_us-gaap_CommonStockSharesIssued_019e2c6b-4f3a-7b75-8697-a1a63909494b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019e2c6b-4f3a-77f6-95ea-f401aefd60ab" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-731b-9d12-f86d4123cb8c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019e2c6b-4f3a-77f6-95ea-f401aefd60ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_019e2c6b-4f3a-7a6b-928f-6d675d251766" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019e2c6b-4f3a-7576-8d52-930452e1c7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019e2c6b-4f3a-7a6b-928f-6d675d251766" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019e2c6b-4f3a-7576-8d52-930452e1c7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_019e2c6b-4f3a-79e2-98cb-47476a603649" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019e2c6b-4f3a-7a6b-928f-6d675d251766" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_019e2c6b-4f3a-79e2-98cb-47476a603649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_019e2c6b-4f3a-7fbb-85b3-ff4cb4f22fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_019e2c6b-4f3a-79e2-98cb-47476a603649" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_019e2c6b-4f3a-7fbb-85b3-ff4cb4f22fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019e2c6b-4f3a-74d6-9317-80b4a8cc4df4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_019e2c6b-4f3a-79e2-98cb-47476a603649" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019e2c6b-4f3a-74d6-9317-80b4a8cc4df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_019e2c6b-4f3a-7106-a88e-15a4e3d477a4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_019e2c6b-4f3a-79e2-98cb-47476a603649" xlink:to="loc_us-gaap_SellingAndMarketingExpense_019e2c6b-4f3a-7106-a88e-15a4e3d477a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019e2c6b-4f3a-7796-a24f-3d35136a85bd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_019e2c6b-4f3a-79e2-98cb-47476a603649" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019e2c6b-4f3a-7796-a24f-3d35136a85bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_019e2c6b-4f3a-7517-84f9-8af140d0da28" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_019e2c6b-4f3a-79e2-98cb-47476a603649" xlink:to="loc_us-gaap_DepreciationAndAmortization_019e2c6b-4f3a-7517-84f9-8af140d0da28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_019e2c6b-4f3a-70fc-bb73-6061160b84b9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_019e2c6b-4f3a-79e2-98cb-47476a603649" xlink:to="loc_us-gaap_CostsAndExpenses_019e2c6b-4f3a-70fc-bb73-6061160b84b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e2c6b-4f3a-7e6f-bd97-17520bc5e4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019e2c6b-4f3a-7a6b-928f-6d675d251766" xlink:to="loc_us-gaap_OperatingIncomeLoss_019e2c6b-4f3a-7e6f-bd97-17520bc5e4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_019e2c6b-4f3a-78dc-aa85-7a4384157009" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019e2c6b-4f3a-7a6b-928f-6d675d251766" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_019e2c6b-4f3a-78dc-aa85-7a4384157009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019e2c6b-4f3a-72c5-8dfc-fe95ee381c29" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_019e2c6b-4f3a-78dc-aa85-7a4384157009" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019e2c6b-4f3a-72c5-8dfc-fe95ee381c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_019e2c6b-4f3a-750d-be93-aa06c507a4a1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestIncomeOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_019e2c6b-4f3a-78dc-aa85-7a4384157009" xlink:to="loc_us-gaap_InterestIncomeOther_019e2c6b-4f3a-750d-be93-aa06c507a4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_019e2c6b-4f3a-74a2-86be-1603c101501a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_019e2c6b-4f3a-78dc-aa85-7a4384157009" xlink:to="loc_us-gaap_InterestExpenseNonoperating_019e2c6b-4f3a-74a2-86be-1603c101501a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019e2c6b-4f3a-73ae-b908-fbcd2fde78db" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_019e2c6b-4f3a-78dc-aa85-7a4384157009" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019e2c6b-4f3a-73ae-b908-fbcd2fde78db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e2c6b-4f3a-7c0c-98ac-b1687b3706ef" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019e2c6b-4f3a-7a6b-928f-6d675d251766" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019e2c6b-4f3a-7c0c-98ac-b1687b3706ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019e2c6b-4f3a-786e-8dd4-a953274d817f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019e2c6b-4f3a-7a6b-928f-6d675d251766" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019e2c6b-4f3a-786e-8dd4-a953274d817f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e2c6b-4f3a-7407-9306-043bd8c1e50e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019e2c6b-4f3a-7a6b-928f-6d675d251766" xlink:to="loc_us-gaap_NetIncomeLoss_019e2c6b-4f3a-7407-9306-043bd8c1e50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019e2c6b-4f3a-7f3c-9648-53b6f3cc4ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019e2c6b-4f3a-7a6b-928f-6d675d251766" xlink:to="loc_us-gaap_EarningsPerShareAbstract_019e2c6b-4f3a-7f3c-9648-53b6f3cc4ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019e2c6b-4f3a-77fb-bd41-ddf7b66a1331" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019e2c6b-4f3a-7f3c-9648-53b6f3cc4ab5" xlink:to="loc_us-gaap_EarningsPerShareBasic_019e2c6b-4f3a-77fb-bd41-ddf7b66a1331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019e2c6b-4f3a-79ca-8b7b-67a81d67d4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019e2c6b-4f3a-7f3c-9648-53b6f3cc4ab5" xlink:to="loc_us-gaap_EarningsPerShareDiluted_019e2c6b-4f3a-79ca-8b7b-67a81d67d4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019e2c6b-4f3a-72f6-b037-f0d6fa400de5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019e2c6b-4f3a-7a6b-928f-6d675d251766" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019e2c6b-4f3a-72f6-b037-f0d6fa400de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019e2c6b-4f3a-7f47-9a2b-297a893ed257" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019e2c6b-4f3a-72f6-b037-f0d6fa400de5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019e2c6b-4f3a-7f47-9a2b-297a893ed257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019e2c6b-4f3a-7087-8e39-10764397bf4f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019e2c6b-4f3a-72f6-b037-f0d6fa400de5" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019e2c6b-4f3a-7087-8e39-10764397bf4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CondensedConsolidatedStatementsofStockholdersEquityUnaudited"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_019e2c6b-4f3a-78a4-b3fc-039127ccb0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019e2c6b-4f3a-7820-a77d-df7283118d67" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_019e2c6b-4f3a-78a4-b3fc-039127ccb0eb" xlink:to="loc_us-gaap_StatementTable_019e2c6b-4f3a-7820-a77d-df7283118d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-72ef-809b-da5c4fe18e21" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019e2c6b-4f3a-7820-a77d-df7283118d67" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-72ef-809b-da5c4fe18e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-74eb-aef8-9d0e5c6f0b00" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-72ef-809b-da5c4fe18e21" xlink:to="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-74eb-aef8-9d0e5c6f0b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019e2c6b-4f3a-7b8d-875a-7954af00dd57" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-74eb-aef8-9d0e5c6f0b00" xlink:to="loc_us-gaap_CommonStockMember_019e2c6b-4f3a-7b8d-875a-7954af00dd57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_019e2c6b-4f3a-7d1e-ae90-bec0e8a23840" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-74eb-aef8-9d0e5c6f0b00" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_019e2c6b-4f3a-7d1e-ae90-bec0e8a23840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_019e2c6b-4f3a-72c8-b92b-77693d0c257a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-74eb-aef8-9d0e5c6f0b00" xlink:to="loc_us-gaap_RetainedEarningsMember_019e2c6b-4f3a-72c8-b92b-77693d0c257a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-79fd-be9e-7876566ff437" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019e2c6b-4f3a-7820-a77d-df7283118d67" xlink:to="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-79fd-be9e-7876566ff437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-79fd-be9e-7876566ff437" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_019e2c6b-4f3a-7933-9508-b642ac0db315" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_SharesOutstanding_019e2c6b-4f3a-7933-9508-b642ac0db315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e2c6b-4f3a-7381-a71d-7e49725b3859" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_StockholdersEquity_019e2c6b-4f3a-7381-a71d-7e49725b3859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019e2c6b-4f3a-7524-9ac5-88ad7875d015" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019e2c6b-4f3a-7524-9ac5-88ad7875d015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019e2c6b-4f3a-7dae-9c49-ec80c42028b8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019e2c6b-4f3a-7dae-9c49-ec80c42028b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019e2c6b-4f3a-74a5-b078-41634da5d9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019e2c6b-4f3a-74a5-b078-41634da5d9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits_019e2c6b-4f3a-7e18-82d8-774afdc30b3e" xlink:href="gdrx-20260630.xsd#gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits_019e2c6b-4f3a-7e18-82d8-774afdc30b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_019e2c6b-4f3a-70a1-a705-ca0ecc62acb8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_019e2c6b-4f3a-70a1-a705-ca0ecc62acb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_019e2c6b-4f3a-7faa-b930-9520bcdd8116" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_019e2c6b-4f3a-7faa-b930-9520bcdd8116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_019e2c6b-4f3a-7952-80cb-f68fb4c3152d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_019e2c6b-4f3a-7952-80cb-f68fb4c3152d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_019e2c6b-4f3a-73f1-a099-750a327edb03" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_019e2c6b-4f3a-73f1-a099-750a327edb03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e2c6b-4f3a-7af0-8d67-e5de3aaf0ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_NetIncomeLoss_019e2c6b-4f3a-7af0-8d67-e5de3aaf0ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_019e2c6b-4f3a-72d7-a0da-323e1820e2e7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_019e2c6b-4f3a-72d7-a0da-323e1820e2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_019e2c6b-4f3a-763f-919e-f1d7d47fca61" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_019e2c6b-4f3a-763f-919e-f1d7d47fca61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_019e2c6b-4f3a-7ac9-8c95-fa6cdf397ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_SharesOutstanding_019e2c6b-4f3a-7ac9-8c95-fa6cdf397ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e2c6b-4f3a-72b0-a220-096928f8d66c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e2c6b-4f3a-7575-ab1b-3ac807acfc43" xlink:to="loc_us-gaap_StockholdersEquity_019e2c6b-4f3a-72b0-a220-096928f8d66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_019e2c6b-4f3a-7f90-9981-91f9a645bde1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019e2c6b-4f3a-7309-b8e7-5c9131647fef" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019e2c6b-4f3a-7f90-9981-91f9a645bde1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019e2c6b-4f3a-7309-b8e7-5c9131647fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e2c6b-4f3a-7787-9759-23653e2f368c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019e2c6b-4f3a-7309-b8e7-5c9131647fef" xlink:to="loc_us-gaap_NetIncomeLoss_019e2c6b-4f3a-7787-9759-23653e2f368c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019e2c6b-4f3a-7df0-a23d-c65d7b5b672f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019e2c6b-4f3a-7309-b8e7-5c9131647fef" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019e2c6b-4f3a-7df0-a23d-c65d7b5b672f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_019e2c6b-4f3a-71f8-94eb-5b977409440f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019e2c6b-4f3a-7df0-a23d-c65d7b5b672f" xlink:to="loc_us-gaap_DepreciationAndAmortization_019e2c6b-4f3a-71f8-94eb-5b977409440f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_019e2c6b-4f3a-77b2-ade9-4cee294deeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019e2c6b-4f3a-7df0-a23d-c65d7b5b672f" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_019e2c6b-4f3a-77b2-ade9-4cee294deeb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019e2c6b-4f3a-7d65-b385-6d4f0bac3d34" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019e2c6b-4f3a-7df0-a23d-c65d7b5b672f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019e2c6b-4f3a-7d65-b385-6d4f0bac3d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019e2c6b-4f3a-7442-aef1-508277eb2e93" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019e2c6b-4f3a-7df0-a23d-c65d7b5b672f" xlink:to="loc_us-gaap_ShareBasedCompensation_019e2c6b-4f3a-7442-aef1-508277eb2e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_019e2c6b-4f3a-7a00-a81b-bd1fc53f987c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019e2c6b-4f3a-7df0-a23d-c65d7b5b672f" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_019e2c6b-4f3a-7a00-a81b-bd1fc53f987c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets_019e2c6b-4f3a-79d4-babd-f0dd74b17408" xlink:href="gdrx-20260630.xsd#gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019e2c6b-4f3a-7df0-a23d-c65d7b5b672f" xlink:to="loc_gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets_019e2c6b-4f3a-79d4-babd-f0dd74b17408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_019e2c6b-4f3a-7781-ac22-c89f418fe808" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019e2c6b-4f3a-7df0-a23d-c65d7b5b672f" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_019e2c6b-4f3a-7781-ac22-c89f418fe808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019e2c6b-4f3a-7315-9920-1d50487d7d89" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019e2c6b-4f3a-7df0-a23d-c65d7b5b672f" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019e2c6b-4f3a-7315-9920-1d50487d7d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019e2c6b-4f3a-767d-8f3f-e67ba055163e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019e2c6b-4f3a-7315-9920-1d50487d7d89" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019e2c6b-4f3a-767d-8f3f-e67ba055163e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets_019e2c6b-4f3a-7caa-85ee-f4e97a4862f9" xlink:href="gdrx-20260630.xsd#gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019e2c6b-4f3a-7315-9920-1d50487d7d89" xlink:to="loc_gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets_019e2c6b-4f3a-7caa-85ee-f4e97a4862f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e2c6b-4f3a-74c5-80df-e556dd10a102" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019e2c6b-4f3a-7315-9920-1d50487d7d89" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e2c6b-4f3a-74c5-80df-e556dd10a102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019e2c6b-4f3a-7144-b752-922cf7b1e222" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019e2c6b-4f3a-7315-9920-1d50487d7d89" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019e2c6b-4f3a-7144-b752-922cf7b1e222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities_019e2c6b-4f3a-78ca-af39-3b091c86965d" xlink:href="gdrx-20260630.xsd#gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019e2c6b-4f3a-7315-9920-1d50487d7d89" xlink:to="loc_gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities_019e2c6b-4f3a-78ca-af39-3b091c86965d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019e2c6b-4f3a-7f8a-917b-9dc7736ef632" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019e2c6b-4f3a-7315-9920-1d50487d7d89" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019e2c6b-4f3a-7f8a-917b-9dc7736ef632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_IncreaseDecreaseOperatingLeaseLiabilities_019e2c6b-4f3a-7e2b-b84b-0d1b3bf8f951" xlink:href="gdrx-20260630.xsd#gdrx_IncreaseDecreaseOperatingLeaseLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019e2c6b-4f3a-7315-9920-1d50487d7d89" xlink:to="loc_gdrx_IncreaseDecreaseOperatingLeaseLiabilities_019e2c6b-4f3a-7e2b-b84b-0d1b3bf8f951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_019e2c6b-4f3a-7f5c-9b59-d6db1e32d842" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019e2c6b-4f3a-7315-9920-1d50487d7d89" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_019e2c6b-4f3a-7f5c-9b59-d6db1e32d842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-7e7a-832c-83040ccdea9e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019e2c6b-4f3a-7309-b8e7-5c9131647fef" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e2c6b-4f3a-7e7a-832c-83040ccdea9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019e2c6b-4f3a-7ac8-b3db-c66b23ddc571" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019e2c6b-4f3a-7f90-9981-91f9a645bde1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019e2c6b-4f3a-7ac8-b3db-c66b23ddc571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019e2c6b-4f3a-74f9-99d8-b157d89eafb9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019e2c6b-4f3a-7ac8-b3db-c66b23ddc571" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019e2c6b-4f3a-74f9-99d8-b157d89eafb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_019e2c6b-4f3a-764c-bffd-48f8786b0232" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019e2c6b-4f3a-7ac8-b3db-c66b23ddc571" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_019e2c6b-4f3a-764c-bffd-48f8786b0232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForSoftware_019e2c6b-4f3a-751d-b092-51b009301431" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsForSoftware"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019e2c6b-4f3a-7ac8-b3db-c66b23ddc571" xlink:to="loc_us-gaap_PaymentsForSoftware_019e2c6b-4f3a-751d-b092-51b009301431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e2c6b-4f3a-71b9-9c85-499f76cb8378" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019e2c6b-4f3a-7ac8-b3db-c66b23ddc571" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e2c6b-4f3a-71b9-9c85-499f76cb8378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019e2c6b-4f3a-7caf-a780-53fd600ba1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019e2c6b-4f3a-7f90-9981-91f9a645bde1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019e2c6b-4f3a-7caf-a780-53fd600ba1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_019e2c6b-4f3a-7de0-8d5d-4147cc51cac3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019e2c6b-4f3a-7caf-a780-53fd600ba1e2" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_019e2c6b-4f3a-7de0-8d5d-4147cc51cac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_019e2c6b-4f3a-747a-8b08-2f2337d1e9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019e2c6b-4f3a-7caf-a780-53fd600ba1e2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_019e2c6b-4f3a-747a-8b08-2f2337d1e9a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019e2c6b-4f3a-70ae-9505-71ab6addadf5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019e2c6b-4f3a-7caf-a780-53fd600ba1e2" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019e2c6b-4f3a-70ae-9505-71ab6addadf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards_019e2c6b-4f3a-7a20-92d3-640cb7389e2b" xlink:href="gdrx-20260630.xsd#gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019e2c6b-4f3a-7caf-a780-53fd600ba1e2" xlink:to="loc_gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards_019e2c6b-4f3a-7a20-92d3-640cb7389e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_019e2c6b-4f3a-7a08-96a8-4864e28b9f50" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019e2c6b-4f3a-7caf-a780-53fd600ba1e2" xlink:to="loc_us-gaap_ProceedsFromStockPlans_019e2c6b-4f3a-7a08-96a8-4864e28b9f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e2c6b-4f3a-7cfb-be61-54ad454c7ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019e2c6b-4f3a-7caf-a780-53fd600ba1e2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e2c6b-4f3a-7cfb-be61-54ad454c7ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e2c6b-4f3a-788b-931a-b73b942150ce" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019e2c6b-4f3a-7f90-9981-91f9a645bde1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e2c6b-4f3a-788b-931a-b73b942150ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract_019e2c6b-4f3a-7cfa-aabb-7e7ebc470918" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019e2c6b-4f3a-7f90-9981-91f9a645bde1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract_019e2c6b-4f3a-7cfa-aabb-7e7ebc470918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_019e2c6b-4f3a-7fff-ac51-9d9dd6ebcb89" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract_019e2c6b-4f3a-7cfa-aabb-7e7ebc470918" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_019e2c6b-4f3a-7fff-ac51-9d9dd6ebcb89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_019e2c6b-4f3a-7309-b38d-c22e10e9e954" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract_019e2c6b-4f3a-7cfa-aabb-7e7ebc470918" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_019e2c6b-4f3a-7309-b38d-c22e10e9e954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_019e2c6b-4f3a-715a-bf84-e336998c12f5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019e2c6b-4f3a-7f90-9981-91f9a645bde1" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_019e2c6b-4f3a-715a-bf84-e336998c12f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_019e2c6b-4f3a-7757-a3b0-91711860f989" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_019e2c6b-4f3a-715a-bf84-e336998c12f5" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_019e2c6b-4f3a-7757-a3b0-91711860f989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_019e6df4-2807-7cbf-b9e0-58815e7f4307" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_019e2c6b-4f3a-7757-a3b0-91711860f989" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_019e6df4-2807-7cbf-b9e0-58815e7f4307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_NoncashStockBasedCompensationIncludedInCapitalizedSoftware_019e2c6b-4f3a-7a89-8e13-ee35bf59a253" xlink:href="gdrx-20260630.xsd#gdrx_NoncashStockBasedCompensationIncludedInCapitalizedSoftware"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_019e2c6b-4f3a-7757-a3b0-91711860f989" xlink:to="loc_gdrx_NoncashStockBasedCompensationIncludedInCapitalizedSoftware_019e2c6b-4f3a-7a89-8e13-ee35bf59a253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities_019e2c6b-4f3a-7f37-b904-92b5a771ea68" xlink:href="gdrx-20260630.xsd#gdrx_CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_019e2c6b-4f3a-7757-a3b0-91711860f989" xlink:to="loc_gdrx_CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities_019e2c6b-4f3a-7f37-b904-92b5a771ea68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnauditedParenthetical" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CondensedConsolidatedStatementsofOperationsUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_019fb437-5495-7f6e-b951-38d464f8e6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019fb437-5495-7830-b154-ac39ed577986" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019fb437-5495-7f6e-b951-38d464f8e6c6" xlink:to="loc_us-gaap_StatementTable_019fb437-5495-7830-b154-ac39ed577986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeLocationBalanceAxis_019fb437-5495-7613-b173-ef98cf2421fb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfIncomeLocationBalanceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019fb437-5495-7830-b154-ac39ed577986" xlink:to="loc_us-gaap_StatementOfIncomeLocationBalanceAxis_019fb437-5495-7613-b173-ef98cf2421fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019fb437-5495-7053-ae27-786139be7003" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019fb437-5495-7830-b154-ac39ed577986" xlink:to="loc_us-gaap_StatementLineItems_019fb437-5495-7053-ae27-786139be7003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019fb437-5495-7d0b-9eee-cc4b18a7312e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019fb437-5495-7053-ae27-786139be7003" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019fb437-5495-7d0b-9eee-cc4b18a7312e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnauditedParenthetical" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CondensedConsolidatedStatementsofStockholdersEquityUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_019e2c6b-4f3a-749c-aa57-e012b9d46414" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019e2c6b-4f3a-79d5-99b4-453db7f29685" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_019e2c6b-4f3a-749c-aa57-e012b9d46414" xlink:to="loc_us-gaap_StatementTable_019e2c6b-4f3a-79d5-99b4-453db7f29685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-744e-afb1-e3ff3bdab86a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019e2c6b-4f3a-79d5-99b4-453db7f29685" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-744e-afb1-e3ff3bdab86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-7f87-b18b-421d9200fa20" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-744e-afb1-e3ff3bdab86a" xlink:to="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-7f87-b18b-421d9200fa20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019e2c6b-4f3a-7383-8b67-e4911a966427" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-7f87-b18b-421d9200fa20" xlink:to="loc_us-gaap_CommonStockMember_019e2c6b-4f3a-7383-8b67-e4911a966427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-793a-bb89-68a5943dc7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019e2c6b-4f3a-79d5-99b4-453db7f29685" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-793a-bb89-68a5943dc7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-70fc-b378-df52802d1ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-793a-bb89-68a5943dc7a1" xlink:to="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-70fc-b378-df52802d1ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_019e2c6b-4f3a-71cf-b1ac-445aa3fc1ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-70fc-b378-df52802d1ac8" xlink:to="loc_us-gaap_RelatedPartyMember_019e2c6b-4f3a-71cf-b1ac-445aa3fc1ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-74e6-b366-9a33cea84adf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019e2c6b-4f3a-79d5-99b4-453db7f29685" xlink:to="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-74e6-b366-9a33cea84adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_019e2c6b-4f3a-7cf2-a361-13b6686fb947" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-74e6-b366-9a33cea84adf" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_019e2c6b-4f3a-7cf2-a361-13b6686fb947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_019e2c6b-4f3a-7c85-977a-f6a64be090a8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-74e6-b366-9a33cea84adf" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_019e2c6b-4f3a-7c85-977a-f6a64be090a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_019e2c6b-4f3a-7627-b075-0c9b535858f4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019e2c6b-4f3a-7d7a-b8a5-4ddc2fcdd563" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019e2c6b-4f3a-7627-b075-0c9b535858f4" xlink:to="loc_us-gaap_StatementTable_019e2c6b-4f3a-7d7a-b8a5-4ddc2fcdd563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-76cb-ab00-ba5b31a9316f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019e2c6b-4f3a-7d7a-b8a5-4ddc2fcdd563" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-76cb-ab00-ba5b31a9316f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-779f-8872-1b7dcf1c2134" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-76cb-ab00-ba5b31a9316f" xlink:to="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-779f-8872-1b7dcf1c2134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_019e2c6b-4f3a-752b-ac6a-46ec2644989e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-779f-8872-1b7dcf1c2134" xlink:to="loc_us-gaap_RelatedPartyMember_019e2c6b-4f3a-752b-ac6a-46ec2644989e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-7822-ba0a-9870f254741e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019e2c6b-4f3a-7d7a-b8a5-4ddc2fcdd563" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-7822-ba0a-9870f254741e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-7078-8aae-e4e6bafdefb7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-7822-ba0a-9870f254741e" xlink:to="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-7078-8aae-e4e6bafdefb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019e2c6b-4f3a-73d8-81e3-c6b30fa686fe" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-7078-8aae-e4e6bafdefb7" xlink:to="loc_us-gaap_CommonStockMember_019e2c6b-4f3a-73d8-81e3-c6b30fa686fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-702c-8943-c6b8ccf61d38" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019e2c6b-4f3a-7d7a-b8a5-4ddc2fcdd563" xlink:to="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-702c-8943-c6b8ccf61d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_019e2c6b-4f3a-796c-87ae-29ac6d488bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-702c-8943-c6b8ccf61d38" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_019e2c6b-4f3a-796c-87ae-29ac6d488bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_019e2c6b-4f3a-7b93-b6ca-9af78f922db6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019e2c6b-4f3a-702c-8943-c6b8ccf61d38" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_019e2c6b-4f3a-7b93-b6ca-9af78f922db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/DescriptionofBusiness" xlink:type="simple" xlink:href="gdrx-20260630.xsd#DescriptionofBusiness"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/DescriptionofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_DescriptionOfBusinessAbstract_019e2c6b-4f3a-76e4-ab04-87b1b8e034b6" xlink:href="gdrx-20260630.xsd#gdrx_DescriptionOfBusinessAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_019e2c6b-4f3a-702f-868c-24f350eab429" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gdrx_DescriptionOfBusinessAbstract_019e2c6b-4f3a-76e4-ab04-87b1b8e034b6" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_019e2c6b-4f3a-702f-868c-24f350eab429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="gdrx-20260630.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019e2c6b-4f3a-75a1-9734-b05ad53b7862" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_019e2c6b-4f3a-78d3-b092-f4e3088fa4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e2c6b-4f3a-75a1-9734-b05ad53b7862" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_019e2c6b-4f3a-78d3-b092-f4e3088fa4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/BusinessCombination" xlink:type="simple" xlink:href="gdrx-20260630.xsd#BusinessCombination"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/BusinessCombination" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_019e2c6b-4f3a-7ccc-be20-7a8b00e97a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_019e2c6b-4f3a-7dad-9051-2a2ee3d28ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_019e2c6b-4f3a-7ccc-be20-7a8b00e97a3e" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_019e2c6b-4f3a-7dad-9051-2a2ee3d28ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilities" xlink:type="simple" xlink:href="gdrx-20260630.xsd#AccruedExpensesandOtherCurrentLiabilities"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_019e2c6b-4f3a-7b75-81cd-0416345dccb0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_019e2c6b-4f3a-74f9-b41a-3bc1af4f6a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019e2c6b-4f3a-7b75-81cd-0416345dccb0" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_019e2c6b-4f3a-74f9-b41a-3bc1af4f6a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/IncomeTaxes" xlink:type="simple" xlink:href="gdrx-20260630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019e2c6b-4f3a-7324-a3df-9a1d43d74b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_019e2c6b-4f3a-7624-b8db-11e5f862d7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019e2c6b-4f3a-7324-a3df-9a1d43d74b2a" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_019e2c6b-4f3a-7624-b8db-11e5f862d7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/Debt" xlink:type="simple" xlink:href="gdrx-20260630.xsd#Debt"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_019e2c6b-4f3a-7a55-98af-ee6693a956b5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_019e2c6b-4f3a-7c30-9286-9494d34a95f1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019e2c6b-4f3a-7a55-98af-ee6693a956b5" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_019e2c6b-4f3a-7c30-9286-9494d34a95f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019e2c6b-4f3a-7bb5-b6eb-bd88dc8150ea" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019e2c6b-4f3a-7601-ba2c-d7b515034b78" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019e2c6b-4f3a-7bb5-b6eb-bd88dc8150ea" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019e2c6b-4f3a-7601-ba2c-d7b515034b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/Revenue" xlink:type="simple" xlink:href="gdrx-20260630.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019e2c6b-4f3a-7ed5-992c-f5795c557a21" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_019e2c6b-4f3a-7b06-9da0-5f0460a0a5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019e2c6b-4f3a-7ed5-992c-f5795c557a21" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_019e2c6b-4f3a-7b06-9da0-5f0460a0a5b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/StockholdersEquity" xlink:type="simple" xlink:href="gdrx-20260630.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019e2c6b-4f3a-708b-84d7-45efac384484" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019e2c6b-4f3a-7a92-bb90-6ff69efc1858" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019e2c6b-4f3a-708b-84d7-45efac384484" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019e2c6b-4f3a-7a92-bb90-6ff69efc1858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/BasicandDilutedEarningsPerShare" xlink:type="simple" xlink:href="gdrx-20260630.xsd#BasicandDilutedEarningsPerShare"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/BasicandDilutedEarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019e2c6b-4f3a-7bfc-b596-aaab59563cab" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_019e2c6b-4f3a-7398-aadf-e8700b14c984" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019e2c6b-4f3a-7bfc-b596-aaab59563cab" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_019e2c6b-4f3a-7398-aadf-e8700b14c984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="gdrx-20260630.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019e2c6b-4f3a-7748-8c5a-86621770865e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019e2c6b-4f3a-773c-8aad-8a98df1fe341" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e2c6b-4f3a-7748-8c5a-86621770865e" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019e2c6b-4f3a-773c-8aad-8a98df1fe341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_019e2c6b-4f3a-7997-8157-037363f96de1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e2c6b-4f3a-7748-8c5a-86621770865e" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_019e2c6b-4f3a-7997-8157-037363f96de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_019e2c6b-4f3a-7cb8-946a-f0817e960498" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e2c6b-4f3a-7748-8c5a-86621770865e" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_019e2c6b-4f3a-7cb8-946a-f0817e960498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_019e2c6b-4f3a-7257-a5db-11e5c576cf53" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e2c6b-4f3a-7748-8c5a-86621770865e" xlink:to="loc_us-gaap_UseOfEstimates_019e2c6b-4f3a-7257-a5db-11e5c576cf53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_019e2c6b-4f3a-7007-8581-dc77f215ae8e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e2c6b-4f3a-7748-8c5a-86621770865e" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_019e2c6b-4f3a-7007-8581-dc77f215ae8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock_019e2c6b-4f3a-7257-85e0-c36e4dd0baca" xlink:href="gdrx-20260630.xsd#gdrx_PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e2c6b-4f3a-7748-8c5a-86621770865e" xlink:to="loc_gdrx_PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock_019e2c6b-4f3a-7257-85e0-c36e4dd0baca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_019e2c6b-4f3a-73f3-a550-0291452fe179" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e2c6b-4f3a-7748-8c5a-86621770865e" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_019e2c6b-4f3a-73f3-a550-0291452fe179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_019e2c6b-4f3a-7a6d-bd2b-be4dde19920d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e2c6b-4f3a-7748-8c5a-86621770865e" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_019e2c6b-4f3a-7a6d-bd2b-be4dde19920d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019e2c6b-4f3a-7b18-9b01-b7668813539e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e2c6b-4f3a-7748-8c5a-86621770865e" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019e2c6b-4f3a-7b18-9b01-b7668813539e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="gdrx-20260630.xsd#AccruedExpensesandOtherCurrentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_019e2c6b-4f3a-766a-b89c-26c69e952e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_019e2c6b-4f3a-7f99-9502-e08ff5e14a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019e2c6b-4f3a-766a-b89c-26c69e952e5e" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_019e2c6b-4f3a-7f99-9502-e08ff5e14a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/DebtTables" xlink:type="simple" xlink:href="gdrx-20260630.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_019e2c6b-4f3a-79af-b788-87348e1e1a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_019e2c6b-4f3a-76bb-a132-972bea145e45" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019e2c6b-4f3a-79af-b788-87348e1e1a1a" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_019e2c6b-4f3a-76bb-a132-972bea145e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/RevenueTables" xlink:type="simple" xlink:href="gdrx-20260630.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019e2c6b-4f3a-7e92-b9cf-71e415a70594" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_019e2c6b-4f3a-75c1-b9d8-c64e6c9a77f2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019e2c6b-4f3a-7e92-b9cf-71e415a70594" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_019e2c6b-4f3a-75c1-b9d8-c64e6c9a77f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="gdrx-20260630.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019e2c6b-4f3a-7caa-a2b8-cbc4fdac8307" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRepurchaseAgreements_019e2c6b-4f3a-7541-8a7b-4cf771b9c1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfRepurchaseAgreements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019e2c6b-4f3a-7caa-a2b8-cbc4fdac8307" xlink:to="loc_us-gaap_ScheduleOfRepurchaseAgreements_019e2c6b-4f3a-7541-8a7b-4cf771b9c1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/BasicandDilutedEarningsPerShareTables" xlink:type="simple" xlink:href="gdrx-20260630.xsd#BasicandDilutedEarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/BasicandDilutedEarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019e2c6b-4f3a-7e32-b580-ed128ca147cd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019e2c6b-4f3a-7e15-821f-51157d0ac30c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019e2c6b-4f3a-7e32-b580-ed128ca147cd" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019e2c6b-4f3a-7e15-821f-51157d0ac30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_019e2c6b-4f3a-7aa9-815b-046a31387bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019e2c6b-4f3a-7e32-b580-ed128ca147cd" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_019e2c6b-4f3a-7aa9-815b-046a31387bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019e2c6b-4f3a-7725-96c5-2bf6d1106456" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_AccountingPoliciesTable_019e2c6b-4f3a-75ea-8cdf-2bf65c15ed43" xlink:href="gdrx-20260630.xsd#gdrx_AccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e2c6b-4f3a-7725-96c5-2bf6d1106456" xlink:to="loc_gdrx_AccountingPoliciesTable_019e2c6b-4f3a-75ea-8cdf-2bf65c15ed43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_019e2c6b-4f3a-720f-96c8-ba1421ed335c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gdrx_AccountingPoliciesTable_019e2c6b-4f3a-75ea-8cdf-2bf65c15ed43" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_019e2c6b-4f3a-720f-96c8-ba1421ed335c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019e2c6b-4f3a-7e85-a03d-08e33a1809c7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_019e2c6b-4f3a-720f-96c8-ba1421ed335c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019e2c6b-4f3a-7e85-a03d-08e33a1809c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_019e2c6b-4f3a-76ad-a0f7-0f01a5a10abf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_019e2c6b-4f3a-7e85-a03d-08e33a1809c7" xlink:to="loc_us-gaap_MoneyMarketFundsMember_019e2c6b-4f3a-76ad-a0f7-0f01a5a10abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019e2c6b-4f3a-71e5-953f-26504406a5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gdrx_AccountingPoliciesTable_019e2c6b-4f3a-75ea-8cdf-2bf65c15ed43" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019e2c6b-4f3a-71e5-953f-26504406a5c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e2c6b-4f3a-7e28-9f99-a657ba432ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019e2c6b-4f3a-71e5-953f-26504406a5c5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e2c6b-4f3a-7e28-9f99-a657ba432ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_019e2c6b-4f3a-735a-bbe5-92c1237e2c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e2c6b-4f3a-7e28-9f99-a657ba432ebe" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_019e2c6b-4f3a-735a-bbe5-92c1237e2c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_019e2c6b-4f3a-7221-a4f5-fc2c39a7380b" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gdrx_AccountingPoliciesTable_019e2c6b-4f3a-75ea-8cdf-2bf65c15ed43" xlink:to="loc_srt_MajorCustomersAxis_019e2c6b-4f3a-7221-a4f5-fc2c39a7380b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_019e2c6b-4f3a-730a-ace7-1da819d41e17" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_019e2c6b-4f3a-7221-a4f5-fc2c39a7380b" xlink:to="loc_srt_NameOfMajorCustomerDomain_019e2c6b-4f3a-730a-ace7-1da819d41e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_CustomerOneMember_019e2c6b-4f3a-71e0-a8c2-5ac43890710c" xlink:href="gdrx-20260630.xsd#gdrx_CustomerOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_019e2c6b-4f3a-730a-ace7-1da819d41e17" xlink:to="loc_gdrx_CustomerOneMember_019e2c6b-4f3a-71e0-a8c2-5ac43890710c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_019e2c6b-4f3a-7f9f-9a6d-6a62c3772e80" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gdrx_AccountingPoliciesTable_019e2c6b-4f3a-75ea-8cdf-2bf65c15ed43" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_019e2c6b-4f3a-7f9f-9a6d-6a62c3772e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_019e2c6b-4f3a-7661-9424-0816c931e9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_019e2c6b-4f3a-7f9f-9a6d-6a62c3772e80" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_019e2c6b-4f3a-7661-9424-0816c931e9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_019e2c6b-4f3a-798f-b7e1-4af1ed58c2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_019e2c6b-4f3a-7661-9424-0816c931e9c2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_019e2c6b-4f3a-798f-b7e1-4af1ed58c2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_019f8793-69df-7346-8ffd-2bfb6aeaf787" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_019e2c6b-4f3a-7661-9424-0816c931e9c2" xlink:to="loc_us-gaap_AccountsReceivableMember_019f8793-69df-7346-8ffd-2bfb6aeaf787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_019e2c6b-4f3a-71fe-a74d-4aed7a727ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gdrx_AccountingPoliciesTable_019e2c6b-4f3a-75ea-8cdf-2bf65c15ed43" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_019e2c6b-4f3a-71fe-a74d-4aed7a727ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_019e2c6b-4f3a-7936-a25f-8869215340c7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_019e2c6b-4f3a-71fe-a74d-4aed7a727ca7" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_019e2c6b-4f3a-7936-a25f-8869215340c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_019e2c6b-4f3a-7ba4-8bb0-60260b680b05" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_019e2c6b-4f3a-7936-a25f-8869215340c7" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_019e2c6b-4f3a-7ba4-8bb0-60260b680b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019e2c6b-4f3a-754e-ab88-a366720c9a68" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gdrx_AccountingPoliciesTable_019e2c6b-4f3a-75ea-8cdf-2bf65c15ed43" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019e2c6b-4f3a-754e-ab88-a366720c9a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_019e2c6b-4f3a-793c-ba5f-1aefd20fec80" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_019e2c6b-4f3a-754e-ab88-a366720c9a68" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_019e2c6b-4f3a-793c-ba5f-1aefd20fec80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_MinorityEquityInterestsMember_019e2c6b-4f3a-73b6-b69e-e523929de7a4" xlink:href="gdrx-20260630.xsd#gdrx_MinorityEquityInterestsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_019e2c6b-4f3a-793c-ba5f-1aefd20fec80" xlink:to="loc_gdrx_MinorityEquityInterestsMember_019e2c6b-4f3a-73b6-b69e-e523929de7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019e2c6b-4f3a-7df4-9a82-f4c3a45aa22b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gdrx_AccountingPoliciesTable_019e2c6b-4f3a-75ea-8cdf-2bf65c15ed43" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019e2c6b-4f3a-7df4-9a82-f4c3a45aa22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e2c6b-4f3a-7a76-8e11-1db9e0f9e16c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019e2c6b-4f3a-7df4-9a82-f4c3a45aa22b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e2c6b-4f3a-7a76-8e11-1db9e0f9e16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_OperatingLeaseRightOfUseAssetsMember_019e2c6b-4f3a-70e4-8d3b-83579ac146b4" xlink:href="gdrx-20260630.xsd#gdrx_OperatingLeaseRightOfUseAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e2c6b-4f3a-7a76-8e11-1db9e0f9e16c" xlink:to="loc_gdrx_OperatingLeaseRightOfUseAssetsMember_019e2c6b-4f3a-70e4-8d3b-83579ac146b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3a-7509-8374-07b2b334ddbd" xlink:href="gdrx-20260630.xsd#gdrx_AccountingPoliciesLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gdrx_AccountingPoliciesTable_019e2c6b-4f3a-75ea-8cdf-2bf65c15ed43" xlink:to="loc_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3a-7509-8374-07b2b334ddbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_019e2c6b-4f3a-7454-83cc-f869e7207a34" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3a-7509-8374-07b2b334ddbd" xlink:to="loc_us-gaap_NumberOfOperatingSegments_019e2c6b-4f3a-7454-83cc-f869e7207a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019e2c6b-4f3a-7134-a69f-eed59bda22eb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3a-7509-8374-07b2b334ddbd" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019e2c6b-4f3a-7134-a69f-eed59bda22eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_019e2c6b-4f3a-79cb-b33e-064859e9b0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3a-7509-8374-07b2b334ddbd" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_019e2c6b-4f3a-79cb-b33e-064859e9b0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties_019f878c-b651-74cd-875b-8b210356968a" xlink:href="gdrx-20260630.xsd#gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3a-7509-8374-07b2b334ddbd" xlink:to="loc_gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties_019f878c-b651-74cd-875b-8b210356968a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_019e2c6b-4f3a-76df-8929-490bfca737f3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3a-7509-8374-07b2b334ddbd" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_019e2c6b-4f3a-76df-8929-490bfca737f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_019e2c6b-4f3a-774a-b40c-3c0f4a371887" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3a-7509-8374-07b2b334ddbd" xlink:to="loc_us-gaap_EquityMethodInvestments_019e2c6b-4f3a-774a-b40c-3c0f4a371887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_019e2c6b-4f3a-7322-9e70-bb3a88f4d397" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3a-7509-8374-07b2b334ddbd" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_019e2c6b-4f3a-7322-9e70-bb3a88f4d397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e2c6b-4f3a-70f3-bfdd-dee6c1f83154" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gdrx_AccountingPoliciesLineItems_019e2c6b-4f3a-7509-8374-07b2b334ddbd" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e2c6b-4f3a-70f3-bfdd-dee6c1f83154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/BusinessCombinationDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#BusinessCombinationDetails"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/BusinessCombinationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_019e2c6b-4f3a-7626-a90e-b9ad2896c9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019e2c6b-4f3a-799e-bc48-7c3c4213fc06" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_019e2c6b-4f3a-7626-a90e-b9ad2896c9c3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019e2c6b-4f3a-799e-bc48-7c3c4213fc06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_019e2c6b-4f3a-7b73-98cd-cdbe9e1c21f3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019e2c6b-4f3a-799e-bc48-7c3c4213fc06" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_019e2c6b-4f3a-7b73-98cd-cdbe9e1c21f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019e2c6b-4f3a-72b2-bebb-eacf357e626b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_019e2c6b-4f3a-7b73-98cd-cdbe9e1c21f3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019e2c6b-4f3a-72b2-bebb-eacf357e626b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_VividRxClearRxIncMember_019e2c6b-4f3a-7c52-bca9-1947e88e387b" xlink:href="gdrx-20260630.xsd#gdrx_VividRxClearRxIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019e2c6b-4f3a-72b2-bebb-eacf357e626b" xlink:to="loc_gdrx_VividRxClearRxIncMember_019e2c6b-4f3a-7c52-bca9-1947e88e387b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_VitacarePrescriptionServicesIncMember_019e2c6b-4f3a-722b-b22a-4bcf1b8b2660" xlink:href="gdrx-20260630.xsd#gdrx_VitacarePrescriptionServicesIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_019e2c6b-4f3a-72b2-bebb-eacf357e626b" xlink:to="loc_gdrx_VitacarePrescriptionServicesIncMember_019e2c6b-4f3a-722b-b22a-4bcf1b8b2660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019e2c6b-4f3a-7af0-a822-0ead2c490429" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019e2c6b-4f3a-799e-bc48-7c3c4213fc06" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019e2c6b-4f3a-7af0-a822-0ead2c490429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019e2c6b-4f3a-76a6-b960-b263ede8f537" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_019e2c6b-4f3a-7af0-a822-0ead2c490429" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019e2c6b-4f3a-76a6-b960-b263ede8f537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_019e2c6b-4f3a-7b5f-a660-465e9b77bb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_019e2c6b-4f3a-76a6-b960-b263ede8f537" xlink:to="loc_us-gaap_CustomerRelationshipsMember_019e2c6b-4f3a-7b5f-a660-465e9b77bb4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_019e2c6b-4f3a-758e-80f7-88f6d415044f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_019e2c6b-4f3a-799e-bc48-7c3c4213fc06" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_019e2c6b-4f3a-758e-80f7-88f6d415044f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_019e2c6b-4f3a-7b65-9937-ce91a180485d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019e2c6b-4f3a-758e-80f7-88f6d415044f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_019e2c6b-4f3a-7b65-9937-ce91a180485d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_019e2c6b-4f3a-7f69-bbbc-6393db46c6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019e2c6b-4f3a-758e-80f7-88f6d415044f" xlink:to="loc_us-gaap_Goodwill_019e2c6b-4f3a-7f69-bbbc-6393db46c6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_019e2c6b-4f3a-7325-bce7-920cbde4988c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019e2c6b-4f3a-758e-80f7-88f6d415044f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_019e2c6b-4f3a-7325-bce7-920cbde4988c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_019e2c6b-4f3a-7723-b7c9-b49d58ce8a16" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_019e2c6b-4f3a-758e-80f7-88f6d415044f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_019e2c6b-4f3a-7723-b7c9-b49d58ce8a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_019e2c6b-4f3a-7de7-9a70-ab5bd07a5a28" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_AccruedBonusAndOtherPayrollRelatedCurrent_019e2c6b-4f3a-71b8-b039-026736d23471" xlink:href="gdrx-20260630.xsd#gdrx_AccruedBonusAndOtherPayrollRelatedCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019e2c6b-4f3a-7de7-9a70-ab5bd07a5a28" xlink:to="loc_gdrx_AccruedBonusAndOtherPayrollRelatedCurrent_019e2c6b-4f3a-71b8-b039-026736d23471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_019e2c6b-4f3a-76f5-b2c1-e822039adc23" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019e2c6b-4f3a-7de7-9a70-ab5bd07a5a28" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_019e2c6b-4f3a-76f5-b2c1-e822039adc23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_019e2c6b-4f3a-78a5-946b-d111963b96e5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019e2c6b-4f3a-7de7-9a70-ab5bd07a5a28" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_019e2c6b-4f3a-78a5-946b-d111963b96e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019e2c6b-4f3a-721d-9f71-b2ec1eddebf6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019e2c6b-4f3a-7de7-9a70-ab5bd07a5a28" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019e2c6b-4f3a-721d-9f71-b2ec1eddebf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019e2c6b-4f3a-7ad2-8d33-5ca510ba40d6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019e2c6b-4f3a-7de7-9a70-ab5bd07a5a28" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019e2c6b-4f3a-7ad2-8d33-5ca510ba40d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_AccruedExpensesAndOtherCurrentLiabilities_019e2c6b-4f3a-7671-9b2b-d87f7b98fc4b" xlink:href="gdrx-20260630.xsd#gdrx_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019e2c6b-4f3a-7de7-9a70-ab5bd07a5a28" xlink:to="loc_gdrx_AccruedExpensesAndOtherCurrentLiabilities_019e2c6b-4f3a-7671-9b2b-d87f7b98fc4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesAdditionalInformationDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#AccruedExpensesandOtherCurrentLiabilitiesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_019e2c6b-4f3a-7c89-a299-0e2c3f019df2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019e2c6b-4f3a-78f3-9948-77a2d7bbff54" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019e2c6b-4f3a-7c89-a299-0e2c3f019df2" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019e2c6b-4f3a-78f3-9948-77a2d7bbff54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_019e2c6b-4f3a-7d7e-854c-e4d7fea278e1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_019e2c6b-4f3a-7c89-a299-0e2c3f019df2" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_019e2c6b-4f3a-7d7e-854c-e4d7fea278e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019e2c6b-4f3a-7acb-9c3a-e54c8ce6ab96" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019e2c6b-4f3a-7d9c-b33d-2fd10ce1e0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019e2c6b-4f3a-7acb-9c3a-e54c8ce6ab96" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019e2c6b-4f3a-7d9c-b33d-2fd10ce1e0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/DebtAdditionalInformationDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#DebtAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/DebtAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_019e2c6b-4f3a-7aae-86e5-fd9e0407c481" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_019e2c6b-4f3a-72c5-8c95-f8b66e595106" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019e2c6b-4f3a-7aae-86e5-fd9e0407c481" xlink:to="loc_us-gaap_DebtInstrumentTable_019e2c6b-4f3a-72c5-8c95-f8b66e595106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019e2c6b-4f3a-7cd9-88bd-67cbbca31ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019e2c6b-4f3a-72c5-8c95-f8b66e595106" xlink:to="loc_us-gaap_DebtInstrumentAxis_019e2c6b-4f3a-7cd9-88bd-67cbbca31ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019e2c6b-4f3a-7e84-b8f8-f78bbf313544" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_019e2c6b-4f3a-7cd9-88bd-67cbbca31ef5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019e2c6b-4f3a-7e84-b8f8-f78bbf313544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_FirstLienCreditAgreementMember_019e2c6b-4f3a-7949-ae59-3a63b49e1f8d" xlink:href="gdrx-20260630.xsd#gdrx_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019e2c6b-4f3a-7e84-b8f8-f78bbf313544" xlink:to="loc_gdrx_FirstLienCreditAgreementMember_019e2c6b-4f3a-7949-ae59-3a63b49e1f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_019e2c6b-4f3a-7a8b-bcdb-9957e19e2549" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019e2c6b-4f3a-72c5-8c95-f8b66e595106" xlink:to="loc_us-gaap_CreditFacilityAxis_019e2c6b-4f3a-7a8b-bcdb-9957e19e2549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_019e2c6b-4f3a-79cd-a62d-555f0ba40a97" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_019e2c6b-4f3a-7a8b-bcdb-9957e19e2549" xlink:to="loc_us-gaap_CreditFacilityDomain_019e2c6b-4f3a-79cd-a62d-555f0ba40a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_019e2c6b-4f3a-7321-ab4f-95bdefcb9ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_019e2c6b-4f3a-79cd-a62d-555f0ba40a97" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_019e2c6b-4f3a-7321-ab4f-95bdefcb9ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_019e2c6b-4f3a-79f2-a5ab-35ffcf3ec333" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_019e2c6b-4f3a-79cd-a62d-555f0ba40a97" xlink:to="loc_us-gaap_LetterOfCreditMember_019e2c6b-4f3a-79f2-a5ab-35ffcf3ec333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-7024-8c2d-9f26d6aeaeec" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019e2c6b-4f3a-72c5-8c95-f8b66e595106" xlink:to="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-7024-8c2d-9f26d6aeaeec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_019e2c6b-4f3a-7af4-8b27-a5539d7f51cd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-7024-8c2d-9f26d6aeaeec" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_019e2c6b-4f3a-7af4-8b27-a5539d7f51cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension_019e2c6b-4f3a-7bc8-a066-b339905b25e6" xlink:href="gdrx-20260630.xsd#gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-7024-8c2d-9f26d6aeaeec" xlink:to="loc_gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension_019e2c6b-4f3a-7bc8-a066-b339905b25e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_019e2c6b-4f3a-728a-b7b0-a61b56b74483" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-7024-8c2d-9f26d6aeaeec" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_019e2c6b-4f3a-728a-b7b0-a61b56b74483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_019e2c6b-4f3a-7fd3-a477-3be3ff2dbc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-7024-8c2d-9f26d6aeaeec" xlink:to="loc_us-gaap_LineOfCredit_019e2c6b-4f3a-7fd3-a477-3be3ff2dbc4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio_019e2c6b-4f3a-7002-ad53-57f3a7996ecb" xlink:href="gdrx-20260630.xsd#gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-7024-8c2d-9f26d6aeaeec" xlink:to="loc_gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio_019e2c6b-4f3a-7002-ad53-57f3a7996ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_019e2c6b-4f3a-71df-aab4-a7c92141ccd1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-7024-8c2d-9f26d6aeaeec" xlink:to="loc_us-gaap_LongTermDebtFairValue_019e2c6b-4f3a-71df-aab4-a7c92141ccd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/DebtScheduleofDebtDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#DebtScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/DebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_019e2c6b-4f3a-7a31-b6ad-e17f3b2f0580" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_019e2c6b-4f3a-7261-8e2c-c114c7261a91" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_019e2c6b-4f3a-7a31-b6ad-e17f3b2f0580" xlink:to="loc_us-gaap_DebtInstrumentTable_019e2c6b-4f3a-7261-8e2c-c114c7261a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_019e2c6b-4f3a-7d4f-90a1-eaf54caed77e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019e2c6b-4f3a-7261-8e2c-c114c7261a91" xlink:to="loc_us-gaap_DebtInstrumentAxis_019e2c6b-4f3a-7d4f-90a1-eaf54caed77e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_019e2c6b-4f3a-7ac6-aec4-d2d5221a89de" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_019e2c6b-4f3a-7d4f-90a1-eaf54caed77e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_019e2c6b-4f3a-7ac6-aec4-d2d5221a89de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_A2024TermLoanMember_019e2c6b-4f3a-78ef-bb51-8d579c81e2f7" xlink:href="gdrx-20260630.xsd#gdrx_A2024TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019e2c6b-4f3a-7ac6-aec4-d2d5221a89de" xlink:to="loc_gdrx_A2024TermLoanMember_019e2c6b-4f3a-78ef-bb51-8d579c81e2f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_FirstLienCreditAgreementMember_019e2c6b-4f3a-78ed-b86c-075043034ba1" xlink:href="gdrx-20260630.xsd#gdrx_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_019e2c6b-4f3a-7ac6-aec4-d2d5221a89de" xlink:to="loc_gdrx_FirstLienCreditAgreementMember_019e2c6b-4f3a-78ed-b86c-075043034ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-70f7-bee3-27fcea00437f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_019e2c6b-4f3a-7261-8e2c-c114c7261a91" xlink:to="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-70f7-bee3-27fcea00437f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_019e2c6b-4f3a-7566-8070-8c641c3c8705" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-70f7-bee3-27fcea00437f" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_019e2c6b-4f3a-7566-8070-8c641c3c8705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_019e2c6b-4f3a-73f2-8397-684d874bf42c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-70f7-bee3-27fcea00437f" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_019e2c6b-4f3a-73f2-8397-684d874bf42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_019e2c6b-4f3a-75d3-a728-a1a78b0b2c48" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_019e2c6b-4f3a-70f7-bee3-27fcea00437f" xlink:to="loc_us-gaap_LongTermDebt_019e2c6b-4f3a-75d3-a728-a1a78b0b2c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019e2c6b-4f3a-7441-b62e-6ce0ba8894df" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_019e2c6b-4f3a-7504-b4d6-683a526d08df" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019e2c6b-4f3a-7441-b62e-6ce0ba8894df" xlink:to="loc_us-gaap_LossContingenciesTable_019e2c6b-4f3a-7504-b4d6-683a526d08df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_019e2c6b-4f3a-7dd2-bd2e-02d537d4b187" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_019e2c6b-4f3a-7504-b4d6-683a526d08df" xlink:to="loc_us-gaap_LitigationStatusAxis_019e2c6b-4f3a-7dd2-bd2e-02d537d4b187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_019e2c6b-4f3a-72af-bd07-bd05b2cf1a57" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_019e2c6b-4f3a-7dd2-bd2e-02d537d4b187" xlink:to="loc_us-gaap_LitigationStatusDomain_019e2c6b-4f3a-72af-bd07-bd05b2cf1a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_019e2c6b-4f3a-7e17-bb10-1677cd96aa42" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_019e2c6b-4f3a-72af-bd07-bd05b2cf1a57" xlink:to="loc_us-gaap_PendingLitigationMember_019e2c6b-4f3a-7e17-bb10-1677cd96aa42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_019e2c6b-4f3a-7adf-bcb8-4503f713741e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_019e2c6b-4f3a-72af-bd07-bd05b2cf1a57" xlink:to="loc_us-gaap_SettledLitigationMember_019e2c6b-4f3a-7adf-bcb8-4503f713741e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_019e2c6b-4f3a-75ad-9ed9-975e27508238" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_019e2c6b-4f3a-7504-b4d6-683a526d08df" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_019e2c6b-4f3a-75ad-9ed9-975e27508238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_019e2c6b-4f3a-7176-982a-7b48938ac387" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_019e2c6b-4f3a-75ad-9ed9-975e27508238" xlink:to="loc_us-gaap_LossContingencyNatureDomain_019e2c6b-4f3a-7176-982a-7b48938ac387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PrivacyProtectionMember_019e2c6b-4f3a-77e1-87ec-4de8ff332d18" xlink:href="gdrx-20260630.xsd#gdrx_PrivacyProtectionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_019e2c6b-4f3a-7176-982a-7b48938ac387" xlink:to="loc_gdrx_PrivacyProtectionMember_019e2c6b-4f3a-77e1-87ec-4de8ff332d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember_019e2c6b-4f3a-729a-b1bc-54959e1aeba6" xlink:href="gdrx-20260630.xsd#gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_019e2c6b-4f3a-7176-982a-7b48938ac387" xlink:to="loc_gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember_019e2c6b-4f3a-729a-b1bc-54959e1aeba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_019e2c6b-4f3a-7f18-968a-01e11fa26432" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_019e2c6b-4f3a-7504-b4d6-683a526d08df" xlink:to="loc_srt_LitigationCaseAxis_019e2c6b-4f3a-7f18-968a-01e11fa26432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_019e2c6b-4f3a-743c-bce3-df92af680ac3" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_019e2c6b-4f3a-7f18-968a-01e11fa26432" xlink:to="loc_srt_LitigationCaseTypeDomain_019e2c6b-4f3a-743c-bce3-df92af680ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_SDFLClassActionMatterMember_019e2c6b-4f3a-7ca1-b0b3-0a910e8889d5" xlink:href="gdrx-20260630.xsd#gdrx_SDFLClassActionMatterMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_019e2c6b-4f3a-743c-bce3-df92af680ac3" xlink:to="loc_gdrx_SDFLClassActionMatterMember_019e2c6b-4f3a-7ca1-b0b3-0a910e8889d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_NDCAClassActionMatterMember_019e2c6b-4f3a-7ee0-bc97-c87d948203c7" xlink:href="gdrx-20260630.xsd#gdrx_NDCAClassActionMatterMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_019e2c6b-4f3a-743c-bce3-df92af680ac3" xlink:to="loc_gdrx_NDCAClassActionMatterMember_019e2c6b-4f3a-7ee0-bc97-c87d948203c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationBalanceAxis_019e2c6b-4f3a-77c3-adc8-09c35b7bc2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfFinancialPositionLocationBalanceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_019e2c6b-4f3a-7504-b4d6-683a526d08df" xlink:to="loc_us-gaap_StatementOfFinancialPositionLocationBalanceAxis_019e2c6b-4f3a-77c3-adc8-09c35b7bc2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_019e2c6b-4f3a-7504-b4d6-683a526d08df" xlink:to="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_019e2c6b-4f3a-77da-8915-70e3d29346d9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_019e2c6b-4f3a-77da-8915-70e3d29346d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_019e2c6b-4f3a-7447-a249-795bc0363252" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_019e2c6b-4f3a-7447-a249-795bc0363252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfDefendants_019e2c6b-4f3a-7fc0-85c5-267aa905fb34" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyNumberOfDefendants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_LossContingencyNumberOfDefendants_019e2c6b-4f3a-7fc0-85c5-267aa905fb34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_019e2c6b-4f3a-7793-bda3-e31d0e57fa99" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_019e2c6b-4f3a-7793-bda3-e31d0e57fa99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_019e2c6b-4f3a-71f9-bc97-6ba8651b8825" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_019e2c6b-4f3a-71f9-bc97-6ba8651b8825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_019e2c6b-4f3a-7d6d-a0aa-7f77c7227787" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_019e2c6b-4f3a-7d6d-a0aa-7f77c7227787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSettlementsReceivable_019e2c6b-4f3a-72d1-a033-9e2f7a7a1a80" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InsuranceSettlementsReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_019e2c6b-4f3a-735c-a1dc-3ff606e5fd92" xlink:to="loc_us-gaap_InsuranceSettlementsReceivable_019e2c6b-4f3a-72d1-a033-9e2f7a7a1a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/RevenueDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#RevenueDetails"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/RevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019e2c6b-4f3a-7349-ac19-e493a706a930" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_019e2c6b-4f3a-70c7-a457-6a450b284380" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_019e2c6b-4f3a-7349-ac19-e493a706a930" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_019e2c6b-4f3a-70c7-a457-6a450b284380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019e2c6b-4f3a-71e4-895d-403f13606c2f" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019e2c6b-4f3a-70c7-a457-6a450b284380" xlink:to="loc_srt_ProductOrServiceAxis_019e2c6b-4f3a-71e4-895d-403f13606c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019e2c6b-4f3a-78f4-a8ed-084fba414a8e" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_019e2c6b-4f3a-71e4-895d-403f13606c2f" xlink:to="loc_srt_ProductsAndServicesDomain_019e2c6b-4f3a-78f4-a8ed-084fba414a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PrescriptionTransactionsRevenueMember_019e2c6b-4f3a-741e-9cba-5adad414b965" xlink:href="gdrx-20260630.xsd#gdrx_PrescriptionTransactionsRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019e2c6b-4f3a-78f4-a8ed-084fba414a8e" xlink:to="loc_gdrx_PrescriptionTransactionsRevenueMember_019e2c6b-4f3a-741e-9cba-5adad414b965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_SubscriptionRevenueMember_019e2c6b-4f3a-778f-b592-5ac846e44c15" xlink:href="gdrx-20260630.xsd#gdrx_SubscriptionRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019e2c6b-4f3a-78f4-a8ed-084fba414a8e" xlink:to="loc_gdrx_SubscriptionRevenueMember_019e2c6b-4f3a-778f-b592-5ac846e44c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_PharmaManufacturerSolutionsRevenuesMember_019e2c6b-4f3a-7c0c-909d-78facc6d8097" xlink:href="gdrx-20260630.xsd#gdrx_PharmaManufacturerSolutionsRevenuesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019e2c6b-4f3a-78f4-a8ed-084fba414a8e" xlink:to="loc_gdrx_PharmaManufacturerSolutionsRevenuesMember_019e2c6b-4f3a-7c0c-909d-78facc6d8097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_OtherRevenueMember_019e2c6b-4f3a-76c7-9e2a-b640078dcd8f" xlink:href="gdrx-20260630.xsd#gdrx_OtherRevenueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019e2c6b-4f3a-78f4-a8ed-084fba414a8e" xlink:to="loc_gdrx_OtherRevenueMember_019e2c6b-4f3a-76c7-9e2a-b640078dcd8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_019e2c6b-4f3a-7402-8883-b45536ce7210" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_019e2c6b-4f3a-70c7-a457-6a450b284380" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_019e2c6b-4f3a-7402-8883-b45536ce7210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019e2c6b-4f3a-70c3-896e-859683022b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_019e2c6b-4f3a-7402-8883-b45536ce7210" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019e2c6b-4f3a-70c3-896e-859683022b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#StockholdersEquityAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019e2c6b-4f3a-7a5e-8b7b-c8de75cc08cd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-75d0-9083-770be1f9f301" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019e2c6b-4f3a-7a5e-8b7b-c8de75cc08cd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-75d0-9083-770be1f9f301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramAxis_019e2c6b-4f3a-717e-ab16-dacd2485e6e5" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-75d0-9083-770be1f9f301" xlink:to="loc_srt_ShareRepurchaseProgramAxis_019e2c6b-4f3a-717e-ab16-dacd2485e6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain_019e2c6b-4f3a-7d96-b0e0-4686d4eedb24" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ShareRepurchaseProgramAxis_019e2c6b-4f3a-717e-ab16-dacd2485e6e5" xlink:to="loc_srt_ShareRepurchaseProgramDomain_019e2c6b-4f3a-7d96-b0e0-4686d4eedb24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_NewRepurchaseProgramMember_019e2c6b-4f3a-7350-9ab9-402bd0cdc320" xlink:href="gdrx-20260630.xsd#gdrx_NewRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ShareRepurchaseProgramDomain_019e2c6b-4f3a-7d96-b0e0-4686d4eedb24" xlink:to="loc_gdrx_NewRepurchaseProgramMember_019e2c6b-4f3a-7350-9ab9-402bd0cdc320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7ebf-8614-87df3da7c4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-75d0-9083-770be1f9f301" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7ebf-8614-87df3da7c4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-70ed-abc6-a2e479ef9563" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7ebf-8614-87df3da7c4ab" xlink:to="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-70ed-abc6-a2e479ef9563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_019e2c6b-4f3a-7ebe-ae12-78cadc0feef3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-70ed-abc6-a2e479ef9563" xlink:to="loc_us-gaap_CommonClassAMember_019e2c6b-4f3a-7ebe-ae12-78cadc0feef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_CommonClassAAndClassBMember_019e2c6b-4f3a-7289-bcc3-bfee3c0a8dcf" xlink:href="gdrx-20260630.xsd#gdrx_CommonClassAAndClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-70ed-abc6-a2e479ef9563" xlink:to="loc_gdrx_CommonClassAAndClassBMember_019e2c6b-4f3a-7289-bcc3-bfee3c0a8dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_019e2c6b-4f3a-767a-9294-f2b64cab04d2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-75d0-9083-770be1f9f301" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_019e2c6b-4f3a-767a-9294-f2b64cab04d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_019e2c6b-4f3a-7d25-85c9-ce8379865369" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_019e2c6b-4f3a-767a-9294-f2b64cab04d2" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_019e2c6b-4f3a-7d25-85c9-ce8379865369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_FranciscoPartnersStockPurchaseAgreementMember_019e2c6b-4f3a-7cc6-b823-dd2c97382717" xlink:href="gdrx-20260630.xsd#gdrx_FranciscoPartnersStockPurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_019e2c6b-4f3a-7d25-85c9-ce8379865369" xlink:to="loc_gdrx_FranciscoPartnersStockPurchaseAgreementMember_019e2c6b-4f3a-7cc6-b823-dd2c97382717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_IdeaMenLLCMember_019e2c6b-4f3a-7947-95a8-9a15357c4844" xlink:href="gdrx-20260630.xsd#gdrx_IdeaMenLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_019e2c6b-4f3a-7d25-85c9-ce8379865369" xlink:to="loc_gdrx_IdeaMenLLCMember_019e2c6b-4f3a-7947-95a8-9a15357c4844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_SpectrumStockPurchaseAgreementMember_019e2c6b-4f3a-72c9-baf1-a17172eb28c2" xlink:href="gdrx-20260630.xsd#gdrx_SpectrumStockPurchaseAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_019e2c6b-4f3a-7d25-85c9-ce8379865369" xlink:to="loc_gdrx_SpectrumStockPurchaseAgreementMember_019e2c6b-4f3a-72c9-baf1-a17172eb28c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-70ec-a6fb-bf069747737e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-75d0-9083-770be1f9f301" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-70ec-a6fb-bf069747737e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-7b8c-9456-24b5c72d94e3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_019e2c6b-4f3a-70ec-a6fb-bf069747737e" xlink:to="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-7b8c-9456-24b5c72d94e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_019e2c6b-4f3a-7132-b19f-59113d6bd6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_019e2c6b-4f3a-7b8c-9456-24b5c72d94e3" xlink:to="loc_us-gaap_RelatedPartyMember_019e2c6b-4f3a-7132-b19f-59113d6bd6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-74bc-82de-9dc0661b2531" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-75d0-9083-770be1f9f301" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-74bc-82de-9dc0661b2531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-7b1a-878f-464a408a94df" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019e2c6b-4f3a-74bc-82de-9dc0661b2531" xlink:to="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-7b1a-878f-464a408a94df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019e2c6b-4f3a-7e74-96cb-a0af461fcf29" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019e2c6b-4f3a-7b1a-878f-464a408a94df" xlink:to="loc_us-gaap_CommonStockMember_019e2c6b-4f3a-7e74-96cb-a0af461fcf29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019e2c6b-4f3a-7035-a5f4-026d2c1a7173" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-75d0-9083-770be1f9f301" xlink:to="loc_us-gaap_ClassOfStockLineItems_019e2c6b-4f3a-7035-a5f4-026d2c1a7173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_019e2c6b-4f3a-74f0-93d4-289350ee7e47" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019e2c6b-4f3a-7035-a5f4-026d2c1a7173" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_019e2c6b-4f3a-74f0-93d4-289350ee7e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_019e2c6b-4f3a-769a-85c8-b2d0325d3a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019e2c6b-4f3a-7035-a5f4-026d2c1a7173" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_019e2c6b-4f3a-769a-85c8-b2d0325d3a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_019e2c6b-4f3a-7639-8079-3fad871a5e14" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019e2c6b-4f3a-7035-a5f4-026d2c1a7173" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_019e2c6b-4f3a-7639-8079-3fad871a5e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_019e2c6b-4f3a-71da-b1e7-a60059f4c861" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019e2c6b-4f3a-7035-a5f4-026d2c1a7173" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_019e2c6b-4f3a-71da-b1e7-a60059f4c861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_019e2c6b-4f3a-7a75-a38a-8df073bcf275" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019e2c6b-4f3a-7035-a5f4-026d2c1a7173" xlink:to="loc_us-gaap_SharePrice_019e2c6b-4f3a-7a75-a38a-8df073bcf275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_019e2c6b-4f3a-703c-834c-22c24a6ad3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019e2c6b-4f3a-7035-a5f4-026d2c1a7173" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_019e2c6b-4f3a-703c-834c-22c24a6ad3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/StockholdersEquityScheduleofRepurchaseAgreementsDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#StockholdersEquityScheduleofRepurchaseAgreementsDetails"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/StockholdersEquityScheduleofRepurchaseAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019e2c6b-4f3a-7991-8bc1-eb2ff4fb855c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-73c7-9048-a3256f4e2295" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019e2c6b-4f3a-7991-8bc1-eb2ff4fb855c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-73c7-9048-a3256f4e2295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7103-aec8-ebd5abc5b00e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-73c7-9048-a3256f4e2295" xlink:to="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7103-aec8-ebd5abc5b00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-77be-894a-defa6dea4018" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_019e2c6b-4f3a-7103-aec8-ebd5abc5b00e" xlink:to="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-77be-894a-defa6dea4018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_019e2c6b-4f3a-7d4d-b18f-4aee191978b8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_019e2c6b-4f3a-77be-894a-defa6dea4018" xlink:to="loc_us-gaap_CommonClassAMember_019e2c6b-4f3a-7d4d-b18f-4aee191978b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e2c6b-4f3a-74b0-bf0a-e4e5c37f300b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e2c6b-4f3a-73c7-9048-a3256f4e2295" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e2c6b-4f3a-74b0-bf0a-e4e5c37f300b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_019e2c6b-4f3a-7a84-89cf-033378f956fe" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e2c6b-4f3a-74b0-bf0a-e4e5c37f300b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_019e2c6b-4f3a-7a84-89cf-033378f956fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_019e2c6b-4f3a-7e75-98ac-956047ea8a86" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e2c6b-4f3a-74b0-bf0a-e4e5c37f300b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_019e2c6b-4f3a-7e75-98ac-956047ea8a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019e2c6b-4f3a-761b-b5f7-307d6c5b70ad" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_019e2c6b-4f3a-7c32-9ce2-f0a683767603" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019e2c6b-4f3a-761b-b5f7-307d6c5b70ad" xlink:to="loc_us-gaap_NetIncomeLossAbstract_019e2c6b-4f3a-7c32-9ce2-f0a683767603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e2c6b-4f3a-79ea-8911-70f376efd558" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_019e2c6b-4f3a-7c32-9ce2-f0a683767603" xlink:to="loc_us-gaap_NetIncomeLoss_019e2c6b-4f3a-79ea-8911-70f376efd558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019e2c6b-4f3a-7d7b-97cf-c861d68b24e2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019e2c6b-4f3a-761b-b5f7-307d6c5b70ad" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019e2c6b-4f3a-7d7b-97cf-c861d68b24e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019e2c6b-4f3a-7ae2-8017-61779186e7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019e2c6b-4f3a-7d7b-97cf-c861d68b24e2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019e2c6b-4f3a-7ae2-8017-61779186e7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_019e2c6b-4f3a-7f70-9695-b3ff3c430544" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019e2c6b-4f3a-7d7b-97cf-c861d68b24e2" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_019e2c6b-4f3a-7f70-9695-b3ff3c430544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019e2c6b-4f3a-7b52-a747-3bd5337ba1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_019e2c6b-4f3a-7d7b-97cf-c861d68b24e2" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019e2c6b-4f3a-7b52-a747-3bd5337ba1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_EarningPerShareBasicAndDilutedAbstract_019e2c6b-4f3a-792c-af2b-461ff1927c3a" xlink:href="gdrx-20260630.xsd#gdrx_EarningPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019e2c6b-4f3a-761b-b5f7-307d6c5b70ad" xlink:to="loc_gdrx_EarningPerShareBasicAndDilutedAbstract_019e2c6b-4f3a-792c-af2b-461ff1927c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019e2c6b-4f3a-7bb7-b5d4-895f48ae8a99" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gdrx_EarningPerShareBasicAndDilutedAbstract_019e2c6b-4f3a-792c-af2b-461ff1927c3a" xlink:to="loc_us-gaap_EarningsPerShareBasic_019e2c6b-4f3a-7bb7-b5d4-895f48ae8a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019e2c6b-4f3a-734c-9614-8155bb59ce03" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_gdrx_EarningPerShareBasicAndDilutedAbstract_019e2c6b-4f3a-792c-af2b-461ff1927c3a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_019e2c6b-4f3a-734c-9614-8155bb59ce03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleofWeightedAveragePotentiallyDilutiveSharesareExcludedfromComputationofDilutedLossEarningsPerShareDetails" xlink:type="simple" xlink:href="gdrx-20260630.xsd#BasicandDilutedEarningsPerShareScheduleofWeightedAveragePotentiallyDilutiveSharesareExcludedfromComputationofDilutedLossEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleofWeightedAveragePotentiallyDilutiveSharesareExcludedfromComputationofDilutedLossEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019e2c6b-4f3a-7f93-90c2-0e881fc23ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019e2c6b-4f3a-7250-965e-aef6d691fd0d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019e2c6b-4f3a-7f93-90c2-0e881fc23ac8" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019e2c6b-4f3a-7250-965e-aef6d691fd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019e2c6b-4f3a-7303-9cef-265ce245b436" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019e2c6b-4f3a-7250-965e-aef6d691fd0d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019e2c6b-4f3a-7303-9cef-265ce245b436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019e2c6b-4f3a-712c-b717-55ba10cd5664" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019e2c6b-4f3a-7303-9cef-265ce245b436" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019e2c6b-4f3a-712c-b717-55ba10cd5664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_gdrx_StockOptionsAndRestrictedStockUnitsMember_019e2c6b-4f3a-7d03-a1ca-90daae2b3859" xlink:href="gdrx-20260630.xsd#gdrx_StockOptionsAndRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019e2c6b-4f3a-712c-b717-55ba10cd5664" xlink:to="loc_gdrx_StockOptionsAndRestrictedStockUnitsMember_019e2c6b-4f3a-7d03-a1ca-90daae2b3859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019e2c6b-4f3a-7571-bdc0-429f1cc53e72" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019e2c6b-4f3a-7250-965e-aef6d691fd0d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019e2c6b-4f3a-7571-bdc0-429f1cc53e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019e2c6b-4f3a-7389-a7fc-5e8c2f108bba" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019e2c6b-4f3a-7571-bdc0-429f1cc53e72" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019e2c6b-4f3a-7389-a7fc-5e8c2f108bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jul. 28, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GoodRx Holdings, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-5104396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2701 Olympic Boulevard<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Santa Monica<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">268-2822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A common stock, $0.0001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GDRX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001809519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107,181,201<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">233,964,187<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 296,113<span></span>
</td>
<td class="nump">$ 261,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">182,140<span></span>
</td>
<td class="nump">235,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_PrescriptionReimbursementAssetsCurrent', window );">Prescription reimbursement assets</a></td>
<td class="nump">1,076,012<span></span>
</td>
<td class="nump">98,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">45,062<span></span>
</td>
<td class="nump">47,205<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,599,327<span></span>
</td>
<td class="nump">643,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">11,514<span></span>
</td>
<td class="nump">12,268<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">430,331<span></span>
</td>
<td class="nump">430,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">58,254<span></span>
</td>
<td class="nump">64,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Capitalized software, net</a></td>
<td class="nump">140,300<span></span>
</td>
<td class="nump">139,261<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets, net</a></td>
<td class="nump">27,630<span></span>
</td>
<td class="nump">28,808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets, net</a></td>
<td class="nump">47,335<span></span>
</td>
<td class="nump">57,111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">28,237<span></span>
</td>
<td class="nump">29,095<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,342,928<span></span>
</td>
<td class="nump">1,404,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">8,906<span></span>
</td>
<td class="nump">19,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_PrescriptionReimbursementLiabilitiesCurrent', window );">Prescription reimbursement liabilities</a></td>
<td class="nump">1,039,995<span></span>
</td>
<td class="nump">130,139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_AccruedExpensesAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">98,610<span></span>
</td>
<td class="nump">86,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of debt</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">5,358<span></span>
</td>
<td class="nump">4,753<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,157,869<span></span>
</td>
<td class="nump">246,002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Debt, net</a></td>
<td class="nump">481,588<span></span>
</td>
<td class="nump">483,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">47,004<span></span>
</td>
<td class="nump">49,789<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">8,866<span></span>
</td>
<td class="nump">8,741<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,695,327<span></span>
</td>
<td class="nump">787,796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value; 50,000 shares authorized and nil shares issued and outstanding at June&#160;30, 2026 and December&#160;31, 2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; Class A: 2,000,000 shares authorized, 106,164 and 107,088 shares issued and outstanding at June&#160;30, 2026 and December&#160;31, 2025, respectively; and Class B: 1,000,000 shares authorized, 233,964 shares issued and outstanding at June&#160;30, 2026 and December&#160;31, 2025</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,048,436<span></span>
</td>
<td class="nump">2,026,802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,400,869)<span></span>
</td>
<td class="num">(1,410,574)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">647,601<span></span>
</td>
<td class="nump">616,262<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 2,342,928<span></span>
</td>
<td class="nump">$ 1,404,058<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gdrx_AccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued expenses and other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gdrx_AccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gdrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gdrx_PrescriptionReimbursementAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prescription Reimbursement Assets, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gdrx_PrescriptionReimbursementAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gdrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gdrx_PrescriptionReimbursementLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prescription Reimbursement Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gdrx_PrescriptionReimbursementLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gdrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 27: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of capitalized cost for software to be sold, leased, or marketed. Excludes capitalized cost for internal-use software.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-41<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478064/805-740-55-13<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-39<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation, depletion, and amortization, of property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478443/942-360-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">106,164,000<span></span>
</td>
<td class="nump">107,088,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">106,164,000<span></span>
</td>
<td class="nump">107,088,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">233,964,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">233,964,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 200,411<span></span>
</td>
<td class="nump">$ 203,070<span></span>
</td>
<td class="nump">$ 394,417<span></span>
</td>
<td class="nump">$ 406,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of revenue, exclusive of depreciation and amortization presented separately below</a></td>
<td class="nump">20,999<span></span>
</td>
<td class="nump">13,350<span></span>
</td>
<td class="nump">41,155<span></span>
</td>
<td class="nump">26,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Product development and technology</a></td>
<td class="nump">26,711<span></span>
</td>
<td class="nump">29,933<span></span>
</td>
<td class="nump">56,888<span></span>
</td>
<td class="nump">61,075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">81,986<span></span>
</td>
<td class="nump">84,870<span></span>
</td>
<td class="nump">163,039<span></span>
</td>
<td class="nump">169,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">24,814<span></span>
</td>
<td class="nump">28,379<span></span>
</td>
<td class="nump">51,633<span></span>
</td>
<td class="nump">58,009<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">22,269<span></span>
</td>
<td class="nump">19,729<span></span>
</td>
<td class="nump">44,061<span></span>
</td>
<td class="nump">40,641<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and operating expenses</a></td>
<td class="nump">176,779<span></span>
</td>
<td class="nump">176,261<span></span>
</td>
<td class="nump">356,776<span></span>
</td>
<td class="nump">355,851<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">23,632<span></span>
</td>
<td class="nump">26,809<span></span>
</td>
<td class="nump">37,641<span></span>
</td>
<td class="nump">50,189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expense, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="nump">625<span></span>
</td>
<td class="nump">694<span></span>
</td>
<td class="nump">625<span></span>
</td>
<td class="nump">694<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOther', window );">Interest income</a></td>
<td class="nump">1,019<span></span>
</td>
<td class="nump">2,803<span></span>
</td>
<td class="nump">2,416<span></span>
</td>
<td class="nump">6,735<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(9,810)<span></span>
</td>
<td class="num">(10,729)<span></span>
</td>
<td class="num">(19,577)<span></span>
</td>
<td class="num">(21,373)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">(8,166)<span></span>
</td>
<td class="num">(7,232)<span></span>
</td>
<td class="num">(16,536)<span></span>
</td>
<td class="num">(13,944)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">15,466<span></span>
</td>
<td class="nump">19,577<span></span>
</td>
<td class="nump">21,105<span></span>
</td>
<td class="nump">36,245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(6,930)<span></span>
</td>
<td class="num">(6,734)<span></span>
</td>
<td class="num">(11,400)<span></span>
</td>
<td class="num">(12,350)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 8,536<span></span>
</td>
<td class="nump">$ 12,843<span></span>
</td>
<td class="nump">$ 9,705<span></span>
</td>
<td class="nump">$ 23,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in usd per share)</a></td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in usd per share)</a></td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares used in computing earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">339,277<span></span>
</td>
<td class="nump">356,623<span></span>
</td>
<td class="nump">339,839<span></span>
</td>
<td class="nump">367,847<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">348,058<span></span>
</td>
<td class="nump">357,159<span></span>
</td>
<td class="nump">344,676<span></span>
</td>
<td class="nump">368,345<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482705/350-40-65-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479719/606-10-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482705/350-40-65-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479719/606-10-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest bearing assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482705/350-40-65-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479719/606-10-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 53: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th" colspan="2"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,815<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 724,658<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2,165,633<span></span>
</td>
<td class="num">$ (1,441,013)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock options exercised (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock options exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits', window );">Vesting and settlement of restricted stock units (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,136<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Common stock withheld related to net share settlement (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(802)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Common stock withheld related to net share settlement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,757)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,757)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchases of Class A common stock (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,340)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchases of Class A common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(100,920)<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(100,918)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,052<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360,813<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">654,347<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,084,272<span></span>
</td>
<td class="num">(1,429,961)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,815<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">724,658<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,165,633<span></span>
</td>
<td class="num">(1,441,013)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">352,771<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">643,031<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,060,114<span></span>
</td>
<td class="num">(1,417,118)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360,813<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">654,347<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,084,272<span></span>
</td>
<td class="num">(1,429,961)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock options exercised (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock options exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits', window );">Vesting and settlement of restricted stock units (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,014<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Common stock withheld related to net share settlement (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,056)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Common stock withheld related to net share settlement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,548)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,548)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchases of Class A common stock (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,224)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchases of Class A common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(46,352)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(46,351)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock through employee stock purchase plan (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock through employee stock purchase plan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">352,771<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">643,031<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,060,114<span></span>
</td>
<td class="num">(1,417,118)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">341,052<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">616,262<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,026,802<span></span>
</td>
<td class="num">(1,410,574)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock options exercised (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock options exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">19,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits', window );">Vesting and settlement of restricted stock units (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,965<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Common stock withheld related to net share settlement (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,096)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Common stock withheld related to net share settlement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,582)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,582)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchases of Class A common stock (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,536)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchases of Class A common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12,641)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(12,641)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,169<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2026</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">337,577<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2026</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">621,986<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,031,357<span></span>
</td>
<td class="num">(1,409,405)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">341,052<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">616,262<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,026,802<span></span>
</td>
<td class="num">(1,410,574)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2026</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">340,128<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2026</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">647,601<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,048,436<span></span>
</td>
<td class="num">(1,400,869)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2026</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">337,577<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2026</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">621,986<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,031,357<span></span>
</td>
<td class="num">(1,409,405)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">19,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits', window );">Vesting and settlement of restricted stock units (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,729<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Common stock withheld related to net share settlement (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,335)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Common stock withheld related to net share settlement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,186)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,186)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchases of Class A common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 8,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock through employee stock purchase plan (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock through employee stock purchase plan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2026</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">340,128<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2026</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 647,601<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2,048,436<span></span>
</td>
<td class="num">$ (1,400,869)<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:381.69pt">Repurchases of Class A common stock for the three months ended March 31, 2025 include </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:476.19pt;position:var(--position);text-decoration:none;white-space:pre;width:46.57pt">20.0 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:522.76pt;position:var(--position);text-decoration:none;white-space:pre;width:30.61pt"> shares</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:456.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:458.86pt">repurchased from related parties (after giving effect to the automatic conversion of Class B common stock to Class</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:467.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:338pt">A common stock upon such repurchase) for an aggregate consideration of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:432.5pt;position:var(--position);text-decoration:none;white-space:pre;width:54.14pt">$84.9 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:486.64pt;position:var(--position);text-decoration:none;white-space:pre;width:59.25pt">. See "Note </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:545.89pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">9</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:550.89pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:478.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:81.18pt">Stockholders' Equity</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:175.68pt;position:var(--position);text-decoration:none;white-space:pre;width:106.61pt">" for additional information.</span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares, vesting of restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gdrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482705/350-40-65-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479719/606-10-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 53: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 9,705<span></span>
</td>
<td class="nump">$ 23,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">44,061<span></span>
</td>
<td class="nump">40,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs and discounts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">932<span></span>
</td>
<td class="nump">869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash operating lease expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,910<span></span>
</td>
<td class="nump">2,065<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">33,102<span></span>
</td>
<td class="nump">40,589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,776<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets', window );">Loss on operating lease asset</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,409<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,069<span></span>
</td>
<td class="nump">456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">53,606<span></span>
</td>
<td class="num">(43,093)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets', window );">Prescription reimbursement assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(977,681)<span></span>
</td>
<td class="num">(16,027)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,929<span></span>
</td>
<td class="nump">231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(9,871)<span></span>
</td>
<td class="nump">3,579<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities', window );">Prescription reimbursement liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">909,856<span></span>
</td>
<td class="num">(1,313)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">16,063<span></span>
</td>
<td class="nump">5,585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_IncreaseDecreaseOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,912)<span></span>
</td>
<td class="num">(3,187)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">125<span></span>
</td>
<td class="nump">294<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">92,670<span></span>
</td>
<td class="nump">58,993<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,498)<span></span>
</td>
<td class="num">(532)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(30,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForSoftware', window );">Capitalized software</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(34,555)<span></span>
</td>
<td class="num">(39,659)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(36,053)<span></span>
</td>
<td class="num">(70,191)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments on long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,500)<span></span>
</td>
<td class="num">(2,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchases of Class A common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(14,520)<span></span>
</td>
<td class="num">(145,888)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">95<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards', window );">Employee taxes paid related to net share settlement of equity awards</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5,768)<span></span>
</td>
<td class="num">(8,305)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from employee stock purchase plan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">369<span></span>
</td>
<td class="nump">860<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(22,324)<span></span>
</td>
<td class="num">(155,830)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">34,293<span></span>
</td>
<td class="num">(167,028)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract', window );"><strong>Cash and cash equivalents</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">261,820<span></span>
</td>
<td class="nump">448,346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">End of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">296,113<span></span>
</td>
<td class="nump">281,318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non cash investing and financing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">732<span></span>
</td>
<td class="nump">9,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_NoncashStockBasedCompensationIncludedInCapitalizedSoftware', window );">Stock-based compensation included in capitalized software</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,416<span></span>
</td>
<td class="nump">8,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities', window );">Capitalized software included in accounts payable and accrued expenses and other current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5,485<span></span>
</td>
<td class="nump">$ 6,645<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:458.91pt">Prior to December 31, 2025, prescription reimbursement assets were presented as a component of prepaid</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:83.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:144.47pt">expenses and other current assets, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:238.97pt;position:var(--position);text-decoration:none;white-space:pre;width:314.53pt">and prescription reimbursement liabilities as a component of accounts payable</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:94.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:201.92pt">and accrued expenses and other current liabilities</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:296.41999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:257.08pt">. Prior period amounts have been reclassified to conform to the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:105pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:458.87pt">current period presentation. These reclassifications had no impact on previously reported cash flows provided by</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:115.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:76.95pt">operating activities.</span></div></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:202.45pt">Repurchases of Class A common stock for the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:296.95pt;position:var(--position);text-decoration:none;white-space:pre;width:139.98pt">six months ended June 30, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:436.93pt;position:var(--position);text-decoration:none;white-space:pre;width:37.48pt"> include </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:474.41pt;position:var(--position);text-decoration:none;white-space:pre;width:47.45pt">20.0 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:521.86pt;position:var(--position);text-decoration:none;white-space:pre;width:31.49pt"> shares</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:137.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:458.86pt">repurchased from related parties (after giving effect to the automatic conversion of Class B common stock to Class</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:148.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:338pt">A common stock upon such repurchase) for an aggregate consideration of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:432.5pt;position:var(--position);text-decoration:none;white-space:pre;width:54.14pt">$84.9 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:486.64pt;position:var(--position);text-decoration:none;white-space:pre;width:59.25pt">. See "Note </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:545.89pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">9</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:550.89pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:159pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:187.79pt">Stockholders' Equity" for additional information.</span></div></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gdrx_CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized Software Included in Accounts Payable and Accrued Expenses and Other Current Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gdrx_CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gdrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee taxes paid related to net share settlement of equity awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gdrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Prescription Reimbursable Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gdrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Prescription Reimbursement Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gdrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gdrx_IncreaseDecreaseOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gdrx_IncreaseDecreaseOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gdrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss On Abandonment And Impairment Of Operating Lease Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gdrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gdrx_NoncashStockBasedCompensationIncludedInCapitalizedSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash stock-based compensation included in capitalized software development costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gdrx_NoncashStockBasedCompensationIncludedInCapitalizedSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gdrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482705/350-40-65-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479719/606-10-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 53: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, classified as other, in reconciling net income to reflect cash provided by (used in) operating activity when indirect cash flow method is applied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Income Statement Location: us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 58<span></span>
</td>
<td class="nump">$ 122<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">$ 222<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_GeneralAndAdministrativeExpense', window );">Income Statement Location: us-gaap:GeneralAndAdministrativeExpense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">7,778<span></span>
</td>
<td class="nump">9,041<span></span>
</td>
<td class="nump">15,778<span></span>
</td>
<td class="nump">16,563<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_ResearchAndDevelopmentExpense', window );">Income Statement Location: us-gaap:ResearchAndDevelopmentExpense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">4,554<span></span>
</td>
<td class="nump">6,323<span></span>
</td>
<td class="nump">8,762<span></span>
</td>
<td class="nump">11,993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_SellingAndMarketingExpense', window );">Income Statement Location: us-gaap:SellingAndMarketingExpense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 4,203<span></span>
</td>
<td class="nump">$ 5,929<span></span>
</td>
<td class="nump">$ 8,452<span></span>
</td>
<td class="nump">$ 11,811<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parenthetical) - Common Stock - Related Party - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchased shares (in shares)</a></td>
<td class="nump">20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) - Related Party - Common Stock - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchased shares (in shares)</a></td>
<td class="nump">20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_DescriptionOfBusinessAbstract', window );"><strong>Description Of Business [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Description of Business</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:102.9pt">Description of Business</span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:112.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:174.11pt">GoodRx Holdings, Inc. was incorporated in </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:250.61pt;position:var(--position);text-decoration:none;white-space:pre;width:66.68pt">September 2015</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:317.28999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:236.21pt"> and has no material assets or standalone operations other</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:123pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">than its ownership in its consolidated subsidiaries. GoodRx, Inc. ("GoodRx"), a Delaware corporation initially formed in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:133.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt">September 2011, is a wholly-owned subsidiary of GoodRx Intermediate Holdings, LLC, which itself is a wholly-owned</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:144.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:142.93pt">subsidiary of GoodRx Holdings, Inc.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:201.43pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:161.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.87pt">GoodRx Holdings, Inc. and its subsidiaries (collectively, "we," "us" or "our") offer information and tools to help</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:172.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">consumers compare prices and save on their prescription drug purchases. We operate a price comparison platform that</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:183pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:193.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">through our codes that can be used to save money on prescriptions across the United States (the "prescription transactions</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:204.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">offering"). We also offer other healthcare products and services, including subscription programs, solutions for</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:215.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt">pharmaceutical manufacturers and other customers, referred to as GoodRx Pharma Direct ("Pharma Direct"), and telehealth</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:226.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:35.48pt">services.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gdrx_DescriptionOfBusinessAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gdrx_DescriptionOfBusinessAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gdrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:188.84pt">Summary of Significant Accounting Policies</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:257.34000000000003pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:271.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:91.92pt">Basis of Presentation</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:150.42000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:288.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:477pt">The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:299.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) and applicable rules and regulations of the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:310.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">Securities and Exchange Commission (&#8220;SEC&#8221;) regarding interim financial information. Certain information and disclosures</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:321pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">normally included in our annual consolidated financial statements prepared in accordance with GAAP have been condensed</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:331.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">or omitted. Accordingly, these condensed consolidated financial statements should be read in conjunction with our audited</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:342.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:215.88pt">consolidated financial statements for the year ended </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:274.38pt;position:var(--position);text-decoration:none;white-space:pre;width:80.53pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:354.91pt;position:var(--position);text-decoration:none;white-space:pre;width:198.43pt"> and the related notes, which are included in our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:353.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:210.48pt">Annual Report on Form 10-K filed with the SEC on </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:268.98pt;position:var(--position);text-decoration:none;white-space:pre;width:74.89pt">February&#160;26, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:343.87pt;position:var(--position);text-decoration:none;white-space:pre;width:9.39pt"> ("</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:353.26pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:373.26pt;position:var(--position);text-decoration:none;white-space:pre;width:52.63pt"> 10-K"). The </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:425.89pt;position:var(--position);text-decoration:none;white-space:pre;width:80.39pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:506.28pt;position:var(--position);text-decoration:none;white-space:pre;width:47.21pt"> condensed</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:364.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt">consolidated balance sheet was derived from our audited consolidated financial statements as of that date. The condensed</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:375pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">consolidated financial statements include, in the opinion of management, all adjustments, consisting of normal and recurring</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:385.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">items, necessary for the fair statement of our condensed consolidated financial statements. The operating results for the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:396.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:178.17pt">three and six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:236.67pt;position:var(--position);text-decoration:none;white-space:pre;width:316.66pt"> are not necessarily indicative of the results expected for the full year ending</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:407.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt">December&#160;31, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:137.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:424.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:328.28pt">There have been no material changes in significant accounting policies during the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:404.78pt;position:var(--position);text-decoration:none;white-space:pre;width:148.69pt">three and six months ended June 30,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:435pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:78.5pt;position:var(--position);text-decoration:none;white-space:pre;width:123.17pt"> from those disclosed in &#8220;Note </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:201.67pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">2</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:206.67pt;position:var(--position);text-decoration:none;white-space:pre;width:5.29pt">. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:211.96pt;position:var(--position);text-decoration:none;white-space:pre;width:173.57pt">Summary of Significant Accounting Policies</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:385.53pt;position:var(--position);text-decoration:none;white-space:pre;width:167.95pt">&#8221; in the notes to our consolidated financial</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:445.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:107.45pt">statements included in our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:165.95pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:185.95pt;position:var(--position);text-decoration:none;white-space:pre;width:23.99pt"> 10-K.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:474.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:116.38pt">Principles of Consolidation</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:174.88pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:491.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:477pt">The condensed consolidated financial statements include the accounts of GoodRx Holdings, Inc., its wholly owned</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:502.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt">subsidiaries and variable interest entities for which we are the primary beneficiary. Intercompany balances and transactions</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:513pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">have been eliminated in consolidation. Results of businesses acquired are included in our condensed consolidated financial</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:523.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:209.9pt">statements from their respective dates of acquisition.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:552.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:82.91pt">Segment Reporting</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:569.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.96pt">Operating segments are defined as components of an enterprise for which separate financial information is available</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:580.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">that is regularly provided to the chief operating decision maker ("CODM") in deciding how to allocate resources and in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:591pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:299.38pt">assessing performance. Our CODM manages our business on the basis of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:357.88pt;position:var(--position);text-decoration:none;white-space:pre;width:15pt">one</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:372.88pt;position:var(--position);text-decoration:none;white-space:pre;width:79.47pt"> operating segment.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:607.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:320.63pt">Our operating segment derives revenue in a manner as described in "Note </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:397.13pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">2</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:402.13pt;position:var(--position);text-decoration:none;white-space:pre;width:6.84pt">. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:408.97pt;position:var(--position);text-decoration:none;white-space:pre;width:144.46pt">Summary of Significant Accounting</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:618.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:30.97pt">Policies</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:89.47pt;position:var(--position);text-decoration:none;white-space:pre;width:300.07pt">" in the notes to our consolidated financial statements included in our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:389.54pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:409.54pt;position:var(--position);text-decoration:none;white-space:pre;width:143.89pt"> 10-K. Our CODM is our principal</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:629.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">executive officer, who is our Chief Executive Officer and President. Consolidated net income or loss is the measure of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:640.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">segment profit or loss reviewed by our CODM in assessing segment performance and deciding how to allocate resources.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:651pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt">Our CODM uses consolidated net income or loss to monitor budget versus actual results, review historical company</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:661.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">performance trends, conduct benchmark analysis of our peers and competitors, and evaluate management&#8217;s compensation.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:672.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">Significant expenses included in the reported measure of segment profit or loss regularly provided to our CODM are on a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:683.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:416.38pt">consolidated basis as presented in the accompanying condensed consolidated statements of operations.</span></div><div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:72.45pt">Use of Estimates</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:61.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.97pt">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:72.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:83.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">including the accompanying notes. We base our estimates on historical factors; current circumstances; macroeconomic</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:94.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">events and conditions; and the experience and judgment of our management. We evaluate our estimates and assumptions</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:105pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.98pt">on an ongoing basis. Actual results can differ materially from these estimates, and such differences can affect the results of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:115.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:147.42pt">operations reported in future periods.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:144.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:144.36pt">Certain Risks and Concentrations</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:202.86pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:161.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.99pt">Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:172.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:168.95pt">cash equivalents and accounts receivable.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:189pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.98pt">We maintain cash deposits with multiple financial institutions in the United States which, at times, may exceed federally</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:199.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">insured limits. Cash may be withdrawn or redeemed on demand. We believe that the financial institutions that hold our cash</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:210.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">are financially sound and, accordingly, minimal credit risk exists with respect to these balances. However, market conditions</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:221.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">can impact the viability of these institutions. In the event of failure of any of the financial institutions where we maintain our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:232.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.81pt">cash and cash equivalents, there can be no assurance that we will be able to access uninsured funds in a timely manner or</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.31pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:243pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:242.77pt">at all. We have not experienced any losses in such accounts.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:259.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.9pt">We consider all short-term, highly liquid investments purchased with an original maturity of three months or less at the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:270.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">date of purchase to be cash equivalents. Cash equivalents, consisting of U.S. treasury securities money market funds, of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:281.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:55.39pt">$114.0 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:113.89pt;position:var(--position);text-decoration:none;white-space:pre;width:21.2pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:135.09pt;position:var(--position);text-decoration:none;white-space:pre;width:56.05pt">$164.0 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:191.14pt;position:var(--position);text-decoration:none;white-space:pre;width:13.7pt"> at </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:204.84pt;position:var(--position);text-decoration:none;white-space:pre;width:58.2pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:263.03999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:21.2pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:284.24pt;position:var(--position);text-decoration:none;white-space:pre;width:80.17pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:364.41pt;position:var(--position);text-decoration:none;white-space:pre;width:189.05pt">, respectively, were classified as Level 1 of the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:292.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:305.34pt">fair value hierarchy and valued using quoted market prices in active markets.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:309pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.99pt">We extend credit to our customers based on an evaluation of their ability to pay amounts due under contractual</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:319.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:251.63pt">arrangements and generally do not obtain or require collateral.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:310.13pt;position:var(--position);text-decoration:none;white-space:pre;width:67.53pt"> For each of the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:377.66pt;position:var(--position);text-decoration:none;white-space:pre;width:173.34pt">three and six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:551pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:330.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:10pt">no</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:143.57pt"> customer accounted for more than </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:212.07pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt">10%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:230.07pt;position:var(--position);text-decoration:none;white-space:pre;width:130.62pt"> of our revenue. For each of the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:360.69pt;position:var(--position);text-decoration:none;white-space:pre;width:172.36pt">three and six months ended June 30, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:533.05pt;position:var(--position);text-decoration:none;white-space:pre;width:5.27pt">, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:538.3199999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:15pt">one</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3199999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:341.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:97.04pt">customer accounted for </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:155.54000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt">12%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:173.54000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:63.55pt"> of our revenue.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:237.09pt;position:var(--position);text-decoration:none;white-space:pre;width:13.39pt"> At </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:250.48pt;position:var(--position);text-decoration:none;white-space:pre;width:57.38pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:307.86pt;position:var(--position);text-decoration:none;white-space:pre;width:5.19pt">, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:313.05pt;position:var(--position);text-decoration:none;white-space:pre;width:15pt">one</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:328.05pt;position:var(--position);text-decoration:none;white-space:pre;width:97.04pt"> customer accounted for</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:425.09pt;position:var(--position);text-decoration:none;white-space:pre;width:2.69pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:427.78pt;position:var(--position);text-decoration:none;white-space:pre;width:17.34pt">11%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:445.12pt;position:var(--position);text-decoration:none;white-space:pre;width:2.69pt"> </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:447.81pt;position:var(--position);text-decoration:none;white-space:pre;width:105.53pt">of our accounts receivable</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:352.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:47pt">balance. At </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:105.5pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:184.47pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:189.47pt;position:var(--position);text-decoration:none;white-space:pre;width:10pt">no</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:199.47pt;position:var(--position);text-decoration:none;white-space:pre;width:141.95pt"> customer accounted for more than </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:341.42pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt">10%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:359.42pt;position:var(--position);text-decoration:none;white-space:pre;width:143.95pt"> of our accounts receivable balance.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:381pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:342.75pt">Prescription Reimbursement Assets and Prescription Reimbursement Liabilities</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:397.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.87pt">Consumer direct pricing is an affordability solution under our pharma direct offering that allows pharma manufacturers to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:408.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">use our platform to set and fund a portion of the consumer cash price for their prescription drugs at the point of sale. We</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:419.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">generally require deposits from pharma manufacturers which are included as a component of prescription reimbursement</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:430.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">liabilities on our condensed consolidated balance sheets and shall not be offset against other amounts owed to us. We</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:441pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">generally invoice pharma manufacturers for the funded amounts a month in arrears and payment is generally due within</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:451.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">thirty days of invoicing. Funded amounts owed to us are presented as a component of prescription reimbursement assets on</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:462.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:177.96pt">our condensed consolidated balance sheets.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:479.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.91pt">We remit reimbursements of the funded amounts to pharmacies, or intermediaries. Funded amounts owed to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:490.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:447.2pt">pharmacies, or intermediaries, are presented as a component of prescription reimbursement liabilities on our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:505.7pt;position:var(--position);text-decoration:none;white-space:pre;width:47.73pt"> condensed</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:501pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:55.54pt">consolidated </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:114.03999999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:439.4pt">balance sheets. Pharmacies, or intermediaries, may also require deposits from us. These deposits are</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:511.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">included as a component of prescription reimbursement assets on our condensed consolidated balance sheets and shall not</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:522.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:159.14pt">be offset against other amounts owed </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:217.64pt;position:var(--position);text-decoration:none;white-space:pre;width:48.92pt">to them. At </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:266.56pt;position:var(--position);text-decoration:none;white-space:pre;width:59.28pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:325.84pt;position:var(--position);text-decoration:none;white-space:pre;width:22.28pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:348.12pt;position:var(--position);text-decoration:none;white-space:pre;width:81.25pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:429.37pt;position:var(--position);text-decoration:none;white-space:pre;width:124.11pt">, a majority of our prescription</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:533.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:112.93pt">reimbursement assets were </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:171.43pt;position:var(--position);text-decoration:none;white-space:pre;width:18.48pt">with </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:189.91pt;position:var(--position);text-decoration:none;white-space:pre;width:13.99pt">two</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:203.9pt;position:var(--position);text-decoration:none;white-space:pre;width:59.47pt"> counterparties</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:263.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:562.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:82.43pt">Equity Investments</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:579pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.96pt">We retain minority equity interests in privately-held companies without readily determinable fair values. Our ownership</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:589.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:97.34pt">interests are less than </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:155.84pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt">20%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:173.84pt;position:var(--position);text-decoration:none;white-space:pre;width:379.63pt"> of the voting stock of the investees and we do not have the ability to exercise significant</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:600.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">influence over the operating and financial policies of the investees. The equity investments are accounted for under the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:611.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:404.8pt">measurement alternative in accordance with Accounting Standards Codification ("ASC") 321, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:463.3pt;position:var(--position);text-decoration:none;white-space:pre;width:90.2pt">Investments &#8211; Equity</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:622.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:39.47pt">Securities</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:97.97pt;position:var(--position);text-decoration:none;white-space:pre;width:455.36pt">, which is cost minus impairment, if any, plus or minus changes resulting from observable price changes. We did</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:633pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt">not recognize any changes resulting from observable price changes or impairment losses on our minority equity interest</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:643.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:93.2pt">investments during the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:151.7pt;position:var(--position);text-decoration:none;white-space:pre;width:171.03pt">three and six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:322.73pt;position:var(--position);text-decoration:none;white-space:pre;width:20.16pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:342.89pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:362.89pt;position:var(--position);text-decoration:none;white-space:pre;width:190.49pt">. Equity investments included in other assets on</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:654.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:199.94pt">our condensed consolidated balance sheets were </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:258.44pt;position:var(--position);text-decoration:none;white-space:pre;width:50.45pt">$15.0 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:308.89pt;position:var(--position);text-decoration:none;white-space:pre;width:24.5pt"> as of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:333.39pt;position:var(--position);text-decoration:none;white-space:pre;width:57pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:390.39pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:410.39pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:489.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:683.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:142.36pt">Impairment of Long-Lived Assets</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:700.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:335.34pt">We account for the impairment of long-lived assets in accordance with ASC 360, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:411.84pt;position:var(--position);text-decoration:none;white-space:pre;width:128.1pt">Property, Plant, and Equipment</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:539.94pt;position:var(--position);text-decoration:none;white-space:pre;width:13.55pt">. In</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:711pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">accordance with ASC 360, long-lived assets to be held and used are reviewed for impairment when events or changes in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:721.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.84pt">circumstances indicate that their carrying values may not be recoverable. We perform impairment testing at the asset group</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:732.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">level that represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">assets and liabilities. An impairment loss is recognized when estimated undiscounted future cash flows expected to result</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:55.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">from the use of the asset and its eventual disposition are less than its carrying value. If an asset is determined to be</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:66.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:438.79pt">impaired, the impairment is measured by the amount that the carrying value of the asset exceeds its fair value.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:83.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:352.98pt">During the three months ended March 31, 2025, we recognized an impairment loss of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:429.48pt;position:var(--position);text-decoration:none;white-space:pre;width:46.21pt">$4.4&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:475.69pt;position:var(--position);text-decoration:none;white-space:pre;width:77.73pt"> within general and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:94.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:425.74pt">administrative expenses to reduce the carrying value of an asset group to its estimated fair value of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:484.24pt;position:var(--position);text-decoration:none;white-space:pre;width:47.18pt">$3.4&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:531.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:22.06pt">. The</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:105pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">impairment charge was due to a significant deterioration in the sublease market and rental rates whereby the carrying value</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:115.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">of the asset group was not recoverable. We otherwise have not recognized any impairment losses of our long-lived assets</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:126.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:42.48pt">during the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:100.97999999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:170.47pt">three and six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:271.45pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:291.45pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:311.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:155.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:157.83pt">Recent Accounting Pronouncements</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:172.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:183.95pt">Recently Adopted Accounting Pronouncement</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:189pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.95pt">In July 2025, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU")</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:199.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:39.62pt">2025-05, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:98.12pt;position:var(--position);text-decoration:none;white-space:pre;width:455.32pt">Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:210.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:300.32pt">Contract Assets for Private Companies and Certain Not-For-Profit Entities. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:358.82pt;position:var(--position);text-decoration:none;white-space:pre;width:194.66pt">This ASU amends ASC 326-20 in part to provide</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:221.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt">a practical expedient election to assume that current conditions as of the balance sheet date do not change for the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:232.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">remaining life of current accounts receivable and/or current contract assets arising from transactions accounted for under</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.34pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:243pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:47.55pt">Topic 606, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:106.05pt;position:var(--position);text-decoration:none;white-space:pre;width:170.02pt">Revenue from Contracts with Customers</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:276.07pt;position:var(--position);text-decoration:none;white-space:pre;width:277.35pt">. This ASU is effective for all entities for annual reporting periods</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:253.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt">beginning after December 15, 2025, and for interim reporting periods within those annual reporting periods. We adopted this</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:264.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">standard effective January 1, 2026, and the adoption did not have a material impact on our condensed consolidated</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:275.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:81.96pt">financial statements.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:298.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:255.43pt">Recently Issued Accounting Pronouncements - Not Yet Adopted</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:315pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:218.4pt">In September 2025, the FASB issued ASU 2025-06, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:294.9pt;position:var(--position);text-decoration:none;white-space:pre;width:258.55pt">Intangibles-Goodwill and Other-Internal-Use Software (Subtopic</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:325.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:37.58pt">350-40), </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:96.08pt;position:var(--position);text-decoration:none;white-space:pre;width:457.29pt">which amends certain aspects of the accounting for and disclosure of software costs under ASC 350-40. The</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:336.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">amendments in this ASU, amongst other things, eliminate accounting considerations of software development stages and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:347.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">instead require entities to capitalize internal-use software costs when management commits to funding the software project</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:358.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.98pt">and it is probable the project will be completed and will be used to perform the function intended. This ASU will be effective</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:369pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">for all entities for annual reporting periods beginning after December 15, 2027, and for interim reporting periods within those</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:379.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt">annual reporting periods. Early adoption of this ASU is permitted and can be applied retrospectively, prospectively or on a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:390.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.83pt">modified prospective basis. We are currently evaluating the impact of the adoption of this ASU on our consolidated financial</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:401.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:141.44pt">statements and related disclosures.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:418.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:211.81pt">In November 2024, the FASB issued ASU 2024-03, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:288.31pt;position:var(--position);text-decoration:none;white-space:pre;width:265.07pt">Income Statement - Reporting Comprehensive Income - Expense</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:429pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:376.4pt">Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:434.9pt;position:var(--position);text-decoration:none;white-space:pre;width:118.48pt">, which is intended to improve</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:439.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">the disclosures of expenses by providing more detailed information about the types of expenses in commonly presented</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:450.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt">expense captions. This ASU requires entities to disclose the amounts of purchases of inventory, employee compensation,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:461.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">depreciation and intangible asset amortization included in each relevant expense caption; as well as a qualitative description</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:472.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. This ASU also</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:483pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">requires disclosure of the total amount of selling expense and, in annual reporting periods, an entity&#8217;s definition of selling</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:493.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.84pt">expenses. In January 2025, the FASB issued ASU 2025-01 which clarified the effective date of this ASU. This ASU applies</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:504.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">to all public entities and will be effective for fiscal years beginning after December 15, 2026, and for interim periods within</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:515.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">fiscal years beginning after December 15, 2027. Early adoption of this ASU is permitted. This ASU should be applied either</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:526.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:495pt">prospectively to financial statements issued for reporting periods after the effective date of this ASU or retrospectively to any</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:537pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">or all prior periods presented in the financial statements. We are currently evaluating the impact of the adoption of this ASU</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:547.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:210.4pt">on our consolidated financial statements disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combination</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre">Business Combination</span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:593.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.91pt">On January 13, 2025, we acquired substantially all of the assets and assembled workforce of VCRx, a prescription</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:604.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:177.33pt">savings business of Vivid Clear Rx, Inc., for </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:235.83pt;position:var(--position);text-decoration:none;white-space:pre;width:50.71pt">$30.0 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:286.53999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:266.96pt"> in cash. VCRx operates a price comparison platform that provides</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:615pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:495pt">consumer prescription savings through its partnership with PBMs. The acquisition expands our consumer reach particularly</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:625.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:208.22pt">with respect to our prescription transactions offering.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:642.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:194.22pt">Goodwill associated with this acquisition totaled </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:270.72pt;position:var(--position);text-decoration:none;white-space:pre;width:50.18pt">$11.0 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:320.9pt;position:var(--position);text-decoration:none;white-space:pre;width:232.48pt"> and primarily related to the expected long-term synergies</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:653.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">and other benefits, including the acquired assembled workforce. The goodwill is deductible for tax purposes. Identifiable</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:664.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:123.6pt">intangible assets related to this</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:182.1pt;position:var(--position);text-decoration:none;white-space:pre;width:47.55pt"> acquisition </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:229.65pt;position:var(--position);text-decoration:none;white-space:pre;width:29.53pt">totaled </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:259.18pt;position:var(--position);text-decoration:none;white-space:pre;width:50.49pt">$19.0 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:309.66999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:40.6pt">, of which </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:350.27pt;position:var(--position);text-decoration:none;white-space:pre;width:50.49pt">$18.1 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:400.76pt;position:var(--position);text-decoration:none;white-space:pre;width:152.66pt"> was attributable to a customer related</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:675pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:190.4pt">intangible asset, with an estimated useful life of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:248.9pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">6</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:253.9pt;position:var(--position);text-decoration:none;white-space:pre;width:24.49pt"> years</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:278.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-38<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 46<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-46<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 43<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-43<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 45<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-45<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-29<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-4<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479326/805-40-45-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/805-30/tableOfContent<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/805-20/tableOfContent<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/805-10/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre">Accrued Expenses and Other Current Liabilities</span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:61.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:276.85pt">Accrued expenses and other current liabilities consist of the following:</span></div><div style="position:var(--position);top:84.6pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:331.5pt"></td><td style="padding:0;width:80.25pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:80.25pt"></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:331.5pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);width:80.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:14.15pt;position:var(--position);text-decoration:none;white-space:pre">June 30, 2026</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);width:80.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:4.16pt;position:var(--position);text-decoration:none;white-space:pre">December 31, 2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:14.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Accrued bonus and other payroll related</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:14.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">23,691<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:14.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">25,434<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:28.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Accrued legal settlement</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:28.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">30,500<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:28.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">30,500<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:42.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Accrued marketing</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:42.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">20,255<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:42.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">11,063<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:57pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Deferred revenue</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:57pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)">8,767<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:57pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)">6,705<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:15.75pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:71.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Other accrued expenses</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:71.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">15,397<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:71.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">13,003<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:15.75pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:87pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Total accrued expenses and other current liabilities</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:87pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">98,610<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:87pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">86,705<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:198.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.9pt">Deferred revenue represents payments received in advance for subscriptions and providing services for certain</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:209.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:153.08pt">advertising contracts with customers</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:211.58pt;position:var(--position);text-decoration:none;white-space:pre;width:246.45pt">. We expect substantially all of the deferred revenue at </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:458.03pt;position:var(--position);text-decoration:none;white-space:pre;width:62.44pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:520.47pt;position:var(--position);text-decoration:none;white-space:pre;width:32.9pt"> will be</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:219.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:273.61pt">recognized as revenue within the subsequent twelve months. Of the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:332.11pt;position:var(--position);text-decoration:none;white-space:pre;width:45.57pt">$6.7 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:377.68pt;position:var(--position);text-decoration:none;white-space:pre;width:94.07pt"> of deferred revenue at </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:471.75pt;position:var(--position);text-decoration:none;white-space:pre;width:79.21pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:550.96pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:230.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:45.57pt">$0.9 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:104.07pt;position:var(--position);text-decoration:none;white-space:pre;width:20.24pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:124.31pt;position:var(--position);text-decoration:none;white-space:pre;width:45.57pt">$5.4 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:169.88pt;position:var(--position);text-decoration:none;white-space:pre;width:157.78pt"> was recognized as revenue during the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:327.66pt;position:var(--position);text-decoration:none;white-space:pre;width:171.31pt">three and six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:498.97pt;position:var(--position);text-decoration:none;white-space:pre;width:54.43pt">, respectively.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:241.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:127.61pt">Revenue recognized during the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:186.11pt;position:var(--position);text-decoration:none;white-space:pre;width:170.75pt">three and six months ended June 30, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:356.86pt;position:var(--position);text-decoration:none;white-space:pre;width:12.58pt"> of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:369.44pt;position:var(--position);text-decoration:none;white-space:pre;width:45.49pt">$0.9 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:414.93pt;position:var(--position);text-decoration:none;white-space:pre;width:20.08pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:435.01pt;position:var(--position);text-decoration:none;white-space:pre;width:45.49pt">$5.2 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:480.5pt;position:var(--position);text-decoration:none;white-space:pre;width:72.88pt">, respectively, was</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:252.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:128.95pt">included as deferred revenue at </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:187.45pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt">December&#160;31, 2024</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:266.41999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:59.47pt">Income Taxes</span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:297.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.98pt">We generally calculate income taxes in interim periods by applying an estimated annual effective income tax rate to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:308.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.82pt">income or loss before income taxes and by calculating the tax effect of discrete items recognized during such periods. Our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3199999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:319.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt">estimated annual effective income tax rate is based on our estimated full year income or loss and the related income taxes</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:330.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">for each jurisdiction in which we operate. This rate can be affected by estimates of full year pre-tax income or loss and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:341.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:91.8pt">permanent differences.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:357.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:147.74pt">The effective income tax rate for the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:224.24pt;position:var(--position);text-decoration:none;white-space:pre;width:140.88pt">three months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:365.12pt;position:var(--position);text-decoration:none;white-space:pre;width:20.56pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:385.68pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:405.68pt;position:var(--position);text-decoration:none;white-space:pre;width:21.55pt"> was </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:427.23pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt">44.8%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:452.73pt;position:var(--position);text-decoration:none;white-space:pre;width:20.56pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:473.29pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt">34.4%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:498.79pt;position:var(--position);text-decoration:none;white-space:pre;width:54.59pt">, respectively.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.34pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:368.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:151.03pt">The effective income tax rate for the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:209.53pt;position:var(--position);text-decoration:none;white-space:pre;width:133.73pt">six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:343.26pt;position:var(--position);text-decoration:none;white-space:pre;width:21.5pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:364.76pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:384.76pt;position:var(--position);text-decoration:none;white-space:pre;width:22.49pt"> was </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:407.25pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt">54.0%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:432.75pt;position:var(--position);text-decoration:none;white-space:pre;width:21.5pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:454.25pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt">34.1%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:479.75pt;position:var(--position);text-decoration:none;white-space:pre;width:73.64pt">, respectively. The</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:379.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:408.77pt">primary differences between our effective income tax rates and the federal statutory tax rate for the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:467.27pt;position:var(--position);text-decoration:none;white-space:pre;width:86.05pt">three and six months</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3199999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:390.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:84.89pt">ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:143.39pt;position:var(--position);text-decoration:none;white-space:pre;width:20.26pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:163.65pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:183.65pt;position:var(--position);text-decoration:none;white-space:pre;width:369.8pt"> were due to the effects of non-deductible officers&#8217; stock-based compensation expense, state</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:401.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:422.17pt">income taxes, benefits from research and development tax credits, and tax effects from our equity awards.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre">Debt</span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:446.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:421.5pt">Our First Lien Credit Agreement (as amended from time to time, the "Credit Agreement") provides for (i) a </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:498pt;position:var(--position);text-decoration:none;white-space:pre;width:55.5pt">$500.0 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:457.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:90.78pt">term loan maturing on </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:149.28pt;position:var(--position);text-decoration:none;white-space:pre;width:53.91pt">July 10, 2029</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:203.19pt;position:var(--position);text-decoration:none;white-space:pre;width:281.45pt"> ("2024 Term Loan Facility"); and (ii) a revolving credit facility for up to </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:484.64pt;position:var(--position);text-decoration:none;white-space:pre;width:50.66pt">$88.0 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:535.3pt;position:var(--position);text-decoration:none;white-space:pre;width:18.2pt"> (the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:468.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:158.35pt">"Revolving Credit Facility") maturing on </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:216.85pt;position:var(--position);text-decoration:none;white-space:pre;width:55.71pt">April 10, 2029</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:272.56pt;position:var(--position);text-decoration:none;white-space:pre;width:27.87pt">. As of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:300.43pt;position:var(--position);text-decoration:none;white-space:pre;width:57.24pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:357.67pt;position:var(--position);text-decoration:none;white-space:pre;width:195.64pt">, there were no changes to the terms of our 2024</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.31pt;position:var(--position);text-decoration:none;white-space:pre;width:2.34pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:479.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:277.33pt">Term Loan Facility and Revolving Credit Facility as disclosed in Note </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:335.83pt;position:var(--position);text-decoration:none;white-space:pre;width:10pt">12</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:345.83pt;position:var(--position);text-decoration:none;white-space:pre;width:207.51pt"> to our consolidated financial statements included in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:489.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:15.49pt">our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:73.99pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:93.99000000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:23.99pt"> 10-K.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:506.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:218.84pt">The effective interest rate on our term loans for the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:295.34000000000003pt;position:var(--position);text-decoration:none;white-space:pre;width:146.78pt">three months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:442.12pt;position:var(--position);text-decoration:none;white-space:pre;width:22.92pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:465.04pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:485.04pt;position:var(--position);text-decoration:none;white-space:pre;width:23.91pt"> was </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:508.95pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt">7.85%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:534.45pt;position:var(--position);text-decoration:none;white-space:pre;width:18.96pt"> and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:517.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt">8.60%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:84pt;position:var(--position);text-decoration:none;white-space:pre;width:272.89pt">, respectively. The effective interest rate on our term loans for the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:356.89pt;position:var(--position);text-decoration:none;white-space:pre;width:134.98pt">six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:491.87pt;position:var(--position);text-decoration:none;white-space:pre;width:22pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:513.87pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:533.87pt;position:var(--position);text-decoration:none;white-space:pre;width:19.49pt"> was</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:528.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt">7.86%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:84pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:104pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt">8.56%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:129.5pt;position:var(--position);text-decoration:none;white-space:pre;width:54.31pt">, respectively.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:545.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:33.33pt">We had </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:109.83pt;position:var(--position);text-decoration:none;white-space:pre;width:10pt">no</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:119.83pt;position:var(--position);text-decoration:none;white-space:pre;width:216.35pt"> borrowings against the Revolving Credit Facility as of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:336.18pt;position:var(--position);text-decoration:none;white-space:pre;width:57pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:393.18pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:413.18pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:492.15pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:561.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:322.86pt">We had outstanding letters of credit issued against the Revolving Credit Facility</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:399.36pt;position:var(--position);text-decoration:none;white-space:pre;width:16.89pt"> for </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:416.25pt;position:var(--position);text-decoration:none;white-space:pre;width:46.15pt">$7.6 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:462.4pt;position:var(--position);text-decoration:none;white-space:pre;width:21.4pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:483.8pt;position:var(--position);text-decoration:none;white-space:pre;width:46.15pt">$7.8 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:529.95pt;position:var(--position);text-decoration:none;white-space:pre;width:23.4pt"> as of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:572.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:59.54pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:118.03999999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:22.54pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:140.57999999999998pt;position:var(--position);text-decoration:none;white-space:pre;width:81.51pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:222.09pt;position:var(--position);text-decoration:none;white-space:pre;width:331.33pt">, respectively, which reduce our available borrowings under the Revolving Credit</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:583.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:29.8pt">Facility.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:600.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:122.44pt">Our debt balance is as follows:</span></div><div style="position:var(--position);top:623.15pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:331.5pt"></td><td style="padding:0;width:80.25pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:80.25pt"></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:331.5pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);width:80.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:14.15pt;position:var(--position);text-decoration:none;white-space:pre">June 30, 2026</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);width:80.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:4.16pt;position:var(--position);text-decoration:none;white-space:pre">December 31, 2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:14.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Principal balance under 2024 Term Loan Facility</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:14.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)">492,500<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:14.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)">495,000<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:28.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Less: Unamortized debt issuance costs and discounts</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:28.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.39pt"></span></span><span style="left:51.02pt;position:var(--position)">(5,912)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:28.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.39pt"></span></span><span style="left:51.02pt;position:var(--position)">(6,736)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:42.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:42.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)">486,588<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:42.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)">488,264<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:691.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:166.66pt">The estimated fair value of our debt was </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:243.16pt;position:var(--position);text-decoration:none;white-space:pre;width:55.98pt">$469.1 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:299.14pt;position:var(--position);text-decoration:none;white-space:pre;width:26.09pt"> as of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:325.23pt;position:var(--position);text-decoration:none;white-space:pre;width:58.06pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:383.29pt;position:var(--position);text-decoration:none;white-space:pre;width:170.13pt"> and approximated its carrying value as of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:701.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:137.47pt;position:var(--position);text-decoration:none;white-space:pre;width:265.73pt">, based on inputs categorized as Level 2 in the fair value hierarchy.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:718.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.98pt">Under the Credit Agreement, we are subject to a financial covenant requiring maintenance of a First Lien Net Leverage</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:729.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:228.5pt">Ratio (as defined in the Credit Agreement) not to exceed </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:287pt;position:var(--position);text-decoration:none;white-space:pre;width:12.5pt">8.2</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:299.5pt;position:var(--position);text-decoration:none;white-space:pre;width:12.82pt"> to </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:312.32pt;position:var(--position);text-decoration:none;white-space:pre;width:12.5pt">1.0</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:324.82pt;position:var(--position);text-decoration:none;white-space:pre;width:228.55pt"> only in the event that the amounts outstanding under the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt">Revolving Credit Facility exceed a specified percentage of commitments under the Revolving Credit Facility, and other</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:55.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:210.31pt">nonfinancial covenants under the Credit Agreement. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:268.81pt;position:var(--position);text-decoration:none;white-space:pre;width:11.23pt">At </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:280.03999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:57.46pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:337.5pt;position:var(--position);text-decoration:none;white-space:pre;width:215.96pt">, we were in compliance with our covenants under the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:66.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:72.46pt">Credit Agreement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-8<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-9<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:142.86pt">Commitments and Contingencies</span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:112.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:113.64pt">Aside from the below, as of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:190.14pt;position:var(--position);text-decoration:none;white-space:pre;width:58.06pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:248.2pt;position:var(--position);text-decoration:none;white-space:pre;width:305.19pt">, there were no material changes to our commitments and contingencies as</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:123pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:310.36pt">disclosed in the notes to our consolidated financial statements included in our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:368.86pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:388.86pt;position:var(--position);text-decoration:none;white-space:pre;width:23.99pt"> 10-K.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:145.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:87.91pt">Legal Contingencies</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:162.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:126.58pt">Consumer privacy class action</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:203.07999999999998pt;position:var(--position);text-decoration:none;white-space:pre;width:219.43pt"> - Between February 2, 2023, and March 30, 2023, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:422.51pt;position:var(--position);text-decoration:none;white-space:pre;width:13.99pt">five</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:436.5pt;position:var(--position);text-decoration:none;white-space:pre;width:102.95pt"> individual plaintiffs filed </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:539.45pt;position:var(--position);text-decoration:none;white-space:pre;width:13.99pt">five</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:173.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">separate putative class action lawsuits against Google, Meta, Criteo and us, alleging generally that we have not adequately</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:184.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:457.3pt">protected consumer privacy and that we communicated consumer information to third parties, including the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:515.8pt;position:var(--position);text-decoration:none;white-space:pre;width:20.49pt">three</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:536.29pt;position:var(--position);text-decoration:none;white-space:pre;width:17.17pt"> co-</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:195pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:50.96pt">defendants. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:109.46000000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:18.48pt">Four</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:127.94pt;position:var(--position);text-decoration:none;white-space:pre;width:425.46pt"> of the plaintiffs allege common law intrusion upon seclusion and unjust enrichment claims, as well as</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:205.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">claims under California&#8217;s Confidentiality of Medical Information Act, Invasion of Privacy Act, Consumer Legal Remedies Act,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:216.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:119.79pt">and Unfair Competition Law. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:178.29000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:17pt">One</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:195.29pt;position:var(--position);text-decoration:none;white-space:pre;width:40.27pt"> of these </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:235.56pt;position:var(--position);text-decoration:none;white-space:pre;width:15.49pt">four</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:251.05pt;position:var(--position);text-decoration:none;white-space:pre;width:302.44pt"> plaintiffs additionally brings a claim under the Electronic Communications</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:227.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">Privacy Act. The fifth plaintiff brings claims for common-law unjust enrichment and violations of New York&#8217;s General</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:238.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:495pt">Business Law. Four of these cases were originally filed in the United States District Court for the Northern District of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:249pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt">California ("NDCA") (Cases No. 3:23-cv-00501; 3:23-cv-00744; 3:23-cv-00940; and 4:23-cv-01293). One case was originally</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:259.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">filed in the United States District Court for the Southern District of New York (Case No. 1:23-cv-00943); however, that case</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:270.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:348pt">was voluntarily dismissed and re-filed in the NDCA (Case No. 3:23-cv-01508). These </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:406.5pt;position:var(--position);text-decoration:none;white-space:pre;width:13.99pt">five</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:420.49pt;position:var(--position);text-decoration:none;white-space:pre;width:132.92pt"> matters have been consolidated</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:281.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">and assigned to U.S. District Judge Araceli Mart&#237;nez-Olgu&#237;n in the NDCA. The court also set a briefing schedule for filing a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:292.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">single consolidated complaint, which the plaintiffs filed on May 21, 2023 (Case No. 3:23-cv-00501-AMO; the "NDCA Class</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:303pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.83pt">Action Matter"), as well as motions to dismiss and motions to compel arbitration. In addition to the aforementioned claims,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:313.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">the plaintiffs in the now consolidated matter bring claims under the Illinois Consumer Fraud and Deceptive Business</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:324.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.83pt">Practices Act, common law negligence and negligence per se, in each case, pleaded in the alternative. The plaintiffs are</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:335.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">seeking various forms of monetary damages (such as statutory damages, compensatory damages, attorneys&#8217; fees and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:346.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt">disgorgement of profits) as well as injunctive relief. Briefing on the motions to dismiss and motions to compel arbitration was</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:357pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:123.99pt">completed on August 24, 2023.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:373.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:91.15pt">On October 27, 2023, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:167.65pt;position:var(--position);text-decoration:none;white-space:pre;width:10.99pt">six</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:178.64pt;position:var(--position);text-decoration:none;white-space:pre;width:374.82pt"> plaintiffs filed a class action complaint (Case No. 1:23-cv-24127-BB; the &#8220;SDFL Class Action</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:384.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.82pt">Matter&#8221;) against us in the United States District Court for the Southern District of Florida ("SDFL"). The plaintiffs alleged, on</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3199999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:395.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">behalf of the same nationwide class as the NDCA Class Action Matter, substantially the same statutory and common law</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:406.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">violation claims as alleged in that matter as well as claims based on the federal Electronic Communications Privacy Act,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:417pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">invasion of privacy under California common law and the California constitution, invasion of privacy under New Jersey's</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:427.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt">Constitution, and violations of Pennsylvania&#8217;s Wiretapping and Electronic Surveillance Control Act, Florida&#8217;s Security of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:438.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">Communications Act, New York&#8217;s Civil Rights Law and Stop Hack and Improve Electronic Data Security Act. The plaintiffs in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:449.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">the SDFL Class Action Matter seek various forms of monetary damages as well as injunctive and other unspecified equitable</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:460.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:21.97pt">relief.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:477pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.9pt">On October 27, 2023, we entered into a proposed settlement agreement with the plaintiffs in the SDFL Class Action</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:487.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">Matter, on behalf of a nationwide settlement class that includes the NDCA Class Action Matter, which provides for a payment</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:498.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:10.36pt">of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:68.86pt;position:var(--position);text-decoration:none;white-space:pre;width:50.81pt">$13.0&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:119.67pt;position:var(--position);text-decoration:none;white-space:pre;width:433.66pt"> by us. On October 30, 2023, the plaintiffs in the SDFL Class Action Matter filed a motion and memorandum</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:509.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">in support of preliminary approval of the proposed class action settlement and, on October 31, 2023, the SDFL granted</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:520.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">preliminary approval of the proposed settlement. Members of the class have the opportunity to opt-out of the class and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:531pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:116.44pt">commence their own actions.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:547.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.83pt">In response to the proposed settlement in the SDFL Class Action Matter, plaintiffs in the NDCA Class Action Matter filed</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:558.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.84pt">(i) on November 1, 2023, a motion in the NDCA for an order to require us to cease litigation of, or alternatively file a motion</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:569.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.84pt">to stay in, the SDFL Class Action Matter and enjoin us from seeking settlement with counsel other than plaintiffs&#8217; counsel in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:580.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.85pt">the NDCA Class Action Matter; and (ii) on November 2, 2023, a motion in the SDFL for that court to allow them to intervene</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:591pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">and appear in the SDFL action, transfer the SDFL Class Action Matter to the NDCA and reconsider and deny its preliminary</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:601.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:495pt">approval of the proposed settlement. The SDFL has issued an order requiring the SDFL plaintiffs to, among other things, file</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:612.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">a response to the NDCA plaintiffs' motion to intervene. Additionally, U.S. District Judge Araceli Mart&#237;nez-Olgu&#237;n in the NDCA</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:623.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">issued an order for us to show cause as to why we should not be sanctioned for an alleged failure to provide notification to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:634.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.8pt">the NDCA of the pendency of the SDFL Class Action Matter. We filed our written response to this order on November 8,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:645pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">2023. The NDCA held a hearing on November 14, 2023, and ordered parties to the litigation to participate in mediation. The</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:655.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">parties participated in mediation on January 10, 2024, and agreed to participate in an additional day of mediation, which</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:666.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:109.96pt">occurred on March 7, 2024.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:683.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.83pt">On December 3, 2024, the SDFL plaintiffs filed a voluntary motion to dismiss, with prejudice, which was approved by</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:694.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">the court on December 4, 2024. On November 25, 2024, we entered into a settlement agreement with the NDCA plaintiffs</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:705pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:13.21pt">for </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:71.71000000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:50.67pt">$25.0&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:122.38pt;position:var(--position);text-decoration:none;white-space:pre;width:431.01pt">, subject to approval by the court. On June 12, 2025, the court denied the motion for preliminary approval of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:715.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">the settlement with prejudice, with leave for the plaintiffs to refile with additional information requested by the court. Based</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:726.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:244.27pt">on the settlement agreement, an estimated probable loss of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:302.77pt;position:var(--position);text-decoration:none;white-space:pre;width:50.99pt">$25.0&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:353.76pt;position:var(--position);text-decoration:none;white-space:pre;width:199.7pt"> was included within accrued expenses and other</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:737.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">current liabilities on our condensed consolidated balance sheets as of June 30, 2026 and December 31, 2025. Additionally,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:137.82pt">we estimated a probable loss of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:196.32pt;position:var(--position);text-decoration:none;white-space:pre;width:46.93pt">$5.5&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:243.25pt;position:var(--position);text-decoration:none;white-space:pre;width:310.1pt"> relating to the indemnification of certain parties named in the class action</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:55.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">lawsuits, which was included within accrued expenses and other current liabilities on our condensed consolidated balance</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:66.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.83pt">sheets as of June 30, 2026 and December 31, 2025. While these amounts represent our best judgment of the probable</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:77.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">losses based on the information currently available to us, they are subject to significant judgments and estimates and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:88.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:366.79pt">numerous factors beyond our control, including, without limitation, final approval of the court.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:425.29pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:105pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.87pt">On November 19, 2025, together with another party named in the class action lawsuit, we filed an amended settlement</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:115.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt">agreement. On November 26, 2025, plaintiffs filed a motion for preliminary approval of the class settlement. On January 16,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:126.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">2026, the court denied the motion for preliminary approval of the settlement, requesting additional information from the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:137.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">plaintiffs. On March 24, 2026, the plaintiffs filed an administrative motion for leave to submit supplemental brief to address</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:148.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">the court's concerns and request for status conference. On March 26, 2026, the court denied the motion but granted</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:159pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:251.65pt">plaintiffs leave to submit a new motion for preliminary approval.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:310.15pt;position:var(--position);text-decoration:none;white-space:pre;width:243.27pt"> Plaintiffs filed a new motion for preliminary approval on June</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:169.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:233.26pt">1, 2026, which is set for a hearing on September 3, 2026.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:291.76pt;position:var(--position);text-decoration:none;white-space:pre;width:261.67pt"> The terms of the amended settlement agreement were reflective</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:180.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:495pt">of the aggregate probable loss recorded in connection with this matter and, as such, we did not accrue for any additional</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:191.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">amounts. The results of legal proceedings are inherently uncertain, and upon final resolution of these matters, it is</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:202.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:278.2pt">reasonably possible that the actual loss may differ from our estimates.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:219pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:106.98pt">Consumer state litigations </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:183.48000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:369.95pt">- On May 28, 2024, The Bert and Annette Mullens Foundation ("Mullens Foundation") filed a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:229.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">lawsuit against us in Pope County, Arkansas, alleging that we violated an Arkansas statute related to the distribution of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:240.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.98pt">health-related discount cards. Specifically, the statute provides that each discount card must &#8220;expressly provide in bold and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:251.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt">prominent type that the discounts are not insurance.&#8221; Ark. Code Ann. &#167; 4-106-201(1). Furthermore, the statute provides that</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:262.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">each card must &#8220;expressly provide in bold and prominent type on the card or in a statement attached to the card that the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:273pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt">consumer has the right to cancel his or her registration within thirty (30) days from the effective date of the card.&#8221; Ark. Code</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:283.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.98pt">Ann. &#167; 4-106-201(2). The plaintiff alleges that our cards did not comply with these requirements, and sought an injunction</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:294.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.83pt">and statutory damages. We filed a motion to dismiss the complaint, which was denied on December 2, 2024. On May 9,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:305.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.85pt">2025, the Arkansas Attorney General moved to intervene in the case. On May 13, 2025, the plaintiff moved for partial</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:316.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">summary judgment, which we and the Arkansas Attorney General opposed. Separately, on September 24, 2025, the State of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:327pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">Arkansas, ex rel. Tim Griffin, Attorney General, filed suit in Faulkner County, Arkansas alleging the same violations of Ark.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:337.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">Code Ann. &#167; 4-106-201 et seq. as the Mullens Foundation in addition to violations of the Arkansas Deceptive Trade</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:348.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">Practices Act ("ADTPA"). On September 25, 2025, the Circuit Court of Faulkner County entered a Consent Judgment</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:359.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt">through which the plaintiff, acting parens patriae for the people of Arkansas, released us from any and all claims and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:370.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">remedies available or potentially available under the ADTPA and the discount card statute, Ark. Code Ann. &#167;&#167; 4-106-201 et</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:381pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">seq. for GoodRx discount cards sold, marketed, promoted, advertised, or otherwise distributed in Arkansas from January 1,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:391.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:277.95pt">2022 until the effective date of the agreement. As part of the Consent </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:336.45pt;position:var(--position);text-decoration:none;white-space:pre;width:41.99pt">Judgment,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:378.44pt;position:var(--position);text-decoration:none;white-space:pre;width:175.02pt"> we also agreed to pay immaterial monetary</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:402.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt">relief. On July 20, 2026, the Arkansas Attorney General moved to intervene to move for summary judgment dismissing the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:413.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:102.45pt">Mullens Foundation case.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:430.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:132.69pt">Furthermore, on June 11, 2024, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:209.19pt;position:var(--position);text-decoration:none;white-space:pre;width:171.17pt">the Minnesota Teamsters Service Bureau </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:380.36pt;position:var(--position);text-decoration:none;white-space:pre;width:173.06pt">also filed a lawsuit against us in Hennepin</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:441pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">County, Minnesota, alleging that we violated a Minnesota statute related to the distribution of health-related discount cards.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:451.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">Specifically, the statute provides that each discount card must &#8220;expressly provide in bold and prominent type that the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:462.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">discounts are not insurance.&#8221; Minn. Stat. Ann. &#167; 325F.784, subd. 1(1). The plaintiff alleges that our cards do not comply with</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:473.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.85pt">these requirements and also seeks an injunction and statutory damages. We filed a motion to dismiss the complaint, which</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:484.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt">was denied on December 17, 2024. On June 10, 2025, the plaintiff moved to dismiss some of our counterclaims; the court</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:495pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">granted the motion to dismiss. Discovery has been completed in Minnesota. On October 10, 2025, we moved for summary</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:505.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">judgment and plaintiff moved for partial summary judgment. On February 5, 2026, the court entered an order on our motion</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:516.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:495pt">for summary judgment, directing that judgment be entered dismissing plaintiff&#8217;s claims as time-barred. On April 10, 2026,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:527.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:335.69pt">plaintiff filed a notice of appeal regarding the court&#8217;s summary judgment decision. O</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:394.19pt;position:var(--position);text-decoration:none;white-space:pre;width:70.9pt">n June 18, 2026, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:465.09pt;position:var(--position);text-decoration:none;white-space:pre;width:88.3pt">plaintiff filed their brief</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:538.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:219.92pt">on appeal and we filed our opposition on July 20, 2026.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:555pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:368.94pt">We intend to vigorously defend against the claims asserted in the Mullens Foundation </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:445.44pt;position:var(--position);text-decoration:none;white-space:pre;width:25.48pt">matter</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:470.92pt;position:var(--position);text-decoration:none;white-space:pre;width:82.54pt"> and the Minnesota</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.34pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:565.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">Teamsters Service Bureau matters as we believe we have meritorious defenses to such claims. While it is reasonably</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:576.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.79pt">possible a loss may have been incurred, we have not accrued a loss as a loss is not probable and we are unable to estimate</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.29pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:587.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:90.46pt">a loss or range of loss.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:604.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.9pt">These pending proceedings involve complex questions of fact and law and may require the expenditure of significant</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:615pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">funds and the diversion of other resources to defend. In addition, during the normal course of business, we (including our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:625.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">directors and officers whom we indemnify) may become subject to, and are presently involved in, legal proceedings, claims</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:636.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">and litigation. Such matters are subject to many uncertainties and outcomes are not predictable with assurance. Aside from</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:647.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.83pt">the consumer privacy class action matter, we have not accrued for a material loss for any other matters as a loss is not</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:658.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">probable and a loss, or a range of loss, is not reasonably estimable. Accruals for loss contingencies are recognized when a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:669pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:363.28pt">loss is probable, and the amount of such loss can be reasonably estimated. See "Note </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:421.78pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">4</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:426.78pt;position:var(--position);text-decoration:none;white-space:pre;width:126.71pt">. Accrued Expenses and Other</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:679.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.98pt">Current Liabilities" for additional information. Loss recoveries are recognized when a loss has been incurred and the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:690.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:227.44pt">recovery is probable. Insurance recovery receivables of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:285.94pt;position:var(--position);text-decoration:none;white-space:pre;width:50.44pt">$11.9&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:336.38pt;position:var(--position);text-decoration:none;white-space:pre;width:217.1pt"> were included in prepaid expenses and other current</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:701.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:399.43pt">assets on our condensed consolidated balance sheets as of June 30, 2026 and December 31, 2025.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:37.47pt">Revenue</span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:61.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:30.98pt">For the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:107.48pt;position:var(--position);text-decoration:none;white-space:pre;width:170.47pt">three and six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:277.95pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:297.95pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:317.95pt;position:var(--position);text-decoration:none;white-space:pre;width:136.42pt">, revenue comprised the following:</span></div><div style="position:var(--position);top:84.6pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:207pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:207pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.75pt;position:var(--position);text-decoration:none;white-space:pre">Three Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.63pt;position:var(--position);text-decoration:none;white-space:pre">Six Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:23.25pt;width:207pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:37.5pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Prescription transactions revenue</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)">106,390<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)">143,064<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)">220,082<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)">291,987<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:51.75pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Subscription revenue</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">28,514<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">20,463<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">52,907<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">41,480<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:66pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Pharma Direct revenue</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:66pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">61,628<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:66pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">34,981<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:66pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:33.51pt;position:var(--position)">113,858<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:66pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">63,629<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:80.25pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Other revenue</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)">3,879<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)">4,562<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)">7,570<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)">8,944<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:94.5pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Total revenue</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:94.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)">200,411<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:94.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)">203,070<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:94.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)">394,417<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:94.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)">406,040<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders Equity</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:89.06pt">Stockholders' Equity</span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:233.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:449.38pt">On February 27, 2024, our board of directors ("Board") authorized the repurchase of up to an aggregate of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:525.88pt;position:var(--position);text-decoration:none;white-space:pre;width:27.5pt">$450.0</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:243.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:25.45pt">million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:83.95pt;position:var(--position);text-decoration:none;white-space:pre;width:469.54pt"> of our Class A common stock with no expiration date. Repurchases under this repurchase program may be made in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:254.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">the open market, in privately negotiated transactions or otherwise, with the amount and timing of repurchases to be</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:265.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">determined at our discretion, depending on market conditions and corporate needs, or under a trading plan intended to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:276.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">satisfy the affirmative defense conditions of Rule 10b5-1(c)(1) under the Exchange Act. This repurchase program does not</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:287.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.81pt">obligate us to acquire any particular amount of Class A common stock and may be modified, suspended or terminated at any</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.31pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:297.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">time at the discretion of our Board. Repurchased shares are subsequently retired and returned to the status of authorized</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:308.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:78.5pt">but unissued. As of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:137pt;position:var(--position);text-decoration:none;white-space:pre;width:57pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:194pt;position:var(--position);text-decoration:none;white-space:pre;width:36.49pt">, we had </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:230.49pt;position:var(--position);text-decoration:none;white-space:pre;width:50.45pt">$60.3 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:280.94pt;position:var(--position);text-decoration:none;white-space:pre;width:272.39pt"> available for future repurchases of our Class A common stock under</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:319.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:99.94pt">this repurchase program.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:336.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:134.9pt">In March 2025, we repurchased </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:211.4pt;position:var(--position);text-decoration:none;white-space:pre;width:46.64pt">10.0&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:258.03999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:6.19pt">, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:264.23pt;position:var(--position);text-decoration:none;white-space:pre;width:41.64pt">7.0&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:305.87pt;position:var(--position);text-decoration:none;white-space:pre;width:24.88pt">, and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:330.75pt;position:var(--position);text-decoration:none;white-space:pre;width:41.64pt">3.0&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:372.39pt;position:var(--position);text-decoration:none;white-space:pre;width:180.96pt"> shares of our Class A common stock (after</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:347.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.85pt">giving effect to the automatic conversion of our Class B common stock to Class A common stock upon such repurchase)</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:357.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">from related parties, Francisco Partners IV, L.P. and Francisco Partners IV-A, Idea Men, LLC, and Spectrum Equity VII, L.P.,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:368.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">Spectrum VII Investment Managers' Fund, L.P., and Spectrum VII Co-Investment Fund, L.P., respectively, for an aggregate</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:379.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:58.72pt">repurchase of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:117.22pt;position:var(--position);text-decoration:none;white-space:pre;width:46.07pt">20.0&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:163.29000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:207.38pt"> shares of our Class A common stock at a price of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:370.67pt;position:var(--position);text-decoration:none;white-space:pre;width:22.5pt">$4.20</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:393.17pt;position:var(--position);text-decoration:none;white-space:pre;width:160.28pt"> per share, in each case representing a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:390.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:159.48pt">discount from our closing share price of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:217.98pt;position:var(--position);text-decoration:none;white-space:pre;width:22.5pt">$4.42</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:240.48pt;position:var(--position);text-decoration:none;white-space:pre;width:312.89pt"> as of the last trading day prior to the execution date of these transactions. The</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:401.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:218.56pt">aggregate consideration for these repurchases was </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:277.06pt;position:var(--position);text-decoration:none;white-space:pre;width:52.39pt">$84.9 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:329.45pt;position:var(--position);text-decoration:none;white-space:pre;width:223.94pt">, inclusive of direct costs and estimated excise taxes</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:411.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:139.45pt">associated with these transactions.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:428.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.89pt">These related party repurchases were approved by our Board and its Audit and Risk Committee as part of the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:439.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:152.92pt">aforementioned repurchase programs.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:456.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:372.33pt">The following table presents information about our repurchases of our Class A common stock:</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:448.83pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="position:var(--position);text-align:justify;text-align-last:var(--justify);top:479.15pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:207pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.75pt;position:var(--position);text-decoration:none;white-space:pre">Three Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.63pt;position:var(--position);text-decoration:none;white-space:pre">Six Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:23.25pt;width:207pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:37.5pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Number of shares repurchased</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:54.38pt"></span></span><span style="left:57.010000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">10,224<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)">5,536<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">33,564<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:51.75pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);white-space:pre">Cost of shares repurchased </span><span style="font-family:'Arial', sans-serif;font-size:5.8500000000000005pt;font-style:normal;font-weight:normal;left:115.58999999999999pt;position:var(--position);top:-2.293pt;vertical-align:super;white-space:pre">(1)</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:45.39pt"></span></span><span style="left:53.02pt;position:var(--position)">(61)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">46,352<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">12,580<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)">147,272<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:550.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:265pt">_____________________________________________________</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:560.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:10.98pt">(1)</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:458.93pt">Cost of shares repurchased for the three months ended June 30, 2026 represents a change to the estimated</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:571.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:305.91pt">excise taxes associated with past repurchases of our Class A common stock.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479951/505-20-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479982/505-20-S25-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479951/505-20-S50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479982/505-20-S25-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 1.D.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479921/505-20-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479951/505-20-S50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 1.B.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480148/855-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S25<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479982/505-20-S25-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Basic and Diluted Earnings Per Share</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:73.5pt;position:var(--position);text-decoration:none;white-space:pre;width:160.89pt">Basic and Diluted Earnings Per Share</span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:617.35pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:79.47pt">The computation of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:155.97pt;position:var(--position);text-decoration:none;white-space:pre;width:74.96pt">earnings per share</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:230.93pt;position:var(--position);text-decoration:none;white-space:pre;width:30.49pt"> for the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:261.41999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:170.47pt">three and six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:431.89pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:451.89pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:471.89pt;position:var(--position);text-decoration:none;white-space:pre;width:53.46pt"> is as follows:</span></div><div style="position:var(--position);text-align:justify;text-align-last:var(--justify);top:634.15pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:207pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:207pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.75pt;position:var(--position);text-decoration:none;white-space:pre">Three Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.63pt;position:var(--position);text-decoration:none;white-space:pre">Six Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:23.25pt;width:207pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands, except per share amounts)</span></div></div></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:37.5pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Numerator:</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:51.75pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Net income</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)">8,536<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">12,843<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)">9,705<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">23,895<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:66pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Denominator:</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:80.25pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Weighted average shares - basic</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:33.51pt;position:var(--position)">339,277<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:33.51pt;position:var(--position)">356,623<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:33.51pt;position:var(--position)">339,839<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:33.51pt;position:var(--position)">367,847<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:207pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td></tr><tr style="height:27.75pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:207pt"><div><div style="line-height:9pt;position:var(--position);top:7.01pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Dilutive impact of stock options and restricted </span></div><div style="line-height:9pt;position:var(--position);top:17.81pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">stock units</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:17.81pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)">8,781<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:17.81pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.38pt"></span></span><span style="left:51.010000000000005pt;position:var(--position)">536<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:17.81pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)">4,837<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:17.81pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.38pt"></span></span><span style="left:51.010000000000005pt;position:var(--position)">498<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:27.75pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Weighted average shares - diluted</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:27.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:34.62pt;position:var(--position);text-decoration:none;white-space:pre">348,058</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:27.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:34.62pt;position:var(--position);text-decoration:none;white-space:pre">357,159</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:27.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:34.62pt;position:var(--position);text-decoration:none;white-space:pre">344,676</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:27.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:34.62pt;position:var(--position);text-decoration:none;white-space:pre">368,345</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:42pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Earnings per share:</span></div></div></div></td><td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:56.25pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Basic</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:56.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)">0.03<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:56.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)">0.04<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:56.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)">0.03<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:56.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)">0.06<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:70.5pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Diluted</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:70.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)">0.02<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:70.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)">0.04<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:70.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)">0.03<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:70.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)">0.06<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:140.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:425.91pt">The following weighted average potentially dilutive shares are excluded from the computation of diluted </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:502.41pt;position:var(--position);text-decoration:none;white-space:pre;width:50.98pt">earnings per</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:151.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:22.49pt">share</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:80.99pt;position:var(--position);text-decoration:none;white-space:pre;width:317.36pt"> for the periods presented because including them would have been antidilutive:</span></div><div style="position:var(--position);top:174.35pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:207pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:207pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.75pt;position:var(--position);text-decoration:none;white-space:pre">Three Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.63pt;position:var(--position);text-decoration:none;white-space:pre">Six Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:23.25pt;width:207pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:37.5pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Stock options and restricted stock units</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:39.62pt;position:var(--position);text-decoration:none;white-space:pre">39,720</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:39.62pt;position:var(--position);text-decoration:none;white-space:pre">57,042</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:39.62pt;position:var(--position);text-decoration:none;white-space:pre">42,808</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">49,102<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481468/505-20-05-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:91.92pt">Basis of Presentation</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:150.42000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:288.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:477pt">The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:299.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) and applicable rules and regulations of the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:310.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">Securities and Exchange Commission (&#8220;SEC&#8221;) regarding interim financial information. Certain information and disclosures</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:321pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">normally included in our annual consolidated financial statements prepared in accordance with GAAP have been condensed</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:331.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">or omitted. Accordingly, these condensed consolidated financial statements should be read in conjunction with our audited</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:342.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:215.88pt">consolidated financial statements for the year ended </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:274.38pt;position:var(--position);text-decoration:none;white-space:pre;width:80.53pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:354.91pt;position:var(--position);text-decoration:none;white-space:pre;width:198.43pt"> and the related notes, which are included in our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:353.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:210.48pt">Annual Report on Form 10-K filed with the SEC on </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:268.98pt;position:var(--position);text-decoration:none;white-space:pre;width:74.89pt">February&#160;26, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:343.87pt;position:var(--position);text-decoration:none;white-space:pre;width:9.39pt"> ("</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:353.26pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:373.26pt;position:var(--position);text-decoration:none;white-space:pre;width:52.63pt"> 10-K"). The </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:425.89pt;position:var(--position);text-decoration:none;white-space:pre;width:80.39pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:506.28pt;position:var(--position);text-decoration:none;white-space:pre;width:47.21pt"> condensed</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:364.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt">consolidated balance sheet was derived from our audited consolidated financial statements as of that date. The condensed</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:375pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">consolidated financial statements include, in the opinion of management, all adjustments, consisting of normal and recurring</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:385.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">items, necessary for the fair statement of our condensed consolidated financial statements. The operating results for the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:396.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:178.17pt">three and six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:236.67pt;position:var(--position);text-decoration:none;white-space:pre;width:316.66pt"> are not necessarily indicative of the results expected for the full year ending</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:407.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt">December&#160;31, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:137.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:424.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:328.28pt">There have been no material changes in significant accounting policies during the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:404.78pt;position:var(--position);text-decoration:none;white-space:pre;width:148.69pt">three and six months ended June 30,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:435pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:78.5pt;position:var(--position);text-decoration:none;white-space:pre;width:123.17pt"> from those disclosed in &#8220;Note </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:201.67pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">2</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:206.67pt;position:var(--position);text-decoration:none;white-space:pre;width:5.29pt">. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:211.96pt;position:var(--position);text-decoration:none;white-space:pre;width:173.57pt">Summary of Significant Accounting Policies</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:385.53pt;position:var(--position);text-decoration:none;white-space:pre;width:167.95pt">&#8221; in the notes to our consolidated financial</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:445.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:107.45pt">statements included in our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:165.95pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:185.95pt;position:var(--position);text-decoration:none;white-space:pre;width:23.99pt"> 10-K.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:116.38pt">Principles of Consolidation</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:174.88pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:491.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:477pt">The condensed consolidated financial statements include the accounts of GoodRx Holdings, Inc., its wholly owned</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:502.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt">subsidiaries and variable interest entities for which we are the primary beneficiary. Intercompany balances and transactions</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:513pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">have been eliminated in consolidation. Results of businesses acquired are included in our condensed consolidated financial</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:523.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:209.9pt">statements from their respective dates of acquisition.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:82.91pt">Segment Reporting</span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:569.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.96pt">Operating segments are defined as components of an enterprise for which separate financial information is available</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:580.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">that is regularly provided to the chief operating decision maker ("CODM") in deciding how to allocate resources and in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:591pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:299.38pt">assessing performance. Our CODM manages our business on the basis of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:357.88pt;position:var(--position);text-decoration:none;white-space:pre;width:15pt">one</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:372.88pt;position:var(--position);text-decoration:none;white-space:pre;width:79.47pt"> operating segment.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:607.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:320.63pt">Our operating segment derives revenue in a manner as described in "Note </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:397.13pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">2</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:402.13pt;position:var(--position);text-decoration:none;white-space:pre;width:6.84pt">. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:408.97pt;position:var(--position);text-decoration:none;white-space:pre;width:144.46pt">Summary of Significant Accounting</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:618.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:30.97pt">Policies</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:89.47pt;position:var(--position);text-decoration:none;white-space:pre;width:300.07pt">" in the notes to our consolidated financial statements included in our </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:389.54pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:409.54pt;position:var(--position);text-decoration:none;white-space:pre;width:143.89pt"> 10-K. Our CODM is our principal</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:629.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">executive officer, who is our Chief Executive Officer and President. Consolidated net income or loss is the measure of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:640.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">segment profit or loss reviewed by our CODM in assessing segment performance and deciding how to allocate resources.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:651pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt">Our CODM uses consolidated net income or loss to monitor budget versus actual results, review historical company</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:661.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">performance trends, conduct benchmark analysis of our peers and competitors, and evaluate management&#8217;s compensation.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:672.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">Significant expenses included in the reported measure of segment profit or loss regularly provided to our CODM are on a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:683.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:416.38pt">consolidated basis as presented in the accompanying condensed consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:72.45pt">Use of Estimates</span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:61.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.97pt">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:72.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:83.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">including the accompanying notes. We base our estimates on historical factors; current circumstances; macroeconomic</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:94.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">events and conditions; and the experience and judgment of our management. We evaluate our estimates and assumptions</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:105pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.98pt">on an ongoing basis. Actual results can differ materially from these estimates, and such differences can affect the results of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:115.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:147.42pt">operations reported in future periods.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Certain Risks and Concentrations</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:144.36pt">Certain Risks and Concentrations</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:202.86pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:161.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.99pt">Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:172.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:168.95pt">cash equivalents and accounts receivable.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:189pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.98pt">We maintain cash deposits with multiple financial institutions in the United States which, at times, may exceed federally</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:199.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">insured limits. Cash may be withdrawn or redeemed on demand. We believe that the financial institutions that hold our cash</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:210.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">are financially sound and, accordingly, minimal credit risk exists with respect to these balances. However, market conditions</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:221.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">can impact the viability of these institutions. In the event of failure of any of the financial institutions where we maintain our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:232.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.81pt">cash and cash equivalents, there can be no assurance that we will be able to access uninsured funds in a timely manner or</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.31pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:243pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:242.77pt">at all. We have not experienced any losses in such accounts.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:259.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.9pt">We consider all short-term, highly liquid investments purchased with an original maturity of three months or less at the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:270.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">date of purchase to be cash equivalents. Cash equivalents, consisting of U.S. treasury securities money market funds, of</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:281.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:55.39pt">$114.0 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:113.89pt;position:var(--position);text-decoration:none;white-space:pre;width:21.2pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:135.09pt;position:var(--position);text-decoration:none;white-space:pre;width:56.05pt">$164.0 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:191.14pt;position:var(--position);text-decoration:none;white-space:pre;width:13.7pt"> at </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:204.84pt;position:var(--position);text-decoration:none;white-space:pre;width:58.2pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:263.03999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:21.2pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:284.24pt;position:var(--position);text-decoration:none;white-space:pre;width:80.17pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:364.41pt;position:var(--position);text-decoration:none;white-space:pre;width:189.05pt">, respectively, were classified as Level 1 of the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:292.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:305.34pt">fair value hierarchy and valued using quoted market prices in active markets.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:309pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.99pt">We extend credit to our customers based on an evaluation of their ability to pay amounts due under contractual</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:251.63pt">arrangements and generally do not obtain or require collateral.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock', window );">Prescription Reimbursement Assets and Prescription Reimbursement Liabilities</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:342.75pt">Prescription Reimbursement Assets and Prescription Reimbursement Liabilities</span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:397.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.87pt">Consumer direct pricing is an affordability solution under our pharma direct offering that allows pharma manufacturers to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:408.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">use our platform to set and fund a portion of the consumer cash price for their prescription drugs at the point of sale. We</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:419.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">generally require deposits from pharma manufacturers which are included as a component of prescription reimbursement</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:430.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">liabilities on our condensed consolidated balance sheets and shall not be offset against other amounts owed to us. We</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:441pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">generally invoice pharma manufacturers for the funded amounts a month in arrears and payment is generally due within</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:451.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">thirty days of invoicing. Funded amounts owed to us are presented as a component of prescription reimbursement assets on</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:462.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:177.96pt">our condensed consolidated balance sheets.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:479.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.91pt">We remit reimbursements of the funded amounts to pharmacies, or intermediaries. Funded amounts owed to</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:490.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:447.2pt">pharmacies, or intermediaries, are presented as a component of prescription reimbursement liabilities on our</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:505.7pt;position:var(--position);text-decoration:none;white-space:pre;width:47.73pt"> condensed</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:501pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:55.54pt">consolidated </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:114.03999999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:439.4pt">balance sheets. Pharmacies, or intermediaries, may also require deposits from us. These deposits are</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:511.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">included as a component of prescription reimbursement assets on our condensed consolidated balance sheets and shall not</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:522.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:159.14pt">be offset against other amounts owed </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:217.64pt;position:var(--position);text-decoration:none;white-space:pre;width:48.92pt">to them. At </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:266.56pt;position:var(--position);text-decoration:none;white-space:pre;width:59.28pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:325.84pt;position:var(--position);text-decoration:none;white-space:pre;width:22.28pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:348.12pt;position:var(--position);text-decoration:none;white-space:pre;width:81.25pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:429.37pt;position:var(--position);text-decoration:none;white-space:pre;width:124.11pt">, a majority of our prescription</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:533.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:112.93pt">reimbursement assets were </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:171.43pt;position:var(--position);text-decoration:none;white-space:pre;width:18.48pt">with </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:189.91pt;position:var(--position);text-decoration:none;white-space:pre;width:13.99pt">two</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:203.9pt;position:var(--position);text-decoration:none;white-space:pre;width:59.47pt"> counterparties</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:263.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Investments</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:82.43pt">Equity Investments</span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:579pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.96pt">We retain minority equity interests in privately-held companies without readily determinable fair values. Our ownership</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:589.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:97.34pt">interests are less than </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:155.84pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt">20%</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:173.84pt;position:var(--position);text-decoration:none;white-space:pre;width:379.63pt"> of the voting stock of the investees and we do not have the ability to exercise significant</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:600.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">influence over the operating and financial policies of the investees. The equity investments are accounted for under the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:611.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:404.8pt">measurement alternative in accordance with Accounting Standards Codification ("ASC") 321, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:463.3pt;position:var(--position);text-decoration:none;white-space:pre;width:90.2pt">Investments &#8211; Equity</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:622.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:39.47pt">Securities</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:97.97pt;position:var(--position);text-decoration:none;white-space:pre;width:455.36pt">, which is cost minus impairment, if any, plus or minus changes resulting from observable price changes. We did</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:633pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt">not recognize any changes resulting from observable price changes or impairment losses on our minority equity interest</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:643.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:93.2pt">investments during the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:151.7pt;position:var(--position);text-decoration:none;white-space:pre;width:171.03pt">three and six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:322.73pt;position:var(--position);text-decoration:none;white-space:pre;width:20.16pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:342.89pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:362.89pt;position:var(--position);text-decoration:none;white-space:pre;width:190.49pt">. Equity investments included in other assets on</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:654.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:199.94pt">our condensed consolidated balance sheets were </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:258.44pt;position:var(--position);text-decoration:none;white-space:pre;width:50.45pt">$15.0 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:308.89pt;position:var(--position);text-decoration:none;white-space:pre;width:24.5pt"> as of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:333.39pt;position:var(--position);text-decoration:none;white-space:pre;width:57pt">June&#160;30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:390.39pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:410.39pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt">December&#160;31, 2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:489.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:142.36pt">Impairment of Long-Lived Assets</span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:700.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:335.34pt">We account for the impairment of long-lived assets in accordance with ASC 360, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:411.84pt;position:var(--position);text-decoration:none;white-space:pre;width:128.1pt">Property, Plant, and Equipment</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:539.94pt;position:var(--position);text-decoration:none;white-space:pre;width:13.55pt">. In</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:711pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt">accordance with ASC 360, long-lived assets to be held and used are reviewed for impairment when events or changes in</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:721.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.84pt">circumstances indicate that their carrying values may not be recoverable. We perform impairment testing at the asset group</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:732.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">level that represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">assets and liabilities. An impairment loss is recognized when estimated undiscounted future cash flows expected to result</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:55.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">from the use of the asset and its eventual disposition are less than its carrying value. If an asset is determined to be</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:66.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:438.79pt">impaired, the impairment is measured by the amount that the carrying value of the asset exceeds its fair value.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:83.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:352.98pt">During the three months ended March 31, 2025, we recognized an impairment loss of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:429.48pt;position:var(--position);text-decoration:none;white-space:pre;width:46.21pt">$4.4&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:475.69pt;position:var(--position);text-decoration:none;white-space:pre;width:77.73pt"> within general and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:94.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:425.74pt">administrative expenses to reduce the carrying value of an asset group to its estimated fair value of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:484.24pt;position:var(--position);text-decoration:none;white-space:pre;width:47.18pt">$3.4&#160;million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:531.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:22.06pt">. The</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:105pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">impairment charge was due to a significant deterioration in the sublease market and rental rates whereby the carrying value</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:115.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt">of the asset group was not recoverable. We otherwise have not recognized any impairment losses of our long-lived assets</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:126.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:42.48pt">during the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:100.97999999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:170.47pt">three and six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:271.45pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:291.45pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:311.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:157.83pt">Recent Accounting Pronouncements</span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:172.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:183.95pt">Recently Adopted Accounting Pronouncement</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:189pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.95pt">In July 2025, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU")</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:199.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:39.62pt">2025-05, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:98.12pt;position:var(--position);text-decoration:none;white-space:pre;width:455.32pt">Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:210.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:300.32pt">Contract Assets for Private Companies and Certain Not-For-Profit Entities. </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:358.82pt;position:var(--position);text-decoration:none;white-space:pre;width:194.66pt">This ASU amends ASC 326-20 in part to provide</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:221.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt">a practical expedient election to assume that current conditions as of the balance sheet date do not change for the</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:232.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt">remaining life of current accounts receivable and/or current contract assets arising from transactions accounted for under</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.34pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:243pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:47.55pt">Topic 606, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:106.05pt;position:var(--position);text-decoration:none;white-space:pre;width:170.02pt">Revenue from Contracts with Customers</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:276.07pt;position:var(--position);text-decoration:none;white-space:pre;width:277.35pt">. This ASU is effective for all entities for annual reporting periods</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:253.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt">beginning after December 15, 2025, and for interim reporting periods within those annual reporting periods. We adopted this</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:264.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">standard effective January 1, 2026, and the adoption did not have a material impact on our condensed consolidated</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:275.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:81.96pt">financial statements.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:298.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:255.43pt">Recently Issued Accounting Pronouncements - Not Yet Adopted</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:315pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:218.4pt">In September 2025, the FASB issued ASU 2025-06, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:294.9pt;position:var(--position);text-decoration:none;white-space:pre;width:258.55pt">Intangibles-Goodwill and Other-Internal-Use Software (Subtopic</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:325.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:37.58pt">350-40), </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:96.08pt;position:var(--position);text-decoration:none;white-space:pre;width:457.29pt">which amends certain aspects of the accounting for and disclosure of software costs under ASC 350-40. The</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:336.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">amendments in this ASU, amongst other things, eliminate accounting considerations of software development stages and</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:347.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt">instead require entities to capitalize internal-use software costs when management commits to funding the software project</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:358.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.98pt">and it is probable the project will be completed and will be used to perform the function intended. This ASU will be effective</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:369pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt">for all entities for annual reporting periods beginning after December 15, 2027, and for interim reporting periods within those</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:379.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt">annual reporting periods. Early adoption of this ASU is permitted and can be applied retrospectively, prospectively or on a</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:390.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.83pt">modified prospective basis. We are currently evaluating the impact of the adoption of this ASU on our consolidated financial</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:401.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:141.44pt">statements and related disclosures.</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:418.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:211.81pt">In November 2024, the FASB issued ASU 2024-03, </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:288.31pt;position:var(--position);text-decoration:none;white-space:pre;width:265.07pt">Income Statement - Reporting Comprehensive Income - Expense</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:429pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:376.4pt">Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:434.9pt;position:var(--position);text-decoration:none;white-space:pre;width:118.48pt">, which is intended to improve</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:439.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">the disclosures of expenses by providing more detailed information about the types of expenses in commonly presented</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:450.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt">expense captions. This ASU requires entities to disclose the amounts of purchases of inventory, employee compensation,</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:461.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt">depreciation and intangible asset amortization included in each relevant expense caption; as well as a qualitative description</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:472.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt">of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. This ASU also</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:483pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt">requires disclosure of the total amount of selling expense and, in annual reporting periods, an entity&#8217;s definition of selling</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:493.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.84pt">expenses. In January 2025, the FASB issued ASU 2025-01 which clarified the effective date of this ASU. This ASU applies</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:504.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt">to all public entities and will be effective for fiscal years beginning after December 15, 2026, and for interim periods within</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:515.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">fiscal years beginning after December 15, 2027. Early adoption of this ASU is permitted. This ASU should be applied either</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:526.2pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:495pt">prospectively to financial statements issued for reporting periods after the effective date of this ASU or retrospectively to any</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:537pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt">or all prior periods presented in the financial statements. We are currently evaluating the impact of the adoption of this ASU</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:547.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:210.4pt">on our consolidated financial statements disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gdrx_PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prescription Reimbursement Assets and Prescription Reimbursement Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gdrx_PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gdrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21D<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-21D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480530/250-10-S99-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:276.85pt">Accrued expenses and other current liabilities consist of the following:</span><div style="position:var(--position);top:84.6pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:331.5pt"></td><td style="padding:0;width:80.25pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:80.25pt"></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:331.5pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);width:80.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:14.15pt;position:var(--position);text-decoration:none;white-space:pre">June 30, 2026</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);width:80.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:4.16pt;position:var(--position);text-decoration:none;white-space:pre">December 31, 2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:14.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Accrued bonus and other payroll related</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:14.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">23,691<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:14.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">25,434<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:28.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Accrued legal settlement</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:28.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">30,500<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:28.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">30,500<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:42.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Accrued marketing</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:42.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">20,255<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:42.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">11,063<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:57pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Deferred revenue</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:57pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)">8,767<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:57pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:51.38pt"></span></span><span style="left:54.010000000000005pt;position:var(--position)">6,705<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:15.75pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:71.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Other accrued expenses</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:71.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">15,397<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:71.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:46.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">13,003<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:15.75pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:87pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Total accrued expenses and other current liabilities</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:87pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">98,610<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:87pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:5.81pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:41.38pt"></span></span><span style="left:49.010000000000005pt;position:var(--position)">86,705<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:122.44pt">Our debt balance is as follows:</span><div style="position:var(--position);top:623.15pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:331.5pt"></td><td style="padding:0;width:80.25pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:80.25pt"></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:331.5pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);width:80.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:14.15pt;position:var(--position);text-decoration:none;white-space:pre">June 30, 2026</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);width:80.25pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:4.16pt;position:var(--position);text-decoration:none;white-space:pre">December 31, 2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:14.25pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Principal balance under 2024 Term Loan Facility</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:14.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)">492,500<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:14.25pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)">495,000<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:28.5pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Less: Unamortized debt issuance costs and discounts</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:28.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.39pt"></span></span><span style="left:51.02pt;position:var(--position)">(5,912)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:28.5pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.39pt"></span></span><span style="left:51.02pt;position:var(--position)">(6,736)</span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:42.75pt;width:331.5pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:331.5pt;position:var(--position);top:42.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)">486,588<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:414.75pt;position:var(--position);top:42.75pt;width:80.25pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:36.38pt"></span></span><span style="left:44.010000000000005pt;position:var(--position)">488,264<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Revenue</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:30.98pt">For the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:107.48pt;position:var(--position);text-decoration:none;white-space:pre;width:170.47pt">three and six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:277.95pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:297.95pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:317.95pt;position:var(--position);text-decoration:none;white-space:pre;width:136.42pt">, revenue comprised the following:</span><div style="position:var(--position);top:84.6pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:207pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:207pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.75pt;position:var(--position);text-decoration:none;white-space:pre">Three Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.63pt;position:var(--position);text-decoration:none;white-space:pre">Six Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:23.25pt;width:207pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:37.5pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Prescription transactions revenue</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)">106,390<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)">143,064<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)">220,082<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)">291,987<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:51.75pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Subscription revenue</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">28,514<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">20,463<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">52,907<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">41,480<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:66pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Pharma Direct revenue</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:66pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">61,628<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:66pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">34,981<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:66pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:33.51pt;position:var(--position)">113,858<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:66pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">63,629<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:80.25pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Other revenue</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)">3,879<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)">4,562<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)">7,570<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)">8,944<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:94.5pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre">Total revenue</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:94.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)">200,411<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:94.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)">203,070<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:94.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)">394,417<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:94.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)">406,040<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRepurchaseAgreements', window );">Schedule of Repurchase Agreements</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:372.33pt">The following table presents information about our repurchases of our Class A common stock:</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:448.83pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span><div style="position:var(--position);text-align:justify;text-align-last:var(--justify);top:479.15pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:207pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.75pt;position:var(--position);text-decoration:none;white-space:pre">Three Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.63pt;position:var(--position);text-decoration:none;white-space:pre">Six Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:23.25pt;width:207pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:37.5pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Number of shares repurchased</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:54.38pt"></span></span><span style="left:57.010000000000005pt;position:var(--position)">&#8212;<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">10,224<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)">5,536<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">33,564<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:51.75pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);white-space:pre">Cost of shares repurchased </span><span style="font-family:'Arial', sans-serif;font-size:5.8500000000000005pt;font-style:normal;font-weight:normal;left:115.58999999999999pt;position:var(--position);top:-2.293pt;vertical-align:super;white-space:pre">(1)</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:45.39pt"></span></span><span style="left:53.02pt;position:var(--position)">(61)</span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">46,352<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">12,580<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:25.88pt"></span></span><span style="left:33.51pt;position:var(--position)">147,272<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:550.15pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:265pt">_____________________________________________________</span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:560.95pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:10.98pt">(1)</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:458.93pt">Cost of shares repurchased for the three months ended June 30, 2026 represents a change to the estimated</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:571.75pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:305.91pt">excise taxes associated with past repurchases of our Class A common stock.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRepurchaseAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for repurchase agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRepurchaseAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule Computation of (Loss) Earnings Per Share</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:79.47pt">The computation of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:155.97pt;position:var(--position);text-decoration:none;white-space:pre;width:74.96pt">earnings per share</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:230.93pt;position:var(--position);text-decoration:none;white-space:pre;width:30.49pt"> for the </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:261.41999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:170.47pt">three and six months ended June 30, 2026</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:431.89pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"> and </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:451.89pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt">2025</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:471.89pt;position:var(--position);text-decoration:none;white-space:pre;width:53.46pt"> is as follows:</span><div style="position:var(--position);text-align:justify;text-align-last:var(--justify);top:634.15pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:207pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:207pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.75pt;position:var(--position);text-decoration:none;white-space:pre">Three Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.63pt;position:var(--position);text-decoration:none;white-space:pre">Six Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:23.25pt;width:207pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands, except per share amounts)</span></div></div></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:37.5pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Numerator:</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:51.75pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Net income</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)">8,536<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">12,843<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)">9,705<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:51.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">23,895<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:66pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Denominator:</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:80.25pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Weighted average shares - basic</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:33.51pt;position:var(--position)">339,277<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:33.51pt;position:var(--position)">356,623<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:33.51pt;position:var(--position)">339,839<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:80.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:30.88pt"></span></span><span style="left:33.51pt;position:var(--position)">367,847<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><div style="position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:207pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td></tr><tr style="height:27.75pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:207pt"><div><div style="line-height:9pt;position:var(--position);top:7.01pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre">Dilutive impact of stock options and restricted </span></div><div style="line-height:9pt;position:var(--position);top:17.81pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre">stock units</span></div></div></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:17.81pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)">8,781<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:17.81pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.38pt"></span></span><span style="left:51.010000000000005pt;position:var(--position)">536<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:17.81pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:43.510000000000005pt;position:var(--position)">4,837<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:17.81pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:48.38pt"></span></span><span style="left:51.010000000000005pt;position:var(--position)">498<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:27.75pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Weighted average shares - diluted</span></div></div></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:27.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:34.62pt;position:var(--position);text-decoration:none;white-space:pre">348,058</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:27.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:34.62pt;position:var(--position);text-decoration:none;white-space:pre">357,159</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:27.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:34.62pt;position:var(--position);text-decoration:none;white-space:pre">344,676</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:27.75pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:34.62pt;position:var(--position);text-decoration:none;white-space:pre">368,345</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:42pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Earnings per share:</span></div></div></div></td><td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"></td></tr><tr style="height:14.25pt"><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:56.25pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Basic</span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:56.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)">0.03<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:56.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)">0.04<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:56.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)">0.03<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:56.25pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)">0.06<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:70.5pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Diluted</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:70.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)">0.02<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:70.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)">0.04<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:70.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)">0.03<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:70.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)">$<span style="display:inline-block;height:6.55pt;width:40.88pt"></span></span><span style="left:48.510000000000005pt;position:var(--position)">0.06<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Weighted-Average Potentially Dilutive Shares are Excluded from Computation of Diluted (Loss) Earnings Per Share</a></td>
<td class="text"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:425.91pt">The following weighted average potentially dilutive shares are excluded from the computation of diluted </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:502.41pt;position:var(--position);text-decoration:none;white-space:pre;width:50.98pt">earnings per</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:151.55pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:22.49pt">share</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:80.99pt;position:var(--position);text-decoration:none;white-space:pre;width:317.36pt"> for the periods presented because including them would have been antidilutive:</span></div><div style="position:var(--position);top:174.35pt;width:612pt"><div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"><div><table style="border-collapse:collapse;display:inline-table;width:100%"><tbody><tr style="height:0"><td style="padding:0;width:207pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td><td style="padding:0;width:3pt"></td><td style="padding:0;width:69.75pt"></td></tr><tr style="height:23.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);width:207pt"><div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"> </span></div></div></div></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.75pt;position:var(--position);text-decoration:none;white-space:pre">Three Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);width:142.5pt"><div><div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.63pt;position:var(--position);text-decoration:none;white-space:pre">Six Months Ended</span></div><div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre">June 30,</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:23.25pt;width:207pt"><div><div style="line-height:8pt;position:var(--position);top:5.27pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">(in thousands)</span></div></div></div></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td><td style="font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2026</span></div></div></div></td><td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:23.25pt;width:69.75pt"><div><div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre">2025</span></div></div></div></td></tr><tr style="height:14.25pt"><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"><div style="position:var(--position);top:37.5pt;width:207pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre">Stock options and restricted stock units</span></div></div></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:207pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:39.62pt;position:var(--position);text-decoration:none;white-space:pre">39,720</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:279.75pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:39.62pt;position:var(--position);text-decoration:none;white-space:pre">57,042</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:352.5pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:39.62pt;position:var(--position);text-decoration:none;white-space:pre">42,808</span></div></div></div></td><td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"><div style="left:425.25pt;position:var(--position);top:37.5pt;width:69.75pt"><div><div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"><span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"><span style="left:2.63pt;position:var(--position)"><span style="display:inline-block;height:6.55pt;width:35.88pt"></span></span><span style="left:38.510000000000005pt;position:var(--position)">49,102<span style="display:inline-block;height:6.55pt;width:2.99pt"></span></span></span></div></div></div></td></tr></tbody></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2026 </div>
<div>USD ($) </div>
<div>counterparty </div>
<div>segment</div>
</th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>counterparty</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties', window );">Number of counterparty | counterparty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity investments included in other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,808<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=gdrx_OperatingLeaseRightOfUseAssetsMember', window );">Operating Lease Right Of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=gdrx_MinorityEquityInterestsMember', window );">Minority Equity Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=gdrx_CustomerOneMember', window );">Customer One | Revenue from Contract with Customer Benchmark | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=gdrx_CustomerOneMember', window );">Customer One | Accounts Receivable | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds | Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents, fair value disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 114,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 164,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gdrx_AccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gdrx_AccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gdrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prescription Reimbursement Assets, Number Of Counterparties</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gdrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=gdrx_OperatingLeaseRightOfUseAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=gdrx_OperatingLeaseRightOfUseAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=gdrx_MinorityEquityInterestsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=gdrx_MinorityEquityInterestsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=gdrx_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=gdrx_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 13, 2025</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 430,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 430,331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=gdrx_VividRxClearRxIncMember', window );">VividRx Clear Rx, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash consideration</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=gdrx_VitacarePrescriptionServicesIncMember', window );">VitaCare Prescription Services, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=gdrx_VitacarePrescriptionServicesIncMember', window );">VitaCare Prescription Services, Inc | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="nump">$ 18,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life (in years)</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-47<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 37: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of identifiable intangible asset acquired in business combination and recognized at acquisition date. Excludes goodwill and financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-41<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 45<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-45<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible asset, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-41<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478064/805-740-55-13<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-39<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=gdrx_VividRxClearRxIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=gdrx_VividRxClearRxIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=gdrx_VitacarePrescriptionServicesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=gdrx_VitacarePrescriptionServicesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_AccruedBonusAndOtherPayrollRelatedCurrent', window );">Accrued bonus and other payroll related</a></td>
<td class="nump">$ 23,691<span></span>
</td>
<td class="nump">$ 25,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrued legal settlement</a></td>
<td class="nump">30,500<span></span>
</td>
<td class="nump">30,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedMarketingCostsCurrent', window );">Accrued marketing</a></td>
<td class="nump">20,255<span></span>
</td>
<td class="nump">11,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">8,767<span></span>
</td>
<td class="nump">6,705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">15,397<span></span>
</td>
<td class="nump">13,003<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_AccruedExpensesAndOtherCurrentLiabilities', window );">Total accrued expenses and other current liabilities</a></td>
<td class="nump">$ 98,610<span></span>
</td>
<td class="nump">$ 86,705<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gdrx_AccruedBonusAndOtherPayrollRelatedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued bonus and other payroll related current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gdrx_AccruedBonusAndOtherPayrollRelatedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gdrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gdrx_AccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued expenses and other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gdrx_AccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gdrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedMarketingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedMarketingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">$ 8,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">$ 5,400<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax rate</a></td>
<td class="nump">44.80%<span></span>
</td>
<td class="nump">34.40%<span></span>
</td>
<td class="nump">54.00%<span></span>
</td>
<td class="nump">34.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Jul. 10, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value of debt</a></td>
<td class="nump">$ 469,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 469,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Fair value of amount outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit</a></td>
<td class="nump">$ 7,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gdrx_FirstLienCreditAgreementMember', window );">First Lien Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Interest rate on used amounts</a></td>
<td class="nump">7.85%<span></span>
</td>
<td class="nump">8.60%<span></span>
</td>
<td class="nump">7.86%<span></span>
</td>
<td class="nump">8.56%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio', window );">Maximum net leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gdrx_FirstLienCreditAgreementMember', window );">First Lien Credit Agreement | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension', window );">Amount subject to maturity extension</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 88,000,000.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Borrowing Capacity, Subject to Maturity Extension</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gdrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of credit maximum financial covenant net leverage ratio.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gdrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.9-06)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-9<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 41: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 42: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-9<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482881/825-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482881/825-10-55-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gdrx_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gdrx_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Schedule of Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gdrx_A2024TermLoanMember', window );">2024 Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal balance under 2024 Term Loan Facility</a></td>
<td class="nump">$ 492,500<span></span>
</td>
<td class="nump">$ 495,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gdrx_FirstLienCreditAgreementMember', window );">First Lien Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: Unamortized debt issuance costs and discounts</a></td>
<td class="num">(5,912)<span></span>
</td>
<td class="num">(6,736)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt</a></td>
<td class="nump">$ 486,588<span></span>
</td>
<td class="nump">$ 488,264<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.9-06)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-9<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 41: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 42: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.9-06)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-9<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gdrx_A2024TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gdrx_A2024TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gdrx_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gdrx_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 25, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 27, 2023 </div>
<div>USD ($) </div>
<div>plaintiff</div>
</th>
<th class="th">
<div>Mar. 30, 2023 </div>
<div>plaintiff </div>
<div>case </div>
<div>Defendant</div>
</th>
<th class="th">
<div>Jun. 30, 2026 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrued legal settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,500<span></span>
</td>
<td class="nump">$ 30,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionLocationBalanceAxis=us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Location, Statement of Financial Position, Balance [Axis]: us-gaap:PrepaidExpenseAndOtherAssetsCurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceSettlementsReceivable', window );">Insurance recovery receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,900<span></span>
</td>
<td class="nump">11,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Pending claims | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfDefendants', window );">Number of defendants | Defendant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending Litigation | SDFL Class Action Matter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Settlement payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrued legal settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending Litigation | Privacy Protection</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending Litigation | Electronic Communication Privacy Act, Privacy Protection</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation | NDCA Class Action Matter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payment for settlements</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceSettlementsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceSettlementsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482645/405-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.W.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479583/944-40-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483359/720-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482395/460-10-55-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of defendants named in a legal action.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionLocationBalanceAxis=us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionLocationBalanceAxis=us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=gdrx_SDFLClassActionMatterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=gdrx_SDFLClassActionMatterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=gdrx_PrivacyProtectionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=gdrx_PrivacyProtectionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=gdrx_NDCAClassActionMatterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=gdrx_NDCAClassActionMatterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 200,411<span></span>
</td>
<td class="nump">$ 203,070<span></span>
</td>
<td class="nump">$ 394,417<span></span>
</td>
<td class="nump">$ 406,040<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gdrx_PrescriptionTransactionsRevenueMember', window );">Prescription transactions revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">106,390<span></span>
</td>
<td class="nump">143,064<span></span>
</td>
<td class="nump">220,082<span></span>
</td>
<td class="nump">291,987<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gdrx_SubscriptionRevenueMember', window );">Subscription revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">28,514<span></span>
</td>
<td class="nump">20,463<span></span>
</td>
<td class="nump">52,907<span></span>
</td>
<td class="nump">41,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gdrx_PharmaManufacturerSolutionsRevenuesMember', window );">Pharma Direct revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">61,628<span></span>
</td>
<td class="nump">34,981<span></span>
</td>
<td class="nump">113,858<span></span>
</td>
<td class="nump">63,629<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=gdrx_OtherRevenueMember', window );">Other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation Of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 3,879<span></span>
</td>
<td class="nump">$ 4,562<span></span>
</td>
<td class="nump">$ 7,570<span></span>
</td>
<td class="nump">$ 8,944<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gdrx_PrescriptionTransactionsRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gdrx_PrescriptionTransactionsRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gdrx_SubscriptionRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gdrx_SubscriptionRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gdrx_PharmaManufacturerSolutionsRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gdrx_PharmaManufacturerSolutionsRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=gdrx_OtherRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=gdrx_OtherRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Additional Information (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Feb. 27, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchased shares (in shares)</a></td>
<td class="nump">20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=gdrx_CommonClassAAndClassBMember', window );">Class A and Class B Common Stock | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Repurchased shares (in usd per share)</a></td>
<td class="nump">$ 4.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price (in usd per share)</a></td>
<td class="nump">$ 4.42<span></span>
</td>
<td class="nump">$ 4.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=gdrx_CommonClassAAndClassBMember', window );">Class A and Class B Common Stock | Francisco Partners Stock Purchase Agreement | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchased shares (in shares)</a></td>
<td class="nump">10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=gdrx_CommonClassAAndClassBMember', window );">Class A and Class B Common Stock | Idea Men, LLC | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchased shares (in shares)</a></td>
<td class="nump">7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=gdrx_CommonClassAAndClassBMember', window );">Class A and Class B Common Stock | Spectrum Stock Purchase Agreement | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchased shares (in shares)</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ShareRepurchaseProgramAxis=gdrx_NewRepurchaseProgramMember', window );">New Repurchase Program | Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase agreement, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, available for future repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-5<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-13<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=gdrx_CommonClassAAndClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=gdrx_CommonClassAAndClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=gdrx_FranciscoPartnersStockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=gdrx_FranciscoPartnersStockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=gdrx_IdeaMenLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=gdrx_IdeaMenLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=gdrx_SpectrumStockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=gdrx_SpectrumStockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ShareRepurchaseProgramAxis=gdrx_NewRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ShareRepurchaseProgramAxis=gdrx_NewRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Repurchase Agreements (Details) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><sup>[1]</sup></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Cost of shares repurchased</a></td>
<td class="num">$ (61)<span></span>
</td>
<td class="nump">$ 12,641<span></span>
</td>
<td class="nump">$ 46,352<span></span>
</td>
<td colspan="2" class="nump">$ 100,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Number of shares repurchased (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,224<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">5,536<span></span>
</td>
<td class="nump">33,564<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Cost of shares repurchased</a></td>
<td class="num">$ (61)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,352<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,580<span></span>
</td>
<td class="nump">$ 147,272<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:381.69pt">Repurchases of Class A common stock for the three months ended March 31, 2025 include </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:476.19pt;position:var(--position);text-decoration:none;white-space:pre;width:46.57pt">20.0 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:522.76pt;position:var(--position);text-decoration:none;white-space:pre;width:30.61pt"> shares</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:456.8pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:458.86pt">repurchased from related parties (after giving effect to the automatic conversion of Class B common stock to Class</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:467.6pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:338pt">A common stock upon such repurchase) for an aggregate consideration of </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:432.5pt;position:var(--position);text-decoration:none;white-space:pre;width:54.14pt">$84.9 million</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:486.64pt;position:var(--position);text-decoration:none;white-space:pre;width:59.25pt">. See "Note </span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:545.89pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">9</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:550.89pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </span></div><div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:478.4pt;width:612pt"><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:81.18pt">Stockholders' Equity</span><span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:175.68pt;position:var(--position);text-decoration:none;white-space:pre;width:106.61pt">" for additional information.</span></div></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Earnings Per Share - Schedule Computation of Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Mar. 31, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 8,536<span></span>
</td>
<td class="nump">$ 1,169<span></span>
</td>
<td class="nump">$ 12,843<span></span>
</td>
<td class="nump">$ 11,052<span></span>
</td>
<td class="nump">$ 9,705<span></span>
</td>
<td class="nump">$ 23,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares - basic (in shares)</a></td>
<td class="nump">339,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">356,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">339,839<span></span>
</td>
<td class="nump">367,847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive impact of stock options and restricted stock units (in shares)</a></td>
<td class="nump">8,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,837<span></span>
</td>
<td class="nump">498<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares - diluted (in shares)</a></td>
<td class="nump">348,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">357,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">344,676<span></span>
</td>
<td class="nump">368,345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gdrx_EarningPerShareBasicAndDilutedAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in usd per share)</a></td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in usd per share)</a></td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gdrx_EarningPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earning per share basic and diluted abstract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gdrx_EarningPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gdrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482705/350-40-65-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479719/606-10-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482705/350-40-65-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479719/606-10-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480454/718-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-28A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482705/350-40-65-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479719/606-10-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 53: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Earnings Per Share - Schedule of Weighted-Average Potentially Dilutive Shares are Excluded from Computation of Diluted (Loss) Earnings Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=gdrx_StockOptionsAndRestrictedStockUnitsMember', window );">Stock options and restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">39,720<span></span>
</td>
<td class="nump">57,042<span></span>
</td>
<td class="nump">42,808<span></span>
</td>
<td class="nump">49,102<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=gdrx_StockOptionsAndRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=gdrx_StockOptionsAndRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>134</ContextCount>
  <ElementCount>196</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>39</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>9952151 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952153 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952154 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952155 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952156 - Statement - Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952157 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952158 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/DescriptionofBusiness</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Business Combination</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/BusinessCombination</Role>
      <ShortName>Business Combination</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Accrued Expenses and Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilities</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Basic and Diluted Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/BasicandDilutedEarningsPerShare</Role>
      <ShortName>Basic and Diluted Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://goodrx.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilities</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://goodrx.com/role/Debt</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://goodrx.com/role/Revenue</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://goodrx.com/role/StockholdersEquity</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Basic and Diluted Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/BasicandDilutedEarningsPerShareTables</Role>
      <ShortName>Basic and Diluted Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://goodrx.com/role/BasicandDilutedEarningsPerShare</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://goodrx.com/role/SummaryofSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Business Combination (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/BusinessCombinationDetails</Role>
      <ShortName>Business Combination (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://goodrx.com/role/BusinessCombination</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Accrued Expenses and Other Current Liabilities - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesAdditionalInformationDetails</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/IncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Debt - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/DebtAdditionalInformationDetails</Role>
      <ShortName>Debt - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Debt - Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/DebtScheduleofDebtDetails</Role>
      <ShortName>Debt - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://goodrx.com/role/CommitmentsandContingencies</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/RevenueDetails</Role>
      <ShortName>Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://goodrx.com/role/RevenueTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Stockholders' Equity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails</Role>
      <ShortName>Stockholders' Equity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Stockholders' Equity - Schedule of Repurchase Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/StockholdersEquityScheduleofRepurchaseAgreementsDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Repurchase Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Basic and Diluted Earnings Per Share - Schedule Computation of Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails</Role>
      <ShortName>Basic and Diluted Earnings Per Share - Schedule Computation of Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="gdrx-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Basic and Diluted Earnings Per Share - Schedule of Weighted-Average Potentially Dilutive Shares are Excluded from Computation of Diluted (Loss) Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleofWeightedAveragePotentiallyDilutiveSharesareExcludedfromComputationofDilutedLossEarningsPerShareDetails</Role>
      <ShortName>Basic and Diluted Earnings Per Share - Schedule of Weighted-Average Potentially Dilutive Shares are Excluded from Computation of Diluted (Loss) Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="gdrx-20260630.htm">gdrx-20260630.htm</File>
    <File>gdrx-20260630.xsd</File>
    <File>gdrx-20260630_cal.xml</File>
    <File>gdrx-20260630_def.xml</File>
    <File>gdrx-20260630_lab.xml</File>
    <File>gdrx-20260630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2026</BaseTaxonomy>
    <BaseTaxonomy items="462">http://fasb.org/us-gaap/2026</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2026</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2026</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>57
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "gdrx-20260630.htm": {
   "nsprefix": "gdrx",
   "nsuri": "http://goodrx.com/20260630",
   "dts": {
    "inline": {
     "local": [
      "gdrx-20260630.htm"
     ]
    },
    "schema": {
     "local": [
      "gdrx-20260630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-roles-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-roles-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd",
      "https://xbrl.sec.gov/country/2026/country-2026.xsd",
      "https://xbrl.sec.gov/dei/2026/dei-2026.xsd",
      "https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd",
      "https://xbrl.sec.gov/stpr/2026/stpr-2026.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "gdrx-20260630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "gdrx-20260630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "gdrx-20260630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gdrx-20260630_pre.xml"
     ]
    }
   },
   "keyStandard": 180,
   "keyCustom": 16,
   "axisStandard": 23,
   "axisCustom": 0,
   "memberStandard": 17,
   "memberCustom": 21,
   "hidden": {
    "total": 5,
    "http://xbrl.sec.gov/dei/2026": 5
   },
   "contextCount": 134,
   "entityCount": 1,
   "segmentCount": 39,
   "elementCount": 434,
   "unitCount": 9,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2026": 462,
    "http://xbrl.sec.gov/dei/2026": 30,
    "http://xbrl.sec.gov/ecd/2026": 4,
    "http://fasb.org/srt/2026": 1
   },
   "report": {
    "R1": {
     "role": "http://goodrx.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
     "longName": "9952151 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited",
     "longName": "9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited)",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
     "longName": "9952153 - Statement - Condensed Consolidated Statements of Operations (Unaudited)",
     "shortName": "Condensed Consolidated Statements of Operations (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
     "longName": "9952154 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited)",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-46",
      "name": "us-gaap:SharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-50",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
     "longName": "9952155 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfFinancingCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnauditedParenthetical",
     "longName": "9952156 - Statement - Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical)",
     "shortName": "Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnauditedParenthetical",
     "longName": "9952157 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parenthetical)",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-124",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R9": {
     "role": "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical",
     "longName": "9952158 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical)",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-124",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R10": {
     "role": "http://goodrx.com/role/DescriptionofBusiness",
     "longName": "9952159 - Disclosure - Description of Business",
     "shortName": "Description of Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://goodrx.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "9952160 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://goodrx.com/role/BusinessCombination",
     "longName": "9952161 - Disclosure - Business Combination",
     "shortName": "Business Combination",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilities",
     "longName": "9952162 - Disclosure - Accrued Expenses and Other Current Liabilities",
     "shortName": "Accrued Expenses and Other Current Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://goodrx.com/role/IncomeTaxes",
     "longName": "9952163 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://goodrx.com/role/Debt",
     "longName": "9952164 - Disclosure - Debt",
     "shortName": "Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://goodrx.com/role/CommitmentsandContingencies",
     "longName": "9952165 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://goodrx.com/role/Revenue",
     "longName": "9952166 - Disclosure - Revenue",
     "shortName": "Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://goodrx.com/role/StockholdersEquity",
     "longName": "9952167 - Disclosure - Stockholders' Equity",
     "shortName": "Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://goodrx.com/role/BasicandDilutedEarningsPerShare",
     "longName": "9952168 - Disclosure - Basic and Diluted Earnings Per Share",
     "shortName": "Basic and Diluted Earnings Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-10",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables",
     "longName": "9955512 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)",
     "shortName": "Accrued Expenses and Other Current Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://goodrx.com/role/DebtTables",
     "longName": "9955513 - Disclosure - Debt (Tables)",
     "shortName": "Debt (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://goodrx.com/role/RevenueTables",
     "longName": "9955514 - Disclosure - Revenue (Tables)",
     "shortName": "Revenue (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://goodrx.com/role/StockholdersEquityTables",
     "longName": "9955515 - Disclosure - Stockholders' Equity (Tables)",
     "shortName": "Stockholders' Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRepurchaseAgreements",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRepurchaseAgreements",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://goodrx.com/role/BasicandDilutedEarningsPerShareTables",
     "longName": "9955516 - Disclosure - Basic and Diluted Earnings Per Share (Tables)",
     "shortName": "Basic and Diluted Earnings Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails",
     "longName": "9955517 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://goodrx.com/role/BusinessCombinationDetails",
     "longName": "9955518 - Disclosure - Business Combination (Details)",
     "shortName": "Business Combination (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-75",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "unique": true
     }
    },
    "R29": {
     "role": "http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails",
     "longName": "9955519 - Disclosure - Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details)",
     "shortName": "Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "gdrx:AccruedBonusAndOtherPayrollRelatedCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "gdrx:AccruedBonusAndOtherPayrollRelatedCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesAdditionalInformationDetails",
     "longName": "9955520 - Disclosure - Accrued Expenses and Other Current Liabilities - Additional Information (Details)",
     "shortName": "Accrued Expenses and Other Current Liabilities - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "unique": true
     }
    },
    "R31": {
     "role": "http://goodrx.com/role/IncomeTaxesAdditionalInformationDetails",
     "longName": "9955521 - Disclosure - Income Taxes - Additional Information (Details)",
     "shortName": "Income Taxes - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://goodrx.com/role/DebtAdditionalInformationDetails",
     "longName": "9955522 - Disclosure - Debt - Additional Information (Details)",
     "shortName": "Debt - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LongTermDebtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-86",
      "name": "us-gaap:LineOfCredit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:LineOfCredit",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "unique": true
     }
    },
    "R33": {
     "role": "http://goodrx.com/role/DebtScheduleofDebtDetails",
     "longName": "9955523 - Disclosure - Debt - Schedule of Debt (Details)",
     "shortName": "Debt - Schedule of Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-89",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-89",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://goodrx.com/role/CommitmentsandContingenciesDetails",
     "longName": "9955524 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-101",
      "name": "us-gaap:InsuranceSettlementsReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "unique": true
     }
    },
    "R35": {
     "role": "http://goodrx.com/role/RevenueDetails",
     "longName": "9955525 - Disclosure - Revenue (Details)",
     "shortName": "Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-103",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "unique": true
     }
    },
    "R36": {
     "role": "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails",
     "longName": "9955526 - Disclosure - Stockholders' Equity - Additional Information (Details)",
     "shortName": "Stockholders' Equity - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-124",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-125",
      "name": "us-gaap:TreasuryStockAcquiredAverageCostPerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "unique": true
     }
    },
    "R37": {
     "role": "http://goodrx.com/role/StockholdersEquityScheduleofRepurchaseAgreementsDetails",
     "longName": "9955527 - Disclosure - Stockholders' Equity - Schedule of Repurchase Agreements (Details)",
     "shortName": "Stockholders' Equity - Schedule of Repurchase Agreements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-127",
      "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "unique": true
     }
    },
    "R38": {
     "role": "http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails",
     "longName": "9955528 - Disclosure - Basic and Diluted Earnings Per Share - Schedule Computation of Earnings Per Share (Details)",
     "shortName": "Basic and Diluted Earnings Per Share - Schedule Computation of Earnings Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "unique": true
     }
    },
    "R39": {
     "role": "http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleofWeightedAveragePotentiallyDilutiveSharesareExcludedfromComputationofDilutedLossEarningsPerShareDetails",
     "longName": "9955529 - Disclosure - Basic and Diluted Earnings Per Share - Schedule of Weighted-Average Potentially Dilutive Shares are Excluded from Computation of Diluted (Loss) Earnings Per Share (Details)",
     "shortName": "Basic and Diluted Earnings Per Share - Schedule of Weighted-Average Potentially Dilutive Shares are Excluded from Computation of Diluted (Loss) Earnings Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-131",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-131",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "div",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gdrx-20260630.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "gdrx_A2024TermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "A2024TermLoanMember",
     "presentation": [
      "http://goodrx.com/role/DebtScheduleofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Term Loan",
        "label": "2024 Term Loan [Member]",
        "documentation": "2024 Term Loan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "gdrx_AccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "AccountingPoliciesLineItems",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Line Items]",
        "label": "Accounting Policies [Line Items]",
        "documentation": "Accounting policies."
       }
      }
     },
     "auth_ref": []
    },
    "gdrx_AccountingPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "AccountingPoliciesTable",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Table]",
        "label": "Accounting Policies [Table]",
        "documentation": "Accounting policies."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "presentation": [
      "http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Expenses and Other Current Liabilities",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r796",
      "r914",
      "r918"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable",
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r690",
      "r993"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, net",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1002"
     ]
    },
    "gdrx_AccruedBonusAndOtherPayrollRelatedCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "AccruedBonusAndOtherPayrollRelatedCurrent",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": "gdrx_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued bonus and other payroll related",
        "label": "Accrued Bonus And Other Payroll Related Current",
        "documentation": "Accrued bonus and other payroll related current."
       }
      }
     },
     "auth_ref": []
    },
    "gdrx_AccruedExpensesAndOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "AccruedExpensesAndOtherCurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails",
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other current liabilities",
        "totalLabel": "Total accrued expenses and other current liabilities",
        "label": "Accrued Expenses And Other Current Liabilities",
        "documentation": "Accrued expenses and other current liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedMarketingCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AccruedMarketingCostsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": "gdrx_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued marketing",
        "label": "Accrued Marketing Costs, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r925",
      "r1041"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r577",
      "r619",
      "r984",
      "r985",
      "r986",
      "r987",
      "r1088",
      "r1161"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Common stock withheld related to net share settlement",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1075"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r339"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r824",
      "r834",
      "r844",
      "r876"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r827",
      "r837",
      "r847",
      "r879"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r828",
      "r838",
      "r848",
      "r872",
      "r880",
      "r884",
      "r892"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total stock-based compensation",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r369",
      "r372",
      "r373"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of debt issuance costs and discounts",
        "label": "Amortization of Debt Issuance Costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r242",
      "r973",
      "r1100"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleofWeightedAveragePotentiallyDilutiveSharesareExcludedfromComputationofDilutedLossEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleofWeightedAveragePotentiallyDilutiveSharesareExcludedfromComputationofDilutedLossEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleofWeightedAveragePotentiallyDilutiveSharesareExcludedfromComputationofDilutedLossEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleofWeightedAveragePotentiallyDilutiveSharesareExcludedfromComputationofDilutedLossEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r48",
      "r59",
      "r96",
      "r99",
      "r100",
      "r139",
      "r148",
      "r162",
      "r163",
      "r173",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r291",
      "r465",
      "r467",
      "r522",
      "r554",
      "r555",
      "r557",
      "r571",
      "r572",
      "r579",
      "r652",
      "r715",
      "r716",
      "r729",
      "r796",
      "r803",
      "r804",
      "r815",
      "r1035",
      "r1036",
      "r1103"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r48",
      "r84",
      "r96",
      "r99",
      "r100",
      "r173",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r291",
      "r465",
      "r467",
      "r522",
      "r796",
      "r912",
      "r1035",
      "r1036",
      "r1103"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r975"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://goodrx.com/role/BusinessCombinationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination",
        "label": "Business Combination [Domain]",
        "documentation": "Business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r459",
      "r460",
      "r461",
      "r609",
      "r693",
      "r743",
      "r744",
      "r1081",
      "r1083",
      "r1085"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://goodrx.com/role/BusinessCombinationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination",
        "label": "Business Combination [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r459",
      "r460",
      "r461",
      "r609",
      "r693",
      "r743",
      "r744",
      "r1081",
      "r1083",
      "r1085"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://goodrx.com/role/BusinessCombinationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination [Line Items]",
        "label": "Business Combination [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r401",
      "r402",
      "r403",
      "r404",
      "r410",
      "r411",
      "r412",
      "r413",
      "r419",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r455",
      "r456",
      "r457",
      "r461",
      "r746",
      "r755",
      "r1081",
      "r1083",
      "r1085"
     ]
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://goodrx.com/role/BusinessCombination"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination",
        "label": "Business Combination [Text Block]",
        "documentation": "The entire disclosure for business combination."
       }
      }
     },
     "auth_ref": [
      "r400",
      "r401",
      "r405",
      "r414",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r425",
      "r426",
      "r432",
      "r435",
      "r436",
      "r442",
      "r443",
      "r444",
      "r452",
      "r456",
      "r457",
      "r458",
      "r460",
      "r462",
      "r746",
      "r747",
      "r748",
      "r749",
      "r752",
      "r753",
      "r754"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://goodrx.com/role/BusinessCombinationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other intangible assets",
        "label": "Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Excluding Goodwill",
        "documentation": "Amount of identifiable intangible asset acquired in business combination and recognized at acquisition date. Excludes goodwill and financial asset."
       }
      }
     },
     "auth_ref": [
      "r746",
      "r751",
      "r753",
      "r1084",
      "r1086"
     ]
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "presentation": [
      "http://goodrx.com/role/DescriptionofBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of Business",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r909",
      "r975"
     ]
    },
    "us-gaap_CapitalizedComputerSoftwareNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CapitalizedComputerSoftwareNet",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized software, net",
        "label": "Capitalized Cost, Software to be Sold, Leased, or Marketed, after Accumulated Amortization",
        "documentation": "Amount, after accumulated amortization, of capitalized cost for software to be sold, leased, or marketed. Excludes capitalized cost for internal-use software."
       }
      }
     },
     "auth_ref": [
      "r692"
     ]
    },
    "gdrx_CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized software included in accounts payable and accrued expenses and other current liabilities",
        "label": "Capitalized Software Included in Accounts Payable and Accrued Expenses and Other Current Liabilities",
        "documentation": "Capitalized Software Included in Accounts Payable and Accrued Expenses and Other Current Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r92",
      "r93",
      "r697",
      "r1105"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents, fair value disclosure",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r516",
      "r517",
      "r518",
      "r1089",
      "r1090"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning of period",
        "periodEndLabel": "End of period",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r92",
      "r93"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net change in cash and cash equivalents",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation",
        "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r20"
     ]
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non cash investing and financing activities:",
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CityAreaCode",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited",
      "http://goodrx.com/role/Cover",
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://goodrx.com/role/StockholdersEquityScheduleofRepurchaseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r50",
      "r51",
      "r74",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r96",
      "r100",
      "r125",
      "r129",
      "r131",
      "r133",
      "r141",
      "r142",
      "r173",
      "r211",
      "r213",
      "r214",
      "r215",
      "r218",
      "r219",
      "r252",
      "r253",
      "r255",
      "r256",
      "r258",
      "r261",
      "r264",
      "r265",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r274",
      "r277",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r286",
      "r287",
      "r290",
      "r291",
      "r292",
      "r522",
      "r554",
      "r555",
      "r563",
      "r564",
      "r565",
      "r577",
      "r613",
      "r614",
      "r615",
      "r616",
      "r619",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r640",
      "r660",
      "r678",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r902",
      "r978",
      "r980",
      "r988",
      "r1043",
      "r1045"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r51",
      "r74",
      "r78",
      "r79",
      "r141",
      "r255",
      "r265",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r274",
      "r277",
      "r280",
      "r281",
      "r283",
      "r284",
      "r286",
      "r287",
      "r290",
      "r292",
      "r485",
      "r554",
      "r555",
      "r564",
      "r565",
      "r613",
      "r614",
      "r615",
      "r616",
      "r902",
      "r976",
      "r978",
      "r1043"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note 7)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r554",
      "r555",
      "r562",
      "r581",
      "r639"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r204",
      "r691",
      "r1022",
      "r1026",
      "r1027"
     ]
    },
    "gdrx_CommonClassAAndClassBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "CommonClassAAndClassBMember",
     "presentation": [
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class A and Class B Common Stock",
        "label": "Common Class A And Class B [Member]",
        "documentation": "Common class A and class B."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited",
      "http://goodrx.com/role/Cover",
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://goodrx.com/role/StockholdersEquityScheduleofRepurchaseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Class A Common Stock",
        "terseLabel": "Common Class A",
        "label": "Common Class A [Member]",
        "documentation": "Classification of common stock representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r923",
      "r1038",
      "r1040",
      "r1108",
      "r1109",
      "r1112",
      "r1161"
     ]
    },
    "us-gaap_CommonClassBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommonClassBMember",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited",
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Class B Common Stock",
        "terseLabel": "Common Class B",
        "label": "Common Class B [Member]",
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r923",
      "r1038",
      "r1040",
      "r1108",
      "r1109",
      "r1112",
      "r1161"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommonStockMember",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnauditedParenthetical",
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r287",
      "r554",
      "r555",
      "r565",
      "r806",
      "r807",
      "r808",
      "r810",
      "r811",
      "r812",
      "r813",
      "r984",
      "r985",
      "r987",
      "r1088",
      "r1159",
      "r1161"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in usd per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r923",
      "r1040",
      "r1108",
      "r1109",
      "r1112"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r287",
      "r554",
      "r555",
      "r565",
      "r640"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r287",
      "r554",
      "r555",
      "r565"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r287",
      "r554",
      "r555",
      "r565",
      "r640",
      "r658",
      "r1037",
      "r1161",
      "r1162"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.0001 par value; Class A: 2,000,000 shares authorized, 106,164 and 107,088 shares issued and outstanding at June\u00a030, 2026 and December\u00a031, 2025, respectively; and Class B: 1,000,000 shares authorized, 233,964 shares issued and outstanding at June\u00a030, 2026 and December\u00a031, 2025",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r253",
      "r260",
      "r287",
      "r554",
      "r555",
      "r565",
      "r583",
      "r796"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r868"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r867"
     ]
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r167",
      "r610",
      "r611",
      "r690",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r167",
      "r610",
      "r611",
      "r690",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r167",
      "r610",
      "r611",
      "r690",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Certain Risks and Concentrations",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r520"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration risk, percentage",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r167",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r167",
      "r610",
      "r611",
      "r690",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r708"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": "gdrx_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesAdditionalInformationDetails",
      "http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r306",
      "r307",
      "r309",
      "r320",
      "r699"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognized",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenue, exclusive of depreciation and amortization presented separately below",
        "label": "Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization",
        "documentation": "Cost of product sold and service rendered, excluding depreciation, depletion, and amortization."
       }
      }
     },
     "auth_ref": [
      "r704",
      "r705",
      "r907",
      "r928"
     ]
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total costs and operating expenses",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CostsAndExpensesAbstract",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Costs and operating expenses:",
        "label": "Costs and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://goodrx.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r61",
      "r210",
      "r554",
      "r555",
      "r558",
      "r1034"
     ]
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://goodrx.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r61",
      "r210",
      "r554",
      "r555",
      "r558",
      "r1034"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Concentration Risk",
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r993"
     ]
    },
    "gdrx_CustomerOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "CustomerOneMember",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer One",
        "label": "Customer One [Member]",
        "documentation": "Customer one."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://goodrx.com/role/BusinessCombinationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer relationships",
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r764",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1014",
      "r1015"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://goodrx.com/role/Debt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r54",
      "r55",
      "r61",
      "r62",
      "r64",
      "r66",
      "r67",
      "r69",
      "r70",
      "r96",
      "r98",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r209",
      "r210",
      "r220",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r236",
      "r243",
      "r244",
      "r246",
      "r485",
      "r533",
      "r554",
      "r555",
      "r561"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://goodrx.com/role/DebtAdditionalInformationDetails",
      "http://goodrx.com/role/DebtScheduleofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r55",
      "r61",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r70",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r232",
      "r233",
      "r234",
      "r235",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r281",
      "r554",
      "r555",
      "r561",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r794",
      "r976",
      "r977",
      "r979",
      "r983",
      "r1023",
      "r1024",
      "r1025",
      "r1099",
      "r1101",
      "r1113"
     ]
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://goodrx.com/role/DebtScheduleofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal balance under 2024 Term Loan Facility",
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r1108",
      "r1109",
      "r1110"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://goodrx.com/role/DebtAdditionalInformationDetails",
      "http://goodrx.com/role/DebtScheduleofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r70",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r232",
      "r233",
      "r234",
      "r235",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r245",
      "r281",
      "r485",
      "r554",
      "r555",
      "r561",
      "r574",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r794",
      "r976",
      "r977",
      "r979",
      "r983",
      "r1099",
      "r1101"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://goodrx.com/role/DebtAdditionalInformationDetails",
      "http://goodrx.com/role/DebtScheduleofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r55",
      "r61",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r70",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r232",
      "r233",
      "r234",
      "r235",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r281",
      "r554",
      "r555",
      "r561",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r794",
      "r976",
      "r977",
      "r979",
      "r983",
      "r1023",
      "r1024",
      "r1025",
      "r1099",
      "r1101",
      "r1113"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://goodrx.com/role/DebtAdditionalInformationDetails",
      "http://goodrx.com/role/DebtScheduleofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r27",
      "r28",
      "r29",
      "r55",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r70",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r232",
      "r233",
      "r234",
      "r235",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r245",
      "r281",
      "r485",
      "r554",
      "r555",
      "r561",
      "r574",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r794",
      "r976",
      "r977",
      "r979",
      "r983",
      "r1099",
      "r1101"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "crdr": "debit",
     "presentation": [
      "http://goodrx.com/role/DebtScheduleofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Unamortized debt issuance costs and discounts",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r248",
      "r532",
      "r533",
      "r534",
      "r725",
      "r726",
      "r794"
     ]
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets, net",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r378",
      "r379"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r33",
      "r976",
      "r982"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r1013",
      "r1018"
     ]
    },
    "gdrx_DescriptionOfBusinessAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "DescriptionOfBusinessAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description Of Business [Abstract]",
        "label": "Description Of Business [Abstract]",
        "documentation": "Description of business."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://goodrx.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation Of Revenue [Line Items]",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r318",
      "r319",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://goodrx.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation Of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r318",
      "r319",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://goodrx.com/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r1046"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentType",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "gdrx_EarningPerShareBasicAndDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "EarningPerShareBasicAndDilutedAbstract",
     "presentation": [
      "http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings per share:",
        "label": "Earning Per Share Basic And Diluted Abstract",
        "documentation": "Earning per share basic and diluted abstract."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings per share:",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in usd per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r90",
      "r108",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r123",
      "r125",
      "r131",
      "r132",
      "r133",
      "r138",
      "r189",
      "r251",
      "r325",
      "r371",
      "r398",
      "r464",
      "r502",
      "r503",
      "r570",
      "r591",
      "r709"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in usd per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r90",
      "r108",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r125",
      "r131",
      "r132",
      "r133",
      "r138",
      "r189",
      "r251",
      "r325",
      "r371",
      "r398",
      "r464",
      "r502",
      "r503",
      "r570",
      "r591",
      "r709"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://goodrx.com/role/BasicandDilutedEarningsPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic and Diluted Earnings Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r134",
      "r135",
      "r136",
      "r137",
      "r296"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://goodrx.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r381",
      "r745"
     ]
    },
    "gdrx_ElectronicCommunicationPrivacyActPrivacyProtectionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "ElectronicCommunicationPrivacyActPrivacyProtectionMember",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Electronic Communication Privacy Act, Privacy Protection",
        "label": "Electronic Communication Privacy Act, Privacy Protection [Member]",
        "documentation": "Electronic Communication Privacy Act, Privacy Protection"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Option",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "gdrx_EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Employee taxes paid related to net share settlement of equity awards",
        "label": "Employee Taxes Paid Related To Net Share Settlement Of Equity Awards",
        "documentation": "Employee taxes paid related to net share settlement of equity awards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r901"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnauditedParenthetical",
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45",
      "r50",
      "r78",
      "r79",
      "r87",
      "r88",
      "r89",
      "r105",
      "r106",
      "r107",
      "r109",
      "r116",
      "r118",
      "r120",
      "r140",
      "r174",
      "r175",
      "r188",
      "r189",
      "r190",
      "r250",
      "r280",
      "r285",
      "r286",
      "r287",
      "r290",
      "r292",
      "r295",
      "r323",
      "r324",
      "r326",
      "r327",
      "r371",
      "r387",
      "r388",
      "r395",
      "r396",
      "r397",
      "r399",
      "r463",
      "r464",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r501",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r535",
      "r540",
      "r550",
      "r554",
      "r555",
      "r564",
      "r565",
      "r577",
      "r590",
      "r602",
      "r603",
      "r604",
      "r619",
      "r678",
      "r1045"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Domain]",
        "label": "Investment, Name [Domain]",
        "documentation": "Name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r171",
      "r172",
      "r394",
      "r522",
      "r904",
      "r905",
      "r906",
      "r1076",
      "r1077",
      "r1078",
      "r1079"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity method investment, ownership percentage",
        "label": "Equity Method Investment, Ownership Percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r522"
     ]
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity investments included in other assets",
        "label": "Equity Method Investments",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r153",
      "r163",
      "r169",
      "r916",
      "r1003"
     ]
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EquityMethodInvestmentsPolicy",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Investments",
        "label": "Equity Method Investments [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r171",
      "r522"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r866"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r824",
      "r834",
      "r844",
      "r876"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r821",
      "r831",
      "r841",
      "r873"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r335",
      "r336",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r512",
      "r513",
      "r515",
      "r516",
      "r546",
      "r547",
      "r548",
      "r549",
      "r725",
      "r726",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r788",
      "r791",
      "r792",
      "r793"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Inputs, Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r328",
      "r333",
      "r335",
      "r506",
      "r513",
      "r516",
      "r546",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r788",
      "r792",
      "r793"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r335",
      "r336",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r512",
      "r513",
      "r515",
      "r516",
      "r546",
      "r547",
      "r548",
      "r549",
      "r725",
      "r726",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r788",
      "r791",
      "r792",
      "r793"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://goodrx.com/role/BusinessCombinationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Useful Life (in years)",
        "label": "Intangible Asset, Finite-Lived, Useful Life",
        "documentation": "Useful life of finite-lived intangible asset, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed."
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://goodrx.com/role/BusinessCombinationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Asset, Finite-Lived, Class",
        "label": "Intangible Asset, Finite-Lived, Class [Axis]",
        "documentation": "Information by class of finite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r181",
      "r183",
      "r184",
      "r185",
      "r186",
      "r552",
      "r553",
      "r609",
      "r693",
      "r695",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r1016",
      "r1164",
      "r1165",
      "r1166"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://goodrx.com/role/BusinessCombinationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Asset, Finite-Lived, Class",
        "label": "Intangible Asset, Finite-Lived, Class [Domain]",
        "documentation": "Class of finite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r181",
      "r183",
      "r184",
      "r185",
      "r186",
      "r609",
      "r693",
      "r695",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r1016",
      "r1164",
      "r1165",
      "r1166"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, net",
        "label": "Intangible Asset, Finite-Lived, after Accumulated Amortization",
        "documentation": "Amount, after accumulated amortization, of finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed."
       }
      }
     },
     "auth_ref": [
      "r552",
      "r1012"
     ]
    },
    "gdrx_FirstLienCreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "FirstLienCreditAgreementMember",
     "presentation": [
      "http://goodrx.com/role/DebtAdditionalInformationDetails",
      "http://goodrx.com/role/DebtScheduleofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First Lien Credit Agreement",
        "label": "First Lien Credit Agreement [Member]",
        "documentation": "First lien credit agreement."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r828",
      "r838",
      "r848",
      "r880"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r828",
      "r838",
      "r848",
      "r880"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r828",
      "r838",
      "r848",
      "r880"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r828",
      "r838",
      "r848",
      "r880"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r828",
      "r838",
      "r848",
      "r880"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "gdrx_FranciscoPartnersStockPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "FranciscoPartnersStockPurchaseAgreementMember",
     "presentation": [
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Francisco Partners Stock Purchase Agreement",
        "label": "Francisco Partners Stock Purchase Agreement [Member]",
        "documentation": "Francisco Partners Stock Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r662"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/BusinessCombinationDetails",
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r57",
      "r176",
      "r554",
      "r555",
      "r556",
      "r716",
      "r718",
      "r746",
      "r750",
      "r751",
      "r783",
      "r789",
      "r796",
      "r1005",
      "r1006",
      "r1087"
     ]
    },
    "gdrx_IdeaMenLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "IdeaMenLLCMember",
     "presentation": [
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Idea Men, LLC",
        "label": "Idea Men, LLC [Member]",
        "documentation": "Idea Men, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of Long-Lived Assets",
        "label": "Long-Lived Asset, Excluding Intangible Asset and Goodwill, Impairment and Disposal [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r1021"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r25",
      "r571",
      "r573",
      "r588",
      "r696",
      "r704",
      "r706",
      "r707",
      "r712",
      "r715",
      "r991",
      "r998",
      "r999",
      "r1000",
      "r1001"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://goodrx.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r101",
      "r377",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r389",
      "r391",
      "r392",
      "r393",
      "r578",
      "r608",
      "r618",
      "r745"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income tax expense",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r34",
      "r96",
      "r119",
      "r120",
      "r139",
      "r152",
      "r163",
      "r380",
      "r381",
      "r390",
      "r592",
      "r696",
      "r704",
      "r706",
      "r707",
      "r745"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other current liabilities",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "gdrx_IncreaseDecreaseInPrescriptionReimbursableLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "IncreaseDecreaseInPrescriptionReimbursableLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prescription reimbursement liabilities",
        "label": "Increase (Decrease) in Prescription Reimbursable Liabilities",
        "documentation": "Increase (Decrease) in Prescription Reimbursable Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "gdrx_IncreaseDecreaseInPrescriptionReimbursementAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "IncreaseDecreaseInPrescriptionReimbursementAssets",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Prescription reimbursement assets",
        "label": "Increase (Decrease) in Prescription Reimbursement Assets",
        "documentation": "Increase (Decrease) in Prescription Reimbursement Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "gdrx_IncreaseDecreaseOperatingLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "IncreaseDecreaseOperatingLeaseLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Increase Decrease Operating Lease Liabilities",
        "documentation": "Increase (decrease) operating lease liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "calculation": {
      "http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dilutive impact of stock options and restricted stock units (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r127",
      "r128",
      "r133",
      "r341"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r828",
      "r838",
      "r848",
      "r872",
      "r880",
      "r884",
      "r892"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r820",
      "r896"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r820",
      "r896"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r820",
      "r896"
     ]
    },
    "us-gaap_InsuranceSettlementsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "InsuranceSettlementsReceivable",
     "crdr": "debit",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance recovery receivable",
        "label": "Insurance Settlements Receivable",
        "documentation": "Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy."
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r704",
      "r707",
      "r929"
     ]
    },
    "us-gaap_InterestIncomeOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "InterestIncomeOther",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Interest Income, Other",
        "documentation": "Amount of interest income earned from interest bearing assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r706"
     ]
    },
    "us-gaap_LetterOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LetterOfCreditMember",
     "presentation": [
      "http://goodrx.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Letter of Credit",
        "label": "Letter of Credit [Member]",
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)."
       }
      }
     },
     "auth_ref": [
      "r1114"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r48",
      "r96",
      "r99",
      "r100",
      "r173",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r291",
      "r466",
      "r467",
      "r468",
      "r522",
      "r638",
      "r711",
      "r729",
      "r815",
      "r927",
      "r1035",
      "r1103",
      "r1104"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders' equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r554",
      "r555",
      "r567",
      "r585",
      "r796",
      "r803",
      "r804",
      "r976",
      "r981",
      "r1004",
      "r1098"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and stockholders' equity",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r48",
      "r49",
      "r63",
      "r96",
      "r99",
      "r100",
      "r173",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r291",
      "r466",
      "r467",
      "r468",
      "r522",
      "r796",
      "r1035",
      "r1103",
      "r1104"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://goodrx.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of amount outstanding",
        "label": "Long-Term Line of Credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r915",
      "r920",
      "r1108",
      "r1109",
      "r1110",
      "r1115"
     ]
    },
    "gdrx_LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension",
     "crdr": "credit",
     "presentation": [
      "http://goodrx.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount subject to maturity extension",
        "label": "Line of Credit Facility, Borrowing Capacity, Subject to Maturity Extension",
        "documentation": "Line of Credit Facility, Borrowing Capacity, Subject to Maturity Extension"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LineOfCreditFacilityInterestRateDuringPeriod",
     "presentation": [
      "http://goodrx.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate on used amounts",
        "label": "Line of Credit Facility, Interest Rate During Period",
        "documentation": "The effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r914",
      "r917"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://goodrx.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r914",
      "r917"
     ]
    },
    "gdrx_LineOfCreditMaximumFinancialCovenantNetLeverageRatio": {
     "xbrltype": "percentItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "LineOfCreditMaximumFinancialCovenantNetLeverageRatio",
     "presentation": [
      "http://goodrx.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum net leverage ratio",
        "label": "Line Of Credit Maximum Financial Covenant Net Leverage Ratio",
        "documentation": "Line of credit maximum financial covenant net leverage ratio."
       }
      }
     },
     "auth_ref": []
    },
    "srt_LitigationCaseAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "LitigationCaseAxis",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation Case [Axis]",
        "label": "Litigation Case [Axis]",
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim."
       }
      }
     },
     "auth_ref": [
      "r1030",
      "r1032"
     ]
    },
    "srt_LitigationCaseTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "LitigationCaseTypeDomain",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation Case [Domain]",
        "label": "Litigation Case [Domain]",
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information."
       }
      }
     },
     "auth_ref": [
      "r1030",
      "r1032"
     ]
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "crdr": "credit",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Settlement payment",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "documentation": "Amount awarded to other party in judgment or settlement of litigation."
       }
      }
     },
     "auth_ref": [
      "r1028"
     ]
    },
    "us-gaap_LitigationStatusAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LitigationStatusAxis",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation Status [Axis]",
        "label": "Litigation Status [Axis]",
        "documentation": "Information by status of pending, threatened, or settled litigation."
       }
      }
     },
     "auth_ref": [
      "r1023",
      "r1024",
      "r1025",
      "r1028"
     ]
    },
    "us-gaap_LitigationStatusDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LitigationStatusDomain",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation Status [Domain]",
        "label": "Litigation Status [Domain]",
        "documentation": "Status of pending, threatened, or settled litigation."
       }
      }
     },
     "auth_ref": [
      "r1023",
      "r1024",
      "r1025",
      "r1028"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://goodrx.com/role/DebtScheduleofDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total debt",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r104",
      "r233",
      "r249",
      "r554",
      "r555",
      "r561",
      "r574",
      "r725",
      "r726",
      "r794",
      "r915",
      "r920",
      "r1115"
     ]
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current portion of debt",
        "label": "Long-Term Debt, Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r701",
      "r702"
     ]
    },
    "us-gaap_LongTermDebtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LongTermDebtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://goodrx.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of debt",
        "label": "Long-Term Debt, Fair Value",
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission."
       }
      }
     },
     "auth_ref": [
      "r792",
      "r793",
      "r1089",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt, net",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r915",
      "r920"
     ]
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingency Nature [Axis]",
        "label": "Loss Contingency Nature [Axis]",
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r194",
      "r205",
      "r206",
      "r207",
      "r208",
      "r374",
      "r607",
      "r723",
      "r1029",
      "r1031"
     ]
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Line Items]",
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r194",
      "r205",
      "r206",
      "r207",
      "r208",
      "r374",
      "r607",
      "r723",
      "r1029",
      "r1031"
     ]
    },
    "us-gaap_LossContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LossContingenciesTable",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Table]",
        "label": "Loss Contingencies [Table]",
        "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r194",
      "r205",
      "r206",
      "r207",
      "r208",
      "r374",
      "r607",
      "r723",
      "r1029",
      "r1031"
     ]
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LossContingencyAccrualAtCarryingValue",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": "gdrx_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails",
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued legal settlement",
        "label": "Loss Contingency Accrual",
        "documentation": "Amount of loss contingency liability."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r903"
     ]
    },
    "us-gaap_LossContingencyNatureDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LossContingencyNatureDomain",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingency, Nature [Domain]",
        "label": "Loss Contingency, Nature [Domain]",
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r194",
      "r205",
      "r206",
      "r207",
      "r208",
      "r374",
      "r607",
      "r723",
      "r1029",
      "r1031"
     ]
    },
    "us-gaap_LossContingencyNumberOfDefendants": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LossContingencyNumberOfDefendants",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of defendants",
        "label": "Loss Contingency, Number of Defendants",
        "documentation": "Number of defendants named in a legal action."
       }
      }
     },
     "auth_ref": [
      "r1029",
      "r1031"
     ]
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LossContingencyNumberOfPlaintiffs",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of plaintiffs",
        "label": "Loss Contingency, Number of Plaintiffs",
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency."
       }
      }
     },
     "auth_ref": [
      "r1029",
      "r1031"
     ]
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LossContingencyPendingClaimsNumber",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pending claims",
        "label": "Loss Contingency, Pending Claims, Number",
        "documentation": "Number of pending claims pertaining to a loss contingency."
       }
      }
     },
     "auth_ref": [
      "r1029",
      "r1031"
     ]
    },
    "gdrx_LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss on operating lease asset",
        "label": "Loss On Abandonment And Impairment Of Operating Lease Assets",
        "documentation": "Loss On Abandonment And Impairment Of Operating Lease Assets"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Axis]",
        "label": "Customer [Axis]",
        "documentation": "Information by name or description of a single external customer or a group of external customers."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r730",
      "r733",
      "r798",
      "r801",
      "r1116",
      "r1120",
      "r1121",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1157",
      "r1158"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "gdrx_MinorityEquityInterestsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "MinorityEquityInterestsMember",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minority Equity Interests",
        "label": "Minority Equity Interests [Member]",
        "documentation": "Minority Equity Interests."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money Market Funds",
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r1047",
      "r1048"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "gdrx_NDCAClassActionMatterMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "NDCAClassActionMatterMember",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NDCA Class Action Matter",
        "label": "NDCA Class Action Matter [Member]",
        "documentation": "NDCA Class Action Matter"
       }
      }
     },
     "auth_ref": []
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Domain]",
        "label": "Customer [Domain]",
        "documentation": "Single external customer or group of external customers."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r730",
      "r733",
      "r798",
      "r801",
      "r1116",
      "r1120",
      "r1121",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1157",
      "r1158"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r22"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income",
        "terseLabel": "Net income",
        "verboseLabel": "Net income",
        "netLabel": "Net income",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r22",
      "r26",
      "r45",
      "r47",
      "r48",
      "r85",
      "r86",
      "r89",
      "r96",
      "r99",
      "r100",
      "r103",
      "r108",
      "r112",
      "r113",
      "r114",
      "r115",
      "r116",
      "r119",
      "r120",
      "r130",
      "r173",
      "r189",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r251",
      "r254",
      "r257",
      "r262",
      "r291",
      "r325",
      "r371",
      "r398",
      "r464",
      "r503",
      "r522",
      "r589",
      "r659",
      "r676",
      "r677",
      "r704",
      "r706",
      "r707",
      "r814",
      "r1035"
     ]
    },
    "us-gaap_NetIncomeLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NetIncomeLossAbstract",
     "presentation": [
      "http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator:",
        "label": "Net Income (Loss) Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recent Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "gdrx_NewRepurchaseProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "NewRepurchaseProgramMember",
     "presentation": [
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Repurchase Program",
        "label": "New Repurchase Program [Member]",
        "documentation": "New Repurchase Program"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r828",
      "r838",
      "r848",
      "r872",
      "r880"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "gdrx_NoncashStockBasedCompensationIncludedInCapitalizedSoftware": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "NoncashStockBasedCompensationIncludedInCapitalizedSoftware",
     "crdr": "debit",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation included in capitalized software",
        "label": "Noncash Stock Based Compensation Included In Capitalized Software",
        "documentation": "Noncash stock-based compensation included in capitalized software development costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other expense, net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r910",
      "r911",
      "r1004"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other expense, net:",
        "label": "Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r716",
      "r997"
     ]
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating income",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r704",
      "r707",
      "r712",
      "r910",
      "r911",
      "r991",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1004"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities, current",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r537",
      "r700"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities, net of current portion",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets, net",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash operating lease expense",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r973"
     ]
    },
    "gdrx_OperatingLeaseRightOfUseAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "OperatingLeaseRightOfUseAssetsMember",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease Right Of Use Assets",
        "label": "Operating Lease Right Of Use Assets [Member]",
        "documentation": "Operating Lease Right Of Use Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": "gdrx_AccruedExpensesAndOtherCurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesSummaryofAccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other accrued expenses",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r919"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r58"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r921"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r784"
     ]
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Other Item",
        "documentation": "Amount of cash inflow (outflow) from operating activity, classified as other, in reconciling net income to reflect cash provided by (used in) operating activity when indirect cash flow method is applied."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "gdrx_OtherRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "OtherRevenueMember",
     "presentation": [
      "http://goodrx.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other revenue",
        "label": "Other Revenue [Member]",
        "documentation": "Other revenue."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r826",
      "r836",
      "r846",
      "r878"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r829",
      "r839",
      "r849",
      "r881"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r829",
      "r839",
      "r849",
      "r881"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables and Accruals [Abstract]",
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PaymentsForLegalSettlements",
     "crdr": "credit",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment for settlements",
        "label": "Payments for Legal Settlements",
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchases of Class A common stock",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_PaymentsForSoftware": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PaymentsForSoftware",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Capitalized software",
        "label": "Payments for Software",
        "documentation": "The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/BusinessCombinationDetails",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Acquisition",
        "verboseLabel": "Cash consideration",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "us-gaap_PendingLitigationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PendingLitigationMember",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pending Litigation",
        "label": "Pending Litigation [Member]",
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process."
       }
      }
     },
     "auth_ref": [
      "r1028"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "gdrx_PharmaManufacturerSolutionsRevenuesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "PharmaManufacturerSolutionsRevenuesMember",
     "presentation": [
      "http://goodrx.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pharma Direct revenue",
        "label": "Pharma Manufacturer Solutions Revenues [member]",
        "documentation": "Pharma Manufacturer Solutions Revenues [member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r900"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in usd per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r267",
      "r913",
      "r922",
      "r1039",
      "r1108",
      "r1109",
      "r1111"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r78",
      "r286",
      "r554",
      "r555",
      "r564",
      "r640"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r78",
      "r267",
      "r286",
      "r554",
      "r555",
      "r564"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r78",
      "r286",
      "r554",
      "r555",
      "r564",
      "r640",
      "r658",
      "r1037",
      "r1161",
      "r1162"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, $0.0001 par value; 50,000 shares authorized and nil shares issued and outstanding at June\u00a030, 2026 and December\u00a031, 2025",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r78",
      "r253",
      "r259",
      "r286",
      "r554",
      "r555",
      "r564",
      "r582",
      "r796"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    },
    "gdrx_PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prescription Reimbursement Assets and Prescription Reimbursement Liabilities",
        "label": "Prescription Reimbursement Assets and Prescription Reimbursement Liabilities [Policy Text Block]",
        "documentation": "Prescription Reimbursement Assets and Prescription Reimbursement Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "gdrx_PrescriptionReimbursementAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "PrescriptionReimbursementAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prescription reimbursement assets",
        "label": "Prescription Reimbursement Assets, Current",
        "documentation": "Prescription Reimbursement Assets, Current"
       }
      }
     },
     "auth_ref": []
    },
    "gdrx_PrescriptionReimbursementAssetsNumberOfCounterparties": {
     "xbrltype": "integerItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "PrescriptionReimbursementAssetsNumberOfCounterparties",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of counterparty",
        "label": "Prescription Reimbursement Assets, Number Of Counterparties",
        "documentation": "Prescription Reimbursement Assets, Number Of Counterparties"
       }
      }
     },
     "auth_ref": []
    },
    "gdrx_PrescriptionReimbursementLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "PrescriptionReimbursementLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prescription reimbursement liabilities",
        "label": "Prescription Reimbursement Liabilities, Current",
        "documentation": "Prescription Reimbursement Liabilities, Current"
       }
      }
     },
     "auth_ref": []
    },
    "gdrx_PrescriptionTransactionsRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "PrescriptionTransactionsRevenueMember",
     "presentation": [
      "http://goodrx.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prescription transactions revenue",
        "label": "Prescription Transactions Revenue [Member]",
        "documentation": "Prescription transactions revenue."
       }
      }
     },
     "auth_ref": []
    },
    "gdrx_PrivacyProtectionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "PrivacyProtectionMember",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Privacy Protection",
        "label": "Privacy Protection [Member]",
        "documentation": "Privacy Protection"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of stock options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r6"
     ]
    },
    "us-gaap_ProceedsFromStockPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ProceedsFromStockPlans",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from employee stock purchase plan",
        "label": "Proceeds from Stock Plans",
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://goodrx.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service",
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r165",
      "r551",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r694",
      "r703",
      "r706",
      "r707",
      "r730",
      "r731",
      "r797",
      "r799",
      "r800",
      "r802",
      "r805",
      "r908",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r1032",
      "r1033",
      "r1116",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://goodrx.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service",
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r165",
      "r551",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r694",
      "r703",
      "r706",
      "r707",
      "r730",
      "r731",
      "r797",
      "r799",
      "r800",
      "r802",
      "r805",
      "r908",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r1032",
      "r1033",
      "r1116",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Asset, Class [Axis]",
        "label": "Long-Lived Asset, Class [Axis]",
        "documentation": "Information by class of long-lived asset. Includes, but is not limited to, property, plant, and equipment; right-of-use asset from finance lease; long-lived asset of lessor subject to operating lease; proved oil and gas property accounted for under successful efforts method; and long-term prepaid asset."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r192",
      "r539",
      "r719",
      "r720",
      "r721",
      "r722",
      "r1016",
      "r1017",
      "r1106"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "label": "Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization",
        "documentation": "Amount, after accumulated depreciation, depletion, and amortization, of property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection."
       }
      }
     },
     "auth_ref": [
      "r539",
      "r554",
      "r555",
      "r569",
      "r575",
      "r576",
      "r587",
      "r796",
      "r1019"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Asset, Class [Domain]",
        "label": "Long-Lived Asset, Class [Domain]",
        "documentation": "Class of long-lived asset. Includes, but is not limited to, property, plant, and equipment; right-of-use asset from finance lease; long-lived asset of lessor subject to operating lease; proved oil and gas property accounted for under successful efforts method; and long-term prepaid asset."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r192",
      "r539",
      "r719",
      "r720",
      "r721",
      "r722",
      "r1016",
      "r1017",
      "r1106"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r821",
      "r831",
      "r841",
      "r873"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnauditedParenthetical",
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party, Type [Domain]",
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r55",
      "r60",
      "r69",
      "r71",
      "r96",
      "r102",
      "r103",
      "r168",
      "r334",
      "r337",
      "r541",
      "r542",
      "r554",
      "r555",
      "r559",
      "r560",
      "r561",
      "r568",
      "r580",
      "r586",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r657",
      "r683",
      "r698",
      "r1160",
      "r1163"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnauditedParenthetical",
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party",
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r55",
      "r60",
      "r69",
      "r71",
      "r96",
      "r102",
      "r103",
      "r541",
      "r542",
      "r543",
      "r544",
      "r554",
      "r555",
      "r561",
      "r580",
      "r586",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r657",
      "r683"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Axis]",
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r102",
      "r103",
      "r541",
      "r542",
      "r1102"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Domain]",
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r102",
      "r103",
      "r1102"
     ]
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnauditedParenthetical",
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party, Type [Axis]",
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r55",
      "r60",
      "r69",
      "r71",
      "r96",
      "r102",
      "r103",
      "r168",
      "r334",
      "r337",
      "r541",
      "r542",
      "r554",
      "r555",
      "r559",
      "r560",
      "r561",
      "r568",
      "r580",
      "r586",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r657",
      "r683",
      "r698",
      "r1102",
      "r1160",
      "r1163"
     ]
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RepaymentsOfLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments on long-term debt",
        "label": "Repayments of Long-Term Debt",
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r616"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product development and technology",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r693",
      "r704",
      "r705",
      "r715",
      "r1107"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r822",
      "r832",
      "r842",
      "r874"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r823",
      "r833",
      "r843",
      "r875"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r830",
      "r840",
      "r850",
      "r882"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r81",
      "r288",
      "r554",
      "r555",
      "r566",
      "r584",
      "r605",
      "r606",
      "r617",
      "r641",
      "r796"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45",
      "r105",
      "r106",
      "r107",
      "r109",
      "r116",
      "r118",
      "r120",
      "r174",
      "r175",
      "r188",
      "r189",
      "r190",
      "r250",
      "r285",
      "r295",
      "r323",
      "r324",
      "r326",
      "r327",
      "r371",
      "r387",
      "r388",
      "r395",
      "r396",
      "r397",
      "r399",
      "r463",
      "r464",
      "r486",
      "r487",
      "r488",
      "r489",
      "r491",
      "r492",
      "r494",
      "r501",
      "r535",
      "r550",
      "r577",
      "r602",
      "r604",
      "r619",
      "r1042",
      "r1044",
      "r1161"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer [Abstract]",
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://goodrx.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r149",
      "r150",
      "r161",
      "r163",
      "r165",
      "r166",
      "r167",
      "r317",
      "r318",
      "r319",
      "r551",
      "r704",
      "r707"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RevenueFromContractWithCustomerMember",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer Benchmark",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r993",
      "r994"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://goodrx.com/role/Revenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r308",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r319",
      "r322"
     ]
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://goodrx.com/role/DebtAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving Credit Facility",
        "label": "Revolving Credit Facility [Member]",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for operating lease liabilities",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r538",
      "r795",
      "r974"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "gdrx_SDFLClassActionMatterMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "SDFLClassActionMatterMember",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SDFL Class Action Matter",
        "label": "SDFL Class Action Matter [Member]",
        "documentation": "SDFL Class Action Matter"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://goodrx.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Expenses and Other Current Liabilities",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleofWeightedAveragePotentiallyDilutiveSharesareExcludedfromComputationofDilutedLossEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://goodrx.com/role/BasicandDilutedEarningsPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Weighted-Average Potentially Dilutive Shares are Excluded from Computation of Diluted (Loss) Earnings Per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r990"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://goodrx.com/role/BusinessCombinationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]",
        "label": "Business Combination [Table]",
        "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r401",
      "r402",
      "r403",
      "r404",
      "r410",
      "r411",
      "r412",
      "r413",
      "r419",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r455",
      "r456",
      "r457",
      "r461",
      "r746",
      "r755",
      "r1081",
      "r1083",
      "r1085"
     ]
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://goodrx.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Debt",
        "label": "Schedule of Debt [Table Text Block]",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://goodrx.com/role/BasicandDilutedEarningsPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Computation of (Loss) Earnings Per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r989"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Axis]",
        "label": "Investment, Name [Axis]",
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r171",
      "r172",
      "r394",
      "r522",
      "r904",
      "r905",
      "r906",
      "r1076",
      "r1077",
      "r1078",
      "r1079"
     ]
    },
    "us-gaap_ScheduleOfRepurchaseAgreements": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfRepurchaseAgreements",
     "presentation": [
      "http://goodrx.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Repurchase Agreements",
        "label": "Schedule of Repurchase Agreements [Table Text Block]",
        "documentation": "The entire disclosure for repurchase agreements."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://goodrx.com/role/StockholdersEquityScheduleofRepurchaseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r340",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r370"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Security12bTitle",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r164",
      "r166",
      "r713",
      "r714",
      "r717"
     ]
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales and marketing",
        "label": "Selling and Marketing Expense",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SettledLitigationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SettledLitigationMember",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Settled Litigation",
        "label": "Settled Litigation [Member]",
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval."
       }
      }
     },
     "auth_ref": [
      "r1028"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://goodrx.com/role/StockholdersEquityScheduleofRepurchaseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r340",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r370"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Award Types",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SharePrice",
     "presentation": [
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock price (in usd per share)",
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ShareRepurchaseProgramAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "ShareRepurchaseProgramAxis",
     "presentation": [
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Repurchase Program [Axis]",
        "label": "Share Repurchase Program [Axis]",
        "documentation": "Information by share repurchase program."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "srt_ShareRepurchaseProgramDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "ShareRepurchaseProgramDomain",
     "presentation": [
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Repurchase Program [Domain]",
        "label": "Share Repurchase Program [Domain]",
        "documentation": "Name of share repurchase program."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r1037",
      "r1042",
      "r1044"
     ]
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Common stock withheld related to net share settlement (in shares)",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1075"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r95"
     ]
    },
    "gdrx_SpectrumStockPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "SpectrumStockPurchaseAgreementMember",
     "presentation": [
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Spectrum Stock Purchase Agreement",
        "label": "Spectrum Stock Purchase Agreement [Member]",
        "documentation": "Spectrum Stock Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited",
      "http://goodrx.com/role/Cover",
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails",
      "http://goodrx.com/role/StockholdersEquityScheduleofRepurchaseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r50",
      "r51",
      "r74",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r96",
      "r100",
      "r125",
      "r129",
      "r131",
      "r133",
      "r141",
      "r142",
      "r173",
      "r211",
      "r213",
      "r214",
      "r215",
      "r218",
      "r219",
      "r252",
      "r253",
      "r255",
      "r256",
      "r258",
      "r261",
      "r264",
      "r265",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r274",
      "r277",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r286",
      "r287",
      "r290",
      "r291",
      "r292",
      "r522",
      "r554",
      "r555",
      "r563",
      "r564",
      "r565",
      "r577",
      "r613",
      "r614",
      "r615",
      "r616",
      "r619",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r640",
      "r660",
      "r678",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r902",
      "r978",
      "r980",
      "r988",
      "r1043",
      "r1045"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnauditedParenthetical",
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r45",
      "r50",
      "r78",
      "r79",
      "r87",
      "r88",
      "r89",
      "r105",
      "r106",
      "r107",
      "r109",
      "r116",
      "r118",
      "r120",
      "r140",
      "r174",
      "r175",
      "r188",
      "r189",
      "r190",
      "r250",
      "r280",
      "r285",
      "r286",
      "r287",
      "r290",
      "r292",
      "r295",
      "r323",
      "r324",
      "r326",
      "r327",
      "r371",
      "r387",
      "r388",
      "r395",
      "r396",
      "r397",
      "r399",
      "r463",
      "r464",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r501",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r535",
      "r540",
      "r550",
      "r554",
      "r555",
      "r564",
      "r565",
      "r577",
      "r590",
      "r602",
      "r603",
      "r604",
      "r619",
      "r678",
      "r1045"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementLineItems",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnauditedParenthetical",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r51",
      "r54",
      "r55",
      "r60",
      "r69",
      "r71",
      "r74",
      "r77",
      "r78",
      "r79",
      "r81",
      "r105",
      "r106",
      "r107",
      "r140",
      "r252",
      "r253",
      "r255",
      "r258",
      "r264",
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r294",
      "r295",
      "r305",
      "r535",
      "r551",
      "r554",
      "r555",
      "r563",
      "r564",
      "r565",
      "r612",
      "r620",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r640",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r661",
      "r662",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r678",
      "r698",
      "r706",
      "r707",
      "r809",
      "r1160"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionLocationBalanceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementOfFinancialPositionLocationBalanceAxis",
     "presentation": [
      "http://goodrx.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Location, Statement of Financial Position, Balance [Axis]",
        "label": "Location, Statement of Financial Position, Balance [Axis]",
        "documentation": "Information by location in statement of financial position line item where disaggregated cumulative balance is reported."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r469",
      "r471",
      "r472",
      "r473",
      "r474",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r521",
      "r785",
      "r786",
      "r1117",
      "r1118"
     ]
    },
    "us-gaap_StatementOfIncomeLocationBalanceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementOfIncomeLocationBalanceAxis",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location",
        "label": "Location, Statement of Income, Balance [Axis]",
        "documentation": "Information by location in statement of income line item where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r200",
      "r201",
      "r202",
      "r470",
      "r475",
      "r476",
      "r484",
      "r510",
      "r511",
      "r514",
      "r523",
      "r524",
      "r525",
      "r600",
      "r601",
      "r663",
      "r693",
      "r746",
      "r751",
      "r786",
      "r787",
      "r790",
      "r792",
      "r793",
      "r1080",
      "r1082",
      "r1119"
     ]
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementTable",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsParentheticalUnaudited",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnauditedParenthetical",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r50",
      "r51",
      "r54",
      "r55",
      "r60",
      "r69",
      "r71",
      "r74",
      "r77",
      "r78",
      "r79",
      "r81",
      "r105",
      "r106",
      "r107",
      "r140",
      "r168",
      "r252",
      "r253",
      "r255",
      "r258",
      "r264",
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r294",
      "r295",
      "r305",
      "r535",
      "r551",
      "r554",
      "r555",
      "r563",
      "r564",
      "r565",
      "r577",
      "r612",
      "r620",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r640",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r661",
      "r662",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r678",
      "r698",
      "r706",
      "r707",
      "r809",
      "r1160"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r825",
      "r835",
      "r845",
      "r877"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock through employee stock purchase plan (in shares)",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r913",
      "r922",
      "r923",
      "r1037",
      "r1039",
      "r1040",
      "r1042",
      "r1044",
      "r1108",
      "r1109",
      "r1111",
      "r1112"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r913",
      "r922",
      "r923",
      "r1037",
      "r1039",
      "r1040",
      "r1042",
      "r1044",
      "r1108",
      "r1109",
      "r1111",
      "r1112"
     ]
    },
    "gdrx_StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting and settlement of restricted stock units (in shares)",
        "label": "Stock Issued During Period Shares Vesting Of Restricted Stock Units",
        "documentation": "Stock issued during period shares, vesting of restricted stock units."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "crdr": "credit",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock through employee stock purchase plan",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r913",
      "r922",
      "r923",
      "r1037",
      "r1039",
      "r1040",
      "r1042",
      "r1044",
      "r1108",
      "r1109",
      "r1111",
      "r1112"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options exercised",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r913",
      "r922",
      "r923",
      "r1037",
      "r1039",
      "r1040",
      "r1042",
      "r1044",
      "r1108",
      "r1109",
      "r1111",
      "r1112"
     ]
    },
    "gdrx_StockOptionsAndRestrictedStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "StockOptionsAndRestrictedStockUnitsMember",
     "presentation": [
      "http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleofWeightedAveragePotentiallyDilutiveSharesareExcludedfromComputationofDilutedLossEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options and restricted stock units",
        "label": "Stock Options and Restricted Stock Units [Member]",
        "documentation": "Stock Options and Restricted Stock Units"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase agreement, authorized amount",
        "label": "Share Repurchase Program, Authorized, Amount",
        "documentation": "Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "crdr": "credit",
     "presentation": [
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program, available for future repurchases",
        "label": "Share Repurchase Program, Remaining Authorized, Amount",
        "documentation": "Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://goodrx.com/role/StockholdersEquityScheduleofRepurchaseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchases of Class A common stock (in shares)",
        "terseLabel": "Number of shares repurchased (in shares)",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "documentation": "Number of shares that have been repurchased and retired during the period."
       }
      }
     },
     "auth_ref": [
      "r913",
      "r922",
      "r923",
      "r1037",
      "r1039",
      "r1040",
      "r1042",
      "r1044",
      "r1108",
      "r1109",
      "r1111",
      "r1112"
     ]
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited",
      "http://goodrx.com/role/StockholdersEquityScheduleofRepurchaseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchases of Class A common stock",
        "terseLabel": "Cost of shares repurchased",
        "label": "Stock Repurchased and Retired During Period, Value",
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital)."
       }
      }
     },
     "auth_ref": [
      "r913",
      "r922",
      "r923",
      "r1037",
      "r1039",
      "r1040",
      "r1042",
      "r1044",
      "r1108",
      "r1109",
      "r1111",
      "r1112"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders' equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r642",
      "r658",
      "r679",
      "r680",
      "r796",
      "r815",
      "r927",
      "r976",
      "r980",
      "r981",
      "r1004",
      "r1098",
      "r1161"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' equity",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://goodrx.com/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders Equity",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r78",
      "r79",
      "r82",
      "r263",
      "r266",
      "r268",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r281",
      "r286",
      "r287",
      "r290",
      "r292",
      "r293",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r485",
      "r499",
      "r500",
      "r545",
      "r681",
      "r682",
      "r689"
     ]
    },
    "gdrx_SubscriptionRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "SubscriptionRevenueMember",
     "presentation": [
      "http://goodrx.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subscription revenue",
        "label": "Subscription Revenue [Member]",
        "documentation": "Subscription Revenue [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of cash flow information",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "us-gaap_TangibleAssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "TangibleAssetImpairmentCharges",
     "crdr": "debit",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment loss",
        "label": "Tangible Asset Impairment Charges",
        "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value."
       }
      }
     },
     "auth_ref": [
      "r1020"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "TradingSymbol",
     "presentation": [
      "http://goodrx.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r895"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "presentation": [
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repurchased shares (in usd per share)",
        "label": "Shares Acquired, Average Cost Per Share",
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "TreasuryStockSharesAcquired",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnauditedParenthetical",
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repurchased shares (in shares)",
        "label": "Treasury Stock, Shares, Acquired",
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury."
       }
      }
     },
     "auth_ref": [
      "r923",
      "r1037",
      "r1040",
      "r1042",
      "r1044",
      "r1108",
      "r1109",
      "r1111",
      "r1112"
     ]
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "crdr": "debit",
     "presentation": [
      "http://goodrx.com/role/CondensedConsolidatedStatementsofCashFlowsUnauditedParenthetical",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofStockholdersEquityUnauditedParenthetical",
      "http://goodrx.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares repurchased",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method."
       }
      }
     },
     "auth_ref": [
      "r913",
      "r922",
      "r923",
      "r1037",
      "r1039",
      "r1040",
      "r1042",
      "r1044"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://goodrx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r143",
      "r145",
      "r146",
      "r147",
      "r571",
      "r573",
      "r710"
     ]
    },
    "gdrx_VitacarePrescriptionServicesIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "VitacarePrescriptionServicesIncMember",
     "presentation": [
      "http://goodrx.com/role/BusinessCombinationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "VitaCare Prescription Services, Inc",
        "label": "VitaCare Prescription Services Inc [Member]",
        "documentation": "vitaCare prescription services inc member."
       }
      }
     },
     "auth_ref": []
    },
    "gdrx_VividRxClearRxIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://goodrx.com/20260630",
     "localname": "VividRxClearRxIncMember",
     "presentation": [
      "http://goodrx.com/role/BusinessCombinationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "VividRx Clear Rx, Inc",
        "label": "VividRx Clear Rx, Inc [Member]",
        "documentation": "VividRx Clear Rx, Inc"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average shares - diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r133"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average shares used in computing earnings per share:",
        "verboseLabel": "Denominator:",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://goodrx.com/role/BasicandDilutedEarningsPerShareScheduleComputationofEarningsPerShareDetails",
      "http://goodrx.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average shares - basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r133"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21D",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-21D"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column A",
   "Publisher": "SEC"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "L",
   "Publisher": "SEC"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-10"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5A"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-11"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-13"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-6"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-7"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-8"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-9"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-28A"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-12"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-6"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-4"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-5"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482705/350-40-65-4"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482705/350-40-65-4"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482645/405-30-50-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-11"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480125/505-10-S35-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-2"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-3"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-4"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-8"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480070/505-10-S50-1"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480070/505-10-S50-6"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 4.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-5"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SAB Topic 5.Q.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-7"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481468/505-20-05-5"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479982/505-20-S25-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479982/505-20-S25-2"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S25",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479982/505-20-S25-3"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479951/505-20-S50-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479951/505-20-S50-2"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479951/505-20-S50-3"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 1.D.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479921/505-20-S99-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-2"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-11"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-7"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-2"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-2"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-3"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-3"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480454/718-10-45-1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/805-10/tableOfContent"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-4"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-5"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-7"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/805-20/tableOfContent"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-2"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-3"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/805-30/tableOfContent"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-3"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479326/805-40-45-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480339/815-10-65-8"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480339/815-10-65-8"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480339/815-10-65-8"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "45",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480865/815-45-50-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482804/825-20-50-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 1.B.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480148/855-10-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(cc)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-5"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477657/942-210-S45-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478478/942-210-S50-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13)(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(7)(e)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.9-06)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478443/942-360-45-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "405",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3A"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-9"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-6"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-3"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-3"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-3"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-3"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-29"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-29"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-38"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "39",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-39"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "45",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-45"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "46",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-46"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-29"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-29"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478064/805-740-55-13"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "181",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-181"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "184",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5A"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-11"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-8"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-9"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(r)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(s)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(t)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(u)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-30"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-31"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-32"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-33"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482558/350-40-50-1"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482222/360-10-30-2"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-2"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-3"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-4"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480070/505-10-S50-1"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480070/505-10-S50-2"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-4"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-2"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "905",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478704/905-360-25-4"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477657/942-210-S45-1"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478478/942-210-S50-1"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.9-06)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "970",
   "SubTopic": "810",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477383/970-810-45-1"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-1"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-1"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-1"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>58
<FILENAME>0001809519-26-000152-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001809519-26-000152-xbrl.zip
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MA)V!LLR-MEPU,^O,EQD(SV78@F9:>3:\0U>L!-G*([*_^?4B7K<*ZK2=#E_
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M5U?!>6:UJ@?9/E#2%!ML&6;;Q*ZF<^BRR<:#]C\BS1M3ACS P>V]=7;?AWP
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M]!MF)=3MM<X9.>Y>@_F9=/;:H)@0J.$>Y'@XM5+4MF'8907JA'B?G7*,6=1
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MINEV%%X(VG(T7S:S67.'NI]@UBQ$W5/H[@X@QQXJIO9VM5U%/!KYY3"XMV"
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MFMX<7\,I(I=>!]?MYX&O1V]/C&#U;%O7K\DH>A=?>ND8$*X#X(Y^?QR,/\R
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MHM"[FCJ>$5ZZG@NNIO"2T=28V\[;Y;5O&\Z0"0PW& 40#M/XW<#^$UQR5S.
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M[*RRQ5/G/QFN_2?^^SU!FK+O&-#E>)/A5 S<L0_L(\O<SA>.]X8J1_HD]+K
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M GQ,5A*-+CEF5)8)?8BW1G=JL&P>/$2UPP(I\SV(.WD5AP"#,1*6..\%MW]
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M.GACS_:*?(3.&K[@!4S@X"!( P%T#F(8:SLX$BK PJ,@0@SZ]ZB$)LUF7^7
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MG-!V[;I1\Y91Y.O='U[=6Q/]-16I6_6:O*8EX>1VL\/_QI4$V,^"X@75T1M
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MM.F@7"G=\DXS)])O9<;>WL1:)C9A4-C2'0GDQL0:"$H=JKR,J9HU*[<*DY#
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MLGMGM]0<:#HKM3$'O,J*!T.,K4DH>-I6%9/"<QQ;E7^P,2MV"&,)<W_@I<'
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M QJ)@K@A7ZDPBZ0W[2O5"&)E,-:U(;0F7?68ZJ:0-+G'F\O5.4P+P[88\+I
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M_O>!(Z+P/1_XYO9%JA*^&H2OJ \%A3)'^["G[O)DJ'>T0N?] J#WW2?& 48
M&!]]S\B;CJ*@FTR2NDLM4E7;OU TQU-:"O87)-</Z!GNI[\'<31:5M.B,S_5
MH2(2ZR?U@4:BR#T3Y.8X254B5^8@<K6AQM$$HGVPTV2:0)1_J,84^#ZPF-!X
MK<@K:I9"TO:<<4+5:__4:XYCE,KRG6MZ<_##>#V6GY=Y7-XKBJV6]_:=/:+(
M/1_DYCA&U2%7&(QE=<CSE#C:!SM=IRE'>=01[GC4HTY'ZXM.56V?56T>>[3J
M??+-<\VC*GIE$<>>@DAL77[?FQM10)\/H/-(I2H C1INZT-.I_V,]F!#X,5>
M)R15V="HXD9&B:*%M\=87H3RP+&F;;O-T89$4!U<V[%0@M:11D=EM:X,M>Y0
ME(2A+K3*XK?<X:AY@!=SLBC"SPGAA3H@E46X@GJ829PTY.3.[M/5?NJSH/7*
MKZKZ)/0OMC&Q'?B1I!]W$$+1F,$O 7[P5]P+*7RKC*5"L[>IB$G(O2@5FE?S
M$$2'(Y) ][:+GI7NK !$J"-$R*!$6PE9Z?&^1=6'@"Z,-W0"6U=R6]<7ESK:
MM3G:A?E,N?4#0+_'(GQ<SU%9'8RUH<ZU>GY@S]-:*6B; FWA\I_6-B&J 2TJ
M^]%AN$QW(?9!3N7ZO M1_[&?;88"Q_I&ZVM.]>P9GJ=P^-S #$%TI.+%1RUP
MHC[4V]T![DBH?+3'1*%\]@73-4-9X5#I-#?D1;VK3E3M3))&/:A\'LF/P,%S
M0*OQI)IEF32J>\\C9>Z0&Y7(=G(:8) >!YBHVXP"+JMY>7P"L\+34NH:/2@*
MX3.!\"'WJ38("X.QI@Q52D#MQ9^N]WG?N2+W*=UX7G@^EG-O"F5YTIF:ZHU%
MIGJV+CTK%PU3V]N-^^*Y3S^ /_\$Y??(B%0<C.4A1SOQU>D64<2>#V)SMN(J
M0*Q$ &))9I!$7J2Y2&7[[V4(HV'*(O6BN'I=&JCN[;/N+=6:+PU$WXY4P^B(
MAZ'8;N' .1=94V"?#[!+=>X[%=C*8"P-55GLJG]5-\LD"FJ?TYPJ+;:N=C]N
MO3"SM=KJ#0&@JO<,<YZ6\>S)*1'H,(@A+ZM#36DU*:+E,NOV"JDIG&G>4W5P
MU@9C05*&'-?9T[-JYZ<DH;_.4T5MCR=AITY_R"XIU9]]UI\E-N2.[O>EZ# "
MU?BAK)TEN=24VT,Q>R:8+;$E=S1F50YA5AP*2JM'_A+-&\E*G[.3ZCD7:VU?
M#GI$*%O)7$]@ZDKBTL;Z4YW;YP31X[;BCE>_\9D0'$?L@>L]R&.B #XC !^W
MY78\@ 4(8'VH:K0P;A_Z5*[':4U5'@U1:?$;"2E,:RM/U6Z?,QV*G ^1(>F/
MU[<B:L&D*6?9@HF(]"4*ZK,!=9$S(BH!M81 K4J=/5ZK=@I*DVCJ4L'4I7ZE
M+*TO/%6W-&7IB ID54:Y2HHN#T6!V,.U^IVK1'%,]^U.Q[$R&*N:.E3U5L,?
MHMDF]#Q]=9.J:2/@S>=VB-J"Q0V8D.S:[A-P3704Q+MO7@@8]7T+&4SE+.5K
M8%^ZMO/K(/0CL FQS#->N]9-]@F76%*1U&^"J%L)).5TTLDSINV=,9)C)XD7
MZ?9]GE)XK/;T%X(V#9L]U4*(W;R6C: DJ(6V7%8WP*.<LI( X/( T%HI^:[>
MS?%1\ P^YFC(['(+Z[I=5665TQ'Z'X>T_7?@/\X,>-FAB/+NV^=-K;^<%XS_
M[X9_[S^&1@BL?QA.!%:C)HXHMS0%^F'KL^]^Y)KN1^,&8XZ%:G8'@[C]0G-+
MS_,<RY>25&9A^,PS>MJK1H64ER565O75CW:ZR.Z5D "M8E"2_EB7#2P(P744
MSCP?/JU5,I+2^-*WEQ/557M[PF L<[N;I;0JSYK <H6E9%NXXYEEC.6\X BD
MR2<05(4]&.HW(-NYBB^6GOLH#$(X/] 17Q>?J?T*K-&?P/=V2(YXFF 7O+>[
M((@VI?K@;4F-3%GIVY(;F:WC5E(9C&&X5D0!D*0B!$UFN7+>6:H6U@..BOQ4
M&(1J;3FJN?M:6U-A8P&.&V.OA(8QPF:= 4%FE8-^2S$E^5^1"_[R"Z]P5R(W
M9 1.4)HV5@J7,58'965;*ALW35R9^RU:D6B"^03XR2KP>!7DKI0GKL>Q%6V:
MK"L$NFN"9D&1"NY^*G!!BHIHI9N?ZV85AX,E3*DZ&/_E%TW@A2M2=S^)XI6/
MV^.D:#T?M)8*ALNB52,"K;L)7EEM?T-#+GA*]RENL\AJ2F?H7;1YY;FM<+M*
M:]RNDA.(QI-2ED@]DMA5Z[@9G3ON9K1:;N808WC@9O1:;D8HPW>31 _PG'X"
M(W[C&$' 7%\V&PUK.LNIC5.&^F$3FY&;$\EFO3QEJ#5V;])@+" >G#PN7!#R
MQ*( _SVLC?12VC+?%25SUXR6O91LODB6YXS+WMPN&CO_OI3!F.>4(;^KDT>;
M0)%%EA>R4<C!2+)]'DZ%]]N\ )=5J2<(L%K[S1TGP.B@=DX=<KO:1[7KL\AE
M(Y)4TY/!YPN24$68TBZ=CTZC.?@0AS5'I?95D%FIX_;U\,Y $P]2>CV'#(34
M D %\ R<MRN\O'%$\+'9B$#@.5:66DV641OSP \Q KOO36GJWGB.PT?,$QD>
MR&5DI+U00518H>.JK&;Q/-[3XKGR:69E[^XH5XOG!!A7B^)0[UNP0)3?Q>LY
MZ9^=\+LDM2QCUWCFA))SB\>Z1+5H7#B?7,<U[HE))(VV;]S8+JNJ]'9M$>F^
M--Z7+EI#KZ :^J8R1S(6,]F(WK:&XF LT@Z,-::&4 SV&X,Y^2!%,"BUC4&2
MR]IE3N]S$6M%A\->6Q:^WG"8A6%;(]ME3&-AAX;3E8S7C76F?4+.N-_/2IJ_
M0V&^<V]B4<[HTM)1OXQWTR5M*(EGV4"Q(7>'HOB,4)SC^M2 8@6C6%"&6G</
M*ZL[2586Q!YWG:[*7S+-:!XY*.$0RO#4-NU33BY;[[769N/I]<6GZK<V]<NQ
MVBZUL:U^X7H(!V_@W4F.4P %!OZVJ7L?0&C )[!N#=^UW:<@(^^?8G$OK7OQ
MJ:\2Q^T\]?4]V60/">VC*33[#<TM;Z@Y:&H8FCPWE-5M'JD@-(GF@$1Z?GW1
M)M!!M?W,BO3?;[M5](9X4-7:YQ:S.=11MIW?+1;^TMI4'XP521TJNTJ,^D\4
MM87T@DX4A?KY0#V'7SH=ZCP'H<XK0T&A;-(^P,D"];M*'KZ!L\ J]L-V!K+P
MYAG+BR8.(,01D^D!W654\W\<J62T]KG_XB=V7+M6!9J:1\R_* E#7=A1(T6&
M6]8<@]4@\ OZ913YYX+\XF=\5(-\(>:=I2$GMXI\[*5=A!//>D/_-2#X=EU[
MK+BK7-*>-<EF0]G55:5&HVU7V]R_IR9KK"R52G1_!( Q3-.;P]M[0_4%KA="
MQR?TD+!8P T /EX#*R*\R3:U7<,U;4Q0P1?P<0OL_AG/S.)H]*\H".WIVV7R
MWZO5G5T:$_@540BNMA7G9_R3J$:H%E]3M7@#?ZZP3,/I>+8#.SX(^=*(0N]J
MZGA&&.,\.]UXMO=,-I?*F*HC)3@W_"?;O>0Y^(UH2&;YVY4'-2[\@I?+F6W!
M2;I:&!8JSH C+!_(!XZ!JORR8G#U I]A].)#=$U\8/P<H;]+^/"JI*;J.+T^
M"?)T>?.-K,S"&\^K!A587JA(9O&W%7?>14YDA4/T_8[<_4+R=D!+5C^!?'9/
M:-?\94Q<ZEK4,9M( Y2)A"#.@(\>=8<U--;OW79G\-["K2'2U_\<V7"PUTM^
MP,Q\9&)^L75^PNN6Q(FJSDL39:I/)T#4)^94T63>FH!_HL#]!]+ C#=E;F(H
M!Q\NC ,Z?.\R+U5(G*X-5P";GOR;$(3!J4I?JDGA[UCM"33":7VFRI8KR?S-
M\ZR'5^9O< BT8S5D[EQS0WD?.P.RC.^EZ3G@=3EN\U9\$FZ6ANTF:]@>E^8,
MR>+] L3B'50S/4K<9:UYGT#0A,.[H]L3].YWUX@L^*+U?N_#'WQ836>EK8?=
M67J&E%LAO;6EIF&PA?5&&F_%@1/45(ZQ",!E^LO5AB^)/Y2,!OWJ_T2L7.P)
M;O%VW!ICMS+QB>N)PYB+0Y<H,IM_D=C14?8<'B1N<YVU4)K913@<GQYN;!!W
MFLIDN@H5AJ=:.1:S$A*3R><]X..@2W!PM@Z?FO)J\)SF89L7Q0*D=.YJ2JRR
M6LS5F,TL9\8VJ^SAARY(24-/"C!?X5?, N86VBVKD#DJ*?/M39/,L6H%?0E1
M>3DC<L/"G-]1U%[CN!&5'*Z^C\@1A4IZESW:KQ0W%>&F^+YF;=N7@KC+2)^T
MEM"749LP^WD.>B5F_YWM,N',B^ -63"N Z\F@,IHZOD,#&3BEB*,,?<B&-Z4
M.!BWI122'']A6QY2O_1TB=@U9N.^@\BJ!UG<PATNE+)+??IJ7A A0+J8YWY1
M&:J\2TH7)277Q:*"0I5-SL:ZH!?86*<R5(6R(3G#3LR>'53$0RV7.5&EA]K&
M^>P/X!FX$:@L=:XEQW-ME8O!N-PZ5POC[F;(%,U;1F<8K)T0=4AKELN0X;G#
M*3*)2'_VO3G:NT1#_F&'LYLH@!8(^+>OIA,A_OPZ" #\G_7#>"V=-2,BO<@-
M)9[8(H8&LN7:BQ$HW,\([GS[<$>'Q7#BD%-W](*F<*\[T*-H/R.TMP]V>3 6
M=0G:=I6"O860G*+]C- NM ]W93"6.&7(2:W:=J+[0_#9HF#*H6RG+@9A7)7H
MQ?F)[A,#7A<HFS&X)+0.G0[:VT'WY #&=68ML[&9PR,KTB,<"7J$5RK)CD&*
M!*4Y^['9PPD#3A38SS@1WP+P(M/& QP^@:SLD9X:"7,HR)7,H3'WH'S^&<\2
M?"4 +LHC#\#"@)\#SALS 8[W0L A$P5H[0Q<*O*$UU>[;Z[PD2W-BGK"8J)N
MFN&QD3:XGZ+B$%SJ"?QGVP1+E_=31AO WQV ?H'776?DO[0OK"*>:PA=_'.,
M?!OBKBFF^XSI'/ZJ!4RC[H7B4)3/DKINAJ"FD.XSI(E#M#X82_R0EV6*Z-I8
M: KI/D,ZAW9N'M,"!SUO9:CR]*"J/?#1N;Z2T!611]]]SXK,$ KV,W"\!:J9
MQRQ1",R9"Q_DJ8(^Q4UP'NL+33< ^Z9[<[/W F#XY@PJU$\K2;Z-MU-*JU4^
M4:O$IND1M'5P+*%! =MOP.:FY%0)6'1\O#[419$"MBZV@N*UWWAM$J[B8"PK
M0TTCMFDLT7 M1D50O/8;K[DY<%4"5D(M^8><VBIW2'*](,]1EN$ &A^A0,6Y
M;G/#_PE0KELW4BFRZTIU:-]T: ZI\ @<!Z4)N];75&J/5:#R8*SQ0UTC]IAK
MHC=?BC$*%*M]QFI.@%(A5A6(56FHG6?57C-D H5J$U 5% )J=1J#+3H*61&'
MG$C3$.MC%2APSP:X.01#A<A%N8:*/I3XSA[X5W<: \_K95MFGAG#\!MP@6\X
MF&,PK+GMVD'HXT-;NI&_L+'"5+?V+7[)X1H2^44)86O2>ZQ.U0=C 08Q[6:&
M=7:+I2#A0#';;\SF!"\58U9$V9S:4%2)#6"(QFPQXH%"MM^0;1:Q_& L\T.%
MYAW523E0R/8;LCE$0]68%2!FM2''M6IEB<YE$,6>-C^NB&OXM-E2(]L]HK*>
MR.V<W[4M %3A]DWAYE 16?$^L4!-1!V/A:&@$!O2-- 4L2X@%^,H*)9[C>6<
M@*=*+$N#,:\/58%BN9V&QA3*_89R<TB6!V-)&G(*L?6-W45R04Z#0KG74,ZA
M-*K$,FY$/%2D5K%,=.Z$I/:U!T0UC8A_>*'A0 G>WX[X= *:X--'-^2#*N->
M9[45Z)Z)NO<DY')06AVC+%15&:KGN8E+]AFQ%.GGA/0"'?A.0KH6(UT@-XKJ
M(]*+,244Z&<$])IQK@_&HHPL.K&UFWW$>4$>A0+]C(!>H/_F*4B7.(1T>:C)
MG>52:D\-401*I.Q%X_V2.+%=TYM7=SPVD;1)1A2HWNT;@9U#DRPE_0X+^A<O
M**]M49--<:B(K1;]$;D)U3Y10K'=8VSG!$Q58%O #72U=G-LSPW;Q:@1"NT>
M0[M^9(LP1E+;WFX^-V07)$,HM'L,[1SRHPIL2X.QS UYK;.5,;6GDJA*7]MP
M5,2 A#/@IVDC0\8%804G65>F6%L\CYD^0_^>@6BB5N=H#5^^IJJ*IVV$<%U;
M4NK@U>7@22*K%7+P)/@QGLO\'%K"BOE7)+W?/-=;]_J6)=';OIT\&"L"/?JQ
M1LZ4PO-\X)E'M)2&IP+AJ1/;JXMH>!:C/2DZSP>=58-3I;:S9N:2HO-\T)E'
M9):&I]:Z[229LQ0XJ:_E;Q51 7=0/'T0A*>S 0WV"]Y85JHS:]OO*9KY*NHL
MUQ(=D$IPK"JQ!BV]^:,/QOR0XXG-V""ZDV$QBH!B]IPPFQ.&5(!9&34,'FH<
M[3Y:&V] (7M.D*T?L2CI>2CQ9UE*UA"90"%[3I#-81.JP*PP&"M#5:1G'^\#
M'*]3>J$ O9"D1?6@07!VQ:E^K4V_BJRX2U-LZU>%Y82#-_"N#K8AH62S7&UI
MW2H.QOI0X[>/6GU/]L8(":U]*0J;0*&@%44A7RT*"T8C5: 0=?;E=G;V/6L8
M%F,(* K[C,+F0"CC]MJRJE(0'A'T4Q3V&84%H_PJ8*@,Q@(_%-5M4KT@#(E.
M!A!%6L"4WPO7VRICZG4'W VIH/JS_Q%]  4&_K:I2 _D7954H^I@K UY97NC
MHP)GIH_][@J&_!2I/4?J5L!1.U*UP5@="CO:,%&DGL *4*#V/"1I'*<H04\9
MRB(UJ=4R!Q2I/4?J%GE0-U05#D)5'.K2=E%" QQ"[=O]DMK3U@+54 BQZ# 3
M (4&)#4%3&B\GG2,SCK5VA9/L+;R5%/VK<54[KY_VEGJL^_-;^!G;3>"NC)I
M/>6YP4<L\_%U/Y#$W[Z&O@%EUG8-_^TN!/, *EGTK;[G.%C-QL1M:0W+0PTK
M#Z4=_ (AB90-;+BT2$-01=!K19"[ZTF.(A#V[II215 _RT'U0*_U0'?4@(AW
M;7GN++LTM,^A4#W0:SV0FWY!CB*0!F-1&0I29ZLU:D\!@8:]I_T@*N5O0N.U
M@HJ-(A1X(]3-^JI3%=V[C>-"Y W4O0FG_1&X8&J7UZ^HC^10%VLIV&AM$ZHI
MVH2"L.<@+!0QG0Y"):Y(/7I[J9\@+$994 SV?+NW&0BJ@S'/#R6.&L)C^ (*
MPIZ#L!!C<#H*-8A"82C*1Z.0Z$0+5:%A^EX,?0,5-&S<6<$&;XZQO&CB "**
M,S)20!5EOJ+\C[JIU?;:/$*1/_YT+T5'%1F[TD?/9X>D!8 7(P8HQIO N%"X
M856CZ10GP5KEL ND2<0V@>PEKHMQ#1369V.ZZX0XCYHDJ6>=V] \P@LR&13B
M?;;<.33&:; 6!F-!'&HZ3578!RZ=ZU.WBHGG6%4R(+>&[]KN4\ L %R_F>&#
M:@_;W52VM=#1=7+<]"'Z]1 DD[4B)_6T*JZB-K@?C< V&W<RCZ)<U]>2NG7U
M16Y%W3I)JBQR^P[\1V0K#Y.OPJ:KEQK;].-8G)=>';?RZL3!F&/)/9*#Z-,"
MB[&E%)[G"$^^&GA*&)[TI-W:2$^*SG-$9S7@E*GMK)FOI.@\1W0*U<!3P?!L
M-8& 9+I2Y+6^5E95Q %\LITH!%;CF;''L0#KRTEUY7GHRG(T0"+1N[2EBK7E
M=EM-0IP9HD_Z*T@$4(2>(T++!1L'$*J1S040C=!B7  %Z#D"M"I\ZF33 43C
MLR =0 %ZC@ MQP?L1ZC&D<H("/$9T&TG!8ABU70 UY?LI3_PL,!B##C%QA.(
M,Y@")@K@:[8+17:^B% K9F9= (Z=.EYBM?;GCN<KF3Q0:>H70;PV';0[@Q+-
MQ<HJY6)KS<=JDHE=7TSJI=;6+J"HDPJ#"X[3,S_:<4YJ;//+UL&FKL-U[#E\
MB^83X-]/L;,:W$=A$!JN!<UCLI%5+BU?XP=C4=2' KDMA8D./ M2MQ32YP7I
MG *Y>B$M0$C+RE 1*)=4']=+$7U>B&X3T&)LHS51IX"NCQRFB#XO1.=4N]8+
M:=RX6QUJ4JMN-]$E9JI "8TZD\N:+#'+K"55K'U7K,?Q&8E ;^G7TJI5AJI5
MTH:<K)'J+1%$;!_-:%!$GQ&BCXM^*D.T@@@-=<C+Q,8_1".Z&*%! 7U&@&X7
MSRJRT-)04<^R.V=3? 8%]!D!^C@RHS)$:XC.T(;BN1U$UF*O(3IH;P<E.<E3
MXKCJ.S_U)LWS,80*;30Q4%8G2ND$;H O1[W[G<A*<SV#,&"@IJ6YGMLSZ,6G
M:+I/Z7&$ <WUI(.2D>LI%U' =>=Z2H)<>9M0N3T%4L/6R W4KXPW97SP#-RH
M@O-,F]@BV5C6BB*VM87M6\1V9&V2)+):H9!-YEFYK@;JXN%X[=J!MV^DH=E'
MY$_<9-R)Y!RI79&8/AB3N_%!D)M][,8'Q6EC-81:09Q*2GTXE6K"J8X/,J'M
M,FK;SZ X/2N<RG7AE$<GGVX?N$AQ6M4^!07J60%5J0NHZ'R1=@TJR=F4DK0=
MX--LRB4(O_N>%9DA%,UGX'B+.7!#3-"&P)RY\$&>WKJ1:)E=9KKI6]>F;^'N
M)G4>P:96HTC+;?3JXF L#669V"YB!/'(1S,,%,/G@F&M%0Q+@[$R%,FM#B4:
MP\7(!PKA<X&PW@J$972ZN:H0RQ\2#>&"O 3%<!,8+GR:<:5'G0HY-4HUP59!
M9.)0UULUO20WLI+DZI,;^L54/$*9BI/'YH;_$Z!,J8XD.,AU\+Q4I1+I%@DY
M%28UZ5<5L1,"[:%<)SM!87Q&,,XI*ZD)QMI@+ ]U@=AJ3Z)A7(R@H"@^(Q17
ME&Q8$L4ZXB@DF5B.@F@4%^0H*(S[35-4E'Y8"KD"QV&:0N/YKM(4M6=3*'KU
M17!]8BE^ R[P#0?S%(8UMUT["-$'GD^IQF@RCV)M@:E>[;5[5%'N:$DERP_&
MZE!5B:W5('H+IR!705%\/BBN*+&T)(J%P5@?<E*KGE)G45R,JJ @[G6(TT8>
MH\"),,21J?FMEYV@R.TU<MO(7A0X"2)7&<I*^SD4%^'$L][0?XV) W9=NT?(
M>2Y/RF5-875.6PDZ+VR)^=&";8<0V^9^"D#66"GO!D<"*VFXP=Q6@@( C&&B
MYC>&^X;ZN+A>" (F])#X6&C)46L<-_ <VT+2P4QMUW!->/OPP> +J/8BV"7"
MQ9\7SV_Q!Y9DCM6$@EYI^O2JK.UZ>G:_X&2$833Z5Q2$]O3M,OGOU>H;+HT)
MG)LH!%?;^OLS_KF:>+X%_$M^\<K@:61^N8$_5QB>\!&?[<">V(X=OET:4>A=
M31W/"&,EE9U#/(5[9I!+H:+J:)'GAO]DNVA>7QDT)+/\[<J#!@-^P<OES+;@
MZEXM# MUD(,C+!_(!PZF?K*R?/4"GV'TXD,],?&!\7.$_B[!P*F2FMJ2]/JD
MNX,N;[Y1#GJ"P/)"1<#;%,0<\DWD8%0K'+K!+7D3"\G; 85?_03R8M;J[YB_
MC'U.G9$Z9A.JL<- WK#B$&? 1X^ZPY0;Z_=NNS-X;^'6$.GK?XYL.-CK)3]@
M9CZREK_8.C_A=4OB1%7GI8DRU:<3(.H3<ZIH,F]-P#]Y;C#^@0P):EUS$T,9
MZD'C@"G:N\Q+%1)O$L$5P.8S_R8$>9!CN_(=M,.+7Z4[ENG>)JOLH8::.QAJ
MS[,>7IF_P2'0T;)#YLXU-Y3WT;7',EN3Y3[<@$V5<'UOB4FX65KDFZQ%?ES:
M822+N*?=#'X-\(.__*()O'K%W/X[@N:EFNE2%%9IQ=$1-(&5RZG;=[^[1F3!
M%ZWW>Q_^X,-J.O:MUA\V\^&,"8:7%=)C6VH;QH!8CZ1A(/86D OA&(L 7*:_
M7&VXR/A#R6@\Q_TGVF.+'=RM73AN;?]M9?*3#VLPRED/13<O4;B\*\YOB#U=
M/\7M#<]:]C6S:W<X1C^H8Y*&E)FLA'3(*D)TK8Q-J*0?)9//X<"'09?@*'4=
M<Q,O#+TY=-3#U%%?/NXI] N>T3R%P L5K*3$*IF%%%I:2"''KA5L"^@80<!<
MXSWI^/>/A0Q867%O:99$@3UHRXKV3IS//3>V^879RZ-(2M][B5$C#*K0:TD
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M[0504.!O-4!8&XSYH<1S0UG=MKWOSQ9^.5MI%'Y-P"]I7-)<A+H#BSF-)"I
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M+ Y5@=C:!Z([8Q2A)"F*:5#6?R04(24I$B@2S@ )!6@ZB@2*A/XCH0A11Y%
MD= (=55WAI7 \]5G6/6)N:+G*!X[<]T\1W$=$%2SU[$)TUX__'WT59,G*8JX
M;X>X8SNE[R=8%>"=*/RH8]7_7( "M!,%0C_LT&D)<'6?8B6*:!^%WU&!TG=;
M5(#OHA"DMJC_MJ@ W46!T%M;5"(9K79;))UHBTCN;":(2E\[F]$3%0\N-4WC
MI6Y##W?)BG Y% @4"+T'0A$NAP*A=B"([??$V^9U#C7P*7KVU+:?+ _&RO;1
M4A2KU9 ^%*O4:/4>"$5('PJ$<S!:VP10/49+:=MH$9V%)7,T"^L0)%%1$6Y\
M[TW7&"$FG,&%>IK1#*Q=LP;F"\=[ R"9JQ2Z#$191SJ$K0.#[CS48(2*=Q/G
MJS%"NS.S\C8B#M86WB:"CB_ZGHCY=RCEP2Y3A)J?DMN[F.C-PB*L'X4L#:!Z
M#X0BK!\%0N]LUQ'97'L,%PZ4]MJM769+&XS%\SSLKQ'>CZ*5FJW> Z$([T>!
M< YFZ\AXJ[S9TELW6T3GA:DRS0L[B,IO(&1L?.3JZ9LQ]9X:7(3/6E]NNJE"
MO0SR=A?K14D1"HFBA*+DO%%2A%^B**$H.7.4%.!U*$IJ#V<;Z$:ZBW@5#D>P
M,'"XPW'#%R\HW6!4X@9C;2B+K1[-UD_0%N&@*&A["MH\VNDTT/($@);D\Q0%
M3>_I>8HY*"F(OH^&@[/,C)#YK\@%C,@-&8$3E-.W ]95*KQ5QO*BB0-BG5KC
MD;9%2*DUJ>B%LDV8!E8[5"I=5"67;#$E%FDQ=1^%06BXJ("ZM)83!F-1XH:\
MH&WK.3+WK5J3_B)D4_^DG[3SG(OO=]58G)4'RQWG.6]##[7+D4@-"7J)X")$
M&$5PW0@N"F > ;@ZS$IUG\$.OV$L##E)&TKDAOK]Q'4!ZH[BNFY<RZQ2J.L0
M+[)"E1WPY#)%9Z<A7$;=5B6.&VH[LE ([W+7&CJ+<'04G76CDR]\6J58WVG-
MM9M@5!DJJ4.%:[\\]"*<>-8;^J\!4;;KVJ-EFY-8/@,77M@2[Z,%&AT(:IO[
M\[!DC96E0S>X)>*/ #"&:7IS>'MOZ-Q&UPM!@+K=0^&P@!L "_V&-0[N@S^U
M7<,UX2W#AX$OX'YQ[/X9S\SB:(0:S-G3M\ODOU>K.[LT)O KHA!<;6O(S_@G
MT8%0_[VF^N\&_EQA&8;3\6P']L1VH%A>&E'H74T=SPAC7&>G&\_VGLGF4AE3
M=>2QS W_R78O>0Y^(QJ26?YVY4'5"K_@Y7)F6W"2KA:&A?@=.,+R@?"Y ?8S
MR(K!U0M\AM&+#]$T\8'Q<X3^+D'JJI*:ZM[T^F3W6I<WW\C*++SQ/!4OL/$-
M5B"S^-N*<W<B!SV.@Q[BEM!*A>3M@%:L?@*AVW08\QF3EOH0=<PFT@!EB%"(
M,^"C1]UA_8SU>[?=&;RW<&N(]/4_1S8<[/62'S S'YF47VR=G_"Z)7&BJO/2
M1)GJTPD0]8DY5329MR;@GSPW&/] &A@W HRA''RX, [H\+W+O%0A6 NC]<2&
M)_\F!&UPLM*O2>'O6.T)-,$)ZRVK["'SO[VDOWF>]?#*_"WNYQD,F3O7W%#>
MQ\Z +.-[:7H.>%5BM7*3<+,T;#=9P_:X-&=(%K/>#L[A4:^8V.NI9KH4A55:
M\1$$36#E<NKVW>^N$5GP1>O]WH<_^+ P?I"V'C;SX8P)AI<5TF-;:AM&65B/
MI(%6'#%!S>48BP!<IK]<;?B6^$.I$\YQ_XFV;6//<&MCEUO;TEV9_.R&Z,6A
M2W"@<_"*\QMB3Z\6<7L/O9:M\N+;XP=U3%+[M*.\HXJH5BMC$RK9'6?R61+X
M,.@2'-^M8ZZ=FHMDVH4*5E)BE<Q""BTMI)!CUPH>:I8T5S9<*VFT_+&0 2LK
M[BW-DBBPA\GE_Y^]-VUN&TO2A?\*@I[I:T=0,/9%ZF&$K"K/]5Q7R6&[NN/]
M- $2AR*Z0( -@%KJU[^9YP @N(/4P4((CN@N6Z(@X"#W?/+)4S:__3B)>?JL
M,F 4/C&M46K2FB--M=(EO:/R8(MJ%16]4X1!ED2- PKD%CP5?MOQ.6F*)=J-
M'PV$FQRL":Y+@RRO' ?7T8-1K.VR\H4>S)VSP+B[:\;C<.>.G_%H@XIHHLW!
ME=Q.)LOYDJT,[9"6F*)Y.*4M=3B_D*DW\<JO![T,+3G20>N4BU7 Q1[&V942
MA)_AEK&\9-.ALA7AKSR48LGI__3&8_-X=E7?7@')KPYYKYY*\W#T+>H,DE%Y
M9>%8Z9!+;>$]Q(_)+%S"#;GQA_)PC$,VO&%4O7KB"%.9%]Z\VO*)C!D(OD1!
M:?T]O_Y5?FR#])3:G=-)Z8%P6N803L_#Y0G[Y%\C(O7^;)MGQU2S'QT[().%
MT;%?R(3,QR025)F.CQT )IPX/M:0*UM[]3W2C_\PKE)V&)<7T&_/Z)I1]>B:
M.1BIEC*T9/T-@^T;"BEZ+:X:K]N*.;=C.EQJS@VYAG=,E_8J6NTD6Z^B5:MH
M0X-L9N4H>AL'V61#'QJJVBMNW:-JO>)6K;A-3:I9M4VJZ1*=5-/DH21OJ_!E
M3*HU-(O6JU_5ZM>*432[:B^JRX.1J6A#0V\T^&TS8;DNL[9F]^J G/C*J10*
MX0(_$@ODF403+R9N[51_9U7ZUM]N;TDKH)0MFX'HE:[;TU^S;H]^\YY)^*^9
M@.\RIPJ=RFMG,M+J_<PERGF]JE:NJCW[<]-Z4*)FUNM!YUS6CM@?(O.SUQ65
M=E?J8*3T[JJ:"EFOIKV[ZKP>E"A5]7KP)MS5D=T$7-R5UK"[:C-:S5CQ*/0U
MJMTUJJNQPWB<Y@L2Q/3CM3<7SBI2%=YM;S_[.*)]S; ZRC^]$O1*T&TE*%'[
MZ96@6EARZ::O55G3]UCAY]9%WDC*T/4S7)$T("?!ER =P*=="QKMW!6"G>_D
MWTL/[HG\(-&C-R$L!/\.I_\0T*O0:/SD%K(.4;DZ5.765I+:K?3'*TF]TO>>
MK]M*4**,U"M!]SW?D1I2ZSR?T0;/MX<Z4*-5UX:Q4Y9T*@E "<65.E27^@>)
M$Z0;1UZZF"2)3ZE7D7DU@N]$W@0)=&(*L.)#N"IKHM6&\U,D+N>'YB2^#*39
MNB[P\&'K[[)W8K6L>#T-7?;@1L^'H66I!;B??L\5GG[^#Y3LDSV228=BVKO9
MJ=7-S!)%R%Z)^W2L^XI0HA#9*T*O"&] $8X7YWI%Z!6A^XI0HD#7*T*O"+44
MK:I&4LE27[(Z(.WIE@!6E'KRDMF,^*Y ][P1%S?F!23IBU6[3HZ6#@IEOLL
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M>IT&VVW0X#;O:50EM:M[&H\H34EE_.3X%('F),+_+ ,BJ-)04"1%?WV;8-W
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M7F?G874&,L2LA[LY.WC'4J3?78[TNRLB_3[G2+\?.=*/$]"OL@[!$8"D8D$
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M(%>E2N)[<S")23[$N?+"HO ];:> *1RGW/R41HVM!]P%Q3UJ=ON2'R=Q5#K
MM*9(-F/]*V+U6?$,>2;!1BX8WRD%$%$YI,+'?E5[4P1=WS5@<1I9"'G \V"
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M<S@U"1G]->6&/6&'7X)&7]!? N@G$;+(M; GZ4*7=F'R]#*"%I4O[8KF<&
MI_1Y47$2<Y3Q8 6C85"D68P]RC+!3;U!W2B#/@6<@2F7)1PRL&\DXPJ<G2M-
M4=^H;V7I?19C$\P\BMD.9#<.3O7R+;IU 0%-R6E-JN\XC2>M8%OTJ=)%(EH<
MX' GG"<ATQ3^1&G8Z6VY./2]5S6!TM8O 9)<=;IY)(><_@B9&/\N[8E"-1E(
MG/M7FA'%_[WH)1 92&H$]+$Q\(VNO$7RRZ1H9)$8!.24 )=P.*1HQP)$KNO>
MRU"=G!+I;& *P?%%1$/<^]QLG;6W/%-9U( %C[KP-:E]&MW3(AWN1O,%:-J<
M&"]A^78T:M?GN<LDRE &'%P$\.\L;&7 [F(]3WB@%Q$3\:DF@@LY@U'\#(IN
M[@#V*I3JSCIQJ.AUF7/(5F?S1.M+E092J]! 8A9JW#SG^N6/->F*>1G1$%]S
M5G+L%7F?NQ3P&;)GZ>\L9+$3 "H?N)=8;$XINOJ=A!5P4_4J95^I9/FO4U<)
M3B8W7TR\U/EC7;4N*> !UW*._4;Y/%RA[1@9VMT8Q=W9"?-D;"IQX*\RS"LM
M]9B(!E@!S\\I]S,['.><EP>I8V]9]Z'(FU7+5#E[POPW^(W^7/H[?,XIUJQ7
MT3<4!IPR\* :WSM9\!5^LI9ZKV;><:_//$^]4S4,HAX,<OJ^U9H0J;>U</PD
M%9[M:4>)I5+"_I E$95O*"_ZY>()-.3+H%O2K.A-+B@2_Q([S0?;EUK>T8T+
MV3%.$\B?B&;'9;0>2GHSN/OIRZ>[P5MR!2L6UZQ:W'=^[*)^?,?IZZ>K6K+@
MJ'>0RHIH&_XI/(&>(Z0>#)H7LD9\+#8TQYA[$5[B4LPQI$EC,+/@"Z(F7#@I
MW$R%TYE%"\Z:5EIZ,/.,V!WR5>/4 8G;?(( !T/]>2N4#)<Z JK;%[(NG/.*
M8T[00]*CDOX# ]X(*?E\K')7?D"L@=SJHMXLHIOE.K<H&PXW%QTW^  ]M7A-
MR!Q=QMYP\AK)+T2U]_<H\GY[6FG$0#)8;RA!V/V5I0R^P@)B1%\YW@.+4S_!
MK^'7B=CA$;XM^W]XGWGA.)+.+&;EFT\]7JKC.+Z Q>&:;0NC#?Z@!@HP]8,=
M=;\*P\,=7\"7_R3W#!N=PM.M^JRPH0K2^]RW;510='M4G]I6;5-6-,XI#\\L
M2**EQ8?/DC_'IFK\]-(<+H.KT?KF_7JT@J%<R/[VL>C>#WPV%=M_P%?2E.JL
M]U&5"?@&7^7CY"L9Y;RJ)A)P_2!K_;A4+V!SNPK"9="Q;LBD4<GK7$Y;;RN&
MJG-01 =51B9QJ7,RRA>!J?DH1:/#P<I85NNJ8*NV*JL%"<9'/PQ9$J6.](4Y
M\P0GVZ3/H+Q\ETD_9C%SLF:]FY%2G^^LVKJL\-% = ?RMH;-PPG_8' 0"[_Y
M;IEO0 T;%Q'"\F)<7D0K!&?G $M%O@X;8)%VCRKTU;B:(&E>0!Q;@K*) 9;5
M=NZV>K,O%I+6A011(VIZ/62 !96C3,TO\E(M6=?,][(],FA%JR=+?)3EL&;9
M:+57MO'4WX6VOQKV!0139:OA>@>U**^!IY@P]C59;J*6ZFJ7[=L-:X+CR+B0
MBAT=ZY8F:M6N=%'S"%39U==: 5\2S2F%S7G8,TQ)\;KQ34E9V)>/:P+CN//+
MP@B*-!@@""NK/)8EK&3I)S3L#PR4(,Y=31@+N8YCH@171#R$V5_=-"(@%[!]
M9)4>;)$3[1DEZE\'I5P*S3J!LDB:4R2RO9M_+<M.*'S/)C%5@LUUUM:BT0O"
M;UQ+FB^*XM#OD5D_,M6+H%NG,]U4UQF"KHP9[_BBZ*3 [H05:*O4?@HT8UBD
MVC=)T=\%'J0_9U<3)XYQF " ?+>(_2!7ILUO +A0\VUJ%\"XKNNFJ%R4ZK'@
MTXVP/Q:]06>Q8$1L=P_A<M[Z3XJP0-]ZG9*Y?@)_'1#8:"T E']M50];X;W"
MN1<]R@U!H^N%+%-6ZKJCT4C6-SUM>*!^S'GP^X5=->D'_0+([S5U+/H;,)O!
MU0 Z4\76(W1Z:'"-#V9$*]T/YU)F-LW.[['2K9%HU/V=4;-(Z/$YF/L(-ZG!
MH7MLBB_F)4JQ#8@[!7 ;:;G*:D-30*,JS3!K;+TUB3Q@<,LY5AN]#S00=7$P
MCD!_T>,MFJF+H+C#+6>Z<58ZV;J4^)8J>%N[+P3=, 8#H*DGV)KVP/#+&>Z+
MF,.=I%'LX_Y%TAFX%I262"!=$VF,?!LMT15+)3-M7[>K"8CV182SAECGN<CY
MBIV2H9B@1ID^/Z35LMZP0&!)U.[EOX*3Q?PK !S^O."%%_X&5@2S,-]*F_,=
M-PW(2UWT:8XN()H=*V2Z!K<"25$LQ4YX3S$LOG NWJBEM%6&JGFO*@G_%RJ*
M+L#UI,14A3+?#Q^BX$&4,]F3Q)<"BI%MW/Q+LATXC_2_J#1$:94/5CS1-5,P
M:?C^RK[I?IBV'ABJEU& (A1.(9))*G.(#^#_^+P[CF_TQ;4,6>QR5X>'2K+T
MH205&$I>%N?)+?YQ*<>5$/HF60(/(TG(AKTI-E-C_-LX&B_4!%G:A3CG?&R1
MY_-QMSF",IJ"ZD*7_'$6S1%#?NBQ>8@W3XIO E>?,VQ=^C?\%D"44_.ATX/M
M=7SGB-"G&,8/US>4#(7OWH\MUH1'_4)\]''.W%?NK9"ESQCL%7%B7(4>O!Q6
M%MRD-!..&,Y2!&G9G =_QO/=E'QROCT]R;OUI+L$6T%QHK:WUO7 T;@ #[UD
MDN0E)$'&NXC]!\=]%LO+'=X\Q\&Y.6CDB_B*V4SR]O.57]S<5U(@2W%ESR=9
M/S+-"ZAT$#+'@EV_3#QP[!!_@+,<3 [S1$5E;Q//2L#O@OY#I#H!AR7A#]".
MY7T6NK[0H;CL#H*:/P'0CS,6-K\DYU)K;Q;6M+N-1]W298WJ&KGRRG$Y+*(<
MOKR.@F.TYAQE<)<3M@[*E#-+,FGP2Y2R9LL]FBK;=36X$\Z,9C^^5=_'5_%B
MQ'HI5 3(_L^8Z$B$D_4K6J\^I*Q)#]@7LB%+K*'#-#H(_+]\9^*C,\^2 7=[
MBBVG$!I.\6-P)_]?^4K5![B9;4:'ZXVB+S?/UN=:IF>"KPF+XPO8CJ5ATYM@
M"Q,-W17+A/DT$0!*Q<_A"P;>/?R8TKZ-CL"/3&J9J,?P*.+.__*#_X1O?!^+
M0"4+_?0W-OW;($N\ ;EY<%5ZP;U2%75 O7#PH9*_#:[,@10Z<X;OO;IWG,5U
M<6*?B]W:R6_%D0VDQ'7PB*R!Y'MP4E>&J0-LCOH$6MV?P!C<JJH\_N'[Y8]Q
MN_8"CN8I-_!< [_9KF@D/*IOIDZU9560!-$28$S^\F8:>-/"\3U>J\A-. ]
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MD6I87+&Q^-AOB/C>=0+Q&H#G0)A5'\*Z(U^U^;O5.L9;!GWFE4MN";@4Y8B
M:W2<5I,M_;4*82T/MO3?U*/G K>#;_G;0!^LB,\D2L$#O587:9X9*6[XA0]0
M4+SN'(\1TFB(3-[KGB:HGO)AEM=LYG&6;K*NDJ2\]FE^(0_B(_<<?D;/86N:
M\Q68;^^83%/67CTZA0S_W)O:C_V7Z:3OVY$;W=0.L8H7)CE6+7KP,WC<O=S4
M(S>;;;TXB]/;>DHKZYN,]*N>I3C"DYM]/X4;=D]L]M_0Q'R4P0?RDK<'Z\&=
M^DO\D'#?K$>P_L1SS_/USWS3-9L67\V47]]D2T&K=>RC?OW3_/XL &2/]SE8
M/88.Q)!Y6K>I9:3L=:)ZH/3*9C>$#$T\RAY#)U<VA_N:Z_T=KLO8=/JJY[WS
M8>BV?)P/NOO(*.;2U9/XH$<FU&OQ03_%+'%C?T&9XS3&16+47I?D2>G#U<>V
M1]NN2[KT_ \3\.,04*^ 'XR!PQ[OTF<Z!#;8@EK]G954_ 3KFGFCE"57F,]P
MP)IJ@05@U@LSHGU2-G<1R1[;@:HO=:#J1];M?WX2T_9W2<+@_[POSA/UO<^=
M]&\#_PG..YM?>1&=-?Z1HF=5+\N[]N!65:RA/E;6VU9?=IB">&#E+%\MBJ\R
MY&W(]T$10R_B%R[B1OLB/@(1-_2A8AF]B#<?ZO42?N$2;K8OX6,(=31EJ(RT
M7L);B,1[$;]P$;=:%W%+ 1$?J\/QR&Y3Q%^3+9G2O]-E2TS1 M&G2[94J+-)
MF2YY?8:DAL=Y:!YD^<GV"G:_@GV92M /UJ\CT*]*Y=\N$WFLLK7;5[8J*-O1
MT%3/-F!ZF?#M<:=JD^B#,A^]4']+0CUJ7Z@UK <-#4OOA?I4N8Y>IK\EF1ZW
M+]/ZX-;4AF.EU:"HLS)]6':C%^IO2*A5I7VA-@:WACHT1JU6),^Y+\0JI]WZ
M-,=:5\C,@4M*/Q'->'V=($WD.2K/M5>SEZUFU?;5K#FXM=2AI8W.U7<Z9<VH
MH21'+]'?C$1K[4NT-;C5C>%XI/82?:H,1R_030BTTDZ=5VV_']/"?DQ5'X[,
MWBR?+J712_$W8Y;;[[^T1N!HZ^!H;R &[D8^X]2=&R/EV&'K;RNE\:M8U%=3
MRT:KY"OKS[O7P*?2P,:A?I2AGU #M]\?:XTA,!J.[%85<%M5HA-+^T%ID%[@
MOR6!;[];UE8&M\;0M,ZV';Z[ G]0EJ27]V])WMMOV+35P:T]-.VSG6'MKKP?
MEE#I!?Y;$OCVFSEM;7 [&HZ-5ANTS[E%9&Q<*'6(JM:24OD2I4Y0.T^(T,'P
M^20ORI N^@R([9:@T*OFRYM.;%\;Z]A:KPP-]9NL/+<G_ <E7WKYOVSY;[^5
MS#90_O6A<KX!V$7*_T&YF%[\+UO\VY=^<W"KCPVP_F<[A7.1TG]89J87_\L6
M__;;3FUK<&LHUE QVA_8^5XL5_J>]BYM?._ZTM^U5S8E6996=&JJ)>L(^D/7
M=!J#_.]7KEVBOHG%@?EG7EF357U =8KIZ59UCB]Y5>?G%(1B!A^ Q<G/?V1^
M^OQ+E+*?_,0-HB2+-RQHM.WU!8VVW?5=G:.QK%AXCM4#^4^)'\F+=LK1F;0I
M?Z#XU>;D[T1K,PUC+.MDYWX-I?=L$F=._"QI-BV6-(:TM7T2.;&'6Y$]FL&+
MXD1Z,_@17QR\Q2WDLRB&>^"+ F.VR&)WYB2T1CE;2&DDP8'D"TKIU2;W))K"
MCM>SZM'FZWK^<EP\OSQ7;^8J(HE3KAY^*\[L4QS=Q\[\KCC3NSEXJ*E:6&FK
M5!,CL-*F(F^PT4T>KZD3?.HY7GZZ*QOHVA-P0^<K-IL7\!I-+."?%I#?PH<,
MX+U-HF.DU[>CU("XQ#0('Z!"4"V]@P>72'>XJ70>X;V *$F/X Q+822QIX7/
M+RIYH'9DJ12R1*)-\Z"N_*2JKQ9<^*2Y\RQ-&/R/QR2_T?-":3)>O2;A3*7)
M-)9H)[HI30:$WR.QFQELV8*%@)/X*TN' !5 D/\ 8 N>I9#=1ZD/7WO+BPRB
M6(JP^?O13]B0@Q4OY)":ISW(J3^'\ TQ'E<0"U9TPAI7[*_>$'>F4+3,:G3:
M82B.<>/NK<=2%@-J &Q.2JH1(G,W9GB%(;@>@%*/,)6#%3T4S^>(1,S!GUO@
M7V2 6^8E0X0IUY$.PI=^&2)]<+W!L:'UXVG4N%[4R]Z77>F6+N/2;C2B/Z6*
MI'1/ N]-IL]<PTVG/B:A_ <&B)RR,&%5%(*Z^RT+F*0J$_-*?>.^?:.^+<PT
MDWY^ CT8WC/ISDUEZ<L6P^U%H"G#*&U<3UZJR1[9;46X=>-1Q4\>3>!V4<ME
M9% =]X\, EK0@,_2PL$$?18X<6Z+ 9$;'4S4E[F'&'G^U&<>W'&6++AB!,W)
ME3'9?@=M^G/C>+Q4_3BV+R @([M-^A%</88000U76NP\O*$$2S5N\:1DYL2@
MXN _@+A)PO[(6)B"MXF_&"/< )OP=1:'9*+IPDGJI!DIV#)3T\<T]0!25T87
M$-/8(WZJDRS%1%:29 QP=Y<TG:I3:XLW3(K0<#GU7[]3+>5&5RB=:35Z-V.C
MIKO1+1*@P2T$C$R:.5ZC3T73E?KDUU1$,NJX#*JF;,Z@+A59UK*HO[&YXX=8
M"RT47_F>'8G5\>#64N1U5F&IA0R:-E+DVH"DV1KYJJ! G0?'#["DBK5A:9J!
MS6!+"8==.3;RRQMW:K1Q^>]"S8DZOH"\Q'A,B,4,V<8P33Z7T]9;B[9KK-^I
M.GB3^,$_A-)'!TX:#9U)EB*N>(Z-ZBQ5E>M2688E6P2FK?:"^\3K)D/=;3*^
MQ,Q)LOB93,=GNL8=CP>]#39AI.!6S0VU-NY?M&$80&(5O:(2K9I.W))5X6PT
M>CN6(6NO'@/*0:.^%#1:K:#!(=9SPHRNF%2\J,=V&J(_;DAA9Z/W 2[IGC&)
M)L"BUPH6;7"KGQ58A+-8CY5"-Y;:?_(<QB[_\HTS35MP,&NKN)^95VE<3!:7
MSO7>?\!Z%)M.D0]<9+F<+(VPND#]> \L3BJ)-(ZQ'Y<Q!K^W.;99X)<9^%&E
M^_2VAV)-4#0O)H%+A==I',T!)P'E^JF$P)*A!+H[=/W$C:1/\%((8)0^_.]0
M^I?\2293N?'G5W=#Z8/''.DC"^&]_WK'S>KG!8 \SN:B45+ZWP\?^)6&??VU
M?GA:EY#.)7CR5ML</( :Z0.HQ22=LS"%.#%T[JG]]GT6>@)/RW##WW@7755^
MJ?I6,.#X1O^!!<]#RB!56SP;1V9=H<^YP=&^A'007,JF#[[<&=QH*EZU94VK
M+R,AN#*.C1>,6N,%&M$_IX!!M719&U<8:NHZ<4VQ18OZ(<$#EMRQ$<]M'&:Z
MK<A6;>&U=D"K^2<6$U#6L;;$T:GMA%H.LCMPF\$LO(N2M+RNP)U2X@Z7.<E:
MNUWG^EB7U;I.&L1%UCB\%BSF$*-N3N9 %."BO@+5!;!C.(-R+SF-V[=+C0;&
MR@6TNZGF6#8(/MC"0:U#%!:@@L(9+X0,8:H=I:2![1O7-J#Q.J5D[51*]$N?
M\(PVJ1T3U8ZQ@?^SR;,T%'K4]53U54VT24H.631,8Z"H%!VWGO.,F,&.,I[D
M8$_,S>B\/3%)!:^">JIVF&-W9-\H7I.&,A3U E)GF@K7HH"PG,(#T4Q\CXD)
M&8S@.)2J+0"/@,M&Q<NV:4:TGK C;W4XJM/$LH[PT?_7"3*6>T_H-GUDZ2S:
MZ*Q;@]L11.5GT5*B:^,:70I-%]5^=)G<($NPP;L8%87C35(^8\! KN:4*&-/
MKH]:RWEB2=^J79.F4M4+R*RJ^ECTAT%@%[E\?BH?DEHU=.=R\EIK2<,ZQ\#A
M6MP;^2+L0)G4?EZV"@Q;YA>+.'J GT^>RUYE$G,?Q/TN\WP^S/:;GWR5WD%X
M[J<I8^CHX 6%Y]++?DT(U"\A3ZB"Q1[3)W? '6&8<X;?8-Z&#K+SD7US8PO9
M<00A[HQY6<!^G5::4\%-HQ-(2A=B RO(J$E6D!,I'FHST(7B 4<T"*)'#'Z(
M[T<2:9<$? O.880.G#.),C[F>&##ZG63FL8P1O*HKDZF-4US#$'*:(T@I6[X
MV^--X=%&<510&@]1&7D1JT)KQK$@+BD(V%Q BK-(V'7^Q<T*&Q7]4JY;%.4_
MD+^;<TFM,7PK2]S>"\?#\/M:6:+&_G[76W+*M)UOTCMZE<VLZ.#WK[&B5Y[V
MX71\\/P0VT1 MOR(V]EG)A!C"-';2:RW.Q=$Q'I6*1_E-:MZZ*7$>J.]6JGD
M<=+5&OKE4$.#69(^PI^8)=+/..ZXU0X?=4J"8;_U8S)-67MU)HO/'4FZ,EP^
MG!W\EMV0F[WDM!<I.58MVPD^^T^]W-0D-X=OZ7@-Y'<>O#!^1VSCV/LLQ1'6
MOXUCY4'Z*=RPNST'6PO<W_@A!/A1!A_(2]X>K =WZJ]V=VXL/_'#:'</>>:;
MKMFT^&JF_/J).NQ&*0=L#WW4KW^:WY\%@ [:V]!CZ! ,F:=UFUI&RD$,_SU0
M>F7S6IKX'D-U*)MSW@BGVQ>Z$:X>'_27;#YA,::%1=-H91RZMOUP+7FC2X^^
MWP%QJN6<IB'ZCO>M@#!M6:EC.>>VSO$]"WE7Z$^\N]#[C3-"_93%?GC_"9Y'
MY'T6%Z\N@YCZ3\R[^I/%T88]$*/1X/:OWXTT5;OYAO? M!<O]%+>B)3K!R]Z
M&=6S@G>;E._9POMR*=^_\F4T1GZ+H::UNG_W B7]H'BO%_3+W+6]3=#'[0GZ
M6!G<FD-3MWHY;R$H[P7]F[+H^IY-SB<5='5PJ^M#TVK5HK\F?S*E?Z?+GYAJ
MM6^WF01*6RF3-5G$<87-N9%7CGR Z)G*JD@=?B.J:LKF:'PHU2.<^94F:\C&
ML0J&)%NP>$-I4CVB'GD*3!Z:XUF&9V\L3K;HTS#%I-#>+(\N[YQI!W =QVJ[
MEM9) #'PU<OL!(TC;;($VN#64M>LP-O7^VHODX8]OEIM(G90CJ67LH:D3#\T
M^*K+)]LH<;6D6(2@'>F/Z8-;PQKJYH81YO.(O,Y:F@_*H_3"_$T)<RUIE)<)
MLS&X5;6A.6IU079GA?FP9$DOS1>^Z;Z>],C+!-@$ 3;LH6:W:HX/7''?VGRC
M:2J7P']AD9#_WTO^G<F@J6DIES#>KQ 5T5(2IHE;&!OUS<G#<7#NUQT9-$&G
M O^/\U)S/O?!U\/E,PZTCJCD%4LD1Q(;#G.NGYPNH^=YK5^:[&77HD%IJA&*
MR.8_IKV&54(5:94Y8X&44@<.2J_,U7^_,EB\Z95-V79GDD1!EC(Z;$M1R$YR
MV^N/U8DZ]@Q%M\>J,;&FX^F$Z>.).[5&INI-V/]9]J!U@.2?N2& 5":IZE2V
M^)E5Y=3ZH_SPUK[)[LU$3?@QY4(U',6=\+,3XWZO)*><^P+O_1%=M-+1L]9I
M$\96@[0)Y?'8>GW/%MP!SM;RHY/ ,2'5RD\^BIPGY6<BP:%(="HO(@_@A[3A
MZ+1M$_Z-"*9JUTBXL0H?.DR(,L11?D%_? .D-C!QC"^ B<,>RX:=$W& 55AD
M*4=$TVS-)MBUN@@%[9P+G>5B47"\-KU$<5P7*8A8R C^5.YH-KNI294-]02+
MIU1;$0#D?C,JM<1_VN$_-TKKHJND<FMBM.:\GPWO33+,VN^A.D/3R"W8-=Z"
MV!T 3\)'OUFP#R77+S.8]D:#::\:S+HMHF[T'#QGS)YSYAP\AT&S1IZ#9<Z*
M$Q(=-#)D)NTOT?3\1CV_T3?)T]+S&W5!<GI^HW.3FY[?J%O\1D,D-&>@C(K,
M@N3,<0](SWRT"PV7123QK9*1],Q'/?-1SWS4*YN>^:AC&.J9C[:VA3;+?%1Y
MN'7Q'N%:)_BT9\1R=-A\]DDNVM_#Y=U#/U;<85XVEN*FL&C.&A]OZ.=PSWD,
MX6#6AKKH63;-).P920#P?B#L_BM*CJ=D& UN1^?,O7+60T/]/.]Y2>LYC "J
MIY36,<WXC0R]%]=^8+?KTGH.MO5TPFHJRN!V/+05LY?5?AZW\\)Z#J95.Z6T
MJH-;31^.QJV*ZSEG."WK8C((=><W?V)A-/?#FC*<W<F?]1<]AXN><^9QI!S;
MM7/.>J/^S./O=&'F20X<LW//\M'M*VF"@U_=2$<N/^3>"SL9A^S!3MC+25&V
MT,;NR4'F,+[C*.9[3GZ=<IK87[,T29T0YPAHFO%HUTQ#VMCQ4+/M/I0Z69:R
M%^*+%^(]V8[3"K$.0FQ:0TOK<Y<GRUWV,GSQ,MRF"!O<#H_T<2_")TMI]C)\
M\3*\)X]Y6B$V08@M>S@R6G6F#V09/(3M:0LK83&37DRNE\^L9(-:E_;W]$^T
MAEVKBZ>\+>P=_+NA)PG0?O 3?^('?OI\[61I=#,-(B?ED*Z*#DG.%L%1\M.T
MQ\A2,W?B>S]$BJ0G"2\I%5_=1  $^ ./US/?\UAX4PYE%S<4LP".XR$?;*>1
M^YM'N(>KQQ@@-8F9\_4*OS\B=V,;1;8F?__:$/XF;80L3WO:H369?\ :J*SH
MKQV>MM$513:,71]P326IQG8P'W"6)SE!5:]N[=EP@!5UGMNN4QSGL>1@(&@L
MQEO=H/F=Y<_NAS/X;.G:)?+7_[SRX6)/U^ 2S6+4K-_M)W)3E<$M42@A@= [
M+LO)#]\[.]25MYN02AOL8M\X+<^&T7-LG"T[QDDY-NS<@6NK'EAC.A_7U)Y!
M.E^U9+6.2B#2M($=EOPYO,C)6)'%4HH6^%L)\2N!&Y?&OIM6%AOM'$K?>X:J
M+8_.X1 UI9:B"#\Q]**3VN9%VB0VJ2F(6W[*?11'MNI,]F?NJ8]\"-V8S<'9
M<()WQ&W+@[F[%/3 )"-S^27*^1Z9]\EYQC??Q3'2+^.7Q_>S6-C8;8_6ERR=
M2:JF@;F>4\G\WGI*+_:G%ON1K!\D]J8*[L7IQ'Y/.K8.L5^7;'MP>\8#&]V5
MZP/)EGJQOGAK?G;&?#2X-88C_6S['[HK]/N+,KW4?R/&?$]9YC3&? R2/1ZU
M7HHYT_91D>GJVT>/;A_U^+Z U]?2E]4O?&;)BS+,"9\##YQ]H>,_W!\U9&O7
M;N=#]7@CK9YB/\5:D?I85P<K-+HQ&BKF!J5XGHTA[4G(841WO9#4+R0OZ\.J
M34A4;*:TAZJYH1.K%Y+C&R=[&3F!C+0K(C@T8!A#R]Z0*>M%Y 6-B;V,G$!&
M7M8*6)N08%.^-1KJQH:IY^Y.*AO:Q82,=4\J_[RV<JQ>2L95K74F([+]37RK
M-W'.V2W3ZH>C=RFK'[LS KW\*"_(.3HW(IK#2X3U$='DNUAWI\JT?9N Q;R&
M\,*4T@LS!K>*K/1SD2>D8.S%\QL43[4>\31)/(U>/$]&N=A+YS<HG?4(I]7;
MSE-S+/;2^0U*IU:/>-HDGJTVJYYSIM)6+FAK3/T)@)]>W<12PP,\- 6P]"Q[
M-?EMJ,GC,@ "SYL4Y8@4I7:N?LP9,5Z^- ?0R^<W*)_'11D[Y'-\WDF LY;/
M@Y( O7A^@^)9DW1JRGEG <Y:.@_+ O3B^0V*YW%)@!WRJ9Y)&N EC&,5=)?X
M(OJJP\'^(GH?%;!0[;@3%#_\"&FEJN^N*]3E9_39G3$O"]BOTSNX)T^PDWQF
M;A;#9V/)ST]ND'G,>Q]'\W?1?)&E=->_3E<?[A?X(S_B$RD?JL;Q B?%O+M4
MO(8?@0$ %O ATCA;E9U3Y1MLZS@>JDUBGDL@+C16\:B_S)@TC8(@>H23D!Y7
M9VT6$=)'P2T$SU)^LOD #OQ'8N)LI2D<KI3"Q=SRA)$91LSH2)MD_%0'92J:
M;.RB,SSFJ$Q%'I.R8I6VLD;OQM1E_=7+IPNU0O:GY.19DK1<06PF^^+(;U-9
MF&I51;Z.4^_(AW D!]RN1P#@)-5.8M0DDD9*#5O,<X8OU99UB[ TC6*2?) +
M/_) /D Y@-( H9\PU\D2AGMG04N@@H'WS:7'* L\:08Z!M[!0LFIJ.V55LU#
MD\RJ#8Y63Q5WMB1O)Z6*T]?+'">I9AQ>PACM"PM$:>8$-8Q1"S4,:7_<"+>#
M;Z'._&7Q:9.U3#6$07S=TS1DJWR8Y36;>9QE^[RN[DL1'_0TO\QBQJ2/\"=F
MB?1SZ*T6I^K!?'O'9)JRMKO2== Q_3,+F:0KPX-S)B]*C30N-P<R!%V8Y%BU
MZ,'/_E,O-S7)S>$M#2?K7!".19UV7QSAR<V^G\(-NR<V^V_\$!SZ*(,/Y"5O
M#\\=[])?+9-MZ,?W@1WRS#==LVGQQ93/JZ._P:VF:-:QC_KU3_/[LP#085P4
M/88.P)!Y6K>I9:0<1LC0 Z57-J\E+.@Q5(.R.>?V6=WNVV=WA5R[-@^<@F2_
M)<]T"087U)O S>6X%6(2?0]]SRO+R7=S0%%Z+%^)AGPEXZ&M*75R^C3$9=".
MQ]W+Q@ED8P]K3SNR80QN37NH&!MZR+\YV3@HQNA%XP2BH9^C:)B#6T,;CI1:
M*44[*AJ'Q4Z7*AMG1GVNFX<NH:VIVW.;V!KG*+86<J,/U7:GHOI-M?VFVLYL
MJMV1S#G@+$]R@OVFVD8WU6YZS(4.2<726*YB]W\(6Q_L*="?H)-UPU;;4S6
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MZJVN/JLNAY$2'PLL_([6<990VW:^4V:>!:F_"'#[&I+WMY<BU5JCKG]9BM2
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M"V7(^G\T>A.V0D'TT;XFJ&6;=.D0.Q6QZD-L8\.E0+S1D!7<'JNN3(FIYN(
M]SEJ0QY,W=@3VVQY,"-RD+@\7$0]MV'7S#9:*C#4Z>GDZL1J6)VH^@M4N*W)
M?,9^697<5!'<-BHH&=:[ZZ=*(VFJ+BN<^</#@P?S\?./'[[\=,?W/J^\]I$\
MQ>:]+UTS9;,NCPN]!T+]7[!;O167"]"EO,3E4F3%:,?E&ENT>* >'6ER':FK
M\JA1)6F S[I[/\$6TZZ,:13Q?'PN$VMCM6V-$9[ 7ZRQ;)Q7+T1WF>=U16VI
MV%JK.Y-G'EO0DC@[\9((B1?NFD_3F/L^[DM4)/C$S?J1$,SMCJVW&%5#Q&W+
M&O)<6A]TM2TFR6^^]4$;BUM)_*=S:7S J:R+:GP8J;+1\<8'9=\M=*+Q0=?;
M6C/VK42L?>-#W_C00.,#KIKH&Q_.IO'!4"Q9Z1L?7FZ7S+;:]R_/+O6-#WWC
MPTLU9=_XL-[X,&XI"]\W/E"@)YM]X\,Y-3YHX$SUC0_?3N.#;K4S '>*M@=3
M'O=M#W5@PN[8J-X9N^O;PF5='AEGW_B@@Y=D5!(=.^%^C+FQQ8Z<OZB:UE)D
M/7ZA^M9EM1W_RU MTASUEOB4AG6F@7G'EW1!J.I&O;GD@)U7^T W[/^X+5Z;
M.CV ,E6'P\Y:&PI%M;K5,# Z3<- LXVGV$!X@0T#AM(6<><+&6%5V30J5;%A
MLU"&&%#1*TFBVDIDAFSJRUF[9C6*]J*&04V5U99TBBY;]@D*8RT_"$WCC*?'
MAB6@%C5>%..Y7B)U+'GFY\RAC9G()<4]&'B+&X7(#(E,HWP#N4L[-9 V"I=/
MN_XBZ/>.'Z1#U>[1U/*"_#T+<6\O+GYV7;80O/&TLC[T\;O/J9,";-X,_GYW
M]VGP5EX+&'<$D0A!D+0K_-42BXT#Z@69OM8!I8T[!B>^G2Y7,[*$[7RX5PYT
MC.L'?/>I6.'$$A:F_(5H>@R>1/O9/$I2P=,>//<+Z@Y D]Y!>EJ*O\6V"N0:
M6U8BA4'#171HQ 3 )E&62H^S9V0*15H[WV/Q$1#KUSX=LCBS>^RT7#ME"9MF
M 5^50HOELJ2Z^KG85!C[R5=.B!SXX!UQUEKQKH15H ?^D9/0'FB)\L'*S7^Q
M9^E] 5*\Q*^T:*J%A1*=U%36N=+1;LD4CG4B,1O<?F1I[+L)PD#5;G[)O9X2
M"Q\%:@82+:O9'OX7'Z'8G4TG,Z9%ZP/)]_XVV+]_=S0:O.KIE7^QH6<QB0+O
M14]B<+M#YB3Q6%I;#4NCA)U)K<"O<<K/WYD$RG(')?'20A1<N@BO'>?).4G"
MDJ2-90,GV69V:B"I=N=<N#&EZ4 4R3\+73;$!0-@+E/<)W#ONX208F<3[EU,
MR-+BRY/,#_@^O=+G6\31OQEGOJ:=BU*8X:)/M,S+2+V(VLRI$:6U-2CVRC7#
MA19:W\Q$BHC2#E_!)N#2"=>A!4S"PZ,M OE:XF*%Q01]..X4WCO9/:.-LOB.
MN1-_97SE3O/]/EV$%)+_=@U2E.LM^<XEAAN84E POU?9U&DS1>%5S+E7D2];
M)+"(#16<"+NRG8<NNF';1;]EYVAXF4TZI'7:P'SE8+'2A/8X(3W_ RLV,.%@
M%+I$8@//5N=+H \',QW,TX.6JN@ZT&Z]]3L 2U8[;#LO7 :K6+*UZDT1A$):
M=^*G$MVN6*N#JZL?BSQ%526!!S7U4[%>KK4EI.;H9/E(N+G =^N)+(MN(%/L
M]-LFD6V=HZ5TBWN<EKE2M@2=]WQ+ND?+;29EY6GPZP.+'WSV.) 2[N[3)G5I
MR[[MK7IR C%&2!OM6EBVJ7;:U%IJM[:Y(F_16*R=P'RLBWOG_LB<..7A(<[X
M'Y!QVY0&LXQ-7L?&=AT%NW4.N@GA'YCYM6Y_2*G((2XYB6*/Q5=N% 3.(F'7
M^1<WGI] C/-\[8<$ /JEX@B4_X"+I9/(>X;_B?-K"9 H^#.ON&/<(1K>7RO%
M+Y- #[[?]29+D[6];]+[J[SZ*M^G\88G*)!77J$"O*J8(P)O0%.FX! &XC4
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M!3U\]L/'VJM\*";^7C0S?D]]CAO?6_EOY6R+;M:BY[7\C.58]3J&WM,_@2'
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MJK(T@?;\Q/V&J$/ !/K0:@=,KUBX0G,K3I!$" F/=CGY8<KB$($0.'PA *(
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M H?=&!@Q>721TS19$6%4I I>+./T$8BKWN^\+G14Y6.6+I0B6F#R%OEW4O_
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MN650E< Q^!NLG^ MU.N^R]*'8B[TV2P3C".C)8AWS.$Q&S6="3>H+_ P?0,
MS+ZBEL?L*8@LFT::"%@?I$E([P&?PT$TBX)M[+X*)TVHOT;PIF 5@QO'UB@X
M\P4T.C=I8)7"($[S7.A3F":'45C;_#$1^P VAY*MREI3D2?<WC0L375Y6<R>
M65;LUV*K/K@T^2JF,3*A^A)TBLY+]AK&$Z=&Z),X'J4,/BH1_".CEIBDK+-5
M>ANU&[".M/H9ASF&I6W5HK#5MB:,89'*0R383D26I6J\O!6XET-3]!S;_,MW
MR-9NBWFZ@E6*!2R0ICJ\G!6DP?ZPM,,=QP7".)V)52YDM@DOR65Y(#+(L_WG
M*L'LP QM0D(SMNA0!C>] HQJL_,*T@58E#@D$6^Q;J7!3_^O6<JV7:4+;C)=
M3[6X&90N-4[A<,1SCH4<U;;Y*TBC.J$M)NI7=O* ];W=UZ#X,7NJT3H(3;=$
MDH7#\0$84?0FIN9VE9)[6DS-<U2*B/Q.D[:5]U%&LK@ZB4LYX':-(RR%] 9(
M>F\(2A<?@D(VMQB:A52=N@^O=%NU.PE!V4#/)U3#@ )FVE]\M,EEF0W\ DR.
MX*(V33_\ 'ODM@6ND+T[?K2)N:39G9]$016F8 FD58)IV$'VL7'*H_;,;O'Z
MFJ._1RR":6[2':2A*Y9JSU+QE25.<,$8@P$4K/@(WDY6)%]TE9'B*WH1'3@8
MP$:DI"!+<)#2Y3$>L^)RW5IKMWI@@FS+WW_^_1HI?A"0]$:Q+HQ^D:">X92)
M5%4X1BS#:]Q,DBX"%A1X':?SY6@C"$B2MG<LZX@E&_L9I@Q=%;D%9?FH$C*S
M?)E%093<B:TEM4ZR97>[97M:\*S/=DT!FR^X\:=Y&J\*?/N\2]!'^E-V*;M!
MRV]5A[)W\'-+S 0,3W4?Y1&K,[CQ5T5Z.XM3OV#'4M\UNFE[]DRKVE,Y'B$Z
M4#YW47*#-/A&<DME_=LML6+@"QYNYE$8XN1VZ8>D[A7NL'Z@#,<^J0ZNT^[M
M SS#]4/F+V^FX+#\<4W^/J)9IF,Z55NTZO-5N87U](TZ9R+M("G#G75=1;P8
MC7[;,9:EUE H^:QSCHY:$=R^&UYD!Y%1ZU&[:P-KO>:JGE>7V,YC!1<P&L[(
MH^YH2^=OKSU*P+B*BF>WJ%[_\SJ"FWV[05?*/,.SGZZ^BSPT15YH:H;C(7-J
MS[S9%!O>-)C9KH7"*?XGTJ[>?"7]NX@T?,=X&;2_?Z#_VWE- 0\?TLD"EF]?
MKW=I7C"#]K<E*9\C@?8/;-I,OE<U7SPY_U(XZ(Z].]^?H"J-)BZ0S2345<)=
M$P5_"^)53CHWP*LAAFN"B#D79,?]10K&]I_TA;Z80>Z@T$9'*U.4G^R\6*#1
MM%57;]G <CBH(RG>=D\H6#)4SQ*..B+7H^@/K\1WRLZOG(Y 1\-6[5-::54C
M3\2#CB2U@IL70VG><L2FM3M&PQ/LRWZT: Y?ZU9:0@/:.HAS;NDANJG:U"M0
M7AFJ6S'&5AEB0*R)?M78#Q>2 )'63UCUF"VEF0ADY=1+91DJQV1+BY4!]A&E
M+7L>F$ P93]#?S^CU.MUE75-><",\4W:*S%IA$H,BO -O_L; D^_GVC>OI"$
MQKJ_[::+(WL-,.="<(<!EUN+.$NG ]E(7U-5VW"/V+RVIKSV?3I2I_675V]J
MO#Y;Q3-X"-K<B7'X+,UZ!=OWLT8?(30@%J9]:.C1EXUG% HS1Z1.?]WT@W0S
MJB*&"L7#J#+<3I:IFGQM]:T!1<"ZUE!3<G_7&N'&U^E8?F^4A7XQO.DBE.:4
M[<7%2GC;YM<]'-EFF4CZ"M4,I'5'.&H@I23F3.#(&:ZUHA?C?R,5G6 $D8;2
MB!Z-\C_K!F;!$V2JWM ,?E\;A003?-KA9>KG$>F&*IRIZVC6 !6'H0^JN8OI
MZJII5/74I+V=4FMO5Z>6//!C3,V[6NK*NBGDI):]073",\U"KMC33Y+#69&=
MMR^6"L07NB?#&5@?SA#X,DZ7U#HC^[.QM?NBGL"T[N=TE'V(F*EZ.IM_T;3%
M@MM8(UH#Q N;KU+(MF)E8I)2/=4[<^P":]LE.C?8@:_5V@(L@QE'0@K53O"O
M.CD"TG_=Y96#9MHTGX)ZZGHG TALBP8 3TC/9@DNXH>.@*[GAL@[JD&W'R&A
ML1)3TQK:1^SI\&.7>;?/0B5"5P_+L'AQ@&M7S1D[#_8T0[?##84@*K+Z9\\?
MLZ..Q2JCMKQ<G.5IDN!8J<(C#" L9V.P#MD^L(E_AY4Y]L,@724%)V.=Q&8&
MD6=S]>8+N#WY=LO\GE FF8TRI(P9!.ME224[]E2IK%G!%6.H8:#A8"Q!_<3P
M604="T[:</G%SDTV(8*4ZJE>-[/H;!6= D9K7?6%-'2;PCY\;$&Z^8);6AM>
MPP/L2PHPRPA?V_%S-9W9KUE/_01 =?-B4X4O H"2:C;JCODAG<*<UW41+VO'
M,2\%H_&V=OY.I_+&+(P?+J(DRFE-XOT%QB^?1E]>-Y'94P%)H^Q"M7]C.[)\
M#(U?1ZJ.+1]'IZUNCP?!RHB9V,5R;%EN@MV!2A"LDW1A0T>J42N5/3Q@>.]4
M#+>C*;P&SUZDU(I&@LT@RSX)#B.N6&LS2.P 7HUR)9\6@,P6$IN98GK>21GT
MH"D<ALF#" VC0B$];<4&=X9J<QK:L+)HB/?E&2PS.4CO$OA>FDA)$RA),D9
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M]L0Q^@(*]YH7VF$<HV4'G@+SK$;]_2:2-A#':&FD9R*3[VA" _$ .7I-O>U
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MGY,!FG"D(??@3#B'93-@DL1 *(>2$RPF)8EJ]SAC/93WI9XIZP0E9N;AIP#
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MM=6SAA6P<)EP.;I!2-D^L+W!:G: VHCM<7AV=H>GJ1O41E>5?R09OHOR@A;
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M+1T]2_U6J@&U#(W4JZ+=P#<5I(4WLS*3?A]U &]]^KX;:EH)6K@RJRYJJG^
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MF7/',T,5E_]S_K,*1ME,*^(9%20+/"-.@B)! W<Z.D>9Z!\Z*<J_?^Z^.-O
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M'1]?V$DGZ$\7 &WS1VEG(3T^; =_GAY-.H)2)6@/\"&/OX/^SES?I9_G@W2
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M<7!J;< WJC-<CT(N+.6AT^M-57^J8OO5ULM[:=U"HG).TEJEM**62X?M1*R
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MD?S%KC'3W$ZON;8S=)UVI<\(9(P'G7O/,_:0B6T?\M'WF@=4_:HKE9&5@'L
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M1H'V6 (5E *:,V$T)3A]H],#T*T5EM"AJ]8@2SE5ZMWT9E[/%A) /?$-UE0
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M>J <M49L)N@,&4.?]?2R,)/E\>G=]4TTB!I<YU>ZNO0M= 1C$$UG"(PA6LI
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MO"YK=^2O:M&[>^X'Y9OG2HAR\J687CX&U]-ZK;DVR]  %#.1 FN4=ZE7_4%
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M];3;XRY] ,:PN.@Y)I25R.,@5AF'?0_?MZ6_K=C+A#)+[6?>+%E&>@>,Y!9
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MXK<EP$1$Q$(MG5TOFC(PR+/E,ZGT,KS '_TDKE1N4=#Q("K?M51QH8'"BH*
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M!8TH(*%0@ 3MI$":>92Z<^X G&/0DU32SN!(?P3M'M39%U_I2W]>SNH+7RT
MMP[>KKFEQPN@.81,!6HE3WVV71?;T:E(*AXR).,L0%Q4A6TAT2).E\BXCKD
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M2IN<T3?BS[9)CSJB5R]H^%RG9]MW[H+M*@6?EUAXV?93@$6B1C!>^0"B[@/
MTA\ .'BIPTQ1G%.@T*8A41V Y]%3X<B2@;9OQ7J7OLURDL<9V=T75=:H,<'B
MU812ZF+B&PDV?,LG7FK:;@"JZ!01JCM8'KK^%BDZ*(%Z+<"45B \!4.=8I2
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MKL\NR-#LP%PB.HI$OS5"@9X[!8V8QUYH,,Q3/\:?:<(S7I9#G$ZU P2J50C
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MM%<O_&MVFQ_3E4.*<IY ))&) ]M(<.+%=A2&*?5"YU/--P;$ IBX:%  .R@
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M8(M]B#"2ZSDK%KFL1R]M1UD]I^\),_7L0_ 9]DU>LYCR\3/=[?@&'<E?SN-
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M":<Q21-L&G'LQJEK^K"I&*Z"[HF:MPQ,=\77"O%/;]@@5FUGQ264Q8*&7NR
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M/UHF[A5AWZ*8CJX\<,Y=2C%Q0PL3+XH\QW'3*#)@? 7K0C5'B(Y1]J )ZE6
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M4MI2[PS./ML[_6+^"P%TV9TUP03S[O8,YJ@!ZE2X&IR%7G6UBI=[O(3)2P&
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MMW$G9[Z'$ED4$YK$V#?]V#*<R+5LT&6H22G;9!$'H>O=C $ 03*&"\R6RA<
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M/XZ#NHB?YM\>/J:%,^LC8TI_9JV%$5(GJNKWHM6I^+TVJ96#O+![K5Z6W%S
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M54:_CA)]!T%<BJT7=/$#<WA[+5CLMI6&CHK0A07A1<HX?WMMU"TQ9#A0M/(
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M=47'<PQL>KY!7,=T;.)9@0,Z,#L.K7NJYU' 5R:)6^JN2M K*1N+!1ILAP]
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M$=,-*!-U**)TU 7:5WR",S'35\0$S.1/A'(J+O8KB>8OO$+A._JC_5-I 0L
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M\M%! ;37X +=%$6=%S6@(=P\*?/+2J5\P$QNG@H-=T"%\<I=?)L=?;W+<*)
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M_0[6XX]*5DQ[>=T6[X1PD[Y[90MC\=7K[""ZU[&MW/:$L9$,K(@VBE_,V)1
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M"KEWQI#V1S9-%,R,$0:C<#@YF'T<6%Y/O#68I%-"S&6YV<K5_U?<=KE=&<*
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M?+1R8S_7SQ==N%\W^W71VE^% #+3"%C$)>&"2)'G@5$T2%"<=G$+@"B<V!/
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M<"^'HU#*2,#^C)<0RSE0VKGZ[2F*F8*"JJ&>/=/*_F==W"Z6.O0BJ JDB@1
M=?DP;\-29X&M/^$"D=7OESDNE7#8.2,"HZF#C-@]%L)HN%T$-DO<"2#F21/%
M3OJYIU\AAH S%N<Y\_^JT(>V0QIBYXHL@I59@DX *&?&-.DR<G4I"_-A?9\,
M_H2M5B2,0Z!<5A<F$6N-EU%.@I<,'J4J[H%_(3 %5D8"\/ILM[)86_-.5FOO
MTVW.M-[=[%9U5Z:WUA6Z: F,&P1XGF&@J.5&H_JEM-#>]G&JXI[Y%X)78&4D
M *^VH%KI?EIZ^TLL@%IF*D>46KV\EQWW[+\0?&8*.X%#_[%C1^NXP8P7#\7
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M66)/$4'=&[9B.>!4,""1I%A 041P+ZF'E+A)U4LC9X*X4T3-P.[,O T5N97
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M0"8S:[')N+9+.5##E,6U10NBJ<^1"JBH].S300<PV=]1;8+5&C_X3%LVD8M
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ML]6V^%;;^A]\.,X$!E1X.\\PH8 [9VJ+KZBTTC$>^@ZFCY:X:2N+8BJ(^!.
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MP2(TA(8I2BI"'@9) 560 * &8VFM()K#0#EC@+&6:N0X1GGH.,,@04D%JL+
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M 4  "N,Y><C%+&/)D#4L8J3%22*8(KG0!&4%Y3FA^9P4N98%@]NCFHU!:R"
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M+,]ZY^J0Q^O:. =;RSS_MJM]7YO5PO\'4$L#!!0    ( !NA!5VOF&EH"0L
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M83(X.]MLO]O_B^+"_%\6_P=02P,$%     @ &Z$%79+%8,1)!@  B",  !(
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M@.DAA*;M!HTXS&VB@MO"8;JF>JY0\E _:B(R(:\_"5^P/$\R6!]<7Z7Z>))
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MJ>WCZHZG_D_T^-PD>">H=L&!FM4T!UJPJ(T>3@L.I"1&YW7[[#*.:0A\",K
MEK+/""XFC+ =_&P$,/S\AJ$<L! ^7$>+!_B;&>;P(Z-@DAQL<L\Z1YMDB6/9
MNED[Y_ZY_ 'FL?P!Y[]02P$"% ,4    "  ;H05=<$.F5 E2   ]8 4 '@
M            @ $     97@Q,#$M=&AI<F1A;65N9&5D<F5S=&%T960N:'1M
M4$L! A0#%     @ &Z$%77BSO>0IJ $ UZP9 !$              ( !15(
M &=D<G@M,C R-C V,S N:'1M4$L! A0#%     @ &Z$%77>V2?2R"P  ''@
M !$              ( !G?H! &=D<G@M,C R-C V,S N>'-D4$L! A0#%
M  @ &Z$%78CPZ/X9$@  M\   !4              ( !?@8" &=D<G@M,C R
M-C V,S!?8V%L+GAM;%!+ 0(4 Q0    ( !NA!5TMNZA+:BT  +QG @ 5
M          "  <H8 @!G9')X+3(P,C8P-C,P7V1E9BYX;6Q02P$"% ,4
M"  ;H05=1I[2J3VG  "1]08 %0              @ %G1@( 9V1R>"TR,#(V
M,#8S,%]L86(N>&UL4$L! A0#%     @ &Z$%7;BUO6V550  P9@$ !4
M         ( !U^T" &=D<G@M,C R-C V,S!?<')E+GAM;%!+ 0(4 Q0    (
M !NA!5UASCB@V0H  #1<   2              "  9]# P!G9')X<3(R-BUE
M>#,Q,2YH=&U02P$"% ,4    "  ;H05=KYAI: D+  #28@  $@
M    @ &H3@, 9V1R>'$R,C8M97@S,3(N:'1M4$L! A0#%     @ &Z$%79+%
M8,1)!@  B",  !(              ( !X5D# &=D<GAQ,C(V+65X,S(Q+FAT
M;5!+ 0(4 Q0    ( !NA!5UO#C ?@P8  ,<I   2              "  5I@
J P!G9')X<3(R-BUE>#,R,BYH=&U02P4&      L "P#6 @  #6<#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>gdrx-20260630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:gdrx="http://goodrx.com/20260630"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="gdrx-20260630.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-28</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-28</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:ResearchAndDevelopmentExpense</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:ResearchAndDevelopmentExpense</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:ResearchAndDevelopmentExpense</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:ResearchAndDevelopmentExpense</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:SellingAndMarketingExpense</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:SellingAndMarketingExpense</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:SellingAndMarketingExpense</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:SellingAndMarketingExpense</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:GeneralAndAdministrativeExpense</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:GeneralAndAdministrativeExpense</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:GeneralAndAdministrativeExpense</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:GeneralAndAdministrativeExpense</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gdrx:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gdrx:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">gdrx:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">gdrx:MinorityEquityInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">gdrx:OperatingLeaseRightOfUseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">gdrx:OperatingLeaseRightOfUseAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gdrx:VividRxClearRxIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-13</startDate>
            <endDate>2025-01-13</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gdrx:VitacarePrescriptionServicesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-13</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">gdrx:VitacarePrescriptionServicesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-13</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gdrx:FirstLienCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-10</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gdrx:FirstLienCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-10</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gdrx:FirstLienCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gdrx:FirstLienCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gdrx:FirstLienCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gdrx:FirstLienCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gdrx:A2024TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gdrx:A2024TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gdrx:FirstLienCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gdrx:FirstLienCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-02</startDate>
            <endDate>2023-03-30</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-30</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">gdrx:PrivacyProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-02</startDate>
            <endDate>2023-03-30</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">gdrx:ElectronicCommunicationPrivacyActPrivacyProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-02</startDate>
            <endDate>2023-03-30</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gdrx:SDFLClassActionMatterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-27</startDate>
            <endDate>2023-10-27</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gdrx:NDCAClassActionMatterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-25</startDate>
            <endDate>2024-11-25</endDate>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gdrx:SDFLClassActionMatterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gdrx:SDFLClassActionMatterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:PrepaidExpenseAndOtherAssetsCurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:PrepaidExpenseAndOtherAssetsCurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:PrescriptionTransactionsRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:PrescriptionTransactionsRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:PrescriptionTransactionsRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:PrescriptionTransactionsRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:SubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:SubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:SubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:SubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:PharmaManufacturerSolutionsRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:PharmaManufacturerSolutionsRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:PharmaManufacturerSolutionsRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:PharmaManufacturerSolutionsRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:OtherRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:OtherRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:OtherRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">gdrx:OtherRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">gdrx:NewRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-27</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">gdrx:NewRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">gdrx:FranciscoPartnersStockPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">gdrx:CommonClassAAndClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">gdrx:IdeaMenLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">gdrx:CommonClassAAndClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">gdrx:SpectrumStockPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">gdrx:CommonClassAAndClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">gdrx:CommonClassAAndClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">gdrx:CommonClassAAndClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">gdrx:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">gdrx:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">gdrx:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001809519</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">gdrx:StockOptionsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>gdrx:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="counterparty">
        <measure>gdrx:counterparty</measure>
    </unit>
    <unit id="plaintiff">
        <measure>gdrx:plaintiff</measure>
    </unit>
    <unit id="case">
        <measure>gdrx:case</measure>
    </unit>
    <unit id="defendant">
        <measure>gdrx:Defendant</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-26">0001809519</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-27">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-28">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-29">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-30">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2026-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-39549</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">GoodRx Holdings, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">47-5104396</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">2701 Olympic Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Santa Monica</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">90404</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">855</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">268-2822</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-15">Class A common stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-16">GDRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-17">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-23">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="0" id="f-24" unitRef="shares">107181201</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="0" id="f-25" unitRef="shares">233964187</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-31" unitRef="usd">296113000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-32" unitRef="usd">261820000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-3" id="f-33" unitRef="usd">182140000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-5" decimals="-3" id="f-34" unitRef="usd">235746000</us-gaap:AccountsReceivableNetCurrent>
    <gdrx:PrescriptionReimbursementAssetsCurrent contextRef="c-4" decimals="-3" id="f-35" unitRef="usd">1076012000</gdrx:PrescriptionReimbursementAssetsCurrent>
    <gdrx:PrescriptionReimbursementAssetsCurrent contextRef="c-5" decimals="-3" id="f-36" unitRef="usd">98331000</gdrx:PrescriptionReimbursementAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-37" unitRef="usd">45062000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-5" decimals="-3" id="f-38" unitRef="usd">47205000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-39" unitRef="usd">1599327000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-5" decimals="-3" id="f-40" unitRef="usd">643102000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-41" unitRef="usd">11514000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="-3" id="f-42" unitRef="usd">12268000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-43" unitRef="usd">430331000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-5" decimals="-3" id="f-44" unitRef="usd">430331000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-4" decimals="-3" id="f-45" unitRef="usd">58254000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-5" decimals="-3" id="f-46" unitRef="usd">64082000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:CapitalizedComputerSoftwareNet contextRef="c-4" decimals="-3" id="f-47" unitRef="usd">140300000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareNet contextRef="c-5" decimals="-3" id="f-48" unitRef="usd">139261000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-49" unitRef="usd">27630000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-50" unitRef="usd">28808000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-4" decimals="-3" id="f-51" unitRef="usd">47335000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-5" decimals="-3" id="f-52" unitRef="usd">57111000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-53" unitRef="usd">28237000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-5" decimals="-3" id="f-54" unitRef="usd">29095000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-55" unitRef="usd">2342928000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-5" decimals="-3" id="f-56" unitRef="usd">1404058000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-57" unitRef="usd">8906000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-5" decimals="-3" id="f-58" unitRef="usd">19405000</us-gaap:AccountsPayableCurrent>
    <gdrx:PrescriptionReimbursementLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-59" unitRef="usd">1039995000</gdrx:PrescriptionReimbursementLiabilitiesCurrent>
    <gdrx:PrescriptionReimbursementLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-60" unitRef="usd">130139000</gdrx:PrescriptionReimbursementLiabilitiesCurrent>
    <gdrx:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-4" decimals="-3" id="f-61" unitRef="usd">98610000</gdrx:AccruedExpensesAndOtherCurrentLiabilities>
    <gdrx:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-5" decimals="-3" id="f-62" unitRef="usd">86705000</gdrx:AccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:LongTermDebtCurrent contextRef="c-4" decimals="-3" id="f-63" unitRef="usd">5000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-5" decimals="-3" id="f-64" unitRef="usd">5000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-65" unitRef="usd">5358000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-66" unitRef="usd">4753000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-67" unitRef="usd">1157869000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-68" unitRef="usd">246002000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-4" decimals="-3" id="f-69" unitRef="usd">481588000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-5" decimals="-3" id="f-70" unitRef="usd">483264000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-71" unitRef="usd">47004000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-72" unitRef="usd">49789000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-73" unitRef="usd">8866000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-5" decimals="-3" id="f-74" unitRef="usd">8741000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-75" unitRef="usd">1695327000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-5" decimals="-3" id="f-76" unitRef="usd">787796000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-77" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-5" id="f-78" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-79"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-80"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="-3" id="f-81" unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-5" decimals="-3" id="f-82" unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-83" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-5" decimals="INF" id="f-84" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c-4" decimals="INF" id="f-85" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-86" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-4" decimals="-3" id="f-87" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-5" decimals="-3" id="f-88" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-6"
      decimals="INF"
      id="f-89"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-7"
      decimals="INF"
      id="f-90"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-8"
      decimals="INF"
      id="f-91"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-9"
      decimals="INF"
      id="f-92"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-9" decimals="-3" id="f-93" unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-8" decimals="-3" id="f-94" unitRef="shares">2000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-9" decimals="-3" id="f-95" unitRef="shares">106164000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-9" decimals="-3" id="f-96" unitRef="shares">106164000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-8" decimals="-3" id="f-97" unitRef="shares">107088000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-8" decimals="-3" id="f-98" unitRef="shares">107088000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-7" decimals="-3" id="f-99" unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-6" decimals="-3" id="f-100" unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-6" decimals="-3" id="f-101" unitRef="shares">233964000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-6" decimals="-3" id="f-102" unitRef="shares">233964000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-103" unitRef="usd">34000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-5" decimals="-3" id="f-104" unitRef="usd">34000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-4" decimals="-3" id="f-105" unitRef="usd">2048436000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-5" decimals="-3" id="f-106" unitRef="usd">2026802000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-107" unitRef="usd">-1400869000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="-3" id="f-108" unitRef="usd">-1410574000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-109" unitRef="usd">647601000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-110" unitRef="usd">616262000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-111" unitRef="usd">2342928000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-5" decimals="-3" id="f-112" unitRef="usd">1404058000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-10" decimals="-3" id="f-113" unitRef="usd">200411000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-11" decimals="-3" id="f-114" unitRef="usd">203070000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-115" unitRef="usd">394417000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-12" decimals="-3" id="f-116" unitRef="usd">406040000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-10" decimals="-3" id="f-117" unitRef="usd">20999000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-11" decimals="-3" id="f-118" unitRef="usd">13350000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-119" unitRef="usd">41155000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-12" decimals="-3" id="f-120" unitRef="usd">26714000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-10" decimals="-3" id="f-121" unitRef="usd">26711000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-11" decimals="-3" id="f-122" unitRef="usd">29933000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-123" unitRef="usd">56888000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-12" decimals="-3" id="f-124" unitRef="usd">61075000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-10" decimals="-3" id="f-125" unitRef="usd">81986000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-11" decimals="-3" id="f-126" unitRef="usd">84870000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-1" decimals="-3" id="f-127" unitRef="usd">163039000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-12" decimals="-3" id="f-128" unitRef="usd">169412000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-10" decimals="-3" id="f-129" unitRef="usd">24814000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-11" decimals="-3" id="f-130" unitRef="usd">28379000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-131" unitRef="usd">51633000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-12" decimals="-3" id="f-132" unitRef="usd">58009000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:DepreciationAndAmortization contextRef="c-10" decimals="-3" id="f-133" unitRef="usd">22269000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-11" decimals="-3" id="f-134" unitRef="usd">19729000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-1" decimals="-3" id="f-135" unitRef="usd">44061000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-12" decimals="-3" id="f-136" unitRef="usd">40641000</us-gaap:DepreciationAndAmortization>
    <us-gaap:CostsAndExpenses contextRef="c-10" decimals="-3" id="f-137" unitRef="usd">176779000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-11" decimals="-3" id="f-138" unitRef="usd">176261000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-1" decimals="-3" id="f-139" unitRef="usd">356776000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-12" decimals="-3" id="f-140" unitRef="usd">355851000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-10" decimals="-3" id="f-141" unitRef="usd">23632000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-11" decimals="-3" id="f-142" unitRef="usd">26809000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-143" unitRef="usd">37641000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-12" decimals="-3" id="f-144" unitRef="usd">50189000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-10" decimals="-3" id="f-145" unitRef="usd">625000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-11" decimals="-3" id="f-146" unitRef="usd">694000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-147" unitRef="usd">625000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-12" decimals="-3" id="f-148" unitRef="usd">694000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestIncomeOther contextRef="c-10" decimals="-3" id="f-149" unitRef="usd">1019000</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther contextRef="c-11" decimals="-3" id="f-150" unitRef="usd">2803000</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther contextRef="c-1" decimals="-3" id="f-151" unitRef="usd">2416000</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther contextRef="c-12" decimals="-3" id="f-152" unitRef="usd">6735000</us-gaap:InterestIncomeOther>
    <us-gaap:InterestExpenseNonoperating contextRef="c-10" decimals="-3" id="f-153" unitRef="usd">9810000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-11" decimals="-3" id="f-154" unitRef="usd">10729000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-1" decimals="-3" id="f-155" unitRef="usd">19577000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-12" decimals="-3" id="f-156" unitRef="usd">21373000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-10" decimals="-3" id="f-157" unitRef="usd">-8166000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-11" decimals="-3" id="f-158" unitRef="usd">-7232000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-159" unitRef="usd">-16536000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-12" decimals="-3" id="f-160" unitRef="usd">-13944000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-10" decimals="-3" id="f-161" unitRef="usd">15466000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-11" decimals="-3" id="f-162" unitRef="usd">19577000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-163" unitRef="usd">21105000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-12" decimals="-3" id="f-164" unitRef="usd">36245000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-10" decimals="-3" id="f-165" unitRef="usd">6930000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-11" decimals="-3" id="f-166" unitRef="usd">6734000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-167" unitRef="usd">11400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-12" decimals="-3" id="f-168" unitRef="usd">12350000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-10" decimals="-3" id="f-169" unitRef="usd">8536000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-11" decimals="-3" id="f-170" unitRef="usd">12843000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-171" unitRef="usd">9705000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-12" decimals="-3" id="f-172" unitRef="usd">23895000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-10"
      decimals="2"
      id="f-173"
      unitRef="usdPerShare">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-11"
      decimals="2"
      id="f-174"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-175"
      unitRef="usdPerShare">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-12"
      decimals="2"
      id="f-176"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-10"
      decimals="2"
      id="f-177"
      unitRef="usdPerShare">0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-11"
      decimals="2"
      id="f-178"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-179"
      unitRef="usdPerShare">0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-12"
      decimals="2"
      id="f-180"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-10" decimals="-3" id="f-181" unitRef="shares">339277000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-11" decimals="-3" id="f-182" unitRef="shares">356623000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-3" id="f-183" unitRef="shares">339839000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-12" decimals="-3" id="f-184" unitRef="shares">367847000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-10" decimals="-3" id="f-185" unitRef="shares">348058000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-11" decimals="-3" id="f-186" unitRef="shares">357159000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-3" id="f-187" unitRef="shares">344676000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-12" decimals="-3" id="f-188" unitRef="shares">368345000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-13" decimals="-3" id="f-189" unitRef="usd">58000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-14" decimals="-3" id="f-190" unitRef="usd">122000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-15" decimals="-3" id="f-191" unitRef="usd">110000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-16" decimals="-3" id="f-192" unitRef="usd">222000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-17" decimals="-3" id="f-193" unitRef="usd">4554000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-18" decimals="-3" id="f-194" unitRef="usd">6323000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-19" decimals="-3" id="f-195" unitRef="usd">8762000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-20" decimals="-3" id="f-196" unitRef="usd">11993000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-21" decimals="-3" id="f-197" unitRef="usd">4203000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-22" decimals="-3" id="f-198" unitRef="usd">5929000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-23" decimals="-3" id="f-199" unitRef="usd">8452000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-24" decimals="-3" id="f-200" unitRef="usd">11811000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-25" decimals="-3" id="f-201" unitRef="usd">7778000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-26" decimals="-3" id="f-202" unitRef="usd">9041000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-27" decimals="-3" id="f-203" unitRef="usd">15778000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-28" decimals="-3" id="f-204" unitRef="usd">16563000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SharesOutstanding contextRef="c-29" decimals="-3" id="f-205" unitRef="shares">341052000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-3" id="f-206" unitRef="usd">34000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-3" id="f-207" unitRef="usd">2026802000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-3" id="f-208" unitRef="usd">-1410574000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-209" unitRef="usd">616262000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-32" decimals="-3" id="f-210" unitRef="shares">192000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-33" decimals="-3" id="f-211" unitRef="usd">95000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-34" decimals="-3" id="f-212" unitRef="usd">95000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-33" decimals="-3" id="f-213" unitRef="usd">19683000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-34" decimals="-3" id="f-214" unitRef="usd">19683000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <gdrx:StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits contextRef="c-32" decimals="-3" id="f-215" unitRef="shares">2965000</gdrx:StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation contextRef="c-32" decimals="-3" id="f-216" unitRef="shares">1096000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-33" decimals="-3" id="f-217" unitRef="usd">2582000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-34" decimals="-3" id="f-218" unitRef="usd">2582000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares contextRef="c-32" decimals="-3" id="f-219" unitRef="shares">5536000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-33" decimals="-3" id="f-220" unitRef="usd">12641000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-34" decimals="-3" id="f-221" unitRef="usd">12641000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:NetIncomeLoss contextRef="c-35" decimals="-3" id="f-222" unitRef="usd">1169000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-34" decimals="-3" id="f-223" unitRef="usd">1169000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c-36" decimals="-3" id="f-224" unitRef="shares">337577000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-36" decimals="-3" id="f-225" unitRef="usd">34000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-37" decimals="-3" id="f-226" unitRef="usd">2031357000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-3" id="f-227" unitRef="usd">-1409405000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-3" id="f-228" unitRef="usd">621986000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-40" decimals="-3" id="f-229" unitRef="usd">19835000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-10" decimals="-3" id="f-230" unitRef="usd">19835000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <gdrx:StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits contextRef="c-41" decimals="-3" id="f-231" unitRef="shares">3729000</gdrx:StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation contextRef="c-41" decimals="-3" id="f-232" unitRef="shares">1335000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-40" decimals="-3" id="f-233" unitRef="usd">3186000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-10" decimals="-3" id="f-234" unitRef="usd">3186000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-40" decimals="-3" id="f-235" unitRef="usd">-61000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-10" decimals="-3" id="f-236" unitRef="usd">-61000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-10" decimals="-3" id="f-237" unitRef="shares">157000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-40" decimals="-3" id="f-238" unitRef="usd">369000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-10" decimals="-3" id="f-239" unitRef="usd">369000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:NetIncomeLoss contextRef="c-42" decimals="-3" id="f-240" unitRef="usd">8536000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-10" decimals="-3" id="f-241" unitRef="usd">8536000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c-43" decimals="-3" id="f-242" unitRef="shares">340128000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-43" decimals="-3" id="f-243" unitRef="usd">34000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-44" decimals="-3" id="f-244" unitRef="usd">2048436000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-45" decimals="-3" id="f-245" unitRef="usd">-1400869000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-246" unitRef="usd">647601000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding contextRef="c-46" decimals="-3" id="f-247" unitRef="shares">382815000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-46" decimals="-3" id="f-248" unitRef="usd">38000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-47" decimals="-3" id="f-249" unitRef="usd">2165633000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-48" decimals="-3" id="f-250" unitRef="usd">-1441013000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-49" decimals="-3" id="f-251" unitRef="usd">724658000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-50" decimals="-3" id="f-252" unitRef="shares">4000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-51" decimals="-3" id="f-253" unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-52" decimals="-3" id="f-254" unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-51" decimals="-3" id="f-255" unitRef="usd">23312000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-52" decimals="-3" id="f-256" unitRef="usd">23312000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <gdrx:StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits contextRef="c-50" decimals="-3" id="f-257" unitRef="shares">2136000</gdrx:StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation contextRef="c-50" decimals="-3" id="f-258" unitRef="shares">802000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-51" decimals="-3" id="f-259" unitRef="usd">3757000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-52" decimals="-3" id="f-260" unitRef="usd">3757000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares contextRef="c-50" decimals="-3" id="f-261" unitRef="shares">23340000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-50" decimals="-3" id="f-262" unitRef="usd">2000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-51" decimals="-3" id="f-263" unitRef="usd">100918000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-52" decimals="-3" id="f-264" unitRef="usd">100920000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:NetIncomeLoss contextRef="c-53" decimals="-3" id="f-265" unitRef="usd">11052000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-52" decimals="-3" id="f-266" unitRef="usd">11052000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c-54" decimals="-3" id="f-267" unitRef="shares">360813000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-54" decimals="-3" id="f-268" unitRef="usd">36000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-55" decimals="-3" id="f-269" unitRef="usd">2084272000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-56" decimals="-3" id="f-270" unitRef="usd">-1429961000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-57" decimals="-3" id="f-271" unitRef="usd">654347000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-58" decimals="-3" id="f-272" unitRef="shares">2000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-59" decimals="-3" id="f-273" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-11" decimals="-3" id="f-274" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-59" decimals="-3" id="f-275" unitRef="usd">25880000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-11" decimals="-3" id="f-276" unitRef="usd">25880000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <gdrx:StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits contextRef="c-58" decimals="-3" id="f-277" unitRef="shares">3014000</gdrx:StockIssuedDuringPeriodSharesVestingOfRestrictedStockUnits>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation contextRef="c-58" decimals="-3" id="f-278" unitRef="shares">1056000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-59" decimals="-3" id="f-279" unitRef="usd">4548000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-11" decimals="-3" id="f-280" unitRef="usd">4548000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares contextRef="c-58" decimals="-3" id="f-281" unitRef="shares">10224000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-58" decimals="-3" id="f-282" unitRef="usd">1000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-59" decimals="-3" id="f-283" unitRef="usd">46351000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-11" decimals="-3" id="f-284" unitRef="usd">46352000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-58" decimals="-3" id="f-285" unitRef="shares">222000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-59" decimals="-3" id="f-286" unitRef="usd">860000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-11" decimals="-3" id="f-287" unitRef="usd">860000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:NetIncomeLoss contextRef="c-60" decimals="-3" id="f-288" unitRef="usd">12843000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-11" decimals="-3" id="f-289" unitRef="usd">12843000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c-61" decimals="-3" id="f-290" unitRef="shares">352771000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-61" decimals="-3" id="f-291" unitRef="usd">35000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-62" decimals="-3" id="f-292" unitRef="usd">2060114000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-63" decimals="-3" id="f-293" unitRef="usd">-1417118000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-64" decimals="-3" id="f-294" unitRef="usd">643031000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-65" decimals="-5" id="f-295" unitRef="shares">20000000.0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-66" decimals="-5" id="f-296" unitRef="usd">84900000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-297" unitRef="usd">9705000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-12" decimals="-3" id="f-298" unitRef="usd">23895000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization contextRef="c-1" decimals="-3" id="f-299" unitRef="usd">44061000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-12" decimals="-3" id="f-300" unitRef="usd">40641000</us-gaap:DepreciationAndAmortization>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-1" decimals="-3" id="f-301" unitRef="usd">932000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-12" decimals="-3" id="f-302" unitRef="usd">869000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-3" id="f-303" unitRef="usd">1910000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-12" decimals="-3" id="f-304" unitRef="usd">2065000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-305" unitRef="usd">33102000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-12" decimals="-3" id="f-306" unitRef="usd">40589000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-307" unitRef="usd">9776000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-12" decimals="-3" id="f-308" unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <gdrx:LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets contextRef="c-1" decimals="-3" id="f-309" unitRef="usd">0</gdrx:LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets>
    <gdrx:LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets contextRef="c-12" decimals="-3" id="f-310" unitRef="usd">4409000</gdrx:LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement contextRef="c-1" decimals="-3" id="f-311" unitRef="usd">1069000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement contextRef="c-12" decimals="-3" id="f-312" unitRef="usd">456000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-3" id="f-313" unitRef="usd">-53606000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-12" decimals="-3" id="f-314" unitRef="usd">43093000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <gdrx:IncreaseDecreaseInPrescriptionReimbursementAssets contextRef="c-1" decimals="-3" id="f-315" unitRef="usd">977681000</gdrx:IncreaseDecreaseInPrescriptionReimbursementAssets>
    <gdrx:IncreaseDecreaseInPrescriptionReimbursementAssets contextRef="c-12" decimals="-3" id="f-316" unitRef="usd">16027000</gdrx:IncreaseDecreaseInPrescriptionReimbursementAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-317" unitRef="usd">-2929000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-12" decimals="-3" id="f-318" unitRef="usd">-231000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-3" id="f-319" unitRef="usd">-9871000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-12" decimals="-3" id="f-320" unitRef="usd">3579000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <gdrx:IncreaseDecreaseInPrescriptionReimbursableLiabilities contextRef="c-1" decimals="-3" id="f-321" unitRef="usd">909856000</gdrx:IncreaseDecreaseInPrescriptionReimbursableLiabilities>
    <gdrx:IncreaseDecreaseInPrescriptionReimbursableLiabilities contextRef="c-12" decimals="-3" id="f-322" unitRef="usd">-1313000</gdrx:IncreaseDecreaseInPrescriptionReimbursableLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c-1" decimals="-3" id="f-323" unitRef="usd">16063000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c-12" decimals="-3" id="f-324" unitRef="usd">5585000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <gdrx:IncreaseDecreaseOperatingLeaseLiabilities contextRef="c-1" decimals="-3" id="f-325" unitRef="usd">-2912000</gdrx:IncreaseDecreaseOperatingLeaseLiabilities>
    <gdrx:IncreaseDecreaseOperatingLeaseLiabilities contextRef="c-12" decimals="-3" id="f-326" unitRef="usd">-3187000</gdrx:IncreaseDecreaseOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="c-1" decimals="-3" id="f-327" unitRef="usd">125000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="c-12" decimals="-3" id="f-328" unitRef="usd">294000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-329" unitRef="usd">92670000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-12" decimals="-3" id="f-330" unitRef="usd">58993000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-331" unitRef="usd">1498000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-12" decimals="-3" id="f-332" unitRef="usd">532000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-1" decimals="-3" id="f-333" unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-12" decimals="-3" id="f-334" unitRef="usd">30000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsForSoftware contextRef="c-1" decimals="-3" id="f-335" unitRef="usd">34555000</us-gaap:PaymentsForSoftware>
    <us-gaap:PaymentsForSoftware contextRef="c-12" decimals="-3" id="f-336" unitRef="usd">39659000</us-gaap:PaymentsForSoftware>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-337" unitRef="usd">-36053000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-12" decimals="-3" id="f-338" unitRef="usd">-70191000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-1" decimals="-3" id="f-339" unitRef="usd">2500000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-12" decimals="-3" id="f-340" unitRef="usd">2500000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-3" id="f-341" unitRef="usd">14520000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-12" decimals="-3" id="f-342" unitRef="usd">145888000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="-3" id="f-343" unitRef="usd">95000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-12" decimals="-3" id="f-344" unitRef="usd">3000</us-gaap:ProceedsFromStockOptionsExercised>
    <gdrx:EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards contextRef="c-1" decimals="-3" id="f-345" unitRef="usd">5768000</gdrx:EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards>
    <gdrx:EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards contextRef="c-12" decimals="-3" id="f-346" unitRef="usd">8305000</gdrx:EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards>
    <us-gaap:ProceedsFromStockPlans contextRef="c-1" decimals="-3" id="f-347" unitRef="usd">369000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans contextRef="c-12" decimals="-3" id="f-348" unitRef="usd">860000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-349" unitRef="usd">-22324000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-12" decimals="-3" id="f-350" unitRef="usd">-155830000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-351" unitRef="usd">34293000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-12" decimals="-3" id="f-352" unitRef="usd">-167028000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-5" decimals="-3" id="f-353" unitRef="usd">261820000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-49" decimals="-3" id="f-354" unitRef="usd">448346000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-4" decimals="-3" id="f-355" unitRef="usd">296113000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-64" decimals="-3" id="f-356" unitRef="usd">281318000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-357" unitRef="usd">732000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-12" decimals="-3" id="f-358" unitRef="usd">9098000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <gdrx:NoncashStockBasedCompensationIncludedInCapitalizedSoftware contextRef="c-1" decimals="-3" id="f-359" unitRef="usd">6416000</gdrx:NoncashStockBasedCompensationIncludedInCapitalizedSoftware>
    <gdrx:NoncashStockBasedCompensationIncludedInCapitalizedSoftware contextRef="c-12" decimals="-3" id="f-360" unitRef="usd">8603000</gdrx:NoncashStockBasedCompensationIncludedInCapitalizedSoftware>
    <gdrx:CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities contextRef="c-1" decimals="-3" id="f-361" unitRef="usd">5485000</gdrx:CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities>
    <gdrx:CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities contextRef="c-12" decimals="-3" id="f-362" unitRef="usd">6645000</gdrx:CapitalizedSoftwareIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-65" decimals="-5" id="f-363" unitRef="shares">20000000.0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-66" decimals="-5" id="f-364" unitRef="usd">84900000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="c-1" id="f-365">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:102.9pt"&gt;Description of Business&lt;/span&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:112.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:174.11pt"&gt;GoodRx Holdings, Inc. was incorporated in &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:250.61pt;position:var(--position);text-decoration:none;white-space:pre;width:66.68pt"&gt;September 2015&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:317.28999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:236.21pt"&gt; and has no material assets or standalone operations other&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:123pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt"&gt;than its ownership in its consolidated subsidiaries. GoodRx, Inc. ("GoodRx"), a Delaware corporation initially formed in&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:133.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt"&gt;September 2011, is a wholly-owned subsidiary of GoodRx Intermediate Holdings, LLC, which itself is a wholly-owned&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:144.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:142.93pt"&gt;subsidiary of GoodRx Holdings, Inc.&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:201.43pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:161.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.87pt"&gt;GoodRx Holdings, Inc. and its subsidiaries (collectively, "we," "us" or "our") offer information and tools to help&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:172.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt"&gt;consumers compare prices and save on their prescription drug purchases. We operate a price comparison platform that&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:183pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt"&gt;provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:193.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt"&gt;through our codes that can be used to save money on prescriptions across the United States (the "prescription transactions&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:204.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt"&gt;offering"). We also offer other healthcare products and services, including subscription programs, solutions for&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:215.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt"&gt;pharmaceutical manufacturers and other customers, referred to as GoodRx Pharma Direct ("Pharma Direct"), and telehealth&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:226.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:35.48pt"&gt;services.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-366">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:188.84pt"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:257.34000000000003pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:271.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:91.92pt"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:150.42000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:288.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:477pt"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:299.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt"&gt;accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) and applicable rules and regulations of the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:310.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt"&gt;Securities and Exchange Commission (&#x201c;SEC&#x201d;) regarding interim financial information. Certain information and disclosures&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:321pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt"&gt;normally included in our annual consolidated financial statements prepared in accordance with GAAP have been condensed&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:331.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt"&gt;or omitted. Accordingly, these condensed consolidated financial statements should be read in conjunction with our audited&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:342.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:215.88pt"&gt;consolidated financial statements for the year ended &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:274.38pt;position:var(--position);text-decoration:none;white-space:pre;width:80.53pt"&gt;December&#160;31, 2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:354.91pt;position:var(--position);text-decoration:none;white-space:pre;width:198.43pt"&gt; and the related notes, which are included in our&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:353.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:210.48pt"&gt;Annual Report on Form 10-K filed with the SEC on &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:268.98pt;position:var(--position);text-decoration:none;white-space:pre;width:74.89pt"&gt;February&#160;26, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:343.87pt;position:var(--position);text-decoration:none;white-space:pre;width:9.39pt"&gt; ("&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:353.26pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:373.26pt;position:var(--position);text-decoration:none;white-space:pre;width:52.63pt"&gt; 10-K"). The &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:425.89pt;position:var(--position);text-decoration:none;white-space:pre;width:80.39pt"&gt;December&#160;31, 2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:506.28pt;position:var(--position);text-decoration:none;white-space:pre;width:47.21pt"&gt; condensed&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:364.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt"&gt;consolidated balance sheet was derived from our audited consolidated financial statements as of that date. The condensed&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:375pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt"&gt;consolidated financial statements include, in the opinion of management, all adjustments, consisting of normal and recurring&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:385.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt"&gt;items, necessary for the fair statement of our condensed consolidated financial statements. The operating results for the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:396.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:178.17pt"&gt;three and six months ended June 30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:236.67pt;position:var(--position);text-decoration:none;white-space:pre;width:316.66pt"&gt; are not necessarily indicative of the results expected for the full year ending&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:407.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt"&gt;December&#160;31, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:137.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:424.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:328.28pt"&gt;There have been no material changes in significant accounting policies during the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:404.78pt;position:var(--position);text-decoration:none;white-space:pre;width:148.69pt"&gt;three and six months ended June 30,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:435pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:78.5pt;position:var(--position);text-decoration:none;white-space:pre;width:123.17pt"&gt; from those disclosed in &#x201c;Note &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:201.67pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt"&gt;2&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:206.67pt;position:var(--position);text-decoration:none;white-space:pre;width:5.29pt"&gt;. &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:211.96pt;position:var(--position);text-decoration:none;white-space:pre;width:173.57pt"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:385.53pt;position:var(--position);text-decoration:none;white-space:pre;width:167.95pt"&gt;&#x201d; in the notes to our consolidated financial&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:445.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:107.45pt"&gt;statements included in our &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:165.95pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:185.95pt;position:var(--position);text-decoration:none;white-space:pre;width:23.99pt"&gt; 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:474.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:116.38pt"&gt;Principles of Consolidation&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:174.88pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:491.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:477pt"&gt;The condensed consolidated financial statements include the accounts of GoodRx Holdings, Inc., its wholly owned&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:502.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt"&gt;subsidiaries and variable interest entities for which we are the primary beneficiary. Intercompany balances and transactions&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:513pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt"&gt;have been eliminated in consolidation. Results of businesses acquired are included in our condensed consolidated financial&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:523.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:209.9pt"&gt;statements from their respective dates of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:552.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:82.91pt"&gt;Segment Reporting&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:569.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.96pt"&gt;Operating segments are defined as components of an enterprise for which separate financial information is available&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:580.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt"&gt;that is regularly provided to the chief operating decision maker ("CODM") in deciding how to allocate resources and in&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:591pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:299.38pt"&gt;assessing performance. Our CODM manages our business on the basis of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:357.88pt;position:var(--position);text-decoration:none;white-space:pre;width:15pt"&gt;one&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:372.88pt;position:var(--position);text-decoration:none;white-space:pre;width:79.47pt"&gt; operating segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:607.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:320.63pt"&gt;Our operating segment derives revenue in a manner as described in "Note &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:397.13pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt"&gt;2&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:402.13pt;position:var(--position);text-decoration:none;white-space:pre;width:6.84pt"&gt;. &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:408.97pt;position:var(--position);text-decoration:none;white-space:pre;width:144.46pt"&gt;Summary of Significant Accounting&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:618.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:30.97pt"&gt;Policies&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:89.47pt;position:var(--position);text-decoration:none;white-space:pre;width:300.07pt"&gt;" in the notes to our consolidated financial statements included in our &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:389.54pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:409.54pt;position:var(--position);text-decoration:none;white-space:pre;width:143.89pt"&gt; 10-K. Our CODM is our principal&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:629.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt"&gt;executive officer, who is our Chief Executive Officer and President. Consolidated net income or loss is the measure of&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:640.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt"&gt;segment profit or loss reviewed by our CODM in assessing segment performance and deciding how to allocate resources.&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:651pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt"&gt;Our CODM uses consolidated net income or loss to monitor budget versus actual results, review historical company&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:661.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt"&gt;performance trends, conduct benchmark analysis of our peers and competitors, and evaluate management&#x2019;s compensation.&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:672.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt"&gt;Significant expenses included in the reported measure of segment profit or loss regularly provided to our CODM are on a&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:683.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:416.38pt"&gt;consolidated basis as presented in the accompanying condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:72.45pt"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:61.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.97pt"&gt;The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:72.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt"&gt;make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:83.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt"&gt;including the accompanying notes. We base our estimates on historical factors; current circumstances; macroeconomic&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:94.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt"&gt;events and conditions; and the experience and judgment of our management. We evaluate our estimates and assumptions&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:105pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.98pt"&gt;on an ongoing basis. Actual results can differ materially from these estimates, and such differences can affect the results of&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:115.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:147.42pt"&gt;operations reported in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:144.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:144.36pt"&gt;Certain Risks and Concentrations&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:202.86pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:161.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.99pt"&gt;Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:172.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:168.95pt"&gt;cash equivalents and accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:189pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.98pt"&gt;We maintain cash deposits with multiple financial institutions in the United States which, at times, may exceed federally&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:199.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt"&gt;insured limits. Cash may be withdrawn or redeemed on demand. We believe that the financial institutions that hold our cash&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:210.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt"&gt;are financially sound and, accordingly, minimal credit risk exists with respect to these balances. However, market conditions&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:221.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt"&gt;can impact the viability of these institutions. In the event of failure of any of the financial institutions where we maintain our&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:232.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.81pt"&gt;cash and cash equivalents, there can be no assurance that we will be able to access uninsured funds in a timely manner or&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.31pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:243pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:242.77pt"&gt;at all. We have not experienced any losses in such accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:259.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.9pt"&gt;We consider all short-term, highly liquid investments purchased with an original maturity of three months or less at the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:270.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt"&gt;date of purchase to be cash equivalents. Cash equivalents, consisting of U.S. treasury securities money market funds, of&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:281.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:55.39pt"&gt;$114.0 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:113.89pt;position:var(--position);text-decoration:none;white-space:pre;width:21.2pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:135.09pt;position:var(--position);text-decoration:none;white-space:pre;width:56.05pt"&gt;$164.0 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:191.14pt;position:var(--position);text-decoration:none;white-space:pre;width:13.7pt"&gt; at &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:204.84pt;position:var(--position);text-decoration:none;white-space:pre;width:58.2pt"&gt;June&#160;30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:263.03999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:21.2pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:284.24pt;position:var(--position);text-decoration:none;white-space:pre;width:80.17pt"&gt;December&#160;31, 2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:364.41pt;position:var(--position);text-decoration:none;white-space:pre;width:189.05pt"&gt;, respectively, were classified as Level 1 of the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:292.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:305.34pt"&gt;fair value hierarchy and valued using quoted market prices in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:309pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.99pt"&gt;We extend credit to our customers based on an evaluation of their ability to pay amounts due under contractual&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:319.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:251.63pt"&gt;arrangements and generally do not obtain or require collateral.&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:310.13pt;position:var(--position);text-decoration:none;white-space:pre;width:67.53pt"&gt; For each of the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:377.66pt;position:var(--position);text-decoration:none;white-space:pre;width:173.34pt"&gt;three and six months ended June 30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:551pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt;,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:330.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:10pt"&gt;no&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:143.57pt"&gt; customer accounted for more than &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:212.07pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt"&gt;10%&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:230.07pt;position:var(--position);text-decoration:none;white-space:pre;width:130.62pt"&gt; of our revenue. For each of the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:360.69pt;position:var(--position);text-decoration:none;white-space:pre;width:172.36pt"&gt;three and six months ended June 30, 2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:533.05pt;position:var(--position);text-decoration:none;white-space:pre;width:5.27pt"&gt;, &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:538.3199999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:15pt"&gt;one&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3199999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:341.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:97.04pt"&gt;customer accounted for &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:155.54000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt"&gt;12%&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:173.54000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:63.55pt"&gt; of our revenue.&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:237.09pt;position:var(--position);text-decoration:none;white-space:pre;width:13.39pt"&gt; At &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:250.48pt;position:var(--position);text-decoration:none;white-space:pre;width:57.38pt"&gt;June&#160;30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:307.86pt;position:var(--position);text-decoration:none;white-space:pre;width:5.19pt"&gt;, &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:313.05pt;position:var(--position);text-decoration:none;white-space:pre;width:15pt"&gt;one&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:328.05pt;position:var(--position);text-decoration:none;white-space:pre;width:97.04pt"&gt; customer accounted for&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:425.09pt;position:var(--position);text-decoration:none;white-space:pre;width:2.69pt"&gt; &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:427.78pt;position:var(--position);text-decoration:none;white-space:pre;width:17.34pt"&gt;11%&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:445.12pt;position:var(--position);text-decoration:none;white-space:pre;width:2.69pt"&gt; &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:447.81pt;position:var(--position);text-decoration:none;white-space:pre;width:105.53pt"&gt;of our accounts receivable&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:352.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:47pt"&gt;balance. At &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:105.5pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt"&gt;December&#160;31, 2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:184.47pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt"&gt;, &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:189.47pt;position:var(--position);text-decoration:none;white-space:pre;width:10pt"&gt;no&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:199.47pt;position:var(--position);text-decoration:none;white-space:pre;width:141.95pt"&gt; customer accounted for more than &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:341.42pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt"&gt;10%&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:359.42pt;position:var(--position);text-decoration:none;white-space:pre;width:143.95pt"&gt; of our accounts receivable balance.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:381pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:342.75pt"&gt;Prescription Reimbursement Assets and Prescription Reimbursement Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:397.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.87pt"&gt;Consumer direct pricing is an affordability solution under our pharma direct offering that allows pharma manufacturers to&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:408.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt"&gt;use our platform to set and fund a portion of the consumer cash price for their prescription drugs at the point of sale. We&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:419.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt"&gt;generally require deposits from pharma manufacturers which are included as a component of prescription reimbursement&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:430.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt"&gt;liabilities on our condensed consolidated balance sheets and shall not be offset against other amounts owed to us. We&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:441pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt"&gt;generally invoice pharma manufacturers for the funded amounts a month in arrears and payment is generally due within&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:451.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt"&gt;thirty days of invoicing. Funded amounts owed to us are presented as a component of prescription reimbursement assets on&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:462.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:177.96pt"&gt;our condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:479.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.91pt"&gt;We remit reimbursements of the funded amounts to pharmacies, or intermediaries. Funded amounts owed to&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:490.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:447.2pt"&gt;pharmacies, or intermediaries, are presented as a component of prescription reimbursement liabilities on our&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:505.7pt;position:var(--position);text-decoration:none;white-space:pre;width:47.73pt"&gt; condensed&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:501pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:55.54pt"&gt;consolidated &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:114.03999999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:439.4pt"&gt;balance sheets. Pharmacies, or intermediaries, may also require deposits from us. These deposits are&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:511.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt"&gt;included as a component of prescription reimbursement assets on our condensed consolidated balance sheets and shall not&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:522.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:159.14pt"&gt;be offset against other amounts owed &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:217.64pt;position:var(--position);text-decoration:none;white-space:pre;width:48.92pt"&gt;to them. At &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:266.56pt;position:var(--position);text-decoration:none;white-space:pre;width:59.28pt"&gt;June&#160;30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:325.84pt;position:var(--position);text-decoration:none;white-space:pre;width:22.28pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:348.12pt;position:var(--position);text-decoration:none;white-space:pre;width:81.25pt"&gt;December&#160;31, 2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:429.37pt;position:var(--position);text-decoration:none;white-space:pre;width:124.11pt"&gt;, a majority of our prescription&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:533.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:112.93pt"&gt;reimbursement assets were &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:171.43pt;position:var(--position);text-decoration:none;white-space:pre;width:18.48pt"&gt;with &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:189.91pt;position:var(--position);text-decoration:none;white-space:pre;width:13.99pt"&gt;two&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:203.9pt;position:var(--position);text-decoration:none;white-space:pre;width:59.47pt"&gt; counterparties&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:263.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:562.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:82.43pt"&gt;Equity Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:579pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.96pt"&gt;We retain minority equity interests in privately-held companies without readily determinable fair values. Our ownership&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:589.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:97.34pt"&gt;interests are less than &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:155.84pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt"&gt;20%&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:173.84pt;position:var(--position);text-decoration:none;white-space:pre;width:379.63pt"&gt; of the voting stock of the investees and we do not have the ability to exercise significant&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:600.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt"&gt;influence over the operating and financial policies of the investees. The equity investments are accounted for under the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:611.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:404.8pt"&gt;measurement alternative in accordance with Accounting Standards Codification ("ASC") 321, &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:463.3pt;position:var(--position);text-decoration:none;white-space:pre;width:90.2pt"&gt;Investments &#x2013; Equity&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:622.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:39.47pt"&gt;Securities&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:97.97pt;position:var(--position);text-decoration:none;white-space:pre;width:455.36pt"&gt;, which is cost minus impairment, if any, plus or minus changes resulting from observable price changes. We did&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:633pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt"&gt;not recognize any changes resulting from observable price changes or impairment losses on our minority equity interest&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:643.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:93.2pt"&gt;investments during the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:151.7pt;position:var(--position);text-decoration:none;white-space:pre;width:171.03pt"&gt;three and six months ended June 30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:322.73pt;position:var(--position);text-decoration:none;white-space:pre;width:20.16pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:342.89pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:362.89pt;position:var(--position);text-decoration:none;white-space:pre;width:190.49pt"&gt;. Equity investments included in other assets on&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:654.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:199.94pt"&gt;our condensed consolidated balance sheets were &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:258.44pt;position:var(--position);text-decoration:none;white-space:pre;width:50.45pt"&gt;$15.0 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:308.89pt;position:var(--position);text-decoration:none;white-space:pre;width:24.5pt"&gt; as of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:333.39pt;position:var(--position);text-decoration:none;white-space:pre;width:57pt"&gt;June&#160;30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:390.39pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:410.39pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt"&gt;December&#160;31, 2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:489.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:683.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:142.36pt"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:700.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:335.34pt"&gt;We account for the impairment of long-lived assets in accordance with ASC 360, &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:411.84pt;position:var(--position);text-decoration:none;white-space:pre;width:128.1pt"&gt;Property, Plant, and Equipment&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:539.94pt;position:var(--position);text-decoration:none;white-space:pre;width:13.55pt"&gt;. In&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:711pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt"&gt;accordance with ASC 360, long-lived assets to be held and used are reviewed for impairment when events or changes in&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:721.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.84pt"&gt;circumstances indicate that their carrying values may not be recoverable. We perform impairment testing at the asset group&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:732.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt"&gt;level that represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt"&gt;assets and liabilities. An impairment loss is recognized when estimated undiscounted future cash flows expected to result&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:55.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt"&gt;from the use of the asset and its eventual disposition are less than its carrying value. If an asset is determined to be&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:66.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:438.79pt"&gt;impaired, the impairment is measured by the amount that the carrying value of the asset exceeds its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:83.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:352.98pt"&gt;During the three months ended March 31, 2025, we recognized an impairment loss of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:429.48pt;position:var(--position);text-decoration:none;white-space:pre;width:46.21pt"&gt;$4.4&#160;million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:475.69pt;position:var(--position);text-decoration:none;white-space:pre;width:77.73pt"&gt; within general and&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:94.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:425.74pt"&gt;administrative expenses to reduce the carrying value of an asset group to its estimated fair value of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:484.24pt;position:var(--position);text-decoration:none;white-space:pre;width:47.18pt"&gt;$3.4&#160;million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:531.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:22.06pt"&gt;. The&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:105pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt"&gt;impairment charge was due to a significant deterioration in the sublease market and rental rates whereby the carrying value&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:115.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt"&gt;of the asset group was not recoverable. We otherwise have not recognized any impairment losses of our long-lived assets&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:126.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:42.48pt"&gt;during the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:100.97999999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:170.47pt"&gt;three and six months ended June 30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:271.45pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:291.45pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:311.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:155.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:157.83pt"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:172.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:183.95pt"&gt;Recently Adopted Accounting Pronouncement&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:189pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.95pt"&gt;In July 2025, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU")&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:199.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:39.62pt"&gt;2025-05, &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:98.12pt;position:var(--position);text-decoration:none;white-space:pre;width:455.32pt"&gt;Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:210.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:300.32pt"&gt;Contract Assets for Private Companies and Certain Not-For-Profit Entities. &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:358.82pt;position:var(--position);text-decoration:none;white-space:pre;width:194.66pt"&gt;This ASU amends ASC 326-20 in part to provide&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:221.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt"&gt;a practical expedient election to assume that current conditions as of the balance sheet date do not change for the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:232.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt"&gt;remaining life of current accounts receivable and/or current contract assets arising from transactions accounted for under&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.34pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:243pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:47.55pt"&gt;Topic 606, &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:106.05pt;position:var(--position);text-decoration:none;white-space:pre;width:170.02pt"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:276.07pt;position:var(--position);text-decoration:none;white-space:pre;width:277.35pt"&gt;. This ASU is effective for all entities for annual reporting periods&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:253.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt"&gt;beginning after December 15, 2025, and for interim reporting periods within those annual reporting periods. We adopted this&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:264.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt"&gt;standard effective January 1, 2026, and the adoption did not have a material impact on our condensed consolidated&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:275.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:81.96pt"&gt;financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:298.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:255.43pt"&gt;Recently Issued Accounting Pronouncements - Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:315pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:218.4pt"&gt;In September 2025, the FASB issued ASU 2025-06, &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:294.9pt;position:var(--position);text-decoration:none;white-space:pre;width:258.55pt"&gt;Intangibles-Goodwill and Other-Internal-Use Software (Subtopic&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:325.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:37.58pt"&gt;350-40), &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:96.08pt;position:var(--position);text-decoration:none;white-space:pre;width:457.29pt"&gt;which amends certain aspects of the accounting for and disclosure of software costs under ASC 350-40. The&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:336.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt"&gt;amendments in this ASU, amongst other things, eliminate accounting considerations of software development stages and&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:347.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt"&gt;instead require entities to capitalize internal-use software costs when management commits to funding the software project&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:358.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.98pt"&gt;and it is probable the project will be completed and will be used to perform the function intended. This ASU will be effective&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:369pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt"&gt;for all entities for annual reporting periods beginning after December 15, 2027, and for interim reporting periods within those&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:379.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt"&gt;annual reporting periods. Early adoption of this ASU is permitted and can be applied retrospectively, prospectively or on a&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:390.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.83pt"&gt;modified prospective basis. We are currently evaluating the impact of the adoption of this ASU on our consolidated financial&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:401.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:141.44pt"&gt;statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:418.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:211.81pt"&gt;In November 2024, the FASB issued ASU 2024-03, &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:288.31pt;position:var(--position);text-decoration:none;white-space:pre;width:265.07pt"&gt;Income Statement - Reporting Comprehensive Income - Expense&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:429pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:376.4pt"&gt;Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:434.9pt;position:var(--position);text-decoration:none;white-space:pre;width:118.48pt"&gt;, which is intended to improve&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:439.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt"&gt;the disclosures of expenses by providing more detailed information about the types of expenses in commonly presented&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:450.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt"&gt;expense captions. This ASU requires entities to disclose the amounts of purchases of inventory, employee compensation,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:461.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt"&gt;depreciation and intangible asset amortization included in each relevant expense caption; as well as a qualitative description&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:472.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt"&gt;of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. This ASU also&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:483pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt"&gt;requires disclosure of the total amount of selling expense and, in annual reporting periods, an entity&#x2019;s definition of selling&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:493.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.84pt"&gt;expenses. In January 2025, the FASB issued ASU 2025-01 which clarified the effective date of this ASU. This ASU applies&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:504.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt"&gt;to all public entities and will be effective for fiscal years beginning after December 15, 2026, and for interim periods within&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:515.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt"&gt;fiscal years beginning after December 15, 2027. Early adoption of this ASU is permitted. This ASU should be applied either&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:526.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:495pt"&gt;prospectively to financial statements issued for reporting periods after the effective date of this ASU or retrospectively to any&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:537pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt"&gt;or all prior periods presented in the financial statements. We are currently evaluating the impact of the adoption of this ASU&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:547.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:210.4pt"&gt;on our consolidated financial statements disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-367">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:91.92pt"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:150.42000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:288.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:477pt"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:299.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt"&gt;accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) and applicable rules and regulations of the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:310.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt"&gt;Securities and Exchange Commission (&#x201c;SEC&#x201d;) regarding interim financial information. Certain information and disclosures&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:321pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt"&gt;normally included in our annual consolidated financial statements prepared in accordance with GAAP have been condensed&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:331.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt"&gt;or omitted. Accordingly, these condensed consolidated financial statements should be read in conjunction with our audited&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:342.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:215.88pt"&gt;consolidated financial statements for the year ended &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:274.38pt;position:var(--position);text-decoration:none;white-space:pre;width:80.53pt"&gt;December&#160;31, 2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:354.91pt;position:var(--position);text-decoration:none;white-space:pre;width:198.43pt"&gt; and the related notes, which are included in our&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:353.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:210.48pt"&gt;Annual Report on Form 10-K filed with the SEC on &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:268.98pt;position:var(--position);text-decoration:none;white-space:pre;width:74.89pt"&gt;February&#160;26, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:343.87pt;position:var(--position);text-decoration:none;white-space:pre;width:9.39pt"&gt; ("&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:353.26pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:373.26pt;position:var(--position);text-decoration:none;white-space:pre;width:52.63pt"&gt; 10-K"). The &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:425.89pt;position:var(--position);text-decoration:none;white-space:pre;width:80.39pt"&gt;December&#160;31, 2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:506.28pt;position:var(--position);text-decoration:none;white-space:pre;width:47.21pt"&gt; condensed&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:364.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt"&gt;consolidated balance sheet was derived from our audited consolidated financial statements as of that date. The condensed&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:375pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt"&gt;consolidated financial statements include, in the opinion of management, all adjustments, consisting of normal and recurring&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:385.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt"&gt;items, necessary for the fair statement of our condensed consolidated financial statements. The operating results for the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:396.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:178.17pt"&gt;three and six months ended June 30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:236.67pt;position:var(--position);text-decoration:none;white-space:pre;width:316.66pt"&gt; are not necessarily indicative of the results expected for the full year ending&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:407.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt"&gt;December&#160;31, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:137.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:424.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:328.28pt"&gt;There have been no material changes in significant accounting policies during the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:404.78pt;position:var(--position);text-decoration:none;white-space:pre;width:148.69pt"&gt;three and six months ended June 30,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:435pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:78.5pt;position:var(--position);text-decoration:none;white-space:pre;width:123.17pt"&gt; from those disclosed in &#x201c;Note &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:201.67pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt"&gt;2&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:206.67pt;position:var(--position);text-decoration:none;white-space:pre;width:5.29pt"&gt;. &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:211.96pt;position:var(--position);text-decoration:none;white-space:pre;width:173.57pt"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:385.53pt;position:var(--position);text-decoration:none;white-space:pre;width:167.95pt"&gt;&#x201d; in the notes to our consolidated financial&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:445.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:107.45pt"&gt;statements included in our &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:165.95pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:185.95pt;position:var(--position);text-decoration:none;white-space:pre;width:23.99pt"&gt; 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-368">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:116.38pt"&gt;Principles of Consolidation&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:174.88pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:491.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:477pt"&gt;The condensed consolidated financial statements include the accounts of GoodRx Holdings, Inc., its wholly owned&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:502.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt"&gt;subsidiaries and variable interest entities for which we are the primary beneficiary. Intercompany balances and transactions&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:513pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt"&gt;have been eliminated in consolidation. Results of businesses acquired are included in our condensed consolidated financial&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:523.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:209.9pt"&gt;statements from their respective dates of acquisition.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c-1" id="f-369">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:82.91pt"&gt;Segment Reporting&lt;/span&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:569.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.96pt"&gt;Operating segments are defined as components of an enterprise for which separate financial information is available&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:580.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt"&gt;that is regularly provided to the chief operating decision maker ("CODM") in deciding how to allocate resources and in&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:591pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:299.38pt"&gt;assessing performance. Our CODM manages our business on the basis of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:357.88pt;position:var(--position);text-decoration:none;white-space:pre;width:15pt"&gt;one&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:372.88pt;position:var(--position);text-decoration:none;white-space:pre;width:79.47pt"&gt; operating segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:607.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:320.63pt"&gt;Our operating segment derives revenue in a manner as described in "Note &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:397.13pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt"&gt;2&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:402.13pt;position:var(--position);text-decoration:none;white-space:pre;width:6.84pt"&gt;. &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:408.97pt;position:var(--position);text-decoration:none;white-space:pre;width:144.46pt"&gt;Summary of Significant Accounting&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:618.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:30.97pt"&gt;Policies&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:89.47pt;position:var(--position);text-decoration:none;white-space:pre;width:300.07pt"&gt;" in the notes to our consolidated financial statements included in our &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:389.54pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:409.54pt;position:var(--position);text-decoration:none;white-space:pre;width:143.89pt"&gt; 10-K. Our CODM is our principal&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:629.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt"&gt;executive officer, who is our Chief Executive Officer and President. Consolidated net income or loss is the measure of&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:640.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt"&gt;segment profit or loss reviewed by our CODM in assessing segment performance and deciding how to allocate resources.&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:651pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt"&gt;Our CODM uses consolidated net income or loss to monitor budget versus actual results, review historical company&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:661.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt"&gt;performance trends, conduct benchmark analysis of our peers and competitors, and evaluate management&#x2019;s compensation.&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:672.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt"&gt;Significant expenses included in the reported measure of segment profit or loss regularly provided to our CODM are on a&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:683.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:416.38pt"&gt;consolidated basis as presented in the accompanying condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-370"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-371">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:72.45pt"&gt;Use of Estimates&lt;/span&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:61.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.97pt"&gt;The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:72.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt"&gt;make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:83.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt"&gt;including the accompanying notes. We base our estimates on historical factors; current circumstances; macroeconomic&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:94.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt"&gt;events and conditions; and the experience and judgment of our management. We evaluate our estimates and assumptions&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:105pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.98pt"&gt;on an ongoing basis. Actual results can differ materially from these estimates, and such differences can affect the results of&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:115.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:147.42pt"&gt;operations reported in future periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-372">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:144.36pt"&gt;Certain Risks and Concentrations&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:202.86pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:161.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.99pt"&gt;Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:172.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:168.95pt"&gt;cash equivalents and accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:189pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.98pt"&gt;We maintain cash deposits with multiple financial institutions in the United States which, at times, may exceed federally&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:199.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt"&gt;insured limits. Cash may be withdrawn or redeemed on demand. We believe that the financial institutions that hold our cash&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:210.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt"&gt;are financially sound and, accordingly, minimal credit risk exists with respect to these balances. However, market conditions&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:221.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt"&gt;can impact the viability of these institutions. In the event of failure of any of the financial institutions where we maintain our&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:232.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.81pt"&gt;cash and cash equivalents, there can be no assurance that we will be able to access uninsured funds in a timely manner or&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.31pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:243pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:242.77pt"&gt;at all. We have not experienced any losses in such accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:259.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.9pt"&gt;We consider all short-term, highly liquid investments purchased with an original maturity of three months or less at the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:270.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt"&gt;date of purchase to be cash equivalents. Cash equivalents, consisting of U.S. treasury securities money market funds, of&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:281.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:55.39pt"&gt;$114.0 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:113.89pt;position:var(--position);text-decoration:none;white-space:pre;width:21.2pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:135.09pt;position:var(--position);text-decoration:none;white-space:pre;width:56.05pt"&gt;$164.0 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:191.14pt;position:var(--position);text-decoration:none;white-space:pre;width:13.7pt"&gt; at &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:204.84pt;position:var(--position);text-decoration:none;white-space:pre;width:58.2pt"&gt;June&#160;30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:263.03999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:21.2pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:284.24pt;position:var(--position);text-decoration:none;white-space:pre;width:80.17pt"&gt;December&#160;31, 2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:364.41pt;position:var(--position);text-decoration:none;white-space:pre;width:189.05pt"&gt;, respectively, were classified as Level 1 of the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:292.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:305.34pt"&gt;fair value hierarchy and valued using quoted market prices in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:309pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.99pt"&gt;We extend credit to our customers based on an evaluation of their ability to pay amounts due under contractual&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:251.63pt"&gt;arrangements and generally do not obtain or require collateral.&lt;/span&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-67" decimals="-5" id="f-373" unitRef="usd">114000000.0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-68" decimals="-5" id="f-374" unitRef="usd">164000000.0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-69" decimals="2" id="f-375" unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-70" decimals="2" id="f-376" unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-71" decimals="2" id="f-377" unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <gdrx:PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock contextRef="c-1" id="f-378">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:342.75pt"&gt;Prescription Reimbursement Assets and Prescription Reimbursement Liabilities&lt;/span&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:397.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.87pt"&gt;Consumer direct pricing is an affordability solution under our pharma direct offering that allows pharma manufacturers to&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:408.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt"&gt;use our platform to set and fund a portion of the consumer cash price for their prescription drugs at the point of sale. We&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:419.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt"&gt;generally require deposits from pharma manufacturers which are included as a component of prescription reimbursement&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:430.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt"&gt;liabilities on our condensed consolidated balance sheets and shall not be offset against other amounts owed to us. We&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:441pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt"&gt;generally invoice pharma manufacturers for the funded amounts a month in arrears and payment is generally due within&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:451.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt"&gt;thirty days of invoicing. Funded amounts owed to us are presented as a component of prescription reimbursement assets on&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:462.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:177.96pt"&gt;our condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:479.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.91pt"&gt;We remit reimbursements of the funded amounts to pharmacies, or intermediaries. Funded amounts owed to&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:490.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:447.2pt"&gt;pharmacies, or intermediaries, are presented as a component of prescription reimbursement liabilities on our&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:505.7pt;position:var(--position);text-decoration:none;white-space:pre;width:47.73pt"&gt; condensed&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:501pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:55.54pt"&gt;consolidated &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:114.03999999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:439.4pt"&gt;balance sheets. Pharmacies, or intermediaries, may also require deposits from us. These deposits are&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:511.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt"&gt;included as a component of prescription reimbursement assets on our condensed consolidated balance sheets and shall not&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:522.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:159.14pt"&gt;be offset against other amounts owed &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:217.64pt;position:var(--position);text-decoration:none;white-space:pre;width:48.92pt"&gt;to them. At &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:266.56pt;position:var(--position);text-decoration:none;white-space:pre;width:59.28pt"&gt;June&#160;30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:325.84pt;position:var(--position);text-decoration:none;white-space:pre;width:22.28pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:348.12pt;position:var(--position);text-decoration:none;white-space:pre;width:81.25pt"&gt;December&#160;31, 2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:429.37pt;position:var(--position);text-decoration:none;white-space:pre;width:124.11pt"&gt;, a majority of our prescription&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:533.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:112.93pt"&gt;reimbursement assets were &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:171.43pt;position:var(--position);text-decoration:none;white-space:pre;width:18.48pt"&gt;with &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:189.91pt;position:var(--position);text-decoration:none;white-space:pre;width:13.99pt"&gt;two&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:203.9pt;position:var(--position);text-decoration:none;white-space:pre;width:59.47pt"&gt; counterparties&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:263.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt;.&lt;/span&gt;&lt;/div&gt;</gdrx:PrescriptionReimbursementAssetsAndPrescriptionReimbursementLiabilitiesPolicyTextBlock>
    <gdrx:PrescriptionReimbursementAssetsNumberOfCounterparties
      contextRef="c-4"
      decimals="INF"
      id="f-379"
      unitRef="counterparty">2</gdrx:PrescriptionReimbursementAssetsNumberOfCounterparties>
    <gdrx:PrescriptionReimbursementAssetsNumberOfCounterparties
      contextRef="c-5"
      decimals="INF"
      id="f-380"
      unitRef="counterparty">2</gdrx:PrescriptionReimbursementAssetsNumberOfCounterparties>
    <us-gaap:EquityMethodInvestmentsPolicy contextRef="c-1" id="f-381">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:82.43pt"&gt;Equity Investments&lt;/span&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:579pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.96pt"&gt;We retain minority equity interests in privately-held companies without readily determinable fair values. Our ownership&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:589.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:97.34pt"&gt;interests are less than &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:155.84pt;position:var(--position);text-decoration:none;white-space:pre;width:18pt"&gt;20%&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:173.84pt;position:var(--position);text-decoration:none;white-space:pre;width:379.63pt"&gt; of the voting stock of the investees and we do not have the ability to exercise significant&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:600.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt"&gt;influence over the operating and financial policies of the investees. The equity investments are accounted for under the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:611.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:404.8pt"&gt;measurement alternative in accordance with Accounting Standards Codification ("ASC") 321, &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:463.3pt;position:var(--position);text-decoration:none;white-space:pre;width:90.2pt"&gt;Investments &#x2013; Equity&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:622.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:39.47pt"&gt;Securities&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:97.97pt;position:var(--position);text-decoration:none;white-space:pre;width:455.36pt"&gt;, which is cost minus impairment, if any, plus or minus changes resulting from observable price changes. We did&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:633pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt"&gt;not recognize any changes resulting from observable price changes or impairment losses on our minority equity interest&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:643.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:93.2pt"&gt;investments during the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:151.7pt;position:var(--position);text-decoration:none;white-space:pre;width:171.03pt"&gt;three and six months ended June 30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:322.73pt;position:var(--position);text-decoration:none;white-space:pre;width:20.16pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:342.89pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:362.89pt;position:var(--position);text-decoration:none;white-space:pre;width:190.49pt"&gt;. Equity investments included in other assets on&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:654.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:199.94pt"&gt;our condensed consolidated balance sheets were &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:258.44pt;position:var(--position);text-decoration:none;white-space:pre;width:50.45pt"&gt;$15.0 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:308.89pt;position:var(--position);text-decoration:none;white-space:pre;width:24.5pt"&gt; as of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:333.39pt;position:var(--position);text-decoration:none;white-space:pre;width:57pt"&gt;June&#160;30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:390.39pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:410.39pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt"&gt;December&#160;31, 2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:489.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-72" decimals="2" id="f-382" unitRef="number">0.20</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-4" decimals="-5" id="f-383" unitRef="usd">15000000.0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-5" decimals="-5" id="f-384" unitRef="usd">15000000.0</us-gaap:EquityMethodInvestments>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c-1" id="f-385">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:142.36pt"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:700.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:335.34pt"&gt;We account for the impairment of long-lived assets in accordance with ASC 360, &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:411.84pt;position:var(--position);text-decoration:none;white-space:pre;width:128.1pt"&gt;Property, Plant, and Equipment&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:539.94pt;position:var(--position);text-decoration:none;white-space:pre;width:13.55pt"&gt;. In&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:711pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt"&gt;accordance with ASC 360, long-lived assets to be held and used are reviewed for impairment when events or changes in&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:721.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.84pt"&gt;circumstances indicate that their carrying values may not be recoverable. We perform impairment testing at the asset group&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:732.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt"&gt;level that represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt"&gt;assets and liabilities. An impairment loss is recognized when estimated undiscounted future cash flows expected to result&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:55.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt"&gt;from the use of the asset and its eventual disposition are less than its carrying value. If an asset is determined to be&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:66.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:438.79pt"&gt;impaired, the impairment is measured by the amount that the carrying value of the asset exceeds its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:83.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:352.98pt"&gt;During the three months ended March 31, 2025, we recognized an impairment loss of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:429.48pt;position:var(--position);text-decoration:none;white-space:pre;width:46.21pt"&gt;$4.4&#160;million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:475.69pt;position:var(--position);text-decoration:none;white-space:pre;width:77.73pt"&gt; within general and&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:94.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:425.74pt"&gt;administrative expenses to reduce the carrying value of an asset group to its estimated fair value of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:484.24pt;position:var(--position);text-decoration:none;white-space:pre;width:47.18pt"&gt;$3.4&#160;million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:531.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:22.06pt"&gt;. The&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:105pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt"&gt;impairment charge was due to a significant deterioration in the sublease market and rental rates whereby the carrying value&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:115.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt"&gt;of the asset group was not recoverable. We otherwise have not recognized any impairment losses of our long-lived assets&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:126.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:42.48pt"&gt;during the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:100.97999999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:170.47pt"&gt;three and six months ended June 30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:271.45pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:291.45pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:311.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:TangibleAssetImpairmentCharges contextRef="c-73" decimals="-5" id="f-386" unitRef="usd">4400000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-74" decimals="-5" id="f-387" unitRef="usd">3400000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-388">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:157.83pt"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:172.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:183.95pt"&gt;Recently Adopted Accounting Pronouncement&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:189pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.95pt"&gt;In July 2025, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU")&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:199.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:39.62pt"&gt;2025-05, &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:98.12pt;position:var(--position);text-decoration:none;white-space:pre;width:455.32pt"&gt;Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:210.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:300.32pt"&gt;Contract Assets for Private Companies and Certain Not-For-Profit Entities. &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:358.82pt;position:var(--position);text-decoration:none;white-space:pre;width:194.66pt"&gt;This ASU amends ASC 326-20 in part to provide&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:221.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt"&gt;a practical expedient election to assume that current conditions as of the balance sheet date do not change for the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:232.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt"&gt;remaining life of current accounts receivable and/or current contract assets arising from transactions accounted for under&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.34pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:243pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:47.55pt"&gt;Topic 606, &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:106.05pt;position:var(--position);text-decoration:none;white-space:pre;width:170.02pt"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:276.07pt;position:var(--position);text-decoration:none;white-space:pre;width:277.35pt"&gt;. This ASU is effective for all entities for annual reporting periods&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:253.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt"&gt;beginning after December 15, 2025, and for interim reporting periods within those annual reporting periods. We adopted this&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:264.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt"&gt;standard effective January 1, 2026, and the adoption did not have a material impact on our condensed consolidated&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:275.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:81.96pt"&gt;financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:298.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:255.43pt"&gt;Recently Issued Accounting Pronouncements - Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:315pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:218.4pt"&gt;In September 2025, the FASB issued ASU 2025-06, &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:294.9pt;position:var(--position);text-decoration:none;white-space:pre;width:258.55pt"&gt;Intangibles-Goodwill and Other-Internal-Use Software (Subtopic&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:325.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:37.58pt"&gt;350-40), &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:96.08pt;position:var(--position);text-decoration:none;white-space:pre;width:457.29pt"&gt;which amends certain aspects of the accounting for and disclosure of software costs under ASC 350-40. The&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:336.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt"&gt;amendments in this ASU, amongst other things, eliminate accounting considerations of software development stages and&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:347.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt"&gt;instead require entities to capitalize internal-use software costs when management commits to funding the software project&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:358.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.98pt"&gt;and it is probable the project will be completed and will be used to perform the function intended. This ASU will be effective&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:369pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt"&gt;for all entities for annual reporting periods beginning after December 15, 2027, and for interim reporting periods within those&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:379.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt"&gt;annual reporting periods. Early adoption of this ASU is permitted and can be applied retrospectively, prospectively or on a&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:390.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.83pt"&gt;modified prospective basis. We are currently evaluating the impact of the adoption of this ASU on our consolidated financial&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:401.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:141.44pt"&gt;statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:418.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:211.81pt"&gt;In November 2024, the FASB issued ASU 2024-03, &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:288.31pt;position:var(--position);text-decoration:none;white-space:pre;width:265.07pt"&gt;Income Statement - Reporting Comprehensive Income - Expense&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:429pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:376.4pt"&gt;Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:434.9pt;position:var(--position);text-decoration:none;white-space:pre;width:118.48pt"&gt;, which is intended to improve&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:439.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt"&gt;the disclosures of expenses by providing more detailed information about the types of expenses in commonly presented&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:450.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt"&gt;expense captions. This ASU requires entities to disclose the amounts of purchases of inventory, employee compensation,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:461.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt"&gt;depreciation and intangible asset amortization included in each relevant expense caption; as well as a qualitative description&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:472.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt"&gt;of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. This ASU also&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:483pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt"&gt;requires disclosure of the total amount of selling expense and, in annual reporting periods, an entity&#x2019;s definition of selling&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:493.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.84pt"&gt;expenses. In January 2025, the FASB issued ASU 2025-01 which clarified the effective date of this ASU. This ASU applies&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:504.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt"&gt;to all public entities and will be effective for fiscal years beginning after December 15, 2026, and for interim periods within&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:515.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt"&gt;fiscal years beginning after December 15, 2027. Early adoption of this ASU is permitted. This ASU should be applied either&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:526.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:495pt"&gt;prospectively to financial statements issued for reporting periods after the effective date of this ASU or retrospectively to any&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:537pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt"&gt;or all prior periods presented in the financial statements. We are currently evaluating the impact of the adoption of this ASU&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:547.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:210.4pt"&gt;on our consolidated financial statements disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="c-1" id="f-389">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Business Combination&lt;/span&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:593.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.91pt"&gt;On January 13, 2025, we acquired substantially all of the assets and assembled workforce of VCRx, a prescription&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:604.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:177.33pt"&gt;savings business of Vivid Clear Rx, Inc., for &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:235.83pt;position:var(--position);text-decoration:none;white-space:pre;width:50.71pt"&gt;$30.0 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:286.53999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:266.96pt"&gt; in cash. VCRx operates a price comparison platform that provides&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:615pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:495pt"&gt;consumer prescription savings through its partnership with PBMs. The acquisition expands our consumer reach particularly&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:625.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:208.22pt"&gt;with respect to our prescription transactions offering.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:642.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:194.22pt"&gt;Goodwill associated with this acquisition totaled &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:270.72pt;position:var(--position);text-decoration:none;white-space:pre;width:50.18pt"&gt;$11.0 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:320.9pt;position:var(--position);text-decoration:none;white-space:pre;width:232.48pt"&gt; and primarily related to the expected long-term synergies&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:653.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt"&gt;and other benefits, including the acquired assembled workforce. The goodwill is deductible for tax purposes. Identifiable&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:664.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:123.6pt"&gt;intangible assets related to this&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:182.1pt;position:var(--position);text-decoration:none;white-space:pre;width:47.55pt"&gt; acquisition &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:229.65pt;position:var(--position);text-decoration:none;white-space:pre;width:29.53pt"&gt;totaled &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:259.18pt;position:var(--position);text-decoration:none;white-space:pre;width:50.49pt"&gt;$19.0 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:309.66999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:40.6pt"&gt;, of which &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:350.27pt;position:var(--position);text-decoration:none;white-space:pre;width:50.49pt"&gt;$18.1 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:400.76pt;position:var(--position);text-decoration:none;white-space:pre;width:152.66pt"&gt; was attributable to a customer related&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:675pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:190.4pt"&gt;intangible asset, with an estimated useful life of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:248.9pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt"&gt;6&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:253.9pt;position:var(--position);text-decoration:none;white-space:pre;width:24.49pt"&gt; years&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:278.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-75" decimals="-5" id="f-390" unitRef="usd">30000000.0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:Goodwill contextRef="c-76" decimals="-5" id="f-391" unitRef="usd">11000000.0</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-76" decimals="-5" id="f-392" unitRef="usd">19000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="c-77" decimals="-5" id="f-393" unitRef="usd">18100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-77" id="f-394">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="c-1" id="f-395">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Accrued Expenses and Other Current Liabilities&lt;/span&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:61.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:276.85pt"&gt;Accrued expenses and other current liabilities consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="position:var(--position);top:84.6pt;width:612pt"&gt;&lt;div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:0"&gt;&lt;td style="padding:0;width:331.5pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:80.25pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:80.25pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.27pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:14.15pt;position:var(--position);text-decoration:none;white-space:pre"&gt;June 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:4.16pt;position:var(--position);text-decoration:none;white-space:pre"&gt;December 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:14.25pt;width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Accrued bonus and other payroll related&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);top:14.25pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:41.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:49.010000000000005pt;position:var(--position)"&gt;23,691&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);top:14.25pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:41.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:49.010000000000005pt;position:var(--position)"&gt;25,434&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:28.5pt;width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Accrued legal settlement&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);top:28.5pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:46.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:49.010000000000005pt;position:var(--position)"&gt;30,500&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);top:28.5pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:46.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:49.010000000000005pt;position:var(--position)"&gt;30,500&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:42.75pt;width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Accrued marketing&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);top:42.75pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:46.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:49.010000000000005pt;position:var(--position)"&gt;20,255&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);top:42.75pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:46.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:49.010000000000005pt;position:var(--position)"&gt;11,063&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:57pt;width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Deferred revenue&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);top:57pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:51.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:54.010000000000005pt;position:var(--position)"&gt;8,767&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);top:57pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:51.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:54.010000000000005pt;position:var(--position)"&gt;6,705&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15.75pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:71.25pt;width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:5.81pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Other accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);top:71.25pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:5.81pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:46.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:49.010000000000005pt;position:var(--position)"&gt;15,397&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);top:71.25pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:5.81pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:46.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:49.010000000000005pt;position:var(--position)"&gt;13,003&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15.75pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:87pt;width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:5.81pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Total accrued expenses and other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);top:87pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:5.81pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:41.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:49.010000000000005pt;position:var(--position)"&gt;98,610&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);top:87pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:5.81pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:41.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:49.010000000000005pt;position:var(--position)"&gt;86,705&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:198.35pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.9pt"&gt;Deferred revenue represents payments received in advance for subscriptions and providing services for certain&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:209.15pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:153.08pt"&gt;advertising contracts with customers&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:211.58pt;position:var(--position);text-decoration:none;white-space:pre;width:246.45pt"&gt;. We expect substantially all of the deferred revenue at &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:458.03pt;position:var(--position);text-decoration:none;white-space:pre;width:62.44pt"&gt;June&#160;30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:520.47pt;position:var(--position);text-decoration:none;white-space:pre;width:32.9pt"&gt; will be&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:219.95pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:273.61pt"&gt;recognized as revenue within the subsequent twelve months. Of the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:332.11pt;position:var(--position);text-decoration:none;white-space:pre;width:45.57pt"&gt;$6.7 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:377.68pt;position:var(--position);text-decoration:none;white-space:pre;width:94.07pt"&gt; of deferred revenue at &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:471.75pt;position:var(--position);text-decoration:none;white-space:pre;width:79.21pt"&gt;December&#160;31, 2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:550.96pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt;,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:230.75pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:45.57pt"&gt;$0.9 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:104.07pt;position:var(--position);text-decoration:none;white-space:pre;width:20.24pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:124.31pt;position:var(--position);text-decoration:none;white-space:pre;width:45.57pt"&gt;$5.4 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:169.88pt;position:var(--position);text-decoration:none;white-space:pre;width:157.78pt"&gt; was recognized as revenue during the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:327.66pt;position:var(--position);text-decoration:none;white-space:pre;width:171.31pt"&gt;three and six months ended June 30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:498.97pt;position:var(--position);text-decoration:none;white-space:pre;width:54.43pt"&gt;, respectively.&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:241.55pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:127.61pt"&gt;Revenue recognized during the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:186.11pt;position:var(--position);text-decoration:none;white-space:pre;width:170.75pt"&gt;three and six months ended June 30, 2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:356.86pt;position:var(--position);text-decoration:none;white-space:pre;width:12.58pt"&gt; of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:369.44pt;position:var(--position);text-decoration:none;white-space:pre;width:45.49pt"&gt;$0.9 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:414.93pt;position:var(--position);text-decoration:none;white-space:pre;width:20.08pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:435.01pt;position:var(--position);text-decoration:none;white-space:pre;width:45.49pt"&gt;$5.2 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:480.5pt;position:var(--position);text-decoration:none;white-space:pre;width:72.88pt"&gt;, respectively, was&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:252.35pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:128.95pt"&gt;included as deferred revenue at &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:187.45pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt"&gt;December&#160;31, 2024&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:266.41999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-396">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:276.85pt"&gt;Accrued expenses and other current liabilities consist of the following:&lt;/span&gt;&lt;div style="position:var(--position);top:84.6pt;width:612pt"&gt;&lt;div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:0"&gt;&lt;td style="padding:0;width:331.5pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:80.25pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:80.25pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.27pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:14.15pt;position:var(--position);text-decoration:none;white-space:pre"&gt;June 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:4.16pt;position:var(--position);text-decoration:none;white-space:pre"&gt;December 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:14.25pt;width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Accrued bonus and other payroll related&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);top:14.25pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:41.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:49.010000000000005pt;position:var(--position)"&gt;23,691&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);top:14.25pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:41.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:49.010000000000005pt;position:var(--position)"&gt;25,434&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:28.5pt;width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Accrued legal settlement&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);top:28.5pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:46.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:49.010000000000005pt;position:var(--position)"&gt;30,500&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);top:28.5pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:46.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:49.010000000000005pt;position:var(--position)"&gt;30,500&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:42.75pt;width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Accrued marketing&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);top:42.75pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:46.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:49.010000000000005pt;position:var(--position)"&gt;20,255&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);top:42.75pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:46.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:49.010000000000005pt;position:var(--position)"&gt;11,063&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:57pt;width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Deferred revenue&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);top:57pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:51.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:54.010000000000005pt;position:var(--position)"&gt;8,767&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);top:57pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:51.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:54.010000000000005pt;position:var(--position)"&gt;6,705&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15.75pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:71.25pt;width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:5.81pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Other accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);top:71.25pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:5.81pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:46.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:49.010000000000005pt;position:var(--position)"&gt;15,397&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);top:71.25pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:5.81pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:46.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:49.010000000000005pt;position:var(--position)"&gt;13,003&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15.75pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:87pt;width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:5.81pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Total accrued expenses and other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);top:87pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:5.81pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:41.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:49.010000000000005pt;position:var(--position)"&gt;98,610&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);top:87pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:5.81pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:41.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:49.010000000000005pt;position:var(--position)"&gt;86,705&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <gdrx:AccruedBonusAndOtherPayrollRelatedCurrent contextRef="c-4" decimals="-3" id="f-397" unitRef="usd">23691000</gdrx:AccruedBonusAndOtherPayrollRelatedCurrent>
    <gdrx:AccruedBonusAndOtherPayrollRelatedCurrent contextRef="c-5" decimals="-3" id="f-398" unitRef="usd">25434000</gdrx:AccruedBonusAndOtherPayrollRelatedCurrent>
    <us-gaap:LossContingencyAccrualAtCarryingValue contextRef="c-4" decimals="-3" id="f-399" unitRef="usd">30500000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue contextRef="c-5" decimals="-3" id="f-400" unitRef="usd">30500000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:AccruedMarketingCostsCurrent contextRef="c-4" decimals="-3" id="f-401" unitRef="usd">20255000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:AccruedMarketingCostsCurrent contextRef="c-5" decimals="-3" id="f-402" unitRef="usd">11063000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-3" id="f-403" unitRef="usd">8767000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-5" decimals="-3" id="f-404" unitRef="usd">6705000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-405" unitRef="usd">15397000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-406" unitRef="usd">13003000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <gdrx:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-4" decimals="-3" id="f-407" unitRef="usd">98610000</gdrx:AccruedExpensesAndOtherCurrentLiabilities>
    <gdrx:AccruedExpensesAndOtherCurrentLiabilities contextRef="c-5" decimals="-3" id="f-408" unitRef="usd">86705000</gdrx:AccruedExpensesAndOtherCurrentLiabilities>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-5" decimals="-5" id="f-409" unitRef="usd">6700000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-10" decimals="-5" id="f-410" unitRef="usd">900000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-1" decimals="-5" id="f-411" unitRef="usd">5400000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-11" decimals="-5" id="f-412" unitRef="usd">900000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-12" decimals="-5" id="f-413" unitRef="usd">900000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-78" decimals="-5" id="f-414" unitRef="usd">5200000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-415">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:59.47pt"&gt;Income Taxes&lt;/span&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:297.95pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.98pt"&gt;We generally calculate income taxes in interim periods by applying an estimated annual effective income tax rate to&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:308.75pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.82pt"&gt;income or loss before income taxes and by calculating the tax effect of discrete items recognized during such periods. Our&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3199999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:319.55pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt"&gt;estimated annual effective income tax rate is based on our estimated full year income or loss and the related income taxes&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:330.35pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt"&gt;for each jurisdiction in which we operate. This rate can be affected by estimates of full year pre-tax income or loss and&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:341.15pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:91.8pt"&gt;permanent differences.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:357.95pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:147.74pt"&gt;The effective income tax rate for the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:224.24pt;position:var(--position);text-decoration:none;white-space:pre;width:140.88pt"&gt;three months ended June 30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:365.12pt;position:var(--position);text-decoration:none;white-space:pre;width:20.56pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:385.68pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:405.68pt;position:var(--position);text-decoration:none;white-space:pre;width:21.55pt"&gt; was &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:427.23pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt"&gt;44.8%&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:452.73pt;position:var(--position);text-decoration:none;white-space:pre;width:20.56pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:473.29pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt"&gt;34.4%&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:498.79pt;position:var(--position);text-decoration:none;white-space:pre;width:54.59pt"&gt;, respectively.&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.34pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:368.75pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:151.03pt"&gt;The effective income tax rate for the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:209.53pt;position:var(--position);text-decoration:none;white-space:pre;width:133.73pt"&gt;six months ended June 30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:343.26pt;position:var(--position);text-decoration:none;white-space:pre;width:21.5pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:364.76pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:384.76pt;position:var(--position);text-decoration:none;white-space:pre;width:22.49pt"&gt; was &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:407.25pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt"&gt;54.0%&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:432.75pt;position:var(--position);text-decoration:none;white-space:pre;width:21.5pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:454.25pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt"&gt;34.1%&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:479.75pt;position:var(--position);text-decoration:none;white-space:pre;width:73.64pt"&gt;, respectively. The&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:379.55pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:408.77pt"&gt;primary differences between our effective income tax rates and the federal statutory tax rate for the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:467.27pt;position:var(--position);text-decoration:none;white-space:pre;width:86.05pt"&gt;three and six months&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3199999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:390.35pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:84.89pt"&gt;ended June 30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:143.39pt;position:var(--position);text-decoration:none;white-space:pre;width:20.26pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:163.65pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:183.65pt;position:var(--position);text-decoration:none;white-space:pre;width:369.8pt"&gt; were due to the effects of non-deductible officers&#x2019; stock-based compensation expense, state&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:401.15pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:422.17pt"&gt;income taxes, benefits from research and development tax credits, and tax effects from our equity awards.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-10" decimals="3" id="f-416" unitRef="number">0.448</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-11" decimals="3" id="f-417" unitRef="number">0.344</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-418" unitRef="number">0.540</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-12" decimals="3" id="f-419" unitRef="number">0.341</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-420">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Debt&lt;/span&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:446.75pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:421.5pt"&gt;Our First Lien Credit Agreement (as amended from time to time, the "Credit Agreement") provides for (i) a &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:498pt;position:var(--position);text-decoration:none;white-space:pre;width:55.5pt"&gt;$500.0 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:457.55pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:90.78pt"&gt;term loan maturing on &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:149.28pt;position:var(--position);text-decoration:none;white-space:pre;width:53.91pt"&gt;July 10, 2029&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:203.19pt;position:var(--position);text-decoration:none;white-space:pre;width:281.45pt"&gt; ("2024 Term Loan Facility"); and (ii) a revolving credit facility for up to &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:484.64pt;position:var(--position);text-decoration:none;white-space:pre;width:50.66pt"&gt;$88.0 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:535.3pt;position:var(--position);text-decoration:none;white-space:pre;width:18.2pt"&gt; (the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:468.35pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:158.35pt"&gt;"Revolving Credit Facility") maturing on &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:216.85pt;position:var(--position);text-decoration:none;white-space:pre;width:55.71pt"&gt;April 10, 2029&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:272.56pt;position:var(--position);text-decoration:none;white-space:pre;width:27.87pt"&gt;. As of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:300.43pt;position:var(--position);text-decoration:none;white-space:pre;width:57.24pt"&gt;June&#160;30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:357.67pt;position:var(--position);text-decoration:none;white-space:pre;width:195.64pt"&gt;, there were no changes to the terms of our 2024&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.31pt;position:var(--position);text-decoration:none;white-space:pre;width:2.34pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:479.15pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:277.33pt"&gt;Term Loan Facility and Revolving Credit Facility as disclosed in Note &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:335.83pt;position:var(--position);text-decoration:none;white-space:pre;width:10pt"&gt;12&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:345.83pt;position:var(--position);text-decoration:none;white-space:pre;width:207.51pt"&gt; to our consolidated financial statements included in&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:489.95pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:15.49pt"&gt;our &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:73.99pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:93.99000000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:23.99pt"&gt; 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:506.75pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:218.84pt"&gt;The effective interest rate on our term loans for the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:295.34000000000003pt;position:var(--position);text-decoration:none;white-space:pre;width:146.78pt"&gt;three months ended June 30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:442.12pt;position:var(--position);text-decoration:none;white-space:pre;width:22.92pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:465.04pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:485.04pt;position:var(--position);text-decoration:none;white-space:pre;width:23.91pt"&gt; was &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:508.95pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt"&gt;7.85%&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:534.45pt;position:var(--position);text-decoration:none;white-space:pre;width:18.96pt"&gt; and&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:517.55pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt"&gt;8.60%&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:84pt;position:var(--position);text-decoration:none;white-space:pre;width:272.89pt"&gt;, respectively. The effective interest rate on our term loans for the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:356.89pt;position:var(--position);text-decoration:none;white-space:pre;width:134.98pt"&gt;six months ended June 30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:491.87pt;position:var(--position);text-decoration:none;white-space:pre;width:22pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:513.87pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:533.87pt;position:var(--position);text-decoration:none;white-space:pre;width:19.49pt"&gt; was&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:528.35pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt"&gt;7.86%&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:84pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:104pt;position:var(--position);text-decoration:none;white-space:pre;width:25.5pt"&gt;8.56%&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:129.5pt;position:var(--position);text-decoration:none;white-space:pre;width:54.31pt"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:545.15pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:33.33pt"&gt;We had &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:109.83pt;position:var(--position);text-decoration:none;white-space:pre;width:10pt"&gt;no&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:119.83pt;position:var(--position);text-decoration:none;white-space:pre;width:216.35pt"&gt; borrowings against the Revolving Credit Facility as of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:336.18pt;position:var(--position);text-decoration:none;white-space:pre;width:57pt"&gt;June&#160;30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:393.18pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:413.18pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt"&gt;December&#160;31, 2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:492.15pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:561.95pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:322.86pt"&gt;We had outstanding letters of credit issued against the Revolving Credit Facility&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:399.36pt;position:var(--position);text-decoration:none;white-space:pre;width:16.89pt"&gt; for &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:416.25pt;position:var(--position);text-decoration:none;white-space:pre;width:46.15pt"&gt;$7.6 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:462.4pt;position:var(--position);text-decoration:none;white-space:pre;width:21.4pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:483.8pt;position:var(--position);text-decoration:none;white-space:pre;width:46.15pt"&gt;$7.8 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:529.95pt;position:var(--position);text-decoration:none;white-space:pre;width:23.4pt"&gt; as of&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:572.75pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:59.54pt"&gt;June&#160;30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:118.03999999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:22.54pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:140.57999999999998pt;position:var(--position);text-decoration:none;white-space:pre;width:81.51pt"&gt;December&#160;31, 2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:222.09pt;position:var(--position);text-decoration:none;white-space:pre;width:331.33pt"&gt;, respectively, which reduce our available borrowings under the Revolving Credit&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:583.55pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:29.8pt"&gt;Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:600.35pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:122.44pt"&gt;Our debt balance is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="position:var(--position);top:623.15pt;width:612pt"&gt;&lt;div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:0"&gt;&lt;td style="padding:0;width:331.5pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:80.25pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:80.25pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.27pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:14.15pt;position:var(--position);text-decoration:none;white-space:pre"&gt;June 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:4.16pt;position:var(--position);text-decoration:none;white-space:pre"&gt;December 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:14.25pt;width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Principal balance under 2024 Term Loan Facility&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);top:14.25pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:36.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:44.010000000000005pt;position:var(--position)"&gt;492,500&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);top:14.25pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:36.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:44.010000000000005pt;position:var(--position)"&gt;495,000&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:28.5pt;width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Less: Unamortized debt issuance costs and discounts&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);top:28.5pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:48.39pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:51.02pt;position:var(--position)"&gt;(5,912)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);top:28.5pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:48.39pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:51.02pt;position:var(--position)"&gt;(6,736)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:42.75pt;width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);top:42.75pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:36.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:44.010000000000005pt;position:var(--position)"&gt;486,588&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);top:42.75pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:36.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:44.010000000000005pt;position:var(--position)"&gt;488,264&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:691.15pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:166.66pt"&gt;The estimated fair value of our debt was &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:243.16pt;position:var(--position);text-decoration:none;white-space:pre;width:55.98pt"&gt;$469.1 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:299.14pt;position:var(--position);text-decoration:none;white-space:pre;width:26.09pt"&gt; as of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:325.23pt;position:var(--position);text-decoration:none;white-space:pre;width:58.06pt"&gt;June&#160;30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:383.29pt;position:var(--position);text-decoration:none;white-space:pre;width:170.13pt"&gt; and approximated its carrying value as of&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:701.95pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:78.97pt"&gt;December&#160;31, 2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:137.47pt;position:var(--position);text-decoration:none;white-space:pre;width:265.73pt"&gt;, based on inputs categorized as Level 2 in the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:718.75pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.98pt"&gt;Under the Credit Agreement, we are subject to a financial covenant requiring maintenance of a First Lien Net Leverage&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:729.55pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:228.5pt"&gt;Ratio (as defined in the Credit Agreement) not to exceed &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:287pt;position:var(--position);text-decoration:none;white-space:pre;width:12.5pt"&gt;8.2&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:299.5pt;position:var(--position);text-decoration:none;white-space:pre;width:12.82pt"&gt; to &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:312.32pt;position:var(--position);text-decoration:none;white-space:pre;width:12.5pt"&gt;1.0&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:324.82pt;position:var(--position);text-decoration:none;white-space:pre;width:228.55pt"&gt; only in the event that the amounts outstanding under the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt"&gt;Revolving Credit Facility exceed a specified percentage of commitments under the Revolving Credit Facility, and other&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:55.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:210.31pt"&gt;nonfinancial covenants under the Credit Agreement. &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:268.81pt;position:var(--position);text-decoration:none;white-space:pre;width:11.23pt"&gt;At &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:280.03999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:57.46pt"&gt;June&#160;30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:337.5pt;position:var(--position);text-decoration:none;white-space:pre;width:215.96pt"&gt;, we were in compliance with our covenants under the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:66.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:72.46pt"&gt;Credit Agreement.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-79" decimals="-5" id="f-421" unitRef="usd">500000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <gdrx:LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension contextRef="c-80" decimals="-5" id="f-422" unitRef="usd">88000000.0</gdrx:LineOfCreditFacilityBorrowingCapacitySubjectToMaturityExtension>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="c-81" decimals="4" id="f-423" unitRef="number">0.0785</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="c-82" decimals="4" id="f-424" unitRef="number">0.0860</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="c-83" decimals="4" id="f-425" unitRef="number">0.0786</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="c-84" decimals="4" id="f-426" unitRef="number">0.0856</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCredit contextRef="c-85" decimals="INF" id="f-427" unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit contextRef="c-86" decimals="INF" id="f-428" unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-87" decimals="-5" id="f-429" unitRef="usd">7600000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-88" decimals="-5" id="f-430" unitRef="usd">7800000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="c-1" id="f-431">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:122.44pt"&gt;Our debt balance is as follows:&lt;/span&gt;&lt;div style="position:var(--position);top:623.15pt;width:612pt"&gt;&lt;div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:0"&gt;&lt;td style="padding:0;width:331.5pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:80.25pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:80.25pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.27pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:14.15pt;position:var(--position);text-decoration:none;white-space:pre"&gt;June 30, 2026&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:4.16pt;position:var(--position);text-decoration:none;white-space:pre"&gt;December 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:14.25pt;width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Principal balance under 2024 Term Loan Facility&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);top:14.25pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:36.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:44.010000000000005pt;position:var(--position)"&gt;492,500&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);top:14.25pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:36.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:44.010000000000005pt;position:var(--position)"&gt;495,000&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:28.5pt;width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Less: Unamortized debt issuance costs and discounts&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);top:28.5pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:48.39pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:51.02pt;position:var(--position)"&gt;(5,912)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);top:28.5pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:48.39pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:51.02pt;position:var(--position)"&gt;(6,736)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:42.75pt;width:331.5pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:331.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:331.5pt;position:var(--position);top:42.75pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:36.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:44.010000000000005pt;position:var(--position)"&gt;486,588&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:414.75pt;position:var(--position);top:42.75pt;width:80.25pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:80.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:36.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:44.010000000000005pt;position:var(--position)"&gt;488,264&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-89" decimals="-3" id="f-432" unitRef="usd">492500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-90" decimals="-3" id="f-433" unitRef="usd">495000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-91" decimals="-3" id="f-434" unitRef="usd">5912000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-92" decimals="-3" id="f-435" unitRef="usd">6736000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt contextRef="c-91" decimals="-3" id="f-436" unitRef="usd">486588000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-92" decimals="-3" id="f-437" unitRef="usd">488264000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtFairValue contextRef="c-4" decimals="-5" id="f-438" unitRef="usd">469100000</us-gaap:LongTermDebtFairValue>
    <gdrx:LineOfCreditMaximumFinancialCovenantNetLeverageRatio contextRef="c-83" decimals="3" id="f-439" unitRef="number">0.082</gdrx:LineOfCreditMaximumFinancialCovenantNetLeverageRatio>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-440">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:142.86pt"&gt;Commitments and Contingencies&lt;/span&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:112.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:113.64pt"&gt;Aside from the below, as of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:190.14pt;position:var(--position);text-decoration:none;white-space:pre;width:58.06pt"&gt;June&#160;30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:248.2pt;position:var(--position);text-decoration:none;white-space:pre;width:305.19pt"&gt;, there were no material changes to our commitments and contingencies as&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:123pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:310.36pt"&gt;disclosed in the notes to our consolidated financial statements included in our &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:368.86pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:388.86pt;position:var(--position);text-decoration:none;white-space:pre;width:23.99pt"&gt; 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:145.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:87.91pt"&gt;Legal Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:162.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:126.58pt"&gt;Consumer privacy class action&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:203.07999999999998pt;position:var(--position);text-decoration:none;white-space:pre;width:219.43pt"&gt; - Between February 2, 2023, and March 30, 2023, &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:422.51pt;position:var(--position);text-decoration:none;white-space:pre;width:13.99pt"&gt;five&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:436.5pt;position:var(--position);text-decoration:none;white-space:pre;width:102.95pt"&gt; individual plaintiffs filed &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:539.45pt;position:var(--position);text-decoration:none;white-space:pre;width:13.99pt"&gt;five&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:173.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt"&gt;separate putative class action lawsuits against Google, Meta, Criteo and us, alleging generally that we have not adequately&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:184.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:457.3pt"&gt;protected consumer privacy and that we communicated consumer information to third parties, including the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:515.8pt;position:var(--position);text-decoration:none;white-space:pre;width:20.49pt"&gt;three&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:536.29pt;position:var(--position);text-decoration:none;white-space:pre;width:17.17pt"&gt; co-&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:195pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:50.96pt"&gt;defendants. &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:109.46000000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:18.48pt"&gt;Four&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:127.94pt;position:var(--position);text-decoration:none;white-space:pre;width:425.46pt"&gt; of the plaintiffs allege common law intrusion upon seclusion and unjust enrichment claims, as well as&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:205.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt"&gt;claims under California&#x2019;s Confidentiality of Medical Information Act, Invasion of Privacy Act, Consumer Legal Remedies Act,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:216.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:119.79pt"&gt;and Unfair Competition Law. &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:178.29000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:17pt"&gt;One&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:195.29pt;position:var(--position);text-decoration:none;white-space:pre;width:40.27pt"&gt; of these &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:235.56pt;position:var(--position);text-decoration:none;white-space:pre;width:15.49pt"&gt;four&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:251.05pt;position:var(--position);text-decoration:none;white-space:pre;width:302.44pt"&gt; plaintiffs additionally brings a claim under the Electronic Communications&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:227.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt"&gt;Privacy Act. The fifth plaintiff brings claims for common-law unjust enrichment and violations of New York&#x2019;s General&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:238.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:495pt"&gt;Business Law. Four of these cases were originally filed in the United States District Court for the Northern District of&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:249pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt"&gt;California ("NDCA") (Cases No. 3:23-cv-00501; 3:23-cv-00744; 3:23-cv-00940; and 4:23-cv-01293). One case was originally&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:259.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt"&gt;filed in the United States District Court for the Southern District of New York (Case No. 1:23-cv-00943); however, that case&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:270.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:348pt"&gt;was voluntarily dismissed and re-filed in the NDCA (Case No. 3:23-cv-01508). These &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:406.5pt;position:var(--position);text-decoration:none;white-space:pre;width:13.99pt"&gt;five&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:420.49pt;position:var(--position);text-decoration:none;white-space:pre;width:132.92pt"&gt; matters have been consolidated&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:281.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt"&gt;and assigned to U.S. District Judge Araceli Mart&#xed;nez-Olgu&#xed;n in the NDCA. The court also set a briefing schedule for filing a&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:292.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt"&gt;single consolidated complaint, which the plaintiffs filed on May 21, 2023 (Case No. 3:23-cv-00501-AMO; the "NDCA Class&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:303pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.83pt"&gt;Action Matter"), as well as motions to dismiss and motions to compel arbitration. In addition to the aforementioned claims,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:313.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt"&gt;the plaintiffs in the now consolidated matter bring claims under the Illinois Consumer Fraud and Deceptive Business&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:324.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.83pt"&gt;Practices Act, common law negligence and negligence per se, in each case, pleaded in the alternative. The plaintiffs are&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:335.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt"&gt;seeking various forms of monetary damages (such as statutory damages, compensatory damages, attorneys&#x2019; fees and&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:346.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt"&gt;disgorgement of profits) as well as injunctive relief. Briefing on the motions to dismiss and motions to compel arbitration was&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:357pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:123.99pt"&gt;completed on August 24, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:373.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:91.15pt"&gt;On October 27, 2023, &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:167.65pt;position:var(--position);text-decoration:none;white-space:pre;width:10.99pt"&gt;six&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:178.64pt;position:var(--position);text-decoration:none;white-space:pre;width:374.82pt"&gt; plaintiffs filed a class action complaint (Case No. 1:23-cv-24127-BB; the &#x201c;SDFL Class Action&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:384.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.82pt"&gt;Matter&#x201d;) against us in the United States District Court for the Southern District of Florida ("SDFL"). The plaintiffs alleged, on&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3199999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:395.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt"&gt;behalf of the same nationwide class as the NDCA Class Action Matter, substantially the same statutory and common law&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:406.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt"&gt;violation claims as alleged in that matter as well as claims based on the federal Electronic Communications Privacy Act,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:417pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt"&gt;invasion of privacy under California common law and the California constitution, invasion of privacy under New Jersey's&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:427.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt"&gt;Constitution, and violations of Pennsylvania&#x2019;s Wiretapping and Electronic Surveillance Control Act, Florida&#x2019;s Security of&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:438.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt"&gt;Communications Act, New York&#x2019;s Civil Rights Law and Stop Hack and Improve Electronic Data Security Act. The plaintiffs in&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:449.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt"&gt;the SDFL Class Action Matter seek various forms of monetary damages as well as injunctive and other unspecified equitable&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:460.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:21.97pt"&gt;relief.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:477pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.9pt"&gt;On October 27, 2023, we entered into a proposed settlement agreement with the plaintiffs in the SDFL Class Action&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:487.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt"&gt;Matter, on behalf of a nationwide settlement class that includes the NDCA Class Action Matter, which provides for a payment&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:498.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:10.36pt"&gt;of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:68.86pt;position:var(--position);text-decoration:none;white-space:pre;width:50.81pt"&gt;$13.0&#160;million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:119.67pt;position:var(--position);text-decoration:none;white-space:pre;width:433.66pt"&gt; by us. On October 30, 2023, the plaintiffs in the SDFL Class Action Matter filed a motion and memorandum&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:509.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt"&gt;in support of preliminary approval of the proposed class action settlement and, on October 31, 2023, the SDFL granted&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:520.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt"&gt;preliminary approval of the proposed settlement. Members of the class have the opportunity to opt-out of the class and&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:531pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:116.44pt"&gt;commence their own actions.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:547.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.83pt"&gt;In response to the proposed settlement in the SDFL Class Action Matter, plaintiffs in the NDCA Class Action Matter filed&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:558.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.84pt"&gt;(i) on November 1, 2023, a motion in the NDCA for an order to require us to cease litigation of, or alternatively file a motion&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:569.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.84pt"&gt;to stay in, the SDFL Class Action Matter and enjoin us from seeking settlement with counsel other than plaintiffs&#x2019; counsel in&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3399999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:580.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.85pt"&gt;the NDCA Class Action Matter; and (ii) on November 2, 2023, a motion in the SDFL for that court to allow them to intervene&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:591pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt"&gt;and appear in the SDFL action, transfer the SDFL Class Action Matter to the NDCA and reconsider and deny its preliminary&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:601.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:495pt"&gt;approval of the proposed settlement. The SDFL has issued an order requiring the SDFL plaintiffs to, among other things, file&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:612.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt"&gt;a response to the NDCA plaintiffs' motion to intervene. Additionally, U.S. District Judge Araceli Mart&#xed;nez-Olgu&#xed;n in the NDCA&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:623.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt"&gt;issued an order for us to show cause as to why we should not be sanctioned for an alleged failure to provide notification to&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:634.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.8pt"&gt;the NDCA of the pendency of the SDFL Class Action Matter. We filed our written response to this order on November 8,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:645pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt"&gt;2023. The NDCA held a hearing on November 14, 2023, and ordered parties to the litigation to participate in mediation. The&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:655.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt"&gt;parties participated in mediation on January 10, 2024, and agreed to participate in an additional day of mediation, which&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:666.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:109.96pt"&gt;occurred on March 7, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:683.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.83pt"&gt;On December 3, 2024, the SDFL plaintiffs filed a voluntary motion to dismiss, with prejudice, which was approved by&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:694.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt"&gt;the court on December 4, 2024. On November 25, 2024, we entered into a settlement agreement with the NDCA plaintiffs&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:705pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:13.21pt"&gt;for &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:71.71000000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:50.67pt"&gt;$25.0&#160;million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:122.38pt;position:var(--position);text-decoration:none;white-space:pre;width:431.01pt"&gt;, subject to approval by the court. On June 12, 2025, the court denied the motion for preliminary approval of&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:715.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt"&gt;the settlement with prejudice, with leave for the plaintiffs to refile with additional information requested by the court. Based&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:726.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:244.27pt"&gt;on the settlement agreement, an estimated probable loss of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:302.77pt;position:var(--position);text-decoration:none;white-space:pre;width:50.99pt"&gt;$25.0&#160;million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:353.76pt;position:var(--position);text-decoration:none;white-space:pre;width:199.7pt"&gt; was included within accrued expenses and other&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:737.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt"&gt;current liabilities on our condensed consolidated balance sheets as of June 30, 2026 and December 31, 2025. Additionally,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:137.82pt"&gt;we estimated a probable loss of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:196.32pt;position:var(--position);text-decoration:none;white-space:pre;width:46.93pt"&gt;$5.5&#160;million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:243.25pt;position:var(--position);text-decoration:none;white-space:pre;width:310.1pt"&gt; relating to the indemnification of certain parties named in the class action&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:55.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt"&gt;lawsuits, which was included within accrued expenses and other current liabilities on our condensed consolidated balance&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:66.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.83pt"&gt;sheets as of June 30, 2026 and December 31, 2025. While these amounts represent our best judgment of the probable&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:77.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt"&gt;losses based on the information currently available to us, they are subject to significant judgments and estimates and&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:88.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:366.79pt"&gt;numerous factors beyond our control, including, without limitation, final approval of the court.&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:425.29pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:105pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.87pt"&gt;On November 19, 2025, together with another party named in the class action lawsuit, we filed an amended settlement&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:115.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt"&gt;agreement. On November 26, 2025, plaintiffs filed a motion for preliminary approval of the class settlement. On January 16,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:126.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt"&gt;2026, the court denied the motion for preliminary approval of the settlement, requesting additional information from the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:137.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt"&gt;plaintiffs. On March 24, 2026, the plaintiffs filed an administrative motion for leave to submit supplemental brief to address&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:148.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt"&gt;the court's concerns and request for status conference. On March 26, 2026, the court denied the motion but granted&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:159pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:251.65pt"&gt;plaintiffs leave to submit a new motion for preliminary approval.&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:310.15pt;position:var(--position);text-decoration:none;white-space:pre;width:243.27pt"&gt; Plaintiffs filed a new motion for preliminary approval on June&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:169.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:233.26pt"&gt;1, 2026, which is set for a hearing on September 3, 2026.&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:291.76pt;position:var(--position);text-decoration:none;white-space:pre;width:261.67pt"&gt; The terms of the amended settlement agreement were reflective&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:180.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:495pt"&gt;of the aggregate probable loss recorded in connection with this matter and, as such, we did not accrue for any additional&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:191.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt"&gt;amounts. The results of legal proceedings are inherently uncertain, and upon final resolution of these matters, it is&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:202.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:278.2pt"&gt;reasonably possible that the actual loss may differ from our estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:219pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:italic;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:106.98pt"&gt;Consumer state litigations &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:183.48000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:369.95pt"&gt;- On May 28, 2024, The Bert and Annette Mullens Foundation ("Mullens Foundation") filed a&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:229.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt"&gt;lawsuit against us in Pope County, Arkansas, alleging that we violated an Arkansas statute related to the distribution of&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:240.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.98pt"&gt;health-related discount cards. Specifically, the statute provides that each discount card must &#x201c;expressly provide in bold and&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:251.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt"&gt;prominent type that the discounts are not insurance.&#x201d; Ark. Code Ann. &#xa7; 4-106-201(1). Furthermore, the statute provides that&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:262.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt"&gt;each card must &#x201c;expressly provide in bold and prominent type on the card or in a statement attached to the card that the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:273pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.91pt"&gt;consumer has the right to cancel his or her registration within thirty (30) days from the effective date of the card.&#x201d; Ark. Code&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:283.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.98pt"&gt;Ann. &#xa7; 4-106-201(2). The plaintiff alleges that our cards did not comply with these requirements, and sought an injunction&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:294.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.83pt"&gt;and statutory damages. We filed a motion to dismiss the complaint, which was denied on December 2, 2024. On May 9,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:305.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.85pt"&gt;2025, the Arkansas Attorney General moved to intervene in the case. On May 13, 2025, the plaintiff moved for partial&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:316.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt"&gt;summary judgment, which we and the Arkansas Attorney General opposed. Separately, on September 24, 2025, the State of&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:327pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt"&gt;Arkansas, ex rel. Tim Griffin, Attorney General, filed suit in Faulkner County, Arkansas alleging the same violations of Ark.&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:337.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt"&gt;Code Ann. &#xa7; 4-106-201 et seq. as the Mullens Foundation in addition to violations of the Arkansas Deceptive Trade&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:348.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt"&gt;Practices Act ("ADTPA"). On September 25, 2025, the Circuit Court of Faulkner County entered a Consent Judgment&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:359.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt"&gt;through which the plaintiff, acting parens patriae for the people of Arkansas, released us from any and all claims and&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:370.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.94pt"&gt;remedies available or potentially available under the ADTPA and the discount card statute, Ark. Code Ann. &#xa7;&#xa7; 4-106-201 et&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.44pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:381pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt"&gt;seq. for GoodRx discount cards sold, marketed, promoted, advertised, or otherwise distributed in Arkansas from January 1,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:391.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:277.95pt"&gt;2022 until the effective date of the agreement. As part of the Consent &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:336.45pt;position:var(--position);text-decoration:none;white-space:pre;width:41.99pt"&gt;Judgment,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:378.44pt;position:var(--position);text-decoration:none;white-space:pre;width:175.02pt"&gt; we also agreed to pay immaterial monetary&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:402.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.92pt"&gt;relief. On July 20, 2026, the Arkansas Attorney General moved to intervene to move for summary judgment dismissing the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:413.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:102.45pt"&gt;Mullens Foundation case.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:430.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:132.69pt"&gt;Furthermore, on June 11, 2024, &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:209.19pt;position:var(--position);text-decoration:none;white-space:pre;width:171.17pt"&gt;the Minnesota Teamsters Service Bureau &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:380.36pt;position:var(--position);text-decoration:none;white-space:pre;width:173.06pt"&gt;also filed a lawsuit against us in Hennepin&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4200000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:441pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt"&gt;County, Minnesota, alleging that we violated a Minnesota statute related to the distribution of health-related discount cards.&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:451.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt"&gt;Specifically, the statute provides that each discount card must &#x201c;expressly provide in bold and prominent type that the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:462.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.88pt"&gt;discounts are not insurance.&#x201d; Minn. Stat. Ann. &#xa7; 325F.784, subd. 1(1). The plaintiff alleges that our cards do not comply with&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:473.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.85pt"&gt;these requirements and also seeks an injunction and statutory damages. We filed a motion to dismiss the complaint, which&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:484.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.95pt"&gt;was denied on December 17, 2024. On June 10, 2025, the plaintiff moved to dismiss some of our counterclaims; the court&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:495pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt"&gt;granted the motion to dismiss. Discovery has been completed in Minnesota. On October 10, 2025, we moved for summary&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:505.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt"&gt;judgment and plaintiff moved for partial summary judgment. On February 5, 2026, the court entered an order on our motion&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:516.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:495pt"&gt;for summary judgment, directing that judgment be entered dismissing plaintiff&#x2019;s claims as time-barred. On April 10, 2026,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:527.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:335.69pt"&gt;plaintiff filed a notice of appeal regarding the court&#x2019;s summary judgment decision. O&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:394.19pt;position:var(--position);text-decoration:none;white-space:pre;width:70.9pt"&gt;n June 18, 2026, &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:465.09pt;position:var(--position);text-decoration:none;white-space:pre;width:88.3pt"&gt;plaintiff filed their brief&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:538.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:219.92pt"&gt;on appeal and we filed our opposition on July 20, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:555pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:368.94pt"&gt;We intend to vigorously defend against the claims asserted in the Mullens Foundation &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:445.44pt;position:var(--position);text-decoration:none;white-space:pre;width:25.48pt"&gt;matter&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:470.92pt;position:var(--position);text-decoration:none;white-space:pre;width:82.54pt"&gt; and the Minnesota&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.34pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:565.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.97pt"&gt;Teamsters Service Bureau matters as we believe we have meritorious defenses to such claims. While it is reasonably&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.47pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:576.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.79pt"&gt;possible a loss may have been incurred, we have not accrued a loss as a loss is not probable and we are unable to estimate&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.29pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:587.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:90.46pt"&gt;a loss or range of loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:604.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.9pt"&gt;These pending proceedings involve complex questions of fact and law and may require the expenditure of significant&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:615pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt"&gt;funds and the diversion of other resources to defend. In addition, during the normal course of business, we (including our&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:625.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.86pt"&gt;directors and officers whom we indemnify) may become subject to, and are presently involved in, legal proceedings, claims&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:636.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.9pt"&gt;and litigation. Such matters are subject to many uncertainties and outcomes are not predictable with assurance. Aside from&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:647.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.83pt"&gt;the consumer privacy class action matter, we have not accrued for a material loss for any other matters as a loss is not&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:658.2pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt"&gt;probable and a loss, or a range of loss, is not reasonably estimable. Accruals for loss contingencies are recognized when a&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:669pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:363.28pt"&gt;loss is probable, and the amount of such loss can be reasonably estimated. See "Note &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:421.78pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt"&gt;4&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:426.78pt;position:var(--position);text-decoration:none;white-space:pre;width:126.71pt"&gt;. Accrued Expenses and Other&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:679.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.98pt"&gt;Current Liabilities" for additional information. Loss recoveries are recognized when a loss has been incurred and the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:690.6pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:227.44pt"&gt;recovery is probable. Insurance recovery receivables of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:285.94pt;position:var(--position);text-decoration:none;white-space:pre;width:50.44pt"&gt;$11.9&#160;million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:336.38pt;position:var(--position);text-decoration:none;white-space:pre;width:217.1pt"&gt; were included in prepaid expenses and other current&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.48pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:701.4pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:399.43pt"&gt;assets on our condensed consolidated balance sheets as of June 30, 2026 and December 31, 2025.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="c-93"
      decimals="INF"
      id="f-441"
      unitRef="plaintiff">5</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyPendingClaimsNumber contextRef="c-94" decimals="INF" id="f-442" unitRef="case">5</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyNumberOfDefendants
      contextRef="c-93"
      decimals="INF"
      id="f-443"
      unitRef="defendant">3</us-gaap:LossContingencyNumberOfDefendants>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="c-95"
      decimals="INF"
      id="f-444"
      unitRef="plaintiff">4</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="c-96"
      decimals="INF"
      id="f-445"
      unitRef="plaintiff">1</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="c-95"
      decimals="INF"
      id="f-446"
      unitRef="plaintiff">4</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="c-93"
      decimals="INF"
      id="f-447"
      unitRef="plaintiff">5</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="c-97"
      decimals="INF"
      id="f-448"
      unitRef="plaintiff">6</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty contextRef="c-97" decimals="-5" id="f-449" unitRef="usd">13000000.0</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:PaymentsForLegalSettlements contextRef="c-98" decimals="-5" id="f-450" unitRef="usd">25000000.0</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:LossContingencyAccrualAtCarryingValue contextRef="c-99" decimals="-5" id="f-451" unitRef="usd">25000000.0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue contextRef="c-100" decimals="-5" id="f-452" unitRef="usd">5500000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:InsuranceSettlementsReceivable contextRef="c-101" decimals="-5" id="f-453" unitRef="usd">11900000</us-gaap:InsuranceSettlementsReceivable>
    <us-gaap:InsuranceSettlementsReceivable contextRef="c-102" decimals="-5" id="f-454" unitRef="usd">11900000</us-gaap:InsuranceSettlementsReceivable>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-455">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:37.47pt"&gt;Revenue&lt;/span&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:61.8pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:30.98pt"&gt;For the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:107.48pt;position:var(--position);text-decoration:none;white-space:pre;width:170.47pt"&gt;three and six months ended June 30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:277.95pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:297.95pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:317.95pt;position:var(--position);text-decoration:none;white-space:pre;width:136.42pt"&gt;, revenue comprised the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="position:var(--position);top:84.6pt;width:612pt"&gt;&lt;div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:0"&gt;&lt;td style="padding:0;width:207pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23.25pt"&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);width:142.5pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.75pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre"&gt;June 30,&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);width:142.5pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Six Months Ended&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre"&gt;June 30,&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:23.25pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.27pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:37.5pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Prescription transactions revenue&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:25.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;106,390&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:25.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;143,064&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:25.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;220,082&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:25.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;291,987&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:51.75pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Subscription revenue&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;28,514&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;20,463&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;52,907&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;41,480&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:66pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Pharma Direct revenue&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:66pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;61,628&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:66pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;34,981&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:66pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:30.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;113,858&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:66pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;63,629&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:80.25pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Other revenue&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:80.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:43.510000000000005pt;position:var(--position)"&gt;3,879&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:80.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:43.510000000000005pt;position:var(--position)"&gt;4,562&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:80.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:43.510000000000005pt;position:var(--position)"&gt;7,570&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:80.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:43.510000000000005pt;position:var(--position)"&gt;8,944&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:94.5pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:94.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:25.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;200,411&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:94.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:25.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;203,070&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:94.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:25.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;394,417&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:94.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:25.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;406,040&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-456">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:30.98pt"&gt;For the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:107.48pt;position:var(--position);text-decoration:none;white-space:pre;width:170.47pt"&gt;three and six months ended June 30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:277.95pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:297.95pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:317.95pt;position:var(--position);text-decoration:none;white-space:pre;width:136.42pt"&gt;, revenue comprised the following:&lt;/span&gt;&lt;div style="position:var(--position);top:84.6pt;width:612pt"&gt;&lt;div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:0"&gt;&lt;td style="padding:0;width:207pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23.25pt"&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);width:142.5pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.75pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre"&gt;June 30,&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);width:142.5pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Six Months Ended&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre"&gt;June 30,&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:23.25pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.27pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:37.5pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Prescription transactions revenue&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:25.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;106,390&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:25.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;143,064&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:25.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;220,082&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:25.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;291,987&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:51.75pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Subscription revenue&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;28,514&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;20,463&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;52,907&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;41,480&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:66pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Pharma Direct revenue&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:66pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;61,628&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:66pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;34,981&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:66pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:30.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;113,858&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:66pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;63,629&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:80.25pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Other revenue&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:80.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:43.510000000000005pt;position:var(--position)"&gt;3,879&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:80.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:43.510000000000005pt;position:var(--position)"&gt;4,562&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:80.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:43.510000000000005pt;position:var(--position)"&gt;7,570&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:80.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:43.510000000000005pt;position:var(--position)"&gt;8,944&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:94.5pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:11.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:94.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:25.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;200,411&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:94.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:25.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;203,070&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:94.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:25.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;394,417&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:94.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:25.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;406,040&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-103" decimals="-3" id="f-457" unitRef="usd">106390000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-104" decimals="-3" id="f-458" unitRef="usd">143064000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-105" decimals="-3" id="f-459" unitRef="usd">220082000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-106" decimals="-3" id="f-460" unitRef="usd">291987000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-107" decimals="-3" id="f-461" unitRef="usd">28514000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-108" decimals="-3" id="f-462" unitRef="usd">20463000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-109" decimals="-3" id="f-463" unitRef="usd">52907000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-110" decimals="-3" id="f-464" unitRef="usd">41480000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-111" decimals="-3" id="f-465" unitRef="usd">61628000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-112" decimals="-3" id="f-466" unitRef="usd">34981000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-113" decimals="-3" id="f-467" unitRef="usd">113858000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-114" decimals="-3" id="f-468" unitRef="usd">63629000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-115" decimals="-3" id="f-469" unitRef="usd">3879000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-116" decimals="-3" id="f-470" unitRef="usd">4562000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-117" decimals="-3" id="f-471" unitRef="usd">7570000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-118" decimals="-3" id="f-472" unitRef="usd">8944000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-10" decimals="-3" id="f-473" unitRef="usd">200411000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-11" decimals="-3" id="f-474" unitRef="usd">203070000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-475" unitRef="usd">394417000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-12" decimals="-3" id="f-476" unitRef="usd">406040000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-477">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:68.5pt;position:var(--position);text-decoration:none;white-space:pre;width:89.06pt"&gt;Stockholders' Equity&lt;/span&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:233.15pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:449.38pt"&gt;On February 27, 2024, our board of directors ("Board") authorized the repurchase of up to an aggregate of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:525.88pt;position:var(--position);text-decoration:none;white-space:pre;width:27.5pt"&gt;$450.0&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.38pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:243.95pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:25.45pt"&gt;million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:83.95pt;position:var(--position);text-decoration:none;white-space:pre;width:469.54pt"&gt; of our Class A common stock with no expiration date. Repurchases under this repurchase program may be made in&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:254.75pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.87pt"&gt;the open market, in privately negotiated transactions or otherwise, with the amount and timing of repurchases to be&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:265.55pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt"&gt;determined at our discretion, depending on market conditions and corporate needs, or under a trading plan intended to&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:276.35pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.89pt"&gt;satisfy the affirmative defense conditions of Rule 10b5-1(c)(1) under the Exchange Act. This repurchase program does not&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:287.15pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.81pt"&gt;obligate us to acquire any particular amount of Class A common stock and may be modified, suspended or terminated at any&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.31pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:297.95pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.99pt"&gt;time at the discretion of our Board. Repurchased shares are subsequently retired and returned to the status of authorized&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.49pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:308.75pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:78.5pt"&gt;but unissued. As of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:137pt;position:var(--position);text-decoration:none;white-space:pre;width:57pt"&gt;June&#160;30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:194pt;position:var(--position);text-decoration:none;white-space:pre;width:36.49pt"&gt;, we had &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:230.49pt;position:var(--position);text-decoration:none;white-space:pre;width:50.45pt"&gt;$60.3 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:280.94pt;position:var(--position);text-decoration:none;white-space:pre;width:272.39pt"&gt; available for future repurchases of our Class A common stock under&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.3299999999999pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:319.55pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:99.94pt"&gt;this repurchase program.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:336.35pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:134.9pt"&gt;In March 2025, we repurchased &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:211.4pt;position:var(--position);text-decoration:none;white-space:pre;width:46.64pt"&gt;10.0&#160;million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:258.03999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:6.19pt"&gt;, &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:264.23pt;position:var(--position);text-decoration:none;white-space:pre;width:41.64pt"&gt;7.0&#160;million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:305.87pt;position:var(--position);text-decoration:none;white-space:pre;width:24.88pt"&gt;, and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:330.75pt;position:var(--position);text-decoration:none;white-space:pre;width:41.64pt"&gt;3.0&#160;million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:372.39pt;position:var(--position);text-decoration:none;white-space:pre;width:180.96pt"&gt; shares of our Class A common stock (after&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:347.15pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.85pt"&gt;giving effect to the automatic conversion of our Class B common stock to Class A common stock upon such repurchase)&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:357.95pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.93pt"&gt;from related parties, Francisco Partners IV, L.P. and Francisco Partners IV-A, Idea Men, LLC, and Spectrum Equity VII, L.P.,&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:368.75pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:494.96pt"&gt;Spectrum VII Investment Managers' Fund, L.P., and Spectrum VII Co-Investment Fund, L.P., respectively, for an aggregate&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.46pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:379.55pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:58.72pt"&gt;repurchase of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:117.22pt;position:var(--position);text-decoration:none;white-space:pre;width:46.07pt"&gt;20.0&#160;million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:163.29000000000002pt;position:var(--position);text-decoration:none;white-space:pre;width:207.38pt"&gt; shares of our Class A common stock at a price of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:370.67pt;position:var(--position);text-decoration:none;white-space:pre;width:22.5pt"&gt;$4.20&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:393.17pt;position:var(--position);text-decoration:none;white-space:pre;width:160.28pt"&gt; per share, in each case representing a&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.45pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:390.35pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:159.48pt"&gt;discount from our closing share price of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:217.98pt;position:var(--position);text-decoration:none;white-space:pre;width:22.5pt"&gt;$4.42&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:240.48pt;position:var(--position);text-decoration:none;white-space:pre;width:312.89pt"&gt; as of the last trading day prior to the execution date of these transactions. The&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:401.15pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:218.56pt"&gt;aggregate consideration for these repurchases was &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:277.06pt;position:var(--position);text-decoration:none;white-space:pre;width:52.39pt"&gt;$84.9 million&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:329.45pt;position:var(--position);text-decoration:none;white-space:pre;width:223.94pt"&gt;, inclusive of direct costs and estimated excise taxes&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:411.95pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:139.45pt"&gt;associated with these transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:428.75pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:476.89pt"&gt;These related party repurchases were approved by our Board and its Audit and Risk Committee as part of the&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:439.55pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:152.92pt"&gt;aforementioned repurchase programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:456.35pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:372.33pt"&gt;The following table presents information about our repurchases of our Class A common stock:&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:448.83pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="position:var(--position);text-align:justify;text-align-last:var(--justify);top:479.15pt;width:612pt"&gt;&lt;div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:0"&gt;&lt;td style="padding:0;width:207pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23.25pt"&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);width:142.5pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.75pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre"&gt;June 30,&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);width:142.5pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Six Months Ended&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre"&gt;June 30,&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:23.25pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.27pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:37.5pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Number of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:54.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:57.010000000000005pt;position:var(--position)"&gt;&#x2014;&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;10,224&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:43.510000000000005pt;position:var(--position)"&gt;5,536&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;33,564&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:51.75pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);white-space:pre"&gt;Cost of shares repurchased &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:5.8500000000000005pt;font-style:normal;font-weight:normal;left:115.58999999999999pt;position:var(--position);top:-2.293pt;vertical-align:super;white-space:pre"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:45.39pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:53.02pt;position:var(--position)"&gt;(61)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:30.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;46,352&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:30.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;12,580&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:25.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;147,272&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:550.15pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:265pt"&gt;_____________________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:560.95pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:10.98pt"&gt;(1)&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:458.93pt"&gt;Cost of shares repurchased for the three months ended June 30, 2026 represents a change to the estimated&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:571.75pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:305.91pt"&gt;excise taxes associated with past repurchases of our Class A common stock.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <srt:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-119" decimals="-5" id="f-478" unitRef="usd">450000000.0</srt:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="c-120" decimals="-5" id="f-479" unitRef="usd">60300000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-121"
      decimals="-5"
      id="f-480"
      unitRef="shares">10000000.0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-122"
      decimals="-5"
      id="f-481"
      unitRef="shares">7000000.0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-123"
      decimals="-5"
      id="f-482"
      unitRef="shares">3000000.0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-124"
      decimals="-5"
      id="f-483"
      unitRef="shares">20000000.0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="c-125"
      decimals="2"
      id="f-484"
      unitRef="usdPerShare">4.20</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:SharePrice
      contextRef="c-126"
      decimals="2"
      id="f-485"
      unitRef="usdPerShare">4.42</us-gaap:SharePrice>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-66" decimals="-5" id="f-486" unitRef="usd">84900000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:ScheduleOfRepurchaseAgreements contextRef="c-1" id="f-487">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:372.33pt"&gt;The following table presents information about our repurchases of our Class A common stock:&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:448.83pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;div style="position:var(--position);text-align:justify;text-align-last:var(--justify);top:479.15pt;width:612pt"&gt;&lt;div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:0"&gt;&lt;td style="padding:0;width:207pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23.25pt"&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);width:142.5pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.75pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre"&gt;June 30,&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);width:142.5pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Six Months Ended&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre"&gt;June 30,&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:23.25pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.27pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:37.5pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Number of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:54.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:57.010000000000005pt;position:var(--position)"&gt;&#x2014;&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;10,224&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:43.510000000000005pt;position:var(--position)"&gt;5,536&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;33,564&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:51.75pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);white-space:pre"&gt;Cost of shares repurchased &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:5.8500000000000005pt;font-style:normal;font-weight:normal;left:115.58999999999999pt;position:var(--position);top:-2.293pt;vertical-align:super;white-space:pre"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:45.39pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:53.02pt;position:var(--position)"&gt;(61)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:30.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;46,352&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:30.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;12,580&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:25.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;147,272&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:550.15pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:265pt"&gt;_____________________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:560.95pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:10.98pt"&gt;(1)&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:458.93pt"&gt;Cost of shares repurchased for the three months ended June 30, 2026 represents a change to the estimated&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4300000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:571.75pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:305.91pt"&gt;excise taxes associated with past repurchases of our Class A common stock.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRepurchaseAgreements>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="c-127"
      decimals="-3"
      id="f-488"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="c-128"
      decimals="-3"
      id="f-489"
      unitRef="shares">10224000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="c-129"
      decimals="-3"
      id="f-490"
      unitRef="shares">5536000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="c-130"
      decimals="-3"
      id="f-491"
      unitRef="shares">33564000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-127" decimals="-3" id="f-492" unitRef="usd">-61000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-128" decimals="-3" id="f-493" unitRef="usd">46352000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-129" decimals="-3" id="f-494" unitRef="usd">12580000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-130" decimals="-3" id="f-495" unitRef="usd">147272000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-496">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:73.5pt;position:var(--position);text-decoration:none;white-space:pre;width:160.89pt"&gt;Basic and Diluted Earnings Per Share&lt;/span&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:617.35pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:79.47pt"&gt;The computation of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:155.97pt;position:var(--position);text-decoration:none;white-space:pre;width:74.96pt"&gt;earnings per share&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:230.93pt;position:var(--position);text-decoration:none;white-space:pre;width:30.49pt"&gt; for the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:261.41999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:170.47pt"&gt;three and six months ended June 30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:431.89pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:451.89pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:471.89pt;position:var(--position);text-decoration:none;white-space:pre;width:53.46pt"&gt; is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="position:var(--position);text-align:justify;text-align-last:var(--justify);top:634.15pt;width:612pt"&gt;&lt;div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:0"&gt;&lt;td style="padding:0;width:207pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23.25pt"&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);width:142.5pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.75pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre"&gt;June 30,&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);width:142.5pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Six Months Ended&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre"&gt;June 30,&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:23.25pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.27pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;(in thousands, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:37.5pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Numerator:&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:51.75pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Net income&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:43.510000000000005pt;position:var(--position)"&gt;8,536&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:30.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;12,843&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:43.510000000000005pt;position:var(--position)"&gt;9,705&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:30.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;23,895&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:66pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Denominator:&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:80.25pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Weighted average shares - basic&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:80.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:30.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;339,277&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:80.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:30.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;356,623&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:80.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:30.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;339,839&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:80.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:30.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;367,847&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"&gt;&lt;div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:0"&gt;&lt;td style="padding:0;width:207pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:27.75pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:7.01pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Dilutive impact of stock options and restricted &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:9pt;position:var(--position);top:17.81pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;stock units&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:17.81pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:43.510000000000005pt;position:var(--position)"&gt;8,781&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:17.81pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:48.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:51.010000000000005pt;position:var(--position)"&gt;536&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:17.81pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:43.510000000000005pt;position:var(--position)"&gt;4,837&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:17.81pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:48.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:51.010000000000005pt;position:var(--position)"&gt;498&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:27.75pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Weighted average shares - diluted&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:27.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:34.62pt;position:var(--position);text-decoration:none;white-space:pre"&gt;348,058&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:27.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:34.62pt;position:var(--position);text-decoration:none;white-space:pre"&gt;357,159&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:27.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:34.62pt;position:var(--position);text-decoration:none;white-space:pre"&gt;344,676&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:27.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:34.62pt;position:var(--position);text-decoration:none;white-space:pre"&gt;368,345&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:42pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Earnings per share:&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:56.25pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Basic&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:56.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:48.510000000000005pt;position:var(--position)"&gt;0.03&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:56.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:48.510000000000005pt;position:var(--position)"&gt;0.04&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:56.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:48.510000000000005pt;position:var(--position)"&gt;0.03&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:56.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:48.510000000000005pt;position:var(--position)"&gt;0.06&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:70.5pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Diluted&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:70.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:48.510000000000005pt;position:var(--position)"&gt;0.02&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:70.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:48.510000000000005pt;position:var(--position)"&gt;0.04&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:70.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:48.510000000000005pt;position:var(--position)"&gt;0.03&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:70.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:48.510000000000005pt;position:var(--position)"&gt;0.06&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:140.75pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:425.91pt"&gt;The following weighted average potentially dilutive shares are excluded from the computation of diluted &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:502.41pt;position:var(--position);text-decoration:none;white-space:pre;width:50.98pt"&gt;earnings per&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:151.55pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:22.49pt"&gt;share&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:80.99pt;position:var(--position);text-decoration:none;white-space:pre;width:317.36pt"&gt; for the periods presented because including them would have been antidilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="position:var(--position);top:174.35pt;width:612pt"&gt;&lt;div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:0"&gt;&lt;td style="padding:0;width:207pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23.25pt"&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);width:142.5pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.75pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre"&gt;June 30,&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);width:142.5pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Six Months Ended&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre"&gt;June 30,&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:23.25pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.27pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:37.5pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Stock options and restricted stock units&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:39.62pt;position:var(--position);text-decoration:none;white-space:pre"&gt;39,720&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:39.62pt;position:var(--position);text-decoration:none;white-space:pre"&gt;57,042&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:39.62pt;position:var(--position);text-decoration:none;white-space:pre"&gt;42,808&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;49,102&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-497">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:79.47pt"&gt;The computation of &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:155.97pt;position:var(--position);text-decoration:none;white-space:pre;width:74.96pt"&gt;earnings per share&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:230.93pt;position:var(--position);text-decoration:none;white-space:pre;width:30.49pt"&gt; for the &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:261.41999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:170.47pt"&gt;three and six months ended June 30, 2026&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:431.89pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt; and &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:451.89pt;position:var(--position);text-decoration:none;white-space:pre;width:20pt"&gt;2025&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:471.89pt;position:var(--position);text-decoration:none;white-space:pre;width:53.46pt"&gt; is as follows:&lt;/span&gt;&lt;div style="position:var(--position);text-align:justify;text-align-last:var(--justify);top:634.15pt;width:612pt"&gt;&lt;div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:0"&gt;&lt;td style="padding:0;width:207pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23.25pt"&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);width:142.5pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.75pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre"&gt;June 30,&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);width:142.5pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Six Months Ended&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre"&gt;June 30,&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:23.25pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.27pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;(in thousands, except per share amounts)&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:37.5pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Numerator:&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:51.75pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Net income&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:43.510000000000005pt;position:var(--position)"&gt;8,536&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:30.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;12,843&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:43.510000000000005pt;position:var(--position)"&gt;9,705&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:51.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:30.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;23,895&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:66pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Denominator:&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:80.25pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Weighted average shares - basic&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:80.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:30.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;339,277&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:80.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:30.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;356,623&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:80.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:30.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;339,839&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:80.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:30.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:33.51pt;position:var(--position)"&gt;367,847&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="position:var(--position);text-align:justify;text-align-last:var(--justify);top:45pt;width:612pt"&gt;&lt;div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:0"&gt;&lt;td style="padding:0;width:207pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:27.75pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:7.01pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:16.13pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Dilutive impact of stock options and restricted &lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:9pt;position:var(--position);top:17.81pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:20.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;stock units&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:17.81pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:43.510000000000005pt;position:var(--position)"&gt;8,781&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:17.81pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:48.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:51.010000000000005pt;position:var(--position)"&gt;536&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:17.81pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:43.510000000000005pt;position:var(--position)"&gt;4,837&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:17.81pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:48.38pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:51.010000000000005pt;position:var(--position)"&gt;498&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:27.75pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Weighted average shares - diluted&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:27.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:34.62pt;position:var(--position);text-decoration:none;white-space:pre"&gt;348,058&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:27.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:34.62pt;position:var(--position);text-decoration:none;white-space:pre"&gt;357,159&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:27.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:34.62pt;position:var(--position);text-decoration:none;white-space:pre"&gt;344,676&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:27.75pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:34.62pt;position:var(--position);text-decoration:none;white-space:pre"&gt;368,345&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:42pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:bold;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Earnings per share:&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:56.25pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Basic&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:56.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:48.510000000000005pt;position:var(--position)"&gt;0.03&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:56.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:48.510000000000005pt;position:var(--position)"&gt;0.04&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:56.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:48.510000000000005pt;position:var(--position)"&gt;0.03&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:56.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:48.510000000000005pt;position:var(--position)"&gt;0.06&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:70.5pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Diluted&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:70.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:48.510000000000005pt;position:var(--position)"&gt;0.02&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:70.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:48.510000000000005pt;position:var(--position)"&gt;0.04&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:70.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:48.510000000000005pt;position:var(--position)"&gt;0.03&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:70.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;$&lt;span style="display:inline-block;height:6.55pt;width:40.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:48.510000000000005pt;position:var(--position)"&gt;0.06&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-10" decimals="-3" id="f-498" unitRef="usd">8536000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-11" decimals="-3" id="f-499" unitRef="usd">12843000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-500" unitRef="usd">9705000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-12" decimals="-3" id="f-501" unitRef="usd">23895000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-10" decimals="-3" id="f-502" unitRef="shares">339277000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-11" decimals="-3" id="f-503" unitRef="shares">356623000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-3" id="f-504" unitRef="shares">339839000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-12" decimals="-3" id="f-505" unitRef="shares">367847000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-10" decimals="-3" id="f-506" unitRef="shares">8781000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-11" decimals="-3" id="f-507" unitRef="shares">536000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-1" decimals="-3" id="f-508" unitRef="shares">4837000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-12" decimals="-3" id="f-509" unitRef="shares">498000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-10" decimals="-3" id="f-510" unitRef="shares">348058000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-11" decimals="-3" id="f-511" unitRef="shares">357159000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-3" id="f-512" unitRef="shares">344676000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-12" decimals="-3" id="f-513" unitRef="shares">368345000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-10"
      decimals="2"
      id="f-514"
      unitRef="usdPerShare">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-11"
      decimals="2"
      id="f-515"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-516"
      unitRef="usdPerShare">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-12"
      decimals="2"
      id="f-517"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-10"
      decimals="2"
      id="f-518"
      unitRef="usdPerShare">0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-11"
      decimals="2"
      id="f-519"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-520"
      unitRef="usdPerShare">0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-12"
      decimals="2"
      id="f-521"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-522">&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:76.5pt;position:var(--position);text-decoration:none;white-space:pre;width:425.91pt"&gt;The following weighted average potentially dilutive shares are excluded from the computation of diluted &lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:502.41pt;position:var(--position);text-decoration:none;white-space:pre;width:50.98pt"&gt;earnings per&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"&gt; &lt;/span&gt;&lt;div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:151.55pt;width:612pt"&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:58.5pt;position:var(--position);text-decoration:none;white-space:pre;width:22.49pt"&gt;share&lt;/span&gt;&lt;span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:80.99pt;position:var(--position);text-decoration:none;white-space:pre;width:317.36pt"&gt; for the periods presented because including them would have been antidilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="position:var(--position);top:174.35pt;width:612pt"&gt;&lt;div style="font-size:0pt;left:58.5pt;position:var(--position);width:495pt"&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:0"&gt;&lt;td style="padding:0;width:207pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:3pt"&gt;&lt;/td&gt;&lt;td style="padding:0;width:69.75pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23.25pt"&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);width:142.5pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:31.75pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Three Months Ended&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre"&gt;June 30,&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);width:142.5pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:4.65pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:36.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Six Months Ended&lt;/span&gt;&lt;/div&gt;&lt;div style="line-height:8pt;position:var(--position);top:14.25pt;width:142.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:55.27pt;position:var(--position);text-decoration:none;white-space:pre"&gt;June 30,&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:23.25pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.27pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:italic;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:23.25pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:8pt;position:var(--position);top:5.25pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:8pt;font-style:normal;font-weight:bold;left:25.99pt;position:var(--position);text-decoration:none;white-space:pre"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14.25pt"&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="position:var(--position);top:37.5pt;width:207pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:207pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:2.63pt;position:var(--position);text-decoration:none;white-space:pre"&gt;Stock options and restricted stock units&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:207pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:39.62pt;position:var(--position);text-decoration:none;white-space:pre"&gt;39,720&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:279.75pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:39.62pt;position:var(--position);text-decoration:none;white-space:pre"&gt;57,042&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:352.5pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:39.62pt;position:var(--position);text-decoration:none;white-space:pre"&gt;42,808&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;font-size:0;text-align:left;vertical-align:top"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;font-size:0;text-align:left;vertical-align:top"&gt;&lt;div style="left:425.25pt;position:var(--position);top:37.5pt;width:69.75pt"&gt;&lt;div&gt;&lt;div style="line-height:9pt;position:var(--position);top:4.31pt;width:69.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;text-decoration:none;white-space:pre"&gt;&lt;span style="left:2.63pt;position:var(--position)"&gt;&lt;span style="display:inline-block;height:6.55pt;width:35.88pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="left:38.510000000000005pt;position:var(--position)"&gt;49,102&lt;span style="display:inline-block;height:6.55pt;width:2.99pt"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-131"
      decimals="-3"
      id="f-523"
      unitRef="shares">39720000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-132"
      decimals="-3"
      id="f-524"
      unitRef="shares">57042000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-133"
      decimals="-3"
      id="f-525"
      unitRef="shares">42808000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-134"
      decimals="-3"
      id="f-526"
      unitRef="shares">49102000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-10" id="f-527">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-10" id="f-528">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-10" id="f-529">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-10" id="f-530">false</ecd:NonRule10b51ArrTrmntdFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#f-264"
          xlink:label="f-264"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-282"
          xlink:label="f-282"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-261"
          xlink:label="f-261"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-262"
          xlink:label="f-262"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-263"
          xlink:label="f-263"
          xlink:type="locator"/>
        <link:footnote id="fn-1" xlink:label="fn-1" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:381.69pt">Repurchases of Class A common stock for the three months ended March 31, 2025 include </xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:476.19pt;position:var(--position);text-decoration:none;white-space:pre;width:46.57pt">20.0 million</xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:522.76pt;position:var(--position);text-decoration:none;white-space:pre;width:30.61pt"> shares</xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </xhtml:span><xhtml:div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:456.8pt;width:612pt"><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:458.86pt">repurchased from related parties (after giving effect to the automatic conversion of Class B common stock to Class</xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"> </xhtml:span></xhtml:div><xhtml:div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:467.6pt;width:612pt"><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:338pt">A common stock upon such repurchase) for an aggregate consideration of </xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:432.5pt;position:var(--position);text-decoration:none;white-space:pre;width:54.14pt">$84.9 million</xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:486.64pt;position:var(--position);text-decoration:none;white-space:pre;width:59.25pt">. See "Note </xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:545.89pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">9</xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:550.89pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </xhtml:span></xhtml:div><xhtml:div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:478.4pt;width:612pt"><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:81.18pt">Stockholders' Equity</xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:175.68pt;position:var(--position);text-decoration:none;white-space:pre;width:106.61pt">" for additional information.</xhtml:span></xhtml:div></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-264"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-282"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-261"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-262"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-263"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-321"
          xlink:label="f-321"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-324"
          xlink:label="f-324"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-322"
          xlink:label="f-322"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-320"
          xlink:label="f-320"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-316"
          xlink:label="f-316"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-317"
          xlink:label="f-317"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-319"
          xlink:label="f-319"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-323"
          xlink:label="f-323"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-315"
          xlink:label="f-315"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-318"
          xlink:label="f-318"
          xlink:type="locator"/>
        <link:footnote id="fn-2" xlink:label="fn-2" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:458.91pt">Prior to December 31, 2025, prescription reimbursement assets were presented as a component of prepaid</xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.4100000000001pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </xhtml:span><xhtml:div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:83.4pt;width:612pt"><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:144.47pt">expenses and other current assets, </xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:238.97pt;position:var(--position);text-decoration:none;white-space:pre;width:314.53pt">and prescription reimbursement liabilities as a component of accounts payable</xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </xhtml:span></xhtml:div><xhtml:div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:94.2pt;width:612pt"><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:201.92pt">and accrued expenses and other current liabilities</xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:296.41999999999996pt;position:var(--position);text-decoration:none;white-space:pre;width:257.08pt">. Prior period amounts have been reclassified to conform to the</xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.5pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </xhtml:span></xhtml:div><xhtml:div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:105pt;width:612pt"><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:458.87pt">current period presentation. These reclassifications had no impact on previously reported cash flows provided by</xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.37pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </xhtml:span></xhtml:div><xhtml:div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:115.8pt;width:612pt"><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:76.95pt">operating activities.</xhtml:span></xhtml:div></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-321"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-324"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-322"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-320"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-316"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-317"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-319"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-323"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-315"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-318"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-341"
          xlink:label="f-341"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-342"
          xlink:label="f-342"
          xlink:type="locator"/>
        <link:footnote id="fn-3" xlink:label="fn-3" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:202.45pt">Repurchases of Class A common stock for the </xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:296.95pt;position:var(--position);text-decoration:none;white-space:pre;width:139.98pt">six months ended June 30, 2025</xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:436.93pt;position:var(--position);text-decoration:none;white-space:pre;width:37.48pt"> include </xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:474.41pt;position:var(--position);text-decoration:none;white-space:pre;width:47.45pt">20.0 million</xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:521.86pt;position:var(--position);text-decoration:none;white-space:pre;width:31.49pt"> shares</xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.35pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </xhtml:span><xhtml:div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:137.4pt;width:612pt"><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:458.86pt">repurchased from related parties (after giving effect to the automatic conversion of Class B common stock to Class</xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.36pt;position:var(--position);text-decoration:none;white-space:pre;width:2.01pt"> </xhtml:span></xhtml:div><xhtml:div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:148.2pt;width:612pt"><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:338pt">A common stock upon such repurchase) for an aggregate consideration of </xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:432.5pt;position:var(--position);text-decoration:none;white-space:pre;width:54.14pt">$84.9 million</xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:486.64pt;position:var(--position);text-decoration:none;white-space:pre;width:59.25pt">. See "Note </xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:545.89pt;position:var(--position);text-decoration:none;white-space:pre;width:5pt">9</xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:550.89pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt">.</xhtml:span><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:553.39pt;position:var(--position);text-decoration:none;white-space:pre;width:2.5pt"> </xhtml:span></xhtml:div><xhtml:div style="font-size:12pt;line-height:9pt;position:var(--position);text-align:justify;text-align-last:var(--justify);top:159pt;width:612pt"><xhtml:span style="font-family:'Arial', sans-serif;font-size:9pt;font-style:normal;font-weight:normal;left:94.5pt;position:var(--position);text-decoration:none;white-space:pre;width:187.79pt">Stockholders' Equity" for additional information.</xhtml:span></xhtml:div></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-341"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-342"
          xlink:to="fn-3"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
